Citrus Sinensis ID: 010186
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 516 | 2.2.26 [Sep-21-2011] | |||||||
| Q9M0X5 | 675 | Cysteine-rich receptor-li | yes | no | 0.893 | 0.682 | 0.412 | 1e-99 | |
| Q8GYA4 | 669 | Cysteine-rich receptor-li | no | no | 0.874 | 0.674 | 0.417 | 1e-94 | |
| O65468 | 676 | Cysteine-rich receptor-li | no | no | 0.866 | 0.661 | 0.410 | 3e-91 | |
| Q8H199 | 658 | Cysteine-rich receptor-li | no | no | 0.821 | 0.644 | 0.392 | 1e-90 | |
| Q9LDT0 | 700 | Putative cysteine-rich re | no | no | 0.903 | 0.665 | 0.396 | 3e-88 | |
| Q8W4G6 | 627 | Cysteine-rich receptor-li | no | no | 0.881 | 0.725 | 0.387 | 3e-88 | |
| O65472 | 690 | Putative cysteine-rich re | no | no | 0.881 | 0.659 | 0.378 | 4e-88 | |
| O65479 | 666 | Putative cysteine-rich re | no | no | 0.914 | 0.708 | 0.407 | 7e-88 | |
| Q9ZP16 | 667 | Cysteine-rich receptor-li | no | no | 0.889 | 0.688 | 0.370 | 5e-87 | |
| O65476 | 662 | Putative cysteine-rich re | no | no | 0.852 | 0.664 | 0.397 | 5e-86 |
| >sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 364 bits (934), Expect = 1e-99, Method: Compositional matrix adjust.
Identities = 210/509 (41%), Positives = 298/509 (58%), Gaps = 48/509 (9%)
Query: 29 YNICSTSTAGSARASTIDDNLQNVLTSLASN--ANAAKFSNASFG--NDSDRVYGLYMCL 84
Y+IC +T S R S+ NL+ VL+SL+S A A+ F NA+ G NDS+RVYG+++C
Sbjct: 31 YHICPNTTTYS-RNSSYLTNLRTVLSSLSSPNAAYASLFDNAAAGEENDSNRVYGVFLCR 89
Query: 85 NYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNR 144
+SAE C DC+ A+ + + CP + A++W + C +RY+ Q+ GQ+ + + N+
Sbjct: 90 GDVSAEICRDCVAFAANETLQRCPREKVAVIWYDECMVRYSNQSIVGQMRIRPGVFLTNK 149
Query: 145 LNISEPERYRSVVNNTLSDLITKLSAFDPF--EMYATDEVPFTNSDTFYALVQCTKDLPA 202
NI+E + R N +L L+ ++ +AT++ FT T Y+LVQCT DL
Sbjct: 150 QNITENQVSR--FNESLPALLIDVAVKAALSSRKFATEKANFTVFQTIYSLVQCTPDLTN 207
Query: 203 DDCITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFY--------------KGATE 248
DC +CL + CC S G R+++ +C RYELY FY T
Sbjct: 208 QDCESCLRQVINYLPRCCDRSVGGRVIAPSCSFRYELYPFYNETIAAAPMAPPPSSTVTA 267
Query: 249 PSILAGNQASGGGKQRKMWMIIV-LASVVALLLVVFASTGYFFATKKITRKRKGTARKQI 307
P + N S GK + + +I+ +A V++ +++ + + A + R K +A +
Sbjct: 268 PPL---NIPSEKGKGKNLTVIVTAIAVPVSVCVLLLGAMCWLLARR---RNNKLSAETE- 320
Query: 308 QLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYK 367
L + G + +Q + AT+ FS+SN LG GGFG VYK
Sbjct: 321 DLDEDGITSTETLQFQ-----------------FSAIEAATNKFSESNKLGHGGFGEVYK 363
Query: 368 GVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427
G L G+ VA+KRLS S QG EF NEV ++ KLQH+NL KLLG+C+DG+EK+LVYEF+
Sbjct: 364 GQLITGETVAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFV 423
Query: 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD 487
PN SLD LFD KR +L W++R I+ GIA+G+LYLH DSRL I+HRDLKASN+LLD+D
Sbjct: 424 PNKSLDYFLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDAD 483
Query: 488 MNSKISDFGMARIFAESEGEANTVRIVGT 516
M+ KISDFGMARIF + +ANT RIVGT
Sbjct: 484 MHPKISDFGMARIFGVDQTQANTKRIVGT 512
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 347 bits (890), Expect = 1e-94, Method: Compositional matrix adjust.
Identities = 213/510 (41%), Positives = 293/510 (57%), Gaps = 59/510 (11%)
Query: 29 YNICSTSTAGSARASTIDDNLQNVLTSLAS-NAN-AAKFSNASFGNDSDRVYGLYMCLNY 86
Y+ C +TA ST ++NL+ +L SL+S NA+ + F NA+ G DRV GL+ C
Sbjct: 41 YHTCQ-NTANYTSNSTYNNNLKTLLASLSSRNASYSTGFQNATVGQAPDRVTGLFNCRGD 99
Query: 87 ISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNRLN 146
+S E C C++ A D CPN+ EA ++ + C LRY+ QN L +G + N N
Sbjct: 100 VSTEVCRRCVSFAVNDTLTRCPNQKEATLYYDECVLRYSNQNILSTLITTGGVILVNTRN 159
Query: 147 ISEPERYRSVVNNTLSDLI------TKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDL 200
++ + + LSDL+ A + + + T + FT +FY LVQCT DL
Sbjct: 160 VTSNQL------DLLSDLVLPTLNQAATVALNSSKKFGTRKNNFTALQSFYGLVQCTPDL 213
Query: 201 PADDCITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYKGATEPSIL-------- 252
DC CL I + GAR+++ +C RYE+YAFY TE ++
Sbjct: 214 TRQDCSRCLQLVINQIPT---DRIGARIINPSCTSRYEIYAFY---TESAVPPPPPPPSI 267
Query: 253 ------AGNQASGGGKQRKMWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQ 306
A ++ G + + + IV+ +VA+LL + GY F T++ ARK
Sbjct: 268 STPPVSAPPRSGKDGNSKVLVIAIVVPIIVAVLLFI---AGYCFLTRR--------ARKS 316
Query: 307 IQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVY 366
++ D+ A +D T+ AT +F +SN +GQGGFG VY
Sbjct: 317 -------------YYTPSAFAGDDITTADSLQLDYRTIQTATDDFVESNKIGQGGFGEVY 363
Query: 367 KGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426
KG LSDG EVAVKRLS S QG EF NEV+L+ KLQH+NLV+LLGFC+DG+E++LVYE+
Sbjct: 364 KGTLSDGTEVAVKRLSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEY 423
Query: 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS 486
+PN SLD LFDP K+G L W +R I+ G+A+G+LYLH+DSRL I+HRDLKASN+LLD+
Sbjct: 424 VPNKSLDYFLFDPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDA 483
Query: 487 DMNSKISDFGMARIFAESEGEANTVRIVGT 516
DMN KI+DFGMARIF + E NT RIVGT
Sbjct: 484 DMNPKIADFGMARIFGLDQTEENTSRIVGT 513
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65468|CRK8_ARATH Cysteine-rich receptor-like protein kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 336 bits (862), Expect = 3e-91, Method: Compositional matrix adjust.
Identities = 202/492 (41%), Positives = 284/492 (57%), Gaps = 45/492 (9%)
Query: 43 STIDDNLQNVLTSLAS-NAN-AAKFSNASFGNDSDRVYGLYMCLNYISAETCNDCITTAS 100
ST NL+ +L+S AS NA+ + F N G DRV GL++C +S E C++C+ +
Sbjct: 54 STYSTNLKTLLSSFASRNASYSTGFQNIRAGQTPDRVTGLFLCRGDLSPEVCSNCVAFSV 113
Query: 101 QDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNRLNISEPERYRSVVNNT 160
+ CPN+ EA+ + E C LRY+++NF + G + N NIS + R +
Sbjct: 114 NESLTRCPNQREAVFYYEECILRYSHKNFLSTVTYEGELIMRNPNNISSIQNQRDQFIDL 173
Query: 161 LSDLITKLS--AFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATADILS 218
+ + + + A + ++T + T+ T Y LVQCT DL DC +CL ++ ++
Sbjct: 174 VQSNMNQAANEAANSSRKFSTIKTELTSLQTLYGLVQCTPDLARQDCFSCLTSSINRMMP 233
Query: 219 CCYFSRGARLLSRNCYLRYELYAFY--------------KGATEPSILAGNQASGGGKQR 264
F GAR +C RYELYAFY G+T P G
Sbjct: 234 L--FRIGARQFWPSCNSRYELYAFYNETAIGTPSPPPLFPGSTPPLTSPSIPGKSGNSTV 291
Query: 265 KMWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQIQLHKIGDANDTDFHYQH 324
+ I+VLA ++ + LV GY F ++ T+K TA ++GD T
Sbjct: 292 LVVAIVVLAVLLFIALV-----GYCFLAQR-TKKTFDTASAS----EVGDDMAT------ 335
Query: 325 VQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC 384
A +D T+ AT++F++SN +G+GGFG VYKG S+GKEVAVKRLS
Sbjct: 336 ---------ADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKN 386
Query: 385 SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI 444
S QG AEF EV+++ KLQH+NLV+LLGF + G+E++LVYE+MPN SLD +LFDP K+
Sbjct: 387 SRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQ 446
Query: 445 LCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504
L W +R NI+ GIA+G+LYLH+DSRL I+HRDLKASN+LLD+D+N KI+DFGMARIF
Sbjct: 447 LDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLD 506
Query: 505 EGEANTVRIVGT 516
+ + NT RIVGT
Sbjct: 507 QTQDNTSRIVGT 518
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8H199|CRK14_ARATH Cysteine-rich receptor-like protein kinase 14 OS=Arabidopsis thaliana GN=CRK14 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 334 bits (856), Expect = 1e-90, Method: Compositional matrix adjust.
Identities = 196/499 (39%), Positives = 276/499 (55%), Gaps = 75/499 (15%)
Query: 52 VLTSLASNANA-AKFSNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQDISKLCPNK 110
+L+SL SN +A F N+S G DRVY L MC+ + C+DCI AS + C N+
Sbjct: 44 LLSSLPSNVSARGGFYNSSIGQGPDRVYALGMCIEGAEPDVCSDCIEYASNLLLDTCLNQ 103
Query: 111 TEAIVWEE---VCQLRYAYQNFFGQL------------DVSGNIPKYNRLNISEPERYRS 155
TE + W E +C +RY+ +FFG L D++ N+ +++++ E R
Sbjct: 104 TEGLAWPEKRILCMVRYSNSSFFGSLKAEPHFYIHNVDDITSNLTEFDQV---WEELARR 160
Query: 156 VVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATAD 215
++ +T S + + YA D T YAL+QCT DL +DC CL + D
Sbjct: 161 MIASTTSPSSKR-------KYYAADVAALTAFQIIYALMQCTPDLSLEDCHICLRQSVGD 213
Query: 216 ILSCCYFSRGARLLSRNCYLRYELYAFYKGATEPSILAGNQASG--------GGKQRK-- 265
+CC +G + +C R+EL+ F + + S+ Q+ +K
Sbjct: 214 YETCCNGKQGGIVYRASCVFRWELFPFSEAFSRISLAPPPQSPAFPTLPAVTNTATKKGS 273
Query: 266 -------MWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQIQLHKIGDANDT 318
+W II+ +V+ + LV+ A G+ + R+RK
Sbjct: 274 ITISIGIVWAIII-PTVIVVFLVLLA-LGFV-----VYRRRKS----------------- 309
Query: 319 DFHYQHVQGRDNDLK-AQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVA 377
QG D+ D + + AT+ FS+SNI+G+GGFG V+ GVL +G EVA
Sbjct: 310 ------YQGSSTDITITHSLQFDFKAIEDATNKFSESNIIGRGGFGEVFMGVL-NGTEVA 362
Query: 378 VKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILF 437
+KRLS S QG EF NEV+++ KL H+NLVKLLGFC++G+EK+LVYEF+PN SLD LF
Sbjct: 363 IKRLSKASRQGAREFKNEVVVVAKLHHRNLVKLLGFCLEGEEKILVYEFVPNKSLDYFLF 422
Query: 438 DPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497
DP K+G L W KR NI+ GI +G+LYLH+DSRL I+HRDLKASN+LLD+DMN KI+DFGM
Sbjct: 423 DPTKQGQLDWTKRYNIIRGITRGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGM 482
Query: 498 ARIFAESEGEANTVRIVGT 516
ARIF + ANT +I GT
Sbjct: 483 ARIFGIDQSGANTKKIAGT 501
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LDT0|CRK30_ARATH Putative cysteine-rich receptor-like protein kinase 30 OS=Arabidopsis thaliana GN=CRK30 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 326 bits (836), Expect = 3e-88, Method: Compositional matrix adjust.
Identities = 202/509 (39%), Positives = 278/509 (54%), Gaps = 43/509 (8%)
Query: 31 ICSTSTAGSARASTIDDNLQNVLTSLASNANAAK-FSNASFGNDSDRVYGLYMCLNYISA 89
+CS T D N + +L+SL S A F NAS G D D++Y + MC+
Sbjct: 26 LCSEKFGTFTPGGTFDKNRRIILSSLPSEVTAQDGFYNASIGTDPDQLYAMGMCIPGAKQ 85
Query: 90 ETCNDCITTASQDISKLCPNKTEAIVW----EEVCQLRYAYQNFFGQLDVSGNIPKYNRL 145
+ C DCI ++ + + CPN+T AI W + VC RY Q LD+ YN
Sbjct: 86 KLCRDCIMDVTRQLIQTCPNQTAAIHWSGGGKTVCMARYYNQPSSRPLDLESVSIGYNVG 145
Query: 146 NISEP-ERYRSVVNNTLSDLITKLSA-------FDPFEMYATDEVPFTNSDTFYALVQCT 197
N+S + + ++ ++TK S+ FD YA DE TNS YAL+QCT
Sbjct: 146 NLSTNLTDFDRLWERLIAHMVTKASSASIKYLSFDNSRFYAADETNLTNSQMVYALMQCT 205
Query: 198 KDLPADDCITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYKG------ATEPSI 251
D+ +C TCL + D + CC+ +G + +C R++LY F A PS
Sbjct: 206 PDVSPSNCNTCLKQSVDDYVGCCHGKQGGYVYRPSCIFRWDLYPFNGAFDLLTLAPPPSS 265
Query: 252 LAGNQASGGGKQRKMWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQIQLHK 311
+ K K I +++ +++VV ++ R +RK+ Q
Sbjct: 266 QLQSPPPVTNKDEK---TIHTGTIIGIVIVVAMVIIMALLALGVSVCR---SRKKYQAFA 319
Query: 312 IGDAND-TDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVL 370
A+D T Y +D + ATSNF SN +GQGGFG VYKG L
Sbjct: 320 SETADDITTVGYLQFDIKD--------------IEAATSNFLASNKIGQGGFGEVYKGTL 365
Query: 371 SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNG 430
S+G EVAVKRLS S+QG EF NEVLL+ KLQH+NLV+LLGF + G+EK+LV+EF+PN
Sbjct: 366 SNGTEVAVKRLSRTSDQGELEFKNEVLLVAKLQHRNLVRLLGFALQGEEKILVFEFVPNK 425
Query: 431 SLDAILF---DPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD 487
SLD LF +P K+G L W +R NI+ GI +G+LYLH+DSRL I+HRD+KASN+LLD+D
Sbjct: 426 SLDYFLFGSTNPTKKGQLDWTRRYNIIGGITRGLLYLHQDSRLTIIHRDIKASNILLDAD 485
Query: 488 MNSKISDFGMARIFAESEGEANTVRIVGT 516
MN KI+DFGMAR F + + E +T R+VGT
Sbjct: 486 MNPKIADFGMARNFRDHQTEDSTGRVVGT 514
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8W4G6|CRK15_ARATH Cysteine-rich receptor-like protein kinase 15 OS=Arabidopsis thaliana GN=CRK15 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 326 bits (835), Expect = 3e-88, Method: Compositional matrix adjust.
Identities = 196/506 (38%), Positives = 285/506 (56%), Gaps = 51/506 (10%)
Query: 30 NICSTSTAGSARASTIDDNLQNVLTSL-ASNAN-AAKFSNASFGNDSDRVYGLYMCLNYI 87
+IC +T S R S NL+ +L+SL A NA+ + F +A G DRV GL++C +
Sbjct: 29 HICPNTTTYS-RNSPYLTNLRTLLSSLSAPNASYSTGFQSARAGQAPDRVTGLFLCRGDV 87
Query: 88 SAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYN---R 144
S C +C+ + D CP++ +++ + + C LRY+ QN L G + N
Sbjct: 88 SPAVCRNCVAFSINDTLVQCPSERKSVFYYDECMLRYSDQNILSTLAYDGAWIRMNGNIS 147
Query: 145 LNISEPERYRSVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADD 204
++ ++ R++ V++T++ K +A P + Y T + +T T Y LVQCT DL D
Sbjct: 148 IDQNQMNRFKDFVSSTMNQAAVK-AASSPRKFY-TVKATWTALQTLYGLVQCTPDLTRQD 205
Query: 205 CITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYKGATEPSILA--------GNQ 256
C +CL ++ I + G R L +C RYEL+AFY T + A
Sbjct: 206 CFSCLESS---IKLMPLYKTGGRTLYSSCNSRYELFAFYNETTVRTQQAPPPLPPSSTPL 262
Query: 257 ASGGGKQRKMW------MIIVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQIQLH 310
+ K W + IVL +VA LL++ GY FA
Sbjct: 263 VTSPSLPGKSWNSNVLVVAIVLTILVAALLLI---AGYCFA------------------K 301
Query: 311 KIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVL 370
++ +++D + +D+ + +D + AT+ FS++N +GQGGFG VYKG
Sbjct: 302 RVKNSSDNAPAFD-----GDDITTESLQLDYRMIRAATNKFSENNKIGQGGFGEVYKGTF 356
Query: 371 SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNG 430
S+G EVAVKRLS S QG EF NEV+++ KLQH+NLV+LLGF + G E++LVYE+MPN
Sbjct: 357 SNGTEVAVKRLSKSSGQGDTEFKNEVVVVAKLQHRNLVRLLGFSIGGGERILVYEYMPNK 416
Query: 431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS 490
SLD LFDP K+ L W +R ++ GIA+G+LYLH+DSRL I+HRDLKASN+LLD+DMN
Sbjct: 417 SLDYFLFDPAKQNQLDWTRRYKVIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNP 476
Query: 491 KISDFGMARIFAESEGEANTVRIVGT 516
K++DFG+ARIF + + NT RIVGT
Sbjct: 477 KLADFGLARIFGMDQTQENTSRIVGT 502
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65472|CRK12_ARATH Putative cysteine-rich receptor-like protein kinase 12 OS=Arabidopsis thaliana GN=CRK12 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 325 bits (834), Expect = 4e-88, Method: Compositional matrix adjust.
Identities = 196/518 (37%), Positives = 271/518 (52%), Gaps = 63/518 (12%)
Query: 43 STIDDNLQNVLTSLASNANAA-KFSNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQ 101
ST D N + +L+ L SN + F N S G +RVY + MCL E+C C+ +AS
Sbjct: 34 STYDTNRRVILSLLPSNVTSHFGFFNGSIGQAPNRVYAVGMCLPGTEEESCIGCLLSASN 93
Query: 102 DISKLCPNKTEAIVW---EEVCQLRYAYQNFFGQLDVSGNIPKYNRLNISEPERYRSVVN 158
+ + C + A++W +C +RY+ +F G ++ P L+I + + N
Sbjct: 94 TLLETCLTEENALIWIANRTICMIRYSDTSFVGSFELE---PHREFLSIHGYKTNETEFN 150
Query: 159 NTLSDLITKL---------SAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADDCITCL 209
S L ++ + + + Y D +S T YA++QCT DL +C CL
Sbjct: 151 TVWSRLTQRMVQEASSSTDATWSGAKYYTADVAALPDSQTLYAMMQCTPDLSPAECNLCL 210
Query: 210 HNATADILSCCYFSRGARLLSRNCYLRYELYAFYKGAT----------EPSILAGNQASG 259
+ + SCC +G ++ +C R ELY F T PS++ +
Sbjct: 211 TESVVNYQSCCLGRQGGSIVRLSCAFRAELYPFGGAFTVMTARPLSQPPPSLIKKGEFFA 270
Query: 260 ---GGKQRKMWMIIVLASVVALLLVVFASTGYF------------------FATKKITRK 298
Q + MI L VV L+ F +G F F + +
Sbjct: 271 KFMSNSQEPVKMIQNLYVVV--LIFYFLDSGKFSTETIAAIVVPIIVVAIIFLVLLVLSR 328
Query: 299 RKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILG 358
RK Q + + T H+Q +D +T+ +AT NF+ +N LG
Sbjct: 329 LFARRRKSYQEIDLDQSGITTLHFQQ--------------LDFKTIEVATENFAKTNKLG 374
Query: 359 QGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD 418
QGGFG VYKG L +G EVAVKRLS SEQG EF NEV+L+ KLQH+NLVKLLG+C++ +
Sbjct: 375 QGGFGEVYKGTLVNGTEVAVKRLSKTSEQGAQEFKNEVVLVAKLQHRNLVKLLGYCLEPE 434
Query: 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLK 478
EK+LVYEF+PN SLD LFDP K+G L W KR NI+ GI +G+LYLH+DSRL I+HRDLK
Sbjct: 435 EKILVYEFVPNKSLDYFLFDPTKQGQLDWTKRYNIIGGITRGILYLHQDSRLTIIHRDLK 494
Query: 479 ASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
ASN+LLD+DM KI+DFGMARI + ANT RI GT
Sbjct: 495 ASNILLDADMIPKIADFGMARISGIDQSVANTKRIAGT 532
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65479|CRK20_ARATH Putative cysteine-rich receptor-like protein kinase 20 OS=Arabidopsis thaliana GN=CRK20 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 325 bits (832), Expect = 7e-88, Method: Compositional matrix adjust.
Identities = 202/496 (40%), Positives = 281/496 (56%), Gaps = 24/496 (4%)
Query: 29 YNICSTSTAGSARASTIDDNLQNVLTSLAS-NAN-AAKFSNASFGNDSDRVYGLYMCLNY 86
Y+ CS +T S+ ST NL+ +L+SL+S NA+ + F NA+ G D V GL++C
Sbjct: 30 YHNCSITTTYSSN-STYSTNLKTLLSSLSSRNASYSTGFQNATAGQAPDMVTGLFLCRGN 88
Query: 87 ISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNRLN 146
+S E C CI + + CPN+ EA+ + E C LRY+ +N L+ G + N N
Sbjct: 89 VSPEVCRSCIALSVNESLSRCPNEREAVFYYEQCMLRYSNRNILSTLNTDGGVFMQNARN 148
Query: 147 -IS-EPERYRSVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADD 204
IS + +R+R +V N ++ + + A + +A + + Y +VQCT DL D
Sbjct: 149 PISVKQDRFRDLVLNPMN--LAAIEAARSIKRFAVTKFDLNALQSLYGMVQCTPDLTEQD 206
Query: 205 CITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYK--GATEPSILAGNQASGGGK 262
C+ CL + I Y G R +C RY+ Y FY P + GG
Sbjct: 207 CLDCLQQS---INQVTYDKIGGRTFLPSCTSRYDNYEFYNEFNVGTPQDSSPRPGKGGNS 263
Query: 263 QRKMWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQIQLHKIGDANDTDFHY 322
+ ++V +V+ LL V F F+ ++ RK+ A I L K+ +T+
Sbjct: 264 SVIVIAVVVPITVLFLLFVAF------FSVRRAKRKKTIGA---IPLFKV-KRKETEVTE 313
Query: 323 QHVQGRDND--LKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKR 380
+ D D A D + + AT F N LGQGGFG VYKG G +VAVKR
Sbjct: 314 PPAETTDGDDITTAGSLQFDFKAIVAATDIFLPINKLGQGGFGEVYKGTFPSGVQVAVKR 373
Query: 381 LSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR 440
LS S QG EF NEV+++ KLQH+NLVKLLG+C++G+EK+LVYEF+PN SLD LFDP
Sbjct: 374 LSKNSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDYFLFDPT 433
Query: 441 KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500
+G L W +R I+ GIA+G+LYLH+DSRL I+HRDLKA N+LLD+DMN K++DFGMARI
Sbjct: 434 MQGQLDWSRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARI 493
Query: 501 FAESEGEANTVRIVGT 516
F + EANT R+VGT
Sbjct: 494 FGMDQTEANTRRVVGT 509
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9ZP16|CRK11_ARATH Cysteine-rich receptor-like protein kinase 11 OS=Arabidopsis thaliana GN=CRK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 322 bits (825), Expect = 5e-87, Method: Compositional matrix adjust.
Identities = 191/515 (37%), Positives = 280/515 (54%), Gaps = 56/515 (10%)
Query: 32 CSTSTAGSARASTIDDNLQNVLTSLASNANAAK--FSNASFGNDSDRVYGLYMCLNYISA 89
C+T T D N + +L+SL SN + N S G +RVY + MC+ ++
Sbjct: 27 CTTDKGTFRPNGTYDVNRRLILSSLPSNVTDQDGLYYNGSIGQQPNRVYAIGMCIPGSTS 86
Query: 90 ETCNDCITTASQDISKLCPNKTEAIVWE---EVCQLRYAYQNFFGQLDVSGNIPKYNRLN 146
E C+DCI S+ K CPN+TEA W +C +RY+ +F G D++ N +
Sbjct: 87 EDCSDCIKKESEFFLKNCPNQTEAYSWPGEPTLCYVRYSNTSFSGSADLNPRNWLTNTGD 146
Query: 147 I-SEPERYRSVVNNTLSDLIT-----KLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDL 200
+ S + + + +I+ K + Y+ D T YAL+QCT DL
Sbjct: 147 LDSNLTEFTKIWEGLMGRMISAASTAKSTPSSSDNHYSADSAVLTPLLNIYALMQCTPDL 206
Query: 201 PADDCITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYKGATEPSI--------- 251
+ DC CL + D SCC RG ++ +C+LR++LY + ++
Sbjct: 207 SSGDCENCLRQSAIDYQSCCSQKRGGVVMRPSCFLRWDLYTYSNAFDNLTVASPPPEPPV 266
Query: 252 ----LAGNQASGGGKQRK-----MWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGT 302
AG+Q + K + + I + +V+A+L+++ F R+RK
Sbjct: 267 TVPQPAGDQDNPTNNDSKGISAGVVVAITVPTVIAILILLVLGFVLF-------RRRKSY 319
Query: 303 ARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFI-DLETLNLATSNFSDSNILGQGG 361
R + + ++D+ D + D +T+ AT+ FS SN LG+GG
Sbjct: 320 QRTKTE-------------------SESDISTTDSLVYDFKTIEAATNKFSTSNKLGEGG 360
Query: 362 FGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421
FG VYKG LS+G +VAVKRLS S QGT EF NE +L+ KLQH+NLV+LLGFC++ +E++
Sbjct: 361 FGAVYKGKLSNGTDVAVKRLSKKSGQGTREFRNEAVLVTKLQHRNLVRLLGFCLEREEQI 420
Query: 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASN 481
L+YEF+ N SLD LFDP K+ L W +R I+ GIA+G+LYLH+DSRL+I+HRDLKASN
Sbjct: 421 LIYEFVHNKSLDYFLFDPEKQSQLDWTRRYKIIGGIARGILYLHQDSRLKIIHRDLKASN 480
Query: 482 VLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
+LLD+DMN KI+DFG+A IF + + NT RI GT
Sbjct: 481 ILLDADMNPKIADFGLATIFGVEQTQGNTNRIAGT 515
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65476|CRK16_ARATH Putative cysteine-rich receptor-like protein kinase 16 OS=Arabidopsis thaliana GN=CRK16 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 318 bits (816), Expect = 5e-86, Method: Compositional matrix adjust.
Identities = 195/490 (39%), Positives = 274/490 (55%), Gaps = 50/490 (10%)
Query: 46 DDNLQNVLTSLASNANA-AKFSNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQDIS 104
D N +L+SLASN +A F NAS G DR+Y C+ E C+ CI +A +
Sbjct: 42 DINRHLLLSSLASNVSARGGFYNASIGQGPDRLYASGTCIQGSEPELCSACIDSAFIRVI 101
Query: 105 KLCPNKTEAIVW-----EEVCQLRYAYQNFFGQLDVSGNIPKYN----RLNISE-PERYR 154
K C N+TEA+ W E C +RY+ ++FFG L+++ YN ++N++E +++
Sbjct: 102 KKCHNQTEALDWSSFNEEYPCMIRYSNRSFFGLLEMTPFFKNYNATDFQVNLTEFYQKWE 161
Query: 155 SVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADDCITCLH-NAT 213
+++ ++D I+ S F T ++ T YA V C+KD+ +C CL N
Sbjct: 162 ALMLGVIADAIS--SPNPKFYGAGTGKI---GIQTVYAFVLCSKDISPWNCSRCLRGNVD 216
Query: 214 ADILSCCYFSRGARLLSRNCYLRYELYAFY---KGATEPSILAG----NQASGGGKQRKM 266
LSC RG S +CY+R++LY FY + P++ ++ S G +
Sbjct: 217 NYKLSCSGKPRGHSF-SPSCYMRWDLYQFYGFIEYRASPTLPREKGRISELSDDGGKIST 275
Query: 267 WMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQIQLHKIGDANDTDFHYQHVQ 326
I+ + +A + V GY ++R+RK YQ
Sbjct: 276 RNILGITVALAFFITVLLVLGY-----ALSRRRKA--------------------YQEFA 310
Query: 327 GRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSE 386
++ + D + + AT+NF SN LG GGFG V+KG +G EVAVKRLS S
Sbjct: 311 TENDITTSGSLQFDFKAIEAATNNFQKSNKLGHGGFGEVFKGTFPNGTEVAVKRLSKISG 370
Query: 387 QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILC 446
QG EF NEVLL+ KLQH+NLV+LLGF V+G+EK+LVYE+MPN SLD LFD R+RG L
Sbjct: 371 QGEEEFKNEVLLVAKLQHRNLVRLLGFSVEGEEKILVYEYMPNKSLDYFLFDHRRRGQLD 430
Query: 447 WRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506
WR R NI+ G+ +G+LYLH+DSRL I+HRDLKA N+LLD DMN KI+DFG+AR F +
Sbjct: 431 WRTRYNIIRGVTRGILYLHQDSRLTIIHRDLKAGNILLDVDMNPKIADFGVARNFRVDQT 490
Query: 507 EANTVRIVGT 516
EA T R+VGT
Sbjct: 491 EATTGRVVGT 500
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 516 | ||||||
| 302144055 | 698 | unnamed protein product [Vitis vinifera] | 0.988 | 0.730 | 0.564 | 1e-156 | |
| 224076497 | 591 | predicted protein [Populus trichocarpa] | 0.905 | 0.790 | 0.570 | 1e-156 | |
| 359483378 | 678 | PREDICTED: cysteine-rich receptor-like p | 0.988 | 0.752 | 0.564 | 1e-156 | |
| 255555023 | 648 | ATP binding protein, putative [Ricinus c | 0.949 | 0.756 | 0.553 | 1e-154 | |
| 356540317 | 647 | PREDICTED: cysteine-rich receptor-like p | 0.891 | 0.710 | 0.576 | 1e-147 | |
| 357480739 | 644 | Cysteine-rich receptor-like protein kina | 0.922 | 0.739 | 0.541 | 1e-140 | |
| 224113911 | 657 | predicted protein [Populus trichocarpa] | 0.947 | 0.744 | 0.524 | 1e-139 | |
| 224113923 | 452 | predicted protein [Populus trichocarpa] | 0.872 | 0.995 | 0.537 | 1e-134 | |
| 359496581 | 666 | PREDICTED: cysteine-rich receptor-like p | 0.903 | 0.699 | 0.432 | 1e-110 | |
| 302144056 | 687 | unnamed protein product [Vitis vinifera] | 0.914 | 0.687 | 0.432 | 1e-106 |
| >gi|302144055|emb|CBI23160.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 558 bits (1437), Expect = e-156, Method: Compositional matrix adjust.
Identities = 296/524 (56%), Positives = 365/524 (69%), Gaps = 14/524 (2%)
Query: 2 VHKAIQLILIYCLTANLHDLAFGDSPPYNICSTSTAGSARASTIDDNLQNVLTSLASNAN 61
V KAIQL+ I + + DL D PPYN+CST+T S NL+N+L SL S A
Sbjct: 31 VSKAIQLLFISSVLSGFPDLVCAD-PPYNVCSTTTTYGLN-SLFQSNLENLLDSLPSKAF 88
Query: 62 AAKFSNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQ 121
+ F N S GN DRV G ++CLNY++ + C +CI+TA+ + KLCPN EAIVWE+ CQ
Sbjct: 89 VSHFDNTSIGNGLDRVNGAFLCLNYVANDQCRNCISTAAYHVKKLCPNMNEAIVWEDECQ 148
Query: 122 LRYAYQNFFGQLDVSGNIPKYNRLNISEPE----RYRSVVNNTLSDLITKLSAFDPFEMY 177
+ Y+ + F G L +GNIP N N+S+ E R+RSVVN+TL +LI + + +MY
Sbjct: 149 ILYSNETFLGHLSTTGNIPLDNMKNVSDLESEQLRFRSVVNDTLQNLIKQAAFNSSTDMY 208
Query: 178 ATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATADILSCCYFSRGARLLSRNCYLRY 237
AT V FT+ D YALVQCT DL D+C CL AT +IL+ YFSRGARLLSR+CYLRY
Sbjct: 209 ATKPVVFTDVDILYALVQCTPDLSPDNCSICLQTATTEILAVYYFSRGARLLSRSCYLRY 268
Query: 238 ELYAFYKGATEPSILAGNQASGGGK--QRKMWMIIVLASV-VALLLVVFASTGYFFATKK 294
E Y FY+ ATEP Q G K +RK MI+++ SV V+L++ A Y AT+
Sbjct: 269 EFYPFYEVATEPQAPVSPQNPGTRKDGRRKTGMILIITSVSVSLVVATLAFYVYCLATRN 328
Query: 295 ITRK-RKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDF-FIDLETLNLATSNFS 352
+K RK +++QL I D + T + H GR + L +Q+F FIDL T++ AT NFS
Sbjct: 329 GKKKERKQYLNREVQLPDIDDPSYTGPYQFH--GRKS-LNSQEFLFIDLATIHEATDNFS 385
Query: 353 DSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
+ N LGQGGFGPVYKGVL DGKEVAVKRLSS SEQG+ EFTNEVLLI+KLQHKNLV+LLG
Sbjct: 386 ELNKLGQGGFGPVYKGVLRDGKEVAVKRLSSDSEQGSEEFTNEVLLIMKLQHKNLVRLLG 445
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
FCVD +E++LVYE+MPN SLD LFDPR+R L W +R NI+ GIA+G+LYLHEDSRLRI
Sbjct: 446 FCVDREERMLVYEYMPNSSLDVFLFDPRRRAQLDWSRRLNIIGGIARGILYLHEDSRLRI 505
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
+HRDLKASNVLLD DM KISDFGMARIF SEGEANT IVGT
Sbjct: 506 IHRDLKASNVLLDCDMKPKISDFGMARIFGGSEGEANTATIVGT 549
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224076497|ref|XP_002304952.1| predicted protein [Populus trichocarpa] gi|222847916|gb|EEE85463.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 557 bits (1436), Expect = e-156, Method: Compositional matrix adjust.
Identities = 291/510 (57%), Positives = 349/510 (68%), Gaps = 43/510 (8%)
Query: 8 LILIYCLTANLHDLAFGDSPPYNICSTSTAGSARASTIDDNLQNVLTSLASNANAAKFSN 67
++L+Y ANL DLA+ D PPY +CS + S +NL+ ++ SL+SNA+ +K N
Sbjct: 1 ILLLYFSIANLLDLAYAD-PPYRLCSNKS-NYIDNSPFQNNLETLMASLSSNASVSKIFN 58
Query: 68 ASFGNDSDRVYGLYMCLNYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQ 127
S G D DRVY YMCLNY++ E+C C+ ASQDI +LCP +A+VWEE+CQLRY+ Q
Sbjct: 59 TSTGIDPDRVYAQYMCLNYVTNESCRTCVAAASQDIRQLCPGDKKAVVWEELCQLRYSNQ 118
Query: 128 NFFGQLDVSGNIPKYNRLNISEPERYRSVVNNTLSDLITKLSAFDP-FEMYATDEVPFTN 186
F G LDVSGN+P+YN NIS PE VVN LS LI K +AFDP MYAT + PFT+
Sbjct: 119 RFLGHLDVSGNVPQYNPKNISNPEHLSLVVNKILSSLIKK-AAFDPSANMYATRDEPFTD 177
Query: 187 SDTFYALVQCTKDLPADDCITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYKGA 246
SD+F++LVQC+ DL +DC TCL A ++ +CCYFSRGAR+LSR+CYLRYELY FY GA
Sbjct: 178 SDSFFSLVQCSTDLSPNDCYTCLEVAVKNVTTCCYFSRGARVLSRSCYLRYELYDFYDGA 237
Query: 247 TEPSILAGNQASGGGKQRKMWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQ 306
TE S + +G G LL I + R G R
Sbjct: 238 TESS---KSPVTGKGTN---------------LL--------------IDQLRHGKFRV- 264
Query: 307 IQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVY 366
N DF Q Q RD + +DL ++N AT NFS++N+LGQGGFGPVY
Sbjct: 265 -----FDHPNHNDFQNQDFQ-RDGLNDRESAIMDLASINAATDNFSETNLLGQGGFGPVY 318
Query: 367 KGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426
KG+LSDGKEVAVKRLS SEQG EFTNEVLLI+KLQHKNLVKLLGFCVDG+EKLLVYEF
Sbjct: 319 KGILSDGKEVAVKRLSDSSEQGKNEFTNEVLLIMKLQHKNLVKLLGFCVDGEEKLLVYEF 378
Query: 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS 486
MPN SLD +LFDPRK L WR R +I+NGIAKG LYLHEDSRLRI+HRDLKASN+LLD+
Sbjct: 379 MPNNSLDVVLFDPRKGAQLSWRSRIHIINGIAKGTLYLHEDSRLRIIHRDLKASNILLDN 438
Query: 487 DMNSKISDFGMARIFAESEGEANTVRIVGT 516
+MN KISDFGMARI +EGEANTVRI GT
Sbjct: 439 NMNPKISDFGMARIMEANEGEANTVRIAGT 468
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483378|ref|XP_002265659.2| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 557 bits (1435), Expect = e-156, Method: Compositional matrix adjust.
Identities = 296/524 (56%), Positives = 365/524 (69%), Gaps = 14/524 (2%)
Query: 2 VHKAIQLILIYCLTANLHDLAFGDSPPYNICSTSTAGSARASTIDDNLQNVLTSLASNAN 61
V KAIQL+ I + + DL D PPYN+CST+T S NL+N+L SL S A
Sbjct: 6 VSKAIQLLFISSVLSGFPDLVCAD-PPYNVCSTTTTYGLN-SLFQSNLENLLDSLPSKAF 63
Query: 62 AAKFSNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQ 121
+ F N S GN DRV G ++CLNY++ + C +CI+TA+ + KLCPN EAIVWE+ CQ
Sbjct: 64 VSHFDNTSIGNGLDRVNGAFLCLNYVANDQCRNCISTAAYHVKKLCPNMNEAIVWEDECQ 123
Query: 122 LRYAYQNFFGQLDVSGNIPKYNRLNISEPE----RYRSVVNNTLSDLITKLSAFDPFEMY 177
+ Y+ + F G L +GNIP N N+S+ E R+RSVVN+TL +LI + + +MY
Sbjct: 124 ILYSNETFLGHLSTTGNIPLDNMKNVSDLESEQLRFRSVVNDTLQNLIKQAAFNSSTDMY 183
Query: 178 ATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATADILSCCYFSRGARLLSRNCYLRY 237
AT V FT+ D YALVQCT DL D+C CL AT +IL+ YFSRGARLLSR+CYLRY
Sbjct: 184 ATKPVVFTDVDILYALVQCTPDLSPDNCSICLQTATTEILAVYYFSRGARLLSRSCYLRY 243
Query: 238 ELYAFYKGATEPSILAGNQASGGGK--QRKMWMIIVLASV-VALLLVVFASTGYFFATKK 294
E Y FY+ ATEP Q G K +RK MI+++ SV V+L++ A Y AT+
Sbjct: 244 EFYPFYEVATEPQAPVSPQNPGTRKDGRRKTGMILIITSVSVSLVVATLAFYVYCLATRN 303
Query: 295 ITRK-RKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDF-FIDLETLNLATSNFS 352
+K RK +++QL I D + T + H GR + L +Q+F FIDL T++ AT NFS
Sbjct: 304 GKKKERKQYLNREVQLPDIDDPSYTGPYQFH--GRKS-LNSQEFLFIDLATIHEATDNFS 360
Query: 353 DSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
+ N LGQGGFGPVYKGVL DGKEVAVKRLSS SEQG+ EFTNEVLLI+KLQHKNLV+LLG
Sbjct: 361 ELNKLGQGGFGPVYKGVLRDGKEVAVKRLSSDSEQGSEEFTNEVLLIMKLQHKNLVRLLG 420
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
FCVD +E++LVYE+MPN SLD LFDPR+R L W +R NI+ GIA+G+LYLHEDSRLRI
Sbjct: 421 FCVDREERMLVYEYMPNSSLDVFLFDPRRRAQLDWSRRLNIIGGIARGILYLHEDSRLRI 480
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
+HRDLKASNVLLD DM KISDFGMARIF SEGEANT IVGT
Sbjct: 481 IHRDLKASNVLLDCDMKPKISDFGMARIFGGSEGEANTATIVGT 524
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555023|ref|XP_002518549.1| ATP binding protein, putative [Ricinus communis] gi|223542394|gb|EEF43936.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 551 bits (1420), Expect = e-154, Method: Compositional matrix adjust.
Identities = 284/513 (55%), Positives = 358/513 (69%), Gaps = 23/513 (4%)
Query: 4 KAIQLILIYCLTANLHDLAFGDSPPYNICSTSTAGSARASTIDDNLQNVLTSLASNANAA 63
K + +L+ L + D A+ D PPY +C +A +NL+N+L SL SNA+
Sbjct: 9 KIFEFLLLCFLVGSFLDFAYAD-PPYLLCPNINNQAANI-PFQNNLKNLLLSLPSNASGL 66
Query: 64 KFSNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLR 123
K ++S GN++D+VY YMCLNY++++ C+ CI TAS+DI + C N EAIVWEEVCQLR
Sbjct: 67 KVFDSSIGNNTDKVYSQYMCLNYVTSDKCSSCIQTASEDIKQSCANSAEAIVWEEVCQLR 126
Query: 124 YAYQNFFGQLDVSGNIPKYNRLNISEPERYRSVVNNTLSDLITKLSAFDPFEMYATDEVP 183
Y+ Q+F G LDVSGN N NIS P+++RS+VN T+S LI K + + MYAT E
Sbjct: 127 YSNQSFLGHLDVSGNQFYDNEKNISNPDQFRSLVNQTVSGLIKKAAFNNSVNMYATGEAA 186
Query: 184 FTNSDTFYALVQCTKDLPADDCITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFY 243
FT+++ YALVQCT DL +DDC TCL A A++ SCCYFSRGARLLSR+CYLRYELYAFY
Sbjct: 187 FTSTEKLYALVQCTTDLSSDDCSTCLQVALANLSSCCYFSRGARLLSRSCYLRYELYAFY 246
Query: 244 KGATEPSILAGNQASGGGKQRKMWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTA 303
KG A NQ +G KQ K WMI L + A+L+V+ S+ F ++ + +
Sbjct: 247 KGENGDPASAQNQGTGKSKQTKTWMIAFLTATTAILVVLALSS--FIYSRSMKK------ 298
Query: 304 RKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFG 363
++ F Q G+D + F+D +++ AT NF +SN+LGQGGFG
Sbjct: 299 ------------DNPAFQNQSFHGKDGLSAKESGFMDFASIHAATDNFCESNLLGQGGFG 346
Query: 364 PVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423
PVYKG+LSDGKE+AVKRL++CSEQG EF E+ LI+KLQHKNLV+LLGFC DG+EKLLV
Sbjct: 347 PVYKGILSDGKEIAVKRLATCSEQGIEEFKTEIQLIMKLQHKNLVRLLGFCFDGEEKLLV 406
Query: 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVL 483
YEFMPN SLD ILFDPRKR L W KR NI+NGIAKG+LYLHEDSRLRI+HRDLK SN+L
Sbjct: 407 YEFMPNSSLDVILFDPRKRAQLDWCKRINIINGIAKGILYLHEDSRLRIIHRDLKPSNIL 466
Query: 484 LDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
LD++MN KISDFG ARIF SEGEANT R+VGT
Sbjct: 467 LDNEMNPKISDFGTARIFG-SEGEANTCRVVGT 498
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356540317|ref|XP_003538636.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 528 bits (1359), Expect = e-147, Method: Compositional matrix adjust.
Identities = 287/498 (57%), Positives = 358/498 (71%), Gaps = 38/498 (7%)
Query: 21 LAFGDSPPYNICSTSTAGSARASTIDDNLQNVLTSLASNANAAKFSN-ASFGNDSDRVYG 79
+ F D PPY ICSTS++ A+ S+ ++NL N+L+SL+S A+ KF N +S+G DRVYG
Sbjct: 37 VVFAD-PPYYICSTSSS-FAKGSSFENNLTNLLSSLSSIASNYKFYNTSSYGIGPDRVYG 94
Query: 80 LYMCLNYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNI 139
LYMCL+YI+ E+C CITTA++DI KLCP TEA+VWEE+CQLRY+ NF G L+V+GNI
Sbjct: 95 LYMCLDYITNESCKTCITTATEDIVKLCPRATEAVVWEELCQLRYSNSNFMGMLNVTGNI 154
Query: 140 PKYNRLNISEPERYRSVVNNTLSDLITKLSAFD-PFEMYATDEVPFTNSDTFYALVQCTK 198
N+ N+SEPE++ S VN T+S+L TK+++F MYAT EVPF + +T YALVQCT+
Sbjct: 155 GLDNKQNLSEPEKFESAVNQTISNL-TKVASFGVSANMYATGEVPFED-ETIYALVQCTR 212
Query: 199 DLPADDCITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYKGATEPSILAGNQAS 258
DL A DC CL +A DI CCY S G R+LSR+CYLRYE YAFY GAT P+ + +
Sbjct: 213 DLTASDCSRCLQSAIGDIPGCCYASIGGRVLSRSCYLRYEFYAFYHGATGPTDSSIGKKE 272
Query: 259 GGGKQRKMWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQIQLHKIGDANDT 318
G K+W+I + VV L++V F F + KRK ++ I H+I
Sbjct: 273 GENNSSKIWVITGIIVVVGLVIVFF-----IFGLYLVRNKRKRQSKNGIDNHQI------ 321
Query: 319 DFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAV 378
+L +L +AT+NFSD N LGQGGFGPVYKG LSDG+EVA+
Sbjct: 322 ---------------------NLGSLRVATNNFSDLNKLGQGGFGPVYKGKLSDGQEVAI 360
Query: 379 KRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD 438
KRLS+CSEQG+ EF NEVLLI++LQHKNLVKLLGFCVDG+EKLLVYEF+PNGSLD +LFD
Sbjct: 361 KRLSTCSEQGSEEFINEVLLIMQLQHKNLVKLLGFCVDGEEKLLVYEFLPNGSLDVVLFD 420
Query: 439 PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498
P +R L W KR +I+NGIA+G+LYLHEDSRL+I+HRDLKASN+LLD DMN KISDFGMA
Sbjct: 421 PNQRERLDWTKRLDIINGIARGILYLHEDSRLKIIHRDLKASNILLDYDMNPKISDFGMA 480
Query: 499 RIFAESEGEANTVRIVGT 516
RIFA SEGEANT IVGT
Sbjct: 481 RIFAGSEGEANTATIVGT 498
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357480739|ref|XP_003610655.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355511990|gb|AES93613.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 503 bits (1296), Expect = e-140, Method: Compositional matrix adjust.
Identities = 286/528 (54%), Positives = 354/528 (67%), Gaps = 52/528 (9%)
Query: 1 MVHKAIQLILIYCLTANLHDLAFGDSPPYNICSTSTAGSARASTIDDNLQNVLTSLASN- 59
+V K IQ L+ L LA D PPY ICST A S+ D+NL N+L SL N
Sbjct: 6 IVFKFIQFFLVLYTLDFLSYLALAD-PPYEICSTRNI-YANGSSFDNNLSNLLLSLPFND 63
Query: 60 -ANAAKFSNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQDISKLCPNKTEAIVWEE 118
+ +KF N S G DRVYGLYMCL+++S ETC C+T A D KLCP EA+V+EE
Sbjct: 64 SNSISKFGNTSSGIGLDRVYGLYMCLDFVSNETCLKCVTNAIADTVKLCPQSKEAVVYEE 123
Query: 119 VCQLRYAYQNFFGQLDVSGNIPKYNRLNISEPERYRSVVNNTLSDLITKLSAFD-PFEMY 177
CQ+RY+ +NF G L+V+GNI K N NISEP ++ + VN L+ L TK+++F+ MY
Sbjct: 124 FCQVRYSNKNFIGSLNVNGNIGKDNVQNISEPVKFETSVNKLLNGL-TKIASFNVSANMY 182
Query: 178 ATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATADILSCCYFSRGARLLSRNCYLRY 237
AT EVPF + T YALVQCT+DL A+DC CL +A DI CCY S GAR++SR+CYLRY
Sbjct: 183 ATGEVPFEDK-TIYALVQCTRDLAANDCSRCLLSAIGDIPGCCYASIGARVMSRSCYLRY 241
Query: 238 ELYAFYKGATEPSILAGNQASGGGKQR--------KMWMIIVLASVVALLLVVFASTGYF 289
E Y FY G E + + N GGK + K+WMI V+A V L++++F F
Sbjct: 242 EFYPFYLGEKEQTKSSTNL---GGKSKHFSSYNSSKIWMITVIAVGVGLVIIIFICYLCF 298
Query: 290 FATKKITRKRKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDF-FIDLETLNLAT 348
R R+ + N ++DF FIDL +L +AT
Sbjct: 299 L------RNRQSN-------------------------KGNGKISKDFPFIDLASLRVAT 327
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
NF+DSN LG+GGFGPVYKG+LSDG+EVA+KRLS CSEQG+ EF NEV+LILKLQHKNLV
Sbjct: 328 RNFTDSNKLGEGGFGPVYKGILSDGQEVAIKRLSICSEQGSEEFINEVMLILKLQHKNLV 387
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
KLLGFCVDG+EKLLVYE++PNGSLD +LF+ + L W KR +I+NGIA+G+LYLHEDS
Sbjct: 388 KLLGFCVDGEEKLLVYEYLPNGSLDVVLFEQHAQ--LDWTKRLDIINGIARGILYLHEDS 445
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
RL+I+HRDLKASNVLLD+DMN KISDFGMARIFA SEGEANT IVGT
Sbjct: 446 RLQIIHRDLKASNVLLDNDMNPKISDFGMARIFAGSEGEANTTTIVGT 493
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113911|ref|XP_002316612.1| predicted protein [Populus trichocarpa] gi|222859677|gb|EEE97224.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 502 bits (1292), Expect = e-139, Method: Compositional matrix adjust.
Identities = 269/513 (52%), Positives = 335/513 (65%), Gaps = 24/513 (4%)
Query: 8 LILIYCLTANL--HDLAFGDSPPYNICSTSTAGSARASTIDDNLQNVLTSLASNANAAKF 65
L+L+Y A L H F PPY CS ++ A S +NLQ +++ LASNA+ +
Sbjct: 15 LLLLYFSIATLSQHSSNFLTHPPYKFCSNTSLYEAN-SPFQNNLQTLMSYLASNASVSNQ 73
Query: 66 SNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYA 125
+A GND D VY YMC NYI E C+ CI ASQDI +LCPN A VWEE+CQLR++
Sbjct: 74 YHAYAGNDPDIVYAQYMCYNYI--ENCSACIYAASQDIMQLCPNNRNATVWEELCQLRFS 131
Query: 126 YQNFFGQLDVSGNIPKYNRLNISEPERYRSVVNNTLSDLITKLSAFDPFE-MYATDEVPF 184
+NF GQLD+SGNI N I P +Y SVVN S+L TK +AFDP + MYAT ++
Sbjct: 132 NKNFIGQLDISGNIIVANTETIENPGQYISVVNENFSNL-TKKAAFDPTQNMYATGKLAL 190
Query: 185 TNSDTFYALVQCTKDLPADDCITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYK 244
++ DT Y L QCT DL + DC TCL A +I SCCY RG RLLS++CY RYELY FY+
Sbjct: 191 SDIDTLYTLGQCTTDLSSHDCSTCLQVAIQNISSCCYIGRGQRLLSQSCYFRYELYPFYE 250
Query: 245 GATEPSILAGNQASGGGKQRKMWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTAR 304
G + SG + + IVL + + +++ F ++I+RK +
Sbjct: 251 GTAD---------SG---ETLTILKIVLGTCIPAVVLAFLIASCIIYFRRISRKETDEEK 298
Query: 305 KQIQ-LHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFG 363
+ L ++ ++ + +G + + +DL + AT NFS SN LGQGGFG
Sbjct: 299 SHLDFLQELRKSSGSTL----AEGNKVSSEELPWMMDLSVIRAATDNFSVSNKLGQGGFG 354
Query: 364 PVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423
VYKG+LSDG EVAVKRLS SEQG EF EVLLI+KLQHKNLV+LLGFCV+G+EKLLV
Sbjct: 355 SVYKGILSDGSEVAVKRLSRSSEQGVKEFKTEVLLIMKLQHKNLVRLLGFCVEGEEKLLV 414
Query: 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVL 483
YEFMPN SLD LFDP KR L W R +I+NGIAKGMLYLHEDSRLRI+HRDLKASNVL
Sbjct: 415 YEFMPNSSLDVFLFDPTKRAELDWSSRIDIINGIAKGMLYLHEDSRLRIIHRDLKASNVL 474
Query: 484 LDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
LD++MN KISDFGMARIF+ +E EANT RIVGT
Sbjct: 475 LDNEMNPKISDFGMARIFSSNEDEANTARIVGT 507
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113923|ref|XP_002316615.1| predicted protein [Populus trichocarpa] gi|222859680|gb|EEE97227.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 485 bits (1249), Expect = e-134, Method: Compositional matrix adjust.
Identities = 257/478 (53%), Positives = 319/478 (66%), Gaps = 28/478 (5%)
Query: 40 ARASTIDDNLQNVLTSLASNANAAKFSNASFGNDSDRVYGLYMCLNYISAETCNDCITTA 99
A S +NL+++++ LASNA+ + +A GND DRVY YMC NYI+ E C+ CI A
Sbjct: 2 AANSPFQNNLKSLMSYLASNASVSNQYHAYAGNDPDRVYAHYMCYNYITFEKCSACIDAA 61
Query: 100 SQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNRLNISEPERYRSVVNN 159
SQDI +LCPN +A VWEE+CQLR++ QNF G LD SGNIP NR I PE+ S VN
Sbjct: 62 SQDIMQLCPNIRDAAVWEELCQLRFSNQNFLGLLDFSGNIPLSNRKTIKNPEQLVSAVNE 121
Query: 160 TLSDLITKLSAFDPFE-MYATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATADILS 218
S+L TK +AF P MYAT ++ ++ DT YAL QC+ DL + DC TCL A +I +
Sbjct: 122 NFSNL-TKKAAFVPARNMYATRKLTLSDIDTLYALGQCSTDLSSHDCNTCLQVAIQNIST 180
Query: 219 CCYFSRGARLLSRNCYLRYELYAFYKGATEPSILAGNQASGGGKQRKMWMIIVLASVVAL 278
CCY SRGARLLSR+CY RYELY FY+G + N G + + IVL + + +
Sbjct: 181 CCYISRGARLLSRSCYFRYELYPFYEGTADS---VYNFPVG---ETLTTLKIVLGTCIPV 234
Query: 279 LLVVFASTGYFFATKKITRKRKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFF 338
+++ F + A + RK ++++ F +G + +
Sbjct: 235 VVLAFLTASCHHAFLQELRK----------------SSESTF----AEGNKVSSEELPWM 274
Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLL 398
+DL + AT NFS SN LGQGGFG VYKG+LSDG EVAVKRLS SEQG EF NEVLL
Sbjct: 275 MDLSVIRAATDNFSVSNKLGQGGFGSVYKGILSDGSEVAVKRLSRSSEQGEKEFKNEVLL 334
Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIA 458
I+KLQHKNL++LLGFCV+G+EKLLVYEFMPN SLD LFDP KR L W R +I+NGIA
Sbjct: 335 IMKLQHKNLIRLLGFCVEGEEKLLVYEFMPNSSLDVFLFDPTKRAKLDWSSRIDIINGIA 394
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
KGMLYLHEDSRLRI+HRDLKASNVLLD++MN KI DFGMARIF+ +E EA T RIVGT
Sbjct: 395 KGMLYLHEDSRLRIIHRDLKASNVLLDNEMNPKIPDFGMARIFSSNEDEAKTARIVGT 452
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359496581|ref|XP_002270035.2| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 404 bits (1039), Expect = e-110, Method: Compositional matrix adjust.
Identities = 216/499 (43%), Positives = 295/499 (59%), Gaps = 33/499 (6%)
Query: 29 YNICSTSTAGSARASTIDDNLQNVLTSLASNA---NAAKFSNASFGNDSDRVYGLYMCLN 85
Y+ C T + ST +L +LTSL+S+A N KF N + G D VYGLY+C
Sbjct: 30 YSFC-TENSNYVPNSTYQSSLNVLLTSLSSDATILNGRKFHNTTAGQAPDMVYGLYLCRG 88
Query: 86 YISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNRL 145
++ C DC+ TASQ+I CPN+ EA+ W + C LRY+ ++ F ++ + N L
Sbjct: 89 DVTDAVCQDCVQTASQEILTKCPNRKEALSWYDQCMLRYSNRSIFSIMEERPMLTMSNSL 148
Query: 146 NISEPERYRSVVNNTLSDLITKLSA-FDPFEMYATDEVPFTNSDTFYALVQCTKDLPADD 204
++ +P+R+ +VN T+ LI K + +M+ T E F S Y LVQCT DL +
Sbjct: 149 DMDDPDRFDQIVNKTMVGLIEKATHNSSERDMFETGEANFNASTKIYGLVQCTPDLSGSN 208
Query: 205 CITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFY------KGATEPSILAGNQAS 258
C TCL N + I +CC +GAR+L +C RYELY FY +
Sbjct: 209 CSTCLENIFSRITNCCLGKQGARILVPSCNFRYELYPFYGDLAAATPPAPAPSPLSLLSP 268
Query: 259 GGGKQRKMWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQIQLHKIGDANDT 318
G K ++I + VA+ +V+F+ Y F +K +K T ++++
Sbjct: 269 PGKKGNSSQLLIAIIVPVAVSVVIFSILCYCFICRKAKKKYSSTEEEKVE---------- 318
Query: 319 DFHYQHVQGRDNDLK-AQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVA 377
ND+ Q D TL AT+NFSD N +G+GGFG VYKG LS GKE+A
Sbjct: 319 -----------NDITTVQSLQFDFGTLEAATNNFSDDNKIGEGGFGDVYKGTLSSGKEIA 367
Query: 378 VKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILF 437
+KRLS S QG EF NEV+L+ KLQH+NLV+LLGFC++G+EK+LVYE++PN SLD LF
Sbjct: 368 IKRLSRSSAQGAVEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEYVPNKSLDCFLF 427
Query: 438 DPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497
DP K+G L W +R I+ GIA+G+LYLHEDS+L+++HRDLKASNVLLD DMN KISDFGM
Sbjct: 428 DPDKQGQLDWSRRYKIIGGIARGILYLHEDSQLKVIHRDLKASNVLLDGDMNPKISDFGM 487
Query: 498 ARIFAESEGEANTVRIVGT 516
ARIF + +T R+VGT
Sbjct: 488 ARIFGGDQTRGSTKRVVGT 506
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302144056|emb|CBI23161.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 390 bits (1003), Expect = e-106, Method: Compositional matrix adjust.
Identities = 213/493 (43%), Positives = 296/493 (60%), Gaps = 21/493 (4%)
Query: 27 PPYNICSTSTAGSARASTIDDNLQNVLTSLASNANAAKFSNASFGNDSDRVYGLYMCLNY 86
P Y C + T S+ ++NL+++L SL SN F+ S G D++RV G +C
Sbjct: 63 PMYTFCDSGTGNYTSNSSFENNLKHLLQSLPSNTYLTCFNITSMGIDANRVSGRALCRGD 122
Query: 87 ISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYN--R 144
++ + C C+ AS++I K C ++ EAI+W E+CQ+ Y+Y+ G +G P +N
Sbjct: 123 VTDKVCWICLENASREIMKECKSQ-EAIIWYELCQVHYSYRILSGMDAYTGKYPLWNNQE 181
Query: 145 LNISEPERYRSVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADD 204
N+S+P + V+N+ + +L K + M+ TD+V F+ SDT Y LVQCT+DL D
Sbjct: 182 KNVSDPLSFYEVLNDLMRNLTIKAAQGPSKLMFGTDQVKFSRSDTIYGLVQCTRDLTVDS 241
Query: 205 CITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYKGATEPSILAGNQASGGGKQR 264
C CL +A D+ +CCY G + SR+C +RY L FY PS+ +
Sbjct: 242 CRKCLSSALGDLKACCYGRGGGTIFSRSCNMRYGLTRFYD---TPSVKG---------EW 289
Query: 265 KMWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQIQLHKIGDANDTDFHYQH 324
K WMI+++ V V + + R R GT + + + N
Sbjct: 290 KTWMIVLVICVPTFAAAVLVGSCVLYY-----RGRTGTQNDEEKSQRALLHNLATPTAAA 344
Query: 325 VQGRDNDLKAQDF-FIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSS 383
+ N L +Q+ F++L T+ AT++FS+SN LG GGFG VYKGVL +GKE+AVKRLS
Sbjct: 345 ITQEFNLLSSQELPFMELATIRAATNDFSESNKLGHGGFGTVYKGVLPNGKEIAVKRLSK 404
Query: 384 CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRG 443
S QG EF NE++LI KLQH+NLV+LLG +G EKLL+YEFMPN SLD +FD KR
Sbjct: 405 KSWQGIEEFKNEIILIAKLQHRNLVRLLGCGTEGQEKLLIYEFMPNKSLDIFIFDADKRQ 464
Query: 444 ILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503
L W NI++GIA+G+LYLHEDSRL+I+HRDLK +NVLL+ DM +KISDFGMARIF E
Sbjct: 465 QLNWEICHNIIDGIARGLLYLHEDSRLKIIHRDLKPNNVLLNHDMVAKISDFGMARIFGE 524
Query: 504 SEGEANTVRIVGT 516
++ ANT RIVGT
Sbjct: 525 NQNAANTRRIVGT 537
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 516 | ||||||
| TAIR|locus:2123111 | 669 | CRK34 "cysteine-rich RLK (RECE | 0.372 | 0.286 | 0.619 | 3.1e-87 | |
| TAIR|locus:2115728 | 675 | CRK25 "cysteine-rich RLK (RECE | 0.901 | 0.688 | 0.394 | 6.9e-86 | |
| TAIR|locus:2121676 | 669 | CRK10 "cysteine-rich RLK (RECE | 0.891 | 0.687 | 0.397 | 7.2e-84 | |
| TAIR|locus:2123116 | 700 | CRK30 "cysteine-rich RLK (RECE | 0.343 | 0.252 | 0.622 | 7.3e-84 | |
| TAIR|locus:2121636 | 659 | CRK7 "cysteine-rich RLK (RECEP | 0.364 | 0.285 | 0.569 | 7.4e-82 | |
| TAIR|locus:2121651 | 676 | CRK8 "cysteine-rich RLK (RECEP | 0.864 | 0.659 | 0.393 | 1.5e-81 | |
| TAIR|locus:2121691 | 667 | CRK11 "cysteine-rich RLK (RECE | 0.377 | 0.292 | 0.568 | 1.9e-81 | |
| TAIR|locus:2077147 | 676 | CRK4 "cysteine-rich RLK (RECEP | 0.385 | 0.294 | 0.545 | 2e-79 | |
| TAIR|locus:2121686 | 645 | CRK19 "cysteine-rich RLK (RECE | 0.362 | 0.289 | 0.595 | 4.1e-79 | |
| TAIR|locus:2123126 | 666 | CRK31 "cysteine-rich RLK (RECE | 0.364 | 0.282 | 0.592 | 2.8e-78 |
| TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 624 (224.7 bits), Expect = 3.1e-87, Sum P(2) = 3.1e-87
Identities = 119/192 (61%), Positives = 145/192 (75%)
Query: 325 VQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC 384
VQ D +T+ AT FSDSN++G+GGFG VY+G LS G EVAVKRLS
Sbjct: 319 VQATDEITTTHSLQFSFKTIEAATDKFSDSNMIGRGGFGEVYRGKLSSGPEVAVKRLSKT 378
Query: 385 SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI 444
S QG EF NE +L+ KLQHKNLV+LLGFC++G+EK+LVYEF+PN SLD LFDP K+G
Sbjct: 379 SGQGAEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLFDPAKQGE 438
Query: 445 LCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504
L W +R NI+ GIA+G+LYLH+DSRL I+HRDLKASN+LLD+DMN KI+DFGMARIF
Sbjct: 439 LDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGVD 498
Query: 505 EGEANTVRIVGT 516
+ +ANT RI GT
Sbjct: 499 QSQANTRRIAGT 510
|
|
| TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 859 (307.4 bits), Expect = 6.9e-86, P = 6.9e-86
Identities = 199/505 (39%), Positives = 275/505 (54%)
Query: 29 YNICXXXXXXXXXXXXIDDNLQNVLTSLXX--XXXXXXXXXXXXG--NDSDRVYGLYMCL 84
Y+IC + NL+ VL+SL G NDS+RVYG+++C
Sbjct: 31 YHICPNTTTYSRNSSYLT-NLRTVLSSLSSPNAAYASLFDNAAAGEENDSNRVYGVFLCR 89
Query: 85 NYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNR 144
+SAE C DC+ A+ + + CP + A++W + C +RY+ Q+ GQ+ + + N+
Sbjct: 90 GDVSAEICRDCVAFAANETLQRCPREKVAVIWYDECMVRYSNQSIVGQMRIRPGVFLTNK 149
Query: 145 LNISEPE--RYRSVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPA 202
NI+E + R+ + L D+ K + +AT++ FT T Y+LVQCT DL
Sbjct: 150 QNITENQVSRFNESLPALLIDVAVKAALSS--RKFATEKANFTVFQTIYSLVQCTPDLTN 207
Query: 203 DDCITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYKG-------ATEPS--ILA 253
DC +CL + CC S G R+++ +C RYELY FY A PS + A
Sbjct: 208 QDCESCLRQVINYLPRCCDRSVGGRVIAPSCSFRYELYPFYNETIAAAPMAPPPSSTVTA 267
Query: 254 G--NQASGGGKQRKMWMIIXXXXXXXXXXXXXXXTGYFFATKKITRKRKGTARKQIQLHK 311
N S GK + + +I+ + ++ R K +A
Sbjct: 268 PPLNIPSEKGKGKNLTVIVTAIAVPVSVCVLLLGAMCWLLARR--RNNKLSA-------- 317
Query: 312 IGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLS 371
+ D D D + + AT+ FS+SN LG GGFG VYKG L
Sbjct: 318 --ETEDLD--------EDGITSTETLQFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLI 367
Query: 372 DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGS 431
G+ VA+KRLS S QG EF NEV ++ KLQH+NL KLLG+C+DG+EK+LVYEF+PN S
Sbjct: 368 TGETVAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKS 427
Query: 432 LDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSK 491
LD LFD KR +L W++R I+ GIA+G+LYLH DSRL I+HRDLKASN+LLD+DM+ K
Sbjct: 428 LDYFLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPK 487
Query: 492 ISDFGMARIFAESEGEANTVRIVGT 516
ISDFGMARIF + +ANT RIVGT
Sbjct: 488 ISDFGMARIFGVDQTQANTKRIVGT 512
|
|
| TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 840 (300.8 bits), Expect = 7.2e-84, P = 7.2e-84
Identities = 199/501 (39%), Positives = 270/501 (53%)
Query: 29 YNICXXXXXXXXXXXXIDDNLQNVLTSLXXXXXXXXXXX--XXXGNDSDRVYGLYMCLNY 86
Y+ C ++NL+ +L SL G DRV GL+ C
Sbjct: 41 YHTCQNTANYTSNSTY-NNNLKTLLASLSSRNASYSTGFQNATVGQAPDRVTGLFNCRGD 99
Query: 87 ISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNRLN 146
+S E C C++ A D CPN+ EA ++ + C LRY+ QN L +G + N N
Sbjct: 100 VSTEVCRRCVSFAVNDTLTRCPNQKEATLYYDECVLRYSNQNILSTLITTGGVILVNTRN 159
Query: 147 IS--EPERYRSVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADD 204
++ + + +V TL+ T A + + + T + FT +FY LVQCT DL D
Sbjct: 160 VTSNQLDLLSDLVLPTLNQAATV--ALNSSKKFGTRKNNFTALQSFYGLVQCTPDLTRQD 217
Query: 205 CITCLHNATADILSCCYFSR-GARLLSRNCYLRYELYAFYKGAT------EPSILAGNQA 257
C CL I + R GAR+++ +C RYE+YAFY + PSI +
Sbjct: 218 CSRCLQLVINQIPT----DRIGARIINPSCTSRYEIYAFYTESAVPPPPPPPSISTPPVS 273
Query: 258 SG--GGKQRKMWMIIXXXXXXXXXXXXXXXTGYFFATKKITRKRKGTARKQIQLHKIGDA 315
+ GK +++ GY F T++ ARK
Sbjct: 274 APPRSGKDGNSKVLVIAIVVPIIVAVLLFIAGYCFLTRR--------ARKS--------- 316
Query: 316 NDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE 375
++ D+ A +D T+ AT +F +SN +GQGGFG VYKG LSDG E
Sbjct: 317 ----YYTPSAFAGDDITTADSLQLDYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTE 372
Query: 376 VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAI 435
VAVKRLS S QG EF NEV+L+ KLQH+NLV+LLGFC+DG+E++LVYE++PN SLD
Sbjct: 373 VAVKRLSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYF 432
Query: 436 LFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDF 495
LFDP K+G L W +R I+ G+A+G+LYLH+DSRL I+HRDLKASN+LLD+DMN KI+DF
Sbjct: 433 LFDPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADF 492
Query: 496 GMARIFAESEGEANTVRIVGT 516
GMARIF + E NT RIVGT
Sbjct: 493 GMARIFGLDQTEENTSRIVGT 513
|
|
| TAIR|locus:2123116 CRK30 "cysteine-rich RLK (RECEPTOR-like protein kinase) 30" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 580 (209.2 bits), Expect = 7.3e-84, Sum P(2) = 7.3e-84
Identities = 112/180 (62%), Positives = 142/180 (78%)
Query: 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLI 399
D++ + ATSNF SN +GQGGFG VYKG LS+G EVAVKRLS S+QG EF NEVLL+
Sbjct: 335 DIKDIEAATSNFLASNKIGQGGFGEVYKGTLSNGTEVAVKRLSRTSDQGELEFKNEVLLV 394
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILF---DPRKRGILCWRKRTNIVNG 456
KLQH+NLV+LLGF + G+EK+LV+EF+PN SLD LF +P K+G L W +R NI+ G
Sbjct: 395 AKLQHRNLVRLLGFALQGEEKILVFEFVPNKSLDYFLFGSTNPTKKGQLDWTRRYNIIGG 454
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
I +G+LYLH+DSRL I+HRD+KASN+LLD+DMN KI+DFGMAR F + + E +T R+VGT
Sbjct: 455 ITRGLLYLHQDSRLTIIHRDIKASNILLDADMNPKIADFGMARNFRDHQTEDSTGRVVGT 514
|
|
| TAIR|locus:2121636 CRK7 "cysteine-rich RLK (RECEPTOR-like protein kinase) 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 576 (207.8 bits), Expect = 7.4e-82, Sum P(2) = 7.4e-82
Identities = 107/188 (56%), Positives = 144/188 (76%)
Query: 329 DNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQG 388
D+ + +D + AT++FS++N +G+GGFG VYKG S+G EVAVKRLS SEQG
Sbjct: 314 DDKTTIESLQLDYRAIQAATNDFSENNKIGRGGFGDVYKGTFSNGTEVAVKRLSKTSEQG 373
Query: 389 TAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWR 448
EF NEV+++ L+HKNLV++LGF ++ +E++LVYE++ N SLD LFDP K+G L W
Sbjct: 374 DTEFKNEVVVVANLRHKNLVRILGFSIEREERILVYEYVENKSLDNFLFDPAKKGQLYWT 433
Query: 449 KRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508
+R +I+ GIA+G+LYLH+DSRL I+HRDLKASN+LLD+DMN KI+DFGMARIF + +
Sbjct: 434 QRYHIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGMDQTQQ 493
Query: 509 NTVRIVGT 516
NT RIVGT
Sbjct: 494 NTSRIVGT 501
|
|
| TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 818 (293.0 bits), Expect = 1.5e-81, P = 1.5e-81
Identities = 190/483 (39%), Positives = 270/483 (55%)
Query: 48 NLQNVLTSLXXXXXXXXXXXXX--XGNDSDRVYGLYMCLNYISAETCNDCITTASQDISK 105
NL+ +L+S G DRV GL++C +S E C++C+ + +
Sbjct: 59 NLKTLLSSFASRNASYSTGFQNIRAGQTPDRVTGLFLCRGDLSPEVCSNCVAFSVNESLT 118
Query: 106 LCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNRLNISEPERYRSVVNNTLSDLI 165
CPN+ EA+ + E C LRY+++NF + G + N NIS + R + + +
Sbjct: 119 RCPNQREAVFYYEECILRYSHKNFLSTVTYEGELIMRNPNNISSIQNQRDQFIDLVQSNM 178
Query: 166 TKLS--AFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATADILSCCYFS 223
+ + A + ++T + T+ T Y LVQCT DL DC +CL ++ ++ F
Sbjct: 179 NQAANEAANSSRKFSTIKTELTSLQTLYGLVQCTPDLARQDCFSCLTSSINRMMPL--FR 236
Query: 224 RGARLLSRNCYLRYELYAFYK----GA-TEPSILAGN-----QASGGGKQRKMWMIIXXX 273
GAR +C RYELYAFY G + P + G+ S GK +++
Sbjct: 237 IGARQFWPSCNSRYELYAFYNETAIGTPSPPPLFPGSTPPLTSPSIPGKSGNSTVLVVAI 296
Query: 274 XXXXXXXXXXXXTGYFFATKKITRKRKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLK 333
GY F ++ T+K TA ++GD T
Sbjct: 297 VVLAVLLFIAL-VGYCFLAQR-TKKTFDTASAS----EVGDDMAT--------------- 335
Query: 334 AQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFT 393
A +D T+ AT++F++SN +G+GGFG VYKG S+GKEVAVKRLS S QG AEF
Sbjct: 336 ADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQGEAEFK 395
Query: 394 NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNI 453
EV+++ KLQH+NLV+LLGF + G+E++LVYE+MPN SLD +LFDP K+ L W +R NI
Sbjct: 396 TEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQLDWMQRYNI 455
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
+ GIA+G+LYLH+DSRL I+HRDLKASN+LLD+D+N KI+DFGMARIF + + NT RI
Sbjct: 456 IGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQTQDNTSRI 515
Query: 514 VGT 516
VGT
Sbjct: 516 VGT 518
|
|
| TAIR|locus:2121691 CRK11 "cysteine-rich RLK (RECEPTOR-like protein kinase) 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 584 (210.6 bits), Expect = 1.9e-81, Sum P(2) = 1.9e-81
Identities = 112/197 (56%), Positives = 148/197 (75%)
Query: 322 YQHVQGR-DNDLKAQDFFI-DLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVK 379
YQ + ++D+ D + D +T+ AT+ FS SN LG+GGFG VYKG LS+G +VAVK
Sbjct: 319 YQRTKTESESDISTTDSLVYDFKTIEAATNKFSTSNKLGEGGFGAVYKGKLSNGTDVAVK 378
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP 439
RLS S QGT EF NE +L+ KLQH+NLV+LLGFC++ +E++L+YEF+ N SLD LFDP
Sbjct: 379 RLSKKSGQGTREFRNEAVLVTKLQHRNLVRLLGFCLEREEQILIYEFVHNKSLDYFLFDP 438
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
K+ L W +R I+ GIA+G+LYLH+DSRL+I+HRDLKASN+LLD+DMN KI+DFG+A
Sbjct: 439 EKQSQLDWTRRYKIIGGIARGILYLHQDSRLKIIHRDLKASNILLDADMNPKIADFGLAT 498
Query: 500 IFAESEGEANTVRIVGT 516
IF + + NT RI GT
Sbjct: 499 IFGVEQTQGNTNRIAGT 515
|
|
| TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 573 (206.8 bits), Expect = 2.0e-79, Sum P(2) = 2.0e-79
Identities = 109/200 (54%), Positives = 145/200 (72%)
Query: 318 TDFHYQHVQGRDNDLK-AQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEV 376
T++ + + +D+ A D + + AT+ F ++N LGQGGFG VYKG+ G +V
Sbjct: 317 TNYEREPLTEESDDITTAGSLQFDFKAIEAATNKFCETNKLGQGGFGEVYKGIFPSGVQV 376
Query: 377 AVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL 436
AVKRLS S QG EF NEV+++ KLQH+NLV+LLGFC++ DE++LVYEF+PN SLD +
Sbjct: 377 AVKRLSKTSGQGEREFANEVIVVAKLQHRNLVRLLGFCLERDERILVYEFVPNKSLDYFI 436
Query: 437 FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496
FD + +L W +R I+ GIA+G+LYLH+DSRL I+HRDLKA N+LL DMN+KI+DFG
Sbjct: 437 FDSTMQSLLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLGDDMNAKIADFG 496
Query: 497 MARIFAESEGEANTVRIVGT 516
MARIF + EANT RIVGT
Sbjct: 497 MARIFGMDQTEANTRRIVGT 516
|
|
| TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 565 (203.9 bits), Expect = 4.1e-79, Sum P(2) = 4.1e-79
Identities = 112/188 (59%), Positives = 138/188 (73%)
Query: 330 NDLK-AQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQG 388
ND+ A D + + AT+ F N LGQGGFG VYKG LS G +VAVKRLS S QG
Sbjct: 304 NDITTAGSLQFDFKAIEAATNCFLPINKLGQGGFGEVYKGTLSSGLQVAVKRLSKTSGQG 363
Query: 389 TAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWR 448
EF NEV+++ KLQH+NLVKLLG+C++G+EK+LVYEF+PN SLD LFD + L W
Sbjct: 364 EKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDHFLFDSTMKMKLDWT 423
Query: 449 KRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508
+R I+ GIA+G+LYLH+DSRL I+HRDLKA N+LLD DMN KI+DFGMARIF + EA
Sbjct: 424 RRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDDDMNPKIADFGMARIFGMDQTEA 483
Query: 509 NTVRIVGT 516
T R+VGT
Sbjct: 484 MTRRVVGT 491
|
|
| TAIR|locus:2123126 CRK31 "cysteine-rich RLK (RECEPTOR-like protein kinase) 31" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 591 (213.1 bits), Expect = 2.8e-78, Sum P(2) = 2.8e-78
Identities = 112/189 (59%), Positives = 146/189 (77%)
Query: 329 DNDLKA-QDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQ 387
D+D+ + Q D T+ +AT NFS +N LGQGGFG VYKG+L + E+AVKRLSS S Q
Sbjct: 316 DDDMTSPQSLQFDFTTIEVATDNFSRNNKLGQGGFGEVYKGMLPNETEIAVKRLSSNSGQ 375
Query: 388 GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCW 447
GT EF NEV+++ KLQHKNLV+LLGFC++ DE++LVYEF+ N SLD LFDP+ + L W
Sbjct: 376 GTQEFKNEVVIVAKLQHKNLVRLLGFCIERDEQILVYEFVSNKSLDYFLFDPKMKSQLDW 435
Query: 448 RKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
++R NI+ G+ +G+LYLH+DSRL I+HRD+KASN+LLD+DMN KI+DFGMAR F + E
Sbjct: 436 KRRYNIIGGVTRGLLYLHQDSRLTIIHRDIKASNILLDADMNPKIADFGMARNFRVDQTE 495
Query: 508 ANTVRIVGT 516
T R+VGT
Sbjct: 496 DQTGRVVGT 504
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 516 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-45 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-44 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-42 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-41 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-40 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-37 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-34 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-30 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-28 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-27 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-27 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-27 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-27 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-27 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-26 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-25 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 6e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-23 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-23 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-23 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-22 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-21 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-21 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-21 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-20 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-20 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 6e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-19 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-19 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-19 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-16 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-15 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-15 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-15 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-15 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-15 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-12 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-12 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-11 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-11 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-07 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-07 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-06 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-06 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-06 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 9e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-05 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-05 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-05 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 7e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.001 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.002 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 0.002 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 0.002 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.003 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.003 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.004 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.004 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 7e-45
Identities = 60/150 (40%), Positives = 78/150 (52%), Gaps = 11/150 (7%)
Query: 356 ILGQGGFGPVYKGVLSDGK-----EVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
LG+G FG VYKG L EVAVK L SEQ EF E ++ KL H N+VK
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
LLG C + + +V E+M G L + L R + L + IA+GM YL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYLE---S 120
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+HRDL A N L+ ++ KISDFG++R
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSR 150
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 3e-44
Identities = 60/150 (40%), Positives = 79/150 (52%), Gaps = 10/150 (6%)
Query: 356 ILGQGGFGPVYKGVLSDGK-----EVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
LG+G FG VYKG L EVAVK L SEQ EF E ++ KL H N+VK
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
LLG C + + ++V E+MP G L L R + + + IA+GM YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKEL-SLSDLLSFALQIARGMEYLE---S 121
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+HRDL A N L+ ++ KISDFG++R
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSR 151
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 2e-42
Identities = 61/156 (39%), Positives = 80/156 (51%), Gaps = 14/156 (8%)
Query: 355 NILGQGGFGPVYKGVLSDGK----EVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVK 409
LG+G FG VYKG L EVAVK L SE+ +F E ++ KL H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAIL------FDPRKRGILCWRKRTNIVNGIAKGMLY 463
LLG C + + LV E+M G L L F ++ L + + IAKGM Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
L + VHRDL A N L+ D+ KISDFG++R
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR 153
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 2e-41
Identities = 61/149 (40%), Positives = 78/149 (52%), Gaps = 11/149 (7%)
Query: 357 LGQGGFGPVYKGVLSDGKE-----VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
LG+G FG VYKG L E VAVK L SE+ EF E ++ KL H N+V+L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
LG C G+ +V E+MP G L L + L + + IAKGM YL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLES---K 121
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMAR 499
VHRDL A N L+ ++ KISDFG++R
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSR 150
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 4e-40
Identities = 60/164 (36%), Positives = 80/164 (48%), Gaps = 11/164 (6%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSE--QGTAEFTNEVLLILKLQHKNLVKLLG 412
LG G FG VYK GK VAVK L SE + E+ ++ +L H N+V+L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
D D LV E+ G L L + G L + I I +G+ YLH I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHS---NGI 119
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
+HRDLK N+LLD + KI+DFG+A+ +S T VGT
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGT 161
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 3e-37
Identities = 60/163 (36%), Positives = 84/163 (51%), Gaps = 10/163 (6%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKLLGFC 414
LG+GGFG VY GK+VA+K + E E+ ++ KL H N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
D + LV E+ GSL +L G L + I+ I +G+ YLH I+H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK--ENEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 475 RDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGT 516
RDLK N+LLDSD K++DFG++++ + T IVGT
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGT 156
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 58/168 (34%), Positives = 83/168 (49%), Gaps = 11/168 (6%)
Query: 351 FSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNLV 408
+ LG+G FG VY GK VA+K + ++ E+ ++ KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
+L D D+ LV E+ G L +L +KRG L + + I + YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARFYLRQILSALEYLHS-- 115
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
IVHRDLK N+LLD D + K++DFG+AR E + T VGT
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE-KLTTF--VGT 159
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 4e-30
Identities = 59/170 (34%), Positives = 90/170 (52%), Gaps = 17/170 (10%)
Query: 355 NILGQGGFGPVYKGVLSD-GKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
+LG+G FG VY + D G+ +AVK LS SE+ E+ ++ LQH N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 412 GFCVDGDEK-LLVY-EFMPNGSLDAILFDPRKRGILCWRKRTNI---VNGIAKGMLYLHE 466
G D ++ L ++ E++ GSL ++L +K G L I I +G+ YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL---KKFGKL---PEPVIRKYTRQILEGLAYLH- 118
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
IVHRD+K +N+L+DSD K++DFG A+ + E T + GT
Sbjct: 119 --SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 5e-30
Identities = 55/161 (34%), Positives = 87/161 (54%), Gaps = 10/161 (6%)
Query: 355 NILGQGGFGPVYKGVLS-DGKE---VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
++G G FG V +G L GK+ VA+K L + S++ +F E ++ + H N+++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
L G +++ E+M NGSLD L G + ++ GIA GM YL S
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL---SE 124
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
+ VHRDL A N+L++S++ K+SDFG++R +SE T
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTT 165
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 56/170 (32%), Positives = 90/170 (52%), Gaps = 11/170 (6%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKN 406
N+ +++G+G FG VYKG+ L G VA+K++S E+ E+ L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
+VK +G D ++ E+ NGSL I+ +K G V + +G+ YLHE
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQII---KKFGPFPESLVAVYVYQVLQGLAYLHE 117
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
++HRD+KA+N+L D K++DFG+A + + +V VGT
Sbjct: 118 QG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV--VGT 162
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 7e-28
Identities = 56/161 (34%), Positives = 86/161 (53%), Gaps = 13/161 (8%)
Query: 354 SNILGQGGFGPVYKGVL-----SDGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNL 407
LG+G FG V + G++VAVK L+ S EQ ++F E+ ++ L H+N+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 408 VKLLGFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
VK G C + L+ E++P+GSL L R R + ++ + I KGM YL
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506
R +HRDL A N+L++S+ KISDFG+A++ E +
Sbjct: 127 S---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKD 164
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 1e-27
Identities = 60/148 (40%), Positives = 77/148 (52%), Gaps = 12/148 (8%)
Query: 357 LGQGGFGPVYKGV--LSDGKE--VAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
LG G FG V KGV + GKE VAVK L G EF E ++ +L H +V+L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
G C G+ +LV E P G L L +KR + + + +A GM YL
Sbjct: 63 GVCK-GEPLMLVMELAPLGPLLKYL---KKRREIPVSDLKELAHQVAMGMAYLESK---H 115
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMAR 499
VHRDL A NVLL + +KISDFGM+R
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSR 143
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 54/144 (37%), Positives = 80/144 (55%), Gaps = 8/144 (5%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKLLGFCV 415
+G+G FG V G G++VAVK L + A+ F E ++ L+H NLV+LLG +
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKD--DSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
G+ +V E+M GSL L R R ++ ++ + +GM YL E VHR
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHR 126
Query: 476 DLKASNVLLDSDMNSKISDFGMAR 499
DL A NVL+ D+ +K+SDFG+A+
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 5e-27
Identities = 53/156 (33%), Positives = 82/156 (52%), Gaps = 4/156 (2%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
F+ LG G FG V++G+ + VA+K L S +F EV + +L+HK+L+
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
L C G+ ++ E M GSL A L P + +L ++ +A+GM YL E
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ-VLPVASLIDMACQVAEGMAYLEEQ- 123
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504
+HRDL A N+L+ D+ K++DFG+AR+ E
Sbjct: 124 --NSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 8e-27
Identities = 57/161 (35%), Positives = 78/161 (48%), Gaps = 21/161 (13%)
Query: 357 LGQGGFGPVYKGVLSDGKE------VAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNLVK 409
LG+G FG V+ G + VAVK L + S +F E L+ QH+N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLD----------AILFDPR-KRGILCWRKRTNIVNGIA 458
G C +GD ++V+E+M +G L+ A L P G L + I IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
GM+YL + VHRDL N L+ D+ KI DFGM+R
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 8e-27
Identities = 57/162 (35%), Positives = 87/162 (53%), Gaps = 20/162 (12%)
Query: 356 ILGQGGFGPVYKGV-LSDGK----EVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
+LG G FG VYKGV + +G+ VA+K L S + E +E ++ + H ++V+
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGIAKGMLYLH 465
LLG C+ + L+ + MP G L + + + +L W + IAKGM YL
Sbjct: 74 LLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLE 126
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
E R+VHRDL A NVL+ + + KI+DFG+A++ E E
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE 165
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 9/154 (5%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRL--SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
LG G FG V+ G + +VAVK L + S F E ++ KL+H LV+L C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
+ + +V E+M GSL L + + + ++ IA+GM YL +H
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL-PQLVDMAAQIAEGMAYLE---SRNYIH 126
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508
RDL A N+L+ ++ KI+DFG+AR+ + E A
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 5e-26
Identities = 57/171 (33%), Positives = 89/171 (52%), Gaps = 17/171 (9%)
Query: 351 FSDSNILGQGGFGPVYKG-VLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVK 409
F +G+GGFG VYK GKEVA+K + S++ + NE+ ++ K +H N+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML----YLH 465
G + DE +V EF GSL +L + + + I + K +L YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLL-KSTNQTL----TESQIAY-VCKELLKGLEYLH 115
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
I+HRD+KA+N+LL SD K+ DFG++ ++++ +VGT
Sbjct: 116 S---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGT 160
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 62/159 (38%), Positives = 84/159 (52%), Gaps = 15/159 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAE----FTNEVLLILKLQHKNLVKLLG 412
+G+G FG VYKGVL EVAVK +C + F E ++ + H N+VKL+G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVK---TCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
CV +V E +P GSL + F +K+ L +K + A GM YL +S+
Sbjct: 60 VCVQKQPIYIVMELVPGGSL--LTFLRKKKNRLTVKKLLQMSLDAAAGMEYL--ESK-NC 114
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV 511
+HRDL A N L+ + KISDFGM+R E EG TV
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTV 150
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 6e-24
Identities = 38/106 (35%), Positives = 59/106 (55%), Gaps = 5/106 (4%)
Query: 29 YNICSTSTAGSARA--STIDDNLQNVLTSLASNA---NAAKFSNASFGNDSDRVYGLYMC 83
+++CS++T+G+ ST + NL +L+SL+SNA + F+ + G D VYGL C
Sbjct: 1 FHLCSSNTSGNYTTANSTFESNLNALLSSLSSNAASSSGKGFAAGTSGAAPDTVYGLAQC 60
Query: 84 LNYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNF 129
+SA C C+ TA ++ + CPNK +W + C LRY F
Sbjct: 61 RGDLSASDCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 2e-23
Identities = 50/154 (32%), Positives = 76/154 (49%), Gaps = 5/154 (3%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
LG G FG V++G+ ++ VAVK L + +F E ++ KL+H L++L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD 476
+ +V E M GSL L L + ++ +A GM YL + +HRD
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQG-GAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRD 128
Query: 477 LKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
L A NVL+ + K++DFG+AR+ E EA
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYEARE 162
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 52/163 (31%), Positives = 75/163 (46%), Gaps = 17/163 (10%)
Query: 357 LGQGGFGPVYKGVLSD------GKEVAVKRLSSCSEQGT-AEFTNEVLLILKLQHKNLVK 409
LGQG FG VY+G+ VA+K ++ + EF NE ++ + ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAIL-------FDPRKRGILCWRKRTNIVNGIAKGML 462
LLG G L+V E M G L + L + G +K + IA GM
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
YL + VHRDL A N ++ D+ KI DFGM R E++
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETD 173
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 3e-23
Identities = 58/159 (36%), Positives = 82/159 (51%), Gaps = 17/159 (10%)
Query: 355 NILGQGGFGPVYKGVLS--DGK----EVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNL 407
LG G FG VY+G+ DG +VAVK L SCSEQ ++F E L++ K H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGIAKGMLY 463
V+L+G + + ++ E M G L + L + R R L + +AKG Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 464 LHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMAR 499
L E+ +HRD+ A N LL +KI+DFGMAR
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 5e-23
Identities = 51/166 (30%), Positives = 83/166 (50%), Gaps = 13/166 (7%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKR--LSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
+G+G FG VY SDGK +K LS+ SE+ + NEV ++ KL H N++K
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN---GIAKGMLYLHEDSRL 470
+ + +V E+ G L + +K G I++ + + YLH
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPF--PEEQILDWFVQLCLALKYLHSR--- 122
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
+I+HRD+K N+ L S+ K+ DFG++++ + + A TV VGT
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV--VGT 166
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 56/186 (30%), Positives = 91/186 (48%), Gaps = 25/186 (13%)
Query: 340 DLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVK--RLSSCSEQGTAEFTNEV 396
D+ + + + +G+G G VYK + GKEVA+K RL +++ NE+
Sbjct: 10 DIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEI 66
Query: 397 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN---- 452
L++ +H N+V + GDE +V E+M GSL I I R N
Sbjct: 67 LIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDI--------ITQNFVRMNEPQI 118
Query: 453 --IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
+ + +G+ YLH ++HRD+K+ N+LL D + K++DFG A + + + N+
Sbjct: 119 AYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS 175
Query: 511 VRIVGT 516
V VGT
Sbjct: 176 V--VGT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 3e-22
Identities = 56/152 (36%), Positives = 70/152 (46%), Gaps = 18/152 (11%)
Query: 357 LGQGGFGPVYKG--VLSDGK--EVAVKRLSSCSEQGT-AEFTNEVLLILKLQHKNLVKLL 411
LG G FG V +G S GK VAVK L S +F E ++ L H+NL++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGIAKGMLYLHED 467
G + ++V E P GSL L LC + IA GM YL
Sbjct: 63 GVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLC-----DYAVQIANGMRYLESK 116
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
R +HRDL A N+LL SD KI DFG+ R
Sbjct: 117 ---RFIHRDLAARNILLASDDKVKIGDFGLMR 145
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 7e-22
Identities = 54/165 (32%), Positives = 93/165 (56%), Gaps = 11/165 (6%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLS-DGKE---VAVKRLSS-CSEQGTAEFTNEVLLILKLQ 403
S+ + ++G G FG V++G+L G++ VA+K L +E+ +F +E ++ +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
H N+++L G +++ E+M NG+LD L D G + ++ GIA GM Y
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKY 122
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508
L S + VHRDL A N+L++S++ K+SDFG++R+ E + E
Sbjct: 123 L---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL-EDDPEG 163
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 7e-22
Identities = 63/174 (36%), Positives = 96/174 (55%), Gaps = 20/174 (11%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEV----AVKRLSSCS-EQGTAEFTNEVLLI 399
L + +LG G FG VYKG+ + +G+ V A+K L+ + + EF +E L++
Sbjct: 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIM 63
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR----KRGILCWRKRTNIVN 455
+ H +LV+LLG C+ +L V + MP+G L + + + + +L W +
Sbjct: 64 ASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ----- 117
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509
IAKGM+YL E R+VHRDL A NVL+ S + KI+DFG+AR+ E E N
Sbjct: 118 -IAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 167
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-21
Identities = 51/156 (32%), Positives = 81/156 (51%), Gaps = 10/156 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
+G G FG V+ G + ++VA+K R + SE+ +F E +++KL H LV+L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
+ LV+EFM +G L L +RG + + +GM YL + ++H
Sbjct: 69 TERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIH 123
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
RDL A N L+ + K+SDFGM R + + ++T
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 1e-21
Identities = 53/155 (34%), Positives = 80/155 (51%), Gaps = 21/155 (13%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSE----QGTAEFTNEVLLILKLQHKNLVKL 410
LG+G +G VYK G+ VA+K++ +E TA E+ L+ +L+H N+VKL
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA--LREISLLKELKHPNIVKL 63
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIA----KGMLYLHE 466
L + LV+E+ L L D R + N++ I +G+ Y H
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYL-DKRPGPL-----SPNLIKSIMYQLLRGLAYCH- 115
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
S RI+HRDLK N+L++ D K++DFG+AR F
Sbjct: 116 -SH-RILHRDLKPQNILINRDGVLKLADFGLARAF 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 56/161 (34%), Positives = 78/161 (48%), Gaps = 21/161 (13%)
Query: 357 LGQGGFGPVYKGVLS------DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
LG+G FG V+ D VAVK L SE +F E L+ LQH+++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 411 LGFCVDGDEKLLVYEFMPNGSL---------DAILFDPRKR---GILCWRKRTNIVNGIA 458
G C +G L+V+E+M +G L DA + + G L + I + IA
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
GM+YL + L VHRDL N L+ + KI DFGM+R
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 3e-21
Identities = 54/165 (32%), Positives = 82/165 (49%), Gaps = 19/165 (11%)
Query: 356 ILGQGGFGPVYKGVLS--DGK--EVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVK 409
ILG+G FG V +G LS DG +VAVK +L + EF +E + H N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 410 LLGFCVDGDEK------LLVYEFMPNGSLDAILFDPRKRGI---LCWRKRTNIVNGIAKG 460
L+G C + +++ FM +G L + L R G+ L + + IA G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAES 504
M YL S +HRDL A N +L DM ++DFG+++ I++
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 3e-21
Identities = 50/171 (29%), Positives = 88/171 (51%), Gaps = 23/171 (13%)
Query: 355 NILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFT----NEVLLILKLQHKNLVK 409
+G+G +G VYK G+ VA+K++ E F E+ L+ KL+H N+V+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRM--ENEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 410 LLGFCVDGDEK--LLVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGIAKGMLY 463
L + +V+E+M + L +L P + I C+ K+ + +G+ Y
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQ------LLEGLQY 115
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
LH + I+HRD+K SN+L+++D K++DFG+AR + + T R++
Sbjct: 116 LHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 4e-21
Identities = 56/156 (35%), Positives = 87/156 (55%), Gaps = 16/156 (10%)
Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRLS-SCSEQGTAE-----FTNEVLLILKLQHKNLV 408
+LG+G +G VY G+ + G+ +AVK++ S AE EV L+ L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAIL--FDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
+ LG C+D + + EF+P GS+ +IL F P + C + I++G+A YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFC-KYTKQILDGVA----YLHN 120
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502
+ +VHRD+K +NV+L + K+ DFG AR A
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 4e-21
Identities = 53/180 (29%), Positives = 86/180 (47%), Gaps = 29/180 (16%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKN 406
S+ +LGQG G VYK GK A+K++ E+ + E+ + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 407 LVKLLG-FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN---------G 456
+VK G F +G+ + V E+M GSL +L K+ +
Sbjct: 61 VVKCYGAFYKEGEISI-VLEYMDGGSLADLL------------KKVGKIPEPVLAYIARQ 107
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
I KG+ YLH ++ I+HRD+K SN+L++S KI+DFG++++ + + NT VGT
Sbjct: 108 ILKGLDYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGT 163
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 5e-21
Identities = 59/162 (36%), Positives = 83/162 (51%), Gaps = 20/162 (12%)
Query: 355 NILGQGGFGPVYKG----VLSDGKE---VAVKRLSSCS-EQGTAEFTNEVLLILKLQHKN 406
N LG G FG VY+G +L G VAVK L + +Q EF E L+ H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGIAKGML 462
+VKLLG C+ + + ++ E M G L + L D R +L ++ +I +AKG +
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 463 YLHEDSRLRIVHRDLKASNVLL-----DSDMNSKISDFGMAR 499
YL ++ +HRDL A N L+ D+D KI DFG+AR
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 6e-21
Identities = 54/149 (36%), Positives = 79/149 (53%), Gaps = 12/149 (8%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTA-----EFTNEVLLILKLQHKNLVKL 410
LG G FG VY+G+ L DG AVK +S + T + E+ L+ KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
LG + D + E +P GSL +L +K G I G+ YLH+
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLL---KKYGSFPEPVIRLYTRQILLGLEYLHDR--- 121
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMAR 499
VHRD+K +N+L+D++ K++DFGMA+
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAK 150
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 6e-21
Identities = 54/173 (31%), Positives = 90/173 (52%), Gaps = 26/173 (15%)
Query: 349 SNFSDSNI---LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFT--NEVLLILKL 402
S D I LG+G FG VYK + G+ VA+K++ +E+ T E+ ++ KL
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL 64
Query: 403 QHKNLVKLLGFCVD-----GDEKLLVYEFMP--NGSLDAILFDPRKR----GILCWRKRT 451
+H N+V L+ V+ ++ VY P + L +L +P + I C+ +
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQ- 123
Query: 452 NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504
+ +G+ YLHE+ I+HRD+KA+N+L+D+ KI+DFG+AR +
Sbjct: 124 -----LLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGP 168
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 51/145 (35%), Positives = 74/145 (51%), Gaps = 10/145 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
LG G FG V+ G +VA+K R + SE +F E +++KL H NLV+L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
+V E+M NG L L ++G L ++ + + + M YL + +H
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIH 123
Query: 475 RDLKASNVLLDSDMNSKISDFGMAR 499
RDL A N L+ D K+SDFG+AR
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 93.7 bits (231), Expect = 1e-20
Identities = 54/153 (35%), Positives = 79/153 (51%), Gaps = 10/153 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAE---FTNEVLLILKLQH-KNLVKLLG 412
LG+G FG VY D K VA+K L+ E + E F E+ ++ L H N+VKL
Sbjct: 8 LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
F D LV E++ GSL+ +L ++G L + I+ I + YLH I
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGI 122
Query: 473 VHRDLKASNVLLDSDMN-SKISDFGMARIFAES 504
+HRD+K N+LLD D K+ DFG+A++ +
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155
|
Length = 384 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 1e-20
Identities = 56/162 (34%), Positives = 84/162 (51%), Gaps = 24/162 (14%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAE-----FTNEVLLILKLQ 403
N+ +LGQG FG VY D G+E+AVK++ + + E+ L+ LQ
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 404 HKNLVKLLGFCVDGDEKLLVY-EFMPNGSLDAILFDPRKRGILCWRKRTNIVNG-----I 457
H+ +V+ G C+ DE L ++ E+MP GS+ L + G L T V I
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL---KAYGAL-----TETVTRKYTRQI 113
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+G+ YLH + IVHRD+K +N+L DS N K+ DFG ++
Sbjct: 114 LEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 152
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-20
Identities = 53/154 (34%), Positives = 85/154 (55%), Gaps = 10/154 (6%)
Query: 356 ILGQGGFGPVYKGVLS-DGKE---VAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKL 410
++G G FG V +G L GK VA+K L S +E+ +F +E ++ + H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
G +++ EFM NG+LD+ L + G + ++ GIA GM YL E +
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYLSE---M 125
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504
VHRDL A N+L++S++ K+SDFG++R +
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 2e-20
Identities = 58/172 (33%), Positives = 90/172 (52%), Gaps = 10/172 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKE---VAVKRLSS-CSEQGTAEFTNEVLLIL 400
+ S ++G G FG V G L GK VA+K L + +E+ +F +E ++
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMG 60
Query: 401 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
+ H N++ L G ++V E+M NGSLDA L + G + ++ GIA G
Sbjct: 61 QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL--RKHDGQFTVIQLVGMLRGIASG 118
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR 512
M YL S + VHRDL A N+L++S++ K+SDFG++R+ + A T R
Sbjct: 119 MKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR 167
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 6e-20
Identities = 32/90 (35%), Positives = 46/90 (51%), Gaps = 2/90 (2%)
Query: 153 YRSVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNA 212
+ S +N LS L + +A + +A DT Y L QC DL A DC +CL A
Sbjct: 19 FESNLNALLSSLSSN-AASSSGKGFAAGTSG-AAPDTVYGLAQCRGDLSASDCRSCLATA 76
Query: 213 TADILSCCYFSRGARLLSRNCYLRYELYAF 242
+++ CC +G R+ +C+LRYE Y F
Sbjct: 77 VSELRRCCPNKKGGRIWYDSCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 7e-20
Identities = 60/162 (37%), Positives = 87/162 (53%), Gaps = 22/162 (13%)
Query: 357 LGQGGFGPVYKGV---LSDGKE---VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
LG+G FG V+ LS K+ VAVK L + +F E L+ LQH+++VK
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDA----------ILFD--PRK-RGILCWRKRTNIVNGI 457
G C DGD ++V+E+M +G L+ IL D PR+ +G L + +I + I
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
A GM+YL + VHRDL N L+ +++ KI DFGM+R
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 7e-20
Identities = 56/156 (35%), Positives = 85/156 (54%), Gaps = 14/156 (8%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAE---FTNEVLLILKLQHKNLVKLLGF 413
LG G FG V+ G + +VA+K L +QG+ F E L+ +LQH LV+L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRLYA- 68
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
V + ++ E+M NGSL L P GI L K ++ IA+GM ++ R
Sbjct: 69 VVTQEPIYIITEYMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIE---RKNY 123
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508
+HRDL+A+N+L+ + KI+DFG+AR+ ++E A
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 8e-20
Identities = 59/151 (39%), Positives = 80/151 (52%), Gaps = 12/151 (7%)
Query: 357 LGQGGFGPVYK---GVLSD--GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
LG+G FG V L D G+ VAVK+L + + +F E+ ++ LQH N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 412 GFCVD-GDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
G C G L LV E++P GSL L R+R L RK + I KGM YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER--LDHRKLLLYASQICKGMEYL---GS 126
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARI 500
R VHRDL N+L++S+ KI DFG+ ++
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKV 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 56/163 (34%), Positives = 74/163 (45%), Gaps = 23/163 (14%)
Query: 357 LGQGGFGPVYKGVL------SDGKEVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
LG+G FG VYKG L VA+K L + + EF E L+ LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILF-------------DPRKRGILCWRKRTNIVNG 456
LLG C +++E++ +G L L D + L +I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
IA GM YL S VHRDL A N L+ + KISDFG++R
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 55/168 (32%), Positives = 90/168 (53%), Gaps = 12/168 (7%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKE----VAVKRL-SSCSEQGTAEFTNEVLLI 399
L + F +LG G FG VYKG+ + +G++ VA+K L + S + E +E ++
Sbjct: 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 63
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
+ + ++ +LLG C+ +L + + MP G L + + + + + N IAK
Sbjct: 64 ASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 120
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
GM YL E R+VHRDL A NVL+ + + KI+DFG+A++ E E
Sbjct: 121 GMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE 165
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 55/169 (32%), Positives = 76/169 (44%), Gaps = 29/169 (17%)
Query: 357 LGQGGFGPVYK----GVLSDGKE--VAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVK 409
+GQG FG V++ G+L VAVK L S A+F E L+ + H N+VK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFD-------------------PRKRGILCWRKR 450
LLG C G L++E+M G L+ L L ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
I +A GM YL E + VHRDL N L+ +M KI+DFG++R
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR 178
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 2e-19
Identities = 58/157 (36%), Positives = 80/157 (50%), Gaps = 15/157 (9%)
Query: 357 LGQGGFGPV----YKGVLSD-GKEVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKL 410
LG+G FG V Y G+ VAVK L C +Q T+ + E+ ++ L H+N+VK
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 411 LGFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
G C + K L+ E++P GSL L P+ + L + I +GM YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHK--LNLAQLLLFAQQICEGMAYLHSQ- 126
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
+HRDL A NVLLD+D KI DFG+A+ E
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 53/164 (32%), Positives = 81/164 (49%), Gaps = 16/164 (9%)
Query: 349 SNFSDSNILGQGGFGPVY----KGVLSDGKE--VAVKRLSSCSEQGT-AEFTNEVLLILK 401
SN + LG+G FG V+ KG+ +G E V VK L ++ +EF E+ + K
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64
Query: 402 LQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL------FDPRKRGILCWRKRTNIVN 455
L HKN+V+LLG C + + ++ E+ G L L + K L +++ +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
IA GM +L S R VHRDL A N L+ S K+S +++
Sbjct: 125 QIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 23/168 (13%)
Query: 357 LGQGGFGPVYK-GVLSDGKEVAVKRLSSCS-EQGTAEFT-NEVLLILKLQHKNLVKLLGF 413
+G+G G V+K G+ VA+K+++ E G E+ + QH +VKLL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRK-------RGILCWRKRTNIVNGIAKGMLYLHE 466
G +LV E+MP L +L D + + + ++ G+A Y+H
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYM-----RMLLKGVA----YMHA 117
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
I+HRDLK +N+L+ +D KI+DFG+AR+F+E E + ++
Sbjct: 118 ---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA 162
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 56/162 (34%), Positives = 91/162 (56%), Gaps = 16/162 (9%)
Query: 351 FSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSC-SEQGTAEFT-NEVLLILKLQ---H 404
+ + +G+G +G VYK L+ G+ VA+K++ SE+G T E+ L+ +L+ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 405 KNLVKLLGFC--VDGDEKL---LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
N+V+LL C D +L LV+E + + L L K G+ + +++ + +
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLR 118
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
G+ +LH RIVHRDLK N+L+ SD KI+DFG+ARI+
Sbjct: 119 GVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 4e-19
Identities = 56/161 (34%), Positives = 80/161 (49%), Gaps = 23/161 (14%)
Query: 357 LGQGGFGPVYKGVL------SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
LG+G FG V+ D VAVK L S+ +F E L+ LQH+++VK
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 411 LGFCVDGDEKLLVYEFMPNGSL---------DAILF---DPRKRGILCWRKRTNIVNGIA 458
G CV+GD ++V+E+M +G L DA+L + L + +I IA
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE--LTQSQMLHIAQQIA 130
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
GM+YL + VHRDL N L+ ++ KI DFGM+R
Sbjct: 131 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 4e-19
Identities = 48/156 (30%), Positives = 76/156 (48%), Gaps = 20/156 (12%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN-----EVLLILKLQHKNLVKL 410
LG+G + VYK G+ VA+K++ + + N E+ L+ +L+H N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGIAKGMLYLHE 466
L LV+EFM L+ ++ D I + T +G+ YLH
Sbjct: 68 LDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMT------LRGLEYLH- 119
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502
I+HRDLK +N+L+ SD K++DFG+AR F
Sbjct: 120 --SNWILHRDLKPNNLLIASDGVLKLADFGLARSFG 153
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 5e-19
Identities = 59/159 (37%), Positives = 84/159 (52%), Gaps = 12/159 (7%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKE----VAVKRLSSCSEQGT-AEFTNEVLLI 399
L + +LG G FG V+KG+ + +G VA+K + S + T E T+ +L +
Sbjct: 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAM 63
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
L H +V+LLG C G LV + P GSL + + R L ++ N IAK
Sbjct: 64 GSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSL--LDHVRQHRDSLDPQRLLNWCVQIAK 120
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498
GM YL E R+VHR+L A N+LL SD +I+DFG+A
Sbjct: 121 GMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVA 156
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 7e-19
Identities = 54/148 (36%), Positives = 76/148 (51%), Gaps = 12/148 (8%)
Query: 356 ILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAE----FTNEVLLILKLQHKNLVKLL 411
+LG+G FG V+KG L D VAVK +C E E F +E ++ + H N+VKL+
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVK---TCKEDLPQELKIKFLSEARILKQYDHPNIVKLI 58
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
G C +V E +P G D + F +K+ L ++ A GM YL +
Sbjct: 59 GVCTQRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--- 113
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMAR 499
+HRDL A N L+ + KISDFGM+R
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 8e-19
Identities = 47/162 (29%), Positives = 82/162 (50%), Gaps = 10/162 (6%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
LG+G +G VYK + G+ VA+K + E+ E E+ ++ + +VK G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
+ +V E+ GS+ I+ K L + I+ KG+ YLH + +H
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNKT--LTEEEIAAILYQTLKGLEYLH---SNKKIH 122
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
RD+KA N+LL+ + +K++DFG++ ++ + NTV +GT
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV--IGT 162
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 9e-19
Identities = 52/169 (30%), Positives = 75/169 (44%), Gaps = 15/169 (8%)
Query: 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKL-Q 403
+F I+G+G F V KE A+K L E+ E ++ +L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 404 HKNLVKLLGFCVDGDEKL-LVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGM 461
H ++KL + +E L V E+ PNG L I RK G L + I +
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI----RKYGSLDEKCTRFYAAEILLAL 115
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
YLH I+HRDLK N+LLD DM+ KI+DFG A++ + +
Sbjct: 116 EYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESN 161
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 9e-19
Identities = 55/173 (31%), Positives = 92/173 (53%), Gaps = 15/173 (8%)
Query: 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKR--LSSCSEQGTAEFTNEVLLILKLQHKN 406
+F N +G+G FG V+K V +D + A+K+ LS + + E +E ++ KL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI---LCWRKRTNIVNGIAKGMLY 463
+++ +D + +V E+ NG L +L R R + WR I+ G+A +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----H 116
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
LH +I+HRD+K+ N+ LD+ N KI D G+A++ +++ ANT IVGT
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGT 164
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 3e-18
Identities = 63/180 (35%), Positives = 94/180 (52%), Gaps = 29/180 (16%)
Query: 337 FFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEV 396
+ ++L+ L L I+G+G FG V +G + G++VAVK + C A F E
Sbjct: 1 WLLNLQKLTLGE-------IIGEGEFGAVLQGEYT-GQKVAVKNIK-CDVTAQA-FLEET 50
Query: 397 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN- 455
++ KL HKNLV+LLG + + +V E M G+L L R RG R +++
Sbjct: 51 AVMTKLHHKNLVRLLGVILH-NGLYIVMELMSKGNLVNFL---RTRG----RALVSVIQL 102
Query: 456 -----GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
+A+GM YL ++VHRDL A N+L+ D +K+SDFG+AR S G N+
Sbjct: 103 LQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLAR--VGSMGVDNS 157
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-18
Identities = 58/158 (36%), Positives = 86/158 (54%), Gaps = 12/158 (7%)
Query: 356 ILGQGGFGPVYKGV-LSDGKE----VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
+LG G FG VYKG+ + DG+ VA+K L + S + E +E ++ + + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
LLG C+ +L V + MP G L + + + R + + N IAKGM YL E
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDR--IGSQDLLNWCVQIAKGMSYLEE--- 127
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
+R+VHRDL A NVL+ S + KI+DFG+AR+ E E
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 165
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 3e-18
Identities = 56/154 (36%), Positives = 85/154 (55%), Gaps = 16/154 (10%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKR--LSSCSEQGTAE-------FTNEVLLILKLQHK 405
++G G FG VY G+ S G+ +AVK+ L S S E+ L+ +LQH+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
N+V+ LG +D D + E++P GS+ A+L G N V I KG+ YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVRNFVRQILKGLNYLH 123
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+R I+HRD+K +N+L+D+ KISDFG+++
Sbjct: 124 --NR-GIIHRDIKGANILVDNKGGIKISDFGISK 154
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-18
Identities = 54/156 (34%), Positives = 86/156 (55%), Gaps = 14/156 (8%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
LG G FG V+ G + +VAVK L + + F E ++ KL+H LV+L + V
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRHDKLVQL--YAVV 70
Query: 417 GDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN---GIAKGMLYLHEDSRLRI 472
+E + +V E+M GSL L D R + K N+V+ +A GM Y+ R+
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKDGEGRAL----KLPNLVDMAAQVAAGMAYIE---RMNY 123
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508
+HRDL+++N+L+ + KI+DFG+AR+ ++E A
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 5e-18
Identities = 51/159 (32%), Positives = 80/159 (50%), Gaps = 9/159 (5%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN 406
+ +LG+G +G VY LS +A+K + + E+ L L+H+N
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG--IAKGMLYL 464
+V+ LG + + E +P GSL A+L K G L ++T I I +G+ YL
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIIFYTKQILEGLKYL 124
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFA 502
H+ +IVHRD+K NVL+++ KISDFG ++ A
Sbjct: 125 HD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 7e-18
Identities = 51/164 (31%), Positives = 80/164 (48%), Gaps = 25/164 (15%)
Query: 355 NILGQGGFGPVYKGVL--SDGKEV--AVKRLSSCSE-QGTAEFTNEVLLILKLQHKNLVK 409
++G+G FG VY G L SDG+++ AVK L+ ++ + +F E +++ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 410 LLGFCVDGD-EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG-------IAKGM 461
LLG C+ + L+V +M +G L + V +AKGM
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSE---------THNPTVKDLIGFGLQVAKGM 111
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
YL + VHRDL A N +LD K++DFG+AR + E
Sbjct: 112 EYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 8e-18
Identities = 45/155 (29%), Positives = 71/155 (45%), Gaps = 11/155 (7%)
Query: 356 ILGQGGFGPVYKGVLSDGK----EVAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKL 410
+G+G FG VY+GV + VAVK +C+ E F E ++ + H ++VKL
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
+G + + +V E P G L + L + L ++ + YL
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES---K 126
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
R VHRD+ A NVL+ S K+ DFG++R +
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 1e-17
Identities = 52/151 (34%), Positives = 77/151 (50%), Gaps = 10/151 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
LG G FG V+ G +VA+K + SE+ +F E +++KL H LV+L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
+V EFM NG L + + +++G L ++ + +GM YL +S +H
Sbjct: 69 TQQKPLYIVTEFMENGCL--LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIH 123
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESE 505
RDL A N L+ S K+SDFGM R + E
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 52/146 (35%), Positives = 78/146 (53%), Gaps = 10/146 (6%)
Query: 356 ILGQGGFGPVYKGVLS-DGKE---VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
ILG G FG + +G L K VA+ L + CS++ F E L + + H N+V+L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
G G+ ++V E+M NG+LD+ L + G L + ++ G+A GM YL E +
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYLSE---M 126
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFG 496
VH+ L A VL++SD+ KIS F
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 53/153 (34%), Positives = 84/153 (54%), Gaps = 8/153 (5%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
LGQG FG V+ G + VA+K L + A F E ++ KL+H+ LV+L + V
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 70
Query: 417 GDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
+E + +V E+M GSL L L + ++ IA GM Y+ R+ VHR
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508
DL+A+N+L+ ++ K++DFG+AR+ ++E A
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTA 159
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 54/153 (35%), Positives = 81/153 (52%), Gaps = 7/153 (4%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
LG G FG V+ G ++ +VAVK L + A F E L+ LQH LV+L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 417 GDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
+ ++ E+M GSL D + D + +L K + IA+GM Y+ R +HR
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNYIHR 127
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508
DL+A+NVL+ + KI+DFG+AR+ ++E A
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 56/163 (34%), Positives = 80/163 (49%), Gaps = 17/163 (10%)
Query: 357 LGQGGFGPVY----KGVLSDGKE--VAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNLVK 409
LGQG FG VY KGV+ D E VA+K ++ + S + EF NE ++ + ++V+
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR-------GILCWRKRTNIVNGIAKGML 462
LLG G L++ E M G L + L R +K + IA GM
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
YL+ + + VHRDL A N ++ D KI DFGM R E++
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 173
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 4e-17
Identities = 57/156 (36%), Positives = 86/156 (55%), Gaps = 14/156 (8%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
LGQG FG V+ G + +VA+K L + A F E ++ KL+H LV L + V
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPL--YAVV 70
Query: 417 GDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN---GIAKGMLYLHEDSRLRI 472
+E + +V EFM GSL D K G + K +V+ IA GM Y+ R+
Sbjct: 71 SEEPIYIVTEFMGKGSL----LDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNY 123
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508
+HRDL+A+N+L+ ++ KI+DFG+AR+ ++E A
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 8e-17
Identities = 50/156 (32%), Positives = 75/156 (48%), Gaps = 18/156 (11%)
Query: 355 NILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
+ LG G +G VY+GV VAVK L EF E ++ +++H NLV+LLG
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV------NGIAKGMLYLHED 467
C ++ EFM G+L L + C R+ N V I+ M YL +
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRE-------CNRQEVNAVVLLYMATQISSAMEYLEKK 123
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503
+ +HRDL A N L+ + K++DFG++R+
Sbjct: 124 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 9e-17
Identities = 52/151 (34%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
LG G FG V G +VA+K + S SE EF E +++KL H+ LV+L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
+V E+M NG L L + KR + + + +GM YL + +H
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESK---QFIH 123
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESE 505
RDL A N L+D K+SDFG++R + E
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 9e-17
Identities = 57/181 (31%), Positives = 87/181 (48%), Gaps = 29/181 (16%)
Query: 347 ATSNFSD---SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTA-EFTNEVLLILK 401
A + S+ N +G G G VYK + G+ A+K + E + E+ ++
Sbjct: 69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRD 128
Query: 402 LQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT------NIVN 455
+ H N+VK E ++ EFM GSL+ G ++ I++
Sbjct: 129 VNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE---------GTHIADEQFLADVARQILS 179
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515
GIA YLH R IVHRD+K SN+L++S N KI+DFG++RI A++ N+ VG
Sbjct: 180 GIA----YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VG 230
Query: 516 T 516
T
Sbjct: 231 T 231
|
Length = 353 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 55/163 (33%), Positives = 77/163 (47%), Gaps = 17/163 (10%)
Query: 357 LGQGGFGPVYKGVLSD------GKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNLVK 409
LGQG FG VY+G D VAVK ++ S S + EF NE ++ ++V+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILF-------DPRKRGILCWRKRTNIVNGIAKGML 462
LLG G L+V E M +G L + L + R ++ + IA GM
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
YL+ + VHRDL A N ++ D KI DFGM R E++
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD 173
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 47/149 (31%), Positives = 77/149 (51%), Gaps = 9/149 (6%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN--EVLLILKLQHKNLVKLLGF 413
+G+G +G VYK G+ VA+K++ E T E+ L+ +L H N++KLL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
+ LV+EFM I R+RG L + + + +G+ + H I+
Sbjct: 67 FRHKGDLYLVFEFMDTDLYKLI--KDRQRG-LPESLIKSYLYQLLQGLAFCH---SHGIL 120
Query: 474 HRDLKASNVLLDSDMNSKISDFGMARIFA 502
HRDLK N+L++++ K++DFG+AR F
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFG 149
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 53/146 (36%), Positives = 77/146 (52%), Gaps = 10/146 (6%)
Query: 356 ILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKLLGFC 414
+G+G FG V G G +VAVK + + TA+ F E ++ +L+H NLV+LLG
Sbjct: 13 TIGKGEFGDVMLGDYR-GNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 415 VDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
V+ L +V E+M GSL L R R +L + + M YL ++ V
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FV 124
Query: 474 HRDLKASNVLLDSDMNSKISDFGMAR 499
HRDL A NVL+ D +K+SDFG+ +
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 62/165 (37%), Positives = 91/165 (55%), Gaps = 16/165 (9%)
Query: 357 LGQGGFGPVY------KGVLSDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVK 409
LG+G FG V +G + G++VAVK L S A+ E+ ++ L H+N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 410 LLGFCV-DGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
G C DG + L+ EF+P+GSL L PR + + +++ I KGM YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYL--G 126
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR 512
SR + VHRDL A NVL++S+ KI DFG+ + E++ E TV+
Sbjct: 127 SR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYYTVK 169
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 2e-16
Identities = 57/171 (33%), Positives = 82/171 (47%), Gaps = 26/171 (15%)
Query: 357 LGQGGFGPVYKGV--LSDGKEVAVKRLS--SCSEQGTAEFT-NEVLLILKLQHKNLVKLL 411
LG+G FG V V GK A+K L ++ E T E ++ ++ H +VKL
Sbjct: 1 LGKGSFGKVLL-VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 412 GFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRT-----NIVNGIAKGMLYLH 465
+ +EKL LV E+ P G L + L K G +R IV + YLH
Sbjct: 60 -YAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFS-EERARFYAAEIVLALE----YLH 110
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
L I++RDLK N+LLD+D + K++DFG+A+ + NT GT
Sbjct: 111 ---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGT 156
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 48/165 (29%), Positives = 82/165 (49%), Gaps = 32/165 (19%)
Query: 358 GQGGFGPVYKGVL---SDGKEVAVKRLSSCSEQGT---AEFTNEVLLILKLQHKNLVKLL 411
G+G +G VYK DGKE A+K+ EQ T E+ L+ +L+H+N+V L+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 412 GFCVDGDEKL--LVYEFMPNGSLDAILFDPRKRGI---------LCWRKRTNIVNGIAKG 460
++ +K L++++ + I F + + + L W+ I+NG+
Sbjct: 69 EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ----ILNGVH-- 122
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNS----KISDFGMARIF 501
YLH + ++HRDLK +N+L+ + KI D G+AR+F
Sbjct: 123 --YLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 4e-16
Identities = 53/159 (33%), Positives = 80/159 (50%), Gaps = 14/159 (8%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRL-----SSCSEQGTAEFTNEVLLILKL 402
+N+ +LGQG FG VY +D G+E+AVK++ S + + E+ L+ L
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 403 QHKNLVKLLGFCVDGDEKLL--VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
H+ +V+ G D E+ L E MP GS+ L + G L I +G
Sbjct: 62 LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL---KSYGALTENVTRKYTRQILEG 118
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+ YLH + IVHRD+K +N+L DS N K+ DFG ++
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 5e-16
Identities = 48/148 (32%), Positives = 69/148 (46%), Gaps = 9/148 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVA---VKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
+G G FG V G G A VK L +S + F EV +L H N+++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT--NIVNGIAKGMLYLHEDSRL 470
C++ LLV EF P G L L R +K + +A G+L+LH +
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QA 119
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMA 498
+H DL N L +D++ KI D+G+A
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 6e-16
Identities = 42/151 (27%), Positives = 74/151 (49%), Gaps = 11/151 (7%)
Query: 351 FSDSNILGQGGFGPVYKGV-LSDGKEVAVKR--LSSCSEQGTAEFTNEVLLILKLQHKNL 407
F+ +G+G FG VYK + + VA+K L +E + E+ + + + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYI 61
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
K G + G + ++ E+ GS D K G L I+ + G+ YLHE+
Sbjct: 62 TKYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498
+HRD+KA+N+LL + + K++DFG++
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 7e-16
Identities = 52/144 (36%), Positives = 83/144 (57%), Gaps = 8/144 (5%)
Query: 357 LGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLG-FC 414
LG G FG VYK + G A K + + SE+ ++ E+ ++ H +VKLLG F
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
DG +++ EF P G++DAI+ + RG+ + + I + + + YLH ++I+H
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIMLE-LDRGLTEPQIQV-ICRQMLEALQYLHS---MKIIH 133
Query: 475 RDLKASNVLLDSDMNSKISDFGMA 498
RDLKA NVLL D + K++DFG++
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVS 157
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 53/170 (31%), Positives = 80/170 (47%), Gaps = 32/170 (18%)
Query: 357 LGQGGFGPVY----KGVLS---------DGKE--VAVKRL-SSCSEQGTAEFTNEVLLIL 400
LG+G FG V+ +G+ DG+ VAVK L + ++ +F E+ ++
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 401 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNI------- 453
+L++ N+++LLG CV D ++ E+M NG L+ L NI
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFT--HANNIPSVSIAN 130
Query: 454 ----VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
IA GM YL + L VHRDL N L+ + KI+DFGM+R
Sbjct: 131 LLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 53/177 (29%), Positives = 87/177 (49%), Gaps = 24/177 (13%)
Query: 355 NILGQGGFGPVYKGV-LSDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
+G+G FG V K SDGK + K + + +E+ + +EV ++ +L+H N+V+
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 412 GFCVDGDEKLL--VYEFMPNGSLDAILFDPRK-RGIL----CWRKRTNIVNGIAKGMLYL 464
+D + L V E+ G L ++ +K R + WR T ++ L L
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLL-------LAL 118
Query: 465 HE-----DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
+E D ++HRDLK +N+ LD++ N K+ DFG+A+I A T VGT
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGT 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 53/165 (32%), Positives = 78/165 (47%), Gaps = 16/165 (9%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHK----NLVKLL 411
LG G G V K + GK +AVK + E A ++L L + HK +V
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRL--EINEAIQ-KQILRELDILHKCNSPYIVGFY 65
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
G + + + E+M GSLD IL +G + R I + KG+ YLHE +
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAVLKGLTYLHEK--HK 121
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
I+HRD+K SN+L++S K+ DFG++ S + VGT
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF----VGT 162
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (188), Expect = 2e-15
Identities = 48/161 (29%), Positives = 71/161 (44%), Gaps = 38/161 (23%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN--------EVLLILKLQ-HKN 406
LG G FG VY G+ VA+K++ +F + EV + KL H N
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSL-------DAILFDPRK-RGILCWRKRTNIVNGIA 458
+VKL + DE V+E+M G+L F R +I+ I
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIR---------SIIYQIL 109
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+G+ ++H + HRDLK N+L+ KI+DFG+AR
Sbjct: 110 QGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-15
Identities = 55/158 (34%), Positives = 83/158 (52%), Gaps = 14/158 (8%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLS-SCSEQGTAEFTN----EVLLILKLQ 403
N+ +LG+G FG VY +D G+E+AVK++ Q T++ N E+ L+ L+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 404 HKNLVKLLGFCVDGDEKLL--VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
H +V+ G D +EK L E+MP GS+ L + G L I +G+
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGALTENVTRRYTRQILQGV 119
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
YLH + IVHRD+K +N+L DS N K+ DFG ++
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 4e-15
Identities = 55/158 (34%), Positives = 80/158 (50%), Gaps = 14/158 (8%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRL-----SSCSEQGTAEFTNEVLLILKLQ 403
N+ +LGQG FG VY D G+E+A K++ S + + + E+ L+ LQ
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 404 HKNLVKLLGFCVDGDEKLLV--YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
H+ +V+ G D EK L E+MP GS+ L + G L I +GM
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL---KAYGALTESVTRKYTRQILEGM 119
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
YLH + IVHRD+K +N+L DS N K+ DFG ++
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 53/148 (35%), Positives = 75/148 (50%), Gaps = 9/148 (6%)
Query: 357 LGQGGFGPVYKGVLSDG---KEVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
+G G FG V G ++ G +V VK L S S Q +F E LQH NL++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT--NIVNGIAKGMLYLHEDSRL 470
C + LLV EF P G L L RK ++ T + IA G+L+LH+++
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN-- 120
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMA 498
+H DL N LL +D+ KI D+G++
Sbjct: 121 -FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 51/153 (33%), Positives = 81/153 (52%), Gaps = 18/153 (11%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
+G+G +G VYK G+ VA+K RL + E + E+ L+ +L H N+V+LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 414 CVDGDEKL-LVYEFMP---NGSLDAILFDPRKRGILCWRKRTN-IVNGIAKGMLYLHEDS 468
V + KL LV+EF+ +D+ ++ + ++ GIA Y H S
Sbjct: 67 -VHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLI--KSYLYQLLQGIA----YCH--S 117
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
R++HRDLK N+L+D + K++DFG+AR F
Sbjct: 118 H-RVLHRDLKPQNLLIDREGALKLADFGLARAF 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 42/154 (27%), Positives = 68/154 (44%), Gaps = 12/154 (7%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL----QHK 405
+ + LG+G G V K L + + + + + ++L L++ +
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSP 59
Query: 406 NLVKLLGFCVDGDEKLL--VYEFMPNGSLDAILFDPRKRGILCWRKRT-NIVNGIAKGML 462
+VK G +D + E+ GSLD+I +KRG K I + KG+
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496
YLH +I+HRD+K SN+LL K+ DFG
Sbjct: 120 YLHSR---KIIHRDIKPSNILLTRKGQVKLCDFG 150
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 4e-15
Identities = 47/157 (29%), Positives = 81/157 (51%), Gaps = 17/157 (10%)
Query: 357 LGQGGFGPVYKGVLSDGK---EVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
LG+G FG V +G L+ +VAVK +++ C+ +F +E + + + H N+++L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 412 GFCVDGDEK------LLVYEFMPNGSLDAILFDPR---KRGILCWRKRTNIVNGIAKGML 462
G C+ E +++ FM +G L + L R L + + IA GM
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
YL S +HRDL A N +L+ +MN ++DFG+++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 47/155 (30%), Positives = 79/155 (50%), Gaps = 17/155 (10%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVK----------RLSSCSEQGTAEFTNEVLLILKLQH 404
++G+G +G VY + ++ G+ +AVK R S + +E+ + L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
N+V+ LGF + + E++P GS+ + L R G + + +G+ YL
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL---RTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
H I+HRDLKA N+L+D+D KISDFG+++
Sbjct: 125 HSKG---ILHRDLKADNLLVDADGICKISDFGISK 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 6e-15
Identities = 45/133 (33%), Positives = 64/133 (48%), Gaps = 12/133 (9%)
Query: 376 VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDA 434
VAVK L S+ +F EV ++ +L N+ +LLG C ++ E+M NG L+
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 435 IL--FDPRKRGILCWRK---RTNIVN---GIAKGMLYLHEDSRLRIVHRDLKASNVLLDS 486
L G+ C K + ++ IA GM YL L VHRDL N L+
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGK 165
Query: 487 DMNSKISDFGMAR 499
+ KI+DFGM+R
Sbjct: 166 NYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 6e-15
Identities = 48/154 (31%), Positives = 73/154 (47%), Gaps = 9/154 (5%)
Query: 354 SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTA--EFTNEVLLILKLQHKNLVKL 410
N +G G FG VY V L G+ +AVK + E +E+ ++ L+H NLVK
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
G V ++ + E+ G+L+ +L R R T + +G+ YLH
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTL---QLLEGLAYLHSH--- 118
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504
IVHRD+K +N+ LD + K+ DFG A +
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 7e-15
Identities = 56/167 (33%), Positives = 83/167 (49%), Gaps = 9/167 (5%)
Query: 355 NILGQGGFGPVYKGV-LSDGKEVAVKR--LSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
++G G VY + L + ++VA+KR L C E EV + + H N+VK
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS-VDELRKEVQAMSQCNHPNVVKYY 65
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
V GDE LV ++ GSL I+ RG L ++ + KG+ YLH + +
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR--IVGT 516
+HRD+KA N+LL D + KI+DFG++ A+ VR VGT
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 8e-15
Identities = 50/160 (31%), Positives = 76/160 (47%), Gaps = 31/160 (19%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
+G+G +G VYKG G+ VA+K RL S E + E+ L+ +LQH N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 414 CVDGDEKLLVYEFM------------PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
+ L++EF+ +DA L IL +G+
Sbjct: 68 LMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQIL-------------QGI 114
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
L+ H R++HRDLK N+L+D+ K++DFG+AR F
Sbjct: 115 LFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF 151
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 51/150 (34%), Positives = 80/150 (53%), Gaps = 8/150 (5%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
LG G FG V+ + +VAVK + S A F E ++ LQH LVKL V
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHA-VVT 71
Query: 417 GDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
+ ++ EFM GSL D + D + L K + IA+GM ++ + + +HR
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YIHR 126
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESE 505
DL+A+N+L+ + + KI+DFG+AR+ ++E
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 54/172 (31%), Positives = 78/172 (45%), Gaps = 31/172 (18%)
Query: 356 ILGQGGFGPVYKGVLSDGK------EVAVKRLSSCSEQGT-AEFTNEVLLILKLQHKNLV 408
LG+G FG V K K VAVK L + + +E L+ ++ H +++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRK-----RGILCWRKRTNIVNG------- 456
KL G C LL+ E+ GSL + L + RK G R + + N
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 457 ---------IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
I++GM YL E +++VHRDL A NVL+ KISDFG++R
Sbjct: 127 GDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 47/158 (29%), Positives = 81/158 (51%), Gaps = 15/158 (9%)
Query: 354 SNILGQGGFGPVYKGVLSDGK-----EVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNL 407
S++L +G FG ++ G+L D K EV VK + SE E L+ L H+N+
Sbjct: 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNI 70
Query: 408 VKLLGFCV-DGDEKLLVYEFMPNGSLDAILFDPRKRGI-----LCWRKRTNIVNGIAKGM 461
+ +L C+ DG+ ++Y +M G+L L R L ++ ++ IA GM
Sbjct: 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
YLH + ++H+D+ A N ++D ++ KI+D ++R
Sbjct: 131 SYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSR 165
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 46/151 (30%), Positives = 77/151 (50%), Gaps = 12/151 (7%)
Query: 349 SNFSDSNILGQGGFGPVYKG-VLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL 407
S + +G+G G V S G++VAVK++ +Q NEV+++ QH N+
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR--KRGILCWRKRTNIVNGIAKGMLYLH 465
V++ + GDE +V EF+ G+L I+ R + I + + K + +LH
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT------VCLAVLKALSFLH 132
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496
++HRD+K+ ++LL SD K+SDFG
Sbjct: 133 AQ---GVIHRDIKSDSILLTSDGRVKLSDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 50/154 (32%), Positives = 86/154 (55%), Gaps = 6/154 (3%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGT-AEFTNEVLLILKLQHKNL 407
NF LG+G + VYKG + G+ VA+K + +E+GT + E+ L+ +L+H+N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
V+L ++ +LV+E+M + L + RG L + + KG+ + HE+
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
R++HRDLK N+L++ K++DFG+AR F
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAF 150
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 53/175 (30%), Positives = 91/175 (52%), Gaps = 19/175 (10%)
Query: 350 NFSDSNILGQGGFGPVYK-GVLSDGKEVAVKR--LSSCSEQGTAEFTNEVLLILKLQHKN 406
+F LG+G +G VYK LSD + A+K L S S++ + NE+ ++ + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGIL-----CWRKRTNIVNGIAKGM 461
++ +DG++ +V E+ P G L + +K+ L WR I + +G+
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR----IFIQLLRGL 116
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
LHE +I+HRDLK++N+LL ++ KI D G++++ + A T +GT
Sbjct: 117 QALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLK--KNMAKTQ--IGT 164
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 55/166 (33%), Positives = 84/166 (50%), Gaps = 26/166 (15%)
Query: 357 LGQGGFGPVYK----GVLSDGKE----VAVKRLS-SCSEQGTAEFTNEV-LLILKLQHKN 406
LG+G FG V + G+ + VAVK L + +++ A+ +E+ L+ L +HKN
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAIL-----------FDPRK--RGILCWRKRTNI 453
++ LLG C ++ E+ G+L L FD K L ++ +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+A+GM YL +SR R +HRDL A NVL+ D KI+DFG+AR
Sbjct: 140 AYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-14
Identities = 45/159 (28%), Positives = 79/159 (49%), Gaps = 18/159 (11%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSC----SEQGTA--EFTNEVLLILKL 402
+ LG G F Y+ + G +AVK+++ SEQ E+ L+ +L
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL--FDPRKRGILCWRKRTNIVNGIAKG 460
H +++++LG + L E+M GS+ +L + K ++ N + +G
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRG 115
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGMA 498
+ YLHE+ +I+HRD+K +N+L+DS +I+DFG A
Sbjct: 116 LSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAA 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 50/167 (29%), Positives = 76/167 (45%), Gaps = 28/167 (16%)
Query: 356 ILGQGGFGPVYKGVLSD------GKEVAVKRL-SSCSEQGTAEFTNEVLLILKL--QHKN 406
LG+G FG V K VAVK L +E+ ++ +E + ++K+ +HKN
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSE-MEMMKMIGKHKN 77
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG---------- 456
++ LLG C +V E+ +G+L L R G
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYA-SPDDPRPPEETLTQKDLVS 136
Query: 457 ----IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+A+GM +L S+ + +HRDL A NVL+ D KI+DFG+AR
Sbjct: 137 FAYQVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 50/169 (29%), Positives = 73/169 (43%), Gaps = 29/169 (17%)
Query: 357 LGQGGFGPVY------------KGVLSDGKE-----VAVKRL-SSCSEQGTAEFTNEVLL 398
LG+G FG V+ K D VAVK L ++ +F E+ +
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG-- 456
+ +L+ N+++LL C+ D ++ E+M NG L+ L + I
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 457 ------IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
IA GM YL S L VHRDL N L+ + KI+DFGM+R
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 45/144 (31%), Positives = 78/144 (54%), Gaps = 8/144 (5%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL-GFC 414
LG G FG VYK G A K + SE+ +F E+ ++ + +H N+V L +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
+ +L+ EF G+LD+I+ +RG+ + R + + + + +LH +++H
Sbjct: 73 YENKLWILI-EFCDGGALDSIM-LELERGLTEPQIRY-VCRQMLEALNFLHSH---KVIH 126
Query: 475 RDLKASNVLLDSDMNSKISDFGMA 498
RDLKA N+LL D + K++DFG++
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 50/160 (31%), Positives = 84/160 (52%), Gaps = 18/160 (11%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKN 406
NF +G+G +G VYK G+ VA+K RL + +E + E+ L+ +L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 407 LVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG----IAKGM 461
+VKLL + + KL LV+EF+ + L + GI ++ + +G+
Sbjct: 61 IVKLLD-VIHTENKLYLVFEFL-HQDLKKFMDASPLSGI-----PLPLIKSYLFQLLQGL 113
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
+ H R++HRDLK N+L++++ K++DFG+AR F
Sbjct: 114 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 3e-14
Identities = 51/154 (33%), Positives = 79/154 (51%), Gaps = 12/154 (7%)
Query: 357 LGQGGFGPVYKGVLS---DGKEVAVKRLSSCSEQGTA--EFTNEVLLILKLQHKNLVKLL 411
LG G FG V KG+ K VAVK L + + E E ++ +L + +V+++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
G C + + +LV E G L+ L +K + + T +V+ ++ GM YL E +
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN--- 115
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
VHRDL A NVLL + +KISDFG+++ E
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE 149
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 5e-14
Identities = 48/173 (27%), Positives = 82/173 (47%), Gaps = 21/173 (12%)
Query: 356 ILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGF 413
++G+G +G VYK G+ VA+K + ++ E E ++ K H N+ G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEE-EIKEEYNILRKYSNHPNIATFYGA 71
Query: 414 ------CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN----IVNGIAKGMLY 463
+ D+ LV E GS+ ++ RK+G R + I+ +G+ Y
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG---KRLKEEWIAYILRETLRGLAY 128
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
LHE+ +++HRD+K N+LL + K+ DFG++ + G NT +GT
Sbjct: 129 LHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF--IGT 176
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 5e-14
Identities = 54/158 (34%), Positives = 89/158 (56%), Gaps = 14/158 (8%)
Query: 357 LGQGGFGPVYKGVLSDGKE-VAVKRL-SSCSEQGTAEFT-NEVLLILKL-QHKNLVKLLG 412
LG+G +G V+K + KE VA+K++ + A+ T E++ + +L H N+VKLL
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLN 74
Query: 413 -FCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
+ D+ + LV+E+M L A++ + IL + I+ + K + Y+H S
Sbjct: 75 VIKAENDKDIYLVFEYMET-DLHAVI----RANILEDVHKRYIMYQLLKALKYIH--SG- 126
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508
++HRDLK SN+LL+SD K++DFG+AR +E E
Sbjct: 127 NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP 164
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 6e-14
Identities = 48/150 (32%), Positives = 78/150 (52%), Gaps = 10/150 (6%)
Query: 357 LGQGGFGPVYKGVLSDGK---EVAVKRLSSCSEQG-TAEFTNEVLLILKLQHKNLVKLLG 412
LG G FG V KGV K +VA+K L + +E+ E E ++ +L + +V+++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
C + + +LV E G L+ L K+ + +++ ++ GM YL +
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN---F 116
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFA 502
VHRDL A NVLL + +KISDFG+++
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALG 146
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 50/168 (29%), Positives = 85/168 (50%), Gaps = 11/168 (6%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLV 408
F+ +G+G FG VYKG+ + KEV ++ +E + E+ ++ + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
+ G + G + ++ E++ GS D K G L I+ I KG+ YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSA----LDLLKPGPLEETYIATILREILKGLDYLHSE- 120
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
R +HRD+KA+NVLL + K++DFG+A +++ + NT VGT
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 164
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 8e-14
Identities = 51/172 (29%), Positives = 86/172 (50%), Gaps = 21/172 (12%)
Query: 346 LATSNFSDSNILGQGGFGPVYKG-VLSDG--KEVAVKRLSS-CSEQGTAEFTNEVLLILK 401
L ++ +++G+G FG V K + DG + A+KR+ S+ +F E+ ++ K
Sbjct: 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 63
Query: 402 L-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL-------FDP------RKRGILCW 447
L H N++ LLG C L E+ P+G+L L DP L
Sbjct: 64 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123
Query: 448 RKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
++ + +A+GM YL S+ + +HRDL A N+L+ + +KI+DFG++R
Sbjct: 124 QQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 9e-14
Identities = 51/148 (34%), Positives = 70/148 (47%), Gaps = 13/148 (8%)
Query: 357 LGQGGFGPVYKGVL-SDGKEVAVKRLSSCSE----QGTAEFTNEVLLILKLQHKNLVKLL 411
+G+G FG V+ G L +D VAVK SC E A+F E ++ + H N+V+L+
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVK---SCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
G C +V E + G L R L ++ +V A GM YL
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTEGPR--LKVKELIQMVENAAAGMEYLESKH--- 114
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMAR 499
+HRDL A N L+ KISDFGM+R
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 52/163 (31%), Positives = 86/163 (52%), Gaps = 21/163 (12%)
Query: 355 NILGQGGFGPVYKGVLS-DGKEV--AVKRLSS-CSEQGTAEFTNEVLLILKL-QHKNLVK 409
+++G+G FG V + ++ DG ++ A+K L SE +F E+ ++ KL H N++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAIL-------FDP---RKRGI---LCWRKRTNIVNG 456
LLG C + + E+ P G+L L DP ++ G L ++ +
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+A GM YL E + +HRDL A NVL+ ++ SKI+DFG++R
Sbjct: 128 VATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 1e-13
Identities = 49/163 (30%), Positives = 82/163 (50%), Gaps = 21/163 (12%)
Query: 355 NILGQGGFGPVYKGVLS-DGKEV--AVKRLSS-CSEQGTAEFTNEVLLILKL-QHKNLVK 409
+++G+G FG V K + DG + A+KR+ S+ +F E+ ++ KL H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAIL-------FDP---RKRGI---LCWRKRTNIVNG 456
LLG C L E+ P+G+L L DP L ++ +
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+A+GM YL + + +HRDL A N+L+ + +KI+DFG++R
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 50/177 (28%), Positives = 87/177 (49%), Gaps = 16/177 (9%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQ 403
NF +G+G F VYK + L DG+ VA+K++ + + E+ L+ +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL--FDPRKRGILCWRKRT--NIVNGIAK 459
H N++K L ++ +E +V E G L ++ F +KR I +RT +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLI---PERTIWKYFVQLCS 117
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
+ ++H RI+HRD+K +NV + + K+ D G+ R F+ A++ +VGT
Sbjct: 118 ALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 53/177 (29%), Positives = 83/177 (46%), Gaps = 37/177 (20%)
Query: 357 LGQGGFGPVYKGVLSDGKE-----------------VAVKRL-SSCSEQGTAEFTNEVLL 398
LG+G FG V+ + + ++ VAVK L ++ +F EV +
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDA-----ILFDPRKRG---------- 443
+ +L+ N+++LLG CVD D ++ E+M NG L+ L D + G
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 444 -ILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+ + ++ IA GM YL S L VHRDL N L+ ++ KI+DFGM+R
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSR 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 55/176 (31%), Positives = 80/176 (45%), Gaps = 25/176 (14%)
Query: 344 LNLATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSCSEQG-TAEFTNEV 396
+NL+T F + LG+ FG VYKG L + VA+K L +E EF +E
Sbjct: 2 INLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEA 59
Query: 397 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILF-------------DPRKRG 443
++ +LQH N+V LLG +++ + + L L D +
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 444 ILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
L +IV IA GM +L S +VH+DL NVL+ +N KISD G+ R
Sbjct: 120 TLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 52/164 (31%), Positives = 83/164 (50%), Gaps = 23/164 (14%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKE-VAVKRLSSCSEQGTAEFTN--EVLLILKLQHK 405
+ F N +G+G +G VY+ + E VA+K++ +E+ ++ E+ L+L L+H
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHP 66
Query: 406 NLVKLLGFCVDG--DEKLLVYEFMPNGSLD-AILFDPRKR-----GILCWRKRTNIVNGI 457
N+V+L V D LV E+ D A L D + C ++ +
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEYCEQ---DLASLLDNMPTPFSESQVKC------LMLQL 117
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
+G+ YLHE+ I+HRDLK SN+LL KI+DFG+AR +
Sbjct: 118 LRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 48/163 (29%), Positives = 88/163 (53%), Gaps = 14/163 (8%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFT-NEVLLILKLQHKNLVKLLGFC 414
+GQG G VY + ++ G+EVA+K+++ +Q E NE+L++ + +H N+V L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMN-LQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 415 VDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
+ GDE +V E++ GSL D + G + + + + +LH + +++
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQI-----AAVCRECLQALEFLHSN---QVI 137
Query: 474 HRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
HRD+K+ N+LL D + K++DFG + + +T +VGT
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 43/166 (25%), Positives = 89/166 (53%), Gaps = 14/166 (8%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQH---KNLVKL 410
++G+G +G VY+G + G+ VA+K ++ + ++ EV L+ +L+ N+ K
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
G + G ++ E+ GS+ ++ K G + + + I+ + + Y+H+
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIHKVG-- 121
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
++HRD+KA+N+L+ + N K+ DFG+A + ++ + +T VGT
Sbjct: 122 -VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGT 164
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 52/180 (28%), Positives = 91/180 (50%), Gaps = 20/180 (11%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFT--NEVLLILKLQHK 405
S + +GQG FG V+K + VA+K++ +E+ T E+ ++ L+H+
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71
Query: 406 NLVKLLGFCVDGDEK--------LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGI 457
N+V L+ C LV+EF + L +L + + L K+ ++ +
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKK--VMKML 128
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN---TVRIV 514
G+ Y+H R +I+HRD+KA+N+L+ D K++DFG+AR F+ S+ T R+V
Sbjct: 129 LNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 50/176 (28%), Positives = 91/176 (51%), Gaps = 25/176 (14%)
Query: 355 NILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFT--NEVLLILKLQHKNLVKLL 411
+G+G +G VYK D G+ VA+K++ +E+ T E+ ++ +L H+N+V L
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 412 GFCVDGDEKL----------LVYEFMPN---GSLDAILFDPRKRGILCWRKRTNIVNGIA 458
D + L LV+E+M + G L++ L + I + K+ +
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQ------LL 126
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
+G+ Y H+ + L HRD+K SN+LL++ K++DFG+AR++ E T +++
Sbjct: 127 EGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 39/124 (31%), Positives = 67/124 (54%), Gaps = 7/124 (5%)
Query: 373 GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432
GK+VAVK++ +Q NEV+++ H+N+V + + GDE +V EF+ G+L
Sbjct: 47 GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106
Query: 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKI 492
I+ R + + + + + + YLH ++HRD+K+ ++LL SD K+
Sbjct: 107 TDIVTHTR----MNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKL 159
Query: 493 SDFG 496
SDFG
Sbjct: 160 SDFG 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 47/147 (31%), Positives = 80/147 (54%), Gaps = 14/147 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKEV----AVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL- 411
LG G FG VYK + KE A K + + SE+ ++ E+ ++ H N+VKLL
Sbjct: 13 LGDGAFGKVYK---AQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 69
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
F + + +L+ EF G++DA++ + + L + + + + YLHE+ +
Sbjct: 70 AFYYENNLWILI-EFCAGGAVDAVMLELERP--LTEPQIRVVCKQTLEALNYLHEN---K 123
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMA 498
I+HRDLKA N+L D + K++DFG++
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-12
Identities = 59/256 (23%), Positives = 102/256 (39%), Gaps = 49/256 (19%)
Query: 246 ATEPSILAGNQASGGG------------KQRKMWMIIVLASVVALLLVVFASTGYFFATK 293
A S +AGN GG ++ W + ++ A L++ + G+ F
Sbjct: 595 AINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVF--- 651
Query: 294 KITRKRKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSD 353
R R K+++ D + Q + T+N S+ +
Sbjct: 652 --IRGRNNLELKRVE------NEDGTWELQFFDSK---------VSKSITINDILSSLKE 694
Query: 354 SNILGQGGFGPVYKG-VLSDGKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQHKNLVK 409
N++ +G G YKG + +G + VK ++ S A+ KLQH N+VK
Sbjct: 695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMG-------KLQHPNIVK 747
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
L+G C L++E++ +L +L R L W +R I GIAK + +LH
Sbjct: 748 LIGLCRSEKGAYLIHEYIEGKNLSEVL-----RN-LSWERRRKIAIGIAKALRFLHCRCS 801
Query: 470 LRIVHRDLKASNVLLD 485
+V +L +++D
Sbjct: 802 PAVVVGNLSPEKIIID 817
|
Length = 968 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 49/173 (28%), Positives = 78/173 (45%), Gaps = 22/173 (12%)
Query: 357 LGQGGFGPVY---KGVLSDGKEVAVKRLSSCSEQGTAEFTN---EVLLILKLQHKNLVKL 410
+ +G +G V+ K S G A+K + + E ++ + Q +VKL
Sbjct: 1 ISKGAYGRVFLAKKK--STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 411 LGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
+ G + L LV E++P G L ++L G L + I + YLH
Sbjct: 59 Y-YSFQGKKNLYLVMEYLPGGDLASLL---ENVGSLDEDVARIYIAEIVLALEYLH---S 111
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFG------MARIFAESEGEANTVRIVGT 516
I+HRDLK N+L+DS+ + K++DFG + R ++ E RIVGT
Sbjct: 112 NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 45/141 (31%), Positives = 74/141 (52%), Gaps = 8/141 (5%)
Query: 357 LGQGGFGPV-YKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
+G+G G V V S GK VAVK++ +Q NEV+++ QH+N+V++ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
GDE +V EF+ G+L I+ R + + + + K + LH ++HR
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLKALSVLHAQG---VIHR 140
Query: 476 DLKASNVLLDSDMNSKISDFG 496
D+K+ ++LL D K+SDFG
Sbjct: 141 DIKSDSILLTHDGRVKLSDFG 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 47/174 (27%), Positives = 79/174 (45%), Gaps = 29/174 (16%)
Query: 356 ILGQGGFGPVYKGVL----SDGKEVAVKR--LSSCSEQGTAEFTNEVLLILKLQHKNLVK 409
+LG+G FG + L D V K L+ SE+ + NE++++ LQH N++
Sbjct: 7 VLGKGAFG---EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIA 63
Query: 410 LLGFCVDGDEKLLVYEFMPNGSL-------DAILFDPRKRGILCWRKRTNIVNGIAKGML 462
+D + L+ E+ G+L LF+ ++ IV+ ++
Sbjct: 64 YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQ----IVSAVS---- 115
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
Y+H+ I+HRD+K N+ L K+ DFG+++I A TV VGT
Sbjct: 116 YIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV--VGT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 46/176 (26%), Positives = 80/176 (45%), Gaps = 41/176 (23%)
Query: 355 NILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEV--------LLILK-LQH 404
+G G +G V V G++VA+K++S+ F + + + +L+ L+H
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-------FDDLIDAKRILREIKLLRHLRH 58
Query: 405 KNLVKLLGFCVDGD----EKL-LVYEFMPNGSLDAILFDPRK------RGILCWRKRTNI 453
+N++ LL + +V E M L ++ P+ + L
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLY------- 110
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509
I +G+ YLH + ++HRDLK SN+L++S+ + KI DFG+AR E E
Sbjct: 111 --QILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG 161
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 46/165 (27%), Positives = 88/165 (53%), Gaps = 18/165 (10%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
+GQG G V+ + ++ G+EVA+K+++ + NE+L++ +L++ N+V L +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 416 DGDEKLLVYEFMPNGSLDAIL----FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
GDE +V E++ GSL ++ D + +C + + +LH + +
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVC--------RECLQALEFLHAN---Q 135
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
++HRD+K+ NVLL D + K++DFG + + +T +VGT
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 49/178 (27%), Positives = 75/178 (42%), Gaps = 27/178 (15%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSS--CSEQG-TAEFTNEVLLILKLQHK 405
+F ++G+G FG V D K++ A+K ++ C E+G NE ++ +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 406 NLVKL-LGFCVDGDEKLLVYEFMPNGSLDAILFDPRK------RGILCWRKRTNIVNGIA 458
LV L F D + LV + + G L L K + +C I
Sbjct: 61 FLVNLWYSFQ-DEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC---------EIV 110
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
+ YLH I+HRD+K N+LLD + I+DF +A + T GT
Sbjct: 111 LALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGT 162
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 43/143 (30%), Positives = 72/143 (50%), Gaps = 6/143 (4%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
+G G +G VYK ++ G+ VA+K + E+ ++ + +H N+V G +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
D+ +V E+ GSL I RG L + + KG+ YLHE +HR
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIY--QVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIHR 125
Query: 476 DLKASNVLLDSDMNSKISDFGMA 498
D+K +N+LL D + K++DFG++
Sbjct: 126 DIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 4e-12
Identities = 45/165 (27%), Positives = 87/165 (52%), Gaps = 18/165 (10%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
+GQG G VY + ++ G+EVA+K+++ + NE+L++ + ++ N+V L +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 416 DGDEKLLVYEFMPNGSLDAIL----FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
GDE +V E++ GSL ++ D + +C + + +LH + +
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVC--------RECLQALDFLHSN---Q 135
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
++HRD+K+ N+LL D + K++DFG + + +T +VGT
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 56/159 (35%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 350 NFSDSNILGQGGFGPVYKGV---LSDGK---EVAVKRLSSCSEQGTAE-FTNEVLLILKL 402
N S LG G FG V + LS +VAVK L + E +E+ ++ L
Sbjct: 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHL 95
Query: 403 -QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR-GILCWRKRTNIVNGIAKG 460
H+N+V LLG C G L++ E+ G D + F RKR L + +AKG
Sbjct: 96 GNHENIVNLLGACTIGGPILVITEYCCYG--DLLNFLRRKRESFLTLEDLLSFSYQVAKG 153
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
M +L + +HRDL A NVLL KI DFG+AR
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 5e-12
Identities = 53/174 (30%), Positives = 88/174 (50%), Gaps = 17/174 (9%)
Query: 350 NFSDSNILGQGGFGPVY--KGVLSDGKEVAVKRLSSCSEQGTAE----FTNEVLLILKLQ 403
+ ++G+G FG V+ + +D K V +K++ EQ T + NE ++ L
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPV--EQMTKDERLAAQNECQVLKLLS 57
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
H N+++ ++ ++V E+ P G+L A R +L I++ + +L
Sbjct: 58 HPNIIEYYENFLEDKALMIVMEYAPGGTL-AEYIQKRCNSLL---DEDTILHFFVQILLA 113
Query: 464 LHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARIFAESEGEANTVRIVGT 516
LH I+HRDLK N+LLD M KI DFG+++I + S+ +A TV VGT
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYTV--VGT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 49/179 (27%), Positives = 83/179 (46%), Gaps = 26/179 (14%)
Query: 350 NFSDSNILGQGGFGPVY--KGVLSDGKEVAVKR--LSSCSEQGTAEFTNEVLLILKLQHK 405
+ +G+G FG +Y K SD + +K L+ + EV+L+ K++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSL-------DAILFDPRKRGILCWRKRTNIVNGIA 458
N+V + +V E+ G L +LF + IL W + I+
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ--ILSWFVQ------IS 111
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGMARIFAESEGEANTVRIVGT 516
G+ ++H+ +I+HRD+K+ N+ L + M +K+ DFG+AR +S A T VGT
Sbjct: 112 LGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC--VGT 165
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 48/164 (29%), Positives = 77/164 (46%), Gaps = 18/164 (10%)
Query: 351 FSDSNILGQGGFGPVYKGVL----SDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQH 404
F+ +LG+G FG V + L ++VAVK L + S EF E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 405 KNLVKLLGFCVDGDEK------LLVYEFMPNGSLDAILFDPR---KRGILCWRKRTNIVN 455
N++KL+G + K +++ FM +G L L R + L + +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
IA GM YL S +HRDL A N +L+ +M ++DFG+++
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 41/164 (25%), Positives = 68/164 (41%), Gaps = 23/164 (14%)
Query: 357 LGQGGFGPVYKG-VLSDGKEVAVKRLSSCSEQGTAEFTNEV-------LLILK-LQHKNL 407
+G+G +G V K + G+ VA+K+ +E +V + +L+ L+H+N+
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFK------ESEDDEDVKKTALREVKVLRQLRHENI 62
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT-NIVNGIAKGMLYLHE 466
V L LV+E++ L+ + P R ++ IA Y H
Sbjct: 63 VNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIA----YCH- 117
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
I+HRD+K N+L+ K+ DFG AR T
Sbjct: 118 --SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT 159
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 46/166 (27%), Positives = 89/166 (53%), Gaps = 20/166 (12%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
+GQG G VY + ++ G+EVA+++++ + NE+L++ + ++ N+V L +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 416 DGDEKLLVYEFMPNGSLDAIL----FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
GDE +V E++ GSL ++ D + +C + + +LH + +
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVC--------RECLQALEFLHSN---Q 136
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGM-ARIFAESEGEANTVRIVGT 516
++HRD+K+ N+LL D + K++DFG A+I E ++ +VGT
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRSTMVGT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 51/163 (31%), Positives = 73/163 (44%), Gaps = 23/163 (14%)
Query: 357 LGQGGFGPVYKGVL-----SDGKEVAVKRLSSCSE-QGTAEFTNEVLLILKLQHKNLVKL 410
LG+ FG +YKG L + VA+K L + Q EF E L+ +L H N+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILF--------------DPRKRGILCWRKRTNIVNG 456
LG +++E++ G L L D + L +I
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
IA GM YL S VH+DL A N+L+ ++ KISD G++R
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 13/136 (9%)
Query: 357 LGQGGFGPVYKGV---LSDGK-----EVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
LGQG F ++KG+ + D EV +K L + F ++ +L HK+LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
G CV GDE ++V E++ GSLD L + + W + + +A + +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120
Query: 469 RLRIVHRDLKASNVLL 484
+ H ++ A NVLL
Sbjct: 121 ---LTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 49/168 (29%), Positives = 78/168 (46%), Gaps = 24/168 (14%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL 407
S + D LG G G V+ V SD K VAVK++ Q E+ +I +L H N+
Sbjct: 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNI 64
Query: 408 VKLLGFCVDGDEKL--------------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNI 453
VK+ L +V E+M + L + ++G L
Sbjct: 65 VKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLSEEHARLF 119
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARI 500
+ + +G+ Y+H + ++HRDLK +NV +++ D+ KI DFG+ARI
Sbjct: 120 MYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARI 164
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 50/169 (29%), Positives = 83/169 (49%), Gaps = 32/169 (18%)
Query: 357 LGQGGFGPVYKGVLSDG-----------KEVAVKRLSS-CSEQGTAEFTNEVLLILKL-Q 403
LG+G FG V V+++ +VAVK L S +E+ ++ +E+ ++ + +
Sbjct: 26 LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------------LCWRKR 450
HKN++ LLG C ++ E+ G+L L R G+ L ++
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+ +A+GM YL + + +HRDL A NVL+ D KI+DFG+AR
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 49/177 (27%), Positives = 86/177 (48%), Gaps = 18/177 (10%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQH 404
+NF +G+G F VY+ L D K VA+K++ + + E+ L+ +L H
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61
Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL--FDPRKRGI---LCWRKRTNIVNGIAK 459
N++K L ++ +E +V E G L ++ F +KR I W+ + + +
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE- 120
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
H SR R++HRD+K +NV + + K+ D G+ R F+ A++ +VGT
Sbjct: 121 -----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 37/124 (29%), Positives = 67/124 (54%), Gaps = 7/124 (5%)
Query: 373 GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432
G++VAVK + +Q NEV+++ QH+N+V++ + G+E ++ EF+ G+L
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKI 492
I+ R L + + + + + YLH ++HRD+K+ ++LL D K+
Sbjct: 106 TDIVSQTR----LNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKL 158
Query: 493 SDFG 496
SDFG
Sbjct: 159 SDFG 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 48/147 (32%), Positives = 67/147 (45%), Gaps = 10/147 (6%)
Query: 357 LGQGGFGPVYKGVLSD-GKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLG 412
LG+GGFG V + GK A K+L +G NE IL+ + L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKK-ILEKVSSRFIVSLA 59
Query: 413 FCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
+ + + L LV M G L +++ + G R I G+ +LH + R
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLH---QRR 115
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMA 498
IV+RDLK NVLLD N +ISD G+A
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 4e-11
Identities = 58/175 (33%), Positives = 75/175 (42%), Gaps = 37/175 (21%)
Query: 357 LGQGGFGPV----YKGVLSDGKEVAVKRLSSCS--EQGTAEFTNEVLLILK-LQHKNLVK 409
LG G FG V +KG GK A+K LS + E IL+ ++H LV
Sbjct: 9 LGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVN 65
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK--------GM 461
L G D LV E++P G L + L RK +A+ +
Sbjct: 66 LYGSFQDDSNLYLVMEYVPGGELFSHL-----------RKSGRFPEPVARFYAAQVVLAL 114
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
YLH L IV+RDLK N+LLDSD KI+DFG A+ T + GT
Sbjct: 115 EYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYTLCGT 161
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 48/158 (30%), Positives = 85/158 (53%), Gaps = 17/158 (10%)
Query: 357 LGQGGFGPVYKG--VLSDGKEVAVKRLS-SCSEQGTAEFTNEVLLILK----LQHKNLVK 409
+G+G +G V+K + + G+ VA+KR+ E+G T + +L+ +H N+V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 410 LLGFCV----DGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
L C D + KL LV+E + + L L + G+ +++ + +G+ +L
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPT-ETIKDMMFQLLRGLDFL 126
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502
H R+VHRDLK N+L+ S K++DFG+ARI++
Sbjct: 127 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 161
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 49/157 (31%), Positives = 80/157 (50%), Gaps = 16/157 (10%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQ---HKNLVKL 410
+G G +G VYK G VA+K R+ + + EV L+ +L+ H N+V+L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 411 LGFC----VDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
+ C D + K+ LV+E + + L L G L +++ +G+ +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPG-LPAETIKDLMRQFLRGLDFLH 125
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502
+ IVHRDLK N+L+ S K++DFG+ARI++
Sbjct: 126 AN---CIVHRDLKPENILVTSGGQVKLADFGLARIYS 159
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 7e-11
Identities = 46/168 (27%), Positives = 87/168 (51%), Gaps = 11/168 (6%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLS-SCSEQGTAEFTNEVLLILKLQHKNLV 408
F+ +G+G FG V+KG+ + ++V A+K + +E + E+ ++ + +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
K G + G + ++ E++ GS D + G + ++ I KG+ YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
+ +HRD+KA+NVLL + K++DFG+A +++ + NT VGT
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 164
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 8e-11
Identities = 46/154 (29%), Positives = 77/154 (50%), Gaps = 10/154 (6%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCSEQGTAEFTN---EVLLILKLQHKN 406
F+D +G G FG VY EV A+K++S +Q ++ + EV + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
++ G + LV E+ + D L + K+ L + I +G +G+ YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKP-LQEVEIAAITHGALQGLAYLHS 143
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500
+ ++HRD+KA N+LL K++DFG A I
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI 174
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 9e-11
Identities = 46/159 (28%), Positives = 79/159 (49%), Gaps = 31/159 (19%)
Query: 357 LGQGGFGPVYKGVLSDGKE-VAVKR--LSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
+G+G +G V+K + E VA+KR L E + E+ L+ +L+HKN+V+L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD- 66
Query: 414 CVDGDEKL-LVYEFMP----------NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
+ D+KL LV+E+ NG +D + + + + KG+
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVK-------------SFMFQLLKGLA 113
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
+ H ++HRDLK N+L++ + K++DFG+AR F
Sbjct: 114 FCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAF 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 9e-11
Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 10/156 (6%)
Query: 351 FSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN---EVLLILKLQHKN 406
FSD +G G FG VY + + + VA+K++S +Q ++ + EV + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
++ G + LV E+ + D L + K+ L + + +G +G+ YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKP-LQEVEIAAVTHGALQGLAYLHS 133
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502
+ ++HRD+KA N+LL K+ DFG A I A
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 26/166 (15%)
Query: 357 LGQGGFGPVYK----GVLSDG-KE---VAVKRLS-SCSEQGTAEFTNEVLLILKL-QHKN 406
LG+G FG V G+ D KE VAVK L +E+ ++ +E+ ++ + +HKN
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------------LCWRKRTNI 453
++ LLG C ++ E+ G+L L R G+ + ++ +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+A+GM YL + + +HRDL A NVL+ + KI+DFG+AR
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 45/169 (26%), Positives = 77/169 (45%), Gaps = 34/169 (20%)
Query: 355 NILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAE------------FT--NEVLLI 399
LG+G +G V K GK VA+K++ FT E+ ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAI------LFDPRKRGILCWRKRTNI 453
+++H+N++ L+ V+GD LV + M L + L + + + IL I
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCIL-----LQI 128
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502
+NG+ LH+ +HRDL +N+ ++S KI+DFG+AR +
Sbjct: 129 LNGLNV----LHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYG 170
|
Length = 335 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 10/158 (6%)
Query: 356 ILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAE--FTNEVLLILKLQHKNLVKLLG 412
++G+G +G V K + G+ VA+K+ + + E+ ++ +L+H+NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
LV+EF+ + LD + P RK + I +G+ + H + I
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRK---YLFQILRGIEFCHSHN---I 121
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
+HRD+K N+L+ K+ DFG AR A + GE T
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYT 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 47/169 (27%), Positives = 86/169 (50%), Gaps = 13/169 (7%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLV 408
F+ +G+G FG V+KG+ + ++V ++ +E + E+ ++ + +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 409 KLLGFCVDGDEKLLVYEFMPNGS-LDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
K G + + ++ E++ GS LD L +P G L + I+ I KG+ YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALD--LLEP---GPLDETQIATILREILKGLDYLHSE 120
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
+ +HRD+KA+NVLL K++DFG+A +++ + N VGT
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGT 164
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 52/159 (32%), Positives = 82/159 (51%), Gaps = 29/159 (18%)
Query: 357 LGQGGFGPVYKGVLSDGKE-VAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
+G+G +G VYK E +A+K RL E + E+ L+ ++QH N+V+L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD- 68
Query: 414 CVDGDEKL-LVYEFMPNGSLDAILF---------DPRKRGILCWRKRTNIVNGIAKGMLY 463
V +++L LV+E++ LD +PR ++ I+ GIA Y
Sbjct: 69 VVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQ----ILRGIA----Y 117
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIF 501
H S R++HRDLK N+L+D N+ K++DFG+AR F
Sbjct: 118 CH--SH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153
|
Length = 294 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 59/193 (30%), Positives = 92/193 (47%), Gaps = 28/193 (14%)
Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRL---SSCSEQGTAEFTN 394
+ LE+L T + +G+G +G VYK DG AVK L S E+ AE+
Sbjct: 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYN- 70
Query: 395 EVLLILKLQHKNLVKLLGFCVDGDEKL-----LVYEFMPNGSLDAILFDPRKRGILCWRK 449
+L L H N+VK G D+ + LV E GS+ ++ +G+L +
Sbjct: 71 -ILQSLP-NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQ 123
Query: 450 RTN------IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503
R + I+ G G+ +LH + RI+HRD+K +N+LL ++ K+ DFG++
Sbjct: 124 RLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180
Query: 504 SEGEANTVRIVGT 516
+ NT VGT
Sbjct: 181 TRLRRNTS--VGT 191
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 46/174 (26%), Positives = 80/174 (45%), Gaps = 19/174 (10%)
Query: 357 LGQGGFGPVYKGVLSDG-------KEVAVKRLS-----SCSEQGTAEFTNEVLLILK-LQ 403
LG G FG VYK + KE+ V + ++ + +EV +I + L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGML 462
H N+V+ ++ D +V + + L + K+ + NI + +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
YLH++ R IVHRDL +N++L D I+DFG+A+ + + E+ +VGT
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGT 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 3e-10
Identities = 46/159 (28%), Positives = 86/159 (54%), Gaps = 11/159 (6%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN--EVLLILKLQHKN 406
+ N + +G +G VY+ G+ VA+K+L E+ T+ E+ ++LKLQH N
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPN 65
Query: 407 LVKLLGFCV--DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
+V + V + D+ +V E++ + L +++ ++ + K ++ + G+ +L
Sbjct: 66 IVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVK--CLMLQLLSGVAHL 122
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503
H++ I+HRDLK SN+LL++ KI DFG+AR +
Sbjct: 123 HDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 49/177 (27%), Positives = 86/177 (48%), Gaps = 18/177 (10%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQH 404
+NF +G+G F VY+ L DG VA+K++ + A+ E+ L+ +L H
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL--FDPRKRGI---LCWRKRTNIVNGIAK 459
N++K ++ +E +V E G L ++ F +KR I W+ + + +
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE- 120
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
H SR R++HRD+K +NV + + K+ D G+ R F+ A++ +VGT
Sbjct: 121 -----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 48/166 (28%), Positives = 79/166 (47%), Gaps = 26/166 (15%)
Query: 357 LGQGGFGPVY--------KGVLSDGKEVAVKRLSS-CSEQGTAEFTNEVLLILKL-QHKN 406
LG+G FG V K + VAVK L +++ ++ +E+ ++ + +HKN
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------------LCWRKRTNI 453
++ LLG C ++ E+ G+L L R G+ L ++ +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+A+GM YL + + +HRDL A NVL+ D KI+DFG+AR
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 49/187 (26%), Positives = 84/187 (44%), Gaps = 17/187 (9%)
Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLL 398
IDL L F ++G G +G VYKG ++A ++ +E E E+ +
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINM 65
Query: 399 ILKL-QHKNLVKLLGFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKR- 450
+ K H+N+ G + D+ LV EF GS+ ++ + + ++
Sbjct: 66 LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN---ALKEDW 122
Query: 451 -TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509
I I +G+ +LH +++HRD+K NVLL + K+ DFG++ + G N
Sbjct: 123 IAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN 179
Query: 510 TVRIVGT 516
T +GT
Sbjct: 180 T--FIGT 184
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 44/168 (26%), Positives = 74/168 (44%), Gaps = 34/168 (20%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKR-LSSCSEQGTAEFT-NEVLLILKLQHKN-LVKLL 411
+G+G +G VYK + GK VA+K+ E+G E+ L+ L +V+LL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 412 GFCVDGDEK-------LLVYEFMPNGSLDAILFDPRKRGILCWRKR-----TNIVNG--- 456
V+ E+ LV+E++ + D +K R +
Sbjct: 68 --DVEHVEEKNGKPSLYLVFEYLDS--------DLKKFMDSNGRGPGRPLPAKTIKSFMY 117
Query: 457 -IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFA 502
+ KG+ + H + ++HRDLK N+L+D KI+D G+ R F+
Sbjct: 118 QLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS 162
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 45/154 (29%), Positives = 70/154 (45%), Gaps = 21/154 (13%)
Query: 357 LGQGGFGPVYKGVLSDGKE-VAVKRLSSCSEQGTAEFTN----EVLLILKLQHKNLVKLL 411
+G G +G V + VA+K+LS + +A E+ L+ + H+N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ--SAIHAKRTYRELRLLKHMDHENVIGLL 80
Query: 412 G-FCVDG-----DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
F + LV M L+ I+ K L +V I +G+ Y+H
Sbjct: 81 DVFTPASSLEDFQDVYLVTHLM-GADLNNIV----KCQKLSDDHIQFLVYQILRGLKYIH 135
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
I+HRDLK SN+ ++ D KI DFG+AR
Sbjct: 136 S---AGIIHRDLKPSNIAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 5e-10
Identities = 51/163 (31%), Positives = 78/163 (47%), Gaps = 15/163 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSE--------QGTAEFTNEVLLILKLQHKNLV 408
LG+G FG VY ++ D K VA +RL E T + E L+ KL H +V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRG-ILCWRKRTNIVNGIAKGMLYLHED 467
K ++ D ++ E+ LD L + + G L + + G+ Y+H+
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
RI+HRDLKA N+ L +++ KI DFG++R+ S A T
Sbjct: 126 ---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 47/154 (30%), Positives = 76/154 (49%), Gaps = 10/154 (6%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGKE-VAVKRLSSCSEQGTAEFTN---EVLLILKLQHKN 406
F + +G G FG VY S E VAVK++S +Q ++ + EV + +L+H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
++ G + LV E+ + D L + K+ L + I +G +G+ YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASD--LLEVHKKP-LQEVEIAAITHGALQGLAYLHS 139
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500
+ ++HRD+KA N+LL K++DFG A
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSASK 170
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 51/170 (30%), Positives = 83/170 (48%), Gaps = 16/170 (9%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGKE-VAVKRLSSCSEQGTAEFTN---EVLLILKLQHKN 406
F+D +G G FG VY E VA+K++S +Q ++ + EV + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
++ G + LV E+ + D + + K+ L + I +G +G+ YLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKKP-LQEVEIAAICHGALQGLAYLHS 133
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
R +HRD+KA N+LL K++DFG A + + AN+ VGT
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASLVS----PANS--FVGT 174
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 50/157 (31%), Positives = 84/157 (53%), Gaps = 12/157 (7%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFT--NEVLLILKLQ 403
A +++ + LG+G + VYKG+ +G+ VA+K +S +E+G FT E L+ L+
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLK 61
Query: 404 HKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
H N+V LL + E L V+E+M ++ P G+ + R + + +G+
Sbjct: 62 HANIV-LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPG--GLHPYNVRLFMFQ-LLRGLA 117
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
Y+H I+HRDLK N+L+ K++DFG+AR
Sbjct: 118 YIH---GQHILHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 49/161 (30%), Positives = 75/161 (46%), Gaps = 25/161 (15%)
Query: 357 LGQGGFGPVYKGVL---SDGK--------EVAVKRLSSCSEQGTAEFTNEVLLILKLQHK 405
LGQG F +YKGVL SD V +K L S + + F L+ +L HK
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGS-DHRDSLAFFETASLMSQLSHK 61
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
+LVKL G CV DE ++V E++ G LD L + L W + ++ +A + YL
Sbjct: 62 HLVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 466 EDSRLRIVHRDLKASNVLL--DSDMNS-----KISDFGMAR 499
+ ++VH ++ N+L+ K+SD G+
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 40/164 (24%), Positives = 77/164 (46%), Gaps = 15/164 (9%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFT-NEVLLILKLQHKN 406
+ + + +G+G +G V G +VA+K++S Q + T E+ ++ + +H+N
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 407 LVKLLGFCVDGD-----EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
++ +L + +V E M I + + + I +G+
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQY-----FLYQILRGL 119
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
Y+H + ++HRDLK SN+LL+++ + KI DFG+ARI
Sbjct: 120 KYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 47/149 (31%), Positives = 71/149 (47%), Gaps = 14/149 (9%)
Query: 357 LGQGGFGPV------YKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
LG+GGFG V G + K++ KRL S + A E IL+ + +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKE---ILEKVNSPFIVN 57
Query: 411 LGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
L + + L LV M G L +++ +RG+ R + I G+L+LH
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERV-IHYSAQITCGILHLHS--- 113
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMA 498
+ IV+RD+K NVLLD N ++SD G+A
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 46/150 (30%), Positives = 69/150 (46%), Gaps = 16/150 (10%)
Query: 357 LGQGGFGPVYKGVLSDGKEVA---VKRL---SSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
+G G FG V + VA VK L +S EQ + IL QH N+++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL--QHPNILQC 60
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILF---DPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
LG CV+ LLV+E+ G L + L R+ L +R + IA G+ ++H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR--MACEIAAGVTHMH-- 116
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGM 497
+ +H DL N L SD+ K+ D+G+
Sbjct: 117 -KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 54/178 (30%), Positives = 86/178 (48%), Gaps = 34/178 (19%)
Query: 357 LGQGGFGPVYKGVLS--DGKEVAVKRLS---SCSEQGTAEFTNEVLLILKL--QHKNLVK 409
+G+G +G V+K VL+ +G + AVK L E+ AE+ ILK H N+VK
Sbjct: 26 IGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDEEIEAEYN-----ILKALSDHPNVVK 79
Query: 410 LLGF-----CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN------IVNGIA 458
G +GD+ LV E GS+ ++ KRG +R I++
Sbjct: 80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRG-----ERMEEPIIAYILHEAL 134
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
G+ +LH + + +HRD+K +N+LL ++ K+ DFG++ + NT VGT
Sbjct: 135 MGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGT 187
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 46/157 (29%), Positives = 72/157 (45%), Gaps = 32/157 (20%)
Query: 357 LGQGGFGPVYKGVLSDGKE-VAVKRLSSCSEQGTAEFTNEVLLILK-------LQHKNLV 408
+GQGG+G V+ D E VA+KR+ + NEV +L + + LV
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMK----KSLLFKLNEVRHVLTERDILTTTKSEWLV 64
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-- 466
KLL D + L E++P G +L + G+L A+ Y+ E
Sbjct: 65 KLLYAFQDDEYLYLAMEYVPGGDFRTLLNN---LGVLS--------EDHAR--FYMAEMF 111
Query: 467 ---DS--RLRIVHRDLKASNVLLDSDMNSKISDFGMA 498
D+ L +HRDLK N L+D+ + K++DFG++
Sbjct: 112 EAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 28/74 (37%), Positives = 42/74 (56%), Gaps = 5/74 (6%)
Query: 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL 484
EFM GSLD I +K G + I + +G+ YL+ RI+HRD+K SN+L+
Sbjct: 83 EFMDCGSLDRIY---KKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILV 137
Query: 485 DSDMNSKISDFGMA 498
+S K+ DFG++
Sbjct: 138 NSRGQIKLCDFGVS 151
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 47/169 (27%), Positives = 76/169 (44%), Gaps = 20/169 (11%)
Query: 356 ILGQGGFGP--VYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL-G 412
++G+G FG + + V SD K + S + E +L+ K++H N+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKR-----GILCWRKRTNIVNGIAKGMLYLHED 467
F DG +V E+ G L + R + IL W + + G+ ++HE
Sbjct: 67 FEADG-HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ------MCLGVQHIHEK 119
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
R++HRD+K+ N+ L + K+ DFG AR+ A T VGT
Sbjct: 120 ---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY--VGT 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 33/145 (22%), Positives = 57/145 (39%), Gaps = 13/145 (8%)
Query: 356 ILGQGGFGPVYKGVLSDGKEVAVKR--LSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
+ K VAVK+ L SCS++ E++ +LQH N++ +
Sbjct: 9 CFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT---NIVNGIAKGMLYLHEDSRL 470
+ E +V M GS + +L G+ I+ + + Y+H
Sbjct: 68 FIVDSELYVVSPLMAYGSCEDLLKTHFPEGL----PELAIAFILKDVLNALDYIH---SK 120
Query: 471 RIVHRDLKASNVLLDSDMNSKISDF 495
+HR +KAS++LL D +S
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 4e-09
Identities = 46/173 (26%), Positives = 79/173 (45%), Gaps = 13/173 (7%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVK 409
F ++G G +G VYKG ++A ++ + E E+ ++ K H+N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 410 LLGFCVD------GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
G + D+ LV EF GS+ ++ + K L I I +G+ +
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSH 126
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
LH+ +++HRD+K NVLL + K+ DFG++ + G NT +GT
Sbjct: 127 LHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGT 174
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 44/163 (26%), Positives = 77/163 (47%), Gaps = 14/163 (8%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGT-AEFTNEVLLILK-LQHK 405
S + +G G +G V + GK+VA+K++ + T A+ T L IL+ +H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 406 NLVKLLGFCV----DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
N++ + D + +V + M + L I+ L + + +G+
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLMES-DLHHII---HSDQPLTEEHIRYFLYQLLRGL 120
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504
Y+H + ++HRDLK SN+L++ D +I DFGMAR + S
Sbjct: 121 KYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 5e-09
Identities = 39/145 (26%), Positives = 73/145 (50%), Gaps = 11/145 (7%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
+G G +G VYK ++ G+ A+K + + A E++++ +H N+V G +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 416 DGDEKLLVYEFMPNGSLDAI--LFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
D+ + EF GSL I + P + + R + +G+ YLH ++
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKGKM--- 128
Query: 474 HRDLKASNVLLDSDMNSKISDFGMA 498
HRD+K +N+LL + + K++DFG++
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 6e-09
Identities = 47/146 (32%), Positives = 74/146 (50%), Gaps = 10/146 (6%)
Query: 357 LGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFT--NEVLLILKLQHKNLVKLLGF 413
LG+G + VYKG +GK VA+K + E+GT FT E L+ L+H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTP-FTAIREASLLKGLKHANIVLLHDI 71
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
+ LV+E++ D + + G L + + +G+ Y+H+ I+
Sbjct: 72 IHTKETLTLVFEYV---HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---IL 125
Query: 474 HRDLKASNVLLDSDMNSKISDFGMAR 499
HRDLK N+L+ K++DFG+AR
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 6e-09
Identities = 45/158 (28%), Positives = 73/158 (46%), Gaps = 34/158 (21%)
Query: 357 LGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFT--NEVLLILKLQHKNLVKLLGF 413
LG+G + VYKG G+ VA+K + E+G A FT E L+ L+H N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIV-TLHD 70
Query: 414 CVDGDEKL-LVYEFM-----------PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
+ + L LV+E++ G + ++ + +G+
Sbjct: 71 IIHTKKTLTLVFEYLDTDLKQYMDDCGGG------LSMHNVRLFLFQ--------LLRGL 116
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
Y H + R++HRDLK N+L+ K++DFG+AR
Sbjct: 117 AYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 9e-09
Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 28/156 (17%)
Query: 357 LGQGGFGPVYK------GVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHK----N 406
LG+G +G VYK GV KE+ RL E ++F N++++ L + HK
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEI---RL----ELDESKF-NQIIMELDILHKAVSPY 60
Query: 407 LVKLLG-FCVDGDEKLLVY---EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
+V G F ++G VY E+M GSLD + + I + KG+
Sbjct: 61 IVDFYGAFFIEGA----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLK 116
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498
+L E+ I+HRD+K +NVL++ + K+ DFG++
Sbjct: 117 FLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 44/168 (26%), Positives = 77/168 (45%), Gaps = 27/168 (16%)
Query: 359 QGGFGPVY--KGVLSDGKEVAVKRLSSCSEQGTAEFTN----EVLLILKLQHKNLVKLLG 412
+G FG VY K + G A+K L + TN +++++ + + KL
Sbjct: 6 KGAFGSVYLAKKRST-GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYY 64
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILC--WRKR--TNIVNGIAKGMLYLHEDS 468
D LV E++ G +++ + G L W K+ +V G+ LH+
Sbjct: 65 SFQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAKQYIAEVVLGVE----DLHQRG 117
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
I+HRD+K N+L+D + K++DFG++R E++ + VGT
Sbjct: 118 ---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGT 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 40/157 (25%), Positives = 71/157 (45%), Gaps = 14/157 (8%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKE-VAVKRLS---SCSEQGTAEFTNEVLLILKLQH 404
+ +G G FG V+ + A+K ++ + NE ++ ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 405 KNLVKLLGFCVDGDEKLL--VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
+++L F + D++ L + E++P G L + L R G + I +
Sbjct: 61 PFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYL---RNSGRFSNSTGLFYASEIVCALE 115
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
YLH IV+RDLK N+LLD + + K++DFG A+
Sbjct: 116 YLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK 149
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 51/175 (29%), Positives = 74/175 (42%), Gaps = 20/175 (11%)
Query: 351 FSDSNILGQGGFGPVYK-GVLSDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKN 406
F +LG+GGFG V V + GK A K+L +G + NE ++ K+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD------PRKRGILCWRKRTNIVNGIAKG 460
+V L D LV M G L ++ R + I G
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF-------YAAEICCG 114
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515
+ LH++ RIV+RDLK N+LLD + +ISD G+A E + V VG
Sbjct: 115 LEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVG 166
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 45/132 (34%), Positives = 72/132 (54%), Gaps = 23/132 (17%)
Query: 394 NEVLLILKLQHK----NLVKLLG-FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWR 448
N+++ LK+ H+ +V G F DG+ + + E M GSLD +L +K G R
Sbjct: 44 NQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVL---KKAG----R 95
Query: 449 KRTNIVNGIA----KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504
NI+ I+ +G+ YL E + +I+HRD+K SN+L++S K+ DFG++ +S
Sbjct: 96 IPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153
Query: 505 EGEANTVRIVGT 516
AN+ VGT
Sbjct: 154 --MANS--FVGT 161
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 49/150 (32%), Positives = 72/150 (48%), Gaps = 14/150 (9%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
+G G +G V + G++VA+K+LS SE E+ L+ +QH+N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 414 ---CVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSR 469
V GDE Y MP D + G L K +V + G+ Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTDL----QKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG- 137
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
I+HRDLK N+ ++ D KI DFG+AR
Sbjct: 138 --IIHRDLKPGNLAVNEDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 48/158 (30%), Positives = 80/158 (50%), Gaps = 14/158 (8%)
Query: 348 TSNFSDSNILGQGGFGPV--YKGVLSDGKEVAVKRL-SSCSEQGTAEFT-NEVLLILKLQ 403
T+ + D +G G FG V + L+ G+ VA+K++ S A+ T E+ L+ L+
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR 67
Query: 404 HKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
H+N++ L + E + V E + L +L L + + I +G+
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELLGT-DLHRLL----TSRPLEKQFIQYFLYQILRGLK 122
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500
Y+H +VHRDLK SN+L++ + + KI DFG+ARI
Sbjct: 123 YVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 60/222 (27%), Positives = 87/222 (39%), Gaps = 45/222 (20%)
Query: 305 KQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGP 364
K +QLHK D++ T R N +K +DF NF + LG G FG
Sbjct: 5 KNLQLHKKKDSDSTK-----EPKRKNKMKYEDF------------NFIRT--LGTGSFGR 45
Query: 365 VYKGVLSDGK--EVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 419
V + VA+KR ++ +E ++ + H V L G D
Sbjct: 46 VILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY 105
Query: 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGI-----AKGMLYLHEDSRLRIVH 474
LV EF+ G L R+ N + A+ +L L IV+
Sbjct: 106 LYLVLEFVIGGEFFTFL-----------RRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVY 154
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
RDLK N+LLD D K++DFG A++ + T + GT
Sbjct: 155 RDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGT 191
|
Length = 340 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 50/183 (27%), Positives = 77/183 (42%), Gaps = 32/183 (17%)
Query: 332 LKAQDFFIDLETLNLATSNFSDSNILGQGGFGPV----YKGVLSDGKEVAVKRLSS---C 384
+KA F +T + S+F LG G FG V +KG G+ A+K L
Sbjct: 1 MKAAYMFTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREIL 57
Query: 385 SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI 444
+ E ++++L H +V ++ D + + EF+ G L L
Sbjct: 58 KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL-------- 109
Query: 445 LCWRKRTNIVNGIAK--------GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496
RK N +AK YLH I++RDLK N+LLD+ + K++DFG
Sbjct: 110 ---RKAGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFG 163
Query: 497 MAR 499
A+
Sbjct: 164 FAK 166
|
Length = 329 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 47/164 (28%), Positives = 81/164 (49%), Gaps = 10/164 (6%)
Query: 356 ILGQGGFGPVYKGVLSDGKE-VAVKRLSSCSEQGTAEFTN--EVLLILKLQHKNLVKLLG 412
++G+G +G V K + KE VA+K+ E + T E+ ++ L+ +N+V+L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
+ LV+E++ L+ L + G+ + R+ I I K + + H++ I
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLI-KAIHWCHKND---I 121
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
VHRD+K N+L+ + K+ DFG AR +E AN V T
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-NANYTEYVAT 164
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 39/143 (27%), Positives = 69/143 (48%), Gaps = 7/143 (4%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
+G G +G VYK L G+ AVK + + E+ ++ + +H N+V G +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
++ + E+ GSL I G L + + +G+ YLH ++ HR
Sbjct: 77 SREKLWICMEYCGGGSLQDIY---HVTGPLSELQIAYVCRETLQGLAYLHSKGKM---HR 130
Query: 476 DLKASNVLLDSDMNSKISDFGMA 498
D+K +N+LL + + K++DFG+A
Sbjct: 131 DIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 52/170 (30%), Positives = 80/170 (47%), Gaps = 20/170 (11%)
Query: 356 ILGQGGFGPV----YKGVLSDGKEVAVKRL----SSCSEQGTAEFTNEVLLILKLQHKNL 407
++G+G +G V ++ +DGK+ +K+L +S E+ AE E L+ +L+H N+
Sbjct: 7 VVGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAE--QEAQLLSQLKHPNI 61
Query: 408 VKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
V D L +V F G L L +K +L + IA + YLHE
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKL-KEQKGKLLPENQVVEWFVQIAMALQYLHE 120
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
I+HRDLK NV L K+ D G+AR+ A+T ++GT
Sbjct: 121 K---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGT 165
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 27/105 (25%), Positives = 50/105 (47%), Gaps = 6/105 (5%)
Query: 395 EVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV 454
E +L+ + H +++++ V G +V +P+ S D + ++ L + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
I +G+ YLH RI+HRD+K N+ ++ I D G A+
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205
|
Length = 357 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 6e-08
Identities = 52/169 (30%), Positives = 73/169 (43%), Gaps = 8/169 (4%)
Query: 351 FSDSNILGQGGFGPVYK-GVLSDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKN 406
F +LG+GGFG V V + GK A KRL +G + NE ++ K+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
+V L D LV M G L +++ G R I G+ LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE-ILCGLEDLHR 120
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515
++ V+RDLK N+LLD + +ISD G+A E E V VG
Sbjct: 121 EN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVG 166
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 6e-08
Identities = 47/147 (31%), Positives = 77/147 (52%), Gaps = 12/147 (8%)
Query: 357 LGQGGFGPVYKG--VLSDGKEVAVKRLSSCSEQGT-AEFTNEVLLILKLQHKNLVKLLGF 413
LG+G + V+KG L++ VA+K + E+G EV L+ L+H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 414 CVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
V D+ L LV+E++ + L + D I+ + I +G+ Y H R ++
Sbjct: 73 -VHTDKSLTLVFEYL-DKDLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCH---RRKV 125
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMAR 499
+HRDLK N+L++ K++DFG+AR
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 6e-08
Identities = 44/162 (27%), Positives = 74/162 (45%), Gaps = 28/162 (17%)
Query: 356 ILGQGGFGPVYKGVLSDGKEV-AVKRLSSC----SEQGTAEFTNEVLLILKLQHKNLVKL 410
++G+G FG V+ D +V A+K L Q A E ++ +VKL
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIVKL 66
Query: 411 LGFCVDGDEKLL--VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG------IAKGML 462
+ DE+ L V E+MP G L +L R ++ IA+ +L
Sbjct: 67 --YYSFQDEEHLYLVMEYMPGGDL---------MNLLI---RKDVFPEETARFYIAELVL 112
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504
L +L +HRD+K N+L+D+D + K++DFG+ + ++
Sbjct: 113 ALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 7e-08
Identities = 53/162 (32%), Positives = 75/162 (46%), Gaps = 15/162 (9%)
Query: 356 ILGQGGFGPVYKGVLSDGKEV-AVKRLSS--CSEQGTAEFT--NEVLLILKLQHKNLVKL 410
+LG+G FG V L E A+K L E E T +L L +H L L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 411 LGFCVDGDEKLL--VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
FC ++ L V E++ G L +F + G + I G+ +LH+
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIICGLQFLHKKG 116
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
I++RDLK NVLLD D + KI+DFGM + EG+A+T
Sbjct: 117 ---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST 155
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 9e-08
Identities = 56/182 (30%), Positives = 76/182 (41%), Gaps = 34/182 (18%)
Query: 351 FSDSNILGQGGFGPVYK-GVLSDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKN 406
F +LG+GGFG V V + GK A K+L +G A NE ++ K+ +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 407 LVKLL-------GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNI 453
+V L C+ GD K +Y G FD +R +
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG------FD-EERAVF-------Y 107
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
I G+ LH R RIV+RDLK N+LLD + +ISD G+A E E V
Sbjct: 108 AAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGT 164
Query: 514 VG 515
VG
Sbjct: 165 VG 166
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 9e-08
Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 18/160 (11%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQH-K 405
+ D +G+G FG V K + G +AVKR+ S E+ ++ ++++
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCP 63
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLD---AILFDPRKRGILCWRKRTNIVNGIA---- 458
+VK G + + E M + SLD +++ K I I+ IA
Sbjct: 64 YIVKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVI-----PEEILGKIAVATV 117
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498
K + YL E+ L+I+HRD+K SN+LLD + N K+ DFG++
Sbjct: 118 KALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 9e-08
Identities = 45/150 (30%), Positives = 69/150 (46%), Gaps = 13/150 (8%)
Query: 356 ILGQGGFGPVYKGVL-SDGKEVAVKRLSS----CSEQGTAEFTNEVLLILKLQHKNLVKL 410
+LG+G FG V L G+ AVK L + T + +L L H L +L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 411 LGFCVDGDEKLL-VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
C ++L V EF+ G L +F +K + I +++LH+
Sbjct: 62 Y-CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDKG- 116
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
I++RDLK NVLLD + + K++DFGM +
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 52/169 (30%), Positives = 73/169 (43%), Gaps = 8/169 (4%)
Query: 351 FSDSNILGQGGFGPVYK-GVLSDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKN 406
F +LG+GGFG V V + GK A K+L +G A NE ++ K+ +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
+V L D LV M G L +++ G + A+ L +
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF----DEQRAIFYAAELCCGLED 117
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515
R RIV+RDLK N+LLD + +ISD G+A E E V VG
Sbjct: 118 LQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVG 166
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 51/167 (30%), Positives = 73/167 (43%), Gaps = 19/167 (11%)
Query: 357 LGQGGFGPVYK-GVLSDGKEVAVKRLS--SCSEQGTAEFT-NEVLLILKLQHKNLVKLLG 412
LG GGFG V V S + A+K + E G E +E ++ + H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 413 FCVDGDEKLLVY---EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
+ D+K +Y E+ G L IL R RG+ + + YLH
Sbjct: 59 YRTFKDKKY-IYMLMEYCLGGELWTIL---RDRGLFDEYTARFYIACVVLAFEYLH---N 111
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
I++RDLK N+LLDS+ K+ DFG A+ + T GT
Sbjct: 112 RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL---KSGQKTWTFCGT 155
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 48/155 (30%), Positives = 74/155 (47%), Gaps = 28/155 (18%)
Query: 357 LGQGGFGPVYKG--VLSDGKEVAVKRLSSCSEQGT-AEFTNEVLLILKLQHKNLVKLLGF 413
LG+G + VYKG L+D VA+K + E+G EV L+ L+H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN---------GIAKGMLYL 464
LV+E++ + L L D C N +N + +G+ Y
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDD-------C----GNSINMHNVKLFLFQLLRGLNYC 120
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
H R +++HRDLK N+L++ K++DFG+AR
Sbjct: 121 H---RRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 44/159 (27%), Positives = 78/159 (49%), Gaps = 19/159 (11%)
Query: 357 LGQGGFGPVYKGVLSDG---KEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLG- 412
+G+G +G VYK DG ++ A+K++ +A E+ L+ +L+H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQKV 66
Query: 413 FCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY-----LHE 466
F D K+ L++++ + I F R +K + G+ K +LY +H
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKF---HRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 467 DSRLRIVHRDLKASNVLLDSD----MNSKISDFGMARIF 501
++HRDLK +N+L+ + KI+D G AR+F
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 52/197 (26%), Positives = 86/197 (43%), Gaps = 20/197 (10%)
Query: 314 DANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDG 373
D + H D + ++ ID + ++ NI+G G FG VY+ + D
Sbjct: 32 DKKLDEEERSHNNNAGED-EDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDT 90
Query: 374 KE-VAVKRLSSCSEQGTAEFTNEVLLILK-LQHKNLVKLLGF----CVDGDEKLL----V 423
E VA+K++ ++ N LLI+K L H N++ L + C +EK + V
Sbjct: 91 SEKVAIKKVLQ-----DPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV 145
Query: 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVL 483
EF+P + R L + + + Y+H I HRDLK N+L
Sbjct: 146 MEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLL 202
Query: 484 LDSDMNS-KISDFGMAR 499
+D + ++ K+ DFG A+
Sbjct: 203 IDPNTHTLKLCDFGSAK 219
|
Length = 440 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 49/168 (29%), Positives = 80/168 (47%), Gaps = 17/168 (10%)
Query: 350 NFSDSNILGQGGFGPVY----KGVLSDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKL 402
NF +LG G +G V+ G GK A+K L + + TAE T +L+
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 403 QHKN--LVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
+ LV L + D KL L+ +++ G L L+ R+ + IA+
Sbjct: 61 VRRCPFLVTLH-YAFQTDTKLHLILDYVNGGELFTHLYQ-REHFTE---SEVRVY--IAE 113
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
+L L +L I++RD+K N+LLDS+ + ++DFG+++ F E E
Sbjct: 114 IVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 20/43 (46%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
IA G+ +LH I++RDLK NV+LD++ + KI+DFGM +
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 46/160 (28%), Positives = 70/160 (43%), Gaps = 11/160 (6%)
Query: 356 ILGQGGFGPVYKGVLS-DGKEVAVKRLSS----CSEQGTAEFTNEVLLILKLQHKNLVKL 410
+LG+G FG V L G+ AVK L + + +L L ++ L L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
+ V EF+ G L +F + +G + T I G+ +LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDL---MFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG-- 116
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
I++RDLK NV+LD D + KI+DFGM + + A+T
Sbjct: 117 -IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST 155
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 40/145 (27%), Positives = 69/145 (47%), Gaps = 8/145 (5%)
Query: 357 LGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGT-AEFTNEVLLILKLQHKNLVKLLGFC 414
LG+G + V+KG VA+K + E+G EV L+ L+H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
LV+E++ + D + ++ + + +G+ Y H + +I+H
Sbjct: 73 HTERCLTLVFEYLDS---DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILH 126
Query: 475 RDLKASNVLLDSDMNSKISDFGMAR 499
RDLK N+L++ K++DFG+AR
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 6e-07
Identities = 44/157 (28%), Positives = 75/157 (47%), Gaps = 22/157 (14%)
Query: 355 NILGQGGFGPVYKG-VLSDGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
ILG G G VYK L + +AVK + + + + +E+ ++ K ++ G
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 413 -FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIA----KGMLYLHED 467
F V+ + + EFM GSLD + + +++ IA KG+ YL
Sbjct: 67 AFFVE-NRISICTEFMDGGSLD-----------VYRKIPEHVLGRIAVAVVKGLTYLWS- 113
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504
L+I+HRD+K SN+L+++ K+ DFG++ S
Sbjct: 114 --LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS 148
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 22/43 (51%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
I G+ +LHE I++RDLK NVLLDS+ + KI+DFGM +
Sbjct: 105 IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 8e-07
Identities = 49/178 (27%), Positives = 79/178 (44%), Gaps = 51/178 (28%)
Query: 357 LGQGGFGPV----YKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLI-----LKL----- 402
LGQG +G V S+ + VA+K++++ F+ ++L LKL
Sbjct: 8 LGQGAYGIVCSARNAET-SEEETVAIKKITNV-------FSKKILAKRALRELKLLRHFR 59
Query: 403 QHKNLVKLLGFCV---DGDEKLLVYEFMPNGSLDAILFDPRKRG----------ILCWRK 449
HKN+ L + +L +YE + L I+ + ILC
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILC--- 116
Query: 450 RTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
G+ Y+H + ++HRDLK N+L+++D KI DFG+AR F+E+ GE
Sbjct: 117 ----------GLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGE 161
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 8e-07
Identities = 51/177 (28%), Positives = 82/177 (46%), Gaps = 18/177 (10%)
Query: 350 NFSDSNILGQGGFGPVY---KGVLSD-GKEVAVKRLSSCS---EQGTAEFTNEVLLILKL 402
NF +LG G +G V+ K D GK A+K L + + T E T +L+
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 403 --QHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
Q LV L + + KL L+ +++ G + L+ +R + I
Sbjct: 61 VRQSPFLVTL-HYAFQTEAKLHLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIIL 116
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
+ +LH +L IV+RD+K N+LLDS+ + ++DFG+++ F E E T GT
Sbjct: 117 ALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGT 169
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 43/159 (27%), Positives = 82/159 (51%), Gaps = 17/159 (10%)
Query: 357 LGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGT-AEFT-NEVLLILKLQHKNLVKLLGF 413
+G+G +G V S+ ++VA+K++++ + A+ T E+ L+ L H+N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKD- 71
Query: 414 CVDGDEK------LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
+ + +VYE M + L I+ R L + + +G+ Y+H
Sbjct: 72 IMPPPHREAFNDVYIVYELM-DTDLHQII---RSSQTLSDDHCQYFLYQLLRGLKYIHSA 127
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506
+ ++HRDLK SN+LL+++ + KI DFG+AR +E
Sbjct: 128 N---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD 163
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 9e-07
Identities = 46/159 (28%), Positives = 80/159 (50%), Gaps = 19/159 (11%)
Query: 357 LGQGGFGPVYKGVLSDG---KEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLG- 412
+G+G +G VYK DG KE A+K++ +A E+ L+ +L+H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA--CREIALLRELKHPNVIALQKV 66
Query: 413 FCVDGDEKL-LVYEFMPNGSLDAILF----DPRKRGILCWRKRT-NIVNGIAKGMLYLHE 466
F D K+ L++++ + I F K+ + R +++ I G+ YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 467 DSRLRIVHRDLKASNVLLDSD----MNSKISDFGMARIF 501
+ ++HRDLK +N+L+ + KI+D G AR+F
Sbjct: 127 N---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 47/150 (31%), Positives = 71/150 (47%), Gaps = 13/150 (8%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAE----FTNEVLLILKLQHKNLVKL 410
++G+G FG V +DGK AVK L + E +L+ ++H LV L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 411 LGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
+ +KL V +++ G L L R+R R R IA + YLH
Sbjct: 62 -HYSFQTADKLYFVLDYVNGGELFFHL--QRERSFPEPRARFYAAE-IASALGYLHS--- 114
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
L I++RDLK N+LLDS + ++DFG+ +
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 43/135 (31%), Positives = 66/135 (48%), Gaps = 17/135 (12%)
Query: 373 GKEVAVKRLSSCSEQGT-AEFTNEVLLILK-LQHKNLVKLLGFCV------DGDEKLLVY 424
G VAVK+LS + T A+ L++LK + HKN++ LL + + LV
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105
Query: 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL 484
E M I + L + + ++ + G+ +LH I+HRDLK SN+++
Sbjct: 106 ELMDANLCQVIHME------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVV 156
Query: 485 DSDMNSKISDFGMAR 499
SD KI DFG+AR
Sbjct: 157 KSDCTLKILDFGLAR 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 50/172 (29%), Positives = 76/172 (44%), Gaps = 24/172 (13%)
Query: 357 LGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLG 412
LG+GGFG V + + GK A K+L+ +G E ++ K+ + +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFD--------PRKRGILCWRKRTNIVNGIAKGMLYL 464
+ LV M G L +++ P R I G+ +L
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACF-------YTAQIISGLEHL 113
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
H+ RI++RDLK NVLLD+D N +ISD G+A +G++ T GT
Sbjct: 114 HQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELK--DGQSKTKGYAGT 160
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 43/153 (28%), Positives = 70/153 (45%), Gaps = 22/153 (14%)
Query: 357 LGQGGFGPVYKG-VLSDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQ-HKNLVKLL 411
+G+G F V K GK A+K + EQ E+ + +L H N+++L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN--LREIQALRRLSPHPNILRLI 64
Query: 412 GFCVDGDEK--LLVYEFMPNGSLDAILFD---PRKRGILCWRKRTNIVNGIAKGMLYLHE 466
D LV+E M D L++ RKR L ++ + + + K + ++H
Sbjct: 65 EVLFDRKTGRLALVFELM-----DMNLYELIKGRKR-PLPEKRVKSYMYQLLKSLDHMH- 117
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
R I HRD+K N+L+ D K++DFG R
Sbjct: 118 --RNGIFHRDIKPENILIKDD-ILKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 41/158 (25%), Positives = 74/158 (46%), Gaps = 27/158 (17%)
Query: 357 LGQGGFGPVYKGVL----SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKL 410
+G+G FG K +L DGK+ +K ++ S + E EV ++ ++H N+V+
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 411 LGFCVDGDEKLLVYEFMPNGSL-------DAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
+ +V ++ G L +LF + IL W + I + +
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQ--ILDWFVQ------ICLALKH 116
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
+H+ +I+HRD+K+ N+ L D K+ DFG+AR+
Sbjct: 117 VHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 54/162 (33%), Positives = 75/162 (46%), Gaps = 15/162 (9%)
Query: 356 ILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS-----EQGTAEFTNEVLLILKLQHKNLVK 409
++G+G FG V SDG AVK L + EQ VLL L+H LV
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLL-KNLKHPFLVG 60
Query: 410 LLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
L + EKL V +++ G L R+R L R R +A + YLH
Sbjct: 61 L-HYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAE-VASAIGYLHS-- 114
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
L I++RDLK N+LLDS + ++DFG+ + E E +T
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST 155
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 51/184 (27%), Positives = 85/184 (46%), Gaps = 21/184 (11%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHK 405
L +F + LG G G V+K + ++L + N+++ L++ H+
Sbjct: 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHE 59
Query: 406 -NLVKLLGFC----VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
N ++GF DG E + E M GSLD +L +K G + + + + KG
Sbjct: 60 CNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKG 115
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG--------MARIFAESEGEANTVR 512
+ YL E + +I+HRD+K SN+L++S K+ DFG MA F + + R
Sbjct: 116 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPER 173
Query: 513 IVGT 516
+ GT
Sbjct: 174 LQGT 177
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 48/155 (30%), Positives = 72/155 (46%), Gaps = 11/155 (7%)
Query: 351 FSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNL 407
+ D +G G +G V + G +VA+K+L SE E+ L+ ++H+N+
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76
Query: 408 VKLLG-FCVDG--DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
+ LL F D D Y MP D L K L + +V + KG+ Y+
Sbjct: 77 IGLLDVFTPDLSLDRFHDFYLVMPFMGTD--LGKLMKHEKLSEDRIQFLVYQMLKGLKYI 134
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
H I+HRDLK N+ ++ D KI DFG+AR
Sbjct: 135 HAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 47/167 (28%), Positives = 80/167 (47%), Gaps = 15/167 (8%)
Query: 350 NFSDSNILGQGGFGPVY---KGVLSD-GKEVAVKRLSSCS---EQGTAEFTNEVLLILK- 401
NF +LG G +G V+ K D GK A+K L + + T E T +L+
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 402 LQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
++ + L + D KL L+ +++ G L L +R ++ I
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL---SQRERFKEQEVQIYSGEIVLA 117
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
+ +LH +L I++RD+K N+LLDS+ + ++DFG+++ F E E E
Sbjct: 118 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE 161
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 47/159 (29%), Positives = 73/159 (45%), Gaps = 22/159 (13%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLL 411
+G G G V Y VL + VA+K+LS + T E++L+ + HKN++ LL
Sbjct: 25 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
+ + LV E M I + L + + ++ + G+ +LH
Sbjct: 83 NVFTPQKSLEEFQDVYLVMELMDANLCQVIQME------LDHERMSYLLYQMLCGIKHLH 136
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504
I+HRDLK SN+++ SD KI DFG+AR S
Sbjct: 137 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 45/161 (27%), Positives = 72/161 (44%), Gaps = 25/161 (15%)
Query: 357 LGQGGFGPVYKGVLSDGKE-------------VAVKRLSSCSEQGTAEFTNEVLLILKLQ 403
LG+G +Y G+L+ + V +K L + F ++ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
HK++V L G CV E ++V EF+ G LD LF RK +L + + +A + Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKVAKQLASALSY 120
Query: 464 LHEDSRLRIVHRDLKASNVLL-----DSDMNS--KISDFGM 497
L ED L VH ++ N+LL D + K+SD G+
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 46/155 (29%), Positives = 65/155 (41%), Gaps = 47/155 (30%)
Query: 373 GKEVAVKRLSSCSEQGTAEFTN---------EVLLILKLQHKNLVKLLGFCVDGDEKL-- 421
G+ VA+K+LS F N E++L+ + HKN++ LL + L
Sbjct: 41 GQNVAIKKLSR-------PFQNVTHAKRAYRELVLMKLVNHKNIIGLLN-VFTPQKSLEE 92
Query: 422 -----LVYEFMPNGSLDAILFD-PRKR------GILCWRKRTNIVNGIAKGMLYLHEDSR 469
LV E M I D +R +LC G+ +LH
Sbjct: 93 FQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLC-------------GIKHLHSAG- 138
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504
I+HRDLK SN+++ SD KI DFG+AR S
Sbjct: 139 --IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 19/46 (41%), Positives = 30/46 (65%), Gaps = 2/46 (4%)
Query: 453 IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498
I I K + YLH +L ++HRD+K SNVL++ + K+ DFG++
Sbjct: 108 IAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 20/44 (45%), Positives = 30/44 (68%), Gaps = 3/44 (6%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500
I +G+ YLH I+HRD+K N+L++S+ KI DFG+AR+
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARV 152
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 38/154 (24%), Positives = 73/154 (47%), Gaps = 9/154 (5%)
Query: 357 LGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAE--FTNEVLLILKLQHKNLVKLLGF 413
+G+G +G V+K + G+ VA+K+ + + E+ ++ +L+H NLV L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
+ LV+E+ + L+ + +PR +K I+ + + + H + +
Sbjct: 69 FRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKK---IIWQTLQAVNFCH---KHNCI 122
Query: 474 HRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
HRD+K N+L+ K+ DFG ARI +
Sbjct: 123 HRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 16/156 (10%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCS----EQGTAEFTNEVLLILKLQ 403
+F ++G+G FG V D G A+K+L EQ A E ++ +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEAD 59
Query: 404 HKNLVKLLGFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
+ +VKL + DE L+ E++P G + +L K+ + T IA+ +
Sbjct: 60 NPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLM---KKDTFT-EEETRFY--IAETI 111
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497
L + +L +HRD+K N+LLD+ + K+SDFG+
Sbjct: 112 LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 48/168 (28%), Positives = 83/168 (49%), Gaps = 17/168 (10%)
Query: 356 ILGQGGFGPVYKGVLSD-GKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKN--LVK 409
I+G+GGFG VY +D GK A+K L +QG NE +++ + + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 410 LLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
+ + +KL + + M G L L + G+ ++ I G+ ++H +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHL---SQHGVFSEKEMRFYATEIILGLEHMH--N 115
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
R +V+RDLK +N+LLD + +ISD G+A F++ + A+ VGT
Sbjct: 116 RF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 158
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 43/154 (27%), Positives = 78/154 (50%), Gaps = 18/154 (11%)
Query: 356 ILGQGGFGPVYKGVLSDGKE----VAVKRLSSC----SEQGTAEFTNEVLLILKLQHKNL 407
+LG+GG+G V++ G + A+K L +++ TA E ++ ++H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 408 VKLL-GFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
V L+ F G KL L+ E++ G L L + GI ++ I+ + +LH
Sbjct: 63 VDLIYAFQTGG--KLYLILEYLSGGELFMHL---EREGIFMEDTACFYLSEISLALEHLH 117
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+ I++RDLK N+LLD+ + K++DFG+ +
Sbjct: 118 ---QQGIIYRDLKPENILLDAQGHVKLTDFGLCK 148
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 9e-06
Identities = 37/132 (28%), Positives = 60/132 (45%), Gaps = 13/132 (9%)
Query: 373 GKEVAVKRLSSCSEQGT---AEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL-VYEFMP 428
G EVA+K L + + + A F E L +L H N+V LL L V+E++P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL---D 485
+L +L G L + ++ + + H IVHRDLK N+++
Sbjct: 63 GRTLREVL---AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTG 116
Query: 486 SDMNSKISDFGM 497
++K+ DFG+
Sbjct: 117 VRPHAKVLDFGI 128
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 9e-06
Identities = 50/160 (31%), Positives = 76/160 (47%), Gaps = 11/160 (6%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSS---CSEQGTAEFTNEVLLILK-LQHKNLVKL 410
++G+G FG V ++ K AVK L ++ +E ++LK ++H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
D+ V +++ G L L R+R L R R IA + YLH L
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYAAE-IASALGYLHS---L 115
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
IV+RDLK N+LLDS + ++DFG+ + E G +T
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST 155
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 31/159 (19%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGT-AEFTNEVLLILK-LQHKNLVKLLGF 413
+G G +G V G VAVK+LS + A+ T L +LK ++H+N++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
F P SL+ L I+ +K T+ ++ I +G
Sbjct: 85 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 132
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+ Y+H I+HRDLK SN+ ++ D KI DFG+AR
Sbjct: 133 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 168
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 49/186 (26%), Positives = 81/186 (43%), Gaps = 22/186 (11%)
Query: 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSS---CSEQGTAEFTNE 395
+ L + +F ++G+G FG V K+V A+K LS +A F E
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 396 VLLILKLQHKNLVKLLGFCVDGDEKLL--VYEFMPNGSLDAILFD---PRKRGILCWRKR 450
++ + +V+L D+K L V E+MP G L ++ + P K W +
Sbjct: 94 RDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK-----WARF 146
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
A+ +L L + +HRD+K N+LLD + K++DFG + ++ G
Sbjct: 147 Y-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMDANGMVRC 200
Query: 511 VRIVGT 516
VGT
Sbjct: 201 DTAVGT 206
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 42/153 (27%), Positives = 65/153 (42%), Gaps = 30/153 (19%)
Query: 357 LGQGGFGPVYKGVL-----------------------SDGKE--VAVKRLSSCSEQGTAE 391
LGQG +Y G L ++G+E V +K L
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62
Query: 392 FTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT 451
F L+ ++ H +L + G CV G E ++V EF+ +G LD L + R + W +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 452 NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL 484
+ +A + YL ED L VH ++ A N+LL
Sbjct: 121 TVAQQLASALSYL-EDKNL--VHGNVCAKNILL 150
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 47/166 (28%), Positives = 71/166 (42%), Gaps = 13/166 (7%)
Query: 356 ILGQGGFGPVYKGVLS-DGKEVAVKRLSS----CSEQGTAEFTNEVLLILKLQHKNLVKL 410
+LG+G FG V+ L + A+K L + + +L L +H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
+ V E++ G L +F + + T I G+ +LH
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG-- 116
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
IV+RDLK N+LLD+D + KI+DFGM + G+A T GT
Sbjct: 117 -IVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGT 159
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 22/159 (13%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLL 411
+G G G V Y +L + VA+K+LS + T E++L+ + HKN++ LL
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
+ + +V E M I + L + + ++ + G+ +LH
Sbjct: 90 NVFTPQKSLEEFQDVYIVMELMDANLCQVIQME------LDHERMSYLLYQMLCGIKHLH 143
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504
I+HRDLK SN+++ SD KI DFG+AR S
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 49/168 (29%), Positives = 81/168 (48%), Gaps = 17/168 (10%)
Query: 356 ILGQGGFGPVYKGVLSD-GKEVAVKRLSSCS---EQGTAEFTNE--VLLILKLQHKNLVK 409
I+G+GGFG VY +D GK A+K L +QG NE +L ++ +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 410 LLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
+ + +KL + + M G L L + G+ + I G+ ++H +
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEAEMRFYAAEIILGLEHMH--N 115
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
R +V+RDLK +N+LLD + +ISD G+A F++ + A+ VGT
Sbjct: 116 RF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 158
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-05
Identities = 32/150 (21%), Positives = 58/150 (38%), Gaps = 15/150 (10%)
Query: 356 ILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV--KLLGF 413
+L G VY + + ++ +K S + A+ EV ++ L K L K+L
Sbjct: 5 LLKGGLTNRVYL-LGTKDEDYVLKINPS--REKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
L+ E++ +LD + + ++ + +AK LH+ L +
Sbjct: 62 GESDGWSYLLMEWIEGETLDEVSEEEKED------IAEQLAELLAK----LHQLPLLVLC 111
Query: 474 HRDLKASNVLLDSDMNSKISDFGMARIFAE 503
H DL N+L+D I D+ A
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 20/43 (46%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
I+ G+ +LH I++RDLK NV+LDS+ + KI+DFGM +
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 47/164 (28%), Positives = 69/164 (42%), Gaps = 44/164 (26%)
Query: 356 ILGQGGFGPV----YKGVLSDGKEVAVKRL------------SSCSEQGTAEFTNEVLLI 399
+LG+G FG V YK G+ A+K L S E+ E N
Sbjct: 6 VLGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETAN----- 57
Query: 400 LKLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSL-----DAILFDPRKRGILCWRKRTNI 453
+H LV L C ++ + V E+ G L + +PR
Sbjct: 58 -SERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAA------- 108
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497
+ G+ YLHE+ +IV+RDLK N+LLD++ KI+DFG+
Sbjct: 109 --CVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGL 147
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 45/163 (27%), Positives = 68/163 (41%), Gaps = 44/163 (26%)
Query: 357 LGQGGFGPVYKG-VLSDGKEVAVKRLSSCSEQGTAEFTNEVLL---ILKLQH--KNLVKL 410
+G G G VYK G +AVK++ G E +L+ ++ H +VK
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMR---RTGNKEENKRILMDLDVVLKSHDCPYIVKC 79
Query: 411 LG-FCVDGD------------EKLL--VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN 455
G F D D +KLL + +P + IL +
Sbjct: 80 YGYFITDSDVFICMELMSTCLDKLLKRIQGPIP----EDIL--------------GKMTV 121
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498
I K + YL E ++HRD+K SN+LLD+ N K+ DFG++
Sbjct: 122 AIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGIS 162
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 21/43 (48%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
IA G+ +LH I++RDLK NV+LDS+ + KI+DFGM +
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 51/151 (33%), Positives = 70/151 (46%), Gaps = 15/151 (9%)
Query: 356 ILGQGGFGPVYKGVLS-DGKEVAVKRLS-----SCSEQGTAEFTNEVLLILKLQHKNLVK 409
++G+G FG V DGK AVK L + EQ VLL ++H LV
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLL-KNVKHPFLVG 60
Query: 410 LLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
L + EKL V +F+ G L R+R R R IA + YLH
Sbjct: 61 L-HYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAAE-IASALGYLHS-- 114
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+ IV+RDLK N+LLDS + ++DFG+ +
Sbjct: 115 -INIVYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 36/131 (27%), Positives = 60/131 (45%), Gaps = 19/131 (14%)
Query: 394 NEVLLILKLQHKNLVKLLGFCVDGDEKLLV--------YEFMPNGSLDAILFDPRKRGIL 445
NE+L + +L H+N++K+ ++ Y FM + + D K L
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDW------KDRPL 265
Query: 446 CWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
+ R I+ + + Y+H+ +++HRD+K N+ L+ D + DFG A F E E
Sbjct: 266 LKQTRA-IMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPF-EKE 320
Query: 506 GEANTVRIVGT 516
EA VGT
Sbjct: 321 REAFDYGWVGT 331
|
Length = 501 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 41/138 (29%), Positives = 69/138 (50%), Gaps = 23/138 (16%)
Query: 394 NEVLLILKLQHK-NLVKLLGFC----VDGDEKLLVYEFMPNGSLDAILFDPRK--RGILC 446
N+++ L++ H+ N ++GF DG E + E M GSLD +L + ++ IL
Sbjct: 48 NQIIRELQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKEAKRIPEEIL- 105
Query: 447 WRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG--------MA 498
+ + +G+ YL E + +I+HRD+K SN+L++S K+ DFG MA
Sbjct: 106 ----GKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 159
Query: 499 RIFAESEGEANTVRIVGT 516
F + + R+ GT
Sbjct: 160 NSFVGTRSYMSPERLQGT 177
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 42/152 (27%), Positives = 72/152 (47%), Gaps = 10/152 (6%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHK 405
+F ++G+G FG V D G A+K L ++ A E ++++
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
+VK+ D L+ EF+P G + +L K+ L + T IA+ +L +
Sbjct: 62 WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM---KKDTLS-EEATQFY--IAETVLAID 115
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497
+L +HRD+K N+LLD+ + K+SDFG+
Sbjct: 116 AIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHK 405
+F ++G+G FG V D G A+K L ++ E ++++
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
+VK+ D L+ EF+P G + +L K+ L + T IA+ +L +
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM---KKDTLT-EEETQFY--IAETVLAID 115
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497
+L +HRD+K N+LLDS + K+SDFG+
Sbjct: 116 SIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 33/117 (28%), Positives = 58/117 (49%), Gaps = 6/117 (5%)
Query: 373 GKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNG 430
G V V+ L +C+E+ NEV+L +H N++ G ++ FM G
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD 487
S +++L G+ NI+ G +G+ YLH++ +HR++KAS++L+ D
Sbjct: 85 SANSLLKTYFPEGMSEALIG-NILFGALRGLNYLHQNG---YIHRNIKASHILISGD 137
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 43/164 (26%), Positives = 71/164 (43%), Gaps = 26/164 (15%)
Query: 350 NFSDSNILGQGGFGPVYKGV--LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL 407
+F ++G+G FG V + V GK A+K L + F + L +K + L
Sbjct: 2 DFHTVKVIGKGAFGEV-RLVQKKDTGKIYAMKTLLK-----SEMFKKDQLAHVKAERDVL 55
Query: 408 --------VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG--I 457
V L D L+ EF+P G L +L + + V +
Sbjct: 56 AESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK--------YDTFSEDVTRFYM 107
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
A+ +L + +L +HRD+K N+L+D + K+SDFG++ F
Sbjct: 108 AECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 43/150 (28%), Positives = 67/150 (44%), Gaps = 13/150 (8%)
Query: 356 ILGQGGFGPVYKGVLSDGKEV-AVKRLSSCS----EQGTAEFTNEVLLILKLQHKNLVKL 410
+LG+G FG V L EV A+K L + T + +L L +H L L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
D V E++ G L +F R R R R + +++LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAE-VTLALMFLHRHG- 116
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+++RDLK N+LLD++ + K++DFGM +
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 44/159 (27%), Positives = 74/159 (46%), Gaps = 31/159 (19%)
Query: 357 LGQGGFGPVYKGVLSDGKE-VAVKRLSSCSEQGT-AEFTNEVLLILK-LQHKNLVKLLGF 413
+G G +G V + ++ VAVK+LS + A T L +LK ++H+N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
F P S++ L I+ +K ++ ++ + +G
Sbjct: 83 ------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRG 130
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+ Y+H I+HRDLK SNV ++ D +I DFG+AR
Sbjct: 131 LKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 7e-05
Identities = 45/166 (27%), Positives = 75/166 (45%), Gaps = 21/166 (12%)
Query: 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSE----QGTAEFTNE 395
+ L + ++ ++G+G FG V ++V +L S E +A F E
Sbjct: 34 KIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 396 VLLILKLQHKNLVKLLGFCVDGDEKLL--VYEFMPNGSLDAILFD---PRKRGILCWRKR 450
++ +V+L FC D+K L V E+MP G L ++ + P K W K
Sbjct: 94 RDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK-----WAKF 146
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496
A+ +L L + ++HRD+K N+LLD + K++DFG
Sbjct: 147 YT-----AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 45/152 (29%), Positives = 76/152 (50%), Gaps = 16/152 (10%)
Query: 356 ILGQGGFGPVY---KGVLSD-GKEVAVKRL--SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
+LGQG FG V+ K D G+ A+K L ++ + E ++ ++ H +VK
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 410 L-LGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
L F +G KL L+ +F+ G L L K + + +A + +LH
Sbjct: 63 LHYAFQTEG--KLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHLH-- 115
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
L I++RDLK N+LLD + + K++DFG+++
Sbjct: 116 -SLGIIYRDLKPENILLDEEGHIKLTDFGLSK 146
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 17/42 (40%), Positives = 27/42 (64%), Gaps = 3/42 (7%)
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500
+ + Y+H + + HRDLK N+L ++D KI DFG+AR+
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 21/43 (48%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+A+GM +L SR + +HRDL A N+LL + KI DFG+AR
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 45/152 (29%), Positives = 67/152 (44%), Gaps = 18/152 (11%)
Query: 356 ILGQGGFGPVYKGVL----SDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQHKNLV 408
+LG+G FG V +L + GK A+K L ++ A E ++ +H L
Sbjct: 2 LLGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLT 58
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG-IAKGMLYLHED 467
L D V E++ G L F R + RT I + YLH
Sbjct: 59 SLKYSFQTKDRLCFVMEYVNGGEL----FFHLSRERVFSEDRTRFYGAEIVSALDYLHSG 114
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+IV+RDLK N++LD D + KI+DFG+ +
Sbjct: 115 ---KIVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 17/37 (45%), Positives = 27/37 (72%), Gaps = 3/37 (8%)
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+LHE I++RDLK NVLLD++ + K++D+GM +
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 26/169 (15%)
Query: 356 ILGQGGFGPVYKGVLSD---GKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQHKNLVK 409
++G+GG G VY D + VA+K++ S + F E + L H +V
Sbjct: 9 LIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 410 LLGFCVDGDEKLLVYEFMP---NGSLDAILFDPRKRGILC--WRKRTN------IVNGIA 458
+ C DGD VY MP +L ++L ++ L ++T+ I + I
Sbjct: 67 VYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
+ Y+H S+ ++HRDLK N+LL I D+G A IF + E E
Sbjct: 124 ATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAA-IFKKLEEE 168
|
Length = 932 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 18/43 (41%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
I + YLH +V+RDLK N++LD D + KI+DFG+ +
Sbjct: 104 IVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 6e-04
Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 13/155 (8%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD---GKEVAVKRL--SSCSEQGTAEFTNEVLLILKLQH 404
+F +++G+G FG V V+ + G A+K + S Q T F E IL + +
Sbjct: 2 DFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59
Query: 405 KNLVKLLGFCV-DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
+ L + D D LV E+ P G L ++L R +A+ +L
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL--NRYEDQF---DEDMAQFYLAELVLA 114
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498
+H ++ VHRD+K NVL+D + K++DFG A
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSA 149
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 26/76 (34%), Positives = 36/76 (47%), Gaps = 4/76 (5%)
Query: 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVL 483
Y+ + + +L D G L + +A+GM +L + VHRDL A NVL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEG-LTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVL 269
Query: 484 LDSDMNSKISDFGMAR 499
L KI DFG+AR
Sbjct: 270 LAQGKIVKICDFGLAR 285
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 7e-04
Identities = 20/43 (46%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
I+ + YLHE I++RDLK NVLLDS+ + K++D+GM +
Sbjct: 105 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 7e-04
Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+AKGM +L SR + +HRDL A N+LL + KI DFG+AR
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 227
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 7e-04
Identities = 42/182 (23%), Positives = 68/182 (37%), Gaps = 44/182 (24%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD-----GKEVAVKRLSSCSEQGTAE-FTNEVLL----- 398
+F LG+G FG VYK L + + +K+ +E G E + NE +
Sbjct: 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKK---ATEYGAVEIWMNERVRRACPN 189
Query: 399 -ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL--------------DAILFDPRK-- 441
+ L + DE LV+ + +L +L +
Sbjct: 190 SCADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247
Query: 442 RGILCWRKRTNIVNGIAKGMLY----LHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFG 496
+G+ + I+ I + +L+ LH IVHRD+K N++ S KI D G
Sbjct: 248 KGL---ERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLG 301
Query: 497 MA 498
A
Sbjct: 302 AA 303
|
Length = 566 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 20/43 (46%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+AKGM +L + +HRDL A N+LL +KI DFG+AR
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR 262
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 15/38 (39%), Positives = 27/38 (71%), Gaps = 3/38 (7%)
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500
YLH I+HRDLK N+L+ ++ + K++DFG++++
Sbjct: 119 YLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 8e-04
Identities = 21/43 (48%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+A+GM +L SR + +HRDL A N+LL + KI DFG+AR
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 222
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 19/43 (44%), Positives = 28/43 (65%), Gaps = 2/43 (4%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
I + YLH S +V+RDLK N++LD D + KI+DFG+ +
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 18/37 (48%), Positives = 27/37 (72%), Gaps = 3/37 (8%)
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+LHE I++RDLK NVLLD+D + K++D+GM +
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 19/43 (44%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+A+GM +L + +HRD+ A NVLL +KI DFG+AR
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR 260
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 16/40 (40%), Positives = 27/40 (67%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496
+A+ +L + +L VHRD+K NVLLD + + +++DFG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 17/43 (39%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
I + YLH +V+RD+K N++LD D + KI+DFG+ +
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 24/179 (13%)
Query: 329 DNDL-KAQDFFIDLETLNLATSNFSDSNILGQGGFGPV----YKGVLSDGKEVAVKRLSS 383
DN L + +D + L + ++ ++G+G FG V +K S K A+K LS
Sbjct: 22 DNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHK---STRKVYAMKLLSK 78
Query: 384 CS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFD-- 438
++ + F E I+ + V L + D L +V E+MP G L ++ +
Sbjct: 79 FEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD 138
Query: 439 -PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496
P K W + A+ +L L + +HRD+K N+LLD + K++DFG
Sbjct: 139 VPEK-----WARFYT-----AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 18/40 (45%), Positives = 28/40 (70%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496
IA+ +L +H +L VHRD+K NVLLD + + +++DFG
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 32/85 (37%), Positives = 39/85 (45%), Gaps = 8/85 (9%)
Query: 356 ILGQGGFGPVYKGV-LSDGKE-----VAVKRLSSCSEQGTAEFTNEVLLILKL--QHKNL 407
LG G FG V + GKE VAVK L + + E L IL QHKN+
Sbjct: 45 TLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNI 104
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSL 432
V LLG C G L++ E+ G L
Sbjct: 105 VNLLGACTHGGPVLVITEYCCYGDL 129
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 33/128 (25%), Positives = 54/128 (42%), Gaps = 14/128 (10%)
Query: 372 DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-DEKLLVYEFMPNG 430
K+V VK ++ G E+ ++ + H+ ++ L + K V MP
Sbjct: 118 QRKKVIVKAVTGGKTPGR-----EIDILKTISHRAIINL----IHAYRWKSTVCMVMPKY 168
Query: 431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS 490
D + R G L + I + + + YLH I+HRD+K N+ LD N+
Sbjct: 169 KCDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENA 224
Query: 491 KISDFGMA 498
+ DFG A
Sbjct: 225 VLGDFGAA 232
|
Length = 392 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 38.4 bits (90), Expect = 0.004
Identities = 24/91 (26%), Positives = 37/91 (40%), Gaps = 14/91 (15%)
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
VD D L+V E++ L L R +++ + + + LH+ IVH
Sbjct: 69 VDPDNGLIVMEYIEGELLKDAL----------EEARPDLLREVGRLVGKLHKAG---IVH 115
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESE 505
DL SN++L DFG+ E E
Sbjct: 116 GDLTTSNIILSGG-RIYFIDFGLGEFSDEVE 145
|
Length = 204 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.004
Identities = 20/52 (38%), Positives = 32/52 (61%), Gaps = 1/52 (1%)
Query: 448 RKRTNIVNGIAKGMLY-LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498
++ N++ G+ + +L L + R+ IVHRD+K N+L+ D KI DFG A
Sbjct: 305 KRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.004
Identities = 18/38 (47%), Positives = 26/38 (68%), Gaps = 3/38 (7%)
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500
YLH IVHRDLK N+L+ S + K++DFG+++I
Sbjct: 116 YLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI 150
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 516 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.97 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.97 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.97 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.97 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.96 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.96 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.96 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.95 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.95 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.95 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.95 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.95 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.95 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.95 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.94 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.94 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.94 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.94 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.94 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.94 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.94 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.94 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.94 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.94 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.93 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.93 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.92 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.92 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.92 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.92 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.92 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.92 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.92 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.92 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.92 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.92 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.92 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.92 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.92 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.92 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.92 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.92 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.92 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.92 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.92 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.92 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.92 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.92 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.91 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.91 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.91 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.91 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.91 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.91 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.91 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.91 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.91 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.91 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.91 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.91 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.91 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.91 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.91 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.91 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.91 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.91 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.91 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.91 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.91 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.91 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.91 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.91 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.91 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.91 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.91 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.9 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.9 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.9 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.9 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.9 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.9 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.9 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.9 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.9 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.9 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.9 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.9 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.9 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.9 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.9 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.9 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.9 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.9 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.9 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.9 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.9 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.9 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.9 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.9 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.9 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.9 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.9 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.9 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.9 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.9 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.9 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.9 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.9 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.9 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.9 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.9 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.9 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.89 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.89 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.89 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.89 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.89 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.89 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.89 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.89 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.89 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.89 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.89 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.89 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.89 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.89 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.89 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.89 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.89 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.89 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.89 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.89 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.89 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.89 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.89 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.89 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.89 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.89 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.89 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.89 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.89 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.89 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.89 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.89 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.89 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.89 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.89 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.89 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.89 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.89 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.89 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.89 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.88 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.88 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.88 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.88 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.88 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.88 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.88 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.88 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.88 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.88 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.88 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.88 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.88 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.88 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.88 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.88 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.88 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.88 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.88 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.88 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.87 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.87 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.87 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.87 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.87 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.87 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.87 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.87 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.87 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.87 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.87 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.87 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.87 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.87 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.87 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.87 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.87 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.87 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.87 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.87 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.87 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.87 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.87 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.87 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.87 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.87 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.87 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.87 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.87 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.87 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.87 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.87 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.87 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.86 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.86 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.86 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.86 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.86 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.86 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.86 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.86 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.86 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.86 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.86 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.86 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.86 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.86 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.86 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.86 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.86 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.86 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.86 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.85 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.85 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.85 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.85 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.85 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.85 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.85 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.85 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.85 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.85 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.85 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.85 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.85 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.85 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.85 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.85 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.85 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.85 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.85 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.85 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.85 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.85 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.85 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.85 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.85 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.84 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.84 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.84 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.84 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.84 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.84 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.84 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.84 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.84 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.84 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.83 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.83 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.83 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.83 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.83 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.83 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.83 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.83 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.83 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.83 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.83 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.83 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.82 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.82 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.82 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.82 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.82 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.82 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.82 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.82 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.82 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.81 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.81 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.81 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.8 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.8 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.8 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.79 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.79 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.79 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.79 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.79 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.79 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.79 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.77 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.77 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.76 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.74 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.73 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.72 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.7 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.67 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.64 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.63 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.62 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.61 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.6 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.58 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.53 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.39 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.36 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.28 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.26 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.25 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.22 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.19 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.17 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.17 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.16 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.07 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.0 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.0 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 98.98 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.93 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.9 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.75 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.73 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.7 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.67 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.63 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.59 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.58 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.44 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.44 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.38 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.34 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.33 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.31 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.28 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.27 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.25 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.21 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.2 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.2 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.17 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.04 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.03 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.94 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.88 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.77 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.73 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.72 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.64 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.56 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.49 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.22 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.19 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.02 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.98 | |
| PLN02236 | 344 | choline kinase | 96.96 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.83 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.7 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.47 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.45 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.44 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.42 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 96.4 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.01 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.97 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 95.84 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.73 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.56 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.56 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.29 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.28 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.25 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.1 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 94.72 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.48 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.34 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.21 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 93.38 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 93.06 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=307.35 Aligned_cols=168 Identities=54% Similarity=0.888 Sum_probs=153.4
Q ss_pred cccccchHHHHHhhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEE
Q 010186 335 QDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414 (516)
Q Consensus 335 ~~~~~~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 414 (516)
....+++.++..+|++|+..++||+|+||.||+|.+++|..||||++.....+...+|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 34568999999999999999999999999999999999999999988764433145699999999999999999999999
Q ss_pred EeCC-eeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEc
Q 010186 415 VDGD-EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKIS 493 (516)
Q Consensus 415 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~ 493 (516)
.+.+ +.+||||||++|+|+++|+..... .++|..+++|+.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999765443 89999999999999999999999988899999999999999999999999
Q ss_pred ccCccccccc
Q 010186 494 DFGMARIFAE 503 (516)
Q Consensus 494 DFGla~~~~~ 503 (516)
|||||+....
T Consensus 220 DFGLa~~~~~ 229 (361)
T KOG1187|consen 220 DFGLAKLGPE 229 (361)
T ss_pred CccCcccCCc
Confidence 9999977665
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=261.78 Aligned_cols=150 Identities=33% Similarity=0.548 Sum_probs=135.1
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
.+|...+.||.|.|++||+|++. ++.+||||.+.+. ..+..+.+..|+++|+.++|||||+|+++++.++..|||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 45677778999999999999964 6789999999764 55567778999999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCC------CcEEEcccCccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD------MNSKISDFGMAR 499 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~------~~~kl~DFGla~ 499 (516)
||.+|+|..+++ ..+.+++.....++.||+.||++||+++ ||||||||.||||+.. -.+||+|||+||
T Consensus 90 yC~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 90 YCNGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred eCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 999999999994 4557999999999999999999999998 9999999999999764 458999999999
Q ss_pred ccccC
Q 010186 500 IFAES 504 (516)
Q Consensus 500 ~~~~~ 504 (516)
.+.+.
T Consensus 164 ~L~~~ 168 (429)
T KOG0595|consen 164 FLQPG 168 (429)
T ss_pred hCCch
Confidence 99854
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=259.18 Aligned_cols=157 Identities=36% Similarity=0.574 Sum_probs=136.8
Q ss_pred CCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhc--CCCCCccceeeEEEeCC----eeEEEEE
Q 010186 352 SDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILK--LQHKNLVKLLGFCVDGD----EKLLVYE 425 (516)
Q Consensus 352 ~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~~----~~~lV~E 425 (516)
...++||+|+||.||||.+. ++.||||++.. ++.+.|.+|-++... ++|+||+++++.-.... +.+||+|
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 44577999999999999994 59999999965 556678888777765 58999999999877655 7899999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC------CCCCeeeCCCCCCCeEecCCCcEEEcccCccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED------SRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~------~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 499 (516)
|.++|+|.++| ....++|.+..+|+..+++||+|||+. .+++|+|||||++||||.+|+++.|+|||||.
T Consensus 289 fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 289 FHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 99999999999 345789999999999999999999975 35789999999999999999999999999999
Q ss_pred ccccCCCccCccceecC
Q 010186 500 IFAESEGEANTVRIVGT 516 (516)
Q Consensus 500 ~~~~~~~~~~~~~~~GT 516 (516)
.+........+..-+||
T Consensus 365 ~~~p~~~~~d~~~qVGT 381 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGT 381 (534)
T ss_pred EecCCCCCcchhhhhhh
Confidence 99887777666667776
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=263.30 Aligned_cols=160 Identities=32% Similarity=0.515 Sum_probs=145.4
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEecc---CCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
..|..++.||+|+|+.||+++. .+|+.||+|++.+ .+....+...+||++.+.|+|||||+++++|++.+..|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4577889999999999999996 8899999999976 34556778999999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
|+|++++|..++. .++.+++.++..++.||+.||.|||+++ |||||||..|++|++++++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999993 5678999999999999999999999998 999999999999999999999999999999866
Q ss_pred CCccCccceecC
Q 010186 505 EGEANTVRIVGT 516 (516)
Q Consensus 505 ~~~~~~~~~~GT 516 (516)
+.+..| ++||
T Consensus 172 ~Erk~T--lCGT 181 (592)
T KOG0575|consen 172 GERKKT--LCGT 181 (592)
T ss_pred ccccce--ecCC
Confidence 544443 7887
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=258.85 Aligned_cols=150 Identities=38% Similarity=0.604 Sum_probs=132.4
Q ss_pred CCCceeeecCcEeEEEEEecCCcEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCCccceeeEEEeCC-eeEEEEEccC
Q 010186 352 SDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSE--QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD-EKLLVYEFMP 428 (516)
Q Consensus 352 ~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey~~ 428 (516)
...+.||+|+||+||+|.++....||||++..... ...+.|.+|+.+|.+++|||||+++|+|.+.. ...|||||++
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 33456999999999999996555599999976332 22668999999999999999999999999988 7999999999
Q ss_pred CCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC-cEEEcccCcccccccC
Q 010186 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-NSKISDFGMARIFAES 504 (516)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~-~~kl~DFGla~~~~~~ 504 (516)
+|+|..+++.. .+..+++..++.++.|||+||.|||++.+ ||||||||+||||+.++ ++||+|||+++.....
T Consensus 124 ~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 124 GGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 99999999653 46679999999999999999999999873 99999999999999997 9999999999987754
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=250.60 Aligned_cols=160 Identities=30% Similarity=0.467 Sum_probs=134.1
Q ss_pred hCCCCCCceeeecCcEeEEEEE-ecCCcEEEEEEeccCCcc-------chHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 010186 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ-------GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 419 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~-------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 419 (516)
.+.|...+.||+|+||.|-+|. -++|+.||||++.+.... ......+|+++|++|+|||||++++++...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 3456678899999999999998 457999999999762111 12235799999999999999999999999999
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCC---CcEEEcccC
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD---MNSKISDFG 496 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~---~~~kl~DFG 496 (516)
.|||||||+||+|.+.+. .++.+.+..-..++.|++.|+.|||++| |+||||||+|||+..+ ..+||+|||
T Consensus 251 ~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 999999999999999883 4455777777889999999999999998 9999999999999665 679999999
Q ss_pred cccccccCCCccCccceecC
Q 010186 497 MARIFAESEGEANTVRIVGT 516 (516)
Q Consensus 497 la~~~~~~~~~~~~~~~~GT 516 (516)
||+...+. +... +++||
T Consensus 325 lAK~~g~~-sfm~--TlCGT 341 (475)
T KOG0615|consen 325 LAKVSGEG-SFMK--TLCGT 341 (475)
T ss_pred hhhccccc-eehh--hhcCC
Confidence 99998733 2333 36776
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=254.21 Aligned_cols=159 Identities=30% Similarity=0.502 Sum_probs=138.9
Q ss_pred CCCCCceeeecCcEeEEEEE-ecCCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEEE
Q 010186 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLLVY 424 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~-~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 424 (516)
.|...++||+|.||.||+++ ..+|+.||+|++.-.. .....-..+||.+|++|+||||++|.+...+. ...|||+
T Consensus 118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 34556779999999999999 6789999999987533 44455678999999999999999999999887 6899999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
|||++ +|.-++.. ..-.+++.++..++.||+.||+|+|+.+ |+|||||.+|||||.+|.+||+|||||+++..+
T Consensus 198 eYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 198 EYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred ecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 99987 77766643 3456999999999999999999999998 999999999999999999999999999999988
Q ss_pred CCccCcccee
Q 010186 505 EGEANTVRIV 514 (516)
Q Consensus 505 ~~~~~~~~~~ 514 (516)
....-|++|+
T Consensus 272 ~~~~~T~rVv 281 (560)
T KOG0600|consen 272 GSAPYTSRVV 281 (560)
T ss_pred CCcccccceE
Confidence 8777777765
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=256.83 Aligned_cols=159 Identities=39% Similarity=0.631 Sum_probs=140.3
Q ss_pred cccccchHHHHHhhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEE
Q 010186 335 QDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414 (516)
Q Consensus 335 ~~~~~~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 414 (516)
..+.++.+++.. .+.||+|.||.||.|.++....||+|.++..+ ...+.|.+|+.+|++|+|+|||+|+|+|
T Consensus 199 d~wei~r~~l~l-------~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~ 270 (468)
T KOG0197|consen 199 DPWEIPREELKL-------IRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVC 270 (468)
T ss_pred CCeeecHHHHHH-------HHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEE
Confidence 344555666655 46699999999999999888899999998753 3456799999999999999999999999
Q ss_pred EeCCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcc
Q 010186 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD 494 (516)
Q Consensus 415 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~D 494 (516)
..++.++||||||+.|+|.++|.. ..+..+...+.+.++.|||+||+||+++. +|||||.++||||+++..+||+|
T Consensus 271 ~~~~piyIVtE~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsD 346 (468)
T KOG0197|consen 271 TKQEPIYIVTEYMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISD 346 (468)
T ss_pred ecCCceEEEEEecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcc
Confidence 999999999999999999999965 35567888999999999999999999998 99999999999999999999999
Q ss_pred cCcccccccCC
Q 010186 495 FGMARIFAESE 505 (516)
Q Consensus 495 FGla~~~~~~~ 505 (516)
|||||.+.+++
T Consensus 347 FGLAr~~~d~~ 357 (468)
T KOG0197|consen 347 FGLARLIGDDE 357 (468)
T ss_pred cccccccCCCc
Confidence 99999665554
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=267.44 Aligned_cols=156 Identities=32% Similarity=0.581 Sum_probs=140.0
Q ss_pred HhhCCCCCCceeeecCcEeEEEEEec----CCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 010186 346 LATSNFSDSNILGQGGFGPVYKGVLS----DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK 420 (516)
Q Consensus 346 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 420 (516)
+..+...++++||.|.||.|++|.++ ....||||.|+.. .++...+|+.|..+|.+++||||++|.|+.......
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv 705 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV 705 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence 44456677899999999999999975 2357999999874 456677899999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
.+|.|||++|+|+.||.. ..+.+++.+...+.++|+.||.||-+.+ +|||||.++||||+++..+|++||||+|.
T Consensus 706 MIiTEyMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred EEEhhhhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceee
Confidence 999999999999999964 4466999999999999999999999887 99999999999999999999999999998
Q ss_pred cccCCC
Q 010186 501 FAESEG 506 (516)
Q Consensus 501 ~~~~~~ 506 (516)
+.++..
T Consensus 781 ledd~~ 786 (996)
T KOG0196|consen 781 LEDDPE 786 (996)
T ss_pred cccCCC
Confidence 877663
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-30 Score=244.50 Aligned_cols=161 Identities=26% Similarity=0.407 Sum_probs=143.3
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 423 (516)
.++|...++||+|+||+||.++. ++++-+|+|++++. ...+.+...+|..+|.+++||.||+++--|++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 45788899999999999999995 46888999999763 345677889999999999999999999999999999999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
+||+.||.|...| .+.+.+++..+.-++.+|+.||.|||+++ ||||||||+|||||++|+++|+||||++..-.
T Consensus 104 ld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999999 45567999999999999999999999998 99999999999999999999999999998766
Q ss_pred CCCccCccceecC
Q 010186 504 SEGEANTVRIVGT 516 (516)
Q Consensus 504 ~~~~~~~~~~~GT 516 (516)
...... +++||
T Consensus 178 ~~~~t~--tfcGT 188 (357)
T KOG0598|consen 178 DGDATR--TFCGT 188 (357)
T ss_pred CCCccc--cccCC
Confidence 544433 48888
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=242.83 Aligned_cols=156 Identities=33% Similarity=0.461 Sum_probs=135.8
Q ss_pred CCCceeeecCcEeEEEEEec-CCcEEEEEEecc-CCccchHHHHHHHHHHhcCCCCCccceeeEEEeCC-eeEEEEEccC
Q 010186 352 SDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD-EKLLVYEFMP 428 (516)
Q Consensus 352 ~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey~~ 428 (516)
...+.||+|..|+|||+.++ +++.+|+|.+.. .+....+++.+|++++.+.+||+||.++|.|..+. ...++||||+
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 34577999999999999975 577889999954 34456778999999999999999999999999998 5999999999
Q ss_pred CCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCCCcc
Q 010186 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508 (516)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~ 508 (516)
+|+|+.++. ..+.+++...-.|+.+|++||.|||+.. +||||||||+||||++.|.+||||||.++.+.++ -+
T Consensus 162 gGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--~a 234 (364)
T KOG0581|consen 162 GGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--IA 234 (364)
T ss_pred CCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--hc
Confidence 999999994 3367999999999999999999999632 4999999999999999999999999999998776 22
Q ss_pred CccceecC
Q 010186 509 NTVRIVGT 516 (516)
Q Consensus 509 ~~~~~~GT 516 (516)
.+++||
T Consensus 235 --~tfvGT 240 (364)
T KOG0581|consen 235 --NTFVGT 240 (364)
T ss_pred --cccccc
Confidence 236776
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=261.57 Aligned_cols=159 Identities=37% Similarity=0.580 Sum_probs=138.6
Q ss_pred chHHHHHhhCCCCCCceeeecCcEeEEEEEec------CCcEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCCccceee
Q 010186 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCSEQ-GTAEFTNEVLLILKLQHKNLVKLLG 412 (516)
Q Consensus 340 ~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g 412 (516)
+....++...+....+.||+|.||+||+|... +.+.||||.++..... ...+|++|+++++.++|||||+|+|
T Consensus 477 ~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlG 556 (774)
T KOG1026|consen 477 DLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLG 556 (774)
T ss_pred ccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 34445556667777788999999999999843 3457999999875444 7889999999999999999999999
Q ss_pred EEEeCCeeEEEEEccCCCChhHHhcCCCC-----------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCC
Q 010186 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRK-----------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASN 481 (516)
Q Consensus 413 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~N 481 (516)
+|.+++..+||+|||..|+|.+||..... ..+|+..+.+.|+.|||.||+||-++. +|||||..+|
T Consensus 557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRN 633 (774)
T KOG1026|consen 557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRN 633 (774)
T ss_pred EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhh
Confidence 99999999999999999999999953211 234889999999999999999999887 9999999999
Q ss_pred eEecCCCcEEEcccCccccc
Q 010186 482 VLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 482 ILld~~~~~kl~DFGla~~~ 501 (516)
+||.++..|||+||||+|.+
T Consensus 634 CLVge~l~VKIsDfGLsRdi 653 (774)
T KOG1026|consen 634 CLVGENLVVKISDFGLSRDI 653 (774)
T ss_pred ceeccceEEEecccccchhh
Confidence 99999999999999999975
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-29 Score=246.40 Aligned_cols=152 Identities=34% Similarity=0.497 Sum_probs=136.6
Q ss_pred hCCCCCCceeeecCcEeEEEEE-ecCCcEEEEEEecc---CCccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~-~~~g~~vavK~l~~---~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 422 (516)
.++|..++.||+|+|++|++++ ..+++++|||++.+ ..+...+-...|-+.|.+| .||.|++|+-.|.+...+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 4578889999999999999999 56789999999875 2334455577888999999 89999999999999999999
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
|+||+++|+|.+++ .+.+.+++.....++.+|+.||+|||+.+ ||||||||+|||||+||++||.|||-|+.++
T Consensus 152 vLe~A~nGdll~~i---~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLI---KKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEecCCCcHHHHH---HHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 99999999999999 45578999999999999999999999998 9999999999999999999999999999986
Q ss_pred cCC
Q 010186 503 ESE 505 (516)
Q Consensus 503 ~~~ 505 (516)
+..
T Consensus 226 ~~~ 228 (604)
T KOG0592|consen 226 PSQ 228 (604)
T ss_pred hhh
Confidence 543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=223.89 Aligned_cols=150 Identities=34% Similarity=0.550 Sum_probs=133.3
Q ss_pred CCCCCceeeecCcEeEEEEE-ecCCcEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSE--QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~-~~~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
+|...++||+|.||.||+|+ ..+|+.||||+++.... .......+||+.|+.++|+||+.|+++|-..+...||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 46667889999999999999 56899999999986432 2244678999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCC
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 505 (516)
|+. +|+..+.+ ....++..+...++.++++||+|||++. |+||||||.|+||++++.+||+||||||.+....
T Consensus 83 m~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 83 MPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 965 89998854 4457899999999999999999999998 9999999999999999999999999999987543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-29 Score=232.05 Aligned_cols=148 Identities=23% Similarity=0.383 Sum_probs=130.1
Q ss_pred CCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCc-cc-hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE-QG-TAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
.|....++|+|+||.|||++.+ +|+.||||++..... .. .+-.++||++|++++|+|+|.|+++|......+||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 4555678999999999999965 699999999976433 23 33468999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
++..-|+++-. ....++.+....++.|+++|+.|+|++. +|||||||+||||+.++.+||||||+||.+..
T Consensus 83 ~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 83 CDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred cchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 99977777652 3345889999999999999999999998 99999999999999999999999999999984
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-28 Score=224.04 Aligned_cols=157 Identities=32% Similarity=0.435 Sum_probs=139.8
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...+.||.|+||.|.+++.+ +|.-+|+|++++.. .+..+...+|..+|+.+.||.++++.+.+.+....||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 35677789999999999999954 67889999997632 344566789999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||++||.|.++| ++.+.+++..+..++.+|+.||+|||+.+ |++|||||+|||||.+|.+||.|||+|+.+...
T Consensus 124 eyv~GGElFS~L---rk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYL---RKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHH---HhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 999999999999 45667999999999999999999999998 999999999999999999999999999987654
Q ss_pred CCccCccceecC
Q 010186 505 EGEANTVRIVGT 516 (516)
Q Consensus 505 ~~~~~~~~~~GT 516 (516)
|-+++||
T Consensus 198 -----T~TlCGT 204 (355)
T KOG0616|consen 198 -----TWTLCGT 204 (355)
T ss_pred -----EEEecCC
Confidence 4457776
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-29 Score=232.81 Aligned_cols=165 Identities=25% Similarity=0.462 Sum_probs=138.4
Q ss_pred CCCCCceeeecCcEeEEEEE-ecCCcEEEEEEecc--CCccchHHHHHHHHHHhcCCCCCccceeeEE-EeCCe-eEEEE
Q 010186 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFC-VDGDE-KLLVY 424 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~-~~~g~~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~-~~~~~-~~lV~ 424 (516)
+|.+.++||.|.||.||++. +.+|..||.|.+.- .+.+..+....|+.+|++|+|||||+++++. .++++ .+|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 34556789999999999998 67899999998863 3455677899999999999999999999954 34444 89999
Q ss_pred EccCCCChhHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHhHcCC-CCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 425 EFMPNGSLDAILFDPR-KRGILCWRKRTNIVNGIAKGMLYLHEDS-RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~-~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
||+..|+|..++..-+ .++.+++..+++++.|+++||..+|++- +.-|+||||||.||+|+.+|.+||+||||+|.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 9999999999885433 3456899999999999999999999842 1239999999999999999999999999999998
Q ss_pred cCCCccCccceecC
Q 010186 503 ESEGEANTVRIVGT 516 (516)
Q Consensus 503 ~~~~~~~~~~~~GT 516 (516)
...+.+. .++||
T Consensus 180 s~~tfA~--S~VGT 191 (375)
T KOG0591|consen 180 SKTTFAH--SLVGT 191 (375)
T ss_pred chhHHHH--hhcCC
Confidence 8766554 37787
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-28 Score=245.43 Aligned_cols=155 Identities=34% Similarity=0.499 Sum_probs=134.9
Q ss_pred HHHHhhCCCCCCceeeecCcEeEEEEEecC--C---cEEEEEEecc---CCccchHHHHHHHHHHhcCCCCCccceeeEE
Q 010186 343 TLNLATSNFSDSNILGQGGFGPVYKGVLSD--G---KEVAVKRLSS---CSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414 (516)
Q Consensus 343 ~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~--g---~~vavK~l~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 414 (516)
.+++.-++....++||+|.||.||+|.+.. + ..||||..+. .......+|++|.++|++++|||||+++|++
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 344444555556899999999999999643 2 2389999874 3456678999999999999999999999999
Q ss_pred EeCCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcc
Q 010186 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD 494 (516)
Q Consensus 415 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~D 494 (516)
....+++||||+|+||+|+++|.+.. ..++..+++.++.+.|.||+|||++. +|||||.++|+|++.++.+||+|
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISD 305 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISD 305 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCc
Confidence 99999999999999999999995432 36999999999999999999999998 99999999999999999999999
Q ss_pred cCcccccc
Q 010186 495 FGMARIFA 502 (516)
Q Consensus 495 FGla~~~~ 502 (516)
|||++.-.
T Consensus 306 FGLs~~~~ 313 (474)
T KOG0194|consen 306 FGLSRAGS 313 (474)
T ss_pred cccccCCc
Confidence 99998754
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=234.30 Aligned_cols=149 Identities=30% Similarity=0.556 Sum_probs=135.9
Q ss_pred CCCCCceeeecCcEeEEEEE-ecCCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~-~~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
+|.+.+.||+|.||+|-++. ...|+.||||.+++. +.+..-.+.+||++|..|+||||+.++.+|+..+.+.||||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 45667889999999999998 468999999999763 44556678999999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
|..+|.|.+++ ...+.|++.+..++++||..|+.|+|.++ ++|||||.+|||||.++++||+||||+-++.+.
T Consensus 134 YaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 134 YASGGELYDYI---SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred ecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 99999999999 45677999999999999999999999987 999999999999999999999999999887654
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=239.17 Aligned_cols=156 Identities=33% Similarity=0.513 Sum_probs=136.9
Q ss_pred HHhhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 010186 345 NLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 345 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 423 (516)
+.+.+...+.++||+|.||.|.+++...+..||||++++.. .....+|..|+++|.+++||||++|+|+|..++..++|
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 45566677889999999999999999888999999998754 34468999999999999999999999999999999999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
+|||++|+|.+|+..... ..+..+..+.|+.||+.||.||.+.. ++||||.++|+|+|.++++||+|||++|-+-.
T Consensus 614 ~EYmEnGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHhcCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccccccc
Confidence 999999999999954322 22445666789999999999999987 99999999999999999999999999996544
Q ss_pred C
Q 010186 504 S 504 (516)
Q Consensus 504 ~ 504 (516)
.
T Consensus 690 g 690 (807)
T KOG1094|consen 690 G 690 (807)
T ss_pred C
Confidence 3
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-28 Score=238.21 Aligned_cols=152 Identities=30% Similarity=0.437 Sum_probs=132.7
Q ss_pred hCCCCCCceeeecCcEeEEEEE-ecCCcEEEEEEeccCCccc-hHHHHHHHHHHhcCC-CCCccceeeEEEeCC-eeEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQG-TAEFTNEVLLILKLQ-HKNLVKLLGFCVDGD-EKLLV 423 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~-~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~-~~~lV 423 (516)
.++|...++||.|.||.||+|+ ..+|+.||||++++.-... .-.=++|+.-|++|+ ||||++|.+++.+.+ .+|+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 4567778899999999999999 5679999999997633222 222368999999998 999999999999988 89999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
||||+. +|.+++.++ +..+++..+..|+.||++||+|+|++| ++|||+||+|||+.....+||+||||||.+..
T Consensus 89 fE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred HHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc
Confidence 999966 888888653 678999999999999999999999998 99999999999999999999999999999875
Q ss_pred CC
Q 010186 504 SE 505 (516)
Q Consensus 504 ~~ 505 (516)
..
T Consensus 163 kp 164 (538)
T KOG0661|consen 163 KP 164 (538)
T ss_pred CC
Confidence 54
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=237.86 Aligned_cols=159 Identities=30% Similarity=0.480 Sum_probs=140.9
Q ss_pred CCCCCCceeeecCcEeEEEEE-ecCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
++|...+.||+|.||.||||+ ..+.+.||+|.+.+. ..++.+.+.+|++++++++||||+.++++|+...+.|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 467778899999999999999 457889999999763 44567789999999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCC
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 505 (516)
|+.+ +|..+| ..++.++++.+..++.++..||.|||+.+ |+|||+||.||||+..+.+|++|||+||....+.
T Consensus 82 ~a~g-~L~~il---~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTIL---EQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9987 999999 45677999999999999999999999997 9999999999999999999999999999987754
Q ss_pred CccCccceecC
Q 010186 506 GEANTVRIVGT 516 (516)
Q Consensus 506 ~~~~~~~~~GT 516 (516)
.. .+++-||
T Consensus 155 ~v--ltsikGt 163 (808)
T KOG0597|consen 155 SV--LTSIKGT 163 (808)
T ss_pred ee--eeeccCc
Confidence 32 2345565
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=234.71 Aligned_cols=150 Identities=28% Similarity=0.459 Sum_probs=133.7
Q ss_pred hhCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC----Cc-cchHHHHHHHHHHhcCC-CCCccceeeEEEeCCe
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC----SE-QGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDE 419 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~----~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~ 419 (516)
..++|...+.||+|+||+|+.+.. .+++.||+|++.+. .. ...+.+.+|+.+++.++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 346788889999999999999984 57899999977653 11 23456678999999998 9999999999999999
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCC-CcEEEcccCcc
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGMA 498 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~-~~~kl~DFGla 498 (516)
.++||||+.+|+|.+++. ..+.+.+.++..++.|++.|++|||+.+ |+||||||+|||+|.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~---~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIV---NKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHH---HcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 999999999999999994 3567899999999999999999999998 9999999999999999 99999999999
Q ss_pred cccc
Q 010186 499 RIFA 502 (516)
Q Consensus 499 ~~~~ 502 (516)
+...
T Consensus 169 ~~~~ 172 (370)
T KOG0583|consen 169 AISP 172 (370)
T ss_pred cccC
Confidence 9885
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.5e-27 Score=228.99 Aligned_cols=154 Identities=31% Similarity=0.440 Sum_probs=130.5
Q ss_pred HHhhCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCc--------------cchHHHHHHHHHHhcCCCCCccc
Q 010186 345 NLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSE--------------QGTAEFTNEVLLILKLQHKNLVK 409 (516)
Q Consensus 345 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~--------------~~~~~~~~Ei~~l~~l~H~niv~ 409 (516)
...-++|...+.||+|.||.|-++.. .+++.||||++.+... ...+...+||.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 34456788899999999999999994 4789999999965211 12347889999999999999999
Q ss_pred eeeEEEeC--CeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCC
Q 010186 410 LLGFCVDG--DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD 487 (516)
Q Consensus 410 l~g~~~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~ 487 (516)
|+++..+. +..|||+|||..|.+...- .....+++.++..++.++..||+|||.++ ||||||||+|+||+++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 99998875 4689999999999986543 22223899999999999999999999998 9999999999999999
Q ss_pred CcEEEcccCcccccccC
Q 010186 488 MNSKISDFGMARIFAES 504 (516)
Q Consensus 488 ~~~kl~DFGla~~~~~~ 504 (516)
+++||+|||.+-.+...
T Consensus 247 g~VKIsDFGVs~~~~~~ 263 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQG 263 (576)
T ss_pred CcEEeeccceeeecccC
Confidence 99999999999887433
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=225.10 Aligned_cols=148 Identities=28% Similarity=0.435 Sum_probs=126.2
Q ss_pred CCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhc--CCCCCccceeeEEEeCC----eeEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILK--LQHKNLVKLLGFCVDGD----EKLL 422 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~~----~~~l 422 (516)
.+....+.||+|.||.||+|.+ .|+.||||++... +...+.+|.++... |+|+||..+++.=..++ .+||
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred heeEEEEEecCccccceeeccc-cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 4566778999999999999999 5899999999753 33455667666654 59999999998654433 5799
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHc-----CCCCCeeeCCCCCCCeEecCCCcEEEcccCc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-----DSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-----~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 497 (516)
|.+|.++|||.++|. ..+++.+..++++..+|.||++||. +++|.|.|||||++|||+.+++.+.|+|+||
T Consensus 287 vTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred eeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 999999999999993 3679999999999999999999994 5789999999999999999999999999999
Q ss_pred ccccccC
Q 010186 498 ARIFAES 504 (516)
Q Consensus 498 a~~~~~~ 504 (516)
|-...++
T Consensus 363 Av~h~~~ 369 (513)
T KOG2052|consen 363 AVRHDSD 369 (513)
T ss_pred eEEeccc
Confidence 9776655
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=232.04 Aligned_cols=152 Identities=23% Similarity=0.364 Sum_probs=138.2
Q ss_pred HHhhCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 010186 345 NLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK 420 (516)
Q Consensus 345 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 420 (516)
.+..++|...++||+|+||.||.++. .+|..+|+|++++. ...+.+..+.|..+|....+|.||+|+-.|.+.+.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 44567899999999999999999995 56899999999874 345667789999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
||||||+|||++..+| ...+.|++..+..++.+++.|++-||+.+ +|||||||+|+|||..|++||+||||+.-
T Consensus 217 YLiMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence 9999999999999999 45678999999999999999999999998 99999999999999999999999999965
Q ss_pred cc
Q 010186 501 FA 502 (516)
Q Consensus 501 ~~ 502 (516)
+.
T Consensus 291 l~ 292 (550)
T KOG0605|consen 291 LD 292 (550)
T ss_pred hh
Confidence 53
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=223.92 Aligned_cols=150 Identities=31% Similarity=0.533 Sum_probs=131.0
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCC--eeEEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD--EKLLVYE 425 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~E 425 (516)
.+|...+.||+|.||.||++... +|...|||.+...+....+.+.+|+.+|.+++|||||+.+|.....+ ..+++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 34666788999999999999964 48999999987643333677999999999999999999999855444 6889999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC-CCcEEEcccCccccccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARIFAE 503 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~-~~~~kl~DFGla~~~~~ 503 (516)
|+++|+|.+++.... +.+++..+..+..||++||.|||+++ ++||||||+||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g--~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYG--GKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 999999999995422 27999999999999999999999998 999999999999999 79999999999998874
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=213.00 Aligned_cols=160 Identities=28% Similarity=0.438 Sum_probs=137.0
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|..++.||+|.||.||.|+. +++-.||+|++.+. ..+-..++.+|+++-..|+||||.++++++.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 5678889999999999999995 46778999999762 2334567899999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||.+.|+|...|.. .....+++.....++.|+|.||.|+|... +|||||||+|+|++.++..||+|||.+-.-+.+
T Consensus 102 Eya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~ 177 (281)
T KOG0580|consen 102 EYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSN 177 (281)
T ss_pred EecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCCC
Confidence 99999999999854 24456888889999999999999999987 999999999999999999999999998554422
Q ss_pred CCccCccceecC
Q 010186 505 EGEANTVRIVGT 516 (516)
Q Consensus 505 ~~~~~~~~~~GT 516 (516)
+.. .++||
T Consensus 178 --kR~--tlcgt 185 (281)
T KOG0580|consen 178 --KRK--TLCGT 185 (281)
T ss_pred --Cce--eeecc
Confidence 222 26666
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=219.36 Aligned_cols=150 Identities=29% Similarity=0.439 Sum_probs=129.9
Q ss_pred CCCCCceeeecCcEeEEEEE-ecCCcEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEEE
Q 010186 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSE--QGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLLVY 424 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~-~~~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 424 (516)
+|...+.|++|.||.||+|+ .++++.||+|+++-... ...-.-++||.+|.+++|||||.+..+.... +..||||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 45667889999999999999 45788999999975332 2233468999999999999999999988754 5699999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
|||++ +|..++.. ..+++...++..++.|+++|++|||... |+|||||++|+|+...|.+||+||||||.+.+.
T Consensus 157 e~~Eh-DLksl~d~--m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 157 EYVEH-DLKSLMET--MKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHHh-hHHHHHHh--ccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 99987 88888854 3467889999999999999999999998 999999999999999999999999999999876
Q ss_pred C
Q 010186 505 E 505 (516)
Q Consensus 505 ~ 505 (516)
.
T Consensus 231 ~ 231 (419)
T KOG0663|consen 231 L 231 (419)
T ss_pred c
Confidence 4
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=250.28 Aligned_cols=152 Identities=42% Similarity=0.672 Sum_probs=135.1
Q ss_pred hhCCCCCCceeeecCcEeEEEEEecC--Cc----EEEEEEecc-CCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLSD--GK----EVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 419 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~--g~----~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 419 (516)
...+....+.||+|.||.||+|+..+ |. .||||.+++ .+.++..+|++|..+|++++|||||+++|+|.+...
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 34556677889999999999999643 33 489999977 456778899999999999999999999999999999
Q ss_pred eEEEEEccCCCChhHHhcCCCC----CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEccc
Q 010186 420 KLLVYEFMPNGSLDAILFDPRK----RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDF 495 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 495 (516)
.++++|||++|+|..+|.+.+. ...|+..+.+.++.|||+|+.||+++. +|||||.++|+||++...+||+||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEccc
Confidence 9999999999999999976532 346889999999999999999999987 999999999999999999999999
Q ss_pred Cccccc
Q 010186 496 GMARIF 501 (516)
Q Consensus 496 Gla~~~ 501 (516)
||||.+
T Consensus 847 GlArDi 852 (1025)
T KOG1095|consen 847 GLARDI 852 (1025)
T ss_pred chhHhh
Confidence 999954
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=232.63 Aligned_cols=159 Identities=34% Similarity=0.571 Sum_probs=143.8
Q ss_pred CCCCCCceeeecCcEeEEEEE-ecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
..|...++||+|..|.||.+. ..+++.||||++........+-+.+|+.+|+..+|+|||.++.-+...+++|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 456677889999999999998 5678899999998766666677899999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCCCc
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 507 (516)
++|+|.+++. .-.+++.++..|.+++++||+|||.++ |||||||.+|||++.++.+||+|||++..+.....+
T Consensus 353 ~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 353 EGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred CCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence 9999999883 334899999999999999999999998 999999999999999999999999999999988876
Q ss_pred cCccceecC
Q 010186 508 ANTVRIVGT 516 (516)
Q Consensus 508 ~~~~~~~GT 516 (516)
..| ++||
T Consensus 426 R~T--mVGT 432 (550)
T KOG0578|consen 426 RST--MVGT 432 (550)
T ss_pred ccc--ccCC
Confidence 654 7887
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-26 Score=230.63 Aligned_cols=157 Identities=29% Similarity=0.482 Sum_probs=131.7
Q ss_pred HHhhCCCCCCceeeecCcEeEEEEEe------cCCcEEEEEEeccCC-ccchHHHHHHHHHHhcC-CCCCccceeeEEEe
Q 010186 345 NLATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVD 416 (516)
Q Consensus 345 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 416 (516)
.+..++|...++||+|+||.||++.. .++..||||+++... ......+.+|+.++..+ +||||+++++.+..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 34567788899999999999999974 235689999987532 23456789999999999 89999999999876
Q ss_pred CC-eeEEEEEccCCCChhHHhcCCCC------------------------------------------------------
Q 010186 417 GD-EKLLVYEFMPNGSLDAILFDPRK------------------------------------------------------ 441 (516)
Q Consensus 417 ~~-~~~lV~Ey~~~gsL~~~l~~~~~------------------------------------------------------ 441 (516)
.+ ..++||||+++|+|.+++.....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 54 57899999999999998853211
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 442 -----RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 442 -----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
...+++.+...++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..+
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~ 227 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKD 227 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccC
Confidence 134788899999999999999999987 999999999999999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=215.93 Aligned_cols=150 Identities=31% Similarity=0.488 Sum_probs=127.4
Q ss_pred CCCCceeeecCcEeEEEEE-ecCCcEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCC-ccceeeEEEeCC------ee
Q 010186 351 FSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSE--QGTAEFTNEVLLILKLQHKN-LVKLLGFCVDGD------EK 420 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~-~~~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~------~~ 420 (516)
|...++||+|.||+||+|+ ..+|+.||+|++..... .......+|+.++++++|+| |++|++++...+ ..
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l 92 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL 92 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence 4445679999999999999 45789999999976433 23445689999999999999 999999999877 78
Q ss_pred EEEEEccCCCChhHHhcCCCCC-CCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccc
Q 010186 421 LLVYEFMPNGSLDAILFDPRKR-GILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 499 (516)
+||+||++. +|..++...... ..++...+..++.||++||.|||+++ |+||||||.||||++++.+||+|||+||
T Consensus 93 ~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 93 YLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred EEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHH
Confidence 899999955 888888543321 45777889999999999999999998 9999999999999999999999999999
Q ss_pred ccccC
Q 010186 500 IFAES 504 (516)
Q Consensus 500 ~~~~~ 504 (516)
.+.-+
T Consensus 169 a~~ip 173 (323)
T KOG0594|consen 169 AFSIP 173 (323)
T ss_pred HhcCC
Confidence 77633
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=221.85 Aligned_cols=153 Identities=32% Similarity=0.505 Sum_probs=131.0
Q ss_pred hCCCCCCceeeecCcEeEEEEEecC-----------------CcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccc
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLSD-----------------GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVK 409 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-----------------g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~ 409 (516)
.++|...++||+|+||.||++.+++ +..||+|.+... .......|.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4567788999999999999998532 336999998763 2334567999999999999999999
Q ss_pred eeeEEEeCCeeEEEEEccCCCChhHHhcCCC----------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCee
Q 010186 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPR----------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473 (516)
Q Consensus 410 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ii 473 (516)
+++++.+.+..++||||+++|+|.+++.... ....+++.....++.||+.||.|||+.+ ++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999874321 1134788899999999999999999987 99
Q ss_pred eCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 474 HRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 474 HrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
||||||+|||++.++.+||+|||+++.+..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~ 190 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYA 190 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceeccc
Confidence 999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-25 Score=226.20 Aligned_cols=148 Identities=25% Similarity=0.398 Sum_probs=131.9
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...+.||+|+||.||++.. .+++.+|+|++.+. .......+.+|+.++..++||||+++++.+.+....+|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 3677889999999999999985 46889999999752 2233456889999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
||+++|+|.+++. ..+.+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 9999999999984 3456899999999999999999999988 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-25 Score=221.25 Aligned_cols=141 Identities=28% Similarity=0.329 Sum_probs=126.2
Q ss_pred ceeeecCcEeEEEEEe-cCCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCC
Q 010186 355 NILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNG 430 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 430 (516)
+.||+|+||.||++.. .+|+.+|+|++++. .......+.+|+.++++++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 47889999999752 2334556889999999999999999999999999999999999999
Q ss_pred ChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 431 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 145 (323)
T cd05571 81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence 9998884 3456899999999999999999999998 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-25 Score=226.89 Aligned_cols=155 Identities=24% Similarity=0.320 Sum_probs=135.6
Q ss_pred HHHHHhhCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 010186 342 ETLNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG 417 (516)
Q Consensus 342 ~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 417 (516)
..+....++|...+.||+|+||.||++... +++.+|+|.+.+. .......+.+|+.+++.++||||+++++.+..+
T Consensus 36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (370)
T cd05621 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD 115 (370)
T ss_pred HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 344555678899999999999999999964 5789999998642 223345688999999999999999999999999
Q ss_pred CeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCc
Q 010186 418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497 (516)
Q Consensus 418 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 497 (516)
+..++||||+++|+|.+++.. ..+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccc
Confidence 999999999999999998842 34788899999999999999999987 99999999999999999999999999
Q ss_pred cccccc
Q 010186 498 ARIFAE 503 (516)
Q Consensus 498 a~~~~~ 503 (516)
++.+..
T Consensus 189 a~~~~~ 194 (370)
T cd05621 189 CMKMDE 194 (370)
T ss_pred ceeccc
Confidence 988754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-25 Score=226.86 Aligned_cols=147 Identities=26% Similarity=0.371 Sum_probs=130.9
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...+.||+|+||.||++.. .+++.||+|++.+. .....+.+.+|+++++.++||||+++++++.+.+..||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3677889999999999999985 47889999998652 2334567889999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
||+++|+|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 81 E~~~gg~L~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 81 EFLPGGDLMTMLI---KYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 9999999999884 3456889999999999999999999998 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.3e-26 Score=229.02 Aligned_cols=153 Identities=32% Similarity=0.551 Sum_probs=135.7
Q ss_pred chHHHHHhhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEecc--CCccchHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 010186 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG 417 (516)
Q Consensus 340 ~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 417 (516)
..+++++..+.+...+.||+|.||+||+|.|. -.||||.++. .+....+.|++|+.++++-+|.||+-++|+|..+
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 34666677777778899999999999999985 3599999975 3445678899999999999999999999999998
Q ss_pred CeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCc
Q 010186 418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497 (516)
Q Consensus 418 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 497 (516)
.. .+|..+++|.+|..+++..+ ..+.....+.|+.||++||.|||.++ |||||||..||+|+++++|||+||||
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred ce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccc
Confidence 77 99999999999999997543 45788889999999999999999998 99999999999999999999999999
Q ss_pred ccc
Q 010186 498 ARI 500 (516)
Q Consensus 498 a~~ 500 (516)
+..
T Consensus 535 atv 537 (678)
T KOG0193|consen 535 ATV 537 (678)
T ss_pred eee
Confidence 964
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-25 Score=215.28 Aligned_cols=155 Identities=27% Similarity=0.381 Sum_probs=136.7
Q ss_pred hhCCCCCCceeeecCcEeEEEEE-ecCCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~-~~~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
..+.|...++||.|.-+.||+|+ .+.++.||||++.-. .....+.+.+|+..|..++||||++++..|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 34567778999999999999999 567899999999752 2234788999999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
.||.+|++.+++...-. ..+.+..+..|.+++++||.|||.+| .||||||+.||||+++|.+||+|||.+..+.++
T Consensus 104 pfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 99999999999865333 34888999999999999999999998 999999999999999999999999998777654
Q ss_pred C
Q 010186 505 E 505 (516)
Q Consensus 505 ~ 505 (516)
-
T Consensus 180 G 180 (516)
T KOG0582|consen 180 G 180 (516)
T ss_pred C
Confidence 3
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.5e-25 Score=220.04 Aligned_cols=142 Identities=29% Similarity=0.343 Sum_probs=126.7
Q ss_pred ceeeecCcEeEEEEEe-cCCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCC
Q 010186 355 NILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNG 430 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 430 (516)
+.||+|+||.||++.. .+++.||+|++.+. .......+.+|+.+++.++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999995 46899999999752 2344567889999999999999999999999999999999999999
Q ss_pred ChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 431 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
+|..++. ....+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~ 146 (328)
T cd05593 81 ELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (328)
T ss_pred CHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence 9988884 3346899999999999999999999987 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.5e-25 Score=225.91 Aligned_cols=146 Identities=24% Similarity=0.368 Sum_probs=130.2
Q ss_pred CCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
.|...+.||+|+||.||++.. .+++.+|+|++... .......+.+|++++..++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 567788999999999999985 46889999999652 23345678999999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
|+++|+|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++++||+|||+++.+
T Consensus 82 ~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 82 YIPGGDMMSLLI---RMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred cCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 999999999984 3346889999999999999999999987 999999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.5e-25 Score=221.70 Aligned_cols=149 Identities=28% Similarity=0.421 Sum_probs=132.7
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...+.||+|+||.||++... +++.||+|++++. .......+.+|++++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 35778899999999999999965 5889999999753 2234567889999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
||+++|+|.+++. ....+++..+..++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999984 3456889999999999999999999998 99999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=230.35 Aligned_cols=160 Identities=33% Similarity=0.477 Sum_probs=137.8
Q ss_pred CCCCceeeecCcEeEEEEEe-cCCcEEEEEEecc-CCccchHHHHHHHHHHhcCCCCCccceeeEEEeCC------eeEE
Q 010186 351 FSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD------EKLL 422 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~~~l 422 (516)
|...+.||+|+||.||+|+. .+|+.||||.+++ ......+...+|+++|++++|+|||++++.=+... ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 34457799999999999994 5799999999976 33455677889999999999999999998765443 5689
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEe--cCCC--cEEEcccCcc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL--DSDM--NSKISDFGMA 498 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILl--d~~~--~~kl~DFGla 498 (516)
|||||.+|+|...|.++.+...|++.+.+.+..++..||.|||+++ |+||||||.||++ .+++ --||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999998888889999999999999999999999998 9999999999998 3334 3699999999
Q ss_pred cccccCCCccCccceecC
Q 010186 499 RIFAESEGEANTVRIVGT 516 (516)
Q Consensus 499 ~~~~~~~~~~~~~~~~GT 516 (516)
|.++++..- ..++||
T Consensus 172 rel~d~s~~---~S~vGT 186 (732)
T KOG4250|consen 172 RELDDNSLF---TSLVGT 186 (732)
T ss_pred ccCCCCCee---eeecCc
Confidence 999988732 348887
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=228.04 Aligned_cols=149 Identities=31% Similarity=0.462 Sum_probs=134.3
Q ss_pred CCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
-|..++.||.|+.|.|..|++ .+|+.+|||++.+. +......+++||.+|+.+.||||++|++++++..++|||+|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 466778899999999999994 58999999999764 33345678999999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
|+++|.|.+++ ..++.+++.++.++++||+.|+.|+|..+ |+||||||+|+|||..+++||+|||||.+-.++
T Consensus 93 yv~gGELFdyl---v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 93 YVPGGELFDYL---VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred ecCCchhHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 99999999998 45678999999999999999999999988 999999999999999999999999999764433
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.4e-25 Score=221.38 Aligned_cols=149 Identities=28% Similarity=0.402 Sum_probs=132.6
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++.+++||||+++++.+.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 45777889999999999999964 6889999998752 2234567899999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
||+++|+|.+++. ....+++.....++.||+.||.|||+.+ |+||||||+||||++++.+||+|||+++.+.+
T Consensus 98 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLR---KAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999999999884 3456888999999999999999999998 99999999999999999999999999987654
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.9e-25 Score=224.81 Aligned_cols=148 Identities=24% Similarity=0.387 Sum_probs=132.3
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...+.||+|+||.||++... +++.||||++... .......+.+|+.++..++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36788899999999999999964 6889999999752 2234456889999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 99999999999843 346899999999999999999999998 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-25 Score=187.41 Aligned_cols=101 Identities=36% Similarity=0.697 Sum_probs=78.6
Q ss_pred cccCC-CCCCCC-CCCChHHHHHHHHHHHhhhccccc---CCcccccCCCCCeEEEEEeecCCCChhhhHHHHHHHHHHH
Q 010186 29 YNICS-TSTAGS-ARASTIDDNLQNVLTSLASNANAA---KFSNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQDI 103 (516)
Q Consensus 29 ~~~c~-~~~~~~-~~~s~~~~nl~~l~~~l~~~~~~~---~f~~~~~g~~~~~vyg~~~C~~d~~~~~C~~Cl~~a~~~~ 103 (516)
|+.|+ +.+++| +.+++|++||+.||++|.++++.. +|++++.|.++++|||++||++|+++.+|..||+.|...+
T Consensus 1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~ 80 (106)
T PF01657_consen 1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSSSKGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADAVANI 80 (106)
T ss_dssp ---E---SSB----TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHHHCCH
T ss_pred CCcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhccccCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHH
Confidence 56798 545677 678899999999999999998764 7999988999999999999999999999999999999999
Q ss_pred hHhCCCCccceEEcCceEEEEeeccc
Q 010186 104 SKLCPNKTEAIVWEEVCQLRYAYQNF 129 (516)
Q Consensus 104 ~~~C~~~~~a~~~~~~C~~ry~~~~f 129 (516)
.+.|+.+++|+||++.|+||||+++|
T Consensus 81 ~~~C~~~~g~~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 81 SSCCPGSRGGRVWYDSCFLRYENYPF 106 (106)
T ss_dssp HHHTTSBSSEEEEESSEEEEEESS--
T ss_pred HHhCCCCceEEEECCCEEEEEECCCC
Confidence 99999999999999999999999998
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.3e-25 Score=221.42 Aligned_cols=149 Identities=28% Similarity=0.345 Sum_probs=131.3
Q ss_pred CCCCCCceeeecCcEeEEEEEecC--CcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLSD--GKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~~--g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 423 (516)
++|...+.||+|+||.||++...+ +..||+|++... .....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 457778999999999999998543 368999998642 233456788999999999999999999999999999999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
|||+++|+|.+++. ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+..
T Consensus 110 ~Ey~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLR---RNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999984 3346889999999999999999999998 99999999999999999999999999987653
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-25 Score=216.01 Aligned_cols=149 Identities=32% Similarity=0.530 Sum_probs=122.5
Q ss_pred CCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCe-----eEEEE
Q 010186 351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE-----KLLVY 424 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-----~~lV~ 424 (516)
|...+++|.|+||.||+|.+. ++++||||++..... ---+|+.+|+.+.|||||+|+-++....+ ..|||
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 445688999999999999954 578999999865332 12368999999999999999988875432 24899
Q ss_pred EccCCCChhHHhcC-CCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCC-CcEEEcccCcccccc
Q 010186 425 EFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGMARIFA 502 (516)
Q Consensus 425 Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~-~~~kl~DFGla~~~~ 502 (516)
||||. +|...+.. ...+..++..++.-+..||.+||.|||+.+ |+||||||.|+|+|.+ +.+||||||-|+.+.
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 99987 77776642 223566888888999999999999999987 9999999999999977 899999999999998
Q ss_pred cCCCc
Q 010186 503 ESEGE 507 (516)
Q Consensus 503 ~~~~~ 507 (516)
.++..
T Consensus 178 ~~epn 182 (364)
T KOG0658|consen 178 KGEPN 182 (364)
T ss_pred cCCCc
Confidence 76643
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-25 Score=226.83 Aligned_cols=163 Identities=26% Similarity=0.395 Sum_probs=140.9
Q ss_pred HHhhCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCe
Q 010186 345 NLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDE 419 (516)
Q Consensus 345 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 419 (516)
.+.-++|...++||+|+||+|+++..+ +++.+|||.+++. ...+.+..+.|-+++... +||.++.|+..|...++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 344567889999999999999999965 5778999999873 455677788898888777 69999999999999999
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccc
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 499 (516)
.|.||||+.||++..+. ..+.+++..+.-++..|+.||.|||+++ ||+||||.+|||||.+|.+||+||||+|
T Consensus 444 l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 99999999999955444 3456999999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCccCccceecC
Q 010186 500 IFAESEGEANTVRIVGT 516 (516)
Q Consensus 500 ~~~~~~~~~~~~~~~GT 516 (516)
.-.-... .|++++||
T Consensus 517 e~m~~g~--~TsTfCGT 531 (694)
T KOG0694|consen 517 EGMGQGD--RTSTFCGT 531 (694)
T ss_pred ccCCCCC--ccccccCC
Confidence 8664433 35569998
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-25 Score=218.21 Aligned_cols=148 Identities=25% Similarity=0.345 Sum_probs=131.9
Q ss_pred CCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
+|...+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 5778899999999999999964 6889999998642 22345568899999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
|+++|+|.+++. ..+.+++.....++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+..
T Consensus 82 ~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 82 YVPGGELFSYLR---NSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred CCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 999999999984 3456889999999999999999999998 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=219.30 Aligned_cols=142 Identities=27% Similarity=0.335 Sum_probs=126.3
Q ss_pred ceeeecCcEeEEEEEe-cCCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCC
Q 010186 355 NILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNG 430 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 430 (516)
+.||+|+||.||++.. .+|+.||+|++... .......+.+|+++++.++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999995 46899999999752 2334556788999999999999999999999999999999999999
Q ss_pred ChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 431 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
+|..++. ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 146 (323)
T cd05595 81 ELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhcccc
Confidence 9988884 3346899999999999999999999987 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=217.60 Aligned_cols=141 Identities=22% Similarity=0.303 Sum_probs=125.7
Q ss_pred eeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCCCh
Q 010186 357 LGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432 (516)
Q Consensus 357 Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 432 (516)
||+|+||.||++... +++.||+|++.+. .......+.+|+.++.+++||||+++++.+...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999964 5789999998652 334456788999999999999999999999999999999999999999
Q ss_pred hHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
.+++. ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~ 145 (312)
T cd05585 81 FHHLQ---REGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMK 145 (312)
T ss_pred HHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCcc
Confidence 99884 3456899999999999999999999988 99999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=216.62 Aligned_cols=142 Identities=27% Similarity=0.330 Sum_probs=125.4
Q ss_pred ceeeecCcEeEEEEEe-cCCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCC
Q 010186 355 NILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNG 430 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 430 (516)
+.||+|+||.||++.. .+++.||+|++++. .......+.+|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 47889999999752 2334567788999999999999999999999999999999999999
Q ss_pred ChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHc-CCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 431 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
+|..++. ....+++..+..++.||+.||.|||+ .+ ++||||||+|||++.++.+||+|||+++...
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~ 147 (325)
T cd05594 81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 147 (325)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence 9998884 33468999999999999999999997 56 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=223.34 Aligned_cols=146 Identities=25% Similarity=0.384 Sum_probs=129.9
Q ss_pred CCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
+|...+.||+|+||.||++.. .+++.||+|++.+. .......+.+|++++..++||||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 577889999999999999995 46889999998652 22345668899999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
|+++|+|.+++. ..+.+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 82 ~~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 82 YIPGGDMMSLLI---RLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred CCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 999999999984 3456888889999999999999999988 999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=223.33 Aligned_cols=157 Identities=23% Similarity=0.304 Sum_probs=137.0
Q ss_pred hHHHHHhhCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEe
Q 010186 341 LETLNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416 (516)
Q Consensus 341 ~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 416 (516)
+.++.+..++|...+.||+|+||.||++... +++.+|+|++.+. .......+.+|+.+++.++||||+++++.+..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4455666788999999999999999999964 6789999998642 22334567899999999999999999999999
Q ss_pred CCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccC
Q 010186 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496 (516)
Q Consensus 417 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 496 (516)
++..++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence 9999999999999999998842 34788888999999999999999998 9999999999999999999999999
Q ss_pred cccccccC
Q 010186 497 MARIFAES 504 (516)
Q Consensus 497 la~~~~~~ 504 (516)
+++.+...
T Consensus 188 ~a~~~~~~ 195 (371)
T cd05622 188 TCMKMNKE 195 (371)
T ss_pred ceeEcCcC
Confidence 99877543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.6e-26 Score=225.23 Aligned_cols=148 Identities=32% Similarity=0.540 Sum_probs=131.8
Q ss_pred CCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCCC
Q 010186 352 SDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGS 431 (516)
Q Consensus 352 ~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 431 (516)
...+.||.|+-|.||+|++ .++.||||+++..+ +.+|+-|++|+||||+.+.|+|.+..-.+||||||+.|.
T Consensus 127 sELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 3457799999999999999 47899999886422 457888999999999999999999999999999999999
Q ss_pred hhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCCCccCcc
Q 010186 432 LDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV 511 (516)
Q Consensus 432 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 511 (516)
|..+| +....++......+..+||.||.|||.+. |||||||+-||||..+..+||+|||-++.+.+-.++.+
T Consensus 199 L~~VL---ka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMS-- 270 (904)
T KOG4721|consen 199 LYEVL---KAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMS-- 270 (904)
T ss_pred HHHHH---hccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhhhhh--
Confidence 99999 45567888999999999999999999987 99999999999999999999999999999887755543
Q ss_pred ceecC
Q 010186 512 RIVGT 516 (516)
Q Consensus 512 ~~~GT 516 (516)
|+||
T Consensus 271 -FaGT 274 (904)
T KOG4721|consen 271 -FAGT 274 (904)
T ss_pred -hhhh
Confidence 7787
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.7e-25 Score=223.94 Aligned_cols=153 Identities=24% Similarity=0.312 Sum_probs=133.5
Q ss_pred HHHhhCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 010186 344 LNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 419 (516)
Q Consensus 344 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 419 (516)
+.+..++|...+.||+|+||.||++... +++.+|+|++.+. .....+.+.+|+.+++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3345567888899999999999999954 6889999998642 22344567899999999999999999999999999
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccc
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 499 (516)
.++||||+++|+|.+++.. ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~ 190 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEecccee
Confidence 9999999999999998842 34788888899999999999999987 9999999999999999999999999998
Q ss_pred cccc
Q 010186 500 IFAE 503 (516)
Q Consensus 500 ~~~~ 503 (516)
.+..
T Consensus 191 ~~~~ 194 (370)
T cd05596 191 KMDA 194 (370)
T ss_pred eccC
Confidence 7654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=223.96 Aligned_cols=146 Identities=25% Similarity=0.379 Sum_probs=129.7
Q ss_pred CCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
+|...++||+|+||.||++.. .+++.+|+|++.+.. ......+.+|+++++.++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 477789999999999999995 468899999987532 2345578899999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
|+++|+|.+++.. ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~ 151 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence 9999999998843 346888899999999999999999998 999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=213.38 Aligned_cols=149 Identities=30% Similarity=0.388 Sum_probs=130.2
Q ss_pred CCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 351 FSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
|...+.||+|+||.||++.. .+++.||+|.+.+.. ......+.+|+.++..++|+||+++++.+.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 56678899999999999995 578999999986522 22344678999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
+++|+|..++... ....+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++.+..
T Consensus 82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 9999998877432 2345899999999999999999999987 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.5e-25 Score=224.07 Aligned_cols=157 Identities=31% Similarity=0.446 Sum_probs=133.3
Q ss_pred HHhhCCCCCCceeeecCcEeEEEEEe------cCCcEEEEEEeccCC-ccchHHHHHHHHHHhcC-CCCCccceeeEEEe
Q 010186 345 NLATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVD 416 (516)
Q Consensus 345 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 416 (516)
....++|...+.||+|+||.||+++. .++..||||+++... ....+.+.+|+.++..+ +||||+++++++..
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 33455788889999999999999973 245689999997532 33456788999999999 89999999999999
Q ss_pred CCeeEEEEEccCCCChhHHhcCCCC-------------------------------------------------------
Q 010186 417 GDEKLLVYEFMPNGSLDAILFDPRK------------------------------------------------------- 441 (516)
Q Consensus 417 ~~~~~lV~Ey~~~gsL~~~l~~~~~------------------------------------------------------- 441 (516)
.+..++||||+++|+|.+++.....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 9999999999999999988853211
Q ss_pred -----------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 442 -----------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 442 -----------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
...+++..+..++.||++||.|||+.+ ++||||||+|||++.++.+||+|||+++.+...
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 124788999999999999999999987 999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=229.34 Aligned_cols=152 Identities=20% Similarity=0.273 Sum_probs=132.5
Q ss_pred CCCCceeeecCcEeEEEEEec-C-CcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccC
Q 010186 351 FSDSNILGQGGFGPVYKGVLS-D-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 428 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~~-~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 428 (516)
|...+.||+|+||.||++... + ++.|++|.+..........+.+|+.+++.++||||+++++++...+..+|||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 677889999999999999843 3 67888887765554555678899999999999999999999999999999999999
Q ss_pred CCChhHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCC
Q 010186 429 NGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 429 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 505 (516)
+|+|.+++... .....+++.+...++.||+.||.|||+.+ |+||||||+||||++++.+||+|||+++.+....
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 99999887432 23456889999999999999999999987 9999999999999999999999999999876543
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=217.49 Aligned_cols=151 Identities=24% Similarity=0.311 Sum_probs=133.4
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...+.||+|+||.||++.. .+++.||+|+++.. .....+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 3577889999999999999995 46889999999753 2234556889999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||+++|+|.+++... ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998532 346899999999999999999999988 999999999999999999999999999877544
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=223.51 Aligned_cols=158 Identities=31% Similarity=0.434 Sum_probs=133.8
Q ss_pred HHHhhCCCCCCceeeecCcEeEEEEEec------CCcEEEEEEeccC-CccchHHHHHHHHHHhcCC-CCCccceeeEEE
Q 010186 344 LNLATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCV 415 (516)
Q Consensus 344 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~ 415 (516)
++...++|.+.++||+|+||.||+|+.. .+..||||++... .....+.+.+|+.+++++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 4445678888999999999999999852 2347999999753 2334567999999999995 999999999999
Q ss_pred eCCeeEEEEEccCCCChhHHhcCCC-------------------------------------------------------
Q 010186 416 DGDEKLLVYEFMPNGSLDAILFDPR------------------------------------------------------- 440 (516)
Q Consensus 416 ~~~~~~lV~Ey~~~gsL~~~l~~~~------------------------------------------------------- 440 (516)
..+..+|||||+++|+|.+++....
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 9999999999999999998875321
Q ss_pred --------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCe
Q 010186 441 --------------------------------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNV 482 (516)
Q Consensus 441 --------------------------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NI 482 (516)
....+++.++..++.||++||.|||+.+ ++||||||+||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Ni 268 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhE
Confidence 0124788889999999999999999987 99999999999
Q ss_pred EecCCCcEEEcccCcccccccC
Q 010186 483 LLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 483 Lld~~~~~kl~DFGla~~~~~~ 504 (516)
|++.++.+||+|||+++.+...
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~ 290 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHD 290 (400)
T ss_pred EEeCCCEEEEEeCCcceecccc
Confidence 9999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=216.93 Aligned_cols=151 Identities=24% Similarity=0.313 Sum_probs=132.8
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...+.||+|+||.||++... +++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36778899999999999999954 6889999998642 2334556889999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999999843 2346889999999999999999999998 999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=219.26 Aligned_cols=151 Identities=25% Similarity=0.411 Sum_probs=134.5
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...+.||+|+||.||++... +++.||+|+++.. .......+.+|++++..++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36778899999999999999964 6899999999752 2244567899999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 99999999999843 256899999999999999999999987 999999999999999999999999999877654
Q ss_pred C
Q 010186 505 E 505 (516)
Q Consensus 505 ~ 505 (516)
.
T Consensus 155 ~ 155 (350)
T cd05573 155 K 155 (350)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-24 Score=216.12 Aligned_cols=149 Identities=26% Similarity=0.346 Sum_probs=129.8
Q ss_pred CCCCCceeeecCcEeEEEEEe----cCCcEEEEEEeccC----CccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCee
Q 010186 350 NFSDSNILGQGGFGPVYKGVL----SDGKEVAVKRLSSC----SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEK 420 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~----~~g~~vavK~l~~~----~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 420 (516)
+|...+.||+|+||.||++.. .+++.||+|++.+. .....+.+..|+.++..+ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 366788999999999999874 35789999998652 223345688899999999 599999999999999999
Q ss_pred EEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
++||||+++|+|.+++. ....+++.++..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999999884 3346899999999999999999999988 99999999999999999999999999987
Q ss_pred cccC
Q 010186 501 FAES 504 (516)
Q Consensus 501 ~~~~ 504 (516)
+...
T Consensus 155 ~~~~ 158 (332)
T cd05614 155 FLSE 158 (332)
T ss_pred cccc
Confidence 6443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-24 Score=215.41 Aligned_cols=142 Identities=29% Similarity=0.459 Sum_probs=125.1
Q ss_pred ceeeecCcEeEEEEEe----cCCcEEEEEEeccC----CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 355 NILGQGGFGPVYKGVL----SDGKEVAVKRLSSC----SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~----~~g~~vavK~l~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
+.||+|+||.||++.. .+++.||+|.++.. .......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 35789999998752 223345678999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
+++++|.+++. ..+.+.+.....++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 151 (323)
T cd05584 82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESI 151 (323)
T ss_pred CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecc
Confidence 99999999884 3456788889999999999999999988 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.5e-24 Score=214.18 Aligned_cols=144 Identities=26% Similarity=0.357 Sum_probs=127.0
Q ss_pred ceeeecCcEeEEEEEe----cCCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccC
Q 010186 355 NILGQGGFGPVYKGVL----SDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 428 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~----~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 428 (516)
+.||+|+||.||++.. .+|+.+|+|++.... ......+.+|++++.+++||||+++++++..++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 367899999997532 2334567889999999999999999999999999999999999
Q ss_pred CCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
+|+|.+++. ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 151 (318)
T cd05582 82 GGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 151 (318)
T ss_pred CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence 999999884 3456899999999999999999999998 999999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-25 Score=230.11 Aligned_cols=152 Identities=40% Similarity=0.634 Sum_probs=133.2
Q ss_pred CCCceeeecCcEeEEEEEe-cCCc----EEEEEEecc-CCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 352 SDSNILGQGGFGPVYKGVL-SDGK----EVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 352 ~~~~~Lg~G~fg~Vy~~~~-~~g~----~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
...++||.|.||+||+|.+ +.|+ +||+|++.. ...+...++++|+.+|.+++|||+++|+|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3458899999999999995 4444 789998865 34456778999999999999999999999998876 789999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCC
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 505 (516)
|||.|+|.++++. .+..+-.++.+.|..|||+||.|||++. ++||||.++||||.+-..+||.|||+|+++..++
T Consensus 778 ~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999965 4456888999999999999999999987 9999999999999999999999999999998877
Q ss_pred CccC
Q 010186 506 GEAN 509 (516)
Q Consensus 506 ~~~~ 509 (516)
.+-.
T Consensus 853 ~ey~ 856 (1177)
T KOG1025|consen 853 KEYS 856 (1177)
T ss_pred cccc
Confidence 6543
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.4e-24 Score=214.68 Aligned_cols=141 Identities=25% Similarity=0.326 Sum_probs=125.1
Q ss_pred ceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEEccCC
Q 010186 355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 429 (516)
++||+|+||.||++... +++.||+|++++. .....+.+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999954 6889999999752 223455688999999988 799999999999999999999999999
Q ss_pred CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
|+|..++. ..+.+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 146 (329)
T cd05588 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccc
Confidence 99988873 3356899999999999999999999998 999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-24 Score=215.90 Aligned_cols=151 Identities=23% Similarity=0.294 Sum_probs=132.4
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...+.||+|+||.||++... +++.+|+|.+.+. .......+.+|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36778899999999999999954 6788999998652 2233456888999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..+
T Consensus 81 Ey~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999853 2346889999999999999999999987 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-24 Score=209.34 Aligned_cols=150 Identities=33% Similarity=0.520 Sum_probs=131.6
Q ss_pred hhCCCCCCceeeecCcEeEEEEEec----CCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLS----DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 421 (516)
..++|...+.||+|+||.||+|.+. .+..||+|.++.. +......|.+|+.++.+++||||++++|++..++..+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 3456788899999999999999853 3568999998763 2334567899999999999999999999999999999
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+||||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+|++|||++...
T Consensus 83 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 83 IVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 999999999999998532 346899999999999999999999987 999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-24 Score=222.28 Aligned_cols=157 Identities=31% Similarity=0.463 Sum_probs=133.0
Q ss_pred HHHhhCCCCCCceeeecCcEeEEEEEe------cCCcEEEEEEeccCC-ccchHHHHHHHHHHhcC-CCCCccceeeEEE
Q 010186 344 LNLATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKL-QHKNLVKLLGFCV 415 (516)
Q Consensus 344 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~ 415 (516)
+....++|...+.||+|+||.||++.. .++..||+|+++... ......+.+|+.+++.+ +|+||+++++.+.
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 344556788889999999999999873 234579999997532 33456788999999999 8999999999999
Q ss_pred eCCeeEEEEEccCCCChhHHhcCCC-------------------------------------------------------
Q 010186 416 DGDEKLLVYEFMPNGSLDAILFDPR------------------------------------------------------- 440 (516)
Q Consensus 416 ~~~~~~lV~Ey~~~gsL~~~l~~~~------------------------------------------------------- 440 (516)
..+..++||||+++|+|.+++....
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 9999999999999999998874311
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 441 ------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 441 ------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
....+++.+...++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++.+..
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~ 264 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence 1124788899999999999999999987 99999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-24 Score=214.07 Aligned_cols=141 Identities=26% Similarity=0.328 Sum_probs=124.4
Q ss_pred ceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEEccCC
Q 010186 355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 429 (516)
+.||+|+||.||++... +++.+|+|++++. .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999954 6789999999753 233455678899888877 899999999999999999999999999
Q ss_pred CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
|+|..++. ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 99988873 3356899999999999999999999998 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.5e-24 Score=218.00 Aligned_cols=147 Identities=25% Similarity=0.405 Sum_probs=131.2
Q ss_pred CCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
+|...+.||+|+||.||++... +++.||+|++... .......+.+|+.++..++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 5777889999999999999954 6889999999652 23345678899999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
|+++|+|.+++. ....+++.....++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 82 ~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 82 FLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred CCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 999999999984 3456899999999999999999999988 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-24 Score=210.16 Aligned_cols=148 Identities=27% Similarity=0.441 Sum_probs=128.8
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
++|...++||+|+||.||++... +++.||+|.++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 45777899999999999999954 68899999986532 23345678999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
+++ +|.+++.. ....+++.....++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 985 88887743 2345788999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-24 Score=213.47 Aligned_cols=145 Identities=28% Similarity=0.403 Sum_probs=125.1
Q ss_pred CCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHH---hcCCCCCccceeeEEEeCCeeEEE
Q 010186 351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLI---LKLQHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l---~~l~H~niv~l~g~~~~~~~~~lV 423 (516)
|...+.||+|+||.||++... +++.||||++++. .....+.+.+|++++ ..++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 455688999999999999854 6889999999753 223445677776655 567899999999999999999999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
|||+++++|..++. ...+++..+..++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 99999999988873 246899999999999999999999987 9999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.2e-25 Score=230.91 Aligned_cols=157 Identities=29% Similarity=0.397 Sum_probs=135.0
Q ss_pred HHHhhCCCCCCceeeecCcEeEEEEEecCC-cEEEEEEeccCCccchHHHHHHHHHHhcCC-CCCccceee-EEEe----
Q 010186 344 LNLATSNFSDSNILGQGGFGPVYKGVLSDG-KEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLG-FCVD---- 416 (516)
Q Consensus 344 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g-~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g-~~~~---- 416 (516)
+.+...++.+.+.|.+|||+.||.++...+ .++|+|++...++...+...+||++|++|. |+|||.+++ ....
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 344555667789999999999999997665 999999998778888899999999999995 999999999 3321
Q ss_pred --CCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcc
Q 010186 417 --GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD 494 (516)
Q Consensus 417 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~D 494 (516)
.-+.+|+||||++|.|-+++... ....|++.++++|+.++++|+.+||... +||||||||.+||||..+++.||||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~R-lq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTR-LQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHH-HhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCc
Confidence 13678999999999999998643 3445999999999999999999999984 8899999999999999999999999
Q ss_pred cCcccccc
Q 010186 495 FGMARIFA 502 (516)
Q Consensus 495 FGla~~~~ 502 (516)
||-|.-..
T Consensus 190 FGSatt~~ 197 (738)
T KOG1989|consen 190 FGSATTKI 197 (738)
T ss_pred cccccccc
Confidence 99886443
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-24 Score=218.26 Aligned_cols=144 Identities=33% Similarity=0.508 Sum_probs=125.2
Q ss_pred CCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccC
Q 010186 351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 428 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 428 (516)
|...++||+|+||.||++... +++.||+|++... .......+.+|+++++.++|+||+++++++...+..++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 445678999999999999954 6899999998653 23345678999999999999999999999999999999999999
Q ss_pred CCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
+|+|.... .+.+.....++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++.+...
T Consensus 156 ~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 156 GGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred CCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 99986432 3457778899999999999999988 999999999999999999999999999876543
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.6e-24 Score=211.94 Aligned_cols=143 Identities=28% Similarity=0.380 Sum_probs=122.8
Q ss_pred ceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEEccCC
Q 010186 355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 429 (516)
++||+|+||.||++... +++.||+|.++.. .....+.+..|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 5788999998752 223345566677777654 899999999999999999999999999
Q ss_pred CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
|+|..++. ....+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~ 148 (316)
T cd05592 81 GDLMFHIQ---SSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMN 148 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCC
Confidence 99998884 3346889999999999999999999987 99999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.6e-24 Score=212.80 Aligned_cols=142 Identities=24% Similarity=0.358 Sum_probs=124.5
Q ss_pred ceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEEccCC
Q 010186 355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 429 (516)
++||+|+||.||+|... +++.||+|++++. .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999964 5789999998752 233455678899988866 899999999999999999999999999
Q ss_pred CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
|+|...+. ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~ 147 (321)
T cd05591 81 GDLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGI 147 (321)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecc
Confidence 99998884 3346889999999999999999999998 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.3e-24 Score=209.16 Aligned_cols=150 Identities=25% Similarity=0.393 Sum_probs=131.2
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
++|...+.||+|+||.||+++.. +++.+|+|++... .....+.+.+|+.++..++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36788899999999999999965 5789999998753 23345678899999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
|++++.+..+.. ....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+...
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 999988876652 2346889999999999999999999987 999999999999999999999999999887543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.9e-24 Score=212.71 Aligned_cols=141 Identities=30% Similarity=0.363 Sum_probs=122.0
Q ss_pred ceeeecCcEeEEEEEe-cCCcEEEEEEeccC---CccchHHHHHHHH-HHhcCCCCCccceeeEEEeCCeeEEEEEccCC
Q 010186 355 NILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVL-LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 429 (516)
++||+|+||.||++.. .+|+.+|+|++.+. .......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999995 46899999998652 2233445566655 46778999999999999999999999999999
Q ss_pred CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
|+|..++. ....+++..+..++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 99988873 3456899999999999999999999988 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.1e-24 Score=212.23 Aligned_cols=141 Identities=28% Similarity=0.365 Sum_probs=121.1
Q ss_pred ceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHH-HHhcCCCCCccceeeEEEeCCeeEEEEEccCC
Q 010186 355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVL-LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 429 (516)
++||+|+||.||++... +++.+|+|++.+. .......+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 6889999998652 2223344555554 67889999999999999999999999999999
Q ss_pred CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
|+|...+. ....+++.....++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 99988873 3346888889999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-24 Score=217.42 Aligned_cols=152 Identities=32% Similarity=0.464 Sum_probs=135.8
Q ss_pred hhCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 423 (516)
....|.+.+.||+|.|++|..++. .++.+||+|.+++.. ......+.+|+++|+.++|||||+++.+.+....+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 345678889999999999999994 478999999998743 33445689999999999999999999999999999999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
|||..+|.+.+++. ..+.+.+.++..++.|+.++++|||++. |+|||||++||||+.++++||+|||++..+..
T Consensus 134 ~eya~~ge~~~yl~---~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLV---KHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEeccCchhHHHHH---hcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence 99999999999994 4455777889999999999999999998 99999999999999999999999999998874
Q ss_pred C
Q 010186 504 S 504 (516)
Q Consensus 504 ~ 504 (516)
+
T Consensus 208 ~ 208 (596)
T KOG0586|consen 208 G 208 (596)
T ss_pred c
Confidence 4
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.6e-24 Score=213.83 Aligned_cols=150 Identities=24% Similarity=0.306 Sum_probs=131.1
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...++||+|+||.||++... +++.+|+|++.+. .......+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 35778899999999999999965 5778999998642 2233455889999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+..
T Consensus 81 ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999853 2345889999999999999999999988 99999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=209.33 Aligned_cols=149 Identities=29% Similarity=0.435 Sum_probs=128.9
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
.++|...+.||+|+||.||++... +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 356888899999999999999964 68899999987533 2234467899999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
|++ ++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 996 577666643 3345889999999999999999999998 9999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.3e-24 Score=212.45 Aligned_cols=146 Identities=27% Similarity=0.333 Sum_probs=126.9
Q ss_pred CCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCC-CccceeeEEEeCCeeEEEE
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHK-NLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~-niv~l~g~~~~~~~~~lV~ 424 (516)
+|...+.||+|+||.||++... +++.||+|++.+. .....+.+..|++++..++|+ +|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4667889999999999999964 5789999998752 234456788899999999664 5888999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
||+++|+|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 81 EYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 9999999998884 3346889999999999999999999987 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.7e-24 Score=212.98 Aligned_cols=152 Identities=25% Similarity=0.341 Sum_probs=133.3
Q ss_pred hhCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
..++|...+.||+|+||.||++... ++..+|+|.+... .....+.+.+|++++++++||||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 3467888899999999999999964 6788999988753 2334567999999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +++||||||+|||++.++.+||+|||+++.+.+
T Consensus 83 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 83 EHMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 99999999999843 345889999999999999999999853 399999999999999999999999999987643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=211.61 Aligned_cols=142 Identities=29% Similarity=0.365 Sum_probs=122.0
Q ss_pred ceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHH-HHhcCCCCCccceeeEEEeCCeeEEEEEccCC
Q 010186 355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVL-LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 429 (516)
+.||+|+||.||++... +|+.||+|++.+. .......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999964 6899999998652 1223344555554 56789999999999999999999999999999
Q ss_pred CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
|+|..++. ....+++.....++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 147 (323)
T cd05575 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGI 147 (323)
T ss_pred CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccc
Confidence 99998884 3456889999999999999999999998 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.9e-24 Score=213.43 Aligned_cols=152 Identities=26% Similarity=0.378 Sum_probs=132.8
Q ss_pred hhCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
..++|...+.||+|+||.||++... ++..+++|.+... .......+.+|+++++.++||||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3467888899999999999999965 6788899988653 2334567899999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
||+++|+|.+++.. ...+++.....++.+++.||.|||+.. +++||||||+|||+++++.+||+|||+++.+..
T Consensus 83 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 83 EHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 99999999999843 345888999999999999999999742 399999999999999999999999999987643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.3e-25 Score=221.11 Aligned_cols=160 Identities=29% Similarity=0.482 Sum_probs=142.1
Q ss_pred hHHHHHhhCCCCCCceeeecCcEeEEEEEecC-CcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 010186 341 LETLNLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 419 (516)
Q Consensus 341 ~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 419 (516)
.+++++...+....++||-|.||.||.|.|+. ...||||.++.. .-+.++|+.|..+|+.++|||+|+|+|+|.....
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 45667777777778899999999999999864 568999999863 3567899999999999999999999999999999
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccc
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 499 (516)
.|||.|||..|+|.++|... .+..++....+.++.||..||+||..+. +|||||.++|+|+.++..+|++||||+|
T Consensus 338 FYIiTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred eEEEEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhh
Confidence 99999999999999999543 4445777778899999999999999988 9999999999999999999999999999
Q ss_pred ccccCC
Q 010186 500 IFAESE 505 (516)
Q Consensus 500 ~~~~~~ 505 (516)
++..+.
T Consensus 414 lMtgDT 419 (1157)
T KOG4278|consen 414 LMTGDT 419 (1157)
T ss_pred hhcCCc
Confidence 987653
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=211.75 Aligned_cols=147 Identities=27% Similarity=0.334 Sum_probs=127.0
Q ss_pred CCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEE
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 424 (516)
+|...+.||+|+||.||++... +++.||+|.+.+. .....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4667789999999999999964 5789999998753 223344567788888777 6899999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
||+++|+|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQ---QVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 9999999998884 3346889999999999999999999987 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.8e-24 Score=211.83 Aligned_cols=151 Identities=33% Similarity=0.600 Sum_probs=129.7
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCc----EEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGK----EVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 421 (516)
..+|...+.||+|+||.||+|.+. +++ .||+|.++... ....+++.+|+.+++.++||||++++|++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 356888899999999999999853 343 48999987532 34456789999999999999999999998764 578
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+|+||+++|+|.+++... ...+++...+.++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++.+
T Consensus 85 ~v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 85 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence 999999999999988532 345889999999999999999999987 999999999999999999999999999987
Q ss_pred ccC
Q 010186 502 AES 504 (516)
Q Consensus 502 ~~~ 504 (516)
...
T Consensus 160 ~~~ 162 (316)
T cd05108 160 GAD 162 (316)
T ss_pred cCC
Confidence 644
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=211.92 Aligned_cols=146 Identities=27% Similarity=0.337 Sum_probs=126.9
Q ss_pred CCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC---CccchHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEE
Q 010186 351 FSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 425 (516)
|...+.||+|+||.||++.. .+++.||+|++.+. .....+.+..|..++..+. |++|+++++++...+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 56678999999999999995 46889999998752 2234456788999998885 5778889999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
|+++|+|..++. ....+++.++..++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 82 y~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 82 YVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred CCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 999999998883 3356899999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=207.23 Aligned_cols=145 Identities=30% Similarity=0.394 Sum_probs=126.3
Q ss_pred eeecCcEeEEEEEe-cCCcEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCCCh
Q 010186 357 LGQGGFGPVYKGVL-SDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432 (516)
Q Consensus 357 Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 432 (516)
||+|+||.||++.. .+++.+|+|.+.... ....+.+..|+++++.++||||+++.+++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 68999999999985 468899999986522 22345678899999999999999999999999999999999999999
Q ss_pred hHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 433 DAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 433 ~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
..++... .....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDG 150 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence 8877432 23456899999999999999999999987 999999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=211.49 Aligned_cols=141 Identities=29% Similarity=0.401 Sum_probs=124.2
Q ss_pred ceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEEccCC
Q 010186 355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 429 (516)
++||+|+||.||++... +++.||+|++.+. .....+.+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999964 6889999998752 233456678888888876 799999999999999999999999999
Q ss_pred CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
|+|..++. ....+++..+..++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~i~---~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 81 GDLMFHIQ---KSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred chHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence 99998884 3346889999999999999999999988 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-23 Score=206.18 Aligned_cols=142 Identities=20% Similarity=0.375 Sum_probs=125.1
Q ss_pred ceeeecCcEeEEEEEecCCcEEEEEEeccCCccc---hHHHHHHHHHHhcCCCCCccceeeEEEe----CCeeEEEEEcc
Q 010186 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQG---TAEFTNEVLLILKLQHKNLVKLLGFCVD----GDEKLLVYEFM 427 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~Ey~ 427 (516)
..|++|+++.||+|.+ +|+.||||.++...... .+.|.+|+.++.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999998 68999999997643333 5678899999999999999999999877 34678999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC-CCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
++|+|.+++.. ...+++.....++.+++.||.|||+. + ++||||||+|||+++++.+||+|||+++.+..
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 99999999943 35689999999999999999999984 5 78999999999999999999999999987654
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.7e-24 Score=224.42 Aligned_cols=160 Identities=24% Similarity=0.328 Sum_probs=134.7
Q ss_pred HHHHHhhCCCCCCceeeecCcEeEEEEE-ecCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 010186 342 ETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD 418 (516)
Q Consensus 342 ~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 418 (516)
.+.....++|...+.||+|+||.||++. ..+++.||||++... +......+.+|+..+..++|+||+++++.+...+
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 3344456789999999999999999998 457899999998653 3344567889999999999999999988775432
Q ss_pred --------eeEEEEEccCCCChhHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCc
Q 010186 419 --------EKLLVYEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN 489 (516)
Q Consensus 419 --------~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~ 489 (516)
..++||||+++|+|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+||||++++.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCC
Confidence 267999999999999988542 23356899999999999999999999987 999999999999999999
Q ss_pred EEEcccCcccccccC
Q 010186 490 SKISDFGMARIFAES 504 (516)
Q Consensus 490 ~kl~DFGla~~~~~~ 504 (516)
+||+|||+++.+...
T Consensus 182 vkL~DFGls~~~~~~ 196 (496)
T PTZ00283 182 VKLGDFGFSKMYAAT 196 (496)
T ss_pred EEEEecccCeecccc
Confidence 999999999887543
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=216.39 Aligned_cols=162 Identities=27% Similarity=0.425 Sum_probs=141.1
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEecc--CCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCe-eEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE-KLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-~~lV~ 424 (516)
++|...+++|+|+||.++..+.+ ++..+++|.+.- .+.......++|+.++++++|||||.+.+.|..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 46777889999999999988854 577899998864 344555678999999999999999999999999888 99999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||++||++.+.+... ++..++++....++.|++.|+.|||+.. |+|||||+.||+++.+..+||+|||+||.+.++
T Consensus 84 ~Y~eGg~l~~~i~~~-k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQ-KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 999999999998653 3567899999999999999999999876 999999999999999999999999999999988
Q ss_pred CCccCccceecC
Q 010186 505 EGEANTVRIVGT 516 (516)
Q Consensus 505 ~~~~~~~~~~GT 516 (516)
..... .++||
T Consensus 160 ~~~a~--tvvGT 169 (426)
T KOG0589|consen 160 DSLAS--TVVGT 169 (426)
T ss_pred hhhhh--eecCC
Confidence 75444 37787
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=203.75 Aligned_cols=153 Identities=31% Similarity=0.509 Sum_probs=136.1
Q ss_pred HhhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 346 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
+..++|...+.||+|++|.||++...+++.|++|.++... ...+++.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 3456688889999999999999998778899999987543 345679999999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
|+++++|.+++.... ...+++.....++.+++.||.|||+.+ ++||||||+||++++++.+||+|||+++.+..
T Consensus 82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 82 LMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred cccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 999999999985432 346899999999999999999999987 99999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=210.46 Aligned_cols=142 Identities=28% Similarity=0.360 Sum_probs=120.4
Q ss_pred ceeeecCcEeEEEEEec-CCcEEEEEEeccCC---ccchHHHHHHH-HHHhcCCCCCccceeeEEEeCCeeEEEEEccCC
Q 010186 355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEV-LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei-~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 429 (516)
+.||+|+||.||++... +++.+|+|++.+.. ......+..|. .+++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999964 57789999986521 22233444444 456788999999999999999999999999999
Q ss_pred CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
|+|.+++.. ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~ 147 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 147 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccc
Confidence 999998843 345788888899999999999999998 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-24 Score=199.95 Aligned_cols=152 Identities=32% Similarity=0.500 Sum_probs=132.9
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC----ccc----hHHHHHHHHHHhcC-CCCCccceeeEEEeCC
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS----EQG----TAEFTNEVLLILKL-QHKNLVKLLGFCVDGD 418 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~----~~~----~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 418 (516)
++|...+.||.|..+.|.++.. .+|.+.|+|++.... ... .+.-..|+.+|+++ .||+|+.+.++++.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 4566678899999999999885 468899999986421 111 23456799999998 8999999999999999
Q ss_pred eeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcc
Q 010186 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (516)
Q Consensus 419 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 498 (516)
..++|+|.|+.|.|.++| .....+++++...|+.|+..|++|||... |+||||||+|||+|+++++||+|||+|
T Consensus 97 F~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred hhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecccee
Confidence 999999999999999999 45667999999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCC
Q 010186 499 RIFAESEG 506 (516)
Q Consensus 499 ~~~~~~~~ 506 (516)
..+.+.+.
T Consensus 171 ~~l~~Gek 178 (411)
T KOG0599|consen 171 CQLEPGEK 178 (411)
T ss_pred eccCCchh
Confidence 99987764
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=212.00 Aligned_cols=146 Identities=24% Similarity=0.482 Sum_probs=125.4
Q ss_pred CCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCC-----eeE
Q 010186 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD-----EKL 421 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~ 421 (516)
+|...++||+|+||.||++.. .+++.||+|++... .......+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 466778999999999999995 46899999998642 2233456889999999999999999999886533 479
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+||||++ ++|.+++. ....+++..+..++.||++||.|||+.+ ++||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999996 68888873 3346899999999999999999999998 999999999999999999999999999865
Q ss_pred c
Q 010186 502 A 502 (516)
Q Consensus 502 ~ 502 (516)
.
T Consensus 154 ~ 154 (338)
T cd07859 154 F 154 (338)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=206.24 Aligned_cols=152 Identities=33% Similarity=0.500 Sum_probs=130.8
Q ss_pred CCCCCCceeeecCcEeEEEEEe-----cCCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-----SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 422 (516)
++|+..+.||+|+||.||+|.+ .++..+++|.+.... ......+.+|+.+++.++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4566778899999999999984 245789999997533 3344678999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhcCCC--------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC
Q 010186 423 VYEFMPNGSLDAILFDPR--------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM 488 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~ 488 (516)
||||+++++|.+++.... ....+++.+.+.++.|++.||.|||+.+ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999884221 1235788999999999999999999987 99999999999999999
Q ss_pred cEEEcccCccccccc
Q 010186 489 NSKISDFGMARIFAE 503 (516)
Q Consensus 489 ~~kl~DFGla~~~~~ 503 (516)
.+||+|||+++.+..
T Consensus 162 ~~kl~dfg~~~~~~~ 176 (283)
T cd05090 162 HVKISDLGLSREIYS 176 (283)
T ss_pred cEEeccccccccccC
Confidence 999999999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=210.94 Aligned_cols=141 Identities=25% Similarity=0.321 Sum_probs=124.8
Q ss_pred ceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEEccCC
Q 010186 355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 429 (516)
++||+|+||.||++... +++.+|+|++++. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999954 6789999999753 223455688999999888 699999999999999999999999999
Q ss_pred CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
|+|..++. ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 99988873 3346899999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=205.98 Aligned_cols=151 Identities=35% Similarity=0.556 Sum_probs=132.0
Q ss_pred CCCCCCceeeecCcEeEEEEEec-----CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-----DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKL 421 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-----~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~ 421 (516)
.+|...+.||+|+||.||++..+ ++..|++|.+........+.+.+|++++..++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46777889999999999999742 5789999998776656677899999999999999999999987643 4578
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+|+||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 99999999999999843 2345899999999999999999999987 999999999999999999999999999977
Q ss_pred ccC
Q 010186 502 AES 504 (516)
Q Consensus 502 ~~~ 504 (516)
...
T Consensus 159 ~~~ 161 (284)
T cd05081 159 PQD 161 (284)
T ss_pred cCC
Confidence 543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=203.02 Aligned_cols=148 Identities=34% Similarity=0.523 Sum_probs=131.6
Q ss_pred CCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccC
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 428 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 428 (516)
++|...+.||+|+||.||++.+.++..+++|.+... ....+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 346677889999999999999888889999988643 2335678999999999999999999999999999999999999
Q ss_pred CCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
+|+|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVL 151 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccC
Confidence 99999988532 245889999999999999999999987 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.4e-24 Score=204.47 Aligned_cols=148 Identities=29% Similarity=0.501 Sum_probs=128.8
Q ss_pred CCCCCceeeecCcEeEEEEEe-cCCcEEEEEEecc--CCccchHHHHHHHHHHhcCCCCCccceeeEEEe-----CCeeE
Q 010186 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD-----GDEKL 421 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-----~~~~~ 421 (516)
.|...+.||+|.||.|..+.. .+|+.||||++.. ......+.-.+|+++|+.++|+||+.+.+++.. -+..|
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 444467899999999999994 5789999999873 344456678899999999999999999998875 34689
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+|+|+| ..+|..++ +.++.|+.....-++.||++||.|+|+.+ ++||||||+|+|++.+..+||+||||||..
T Consensus 103 iV~elM-etDL~~ii---k~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 103 LVFELM-ETDLHQII---KSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred EehhHH-hhHHHHHH---HcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeec
Confidence 999999 56899998 34455999999999999999999999998 999999999999999999999999999998
Q ss_pred ccC
Q 010186 502 AES 504 (516)
Q Consensus 502 ~~~ 504 (516)
.+.
T Consensus 176 ~~~ 178 (359)
T KOG0660|consen 176 DKF 178 (359)
T ss_pred ccc
Confidence 654
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=217.10 Aligned_cols=157 Identities=31% Similarity=0.466 Sum_probs=132.6
Q ss_pred HHHhhCCCCCCceeeecCcEeEEEEEec------CCcEEEEEEeccCC-ccchHHHHHHHHHHhcCC-CCCccceeeEEE
Q 010186 344 LNLATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQ-HKNLVKLLGFCV 415 (516)
Q Consensus 344 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~ 415 (516)
+++..++|...++||+|+||.||++.+. .++.||+|+++... ....+.+.+|++++.++. ||||+++++.+.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4455566777899999999999999853 34689999997532 233457899999999997 999999999999
Q ss_pred eCCeeEEEEEccCCCChhHHhcCCC-------------------------------------------------------
Q 010186 416 DGDEKLLVYEFMPNGSLDAILFDPR------------------------------------------------------- 440 (516)
Q Consensus 416 ~~~~~~lV~Ey~~~gsL~~~l~~~~------------------------------------------------------- 440 (516)
..+..++|+||+++|+|.++++...
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 9999999999999999999885321
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCC
Q 010186 441 ----------------------------------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKAS 480 (516)
Q Consensus 441 ----------------------------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~ 480 (516)
....+++...+.++.||+.||.|||+.+ ++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence 1124678888999999999999999887 999999999
Q ss_pred CeEecCCCcEEEcccCccccccc
Q 010186 481 NVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 481 NILld~~~~~kl~DFGla~~~~~ 503 (516)
|||+++++.+||+|||+++.+..
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~ 291 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMR 291 (401)
T ss_pred eEEEeCCCEEEEEecCcceeccc
Confidence 99999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=215.85 Aligned_cols=143 Identities=20% Similarity=0.295 Sum_probs=126.3
Q ss_pred hhCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
..++|...+.||+|+||.||++.. .+++.||+|... ...+.+|++++++++||||+++++++......++|+|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 346799999999999999999995 568899999653 2357899999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
++. ++|..++. ....+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 164 ~~~-~~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 164 RYK-TDLYCYLA---AKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred cCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 995 68877773 2345889999999999999999999987 9999999999999999999999999997643
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-24 Score=186.89 Aligned_cols=148 Identities=28% Similarity=0.447 Sum_probs=128.2
Q ss_pred CCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 351 FSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
|...++||+|.||+||+++. ++++.||+|++... ++......++||-+++.++|+|||+++++...+...-||+||+
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 44457899999999999994 56889999998653 3334557889999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
.. +|..+.. .-++.++.+....++.|+++||.|+|++. +.||||||.|.||+.++..|++|||+||-+.-.
T Consensus 84 dq-dlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 84 DQ-DLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred hH-HHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 65 7777763 34566888999999999999999999998 999999999999999999999999999987543
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=204.91 Aligned_cols=153 Identities=35% Similarity=0.587 Sum_probs=137.6
Q ss_pred hhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
...+|...++||+|+||.||++...++..+++|.+..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34567778899999999999999888999999999876555667899999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
+++++|.+++... ....+++.....++.+|+.||.|||+.+ ++||||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 9999999999653 3456899999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=202.10 Aligned_cols=149 Identities=26% Similarity=0.441 Sum_probs=133.4
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
++|...+.||+|+||.||+|.. .+++.|++|++..........+.+|+.++.+++||||+++++.+..++..++|+||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4678889999999999999995 578899999987654445567889999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
++++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.+..
T Consensus 89 ~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 89 GGGSLQDIYH---VTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred CCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 9999999884 2346889999999999999999999987 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=208.60 Aligned_cols=141 Identities=28% Similarity=0.380 Sum_probs=123.0
Q ss_pred ceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEEccCC
Q 010186 355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 429 (516)
+.||+|+||.||++... +++.||+|+++.. .......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 5789999999753 123445667788888764 999999999999999999999999999
Q ss_pred CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
|+|..++. ....+++.+...++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 81 GDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 99999884 3346889999999999999999999987 999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=206.10 Aligned_cols=150 Identities=31% Similarity=0.395 Sum_probs=130.4
Q ss_pred CCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
+|...++||+|+||.||++.. .+++.||+|++.... ......+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 356678899999999999995 468899999986522 2223457889999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
|+++|+|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||+++.+..
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 99999999887432 3346899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=202.84 Aligned_cols=150 Identities=34% Similarity=0.586 Sum_probs=132.5
Q ss_pred hCCCCCCceeeecCcEeEEEEEecC----CcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLSD----GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 422 (516)
.++|...+.||+|+||.||+|.+.. ...|++|.++.. .......|.+|+.++.+++||||+++++.+...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3568888999999999999999642 357899988753 33345678999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+|||+++++.+||+|||+++.+.
T Consensus 83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 99999999999998542 346899999999999999999999987 9999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=204.55 Aligned_cols=148 Identities=25% Similarity=0.271 Sum_probs=132.0
Q ss_pred CCCCceeeecCcEeEEEEEecC-CcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 351 FSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
|...+.||.|.-|+||++.+++ +...|+|++.+. +.+.......|.+||+.++||.++.|+..++.++..+|+|||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey 158 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY 158 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence 4445789999999999999764 578999999873 334455677899999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
|+||+|..++++ +..+.+++..+..++.+|+-||+|||-.| ||.|||||+||||.++|++.|+||.|+....
T Consensus 159 CpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 159 CPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred CCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 999999998854 56678999999999999999999999998 9999999999999999999999999997663
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=208.79 Aligned_cols=141 Identities=30% Similarity=0.407 Sum_probs=123.0
Q ss_pred ceeeecCcEeEEEEEec-CCcEEEEEEeccCC---ccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEEccCC
Q 010186 355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 429 (516)
++||+|+||.||++... +|+.||+|.+++.. ......+..|..++... +||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999964 68899999997521 23445677788888754 899999999999999999999999999
Q ss_pred CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
|+|..++. ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~i~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 81 GDLMFHIQ---DKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 99998884 3356889999999999999999999988 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=211.76 Aligned_cols=159 Identities=33% Similarity=0.468 Sum_probs=136.6
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCc---cchHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE---QGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~l 422 (516)
...|...+.||.|.||.||+++.. +|+.+|+|.+.+... ...+.+.+|+.+|.++. |||||.+.+.++.....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 345777789999999999999965 599999999976433 34568999999999998 9999999999999999999
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCC----CcEEEcccCcc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD----MNSKISDFGMA 498 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~----~~~kl~DFGla 498 (516)
|||++.||.|.+.+... .+++.++..++.||+.++.|||+.+ ++||||||+|+|+... +.+|++|||+|
T Consensus 114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 99999999999888543 3999999999999999999999988 9999999999999543 47999999999
Q ss_pred cccccCCCccCccceecC
Q 010186 499 RIFAESEGEANTVRIVGT 516 (516)
Q Consensus 499 ~~~~~~~~~~~~~~~~GT 516 (516)
+.+.... ....++||
T Consensus 187 ~~~~~~~---~~~~~~Gt 201 (382)
T KOG0032|consen 187 KFIKPGE---RLHTIVGT 201 (382)
T ss_pred eEccCCc---eEeeecCC
Confidence 9988722 22346665
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=209.02 Aligned_cols=155 Identities=35% Similarity=0.528 Sum_probs=132.6
Q ss_pred CceeeecCcEeEEEEEe-cCCcEEEEEEecc--CCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCC
Q 010186 354 SNILGQGGFGPVYKGVL-SDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNG 430 (516)
Q Consensus 354 ~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 430 (516)
.++||.|.||+||-|.. ++|+.||||++.+ ...+....+++|+.+|.+++||.||.|.-.|+..+..++|||-+.|-
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 57899999999999996 4799999999976 34455578999999999999999999999999999999999999665
Q ss_pred ChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCC---CcEEEcccCcccccccCCCc
Q 010186 431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD---MNSKISDFGMARIFAESEGE 507 (516)
Q Consensus 431 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~---~~~kl~DFGla~~~~~~~~~ 507 (516)
-|+-+|. ...+.|++.....++.||+.||.|||.++ |+|.||||+|||+.+. -.+||||||+||++.+..-.
T Consensus 649 MLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 649 MLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred HHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 5666663 35567999888899999999999999998 9999999999999654 36999999999999875432
Q ss_pred cCccceecC
Q 010186 508 ANTVRIVGT 516 (516)
Q Consensus 508 ~~~~~~~GT 516 (516)
. .++||
T Consensus 724 r---sVVGT 729 (888)
T KOG4236|consen 724 R---SVVGT 729 (888)
T ss_pred h---hhcCC
Confidence 2 26776
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=203.58 Aligned_cols=145 Identities=41% Similarity=0.696 Sum_probs=126.0
Q ss_pred CceeeecCcEeEEEEEec-----CCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 354 SNILGQGGFGPVYKGVLS-----DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 354 ~~~Lg~G~fg~Vy~~~~~-----~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
.+.||.|.||.||+|.+. .+..|+||.++.. .....+.|.+|++.+++++||||++++|++...+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999999999999976 3568999999653 3334788999999999999999999999999888899999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
++|+|.+++... ....+++..+..|+.||++||.|||+.+ ++|+||+++||++++++.+||+|||+++...
T Consensus 84 ~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 84 PGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred cccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence 999999999643 3456899999999999999999999987 9999999999999999999999999998873
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=201.65 Aligned_cols=149 Identities=32% Similarity=0.503 Sum_probs=131.7
Q ss_pred CCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCC
Q 010186 350 NFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 429 (516)
+|...+.||+|+||.||++...++..+|+|.+.... ...+.|.+|+.++.+++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 466678899999999999998777789999887532 3456799999999999999999999999998899999999999
Q ss_pred CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
|+|.+++... ...+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+..+
T Consensus 84 ~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 84 GCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 9999988542 236899999999999999999999987 999999999999999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=227.54 Aligned_cols=150 Identities=24% Similarity=0.357 Sum_probs=130.7
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...++||+|+||.||+|... +++.||+|++.... ....+.|.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46788899999999999999954 68899999987522 223457899999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccC
Q 010186 425 EFMPNGSLDAILFDPR--------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 496 (516)
||+++|+|.+++.... ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999885321 1234567788999999999999999987 9999999999999999999999999
Q ss_pred ccccc
Q 010186 497 MARIF 501 (516)
Q Consensus 497 la~~~ 501 (516)
+++..
T Consensus 159 LAk~i 163 (932)
T PRK13184 159 AAIFK 163 (932)
T ss_pred cceec
Confidence 99877
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=204.84 Aligned_cols=155 Identities=34% Similarity=0.568 Sum_probs=131.9
Q ss_pred HhhCCCCCCceeeecCcEeEEEEEec------CCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 010186 346 LATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD 418 (516)
Q Consensus 346 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 418 (516)
+..++|...+.||+|+||.||++... .+..||+|.+.... .....++.+|+.+++.++||||+++++++..+.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35667888999999999999998753 24679999886432 234557899999999999999999999999999
Q ss_pred eeEEEEEccCCCChhHHhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEE
Q 010186 419 EKLLVYEFMPNGSLDAILFDPRK-------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSK 491 (516)
Q Consensus 419 ~~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~k 491 (516)
..++||||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence 99999999999999998854221 234678889999999999999999987 99999999999999999999
Q ss_pred EcccCccccccc
Q 010186 492 ISDFGMARIFAE 503 (516)
Q Consensus 492 l~DFGla~~~~~ 503 (516)
|+|||+++.+..
T Consensus 160 l~dfg~~~~~~~ 171 (277)
T cd05062 160 IGDFGMTRDIYE 171 (277)
T ss_pred ECCCCCccccCC
Confidence 999999986543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=202.92 Aligned_cols=152 Identities=32% Similarity=0.541 Sum_probs=134.8
Q ss_pred hhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
..++|...++||+|+||.||++...++..|++|.+.... ...+.+.+|+.+++.++|+||+++++.+...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 345677889999999999999998888899999886532 3456899999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+..
T Consensus 83 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 83 MAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCC
Confidence 9999999988542 3346888999999999999999999987 99999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=202.59 Aligned_cols=143 Identities=31% Similarity=0.471 Sum_probs=122.1
Q ss_pred eeeecCcEeEEEEEecC---CcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCCC
Q 010186 356 ILGQGGFGPVYKGVLSD---GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGS 431 (516)
Q Consensus 356 ~Lg~G~fg~Vy~~~~~~---g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 431 (516)
.||+|+||.||+|...+ ...+++|.+... .......|.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999998543 346788877543 23345578899999999999999999999999999999999999999
Q ss_pred hhHHhcCCCC--CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 432 LDAILFDPRK--RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 432 L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
|.+++..... ....++.....++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 150 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQ 150 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEecccccccc
Confidence 9999854332 233567888899999999999999987 999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-23 Score=212.14 Aligned_cols=148 Identities=28% Similarity=0.452 Sum_probs=128.1
Q ss_pred CCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCC-----eeE
Q 010186 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD-----EKL 421 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~ 421 (516)
+|+..+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 467789999999999999995 57899999998652 2234567889999999999999999999998776 789
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+|+||++ ++|.+++. ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 57777763 3456899999999999999999999998 999999999999999999999999999876
Q ss_pred ccC
Q 010186 502 AES 504 (516)
Q Consensus 502 ~~~ 504 (516)
...
T Consensus 154 ~~~ 156 (372)
T cd07853 154 EPD 156 (372)
T ss_pred ccC
Confidence 543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-23 Score=207.14 Aligned_cols=141 Identities=30% Similarity=0.400 Sum_probs=124.6
Q ss_pred ceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEEccCC
Q 010186 355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 429 (516)
+.||+|+||.||++... +++.+|+|++++. .......+..|++++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 5789999999753 233456678899999888 799999999999999999999999999
Q ss_pred CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
|+|..++. ....+++..+..++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 81 GDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 99988884 3346899999999999999999999987 999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-23 Score=204.34 Aligned_cols=154 Identities=36% Similarity=0.580 Sum_probs=133.9
Q ss_pred hhCCCCCCceeeecCcEeEEEEEec------CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK 420 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 420 (516)
...+|...+.||+|+||.||++... ++..+++|.+........+.+.+|++++.+++||||+++++++...+..
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3456788899999999999999742 3456899998766555667899999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcE
Q 010186 421 LLVYEFMPNGSLDAILFDPR----------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS 490 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~ 490 (516)
++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcE
Confidence 99999999999999885321 2235899999999999999999999987 9999999999999999999
Q ss_pred EEcccCccccccc
Q 010186 491 KISDFGMARIFAE 503 (516)
Q Consensus 491 kl~DFGla~~~~~ 503 (516)
||+|||+++.+..
T Consensus 160 kl~dfg~~~~~~~ 172 (288)
T cd05093 160 KIGDFGMSRDVYS 172 (288)
T ss_pred EeccCCccccccC
Confidence 9999999986643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=205.03 Aligned_cols=155 Identities=34% Similarity=0.523 Sum_probs=131.2
Q ss_pred HhhCCCCCCceeeecCcEeEEEEEec------CCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 010186 346 LATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD 418 (516)
Q Consensus 346 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 418 (516)
+..++|.+.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++||||+++++.+...+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45667888999999999999999743 24579999886432 233456889999999999999999999999999
Q ss_pred eeEEEEEccCCCChhHHhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEE
Q 010186 419 EKLLVYEFMPNGSLDAILFDPR-------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSK 491 (516)
Q Consensus 419 ~~~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~k 491 (516)
..++||||+++|+|.+++.... ....+++..+..++.||+.||.|||+.+ ++||||||+|||+++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 9999999999999999985321 1234577888999999999999999987 99999999999999999999
Q ss_pred EcccCccccccc
Q 010186 492 ISDFGMARIFAE 503 (516)
Q Consensus 492 l~DFGla~~~~~ 503 (516)
|+|||+++.+..
T Consensus 160 L~Dfg~~~~~~~ 171 (288)
T cd05061 160 IGDFGMTRDIYE 171 (288)
T ss_pred ECcCCccccccc
Confidence 999999986543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-23 Score=216.07 Aligned_cols=146 Identities=26% Similarity=0.291 Sum_probs=127.0
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
...|.+.+.||+|+||.||++... .++.|+||... ...+.+|++++++++|+||+++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 346888899999999999999965 57889999532 23467899999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCC
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 505 (516)
+. ++|..++.. ....++|.+++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 95 688777743 2346899999999999999999999988 9999999999999999999999999998875443
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=210.90 Aligned_cols=154 Identities=30% Similarity=0.468 Sum_probs=129.3
Q ss_pred hhCCCCCCceeeecCcEeEEEEEe------cCCcEEEEEEeccCC-ccchHHHHHHHHHHhcC-CCCCccceeeEEEeC-
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDG- 417 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~- 417 (516)
..++|...+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 456788899999999999999973 356789999997532 33456788999999999 789999999988754
Q ss_pred CeeEEEEEccCCCChhHHhcCCCC--------------------------------------------------------
Q 010186 418 DEKLLVYEFMPNGSLDAILFDPRK-------------------------------------------------------- 441 (516)
Q Consensus 418 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------------------------------------------------- 441 (516)
...++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 467899999999999998753210
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 442 --------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 442 --------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
...+++.....++.||++||.|||+.+ ++||||||+|||+++++.+||+|||+++.+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~ 231 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 231 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEeccccccccc
Confidence 124688888999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=210.92 Aligned_cols=156 Identities=28% Similarity=0.454 Sum_probs=130.2
Q ss_pred HhhCCCCCCceeeecCcEeEEEEEec------CCcEEEEEEeccCC-ccchHHHHHHHHHHhcC-CCCCccceeeEEEeC
Q 010186 346 LATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDG 417 (516)
Q Consensus 346 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 417 (516)
++.++|.+.+.||+|+||.||++... +++.||+|+++... ....+.+..|+.++.++ +|+||+++++++...
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 34567888899999999999999632 34789999987532 23455688899999999 899999999988754
Q ss_pred -CeeEEEEEccCCCChhHHhcCCCC-------------------------------------------------------
Q 010186 418 -DEKLLVYEFMPNGSLDAILFDPRK------------------------------------------------------- 441 (516)
Q Consensus 418 -~~~~lV~Ey~~~gsL~~~l~~~~~------------------------------------------------------- 441 (516)
...++++||+++++|.+++.....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 567899999999999988743211
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 442 ---RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 442 ---~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
...++|..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~ 226 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKD 226 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccC
Confidence 126889999999999999999999987 999999999999999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-23 Score=201.51 Aligned_cols=151 Identities=34% Similarity=0.594 Sum_probs=131.5
Q ss_pred CCCCCCceeeecCcEeEEEEEec-C---CcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-D---GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~---g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 423 (516)
.+|...+.||+|+||.||+|... + +..+++|.++.. .....+.+.+|+.++.+++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46777899999999999999853 2 337899988653 233456789999999999999999999999999999999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
|||+++++|.+++.. ....+++.+...++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRK--HDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999853 2346899999999999999999999987 99999999999999999999999999987754
Q ss_pred C
Q 010186 504 S 504 (516)
Q Consensus 504 ~ 504 (516)
.
T Consensus 159 ~ 159 (267)
T cd05066 159 D 159 (267)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-23 Score=208.21 Aligned_cols=140 Identities=26% Similarity=0.343 Sum_probs=120.1
Q ss_pred eeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcC---CCCCccceeeEEEeCCeeEEEEEccCC
Q 010186 357 LGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL---QHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (516)
Q Consensus 357 Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~~~lV~Ey~~~ 429 (516)
||+|+||.||++... +++.||+|++.+. .......+..|..++... +||||+++++.+...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999954 6899999998642 122334455666666655 799999999999999999999999999
Q ss_pred CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
|+|..++. ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~ 147 (330)
T cd05586 81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANL 147 (330)
T ss_pred ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCC
Confidence 99998884 3456899999999999999999999998 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=205.49 Aligned_cols=154 Identities=31% Similarity=0.471 Sum_probs=130.7
Q ss_pred hhCCCCCCceeeecCcEeEEEEEecC---------------CcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccce
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLSD---------------GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKL 410 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~---------------g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l 410 (516)
+.++|...+.||+|+||.||++...+ ...||+|.+... .......|.+|++++++++||||+++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 34578888999999999999987532 225899998753 33345679999999999999999999
Q ss_pred eeEEEeCCeeEEEEEccCCCChhHHhcCCC---------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCC
Q 010186 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPR---------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASN 481 (516)
Q Consensus 411 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~N 481 (516)
++++...+..++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhh
Confidence 999999999999999999999999884321 1124688999999999999999999987 9999999999
Q ss_pred eEecCCCcEEEcccCccccccc
Q 010186 482 VLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 482 ILld~~~~~kl~DFGla~~~~~ 503 (516)
|++++++.+||+|||+++.+..
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~ 181 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYS 181 (295)
T ss_pred EEEcCCCcEEeccccccccccc
Confidence 9999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-23 Score=200.20 Aligned_cols=148 Identities=32% Similarity=0.522 Sum_probs=131.1
Q ss_pred CCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCC
Q 010186 350 NFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 429 (516)
+|...+.||+|+||.||++...++..+++|.+.+.. .....+.+|+++++.++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 466778899999999999998777789999886532 2345788999999999999999999999999999999999999
Q ss_pred CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
++|.+++... ...+++.....++.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++...+
T Consensus 84 ~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 84 GCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD 152 (256)
T ss_pred CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccc
Confidence 9999988532 236899999999999999999999988 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.5e-23 Score=202.79 Aligned_cols=156 Identities=29% Similarity=0.523 Sum_probs=134.4
Q ss_pred HhhCCCCCCceeeecCcEeEEEEEecC-----CcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEe-CC
Q 010186 346 LATSNFSDSNILGQGGFGPVYKGVLSD-----GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD-GD 418 (516)
Q Consensus 346 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~-----g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~ 418 (516)
+..++|...++||+|+||.||+|...+ +..|++|++... +....+.+.+|+.++++++||||+++++++.. +.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 345678888999999999999999755 678999988753 33446678999999999999999999998876 46
Q ss_pred eeEEEEEccCCCChhHHhcCCCCC-----CCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEc
Q 010186 419 EKLLVYEFMPNGSLDAILFDPRKR-----GILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKIS 493 (516)
Q Consensus 419 ~~~lV~Ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~ 493 (516)
..++++||+++++|.+++...... ..+++..+..++.||+.||.|||+.+ ++||||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEEC
Confidence 789999999999999998543322 46899999999999999999999987 9999999999999999999999
Q ss_pred ccCcccccccC
Q 010186 494 DFGMARIFAES 504 (516)
Q Consensus 494 DFGla~~~~~~ 504 (516)
|||+++.+.+.
T Consensus 160 d~g~~~~~~~~ 170 (280)
T cd05043 160 DNALSRDLFPM 170 (280)
T ss_pred CCCCcccccCC
Confidence 99999876543
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.2e-25 Score=204.29 Aligned_cols=157 Identities=29% Similarity=0.527 Sum_probs=140.1
Q ss_pred CCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCC
Q 010186 351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 429 (516)
|.+.++||+|+||.||++.++ .|+.+|+|.+.. ....+++..|+.+|.+...|+||+++|-+.....+|+|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 455678999999999999964 689999999865 34677899999999999999999999999999999999999999
Q ss_pred CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCCCccC
Q 010186 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509 (516)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 509 (516)
|++.+++.. ++++|++.++..++.+.++||+|||... -||||||+.||||+.+|.+||+|||.|..+.+.-.+.+
T Consensus 113 GSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRN 187 (502)
T KOG0574|consen 113 GSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRN 187 (502)
T ss_pred CcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHhhC
Confidence 999999853 5568999999999999999999999875 89999999999999999999999999999887655555
Q ss_pred ccceecC
Q 010186 510 TVRIVGT 516 (516)
Q Consensus 510 ~~~~~GT 516 (516)
| ++||
T Consensus 188 T--VIGT 192 (502)
T KOG0574|consen 188 T--VIGT 192 (502)
T ss_pred c--cccC
Confidence 4 7787
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.7e-23 Score=200.39 Aligned_cols=144 Identities=33% Similarity=0.458 Sum_probs=123.3
Q ss_pred eeeecCcEeEEEEEecC---CcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCCC
Q 010186 356 ILGQGGFGPVYKGVLSD---GKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGS 431 (516)
Q Consensus 356 ~Lg~G~fg~Vy~~~~~~---g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 431 (516)
.||+|+||.||+|...+ +..+++|.++... ......+.+|+.++++++||||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998643 4578999886533 2344578899999999999999999999999999999999999999
Q ss_pred hhHHhcCCC--CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 432 LDAILFDPR--KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 432 L~~~l~~~~--~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCcccccccc
Confidence 999985422 2234667788899999999999999987 9999999999999999999999999997543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.4e-23 Score=204.43 Aligned_cols=148 Identities=28% Similarity=0.457 Sum_probs=128.2
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
++|...+.||+|+||.||++... +++.||+|.++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 45777899999999999999854 67889999987532 23344678999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
+++ +|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecC
Confidence 985 77777643 2345788999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-24 Score=210.28 Aligned_cols=159 Identities=28% Similarity=0.493 Sum_probs=141.1
Q ss_pred CCCCCceeeecCcEeEEEEE-ecCCcEEEEEEecc-CCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~-~~~g~~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
.|...+.||+|.||.||+|. ...++.||+|++.. ....+.+++.+|+.++..++++||.+++|.+..+..+|++|||+
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 45566889999999999999 45788999999975 44566788999999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCCCc
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 507 (516)
.+|++.+.| +....+.+....-++++++.||.|||+++ .+|||||+.|||+..++.+||+|||++-.+.....+
T Consensus 94 ~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 94 GGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred cCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 999999988 44555678888889999999999999998 999999999999999999999999999999887665
Q ss_pred cCccceecC
Q 010186 508 ANTVRIVGT 516 (516)
Q Consensus 508 ~~~~~~~GT 516 (516)
.. +++||
T Consensus 168 r~--tfvGT 174 (467)
T KOG0201|consen 168 RK--TFVGT 174 (467)
T ss_pred cc--ccccc
Confidence 54 48887
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.89 E-value=8e-23 Score=199.94 Aligned_cols=149 Identities=30% Similarity=0.569 Sum_probs=125.1
Q ss_pred CCCceeeecCcEeEEEEEecCC-c--EEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeC------Cee
Q 010186 352 SDSNILGQGGFGPVYKGVLSDG-K--EVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG------DEK 420 (516)
Q Consensus 352 ~~~~~Lg~G~fg~Vy~~~~~~g-~--~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~ 420 (516)
..+++||+|+||.||+|...+. . .+|+|.++.. +....+.+.+|+.+++.++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4568899999999999996543 2 6899988653 334567789999999999999999999988543 246
Q ss_pred EEEEEccCCCChhHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCc
Q 010186 421 LLVYEFMPNGSLDAILFDPR---KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 497 (516)
++++||+++|+|.+++...+ ....+++.....++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999998874221 2345889999999999999999999987 99999999999999999999999999
Q ss_pred cccccc
Q 010186 498 ARIFAE 503 (516)
Q Consensus 498 a~~~~~ 503 (516)
++.+..
T Consensus 159 ~~~~~~ 164 (272)
T cd05075 159 SKKIYN 164 (272)
T ss_pred ccccCc
Confidence 987754
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.3e-23 Score=202.10 Aligned_cols=151 Identities=36% Similarity=0.601 Sum_probs=131.9
Q ss_pred CCCCCCceeeecCcEeEEEEEec------CCcEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCSEQ-GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 421 (516)
++|...+.||+|+||.||+|... ++..|++|.++..... ..+.+.+|++++..++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 45677788999999999999863 3478999998764433 4568999999999999999999999999999999
Q ss_pred EEEEccCCCChhHHhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcE
Q 010186 422 LVYEFMPNGSLDAILFDPR-----------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS 490 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~ 490 (516)
+||||+++++|.+++.... ....+++.....++.||+.||.|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999985321 2345789999999999999999999987 9999999999999999999
Q ss_pred EEcccCcccccc
Q 010186 491 KISDFGMARIFA 502 (516)
Q Consensus 491 kl~DFGla~~~~ 502 (516)
||+|||+++.+.
T Consensus 162 kl~d~g~~~~~~ 173 (280)
T cd05049 162 KIGDFGMSRDVY 173 (280)
T ss_pred EECCcccceecc
Confidence 999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.3e-23 Score=225.40 Aligned_cols=150 Identities=24% Similarity=0.379 Sum_probs=132.7
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|.+.++||+|+||.||++... +++.||+|+++... ......+..|+.++..++||||+++++.+...+..+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 46778899999999999999965 68899999997532 233467889999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||+++++|.+++.. .+.+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~ 157 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNR 157 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCccccCC
Confidence 99999999999843 345888999999999999999999987 999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.89 E-value=7e-23 Score=198.10 Aligned_cols=143 Identities=33% Similarity=0.518 Sum_probs=126.6
Q ss_pred ceeeecCcEeEEEEEe-cCCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCCCh
Q 010186 355 NILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 432 (516)
+.||+|+||.||++.. .+++.+++|.+... .......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3689999999999996 47889999987643 233456799999999999999999999999999999999999999999
Q ss_pred hHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 145 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEE 145 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccc
Confidence 999843 2345889999999999999999999987 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.2e-23 Score=201.45 Aligned_cols=150 Identities=38% Similarity=0.567 Sum_probs=125.9
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCc----EEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGK----EVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 422 (516)
++|...+.||+|+||.||+|.+. +++ .+++|.+.... .....++..|+..++++.||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 35667788999999999999963 444 47777775432 234467888899999999999999999875 455789
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
++||+++|+|.+++.. ....+++.....++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999999853 2346899999999999999999999987 9999999999999999999999999998775
Q ss_pred cC
Q 010186 503 ES 504 (516)
Q Consensus 503 ~~ 504 (516)
+.
T Consensus 161 ~~ 162 (279)
T cd05111 161 PD 162 (279)
T ss_pred CC
Confidence 44
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.6e-23 Score=198.45 Aligned_cols=153 Identities=32% Similarity=0.551 Sum_probs=136.4
Q ss_pred HhhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 346 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
+..++|.+.++||+|+||.||++..++++.+++|.+.... ...+++.+|+.++++++|+||+++++.+......++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 4556788889999999999999998888899999987533 345679999999999999999999999999899999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
|+++++|.+++... ....+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 82 ~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 82 YMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred ccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccc
Confidence 99999999998542 3346899999999999999999999987 99999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=200.84 Aligned_cols=150 Identities=29% Similarity=0.466 Sum_probs=123.2
Q ss_pred CCCCCceeeecCcEeEEEEEe-c-CCcEEEEEEeccCC--ccchHHHHHHHHHHhcC---CCCCccceeeEEEe-----C
Q 010186 350 NFSDSNILGQGGFGPVYKGVL-S-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKL---QHKNLVKLLGFCVD-----G 417 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~-~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~-----~ 417 (516)
+|...+.||+|+||.||++.. . +++.||+|+++... ......+.+|+.+++.+ +||||+++++++.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 577889999999999999985 2 46789999886532 22334566777777665 69999999999863 3
Q ss_pred CeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCc
Q 010186 418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497 (516)
Q Consensus 418 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 497 (516)
...++||||++ ++|.+++... ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 45899999997 5888888532 2345899999999999999999999988 99999999999999999999999999
Q ss_pred ccccccC
Q 010186 498 ARIFAES 504 (516)
Q Consensus 498 a~~~~~~ 504 (516)
++.....
T Consensus 157 ~~~~~~~ 163 (290)
T cd07862 157 ARIYSFQ 163 (290)
T ss_pred eEeccCC
Confidence 9876543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.1e-23 Score=204.51 Aligned_cols=155 Identities=29% Similarity=0.491 Sum_probs=132.4
Q ss_pred HhhCCCCCCceeeecCcEeEEEEEec--------CCcEEEEEEeccC-CccchHHHHHHHHHHhcC-CCCCccceeeEEE
Q 010186 346 LATSNFSDSNILGQGGFGPVYKGVLS--------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCV 415 (516)
Q Consensus 346 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~ 415 (516)
+..++|...+.||+|+||.||++... ++..|++|.+... .......+.+|+.++..+ +||||+++++.+.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34556778899999999999999731 2457899988653 234556799999999999 8999999999999
Q ss_pred eCCeeEEEEEccCCCChhHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCe
Q 010186 416 DGDEKLLVYEFMPNGSLDAILFDPRK-------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNV 482 (516)
Q Consensus 416 ~~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NI 482 (516)
.....++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ ++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 99999999999999999999854321 235788999999999999999999987 99999999999
Q ss_pred EecCCCcEEEcccCccccccc
Q 010186 483 LLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 483 Lld~~~~~kl~DFGla~~~~~ 503 (516)
|++.++.+||+|||+++.+..
T Consensus 169 li~~~~~~kl~D~g~~~~~~~ 189 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNN 189 (304)
T ss_pred EEcCCCcEEECCCccceeccc
Confidence 999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.5e-23 Score=203.52 Aligned_cols=156 Identities=31% Similarity=0.504 Sum_probs=133.8
Q ss_pred HHhhCCCCCCceeeecCcEeEEEEEec------CCcEEEEEEeccC-CccchHHHHHHHHHHhcC-CCCCccceeeEEEe
Q 010186 345 NLATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVD 416 (516)
Q Consensus 345 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 416 (516)
.+..++|...+.||+|+||.||++... +...+++|.+... .......+.+|++++.++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 345566788899999999999999853 2357899988753 333455688999999999 89999999999999
Q ss_pred CCeeEEEEEccCCCChhHHhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeE
Q 010186 417 GDEKLLVYEFMPNGSLDAILFDP-------------RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVL 483 (516)
Q Consensus 417 ~~~~~lV~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIL 483 (516)
++..+++|||+++|+|..++... .....+++..++.++.||+.||.|||+.+ ++||||||+|||
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEE
Confidence 99999999999999999988532 22356899999999999999999999987 999999999999
Q ss_pred ecCCCcEEEcccCccccccc
Q 010186 484 LDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 484 ld~~~~~kl~DFGla~~~~~ 503 (516)
++.++.+||+|||+++.+..
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~ 184 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHH 184 (293)
T ss_pred EcCCCeEEeCcccccccccc
Confidence 99999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.8e-23 Score=201.62 Aligned_cols=142 Identities=28% Similarity=0.412 Sum_probs=121.0
Q ss_pred eeeecCcEeEEEEEecC-------------------------CcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccce
Q 010186 356 ILGQGGFGPVYKGVLSD-------------------------GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410 (516)
Q Consensus 356 ~Lg~G~fg~Vy~~~~~~-------------------------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l 410 (516)
+||+|+||.||+|.+.. ...|++|.+..........|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997421 13588898876444445678899999999999999999
Q ss_pred eeEEEeCCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC--
Q 010186 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-- 488 (516)
Q Consensus 411 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~-- 488 (516)
++++.+....++||||+++|+|..++.. ..+.+++..+..++.||++||.|||+.+ ++||||||+|||++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999998843 3446889999999999999999999987 99999999999997643
Q ss_pred -----cEEEcccCcccccc
Q 010186 489 -----NSKISDFGMARIFA 502 (516)
Q Consensus 489 -----~~kl~DFGla~~~~ 502 (516)
.+||+|||+++...
T Consensus 157 ~~~~~~~kl~d~g~~~~~~ 175 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTAL 175 (274)
T ss_pred cCccceeeecCCccccccc
Confidence 38999999986543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.9e-23 Score=200.96 Aligned_cols=148 Identities=27% Similarity=0.471 Sum_probs=132.0
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
++|...+.||+|+||.||++.. .+++.+++|.++.........+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 3566678899999999999985 468899999987655455567889999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
++++|.+++. ..+.+++.+...++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+.
T Consensus 89 ~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 89 GGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQIT 157 (267)
T ss_pred CCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence 9999999883 3446899999999999999999999997 9999999999999999999999999997664
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.7e-23 Score=199.72 Aligned_cols=151 Identities=31% Similarity=0.498 Sum_probs=132.9
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
..+|...+.||+|+||.||++... +++.|++|.+... .....++.+|++++..++||||+++++++...+..+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 345667788999999999999954 5889999988753 33466799999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
+++++|.+++... ....+++..++.++.|+++||.|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 84 ~~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 84 MTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred CCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 9999999988532 3346899999999999999999999987 99999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=203.20 Aligned_cols=150 Identities=27% Similarity=0.369 Sum_probs=130.6
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
++|...+.||+|+||.||++... ++..+++|.+... .......+.+|++++.+++||||+++++.+..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 35788899999999999999954 6788899988653 233455688999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
+++++|.+++.. ...+++.....++.||++||.|||+.. +++||||||+|||++.++.+||+|||+++.+..
T Consensus 81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 152 (308)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence 999999999843 356889999999999999999999741 399999999999999999999999999986643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-23 Score=211.28 Aligned_cols=156 Identities=32% Similarity=0.590 Sum_probs=134.4
Q ss_pred HHHhhCCCCCCceeeecCcEeEEEEEec---CCc--EEEEEEecc-CCccchHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 010186 344 LNLATSNFSDSNILGQGGFGPVYKGVLS---DGK--EVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG 417 (516)
Q Consensus 344 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~---~g~--~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 417 (516)
+++..+.....+.||+|-||.||+|+.. .|+ .||||..+. ......+.|+.|..+|++++||||++|+|+|.+.
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~ 463 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ 463 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc
Confidence 3444455556788999999999999953 233 578998876 5556688999999999999999999999999774
Q ss_pred CeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCc
Q 010186 418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497 (516)
Q Consensus 418 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 497 (516)
..|+|||.++-|.|..+|.. .+..|+......++.||..+|.|||+.. ++||||.++|||+.+..-+||+||||
T Consensus 464 -P~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 464 -PMWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred -ceeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccch
Confidence 68999999999999999964 4456888889999999999999999987 99999999999999999999999999
Q ss_pred ccccccCC
Q 010186 498 ARIFAESE 505 (516)
Q Consensus 498 a~~~~~~~ 505 (516)
+|-+.++.
T Consensus 538 SR~~ed~~ 545 (974)
T KOG4257|consen 538 SRYLEDDA 545 (974)
T ss_pred hhhccccc
Confidence 99887553
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=201.06 Aligned_cols=151 Identities=34% Similarity=0.496 Sum_probs=128.9
Q ss_pred CCCCCceeeecCcEeEEEEEec------CCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 422 (516)
+|...+.||+|+||.||+|... ....+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 3667788999999999999852 23568888886532 3345678999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhcCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCC
Q 010186 423 VYEFMPNGSLDAILFDPR---------------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASN 481 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~N 481 (516)
++||+++++|.+++...+ ....+++...+.++.|++.||.|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999874321 1235789999999999999999999987 9999999999
Q ss_pred eEecCCCcEEEcccCccccccc
Q 010186 482 VLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 482 ILld~~~~~kl~DFGla~~~~~ 503 (516)
||+++++.+||+|||+++.+..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~ 179 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYE 179 (290)
T ss_pred EEEcCCCcEEeccccccccccC
Confidence 9999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=201.09 Aligned_cols=150 Identities=33% Similarity=0.411 Sum_probs=133.0
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...+.||+|+||.||++... +++.+++|.+... .....+.+.+|++++++++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 35777899999999999999954 6889999998652 2234567889999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999999843 356899999999999999999999987 999999999999999999999999999887544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=198.55 Aligned_cols=156 Identities=28% Similarity=0.392 Sum_probs=133.3
Q ss_pred HHHhhCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 010186 344 LNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 344 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 422 (516)
++.+++++.....||+|+||.||+|... ++..|++|.+........+.+.+|+.+++.++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3445666777788999999999999954 677899999877655566789999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC-CCcEEEcccCccccc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARIF 501 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~-~~~~kl~DFGla~~~ 501 (516)
|+||+++++|.+++.........++..+..++.||+.||.|||+.+ ++||||||+||+++. ++.+||+|||++..+
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 9999999999999854222112277888899999999999999987 999999999999986 679999999999765
Q ss_pred c
Q 010186 502 A 502 (516)
Q Consensus 502 ~ 502 (516)
.
T Consensus 160 ~ 160 (268)
T cd06624 160 A 160 (268)
T ss_pred c
Confidence 4
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.9e-23 Score=200.89 Aligned_cols=151 Identities=36% Similarity=0.567 Sum_probs=130.0
Q ss_pred CCCCCCceeeecCcEeEEEEEecC------CcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLSD------GKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 421 (516)
++|...+.||+|+||.||+|.... ...|++|.+.... ......|.+|+.++..++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 356778899999999999998532 2578999886532 334567899999999999999999999999999999
Q ss_pred EEEEccCCCChhHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC
Q 010186 422 LVYEFMPNGSLDAILFDPRK-------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM 488 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~ 488 (516)
++|||+++++|.+++..... ...+++...+.++.|++.||.|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999998854211 145888999999999999999999987 99999999999999999
Q ss_pred cEEEcccCcccccc
Q 010186 489 NSKISDFGMARIFA 502 (516)
Q Consensus 489 ~~kl~DFGla~~~~ 502 (516)
.+||+|||+++...
T Consensus 162 ~~~L~dfg~~~~~~ 175 (283)
T cd05048 162 TVKISDFGLSRDIY 175 (283)
T ss_pred cEEECCCcceeecc
Confidence 99999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.9e-24 Score=214.83 Aligned_cols=156 Identities=29% Similarity=0.503 Sum_probs=131.2
Q ss_pred CCceeeecCcEeEEEEEe-cCCcEEEEEEec--c--CCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCe--eEEEEE
Q 010186 353 DSNILGQGGFGPVYKGVL-SDGKEVAVKRLS--S--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE--KLLVYE 425 (516)
Q Consensus 353 ~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~--~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~--~~lV~E 425 (516)
...+||+|.|-+||+|.. .+|.+||--.++ . .+....+.|..|+.+|+.|+||||++++..|.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 346799999999999995 357788743332 1 345567899999999999999999999999988765 778999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCC-CcEEEcccCcccccccC
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGMARIFAES 504 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~-~~~kl~DFGla~~~~~~ 504 (516)
.+..|+|..|+. +.+.+..+-...|++||++||.|||++. |||||||||-.||+|+.+ |.|||+|+|||.++..+
T Consensus 124 L~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999994 4456788899999999999999999986 789999999999999754 79999999999998765
Q ss_pred CCccCccceecC
Q 010186 505 EGEANTVRIVGT 516 (516)
Q Consensus 505 ~~~~~~~~~~GT 516 (516)
.-+ .++||
T Consensus 200 ~ak----svIGT 207 (632)
T KOG0584|consen 200 HAK----SVIGT 207 (632)
T ss_pred ccc----eeccC
Confidence 422 27787
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.1e-23 Score=201.93 Aligned_cols=152 Identities=36% Similarity=0.573 Sum_probs=132.1
Q ss_pred CCCCCCceeeecCcEeEEEEEec------CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 422 (516)
.+|...+.||+|+||.||++... ++..+++|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45667789999999999999742 345688998876555556789999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCc
Q 010186 423 VYEFMPNGSLDAILFDPR-------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN 489 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~ 489 (516)
||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999985321 2245899999999999999999999998 999999999999999999
Q ss_pred EEEcccCccccccc
Q 010186 490 SKISDFGMARIFAE 503 (516)
Q Consensus 490 ~kl~DFGla~~~~~ 503 (516)
+||+|||+++....
T Consensus 162 ~~l~dfg~a~~~~~ 175 (291)
T cd05094 162 VKIGDFGMSRDVYS 175 (291)
T ss_pred EEECCCCcccccCC
Confidence 99999999986644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.6e-23 Score=201.07 Aligned_cols=156 Identities=35% Similarity=0.542 Sum_probs=133.1
Q ss_pred HhhCCCCCCceeeecCcEeEEEEEec------CCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 010186 346 LATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD 418 (516)
Q Consensus 346 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 418 (516)
+..++|...+.||+|+||.||++... .+..|++|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 34567788899999999999999854 23689999986532 234557889999999999999999999999999
Q ss_pred eeEEEEEccCCCChhHHhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEE
Q 010186 419 EKLLVYEFMPNGSLDAILFDPR-------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSK 491 (516)
Q Consensus 419 ~~~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~k 491 (516)
..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ ++||||||+|||+++++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEE
Confidence 9999999999999999885322 1234788999999999999999999987 99999999999999999999
Q ss_pred EcccCcccccccC
Q 010186 492 ISDFGMARIFAES 504 (516)
Q Consensus 492 l~DFGla~~~~~~ 504 (516)
|+|||+++.+...
T Consensus 160 l~dfg~~~~~~~~ 172 (277)
T cd05032 160 IGDFGMTRDIYET 172 (277)
T ss_pred ECCcccchhhccC
Confidence 9999999876543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.4e-23 Score=197.69 Aligned_cols=150 Identities=35% Similarity=0.578 Sum_probs=133.8
Q ss_pred hCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
.++|...+.||.|+||.||++.. .|+.|++|.++.... ..+++.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 45677789999999999999987 478999999976433 5678999999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
++++|.+++... ....+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 83 AKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccc
Confidence 999999998532 2236899999999999999999999988 99999999999999999999999999987743
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=200.03 Aligned_cols=147 Identities=30% Similarity=0.471 Sum_probs=130.7
Q ss_pred CCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCC
Q 010186 351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 429 (516)
|...+.||+|+||.||++... ++..+++|.+........+.+.+|+++++.++||||+++++.+..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 345677999999999999965 5778899988765556677899999999999999999999999999999999999999
Q ss_pred CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
++|..++.. ....+++..+..++.||++||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT 154 (282)
T ss_pred CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccc
Confidence 999888743 2346899999999999999999999987 9999999999999999999999999997654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.8e-23 Score=198.86 Aligned_cols=152 Identities=31% Similarity=0.509 Sum_probs=131.2
Q ss_pred hhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
..++|...++||+|+||.||++...+...|++|+++... ...+.|.+|+.++..++||||+++++.+. .+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 345688889999999999999998777789999987532 23467899999999999999999999874 4567999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
+++|+|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.+...
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 82 MSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred CCCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 9999999998532 2345789999999999999999999987 999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=201.97 Aligned_cols=154 Identities=29% Similarity=0.475 Sum_probs=131.3
Q ss_pred hhCCCCCCceeeecCcEeEEEEEec-----------------CCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCcc
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLS-----------------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLV 408 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-----------------~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv 408 (516)
+.++|+..+.||+|+||.||++... ++..+|+|.+... .......|.+|+.+++.++|+||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 3456888899999999999998532 2346899998753 333456799999999999999999
Q ss_pred ceeeEEEeCCeeEEEEEccCCCChhHHhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCC
Q 010186 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR--------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKAS 480 (516)
Q Consensus 409 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~ 480 (516)
++++++...+..++||||+++++|.+++.... ....+++.....++.||+.||.|||+.+ ++||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChh
Confidence 99999999999999999999999999885422 1134788899999999999999999998 999999999
Q ss_pred CeEecCCCcEEEcccCccccccc
Q 010186 481 NVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 481 NILld~~~~~kl~DFGla~~~~~ 503 (516)
|||++.++.+||+|||+++.+..
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~ 182 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYS 182 (296)
T ss_pred eEEEcCCCCEEeccCcccccccC
Confidence 99999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=200.28 Aligned_cols=148 Identities=30% Similarity=0.377 Sum_probs=129.0
Q ss_pred CCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 351 FSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
|...+.||+|+||.||++.. .+++.+|+|.+.... ......+.+|++++..++|+||+++.+.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 45567899999999999985 468899999986532 22344578899999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
+++++|.+++... ....+++.....++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIP 153 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence 9999999887532 2346899999999999999999999987 9999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=197.81 Aligned_cols=152 Identities=24% Similarity=0.441 Sum_probs=132.4
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...+.||+|+||.||++.. .+++.|++|.+... +......+.+|+++++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4678889999999999999995 47899999987642 2333456899999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 425 EFMPNGSLDAILFDPR-KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
||+++++|.+++.... ....+++.....++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998874322 2345788999999999999999999987 99999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=197.76 Aligned_cols=151 Identities=32% Similarity=0.541 Sum_probs=128.2
Q ss_pred CCCCceeeecCcEeEEEEEecC----CcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCe-----
Q 010186 351 FSDSNILGQGGFGPVYKGVLSD----GKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE----- 419 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~~~----g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 419 (516)
|...+.||+|+||.||+|.... +..||+|+++.. +......+.+|++.++.++||||+++++.+...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567889999999999998642 367999998753 23345679999999999999999999999876554
Q ss_pred -eEEEEEccCCCChhHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEccc
Q 010186 420 -KLLVYEFMPNGSLDAILFDPR---KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDF 495 (516)
Q Consensus 420 -~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 495 (516)
.++++||+++|+|..++...+ ....+++.....++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999998875432 2346899999999999999999999987 999999999999999999999999
Q ss_pred CcccccccC
Q 010186 496 GMARIFAES 504 (516)
Q Consensus 496 Gla~~~~~~ 504 (516)
|+++.+...
T Consensus 158 g~~~~~~~~ 166 (273)
T cd05035 158 GLSKKIYSG 166 (273)
T ss_pred cceeecccc
Confidence 999876543
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=198.91 Aligned_cols=150 Identities=35% Similarity=0.596 Sum_probs=131.1
Q ss_pred CCCCCceeeecCcEeEEEEEecC-C---cEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 350 NFSDSNILGQGGFGPVYKGVLSD-G---KEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~~-g---~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
+|...+.||+|+||.||+|.... + ..|++|.++.. +......|..|+.+++.++||||+++++++..++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46677899999999999999642 3 36999998753 3445668999999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||+++++|.+++.. ..+.+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+...
T Consensus 85 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999853 2346899999999999999999999987 999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=197.54 Aligned_cols=144 Identities=26% Similarity=0.440 Sum_probs=123.8
Q ss_pred ceeeecCcEeEEEEEecC-------------CcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 010186 355 NILGQGGFGPVYKGVLSD-------------GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~-------------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 421 (516)
+.||+|+||.||+|.+.+ ...|++|.+..........|.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 358999999999998532 2258889887655555667899999999999999999999999999999
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCc-------EEEcc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN-------SKISD 494 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~-------~kl~D 494 (516)
+||||+++|+|+.++.. ....+++..+..++.||++||.|||+.+ ++||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999988843 3345899999999999999999999987 999999999999987664 89999
Q ss_pred cCccccccc
Q 010186 495 FGMARIFAE 503 (516)
Q Consensus 495 FGla~~~~~ 503 (516)
||++..+..
T Consensus 156 ~g~~~~~~~ 164 (262)
T cd05077 156 PGIPITVLS 164 (262)
T ss_pred CCCCccccC
Confidence 999976643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=212.27 Aligned_cols=150 Identities=26% Similarity=0.439 Sum_probs=122.9
Q ss_pred hhCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeC--------
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-------- 417 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-------- 417 (516)
..++|...++||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 456799999999999999999995 468899999885422 2345799999999999999999887532
Q ss_pred CeeEEEEEccCCCChhHHhcC-CCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC-cEEEccc
Q 010186 418 DEKLLVYEFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-NSKISDF 495 (516)
Q Consensus 418 ~~~~lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~-~~kl~DF 495 (516)
...++||||+++ +|.+++.. ......+++..+..++.||+.||.|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 136689999986 56555432 234457899999999999999999999998 99999999999999665 7999999
Q ss_pred CcccccccC
Q 010186 496 GMARIFAES 504 (516)
Q Consensus 496 Gla~~~~~~ 504 (516)
|+|+.+...
T Consensus 216 Gla~~~~~~ 224 (440)
T PTZ00036 216 GSAKNLLAG 224 (440)
T ss_pred ccchhccCC
Confidence 999977543
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=201.02 Aligned_cols=149 Identities=26% Similarity=0.485 Sum_probs=134.0
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
.+|...+.||+|+||.||++.. .+++.|++|.+........+.+.+|+.+++.++||||+++++.+..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5678889999999999999995 578999999997655555677899999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
++++|.+++.. ..+++.++..++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.....
T Consensus 99 ~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred CCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 99999998832 35788999999999999999999987 999999999999999999999999999876544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=197.37 Aligned_cols=151 Identities=32% Similarity=0.537 Sum_probs=132.9
Q ss_pred HhhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 346 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
+..++|...++||+|+||.||++...+++.+++|.+.... .....+.+|+.++++++|+||+++++++. .+..+++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 4456788889999999999999998889999999987533 34567999999999999999999999864 456899999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
|+++++|.+++... ....+++.++..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||+++.+.
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 81 YMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred cCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 99999999988542 3346899999999999999999999987 9999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=199.93 Aligned_cols=152 Identities=36% Similarity=0.558 Sum_probs=132.7
Q ss_pred hCCCCCCceeeecCcEeEEEEEec------CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 421 (516)
..++...++||+|+||.||++... ++..+++|.+..........+.+|+++++.++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 346677889999999999999732 35678999888766666778999999999999999999999999999999
Q ss_pred EEEEccCCCChhHHhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCc
Q 010186 422 LVYEFMPNGSLDAILFDPRK------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN 489 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~ 489 (516)
+++||+++++|.+++..... ...+++..+..++.||+.||.|||+.+ ++||||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence 99999999999998853221 135889999999999999999999987 999999999999999999
Q ss_pred EEEcccCcccccc
Q 010186 490 SKISDFGMARIFA 502 (516)
Q Consensus 490 ~kl~DFGla~~~~ 502 (516)
+||+|||+++.+.
T Consensus 161 ~kL~dfg~~~~~~ 173 (280)
T cd05092 161 VKIGDFGMSRDIY 173 (280)
T ss_pred EEECCCCceeEcC
Confidence 9999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=199.99 Aligned_cols=150 Identities=32% Similarity=0.466 Sum_probs=134.0
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
.+.|.+.++||.|+||.||++... +++.+++|.+...+....+.+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 356778889999999999999964 5889999999876666677899999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
+++++|..++.. ....+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 91 ~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 91 CPGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161 (292)
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecc
Confidence 999999887743 2345899999999999999999999987 9999999999999999999999999987643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.3e-23 Score=200.51 Aligned_cols=151 Identities=28% Similarity=0.425 Sum_probs=134.7
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
.++|...+.||+|+||.||++... +++.+++|.+........+.|.+|++++++++||||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 345777788999999999999964 6889999998766556667899999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~~~~~L~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~ 155 (280)
T cd06611 84 CDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKS 155 (280)
T ss_pred cCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence 999999998843 2346899999999999999999999998 99999999999999999999999999876543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.4e-24 Score=191.99 Aligned_cols=158 Identities=25% Similarity=0.321 Sum_probs=139.3
Q ss_pred HHHHhhCCCCCCceeeecCcEeEEEEE-ecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeC----
Q 010186 343 TLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG---- 417 (516)
Q Consensus 343 ~l~~~~~~f~~~~~Lg~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~---- 417 (516)
.+.+..++|.+.+.||+|||+.||.++ ..++..+|+|++.-.+.++.+..++|++..++++||||++++++...+
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 344567889999999999999999999 678899999999877777888999999999999999999999877543
Q ss_pred -CeeEEEEEccCCCChhHHhcCCCC-CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEccc
Q 010186 418 -DEKLLVYEFMPNGSLDAILFDPRK-RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDF 495 (516)
Q Consensus 418 -~~~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 495 (516)
.+.||+++|...|+|.+.+..... +..+++.+.+.|+.+|.+||++||+.. +++.||||||.|||+.+++.++|.||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEec
Confidence 358999999999999888754443 347999999999999999999999986 68999999999999999999999999
Q ss_pred Cccccc
Q 010186 496 GMARIF 501 (516)
Q Consensus 496 Gla~~~ 501 (516)
|-+...
T Consensus 174 GS~~~a 179 (302)
T KOG2345|consen 174 GSATQA 179 (302)
T ss_pred cCcccc
Confidence 988754
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=194.68 Aligned_cols=143 Identities=35% Similarity=0.559 Sum_probs=127.0
Q ss_pred ceeeecCcEeEEEEEecCCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCCChh
Q 010186 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLD 433 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 433 (516)
++||+|+||.||++...++..+++|.+.... ......+.+|+++++.++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999998888999999987543 233456889999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 434 AILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 434 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
+++.. ....+++.....++.+++.+|.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 144 (250)
T cd05085 81 SFLRK--KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQED 144 (250)
T ss_pred HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecc
Confidence 98843 2345789999999999999999999987 9999999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=200.46 Aligned_cols=151 Identities=25% Similarity=0.390 Sum_probs=131.9
Q ss_pred CCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
+|+..+.||+|+||.||++... ++..+|+|.+... .......+.+|+.++.+++||||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 4667788999999999999965 6889999988643 3334567899999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
++++|..++........+++..+..++.+|+.||.|||+.. +++||||||+||+++.++.+||+|||+++.+.
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999998854333457899999999999999999999741 39999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=200.74 Aligned_cols=153 Identities=31% Similarity=0.466 Sum_probs=131.9
Q ss_pred hCCCCCCceeeecCcEeEEEEEecC-----------------CcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccc
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLSD-----------------GKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVK 409 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-----------------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~ 409 (516)
.++|...+.||+|+||.||++...+ +..|++|.+.... ....+.+.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4577888999999999999988532 2458999987532 344667899999999999999999
Q ss_pred eeeEEEeCCeeEEEEEccCCCChhHHhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCC
Q 010186 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPR--------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASN 481 (516)
Q Consensus 410 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~N 481 (516)
+++++..++..++++||+++++|.+++.... ....+++...+.++.|++.||.|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999985422 1236899999999999999999999987 9999999999
Q ss_pred eEecCCCcEEEcccCccccccc
Q 010186 482 VLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 482 ILld~~~~~kl~DFGla~~~~~ 503 (516)
|+++.++.++|+|||+++.+..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~ 182 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYS 182 (296)
T ss_pred eeecCCCceEEccccceeeccc
Confidence 9999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=199.38 Aligned_cols=151 Identities=34% Similarity=0.539 Sum_probs=130.3
Q ss_pred CCCCCCceeeecCcEeEEEEEe-----cCCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeC--Cee
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-----SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEK 420 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 420 (516)
..|...+.||+|+||.||++.. .++..|++|.++... ......+.+|+.+++.++||||+++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467788999999999999974 357789999987543 33456799999999999999999999998875 568
Q ss_pred EEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
++||||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPR--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 899999999999999843 2235899999999999999999999987 99999999999999999999999999987
Q ss_pred cccC
Q 010186 501 FAES 504 (516)
Q Consensus 501 ~~~~ 504 (516)
+...
T Consensus 159 ~~~~ 162 (284)
T cd05079 159 IETD 162 (284)
T ss_pred cccC
Confidence 6543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=210.32 Aligned_cols=148 Identities=22% Similarity=0.311 Sum_probs=128.2
Q ss_pred hhCCCCCCceeeecCcEeEEEEEec---CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLS---DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 423 (516)
...+|...+.||+|+||.||++... .+..|++|.+... ..+.+|+++++.++||||+++++++......++|
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 3457888999999999999999753 3568999987642 2456899999999999999999999999999999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
||++. ++|.+++ .....+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 165 ~e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 165 MPKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred ehhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 99996 5787777 23456899999999999999999999988 99999999999999999999999999987765
Q ss_pred CCC
Q 010186 504 SEG 506 (516)
Q Consensus 504 ~~~ 506 (516)
...
T Consensus 238 ~~~ 240 (392)
T PHA03207 238 HPD 240 (392)
T ss_pred ccc
Confidence 443
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=196.98 Aligned_cols=152 Identities=30% Similarity=0.519 Sum_probs=132.0
Q ss_pred hhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
..++|...+.||+|+||.||++...++..+++|.+..... ..+.+.+|+.++++++|+|++++++++. .+..+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 3456777889999999999999988888999999876332 3567999999999999999999999875 4568999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
+++++|.+++... ....+++..+..++.+++.||.|||+.+ ++||||||+||++++++.+||+|||+++.+...
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 82 MSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 9999999988542 2345899999999999999999999987 999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.1e-24 Score=213.76 Aligned_cols=150 Identities=31% Similarity=0.482 Sum_probs=129.4
Q ss_pred CCCCceeeecCcEeEEEEE-ecCCcEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 351 FSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
|.+.+.||.|+||.||.+. ..+.+.||||++.-.. .....++..|++.|.+++|||++.+-|++......||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 5566779999999999999 4578899999986432 33355789999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCCC
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 506 (516)
|-| +-.+++. -.++++.+.++..|..+.+.||.|||++. .||||||+.||||.+.+.|||+|||-|.+..+..+
T Consensus 108 ClG-SAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAns 181 (948)
T KOG0577|consen 108 CLG-SASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPANS 181 (948)
T ss_pred Hhc-cHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCchhc
Confidence 954 6666663 23456888899999999999999999998 99999999999999999999999999988877654
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=202.24 Aligned_cols=155 Identities=32% Similarity=0.479 Sum_probs=133.3
Q ss_pred HHhhCCCCCCceeeecCcEeEEEEEec------CCcEEEEEEeccCC-ccchHHHHHHHHHHhcC-CCCCccceeeEEEe
Q 010186 345 NLATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVD 416 (516)
Q Consensus 345 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 416 (516)
....++|...+.||+|+||.||++... .+..||+|+++... ....+.+.+|+.+++++ +||||+++++.+..
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 344567888899999999999999741 34579999887532 33456789999999999 89999999999999
Q ss_pred CCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccC
Q 010186 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496 (516)
Q Consensus 417 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 496 (516)
.+..++||||+++|+|.+++... ....+++.+...++.+|+.||.|||+.+ ++|+||||+|||++.++.+||+|||
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCc
Confidence 99999999999999999998532 2234899999999999999999999987 9999999999999999999999999
Q ss_pred ccccccc
Q 010186 497 MARIFAE 503 (516)
Q Consensus 497 la~~~~~ 503 (516)
+++.+..
T Consensus 187 ~~~~~~~ 193 (302)
T cd05055 187 LARDIMN 193 (302)
T ss_pred ccccccC
Confidence 9987654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-23 Score=215.21 Aligned_cols=150 Identities=40% Similarity=0.580 Sum_probs=134.2
Q ss_pred CCceeeecCcEeEEEEEec--CCc--EEEEEEeccCCcc-chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 353 DSNILGQGGFGPVYKGVLS--DGK--EVAVKRLSSCSEQ-GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 353 ~~~~Lg~G~fg~Vy~~~~~--~g~--~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
..++||+|.||.|++|.|. +|+ .||||+++..... ...+|++|+.+|.+|+|||+++|+|+..+ ....||+|.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 3477999999999999975 343 6899999875544 77899999999999999999999999988 6788999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCCCc
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 507 (516)
+.|+|.+.|++ .....|-......++.|||.||.||.++. +|||||.++|+||-....+||+||||.|-+..+++.
T Consensus 193 plGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 193 PLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred ccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 99999999976 56667888889999999999999999987 999999999999999999999999999999887754
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=200.20 Aligned_cols=149 Identities=26% Similarity=0.484 Sum_probs=133.2
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
.+|...+.||+|+||.||++.. .+++.+++|.+........+.+.+|+.+++.+.||||+++++.+..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4677788999999999999984 468899999987655555677899999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
++++|.+++.. ..+++.+...++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 99999998842 34789999999999999999999987 999999999999999999999999999876443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=195.97 Aligned_cols=142 Identities=32% Similarity=0.508 Sum_probs=122.2
Q ss_pred ceeeecCcEeEEEEEecCCc-----------EEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 010186 355 NILGQGGFGPVYKGVLSDGK-----------EVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~g~-----------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 423 (516)
+.||+|+||.||+|...+.. .+++|.+...... ...|.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999975432 4777877653332 6789999999999999999999999988 778999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC-------cEEEcccC
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-------NSKISDFG 496 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~-------~~kl~DFG 496 (516)
|||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999998542 226889999999999999999999987 99999999999999887 79999999
Q ss_pred ccccccc
Q 010186 497 MARIFAE 503 (516)
Q Consensus 497 la~~~~~ 503 (516)
+++.+..
T Consensus 154 ~a~~~~~ 160 (259)
T cd05037 154 IPITVLS 160 (259)
T ss_pred ccccccc
Confidence 9987544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=202.51 Aligned_cols=151 Identities=32% Similarity=0.581 Sum_probs=129.0
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCc--EEEEEEeccC-CccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGK--EVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~--~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 422 (516)
.++|+..+.||+|+||.||++... ++. .+++|.++.. .......+.+|++++.++ +||||+++++++...+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 456788899999999999999964 454 4577777642 233456788999999999 89999999999999999999
Q ss_pred EEEccCCCChhHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCc
Q 010186 423 VYEFMPNGSLDAILFDPR-------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN 489 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~ 489 (516)
||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ++||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999885322 1235889999999999999999999987 999999999999999999
Q ss_pred EEEcccCccccc
Q 010186 490 SKISDFGMARIF 501 (516)
Q Consensus 490 ~kl~DFGla~~~ 501 (516)
+||+|||+++..
T Consensus 163 ~kl~dfg~~~~~ 174 (303)
T cd05088 163 AKIADFGLSRGQ 174 (303)
T ss_pred EEeCccccCccc
Confidence 999999999743
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=203.08 Aligned_cols=155 Identities=31% Similarity=0.488 Sum_probs=132.4
Q ss_pred HhhCCCCCCceeeecCcEeEEEEEec--------CCcEEEEEEeccC-CccchHHHHHHHHHHhcC-CCCCccceeeEEE
Q 010186 346 LATSNFSDSNILGQGGFGPVYKGVLS--------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCV 415 (516)
Q Consensus 346 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~ 415 (516)
+..++|...+.||+|+||.||++... +...+|+|.++.. .......+.+|++++..+ +||||+++++++.
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 33457888899999999999999742 2346999998753 234456788999999999 8999999999999
Q ss_pred eCCeeEEEEEccCCCChhHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCe
Q 010186 416 DGDEKLLVYEFMPNGSLDAILFDPRK-------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNV 482 (516)
Q Consensus 416 ~~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NI 482 (516)
..+..++||||+++|+|.+++..... ...+++.+++.++.|++.||.|||+.+ ++||||||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni 171 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 171 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHhe
Confidence 99999999999999999999854321 235889999999999999999999987 99999999999
Q ss_pred EecCCCcEEEcccCccccccc
Q 010186 483 LLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 483 Lld~~~~~kl~DFGla~~~~~ 503 (516)
+++.++.+||+|||+++.+..
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~ 192 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHH 192 (307)
T ss_pred EEcCCCcEEECCCcccccccc
Confidence 999999999999999986643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-22 Score=194.89 Aligned_cols=152 Identities=26% Similarity=0.468 Sum_probs=134.1
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...+.||+|+||.||++... +|+.+++|.++.. +....+.+.+|++++++++|+||+++++.+...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 56888899999999999999965 7899999988642 2334567999999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 425 EFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
||+++++|..++... .....+++..+..++.++++||.|||+.+ ++||||+|+||+++.++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999888532 23456889999999999999999999987 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=197.75 Aligned_cols=144 Identities=30% Similarity=0.385 Sum_probs=124.1
Q ss_pred eeecCcEeEEEEEe-cCCcEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCCCh
Q 010186 357 LGQGGFGPVYKGVL-SDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432 (516)
Q Consensus 357 Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 432 (516)
||+|+||.||++.. .+|+.+|+|.+.... ......+..|++++.+++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999985 468999999986421 12234566799999999999999999999999999999999999999
Q ss_pred hHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
.+++... ....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++..+...
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 148 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG 148 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence 8887432 3345889999999999999999999987 999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=198.08 Aligned_cols=151 Identities=36% Similarity=0.586 Sum_probs=128.9
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCc----EEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGK----EVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~----~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 421 (516)
.++|...++||+|+||.||+|.+ .+++ .||+|.++.. .......+.+|+.++..++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 35677789999999999999984 3444 4799988653 33445678899999999999999999999875 4578
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+++||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++.+
T Consensus 85 l~~~~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 99999999999998853 2346899999999999999999999987 999999999999999999999999999877
Q ss_pred ccC
Q 010186 502 AES 504 (516)
Q Consensus 502 ~~~ 504 (516)
...
T Consensus 160 ~~~ 162 (279)
T cd05109 160 DID 162 (279)
T ss_pred ccc
Confidence 543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-22 Score=197.93 Aligned_cols=149 Identities=30% Similarity=0.488 Sum_probs=130.1
Q ss_pred CCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
+|...+.||+|++|.||+|... +++.|++|.+... .......+.+|+.++..++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 3667788999999999999964 6889999998643 223346788999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
++ ++|.+++........+++..+..++.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++.+.
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence 97 688888754444467899999999999999999999987 9999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=197.90 Aligned_cols=142 Identities=30% Similarity=0.424 Sum_probs=120.2
Q ss_pred eeeecCcEeEEEEEecCCc---EEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCCC
Q 010186 356 ILGQGGFGPVYKGVLSDGK---EVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGS 431 (516)
Q Consensus 356 ~Lg~G~fg~Vy~~~~~~g~---~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 431 (516)
.||+|+||.||++...++. .+++|.+... .....+.|.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5899999999999854433 4566666543 23456789999999999999999999999999999999999999999
Q ss_pred hhHHhcCCCC-CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 432 LDAILFDPRK-RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 432 L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
|.+++..... ...+++.....++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccc
Confidence 9999854322 234667778899999999999999987 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-22 Score=194.03 Aligned_cols=147 Identities=40% Similarity=0.625 Sum_probs=130.7
Q ss_pred ceeeecCcEeEEEEEecC----CcEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCC
Q 010186 355 NILGQGGFGPVYKGVLSD----GKEVAVKRLSSCSEQ-GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~----g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 429 (516)
+.||+|+||.||++.... +..+++|.+...... ..+.+.+|++++..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999999653 789999999764333 367899999999999999999999999999999999999999
Q ss_pred CChhHHhcCCCC------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 430 GSLDAILFDPRK------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 430 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
++|.+++..... ...+++.++..++.|+++||.|||+.+ ++||||||+||++++++.+||+|||+++.+..
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999854321 367899999999999999999999987 99999999999999999999999999998765
Q ss_pred C
Q 010186 504 S 504 (516)
Q Consensus 504 ~ 504 (516)
.
T Consensus 158 ~ 158 (262)
T cd00192 158 D 158 (262)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=195.93 Aligned_cols=149 Identities=34% Similarity=0.545 Sum_probs=131.3
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC-----ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS-----EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 422 (516)
++|...+.||+|++|.||++.. .+++++++|.+.... ....+.+.+|++++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688889999999999999985 468999999886422 1234578899999999999999999999999999999
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
|+||+++++|.+++.. ...+++.....++.+++.||.|||+.+ ++||||+|+||++++++.+||+|||+++.+.
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999998843 345888999999999999999999987 9999999999999999999999999998664
Q ss_pred c
Q 010186 503 E 503 (516)
Q Consensus 503 ~ 503 (516)
.
T Consensus 156 ~ 156 (263)
T cd06625 156 T 156 (263)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=197.67 Aligned_cols=152 Identities=34% Similarity=0.655 Sum_probs=132.4
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CC---cEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DG---KEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g---~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 422 (516)
.++|...+.||+|+||.||++... ++ ..+++|.++.. .....+.+.+|++++.+++||||+++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 456777899999999999999964 33 36899988653 23345678999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
||||+++++|.+++.. ....+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999999843 2356899999999999999999999987 9999999999999999999999999998765
Q ss_pred cC
Q 010186 503 ES 504 (516)
Q Consensus 503 ~~ 504 (516)
..
T Consensus 159 ~~ 160 (268)
T cd05063 159 DD 160 (268)
T ss_pred cc
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.9e-23 Score=201.36 Aligned_cols=150 Identities=33% Similarity=0.471 Sum_probs=128.1
Q ss_pred CCCCceeeecCcEeEEEEEec------CCcEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 010186 351 FSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCSE-QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 423 (516)
|...+.||+|+||.||+|... +++.||+|+++.... ...+.+.+|+.++..++||||+++++.+...+..+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 445677999999999999853 247899999975432 2345688999999999999999999999999999999
Q ss_pred EEccCCCChhHHhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcE
Q 010186 424 YEFMPNGSLDAILFDP-------------RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS 490 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~ 490 (516)
+||+++++|.+++... ..+..+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCce
Confidence 9999999999987421 11235888899999999999999999987 9999999999999999999
Q ss_pred EEcccCccccccc
Q 010186 491 KISDFGMARIFAE 503 (516)
Q Consensus 491 kl~DFGla~~~~~ 503 (516)
||+|||+++.+..
T Consensus 164 kl~Dfg~~~~~~~ 176 (283)
T cd05091 164 KISDLGLFREVYA 176 (283)
T ss_pred Eeccccccccccc
Confidence 9999999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-22 Score=194.20 Aligned_cols=149 Identities=35% Similarity=0.570 Sum_probs=131.6
Q ss_pred CCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC-----ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-----EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 423 (516)
+|...+.||+|+||.||+|... +++.|++|.+.... .+..+.+.+|+.+++.++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667788999999999999965 78999999886532 23456789999999999999999999999999999999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
+||+++++|.+++.. ...+++.....++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999843 345889999999999999999999987 99999999999999999999999999987644
Q ss_pred C
Q 010186 504 S 504 (516)
Q Consensus 504 ~ 504 (516)
.
T Consensus 155 ~ 155 (258)
T cd06632 155 F 155 (258)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-22 Score=197.43 Aligned_cols=150 Identities=23% Similarity=0.377 Sum_probs=131.7
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
++|...+.||+|+||.||++... +++.|++|++.... ....+.+.+|+.+++.++||||+++++.+......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 35777889999999999999965 58899999886532 2234568899999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
|+++++|..+.. ....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+...
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999999988773 3345899999999999999999999987 999999999999999999999999999877544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=202.54 Aligned_cols=155 Identities=31% Similarity=0.507 Sum_probs=131.9
Q ss_pred HhhCCCCCCceeeecCcEeEEEEEec--------CCcEEEEEEeccC-CccchHHHHHHHHHHhcC-CCCCccceeeEEE
Q 010186 346 LATSNFSDSNILGQGGFGPVYKGVLS--------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCV 415 (516)
Q Consensus 346 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~ 415 (516)
...++|...+.||+|+||.||++... ....+++|.++.. .......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 34456778899999999999999742 2457899988753 234456788999999999 6999999999999
Q ss_pred eCCeeEEEEEccCCCChhHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCe
Q 010186 416 DGDEKLLVYEFMPNGSLDAILFDPR-------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNV 482 (516)
Q Consensus 416 ~~~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NI 482 (516)
..+..++||||+++|+|.+++.... ....+++.+...++.||+.||.|||+.+ ++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeE
Confidence 9999999999999999999985422 1245889999999999999999999987 99999999999
Q ss_pred EecCCCcEEEcccCccccccc
Q 010186 483 LLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 483 Lld~~~~~kl~DFGla~~~~~ 503 (516)
|++.++.+||+|||+++.+..
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~ 186 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHD 186 (314)
T ss_pred EEcCCCcEEEccccccccccc
Confidence 999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-22 Score=197.10 Aligned_cols=144 Identities=26% Similarity=0.385 Sum_probs=127.5
Q ss_pred CCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
+|+..++||+|+||.||++.. .+++.+|+|.+... .......+.+|++++++++||||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 566778999999999999984 57889999998653 3334567899999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
++++|..+. .+++.....++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||+++.+..
T Consensus 82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 999997653 3678888999999999999999987 99999999999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-22 Score=194.80 Aligned_cols=151 Identities=28% Similarity=0.464 Sum_probs=135.2
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
.++|...+.||+|+||.||++... +++.+++|.+........+.+.+|++++++++||||+++++.+...+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 356788899999999999999964 5788999999765555677899999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
+++++|.+++.. ....+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++..+..
T Consensus 82 ~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 82 CGGGSLQDIYQV--TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred CCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 999999998843 2256889999999999999999999987 99999999999999999999999999987654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=197.88 Aligned_cols=151 Identities=30% Similarity=0.491 Sum_probs=131.5
Q ss_pred hCCCCCCceeeecCcEeEEEEEec------CCcEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCSEQ-GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK 420 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 420 (516)
.++|...+.||+|+||.||++... +.+.+++|.+...... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 356778889999999999999953 2457899988654433 456899999999999999999999999998999
Q ss_pred EEEEEccCCCChhHHhcCCCCC------CCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcc
Q 010186 421 LLVYEFMPNGSLDAILFDPRKR------GILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD 494 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~D 494 (516)
++||||+++|+|.+++...... ..+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcc
Confidence 9999999999999998543322 25899999999999999999999988 99999999999999999999999
Q ss_pred cCccccc
Q 010186 495 FGMARIF 501 (516)
Q Consensus 495 FGla~~~ 501 (516)
||+++..
T Consensus 161 ~~~~~~~ 167 (275)
T cd05046 161 LSLSKDV 167 (275)
T ss_pred ccccccc
Confidence 9998754
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=198.66 Aligned_cols=150 Identities=30% Similarity=0.400 Sum_probs=129.5
Q ss_pred CCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 351 FSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
|...++||+|+||.||++.. .+++.+|+|.+.+.. ......+.+|+.++++++|+||+.+++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 55668899999999999995 468899999986532 22234578899999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++......
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 9999999888432 2345889999999999999999999987 999999999999999999999999999766443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-23 Score=194.93 Aligned_cols=141 Identities=33% Similarity=0.485 Sum_probs=128.0
Q ss_pred ceeeecCcEeEEEEE-ecCCcEEEEEEeccCCccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEEccCCCCh
Q 010186 355 NILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 432 (516)
++||+|+++.|-.++ +.+|.++|||++.+..........+|++++... .|+||+.|+++|+++...|||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 679999999999988 779999999999987777788899999999998 699999999999999999999999999999
Q ss_pred hHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC---cEEEcccCccccc
Q 010186 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM---NSKISDFGMARIF 501 (516)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~---~~kl~DFGla~~~ 501 (516)
...++ .+..+++.++.++..+|+.||.|||.++ |.||||||+|||-.+.. -+||+||.|..-+
T Consensus 164 LshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 164 LSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred HHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccccccc
Confidence 88774 4456999999999999999999999998 99999999999996554 4799999998654
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=197.32 Aligned_cols=152 Identities=28% Similarity=0.489 Sum_probs=130.9
Q ss_pred hhCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcC-CCCCccceeeEEEeC------C
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDG------D 418 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~------~ 418 (516)
+++.|...+.||+|+||.||+|... +++.+|+|++.... .....+..|+.++.++ +||||+++++.+... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4566777889999999999999954 57889999986532 4456788999999998 799999999998753 3
Q ss_pred eeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcc
Q 010186 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (516)
Q Consensus 419 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 498 (516)
..++||||+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 578999999999999988542 3346889999999999999999999987 999999999999999999999999999
Q ss_pred ccccc
Q 010186 499 RIFAE 503 (516)
Q Consensus 499 ~~~~~ 503 (516)
+.+..
T Consensus 159 ~~~~~ 163 (272)
T cd06637 159 AQLDR 163 (272)
T ss_pred eeccc
Confidence 87644
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-22 Score=194.12 Aligned_cols=151 Identities=28% Similarity=0.422 Sum_probs=133.4
Q ss_pred CCCCCceeeecCcEeEEEEEec-CCcEEEEEEecc--CCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
+|...+.||+|++|.||++... +++.+++|.+.. ........+.+|+++++.++||||+++++.+.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 3666788999999999999964 688999998864 2344567899999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
+++++|.+++... ....+++.....++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 9999999998542 2356889999999999999999999987 999999999999999999999999999877544
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-22 Score=195.08 Aligned_cols=142 Identities=32% Similarity=0.556 Sum_probs=122.9
Q ss_pred eeecCcEeEEEEEec---CCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCCCh
Q 010186 357 LGQGGFGPVYKGVLS---DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432 (516)
Q Consensus 357 Lg~G~fg~Vy~~~~~---~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 432 (516)
||+|+||.||+|.+. ++..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++||||+++++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 899999999999853 35579999987643 233567999999999999999999999875 4568999999999999
Q ss_pred hHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
.+++.. ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+...
T Consensus 82 ~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 148 (257)
T cd05115 82 NKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGAD 148 (257)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCC
Confidence 998843 2346899999999999999999999987 999999999999999999999999999866543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-22 Score=195.20 Aligned_cols=147 Identities=35% Similarity=0.601 Sum_probs=130.3
Q ss_pred CCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCC------ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 010186 350 NFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCS------EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 423 (516)
+|...+.||+|+||.||++...+++.+|+|.+.... ......+.+|+++++.++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 366788999999999999998889999999886422 12235688999999999999999999999999999999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
+||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+.
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 999999999999842 345889999999999999999999987 9999999999999999999999999998653
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-22 Score=203.78 Aligned_cols=154 Identities=30% Similarity=0.487 Sum_probs=131.2
Q ss_pred hhCCCCCCceeeecCcEeEEEEEec--------CCcEEEEEEeccC-CccchHHHHHHHHHHhcC-CCCCccceeeEEEe
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLS--------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVD 416 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 416 (516)
...+|...+.||+|+||.||++... .+..|++|.++.. .....+.+.+|+.++.++ +||||+++++++..
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 3456778899999999999999742 1236899988643 234456899999999999 89999999999999
Q ss_pred CCeeEEEEEccCCCChhHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeE
Q 010186 417 GDEKLLVYEFMPNGSLDAILFDPR-------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVL 483 (516)
Q Consensus 417 ~~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIL 483 (516)
.+..++++||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ ++||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 166 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVL 166 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEE
Confidence 999999999999999999985422 1235889999999999999999999987 999999999999
Q ss_pred ecCCCcEEEcccCccccccc
Q 010186 484 LDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 484 ld~~~~~kl~DFGla~~~~~ 503 (516)
++.++.+||+|||+++.+..
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~ 186 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHN 186 (334)
T ss_pred EcCCCcEEECCcccceeccc
Confidence 99999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-24 Score=197.24 Aligned_cols=149 Identities=30% Similarity=0.455 Sum_probs=128.2
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEecc--CCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
++|+..++||+|.|+.||++.. .+|+.+|+|++.. .+....+++.+|+++-..|+||||++|.....+....|||+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 4566678899999999999984 5789999998753 445578899999999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCC---CcEEEcccCcccccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD---MNSKISDFGMARIFA 502 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~---~~~kl~DFGla~~~~ 502 (516)
+|.|++|..-+.. +...++..+.+++.||+.+|.|+|..+ |||||+||+|+|+.+. -.+||+|||+|..+.
T Consensus 91 ~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 91 LVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred cccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 9999998654422 234678888999999999999999998 9999999999999543 358999999999998
Q ss_pred c
Q 010186 503 E 503 (516)
Q Consensus 503 ~ 503 (516)
.
T Consensus 165 ~ 165 (355)
T KOG0033|consen 165 D 165 (355)
T ss_pred C
Confidence 3
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-22 Score=199.12 Aligned_cols=153 Identities=35% Similarity=0.538 Sum_probs=132.2
Q ss_pred hhCCCCCCceeeecCcEeEEEEEec------CCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 419 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 419 (516)
..++|...+.||+|+||.||++... ++..+++|.+... +......+.+|+.++++++||||+++++++..++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 4567888899999999999999853 4678999998753 23345679999999999999999999999999999
Q ss_pred eEEEEEccCCCChhHHhcCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCC
Q 010186 420 KLLVYEFMPNGSLDAILFDPR-------------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKAS 480 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~ 480 (516)
.++|+||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ ++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence 999999999999999985321 1234788899999999999999999987 999999999
Q ss_pred CeEecCCCcEEEcccCcccccc
Q 010186 481 NVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 481 NILld~~~~~kl~DFGla~~~~ 502 (516)
||++++++.+||+|||+++.+.
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~ 181 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIY 181 (288)
T ss_pred heEecCCCceEECccccceecc
Confidence 9999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=199.38 Aligned_cols=150 Identities=33% Similarity=0.586 Sum_probs=128.3
Q ss_pred CCCCCCceeeecCcEeEEEEEecC-Cc--EEEEEEeccC-CccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLSD-GK--EVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~~-g~--~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 423 (516)
++|...++||+|+||.||++...+ +. .+++|.++.. .....+.+.+|+.++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 467888999999999999998643 33 4688887642 333456789999999999 799999999999999999999
Q ss_pred EEccCCCChhHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcE
Q 010186 424 YEFMPNGSLDAILFDPR-------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS 490 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~ 490 (516)
+||+++++|.+++.... ....+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999985321 1135889999999999999999999987 9999999999999999999
Q ss_pred EEcccCccccc
Q 010186 491 KISDFGMARIF 501 (516)
Q Consensus 491 kl~DFGla~~~ 501 (516)
||+|||+++..
T Consensus 159 kl~dfg~~~~~ 169 (297)
T cd05089 159 KIADFGLSRGE 169 (297)
T ss_pred EECCcCCCccc
Confidence 99999998643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-22 Score=195.44 Aligned_cols=147 Identities=30% Similarity=0.513 Sum_probs=128.2
Q ss_pred CCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCc----------cchHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 010186 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSE----------QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD 418 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~----------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 418 (516)
+|...+.||+|+||.||+|.. .+++.+++|.++.... ...+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 356678999999999999985 4688999998753111 11346788999999999999999999999999
Q ss_pred eeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcc
Q 010186 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (516)
Q Consensus 419 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 498 (516)
..++|+||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||+|+||++++++.+||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 99999999999999999843 356889999999999999999999987 999999999999999999999999999
Q ss_pred cccc
Q 010186 499 RIFA 502 (516)
Q Consensus 499 ~~~~ 502 (516)
+...
T Consensus 156 ~~~~ 159 (272)
T cd06629 156 KKSD 159 (272)
T ss_pred cccc
Confidence 8654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=196.67 Aligned_cols=145 Identities=34% Similarity=0.550 Sum_probs=127.7
Q ss_pred CCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccch--HHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~--~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
|...+.||+|+||.||++... +++.+|+|++........ ....+|+.++.+++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 345688999999999999965 566899999987543322 23456999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
++++|.+++. ....+++..+..++.||++||.|||+.+ ++|+||||+||++++++.++|+|||.+..+
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 9999999995 3456899999999999999999999997 999999999999999999999999999764
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=194.38 Aligned_cols=150 Identities=32% Similarity=0.514 Sum_probs=129.6
Q ss_pred hCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
.++|...+.||+|++|.||++...++..+++|.+.... ...+.+.+|+.++++++|||++++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 34577778899999999999998777789999886533 33467899999999999999999999875 45689999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
++++|.+++... ....+++..+..++.+++.||.|||+.+ ++||||||+||++++++.+||+|||+++.+..
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 83 GKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred CCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 999999998542 3345789999999999999999999987 99999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-22 Score=196.69 Aligned_cols=152 Identities=24% Similarity=0.447 Sum_probs=132.6
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...+.||+|+||.||++.. .+++.++||.+... .......+.+|+.+++.++||||+++++.+..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3567778899999999999994 57899999988642 2234567899999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 425 EFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
||+++++|.+++... .....+++.....++.+|+.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999987532 23456899999999999999999999988 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=195.03 Aligned_cols=152 Identities=30% Similarity=0.500 Sum_probs=133.4
Q ss_pred HhhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 346 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
+..++|...+.||+|+||.||++...++..+++|.+.... ...+.+.+|+++++.++|+||+++.+.+.. ...+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 4456788889999999999999998778889999887532 345678999999999999999999999887 77899999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
|+++++|.+++... ....+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 81 FMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred eCCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 99999999998542 3446788999999999999999999987 99999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=198.45 Aligned_cols=149 Identities=27% Similarity=0.511 Sum_probs=134.0
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
.+|...+.||.|++|.||++.. .+++.|++|.+........+.+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4578888999999999999984 578999999987655555677899999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
++++|..++.. ..+++.++..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+...
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 99999998832 35899999999999999999999997 999999999999999999999999999876544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-22 Score=197.64 Aligned_cols=149 Identities=31% Similarity=0.484 Sum_probs=130.4
Q ss_pred CCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCcc-----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQ-----GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 423 (516)
+|...+.||+|+||.||+|... +++.|++|.+...... ....+.+|+++++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3666788999999999999964 6899999999753322 234577899999999999999999999999999999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
|||+ +++|.+++.... ..+++..+..++.||++||.|||+.+ ++|+||+|+||+++.++.+||+|||+++.+..
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999985322 36899999999999999999999998 99999999999999999999999999987754
Q ss_pred C
Q 010186 504 S 504 (516)
Q Consensus 504 ~ 504 (516)
.
T Consensus 155 ~ 155 (298)
T cd07841 155 P 155 (298)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=194.42 Aligned_cols=147 Identities=36% Similarity=0.605 Sum_probs=129.5
Q ss_pred CCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCcc---------chHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 010186 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQ---------GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 419 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~---------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 419 (516)
+|...+.||+|+||.||+|.. .+++.+++|.+...... ..+.+.+|+.++.+++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 366778999999999999985 46789999988653221 23568899999999999999999999999999
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccc
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 499 (516)
.++|+||+++++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLN---NYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHH---hccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999999984 3356888999999999999999999987 9999999999999999999999999998
Q ss_pred ccc
Q 010186 500 IFA 502 (516)
Q Consensus 500 ~~~ 502 (516)
.+.
T Consensus 155 ~~~ 157 (267)
T cd06628 155 KLE 157 (267)
T ss_pred ccc
Confidence 775
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.1e-22 Score=192.43 Aligned_cols=152 Identities=24% Similarity=0.385 Sum_probs=133.5
Q ss_pred CCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
+|+..+.||+|+||.||.+.. .+++.+++|.+... +......+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 467788999999999999884 56889999988643 344566789999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCC
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 505 (516)
+++++|.+++... ....+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQ-KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 9999999998543 2456899999999999999999999987 9999999999999999999999999998775443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-22 Score=196.08 Aligned_cols=150 Identities=35% Similarity=0.608 Sum_probs=129.5
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCc----EEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGK----EVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 422 (516)
.+|...+.||+|+||.||+|... +|+ .+++|.+.... ......+.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 45677789999999999999854 333 58999886543 3345678999999999999999999999987 78899
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
|+||+++|+|.+++.. ....+++.....++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999999853 2345899999999999999999999987 9999999999999999999999999998775
Q ss_pred cC
Q 010186 503 ES 504 (516)
Q Consensus 503 ~~ 504 (516)
..
T Consensus 161 ~~ 162 (279)
T cd05057 161 VD 162 (279)
T ss_pred Cc
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=193.90 Aligned_cols=145 Identities=37% Similarity=0.527 Sum_probs=127.7
Q ss_pred ceeeecCcEeEEEEEecC--C--cEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCC
Q 010186 355 NILGQGGFGPVYKGVLSD--G--KEVAVKRLSSCSE-QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~--g--~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 429 (516)
++||+|++|.||++.+.+ + ..|++|.+..... ...+.+.+|+.++++++||||+++++.+.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 3689999977544 556789999999999999999999999988 889999999999
Q ss_pred CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
++|.+++..... ..+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+...
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~ 150 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQN 150 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccc
Confidence 999999854322 46899999999999999999999987 999999999999999999999999999887553
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-23 Score=194.69 Aligned_cols=152 Identities=29% Similarity=0.477 Sum_probs=125.5
Q ss_pred CCCCCceeeecCcEeEEEEEec---C--CcEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCCccceeeEEEe-CCeeE
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS---D--GKEVAVKRLSSCSE--QGTAEFTNEVLLILKLQHKNLVKLLGFCVD-GDEKL 421 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~---~--g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~ 421 (516)
.|.....||+|.||.||++.-. + ...+|+|+++..+. .......+|+.+++.++||||+.|..++.. +...|
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 3556778999999999999632 2 23689999875322 223457899999999999999999999988 67899
Q ss_pred EEEEccCCCChhHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCC----CcEEEccc
Q 010186 422 LVYEFMPNGSLDAILFDP--RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD----MNSKISDF 495 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~----~~~kl~DF 495 (516)
|++||.+. +|..+++.. .....++...+..|+.||+.|+.|||++- |+||||||.||||..+ |.+||+||
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999988 666666422 23357888999999999999999999998 9999999999999877 89999999
Q ss_pred CcccccccCC
Q 010186 496 GMARIFAESE 505 (516)
Q Consensus 496 Gla~~~~~~~ 505 (516)
||+|++.+.-
T Consensus 181 GlaR~~~~pl 190 (438)
T KOG0666|consen 181 GLARLFNNPL 190 (438)
T ss_pred cHHHHhhccc
Confidence 9999987654
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-22 Score=196.84 Aligned_cols=146 Identities=37% Similarity=0.560 Sum_probs=126.4
Q ss_pred CCCCceeeecCcEeEEEEEe-----cCCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEE
Q 010186 351 FSDSNILGQGGFGPVYKGVL-----SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLL 422 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 422 (516)
|...+.||+|+||+||++.. .++..||+|.++... ......|.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 36778899999999988653 357789999987532 23456789999999999999999999988764 35789
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
||||+++++|.+++.. ..+++.++..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999999842 35899999999999999999999987 9999999999999999999999999998765
Q ss_pred c
Q 010186 503 E 503 (516)
Q Consensus 503 ~ 503 (516)
.
T Consensus 159 ~ 159 (283)
T cd05080 159 E 159 (283)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.7e-22 Score=227.15 Aligned_cols=142 Identities=27% Similarity=0.524 Sum_probs=122.6
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
..+...++||+|+||.||+|.. .++..||||++..... ....|++.+++++||||++++|++.+.+..++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4567788999999999999996 5789999999865332 1235688999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
++|+|.+++. .++|.++..++.||++||+|||....++++||||||+||+++.++.+++. ||+.+..
T Consensus 766 ~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 766 EGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832 (968)
T ss_pred CCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence 9999999983 27899999999999999999997655679999999999999999988875 6665543
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-22 Score=193.31 Aligned_cols=142 Identities=35% Similarity=0.553 Sum_probs=123.2
Q ss_pred eeeecCcEeEEEEEe---cCCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCC
Q 010186 356 ILGQGGFGPVYKGVL---SDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNG 430 (516)
Q Consensus 356 ~Lg~G~fg~Vy~~~~---~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 430 (516)
.||+|+||.||+|.+ .++..+|+|+++... ....+++.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999975 357889999986532 234567899999999999999999999875 45678999999999
Q ss_pred ChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 431 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
+|.+++. ....+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+...
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 81 PLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 9999984 3346889999999999999999999987 999999999999999999999999999877544
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.2e-22 Score=190.97 Aligned_cols=150 Identities=21% Similarity=0.355 Sum_probs=131.5
Q ss_pred CCCCCceeeecCcEeEEEEEec-CCcEEEEEEecc-CCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
+|...+.||+|+||.||++... +++.+++|.++. ......+.+.+|+.+++.++|+||+++++.+..++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 3667789999999999999954 688999998864 23345667889999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
++++|.+++... ....+++.....++.||+.||.|||+.+ ++|+||||+||++++++.++|+|||+++.+..
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 152 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence 999998887432 3345788999999999999999999987 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-22 Score=194.53 Aligned_cols=148 Identities=33% Similarity=0.506 Sum_probs=127.6
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC-----ccchHHHHHHHHHHhcCCCCCccceeeEEEeC--Cee
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS-----EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEK 420 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 420 (516)
.+|...++||+|+||.||++.. .++..|++|.+.... ....+.+.+|+.++.+++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4677889999999999999995 468899999875311 12345788999999999999999999988764 457
Q ss_pred EEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
+++|||+++++|.+++. ....+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLK---SYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 89999999999999884 2345788889999999999999999987 99999999999999999999999999986
Q ss_pred cc
Q 010186 501 FA 502 (516)
Q Consensus 501 ~~ 502 (516)
+.
T Consensus 156 ~~ 157 (265)
T cd06652 156 LQ 157 (265)
T ss_pred cc
Confidence 54
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-22 Score=196.24 Aligned_cols=153 Identities=34% Similarity=0.565 Sum_probs=130.6
Q ss_pred hhCCCCCCceeeecCcEeEEEEEecC------CcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLSD------GKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 419 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 419 (516)
.+++|...+.||+|+||.||++...+ +..|++|.+.... ......|.+|+.+++.++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34668888999999999999999643 5678999886432 3334578999999999999999999999999999
Q ss_pred eEEEEEccCCCChhHHhcCCCC----CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC---cEEE
Q 010186 420 KLLVYEFMPNGSLDAILFDPRK----RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM---NSKI 492 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~---~~kl 492 (516)
.++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ ++||||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999998854321 235899999999999999999999987 99999999999998754 5999
Q ss_pred cccCcccccc
Q 010186 493 SDFGMARIFA 502 (516)
Q Consensus 493 ~DFGla~~~~ 502 (516)
+|||+++.+.
T Consensus 161 ~dfg~~~~~~ 170 (277)
T cd05036 161 ADFGMARDIY 170 (277)
T ss_pred ccCccccccC
Confidence 9999998763
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.3e-22 Score=197.45 Aligned_cols=148 Identities=28% Similarity=0.434 Sum_probs=128.8
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
++|...+.||+|+||.||++... +++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 45777889999999999999854 67899999986532 33345678999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
++ ++|.+++.. ....+++..+..++.||++||.|||+.+ ++|+||||+||++++++.+||+|||+++...
T Consensus 86 ~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 86 LD-KDLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 97 588887743 2345889999999999999999999987 9999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-22 Score=196.93 Aligned_cols=159 Identities=25% Similarity=0.419 Sum_probs=134.0
Q ss_pred hHHHHHhhCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcC-CCCCccceeeEEEe--
Q 010186 341 LETLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVD-- 416 (516)
Q Consensus 341 ~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~-- 416 (516)
++.+....++|...+.||+|+||.||++.. .+++.+++|.+.... .....+.+|+.++..+ +||||+++++++..
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 445556778899999999999999999985 467899999886532 2345688999999999 79999999998853
Q ss_pred ---CCeeEEEEEccCCCChhHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEE
Q 010186 417 ---GDEKLLVYEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKI 492 (516)
Q Consensus 417 ---~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl 492 (516)
++..++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence 35689999999999999887432 23356888999999999999999999987 999999999999999999999
Q ss_pred cccCccccccc
Q 010186 493 SDFGMARIFAE 503 (516)
Q Consensus 493 ~DFGla~~~~~ 503 (516)
+|||+++.+..
T Consensus 166 ~dfg~~~~~~~ 176 (286)
T cd06638 166 VDFGVSAQLTS 176 (286)
T ss_pred ccCCceeeccc
Confidence 99999987654
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-22 Score=203.78 Aligned_cols=147 Identities=30% Similarity=0.423 Sum_probs=124.4
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCC------
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD------ 418 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 418 (516)
.++|...+.||+|+||.||++.. .+|+.||+|++... .......+.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 36788889999999999999985 46889999998642 2334567889999999999999999999987543
Q ss_pred eeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcc
Q 010186 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (516)
Q Consensus 419 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 498 (516)
..++||||+++ +|...+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 100 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCc
Confidence 46999999976 4555442 23788889999999999999999998 999999999999999999999999999
Q ss_pred ccccc
Q 010186 499 RIFAE 503 (516)
Q Consensus 499 ~~~~~ 503 (516)
+....
T Consensus 171 ~~~~~ 175 (359)
T cd07876 171 RTACT 175 (359)
T ss_pred ccccc
Confidence 86543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-22 Score=198.50 Aligned_cols=146 Identities=23% Similarity=0.350 Sum_probs=129.6
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...+.||+|+||.||++... .++.|++|.+.... ......+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 35777899999999999999954 57899999987532 234557889999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
||+++++|.+++.. ...+++.....++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 99999999999843 346899999999999999999999987 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.1e-22 Score=201.99 Aligned_cols=145 Identities=22% Similarity=0.315 Sum_probs=125.6
Q ss_pred HhhCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 346 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
....+|...+.||+|+||.||++... +++.||+|..... ....|+.++++++||||+++++++...+..++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 44567999999999999999999964 5678999975432 2357999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
||+. ++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 9995 577777743 3356899999999999999999999987 9999999999999999999999999998543
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=202.81 Aligned_cols=148 Identities=29% Similarity=0.445 Sum_probs=126.9
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeC------C
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG------D 418 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~ 418 (516)
.++|...+.||+|+||.||++.. .+++.||||++... .......+.+|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 46788889999999999999985 56889999998652 223345678999999999999999999987643 3
Q ss_pred eeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcc
Q 010186 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (516)
Q Consensus 419 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 498 (516)
..++++|++ +++|..++. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 94 ~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred cEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccc
Confidence 468999987 778988773 345899999999999999999999998 999999999999999999999999999
Q ss_pred ccccc
Q 010186 499 RIFAE 503 (516)
Q Consensus 499 ~~~~~ 503 (516)
+....
T Consensus 166 ~~~~~ 170 (343)
T cd07878 166 RQADD 170 (343)
T ss_pred eecCC
Confidence 87654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-22 Score=200.38 Aligned_cols=142 Identities=22% Similarity=0.289 Sum_probs=114.2
Q ss_pred HhhCCCCCCceeeecCcEeEEEEEec--CCcEEEEEEeccC-----CccchHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 010186 346 LATSNFSDSNILGQGGFGPVYKGVLS--DGKEVAVKRLSSC-----SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD 418 (516)
Q Consensus 346 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~--~g~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 418 (516)
...++|...+.||+|+||+||+|... +++.+|||++... .....+.|.+|+++|++++|+|++..+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 34567888999999999999999864 5777899987532 12234568999999999999999853322 24
Q ss_pred eeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCC-CCCCeEecCCCcEEEcccCc
Q 010186 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDL-KASNVLLDSDMNSKISDFGM 497 (516)
Q Consensus 419 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDl-k~~NILld~~~~~kl~DFGl 497 (516)
..+|||||+++++|.... ... ...++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+|||+
T Consensus 92 ~~~LVmE~~~G~~L~~~~----~~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLAR----PHG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CcEEEEEccCCCCHHHhC----ccc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 679999999999996321 111 1467889999999999987 999999 99999999999999999999
Q ss_pred cccccc
Q 010186 498 ARIFAE 503 (516)
Q Consensus 498 a~~~~~ 503 (516)
|+.+..
T Consensus 159 A~~~~~ 164 (365)
T PRK09188 159 ASVFRR 164 (365)
T ss_pred ceeccc
Confidence 997754
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.4e-22 Score=191.45 Aligned_cols=149 Identities=33% Similarity=0.486 Sum_probs=128.8
Q ss_pred hCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEe-CCeeEEEEEc
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD-GDEKLLVYEF 426 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~Ey 426 (516)
..+|...+.||+|+||.||++.. .+..+++|.++.. ...+.+.+|+.++++++|+|++++++++.. ++..++|+||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 34677789999999999999987 4788999988643 235678999999999999999999997654 4568999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
+++++|.+++... ....+++...+.++.+|+.||.|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 82 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred CCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccc
Confidence 9999999998542 2345889999999999999999999987 99999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.5e-22 Score=194.58 Aligned_cols=150 Identities=35% Similarity=0.579 Sum_probs=130.8
Q ss_pred CCCCCCceeeecCcEeEEEEEec-----CCcEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCCccceeeEEEe--CCee
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-----DGKEVAVKRLSSCSEQ-GTAEFTNEVLLILKLQHKNLVKLLGFCVD--GDEK 420 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-----~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~ 420 (516)
..|...+.||+|+||.||++.+. +++.+|+|.+...... ..+.|.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 34566788999999999999854 3678999999764432 46789999999999999999999999887 5578
Q ss_pred EEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999998532 235899999999999999999999987 99999999999999999999999999988
Q ss_pred ccc
Q 010186 501 FAE 503 (516)
Q Consensus 501 ~~~ 503 (516)
+..
T Consensus 159 ~~~ 161 (284)
T cd05038 159 LPE 161 (284)
T ss_pred ccc
Confidence 763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-22 Score=198.51 Aligned_cols=143 Identities=29% Similarity=0.483 Sum_probs=127.9
Q ss_pred CceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCCCh
Q 010186 354 SNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432 (516)
Q Consensus 354 ~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 432 (516)
...||+|+||.||++.. .++..|++|.+........+.+.+|+.+++.++|+||+++++.+..++..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 35699999999999985 46889999998765555566789999999999999999999999999999999999999999
Q ss_pred hHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
.+++. ...+++.+...++.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++.+..
T Consensus 107 ~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (292)
T cd06658 107 TDIVT----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK 170 (292)
T ss_pred HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence 99873 235889999999999999999999987 99999999999999999999999999986643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5e-22 Score=193.79 Aligned_cols=149 Identities=30% Similarity=0.511 Sum_probs=130.4
Q ss_pred CCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC------ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 010186 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS------EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 422 (516)
+|+..+.||+|++|.||++.. .+++.+++|.+.... ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 467788999999999999984 578999999986422 1134678999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC-cEEEcccCccccc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-NSKISDFGMARIF 501 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~-~~kl~DFGla~~~ 501 (516)
|+||+++++|.+++.. ...+++.....++.||+.||.|||+.+ ++|+||+|+||+++.++ .+||+|||+++.+
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999843 346889999999999999999999998 99999999999998776 5999999999877
Q ss_pred ccC
Q 010186 502 AES 504 (516)
Q Consensus 502 ~~~ 504 (516)
...
T Consensus 155 ~~~ 157 (268)
T cd06630 155 AAK 157 (268)
T ss_pred ccc
Confidence 543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.3e-22 Score=191.65 Aligned_cols=149 Identities=31% Similarity=0.487 Sum_probs=132.7
Q ss_pred CCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE--QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
+|...+.||+|+||.||++... +++.+++|.++.... ...+.+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4677789999999999999954 688999999876433 3567899999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
+++++|.+++.. ...+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||++..+...
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 999999999843 345788999999999999999999988 999999999999999999999999999877543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.88 E-value=8e-22 Score=197.58 Aligned_cols=145 Identities=28% Similarity=0.458 Sum_probs=119.2
Q ss_pred CceeeecCcEeEEEEEec---CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEe--CCeeEEEEEccC
Q 010186 354 SNILGQGGFGPVYKGVLS---DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD--GDEKLLVYEFMP 428 (516)
Q Consensus 354 ~~~Lg~G~fg~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~~ 428 (516)
+++||+|+||.||++... +++.+|+|.+... .....+.+|+.++++++||||+++++++.. +...++++||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 467999999999999854 4678999998653 223457899999999999999999999865 346789999986
Q ss_pred CCChhHHhcCCC------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEe----cCCCcEEEcccCcc
Q 010186 429 NGSLDAILFDPR------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL----DSDMNSKISDFGMA 498 (516)
Q Consensus 429 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILl----d~~~~~kl~DFGla 498 (516)
+ +|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 7777663211 2235889999999999999999999998 9999999999999 45678999999999
Q ss_pred cccccC
Q 010186 499 RIFAES 504 (516)
Q Consensus 499 ~~~~~~ 504 (516)
+.+...
T Consensus 160 ~~~~~~ 165 (317)
T cd07868 160 RLFNSP 165 (317)
T ss_pred eccCCC
Confidence 887544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-21 Score=190.71 Aligned_cols=154 Identities=31% Similarity=0.494 Sum_probs=135.5
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
++|+..+.||.|+||.||++.. .++..+++|++.... ....+.+.+|++.++.++|+||+++++.+...+..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 3678889999999999999995 467899999986532 33567899999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCC
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 505 (516)
+++++|.+++........+++.....++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999854333356899999999999999999999987 9999999999999999999999999998776543
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=191.42 Aligned_cols=148 Identities=34% Similarity=0.536 Sum_probs=128.1
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC-----ccchHHHHHHHHHHhcCCCCCccceeeEEEeC--Cee
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS-----EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEK 420 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 420 (516)
.+|...+.||+|+||.||++.. .++..+++|++.... ......+.+|+.+++.++||||+++++.+... ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688889999999999999985 468899999886421 12345688999999999999999999988763 567
Q ss_pred EEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
++++||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999998842 345889999999999999999999987 99999999999999999999999999986
Q ss_pred cc
Q 010186 501 FA 502 (516)
Q Consensus 501 ~~ 502 (516)
+.
T Consensus 156 ~~ 157 (266)
T cd06651 156 LQ 157 (266)
T ss_pred cc
Confidence 64
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.3e-22 Score=197.17 Aligned_cols=151 Identities=38% Similarity=0.670 Sum_probs=126.9
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCc----EEEEEEeccCCc-cchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGK----EVAVKRLSSCSE-QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~----~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 421 (516)
.++|...+.||+|+||.||++.. .++. .+++|.+..... ....++.+|+.+++.++||||++++|++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 34567778999999999999985 3444 478888865322 2344688999999999999999999998754 467
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+++||+++|+|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+
T Consensus 85 ~v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 99999999999998853 2345889999999999999999999987 999999999999999999999999999876
Q ss_pred ccC
Q 010186 502 AES 504 (516)
Q Consensus 502 ~~~ 504 (516)
...
T Consensus 160 ~~~ 162 (303)
T cd05110 160 EGD 162 (303)
T ss_pred cCc
Confidence 543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.5e-22 Score=194.59 Aligned_cols=151 Identities=28% Similarity=0.485 Sum_probs=129.1
Q ss_pred hCCCCCCceeeecCcEeEEEEEecC----CcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLSD----GKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 422 (516)
.++|...++||+|+||.||+|...+ ...|++|...... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4557778999999999999998543 2468999886543 3455679999999999999999999998875 55789
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
||||+++|+|.+++... ...+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999998532 335899999999999999999999987 9999999999999999999999999998764
Q ss_pred cC
Q 010186 503 ES 504 (516)
Q Consensus 503 ~~ 504 (516)
..
T Consensus 159 ~~ 160 (270)
T cd05056 159 DE 160 (270)
T ss_pred cc
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.6e-22 Score=192.38 Aligned_cols=143 Identities=33% Similarity=0.618 Sum_probs=122.9
Q ss_pred ceeeecCcEeEEEEEecC-Cc--EEEEEEeccC-CccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEEccCC
Q 010186 355 NILGQGGFGPVYKGVLSD-GK--EVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~-g~--~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 429 (516)
+.||+|+||.||++...+ +. .+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 358999999999999643 43 4688888653 334456789999999999 899999999999999999999999999
Q ss_pred CChhHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccC
Q 010186 430 GSLDAILFDPR-------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496 (516)
Q Consensus 430 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 496 (516)
|+|.+++.... ....+++.....++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999885322 1235789999999999999999999987 9999999999999999999999999
Q ss_pred cccc
Q 010186 497 MARI 500 (516)
Q Consensus 497 la~~ 500 (516)
+++.
T Consensus 158 l~~~ 161 (270)
T cd05047 158 LSRG 161 (270)
T ss_pred Cccc
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.1e-22 Score=197.32 Aligned_cols=144 Identities=28% Similarity=0.467 Sum_probs=128.5
Q ss_pred CceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCCCh
Q 010186 354 SNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432 (516)
Q Consensus 354 ~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 432 (516)
...||+|+||.||++.. .+++.|++|.+........+.+.+|+.++..++||||+++++.+..++..++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 34699999999999985 46889999998765555567789999999999999999999999999999999999999999
Q ss_pred hHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
..++. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+..+
T Consensus 106 ~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~ 170 (297)
T cd06659 106 TDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD 170 (297)
T ss_pred HHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccc
Confidence 98873 245889999999999999999999987 999999999999999999999999999866543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=196.11 Aligned_cols=150 Identities=26% Similarity=0.314 Sum_probs=132.7
Q ss_pred CCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCc---cchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE---QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
+|...+.||+|+||.||++... +++.+++|.+..... ...+.+.+|++++..++||||+++++.+...+..++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 5777889999999999999965 589999999975332 245678999999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
|+++++|.+++.. .....+++.....++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 82 YCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred ecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999998853 23456899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.2e-23 Score=222.01 Aligned_cols=172 Identities=27% Similarity=0.292 Sum_probs=149.5
Q ss_pred ccchHHHHHhhCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEecc---CCccchHHHHHHHHHHhcCCCCCccceeeE
Q 010186 338 FIDLETLNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413 (516)
Q Consensus 338 ~~~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~ 413 (516)
.....++.+..++|.+.++||+|+||.|..++++ +++.+|+|++.+ .......-|..|-.+|..-+.+-|+.|+-.
T Consensus 64 v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA 143 (1317)
T KOG0612|consen 64 VKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA 143 (1317)
T ss_pred HHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH
Confidence 3456777888899999999999999999999965 577889999987 345567789999999999999999999999
Q ss_pred EEeCCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEc
Q 010186 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKIS 493 (516)
Q Consensus 414 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~ 493 (516)
|.+...+|||||||+||+|-.++.+ ...+++.-+..++..|.-||.-||+.| +|||||||+|||||..|++||+
T Consensus 144 FQD~~~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLA 217 (1317)
T KOG0612|consen 144 FQDERYLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLA 217 (1317)
T ss_pred hcCccceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeec
Confidence 9999999999999999999999843 336889989999999999999999988 9999999999999999999999
Q ss_pred ccCcccccccCCCccCccceecC
Q 010186 494 DFGMARIFAESEGEANTVRIVGT 516 (516)
Q Consensus 494 DFGla~~~~~~~~~~~~~~~~GT 516 (516)
|||-+-.+..+-+.. ....+||
T Consensus 218 DFGsClkm~~dG~V~-s~~aVGT 239 (1317)
T KOG0612|consen 218 DFGSCLKMDADGTVR-SSVAVGT 239 (1317)
T ss_pred cchhHHhcCCCCcEE-eccccCC
Confidence 999998877654433 3345777
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=194.02 Aligned_cols=149 Identities=29% Similarity=0.446 Sum_probs=127.5
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
.++|...+.||+|+||.||+|.. .+++.+++|++.... ......+.+|+.+++.++|+||+++++++..++..++|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 46788889999999999999985 468899999986532 2334467899999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
|++ ++|.+++.. ....+++.....++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 84 YMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred ccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 996 676666532 2345788888999999999999999987 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=193.84 Aligned_cols=147 Identities=29% Similarity=0.460 Sum_probs=128.3
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
++|...+.||+|++|.||++... +++.|++|.+.... ......+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 46777899999999999999964 68899999986532 22334577899999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+++ +|.+++... ...+++.....++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 153 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAK 153 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccccc
Confidence 985 898887432 236889999999999999999999987 999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.3e-22 Score=196.22 Aligned_cols=149 Identities=27% Similarity=0.438 Sum_probs=130.7
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
++|+..++||+|+||.||++... +++.+++|++.... ....+.+.+|+++++.++||||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 35777899999999999999975 58899999886532 2235578899999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
|+++++|..+.. ....+++.....++.||++||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+..
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 999999988763 2335899999999999999999999987 99999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.9e-22 Score=190.42 Aligned_cols=149 Identities=32% Similarity=0.590 Sum_probs=131.3
Q ss_pred CCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccC
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 428 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 428 (516)
.+|...+.||+|+||.||++...++..+++|.+.... .....|.+|++++.+++|||++++++++......++|+||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 3566678899999999999998778899999886532 234578999999999999999999999999999999999999
Q ss_pred CCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
+++|.+++.. ....+++..+..++.+++.+|.|||+.+ ++||||||+||+++.++.+||+|||+++...+
T Consensus 83 ~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 83 HGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred CCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeeccc
Confidence 9999998843 2345889999999999999999999987 99999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=193.21 Aligned_cols=149 Identities=30% Similarity=0.499 Sum_probs=122.5
Q ss_pred CCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHhcC---CCCCccceeeEEEeC-----C
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKL---QHKNLVKLLGFCVDG-----D 418 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~-----~ 418 (516)
+|...+.||+|+||.||++... +++.||+|.++... ......+.+|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 3667789999999999999954 68899999987532 22233566777777665 799999999988642 3
Q ss_pred eeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcc
Q 010186 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (516)
Q Consensus 419 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 498 (516)
..++||||+++ +|.+++... ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57899999985 888877432 2345899999999999999999999998 999999999999999999999999999
Q ss_pred ccccc
Q 010186 499 RIFAE 503 (516)
Q Consensus 499 ~~~~~ 503 (516)
+.+..
T Consensus 156 ~~~~~ 160 (288)
T cd07863 156 RIYSC 160 (288)
T ss_pred ccccC
Confidence 87754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=189.23 Aligned_cols=143 Identities=38% Similarity=0.572 Sum_probs=127.9
Q ss_pred ceeeecCcEeEEEEEecCCcEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCCChh
Q 010186 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQ-GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLD 433 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 433 (516)
++||+|+||.||++...+++.|++|.+...... ....+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 368999999999999767999999988764332 4567999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 434 AILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 434 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
+++... ...+++.....++.+++.+|.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 144 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEE 144 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeecccccccc
Confidence 988432 335789999999999999999999987 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=8e-22 Score=194.01 Aligned_cols=151 Identities=26% Similarity=0.361 Sum_probs=126.2
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC-ccchHHHHHHHHH-HhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLL-ILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
++|...+.||+|+||.||++... +|+.||+|+++... ......+..|+.. ++.++||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36778889999999999999964 68999999987532 2234456666665 566799999999999999999999999
Q ss_pred ccCCCChhHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcC-CCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 426 FMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 426 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
|++ |+|.+++... .....+++..+..++.||+.||.|||++ + ++||||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 6887776432 2345689999999999999999999986 5 99999999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.7e-22 Score=202.03 Aligned_cols=147 Identities=29% Similarity=0.412 Sum_probs=124.6
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCC------
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD------ 418 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 418 (516)
.++|...+.||+|+||.||++.. ..++.||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 46788889999999999999985 46889999998753 2334567889999999999999999999886543
Q ss_pred eeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcc
Q 010186 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (516)
Q Consensus 419 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 498 (516)
..++||||+++ +|...+. ..+++..+..++.||+.||.|||+.+ ++||||||+||||+.++.+||+|||++
T Consensus 96 ~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred eeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCccc
Confidence 46999999976 5555552 24788899999999999999999988 999999999999999999999999999
Q ss_pred ccccc
Q 010186 499 RIFAE 503 (516)
Q Consensus 499 ~~~~~ 503 (516)
+....
T Consensus 167 ~~~~~ 171 (355)
T cd07874 167 RTAGT 171 (355)
T ss_pred ccCCC
Confidence 87644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=189.88 Aligned_cols=150 Identities=27% Similarity=0.482 Sum_probs=134.4
Q ss_pred hCCCCCCceeeecCcEeEEEEEecC-CcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
.++|...+.||+|+||.||++...+ ++.+++|.+..... .+.+.+|+++++.++||||+++++.+......++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3568888999999999999999764 78999999875332 67899999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
+++++|.+++.. ....+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++..+...
T Consensus 80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 999999999843 2356899999999999999999999987 999999999999999999999999999877644
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=189.66 Aligned_cols=149 Identities=38% Similarity=0.608 Sum_probs=130.6
Q ss_pred CCCceeeecCcEeEEEEEecC-----CcEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 352 SDSNILGQGGFGPVYKGVLSD-----GKEVAVKRLSSCSEQ-GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 352 ~~~~~Lg~G~fg~Vy~~~~~~-----g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
...+.||.|+||.||++...+ +..|++|.+...... ..+.+.+|+.++..++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456789999999999999653 378999999764433 56789999999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
|+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||+++.....
T Consensus 82 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 82 YMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred ccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999985322 122899999999999999999999997 999999999999999999999999999877544
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=194.56 Aligned_cols=149 Identities=27% Similarity=0.499 Sum_probs=132.8
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
++|...+.||+|+||.||++.. .++..+++|.+........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5677889999999999999984 467899999987544455677899999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
++++|.+++.. ..+++.++..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++..+...
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 99999999842 34789999999999999999999987 999999999999999999999999998766543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=192.60 Aligned_cols=150 Identities=31% Similarity=0.520 Sum_probs=130.9
Q ss_pred CCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
+|+..+.||+|++|.||+|+.. +|+.|++|.++... ......+.+|+.++++++||||+++++.+...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4677889999999999999964 68899999987543 234567789999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
++ +|.+++........+++..+..++.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++.+..
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~ 152 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGI 152 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence 85 78877754443456899999999999999999999987 99999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-23 Score=211.19 Aligned_cols=157 Identities=28% Similarity=0.452 Sum_probs=136.6
Q ss_pred CCceeeecCcEeEEEEEecC-CcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCCC
Q 010186 353 DSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGS 431 (516)
Q Consensus 353 ~~~~Lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 431 (516)
+...||.|+||+||++..++ +-..|.|.+...+..+.++|+-||++|+...||+||+|++.+...+.+||+.|||.||-
T Consensus 36 IiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGA 115 (1187)
T KOG0579|consen 36 IIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGA 115 (1187)
T ss_pred HHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCch
Confidence 34559999999999999764 34457788887788889999999999999999999999999999999999999999999
Q ss_pred hhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCCCccCcc
Q 010186 432 LDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV 511 (516)
Q Consensus 432 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 511 (516)
.+.++.. ....|++.++.-++.+++.||.|||++. |||||||+.|||++-+|.++|+|||.+........+..
T Consensus 116 VDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRD-- 188 (1187)
T KOG0579|consen 116 VDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRD-- 188 (1187)
T ss_pred HhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHHhhhc--
Confidence 9988743 4556999999999999999999999998 99999999999999999999999999877655444433
Q ss_pred ceecC
Q 010186 512 RIVGT 516 (516)
Q Consensus 512 ~~~GT 516 (516)
.|+||
T Consensus 189 sFIGT 193 (1187)
T KOG0579|consen 189 SFIGT 193 (1187)
T ss_pred cccCC
Confidence 27776
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.6e-22 Score=194.74 Aligned_cols=147 Identities=29% Similarity=0.508 Sum_probs=129.1
Q ss_pred CCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccC
Q 010186 351 FSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 428 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 428 (516)
|+..+.||+|+||.||+|.. .+++.||+|.+... .....+.+.+|++++++++||||+++++.+..++..++|+||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 44456799999999999985 45788999988743 23445678999999999999999999999999999999999999
Q ss_pred CCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
+++|.+++. ...+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+...
T Consensus 86 ~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06642 86 GGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred CCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCc
Confidence 999999883 245889999999999999999999987 999999999999999999999999999876543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.9e-22 Score=194.87 Aligned_cols=149 Identities=27% Similarity=0.376 Sum_probs=129.9
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
++|...+.||+|+||.||++.. ++++.+++|++... .....+.+.+|++++..++||||+++++.+...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 4566678899999999999995 46889999988653 234456899999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
+++++|..++. ..+.+++.....++.+++.+|.|||+.. +++||||||+||+++.++.++|+|||+++.+.
T Consensus 85 ~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 85 MDCGSLDRIYK---KGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred CCCCCHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 99999998883 3346899999999999999999999742 39999999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=194.94 Aligned_cols=150 Identities=29% Similarity=0.471 Sum_probs=126.9
Q ss_pred CCCCceeeecCcEeEEEEEec---CCcEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEE
Q 010186 351 FSDSNILGQGGFGPVYKGVLS---DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLL 422 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~~---~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 422 (516)
|...+.||+|+||.||+|... +++.+|+|.+.... ....+.+.+|+.++..++||||+++++++.+. +..++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 666788999999999999964 47899999997632 34456788999999999999999999999988 78999
Q ss_pred EEEccCCCChhHHhcCC-C-CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC----CCcEEEcccC
Q 010186 423 VYEFMPNGSLDAILFDP-R-KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS----DMNSKISDFG 496 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~-~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~----~~~~kl~DFG 496 (516)
||||+++ +|.+++... . ....+++.....++.||+.||.|||+.+ ++||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999986 555555322 1 2236889999999999999999999988 999999999999999 8999999999
Q ss_pred cccccccC
Q 010186 497 MARIFAES 504 (516)
Q Consensus 497 la~~~~~~ 504 (516)
+++.+...
T Consensus 158 ~~~~~~~~ 165 (316)
T cd07842 158 LARLFNAP 165 (316)
T ss_pred cccccCCC
Confidence 99876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=193.85 Aligned_cols=149 Identities=27% Similarity=0.354 Sum_probs=129.5
Q ss_pred CCCCCceeeecCcEeEEEEEe----cCCcEEEEEEeccCC----ccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCee
Q 010186 350 NFSDSNILGQGGFGPVYKGVL----SDGKEVAVKRLSSCS----EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEK 420 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 420 (516)
+|+..+.||+|+||.||++.. .+|..||+|++.... ....+.+.+|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 366778999999999999985 368899999987522 22345688999999999 699999999999999999
Q ss_pred EEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
++|+||+++++|.+++.. ...+++.....++.||+.||.|||+.+ ++||||+|+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999998843 345888999999999999999999987 99999999999999999999999999987
Q ss_pred cccC
Q 010186 501 FAES 504 (516)
Q Consensus 501 ~~~~ 504 (516)
+...
T Consensus 155 ~~~~ 158 (290)
T cd05613 155 FHED 158 (290)
T ss_pred cccc
Confidence 6543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=192.27 Aligned_cols=149 Identities=32% Similarity=0.477 Sum_probs=132.1
Q ss_pred CCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
+|...+.||+|+||.||++.. .+|+.|++|++.... ....+.+.+|+.++++++||||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 366778899999999999995 468999999987533 33456799999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
+ +++|.+++... ...+++.++..++.||+++|.|||+.+ ++|+||||+||++++++.++|+|||+++.+...
T Consensus 81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 99999988532 256899999999999999999999987 999999999999999999999999999887554
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.6e-22 Score=206.21 Aligned_cols=172 Identities=31% Similarity=0.514 Sum_probs=149.6
Q ss_pred ccchHHHHHhhCCCCCCceeeecCcEeEEEEE-ecCCcEEEEEEeccCCccchHHHHHHHHHHhcC-CCCCccceeeEEE
Q 010186 338 FIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCV 415 (516)
Q Consensus 338 ~~~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~ 415 (516)
.++++.+...++.|.+.++||.|.+|.||+++ .++++.+|+|++... ....++.+.|.++++.. .|||++.++|++.
T Consensus 8 ~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 8 DIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred ccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence 34566666778889999999999999999999 567899999998763 34556788899999988 7999999999987
Q ss_pred e-----CCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcE
Q 010186 416 D-----GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS 490 (516)
Q Consensus 416 ~-----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~ 490 (516)
. ++.+|||||||.+|+.-++..... ...+.|..+.-|+++++.|+.+||... +||||||-.|||++.++.+
T Consensus 87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred EecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcE
Confidence 4 467999999999999999986544 678999999999999999999999987 9999999999999999999
Q ss_pred EEcccCcccccccCCCccCccceecC
Q 010186 491 KISDFGMARIFAESEGEANTVRIVGT 516 (516)
Q Consensus 491 kl~DFGla~~~~~~~~~~~~~~~~GT 516 (516)
||.|||++..++......+| .+||
T Consensus 163 KLvDFGvSaQldsT~grRnT--~iGt 186 (953)
T KOG0587|consen 163 KLVDFGVSAQLDSTVGRRNT--FIGT 186 (953)
T ss_pred EEeeeeeeeeeecccccccC--cCCC
Confidence 99999999999887766665 5676
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=7e-22 Score=217.30 Aligned_cols=157 Identities=23% Similarity=0.365 Sum_probs=129.6
Q ss_pred hhCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeE
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKL 421 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~ 421 (516)
..++|.+.+.||+|+||.||++... ++..+++|.+... .......|..|+.++..|+||||+++++++... ...|
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 3457888899999999999999954 5778899988642 334456789999999999999999999988653 4689
Q ss_pred EEEEccCCCChhHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCC----CCeeeCCCCCCCeEecCC---------
Q 010186 422 LVYEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSR----LRIVHRDLKASNVLLDSD--------- 487 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~----~~iiHrDlk~~NILld~~--------- 487 (516)
|||||+++|+|.+++... .....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.+
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 999999999999988532 223568999999999999999999998542 349999999999999643
Q ss_pred --------CcEEEcccCccccccc
Q 010186 488 --------MNSKISDFGMARIFAE 503 (516)
Q Consensus 488 --------~~~kl~DFGla~~~~~ 503 (516)
..+||+|||+++.+..
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~ 194 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGI 194 (1021)
T ss_pred cccccCCCCceEEccCCccccccc
Confidence 3489999999987653
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=196.84 Aligned_cols=144 Identities=22% Similarity=0.298 Sum_probs=124.7
Q ss_pred Cceeeec--CcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccC
Q 010186 354 SNILGQG--GFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 428 (516)
Q Consensus 354 ~~~Lg~G--~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 428 (516)
.++||+| +|++||++.. .+|+.||+|+++.. .......+.+|+.+++.++||||+++++++..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4679999 7899999985 57899999998753 22334567889999999999999999999999999999999999
Q ss_pred CCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+|+|.+++... ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.++++||+.....
T Consensus 83 ~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~ 151 (327)
T cd08227 83 YGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 151 (327)
T ss_pred CCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcc
Confidence 99999988432 2335899999999999999999999988 999999999999999999999999865443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.4e-22 Score=192.05 Aligned_cols=149 Identities=26% Similarity=0.363 Sum_probs=132.7
Q ss_pred CCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
+|...+.||.|+||.||++... +++.+++|.+.... ....+.+.+|++++++++||||+++++.+..++..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4677889999999999999965 68899999987532 2456789999999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
|+++++|..++.. ...+++.....++.||++||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999843 257889999999999999999999987 999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=191.07 Aligned_cols=149 Identities=26% Similarity=0.534 Sum_probs=131.6
Q ss_pred CCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC-CccchHHHHHHHHHHhcCC---CCCccceeeEEEeCCeeEEEE
Q 010186 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQ---HKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~ 424 (516)
.|+..+.||+|+||.||+|.. .+++.+++|.+... .....+.+.+|+.+++.++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 356678899999999999995 57889999998653 3445667889999999986 999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||+++++|.+++.. ..+++.....++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999998842 36899999999999999999999987 999999999999999999999999999877554
Q ss_pred C
Q 010186 505 E 505 (516)
Q Consensus 505 ~ 505 (516)
.
T Consensus 155 ~ 155 (277)
T cd06917 155 S 155 (277)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=193.46 Aligned_cols=160 Identities=31% Similarity=0.436 Sum_probs=135.4
Q ss_pred chHHHHHhhCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcC-CCCCccceeeEEEeC
Q 010186 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDG 417 (516)
Q Consensus 340 ~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 417 (516)
..+++..+.++|...+.||+|+||.||++.. .+++.+++|.+.... .....+.+|+.++.++ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 3455556678899999999999999999996 468899999986532 2345678899999999 899999999998754
Q ss_pred C-----eeEEEEEccCCCChhHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEE
Q 010186 418 D-----EKLLVYEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSK 491 (516)
Q Consensus 418 ~-----~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~k 491 (516)
+ ..++|+||+++++|.+++... .....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence 3 579999999999999887432 23356899999999999999999999987 99999999999999999999
Q ss_pred EcccCccccccc
Q 010186 492 ISDFGMARIFAE 503 (516)
Q Consensus 492 l~DFGla~~~~~ 503 (516)
|+|||+++.+..
T Consensus 169 l~dfg~~~~~~~ 180 (291)
T cd06639 169 LVDFGVSAQLTS 180 (291)
T ss_pred Eeecccchhccc
Confidence 999999987643
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-21 Score=190.77 Aligned_cols=146 Identities=29% Similarity=0.492 Sum_probs=129.4
Q ss_pred CCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccC
Q 010186 351 FSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 428 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 428 (516)
|...+.||+|+||.||++.. .+++.+|+|.+.... ......+.+|+.++.+++||||+++++.+..++..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 55678899999999999985 468899999886432 3345678999999999999999999999999999999999999
Q ss_pred CCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
+++|.+++. ...+++.....++.+++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||+++.+..
T Consensus 86 ~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 86 GGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred CCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 999999883 235889999999999999999999987 99999999999999999999999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=189.19 Aligned_cols=146 Identities=36% Similarity=0.578 Sum_probs=126.9
Q ss_pred CCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccC
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 428 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 428 (516)
++|...+.||+|+||.||++.. +++.+++|.+... .....+.+|+.++..++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 3567788999999999999975 6788999988643 2345789999999999999999999998764 4799999999
Q ss_pred CCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
+++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGS 151 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecc
Confidence 99999998542 3345889999999999999999999987 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=189.46 Aligned_cols=143 Identities=32% Similarity=0.544 Sum_probs=121.5
Q ss_pred ceeeecCcEeEEEEEec----CCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEe-CCeeEEEEEccC
Q 010186 355 NILGQGGFGPVYKGVLS----DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD-GDEKLLVYEFMP 428 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~Ey~~ 428 (516)
+.||+|+||.||+|... +...+|+|++... .....+.+.+|+.+++.++||||+++++++.. +...++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2357899988643 33456688999999999999999999998764 456889999999
Q ss_pred CCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
+|+|.+++... ...+++.....++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCcccccccc
Confidence 99999998532 234678888999999999999999987 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-21 Score=189.71 Aligned_cols=150 Identities=31% Similarity=0.517 Sum_probs=125.4
Q ss_pred CCCCceeeecCcEeEEEEEec----CCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCC------
Q 010186 351 FSDSNILGQGGFGPVYKGVLS----DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD------ 418 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~~----~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 418 (516)
|...++||+|+||.||++.+. +++.||+|++... +....+++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 455678999999999999853 3678999998653 2334567899999999999999999999887543
Q ss_pred eeEEEEEccCCCChhHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEccc
Q 010186 419 EKLLVYEFMPNGSLDAILFDPR---KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDF 495 (516)
Q Consensus 419 ~~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 495 (516)
..++++||+++|+|..++.... ....+++.....++.||+.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478999999999988764322 2235788999999999999999999987 999999999999999999999999
Q ss_pred Cccccccc
Q 010186 496 GMARIFAE 503 (516)
Q Consensus 496 Gla~~~~~ 503 (516)
|+++.+..
T Consensus 158 g~~~~~~~ 165 (273)
T cd05074 158 GLSKKIYS 165 (273)
T ss_pred cccccccC
Confidence 99987653
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.7e-22 Score=202.82 Aligned_cols=144 Identities=33% Similarity=0.501 Sum_probs=128.2
Q ss_pred ceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCCChh
Q 010186 355 NILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLD 433 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 433 (516)
-+||+|.||+||-|+. ++...+|||-+.....+..+.+.+||.+.+.++|.|||+++|.+.+++..-+.||-+|||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 3699999999999994 456688999998877788888999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCC--CHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEec-CCCcEEEcccCccccccc
Q 010186 434 AILFDPRKRGIL--CWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD-SDMNSKISDFGMARIFAE 503 (516)
Q Consensus 434 ~~l~~~~~~~~l--~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld-~~~~~kl~DFGla~~~~~ 503 (516)
++|.. ..+++ .+...-.+..||++||.|||++. |+|||||-.||||+ -.|.+||+|||-++.+-.
T Consensus 661 sLLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg 728 (1226)
T KOG4279|consen 661 SLLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG 728 (1226)
T ss_pred HHHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc
Confidence 99943 44566 66777788999999999999998 99999999999996 578999999999987753
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=199.90 Aligned_cols=147 Identities=28% Similarity=0.404 Sum_probs=124.7
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeC------C
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG------D 418 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~ 418 (516)
.++|...+.||+|+||.||++.. ..++.||||++... .......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 46788889999999999999985 46889999998752 233456788999999999999999999987643 3
Q ss_pred eeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcc
Q 010186 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (516)
Q Consensus 419 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 498 (516)
..++||||+++ +|...+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 47999999976 6666552 23788899999999999999999987 999999999999999999999999999
Q ss_pred ccccc
Q 010186 499 RIFAE 503 (516)
Q Consensus 499 ~~~~~ 503 (516)
+....
T Consensus 174 ~~~~~ 178 (364)
T cd07875 174 RTAGT 178 (364)
T ss_pred cccCC
Confidence 87654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-21 Score=190.46 Aligned_cols=148 Identities=27% Similarity=0.460 Sum_probs=132.3
Q ss_pred CCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
+|...+.||.|++|.||++... +++.+++|.+.... ......+.+|+.+++.++|+||+++++.+.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5677788999999999999954 68899999986532 344567899999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
++++|.+++.. ..+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.+...
T Consensus 82 ~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 82 GGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 99999999843 26899999999999999999999987 999999999999999999999999999887644
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.5e-22 Score=181.91 Aligned_cols=141 Identities=21% Similarity=0.208 Sum_probs=109.3
Q ss_pred CceeeecCcEeEEEEEecCCcEEEEEEeccCCcc--c-------hHHH-----------------HHHHHHHhcCCCCCc
Q 010186 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQ--G-------TAEF-----------------TNEVLLILKLQHKNL 407 (516)
Q Consensus 354 ~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~--~-------~~~~-----------------~~Ei~~l~~l~H~ni 407 (516)
...||+|+||.||+|...+|++||||++++.... . ...| ..|+..+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999999878999999999753211 1 1122 349999999988776
Q ss_pred cceeeEEEeCCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHh-HcCCCCCeeeCCCCCCCeEecC
Q 010186 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL-HEDSRLRIVHRDLKASNVLLDS 486 (516)
Q Consensus 408 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yL-H~~~~~~iiHrDlk~~NILld~ 486 (516)
.....+. ....+|||||++++++..... ....+++.+...++.|++.+|.|| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 4433222 223489999999987765431 234688999999999999999999 6777 99999999999998
Q ss_pred CCcEEEcccCccccccc
Q 010186 487 DMNSKISDFGMARIFAE 503 (516)
Q Consensus 487 ~~~~kl~DFGla~~~~~ 503 (516)
++.++|+|||+|.....
T Consensus 153 ~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 153 DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred CCcEEEEEccccccCCC
Confidence 47899999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.6e-21 Score=188.07 Aligned_cols=150 Identities=31% Similarity=0.454 Sum_probs=134.6
Q ss_pred CCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE-QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
+|...+.||+|++|.||++... +++.+++|++..... .....+.+|+..+.+++|+||+++++.+...+..++|+||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 5777899999999999999965 589999999876433 45678999999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHc-CCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCC
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 505 (516)
++++|.+++.. ...+++.....++.|++++|.|||+ .+ ++||||+|+||+++.++.++|+|||+++.+....
T Consensus 82 ~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 82 DGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999999843 2568999999999999999999999 87 9999999999999999999999999998775443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-21 Score=188.07 Aligned_cols=144 Identities=40% Similarity=0.598 Sum_probs=123.8
Q ss_pred ceeeecCcEeEEEEEec--C--CcEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCC
Q 010186 355 NILGQGGFGPVYKGVLS--D--GKEVAVKRLSSCSE-QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~--~--g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 429 (516)
++||+|+||.||+|... + +..+++|.+..... ...+.+.+|+.+++.+.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999743 2 26899999875433 34567899999999999999999999876 4567999999999
Q ss_pred CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCC
Q 010186 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 505 (516)
++|.+++.. ...+++..+..++.|++.+|.|||+.+ ++||||||+|||++.++.+||+|||+++.+....
T Consensus 80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~ 149 (257)
T cd05060 80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS 149 (257)
T ss_pred CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCC
Confidence 999999943 236899999999999999999999987 9999999999999999999999999998775443
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-21 Score=189.30 Aligned_cols=148 Identities=32% Similarity=0.523 Sum_probs=128.2
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC-----CccchHHHHHHHHHHhcCCCCCccceeeEEEeC--Cee
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-----SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEK 420 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 420 (516)
.+|...+.||+|+||.||++.. .+++.+++|.+... .......+.+|+.++++++|+||+++++.+.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4678889999999999999995 46889999987531 123445789999999999999999999998764 457
Q ss_pred EEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
++++||+++++|.+++. ....+++.....++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLK---AYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 89999999999999884 3345789999999999999999999987 99999999999999999999999999987
Q ss_pred cc
Q 010186 501 FA 502 (516)
Q Consensus 501 ~~ 502 (516)
+.
T Consensus 156 ~~ 157 (264)
T cd06653 156 IQ 157 (264)
T ss_pred cc
Confidence 64
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-21 Score=193.56 Aligned_cols=145 Identities=28% Similarity=0.458 Sum_probs=118.8
Q ss_pred CceeeecCcEeEEEEEec---CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEe--CCeeEEEEEccC
Q 010186 354 SNILGQGGFGPVYKGVLS---DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD--GDEKLLVYEFMP 428 (516)
Q Consensus 354 ~~~Lg~G~fg~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~~ 428 (516)
+.+||+|+||.||++... ++..+|+|.+.... ....+.+|+.+++.++||||+++++++.. +...++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999964 35689999886532 23467899999999999999999999864 456789999987
Q ss_pred CCChhHHhcCC------CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEe----cCCCcEEEcccCcc
Q 010186 429 NGSLDAILFDP------RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL----DSDMNSKISDFGMA 498 (516)
Q Consensus 429 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILl----d~~~~~kl~DFGla 498 (516)
+ +|.+++... .....+++..+..++.||+.||.|||+.+ ++||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 666655311 12235889999999999999999999987 9999999999999 55678999999999
Q ss_pred cccccC
Q 010186 499 RIFAES 504 (516)
Q Consensus 499 ~~~~~~ 504 (516)
+.+...
T Consensus 160 ~~~~~~ 165 (317)
T cd07867 160 RLFNSP 165 (317)
T ss_pred eccCCC
Confidence 887544
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.9e-22 Score=192.52 Aligned_cols=144 Identities=29% Similarity=0.481 Sum_probs=123.4
Q ss_pred ceeeecCcEeEEEEEecC--------CcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 355 NILGQGGFGPVYKGVLSD--------GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
+.||+|+||.||+|.... ..++++|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 368999999999998532 234888887665445566889999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCc--------EEEcccCcc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN--------SKISDFGMA 498 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~--------~kl~DFGla 498 (516)
+++|+|.+++... ...+++.....++.||+.||.|||+.+ ++||||||+|||++.++. +|++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999998542 236889999999999999999999987 999999999999987765 699999998
Q ss_pred ccccc
Q 010186 499 RIFAE 503 (516)
Q Consensus 499 ~~~~~ 503 (516)
.....
T Consensus 156 ~~~~~ 160 (258)
T cd05078 156 ITVLP 160 (258)
T ss_pred cccCC
Confidence 76543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.1e-21 Score=186.99 Aligned_cols=150 Identities=29% Similarity=0.400 Sum_probs=129.0
Q ss_pred CCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEe-CCeeEEEEE
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD-GDEKLLVYE 425 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~E 425 (516)
.|...+.||+|++|.||++... +++.+++|.+... .....+.+.+|++++++++|+|++++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 3667789999999999999954 5788999998642 23445678999999999999999999998764 446789999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
|+++++|.+++... ....+++.++..++.+++.||.|||+.+ ++||||||+||+++.++.++|+|||+++.+..
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 99999999988542 3346899999999999999999999988 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=192.56 Aligned_cols=150 Identities=25% Similarity=0.400 Sum_probs=131.8
Q ss_pred CCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
+|...+.||+|+||.||++... +++.|++|.++.. .....+.+.+|+++++.++|+||+++++++..++..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5777889999999999999965 5889999988652 333456799999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCC
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 505 (516)
++++.+..+.. ....+++.+...++.+|+.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+....
T Consensus 82 ~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 82 VERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred CCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 99988876663 3345899999999999999999999987 9999999999999999999999999998876543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-21 Score=190.17 Aligned_cols=148 Identities=28% Similarity=0.490 Sum_probs=130.7
Q ss_pred CCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
.|+..+.||+|+||.||+|... +++.|++|.+... .......+.+|+.+++.++||||+++++.+.+.+..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4556678999999999999964 5889999988753 2345667899999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
++++|.+++.. ..+++.+...++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.+...
T Consensus 85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 99999998832 35888999999999999999999987 999999999999999999999999999876543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3e-21 Score=187.04 Aligned_cols=150 Identities=23% Similarity=0.395 Sum_probs=131.6
Q ss_pred CCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
+|...+.||+|+||.+|++.. .+++.+++|.+... .....+++.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 467788999999999999985 46889999998642 334556899999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
+++++|.+++... ....+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+..
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence 9999999888432 2335789999999999999999999987 99999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=192.88 Aligned_cols=148 Identities=27% Similarity=0.452 Sum_probs=127.8
Q ss_pred CCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
+|...+.||+|+||.||++... +|+.+++|++.... ......+.+|+.++++++||||+++++.+.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 3667788999999999999964 68899999986432 22345688899999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
+++ +|.+++.. ....+++..+..++.||++||.|||+.+ ++||||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 81 CDQ-DLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGI 151 (284)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence 975 77776642 2346899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.2e-22 Score=196.05 Aligned_cols=151 Identities=26% Similarity=0.340 Sum_probs=132.1
Q ss_pred CCCCCceeeecCcEeEEEEE-ecCCcEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSE--QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~-~~~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
-|..++.||+|.|..|-+++ .-+|+.||||++.+.+- .....+..|++.|+.++|||||+|+++...+..+|||+|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 35556789999999999998 34899999999987443 3345688999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEe-cCCCcEEEcccCcccccccCC
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL-DSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILl-d~~~~~kl~DFGla~~~~~~~ 505 (516)
=.+|+|.+++-+ ....+.+....+++.||..|+.|+|+.. ++||||||+||.. ..-|-+||.|||++-.|.+.+
T Consensus 99 GD~GDl~DyImK--He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 99 GDGGDLFDYIMK--HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred cCCchHHHHHHh--hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 999999999854 3345899999999999999999999887 9999999999876 556889999999999887765
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=5e-21 Score=184.85 Aligned_cols=150 Identities=33% Similarity=0.534 Sum_probs=133.6
Q ss_pred CCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE--QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
+|...+.||+|++|.||++... +++.+++|.+..... ...+.+.+|++++.+++|||++++++++...+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 3667789999999999999854 678999999976443 4567899999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCC
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 505 (516)
+++++|.+++.. ...+++..+..++.|++.+|.|||+.+ ++||||+|+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 999999998843 356899999999999999999999987 9999999999999999999999999998776544
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.6e-21 Score=190.65 Aligned_cols=150 Identities=27% Similarity=0.402 Sum_probs=126.7
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCe-----
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDE----- 419 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~----- 419 (516)
++|...+.||+|+||.||++... +++.|++|.+.... ......+.+|+.+++.+ +||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 35778899999999999999964 68899999876532 22345788999999999 56999999999987665
Q ss_pred eEEEEEccCCCChhHHhcCCCC--CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC-CCcEEEcccC
Q 010186 420 KLLVYEFMPNGSLDAILFDPRK--RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFG 496 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~-~~~~kl~DFG 496 (516)
.++||||+++ +|.+++..... ...+++.....++.||+.||.|||+.+ ++||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 78777643222 346899999999999999999999987 999999999999998 8899999999
Q ss_pred cccccc
Q 010186 497 MARIFA 502 (516)
Q Consensus 497 la~~~~ 502 (516)
+++.+.
T Consensus 157 ~~~~~~ 162 (295)
T cd07837 157 LGRAFS 162 (295)
T ss_pred cceecC
Confidence 998654
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-21 Score=190.11 Aligned_cols=158 Identities=29% Similarity=0.482 Sum_probs=133.5
Q ss_pred chHHHHHhhCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcC-CCCCccceeeEEEe-
Q 010186 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVD- 416 (516)
Q Consensus 340 ~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~- 416 (516)
++.++..+.+.|...+.||+|+||.||++.. .+++.+++|.+.... .....+..|+.++.++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 3444555667888889999999999999995 467899999886532 3446788999999998 79999999999863
Q ss_pred -----CCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEE
Q 010186 417 -----GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSK 491 (516)
Q Consensus 417 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~k 491 (516)
.+..+++|||+++|+|.+++... ....+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 45689999999999999988542 3345788888999999999999999987 99999999999999999999
Q ss_pred EcccCcccccc
Q 010186 492 ISDFGMARIFA 502 (516)
Q Consensus 492 l~DFGla~~~~ 502 (516)
|+|||+++.+.
T Consensus 162 l~dfg~~~~~~ 172 (282)
T cd06636 162 LVDFGVSAQLD 172 (282)
T ss_pred EeeCcchhhhh
Confidence 99999998654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=190.87 Aligned_cols=149 Identities=29% Similarity=0.485 Sum_probs=129.2
Q ss_pred CCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
+|...+.||+|++|.||++... +++.|++|++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4677789999999999999864 68899999886432 22345789999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
++ ++|..++... ....+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++.+..
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~ 152 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 152 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhccc
Confidence 96 5888887432 3456899999999999999999999987 99999999999999999999999999986643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-21 Score=189.33 Aligned_cols=143 Identities=31% Similarity=0.391 Sum_probs=125.0
Q ss_pred eeecCcEeEEEEEe-cCCcEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCCCh
Q 010186 357 LGQGGFGPVYKGVL-SDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432 (516)
Q Consensus 357 Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 432 (516)
||+|+||.||++.. .+|+.+++|.+.... ......+.+|++++..++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999985 468899999986422 22345678899999999999999999999999999999999999999
Q ss_pred hHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
.+++... ....+++.++..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++.+..
T Consensus 81 ~~~l~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~ 147 (277)
T cd05577 81 KYHIYNV-GEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG 147 (277)
T ss_pred HHHHHHc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc
Confidence 9988543 2246899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.1e-22 Score=165.12 Aligned_cols=93 Identities=38% Similarity=0.716 Sum_probs=75.6
Q ss_pred CChHHHHHHHHHHHHHHHHHhccCCCCCccccccccCCCCCceEEEecccCCCChhhHHHHHHHHHHHHhhhcCCCCCcE
Q 010186 148 SEPERYRSVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATADILSCCYFSRGAR 227 (516)
Q Consensus 148 ~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~a~~~~~~~~~~~vyglaQC~~Dls~~~C~~Cl~~a~~~~~~~c~~~~g~~ 227 (516)
++++.|..+++++|.+|...++... ..+|++++.+ .+.++||||+||++||+++||..||+.++..++.+|+.++||+
T Consensus 14 ~~~~~f~~~l~~ll~~l~~~a~~~~-~~~f~~~~~~-~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~~~~C~~~~g~~ 91 (106)
T PF01657_consen 14 TDNSTFEQNLNSLLSSLVSNAASSS-SKGFATGSAG-SGPDTVYGLAQCRGDLSPSDCRACLADAVANISSCCPGSRGGR 91 (106)
T ss_dssp -TT-THHHHHHHHHHHHHHHGGGTT--TEEEEEE---ST---EEEEEEE-TTS-HHHHHHHHHHHHCCHHHHTTSBSSEE
T ss_pred CCCchHHHHHHHHHHHHHHHHhhcc-ccCcEEeecC-CCCCeEEEEEEcCCCCChhhhHHHHHHHHHHHHHhCCCCceEE
Confidence 4555699999999999999987632 4789999875 5778999999999999999999999999999999999999999
Q ss_pred Eecccccceeeeccc
Q 010186 228 LLSRNCYLRYELYAF 242 (516)
Q Consensus 228 v~~~~C~lr~~~~~f 242 (516)
|++++|+||||.++|
T Consensus 92 v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 92 VWYDSCFLRYENYPF 106 (106)
T ss_dssp EEESSEEEEEESS--
T ss_pred EECCCEEEEEECCCC
Confidence 999999999999987
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.1e-21 Score=191.64 Aligned_cols=150 Identities=30% Similarity=0.465 Sum_probs=128.5
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
..|...+.||+|+||.||++... +++.|++|.+.... ....+.+.+|+++++.++||||+++++++...+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45777889999999999999964 68899999886432 233456889999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||++ |+|.+++.. ....+++..+..++.||+.||.|||+.+ ++||||+|+||++++++.+||+|||+++.....
T Consensus 95 e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9997 566666532 2345899999999999999999999987 999999999999999999999999999766433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-21 Score=187.03 Aligned_cols=142 Identities=29% Similarity=0.390 Sum_probs=126.3
Q ss_pred eeecCcEeEEEEEec-CCcEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCCCh
Q 010186 357 LGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432 (516)
Q Consensus 357 Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 432 (516)
||.|+||.||++... +++.+++|.+.+.. ....+.+.+|+.+++.++||||+++++.+.+++..++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999964 48899999986532 23456799999999999999999999999999999999999999999
Q ss_pred hHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++.....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence 999843 345889999999999999999999987 999999999999999999999999999887654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.9e-21 Score=185.36 Aligned_cols=151 Identities=26% Similarity=0.425 Sum_probs=130.9
Q ss_pred CCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
+|...+.||+|+||.||++.. .+++.+++|.+... +......+.+|+++++.++||||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 466778999999999999985 46889999998653 334566799999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCC-CcEEEcccCcccccccC
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGMARIFAES 504 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~-~~~kl~DFGla~~~~~~ 504 (516)
+++++|.+++... ....+++..+..++.+++++|.|||+++ ++|+||+|+||+++++ +.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999999998542 2345899999999999999999999987 9999999999999865 46899999999877543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.6e-21 Score=188.10 Aligned_cols=146 Identities=29% Similarity=0.485 Sum_probs=129.9
Q ss_pred CCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCC
Q 010186 351 FSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 429 (516)
|...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457899999999999985 46889999998755445566789999999999999999999999999999999999999
Q ss_pred CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
++|.+++.. ..+++.++..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||+++....
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~ 167 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK 167 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence 999998843 45889999999999999999999988 99999999999999999999999999876644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.3e-21 Score=188.87 Aligned_cols=141 Identities=30% Similarity=0.403 Sum_probs=118.3
Q ss_pred eeeecCcEeEEEEEe-cCCcEEEEEEeccCCc---cchHHHHHHHHHH---hcCCCCCccceeeEEEeCCeeEEEEEccC
Q 010186 356 ILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSE---QGTAEFTNEVLLI---LKLQHKNLVKLLGFCVDGDEKLLVYEFMP 428 (516)
Q Consensus 356 ~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~Ei~~l---~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 428 (516)
.||+|+||.||++.. .+++.+|+|.+.+... .....+.+|..++ ...+||||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999995 4688999998865321 2223344554433 33479999999999999999999999999
Q ss_pred CCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
+++|.+++. ..+.+++.....++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 81 GGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (279)
T ss_pred CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence 999998884 3456899999999999999999999988 9999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.4e-21 Score=188.20 Aligned_cols=142 Identities=27% Similarity=0.422 Sum_probs=126.3
Q ss_pred eeecCcEeEEEEEec-CCcEEEEEEeccCCc---cchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCCCh
Q 010186 357 LGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE---QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432 (516)
Q Consensus 357 Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 432 (516)
||.|+||.||++... +++.+++|.+..... ...+.+.+|++++.+++||||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999975 489999999865332 4556789999999999999999999999999999999999999999
Q ss_pred hHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~ 146 (265)
T cd05579 81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR 146 (265)
T ss_pred HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence 999843 236899999999999999999999987 999999999999999999999999999865433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-21 Score=187.90 Aligned_cols=153 Identities=28% Similarity=0.474 Sum_probs=132.4
Q ss_pred hhCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcC-CCCCccceeeEEEeCC------
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGD------ 418 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~------ 418 (516)
++++|...+.||+|++|.||++... +++.+++|++.... ...+.+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4678899999999999999999964 57889999887543 3456799999999999 7999999999997654
Q ss_pred eeEEEEEccCCCChhHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCc
Q 010186 419 EKLLVYEFMPNGSLDAILFDPR-KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497 (516)
Q Consensus 419 ~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 497 (516)
..++||||+++++|.+++.... .+..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999885422 2456899999999999999999999987 99999999999999999999999999
Q ss_pred cccccc
Q 010186 498 ARIFAE 503 (516)
Q Consensus 498 a~~~~~ 503 (516)
+.....
T Consensus 160 ~~~~~~ 165 (275)
T cd06608 160 SAQLDS 165 (275)
T ss_pred ceeccc
Confidence 876543
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-21 Score=190.72 Aligned_cols=150 Identities=29% Similarity=0.454 Sum_probs=128.8
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLLV 423 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV 423 (516)
++|...+.||+|+||.||+|... +++.+++|.++... ......+.+|+.++.+++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 35677788999999999999965 58899999987532 22234577899999999999999999999877 789999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
+||+++ +|.+++... ...+++.....++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 85 ~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999974 888887432 236899999999999999999999988 99999999999999999999999999987755
Q ss_pred C
Q 010186 504 S 504 (516)
Q Consensus 504 ~ 504 (516)
.
T Consensus 159 ~ 159 (293)
T cd07843 159 P 159 (293)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.5e-21 Score=183.72 Aligned_cols=150 Identities=33% Similarity=0.542 Sum_probs=133.8
Q ss_pred CCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEEE
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLLVY 424 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 424 (516)
+|...+.||+|++|.||+|... +++.|++|.+.... ....+.+.+|+.++++++||||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667789999999999999965 68899999987643 24567899999999999999999999999988 8899999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||+++++|.+++.. ...+++..+..++.+++.+|.|||+.+ ++|+||+|+||+++.++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 99999999999843 237899999999999999999999987 999999999999999999999999999887655
Q ss_pred C
Q 010186 505 E 505 (516)
Q Consensus 505 ~ 505 (516)
.
T Consensus 155 ~ 155 (260)
T cd06606 155 E 155 (260)
T ss_pred c
Confidence 4
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.5e-21 Score=190.02 Aligned_cols=142 Identities=30% Similarity=0.478 Sum_probs=127.5
Q ss_pred ceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCCChh
Q 010186 355 NILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLD 433 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 433 (516)
.+||+|+||.||++.. .+++.|++|.+..........+.+|+.+++.++|+||+++++.+...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5699999999999986 478899999986545455667999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 434 AILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 434 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
+++.. ..+++.....++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++..+..
T Consensus 106 ~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 106 DIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence 98732 35789999999999999999999987 99999999999999999999999999876654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-20 Score=181.64 Aligned_cols=150 Identities=36% Similarity=0.594 Sum_probs=134.5
Q ss_pred CCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCC
Q 010186 351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 429 (516)
|...+.||+|++|.||++... +++.+++|++..........+.+|+++++.++|+|++++++.+...+..++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 566788999999999999965 6889999999775545667899999999999999999999999999999999999999
Q ss_pred CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCC
Q 010186 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 505 (516)
++|.+++... ...+++..+..++.+++.+|.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 82 ~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 82 GSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred CcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 9999998432 256899999999999999999999987 9999999999999999999999999998876543
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.8e-22 Score=194.32 Aligned_cols=164 Identities=29% Similarity=0.401 Sum_probs=132.8
Q ss_pred CCCCCCceeeecCcEeEEEEE-ecCCcEEEEEEeccC-------CccchHHHHHHHHHHhcCCCCCccceeeEEEe-CCe
Q 010186 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSC-------SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD-GDE 419 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~-~~~g~~vavK~l~~~-------~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~ 419 (516)
++|-...+||+|+|+.||++. +...+-||||+-... .....+...+|-++.+.|.||.||++++++.- .+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 345556789999999999998 556788999975321 11223346789999999999999999999874 566
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC---CCcEEEcccC
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFG 496 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~---~~~~kl~DFG 496 (516)
.+-|+||++|.+|+-+|. ....++++++..|+.||..||.||.+.. +||||=||||.||||-+ .|.+||.|||
T Consensus 543 FCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecc
Confidence 789999999999999993 4566899999999999999999999874 78999999999999944 4789999999
Q ss_pred cccccccCCCc-----cCccceecC
Q 010186 497 MARIFAESEGE-----ANTVRIVGT 516 (516)
Q Consensus 497 la~~~~~~~~~-----~~~~~~~GT 516 (516)
|++++.++... .-|+..+||
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGT 643 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGT 643 (775)
T ss_pred hhhhccCCccCcccceeeecccCce
Confidence 99998755322 235667776
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-22 Score=188.13 Aligned_cols=162 Identities=28% Similarity=0.332 Sum_probs=138.2
Q ss_pred hhCCCCCCceeeecCcEeEEEEE-ecCCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~-~~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 422 (516)
..++|...++||+|.||+|-.++ ..+++.+|+|++++. ...+...-+.|-++|..-+||.+..|---+...+.++.
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 44678889999999999999998 457899999999862 33455566789999999999999999888899999999
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
||||..||.|...|. ....+++.....+..+|..||.|||+++ ||.||||.+|.|+|.||++||.||||++.--
T Consensus 246 VMeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence 999999999988773 4456888888889999999999999988 9999999999999999999999999998754
Q ss_pred cCCCccCccceecC
Q 010186 503 ESEGEANTVRIVGT 516 (516)
Q Consensus 503 ~~~~~~~~~~~~GT 516 (516)
..... +..++||
T Consensus 320 ~~g~t--~kTFCGT 331 (516)
T KOG0690|consen 320 KYGDT--TKTFCGT 331 (516)
T ss_pred cccce--eccccCC
Confidence 33322 3347887
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.6e-21 Score=176.44 Aligned_cols=142 Identities=22% Similarity=0.223 Sum_probs=112.4
Q ss_pred CceeeecCcEeEEEEEecCCcEEEEEEeccCCcc--c------------------------hHHHHHHHHHHhcCCCCCc
Q 010186 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQ--G------------------------TAEFTNEVLLILKLQHKNL 407 (516)
Q Consensus 354 ~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~--~------------------------~~~~~~Ei~~l~~l~H~ni 407 (516)
...||+|+||.||+|...+|+.||||++++.... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999778999999998763211 0 1124678999999999987
Q ss_pred cceeeEEEeCCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHc-CCCCCeeeCCCCCCCeEecC
Q 010186 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-DSRLRIVHRDLKASNVLLDS 486 (516)
Q Consensus 408 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~iiHrDlk~~NILld~ 486 (516)
.....+... ..+|||||++++++..... ....++..+...++.+++.+|.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 554443332 3489999999886543321 22357788899999999999999999 87 99999999999998
Q ss_pred CCcEEEcccCcccccccC
Q 010186 487 DMNSKISDFGMARIFAES 504 (516)
Q Consensus 487 ~~~~kl~DFGla~~~~~~ 504 (516)
++.++|+|||+++.+..+
T Consensus 153 ~~~~~liDFG~a~~~~~~ 170 (190)
T cd05145 153 DGKPYIIDVSQAVELDHP 170 (190)
T ss_pred CCCEEEEEcccceecCCC
Confidence 899999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.6e-21 Score=201.46 Aligned_cols=154 Identities=24% Similarity=0.383 Sum_probs=120.8
Q ss_pred hhCCCCCCceeeecCcEeEEEEEe-----------------cCCcEEEEEEeccCCccchHH--------------HHHH
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVL-----------------SDGKEVAVKRLSSCSEQGTAE--------------FTNE 395 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~-----------------~~g~~vavK~l~~~~~~~~~~--------------~~~E 395 (516)
..++|.+.++||+|+||.||+|.. ..++.||||++........++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 456889999999999999999963 235679999986533322223 3457
Q ss_pred HHHHhcCCCCCc-----cceeeEEEe--------CCeeEEEEEccCCCChhHHhcCCC---------------------C
Q 010186 396 VLLILKLQHKNL-----VKLLGFCVD--------GDEKLLVYEFMPNGSLDAILFDPR---------------------K 441 (516)
Q Consensus 396 i~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~---------------------~ 441 (516)
+.++.+++|.++ ++++++|.. .+..||||||+++++|.++++... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766654 678888753 346899999999999999885321 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 442 RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 442 ~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
...++|..+..++.|++.+|.|||+.+ ++||||||+|||++.++.+||+|||+++.+..
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~ 361 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCT 361 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCcccccc
Confidence 123567788899999999999999987 99999999999999999999999999976543
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.4e-21 Score=186.74 Aligned_cols=153 Identities=27% Similarity=0.452 Sum_probs=127.7
Q ss_pred CCCCCceeeecCcEeEEEEEecC--CcEEEEEEeccC----------CccchHHHHHHHHHHhc-CCCCCccceeeEEEe
Q 010186 350 NFSDSNILGQGGFGPVYKGVLSD--GKEVAVKRLSSC----------SEQGTAEFTNEVLLILK-LQHKNLVKLLGFCVD 416 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~~--g~~vavK~l~~~----------~~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~ 416 (516)
+|...+.||+|+||.||++.... ++.+++|.+... ......++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36677889999999999999754 678999987531 12234457788888865 799999999999999
Q ss_pred CCeeEEEEEccCCCChhHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEccc
Q 010186 417 GDEKLLVYEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDF 495 (516)
Q Consensus 417 ~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 495 (516)
.+..++||||+++++|.+++... .....+++..++.++.|++.+|.|||+.. +++|+||+|+||++++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999998887431 23446889999999999999999999632 3999999999999999999999999
Q ss_pred CcccccccC
Q 010186 496 GMARIFAES 504 (516)
Q Consensus 496 Gla~~~~~~ 504 (516)
|++......
T Consensus 159 g~~~~~~~~ 167 (269)
T cd08528 159 GLAKQKQPE 167 (269)
T ss_pred cceeecccc
Confidence 999876554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.1e-21 Score=190.18 Aligned_cols=153 Identities=27% Similarity=0.467 Sum_probs=129.7
Q ss_pred HhhCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeCC----
Q 010186 346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD---- 418 (516)
Q Consensus 346 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~---- 418 (516)
...++|...+.||+|+||.||+|... +++.|++|+++... ......+.+|+++++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34567888899999999999999964 58899999986532 233456788999999999999999999987655
Q ss_pred ------eeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEE
Q 010186 419 ------EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKI 492 (516)
Q Consensus 419 ------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl 492 (516)
..++|+||+++ ++..++.. ....+++..+..++.||+.||.|||+.+ ++||||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 68999999986 66666632 2346899999999999999999999987 999999999999999999999
Q ss_pred cccCcccccccC
Q 010186 493 SDFGMARIFAES 504 (516)
Q Consensus 493 ~DFGla~~~~~~ 504 (516)
+|||+++.+...
T Consensus 158 ~dfg~~~~~~~~ 169 (302)
T cd07864 158 ADFGLARLYNSE 169 (302)
T ss_pred CcccccccccCC
Confidence 999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.3e-21 Score=188.21 Aligned_cols=145 Identities=39% Similarity=0.618 Sum_probs=124.3
Q ss_pred ceeeecCcEeEEEEEecC-------CcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 355 NILGQGGFGPVYKGVLSD-------GKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~-------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
+.||+|+||.||++...+ ++.+++|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 358999999999998542 2578999886532 34566799999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCC----CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC-----cEEEcccCc
Q 010186 427 MPNGSLDAILFDPR----KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-----NSKISDFGM 497 (516)
Q Consensus 427 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~-----~~kl~DFGl 497 (516)
+++++|.+++.... ....+++.++..++.||+.||.|||+.+ ++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999885321 2234789999999999999999999987 99999999999999877 899999999
Q ss_pred ccccc
Q 010186 498 ARIFA 502 (516)
Q Consensus 498 a~~~~ 502 (516)
++.+.
T Consensus 158 ~~~~~ 162 (269)
T cd05044 158 ARDIY 162 (269)
T ss_pred ccccc
Confidence 98664
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.6e-22 Score=199.61 Aligned_cols=155 Identities=24% Similarity=0.391 Sum_probs=133.5
Q ss_pred hHHHHHhhCCCCCCceeeecCcEeEEEEE-ecCCcEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCCccceeeEEEe
Q 010186 341 LETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416 (516)
Q Consensus 341 ~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 416 (516)
+..-.....-|...+.||-|.||+|.++. .++...+|+|.|.+.+ .......+.|.+||+....+-||+|+--|.+
T Consensus 621 LkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD 700 (1034)
T KOG0608|consen 621 LKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD 700 (1034)
T ss_pred HHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc
Confidence 33334445567788899999999999998 4556678999997643 3445567889999999999999999999999
Q ss_pred CCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccC
Q 010186 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496 (516)
Q Consensus 417 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 496 (516)
.+.+|+||||++||++..+|- ..+.+.+..+..++.++..|+++.|.-| +|||||||+|||||.+|++||.|||
T Consensus 701 kdnLYFVMdYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFG 774 (1034)
T KOG0608|consen 701 KDNLYFVMDYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFG 774 (1034)
T ss_pred CCceEEEEeccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecc
Confidence 999999999999999999883 4467888888999999999999999887 9999999999999999999999999
Q ss_pred ccccc
Q 010186 497 MARIF 501 (516)
Q Consensus 497 la~~~ 501 (516)
|+.=|
T Consensus 775 LCTGf 779 (1034)
T KOG0608|consen 775 LCTGF 779 (1034)
T ss_pred ccccc
Confidence 98643
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=3e-21 Score=189.33 Aligned_cols=150 Identities=32% Similarity=0.470 Sum_probs=132.8
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV 423 (516)
++|...+.||+|+||.||++... +++.+++|++.+. .....+.+.+|++++.+++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 35777889999999999999964 7899999998652 2233567889999999998 99999999999999999999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
|||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+..
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999843 346999999999999999999999987 99999999999999999999999999987654
Q ss_pred C
Q 010186 504 S 504 (516)
Q Consensus 504 ~ 504 (516)
.
T Consensus 155 ~ 155 (280)
T cd05581 155 N 155 (280)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.8e-21 Score=185.46 Aligned_cols=156 Identities=27% Similarity=0.451 Sum_probs=129.9
Q ss_pred CCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEe--CCeeEEEE
Q 010186 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD--GDEKLLVY 424 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 424 (516)
+|...+.||.|+||.||++.. .+++.+++|.+... .....+.+.+|+++++.++||||+++++.+.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 366778899999999999985 46789999988642 33445678899999999999999999998764 44679999
Q ss_pred EccCCCChhHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCC--CCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 425 EFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDS--RLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
||+++++|.+++... .....+++...+.++.+|+.||.|||..+ ..+++|+||+|+||++++++.+||+|||+++.+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999988532 23457899999999999999999999321 223999999999999999999999999999987
Q ss_pred ccCC
Q 010186 502 AESE 505 (516)
Q Consensus 502 ~~~~ 505 (516)
....
T Consensus 161 ~~~~ 164 (265)
T cd08217 161 GHDS 164 (265)
T ss_pred cCCc
Confidence 6544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.5e-21 Score=186.72 Aligned_cols=148 Identities=31% Similarity=0.434 Sum_probs=131.1
Q ss_pred CCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
+|...+.||+|++|.||++... +++.+++|.+.... ....+.+.+|++++++++||||+++++.+...+..++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 4666788999999999999965 68899999987643 344567899999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHc-CCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
++++|.+++.... ..+++.....++.|++.+|.|||+ .+ ++|+||||+||++++++.+||+|||++..+.
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 9999999985322 568899999999999999999999 76 9999999999999999999999999987664
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.1e-21 Score=199.19 Aligned_cols=148 Identities=26% Similarity=0.402 Sum_probs=127.3
Q ss_pred CCCCCceeeecCcEeEEEEE-ecCCcEEEEEEeccCCccchHHHHHHHHHHhcCC-C-----CCccceeeEEEeCCeeEE
Q 010186 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-H-----KNLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H-----~niv~l~g~~~~~~~~~l 422 (516)
+|.+.++||+|.||.|.++. ..+++.||||+++... ....+-..|+.+|..|+ | -|+|++++++...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 67888999999999999999 5579999999998633 34455678999999986 4 489999999999999999
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC--cEEEcccCcccc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM--NSKISDFGMARI 500 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~--~~kl~DFGla~~ 500 (516)
|+|.++ -+|.+++...+ -..++...+..|+.||+.||.+||+.+ |||.||||+||||.+.. .+||+|||.|..
T Consensus 266 VfELL~-~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhhh-hhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 999884 49999996543 345899999999999999999999988 99999999999996544 699999999976
Q ss_pred ccc
Q 010186 501 FAE 503 (516)
Q Consensus 501 ~~~ 503 (516)
..+
T Consensus 341 ~~q 343 (586)
T KOG0667|consen 341 ESQ 343 (586)
T ss_pred cCC
Confidence 543
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.4e-21 Score=186.93 Aligned_cols=151 Identities=30% Similarity=0.510 Sum_probs=133.9
Q ss_pred hhCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
.++.|...+.||+|++|.||++... ++..+++|.+..... ..+.+.+|+++++.++|+|++++++.+...+..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4456777788999999999999975 688999999976443 56678999999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
|+++++|.+++.... ..+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 999999999995422 36899999999999999999999987 99999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.8e-21 Score=184.46 Aligned_cols=151 Identities=23% Similarity=0.437 Sum_probs=130.7
Q ss_pred CCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
+|...+.||+|+||.||++... +|..+++|.+... +....+.+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677789999999999999964 5889999998652 223456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC-cEEEcccCcccccccC
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-NSKISDFGMARIFAES 504 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~-~~kl~DFGla~~~~~~ 504 (516)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++ .+||+|||.+..+...
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999988532 2335789999999999999999999987 99999999999999885 4699999999877544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.2e-22 Score=213.76 Aligned_cols=148 Identities=31% Similarity=0.497 Sum_probs=119.1
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeC--------
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-------- 417 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-------- 417 (516)
.++|...+.||+|+||.||+++.+ ||+.+|||++... +......+.+|+.++++|+|||||+++..+.+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 345666778999999999999954 8999999999653 344556788999999999999999988411000
Q ss_pred --------------------------------------------------------------------------------
Q 010186 418 -------------------------------------------------------------------------------- 417 (516)
Q Consensus 418 -------------------------------------------------------------------------------- 417 (516)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred -------------------------------CeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 010186 418 -------------------------------DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466 (516)
Q Consensus 418 -------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~ 466 (516)
.-+||-||||+...|.+++....-.. .....++++.+|+.||.|+|+
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHh
Confidence 01367888888888888874322111 356778999999999999999
Q ss_pred CCCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 467 ~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
++ +|||||||.||+||++..|||+|||+|..
T Consensus 716 ~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 716 QG---IIHRDLKPRNIFLDSRNSVKIGDFGLATD 746 (1351)
T ss_pred Cc---eeeccCCcceeEEcCCCCeeecccccchh
Confidence 98 99999999999999999999999999987
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.2e-21 Score=192.89 Aligned_cols=148 Identities=26% Similarity=0.484 Sum_probs=126.8
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCC-----ee
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD-----EK 420 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~ 420 (516)
.++|...++||+|+||.||++.. .+|+.||+|.+.+.. ......+.+|+.++.+++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 35788889999999999999985 468999999987532 234556889999999999999999999876543 57
Q ss_pred EEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
++|+||+++ +|..++. ...+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999975 7777762 245899999999999999999999998 99999999999999999999999999987
Q ss_pred ccc
Q 010186 501 FAE 503 (516)
Q Consensus 501 ~~~ 503 (516)
...
T Consensus 156 ~~~ 158 (336)
T cd07849 156 ADP 158 (336)
T ss_pred ccc
Confidence 654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.4e-21 Score=203.92 Aligned_cols=154 Identities=20% Similarity=0.385 Sum_probs=119.3
Q ss_pred hCCCCCCceeeecCcEeEEEEEecC--CcEEEEE--------------Eecc---CCccchHHHHHHHHHHhcCCCCCcc
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLSD--GKEVAVK--------------RLSS---CSEQGTAEFTNEVLLILKLQHKNLV 408 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~~--g~~vavK--------------~l~~---~~~~~~~~~~~Ei~~l~~l~H~niv 408 (516)
.++|...+.||+|+||.||++..+. +...++| .+.+ ........+.+|++++.+++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4679999999999999999987532 2222222 1110 1122345688999999999999999
Q ss_pred ceeeEEEeCCeeEEEEEccCCCChhHHhcCCCC--CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC
Q 010186 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRK--RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS 486 (516)
Q Consensus 409 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~ 486 (516)
++++++...+..|+|+|++.. +|..++..... .......+...++.||+.||.|||+.+ |+||||||+||||+.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECC
Confidence 999999999999999999854 66665533211 122345667789999999999999988 999999999999999
Q ss_pred CCcEEEcccCcccccccCC
Q 010186 487 DMNSKISDFGMARIFAESE 505 (516)
Q Consensus 487 ~~~~kl~DFGla~~~~~~~ 505 (516)
++.+||+|||+++.+....
T Consensus 303 ~~~vkL~DFGla~~~~~~~ 321 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKER 321 (501)
T ss_pred CCCEEEEeCCCceecCccc
Confidence 9999999999998876543
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.1e-21 Score=192.63 Aligned_cols=150 Identities=29% Similarity=0.454 Sum_probs=128.3
Q ss_pred hhCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCC-----
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD----- 418 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----- 418 (516)
..++|...+.||+|+||.||++.. .++..||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 456788889999999999999984 47899999998642 2223456889999999999999999999987654
Q ss_pred -eeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCc
Q 010186 419 -EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497 (516)
Q Consensus 419 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 497 (516)
..++||||+ +++|..++. ...+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence 358999998 778988873 245889999999999999999999987 99999999999999999999999999
Q ss_pred ccccccC
Q 010186 498 ARIFAES 504 (516)
Q Consensus 498 a~~~~~~ 504 (516)
++.....
T Consensus 165 ~~~~~~~ 171 (343)
T cd07880 165 ARQTDSE 171 (343)
T ss_pred ccccccC
Confidence 9876543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.4e-21 Score=188.32 Aligned_cols=148 Identities=24% Similarity=0.347 Sum_probs=128.5
Q ss_pred CCCCceeeecCcEeEEEEEe----cCCcEEEEEEeccCC----ccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeE
Q 010186 351 FSDSNILGQGGFGPVYKGVL----SDGKEVAVKRLSSCS----EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 421 (516)
|...+.||+|++|.||++.. .+++.++||.+++.. ....+.+.+|+.++.++ +||||+++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 56678899999999999884 357889999986522 23345688999999999 6999999999999999999
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+||||+++|+|.+++.. ...+++.....++.|++++|.|||+.+ ++||||+|+||+++.++.++|+|||+++.+
T Consensus 82 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 82 LILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 99999999999998842 346889999999999999999999987 999999999999999999999999999876
Q ss_pred ccC
Q 010186 502 AES 504 (516)
Q Consensus 502 ~~~ 504 (516)
...
T Consensus 156 ~~~ 158 (288)
T cd05583 156 LAE 158 (288)
T ss_pred ccc
Confidence 543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=185.92 Aligned_cols=142 Identities=30% Similarity=0.393 Sum_probs=118.8
Q ss_pred eeeecCcEeEEEEEe-cCCcEEEEEEeccCCc---cchHHHHHHHH---HHhcCCCCCccceeeEEEeCCeeEEEEEccC
Q 010186 356 ILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSE---QGTAEFTNEVL---LILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 428 (516)
Q Consensus 356 ~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~Ei~---~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 428 (516)
+||+|+||.||++.. .+++.||+|.+.+... .....+..|.. .+....||||+++++.+...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 4688999999865321 11223444443 3444589999999999999999999999999
Q ss_pred CCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
+++|..++. ....+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+||+|||+++.+..
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~ 149 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK 149 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCc
Confidence 999998883 3456899999999999999999999987 99999999999999999999999999986643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.7e-21 Score=187.38 Aligned_cols=150 Identities=27% Similarity=0.407 Sum_probs=128.4
Q ss_pred CCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEEEE
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLLVYE 425 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~E 425 (516)
+|...+.||.|++|.||++... +++.+++|.+.... ......+.+|++++++++||||+++++++... +..++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 5667789999999999999964 67899999987532 23456789999999999999999999998654 36899999
Q ss_pred ccCCCChhHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 426 FMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 426 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
|+++++|.+++... .....+++.....++.||+.||.|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999998876421 23345888999999999999999999987 9999999999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-20 Score=188.54 Aligned_cols=147 Identities=29% Similarity=0.472 Sum_probs=126.7
Q ss_pred CCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 351 FSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
|...+.||+|+||.||++.. .+++.+++|++.... ......+.+|+.+++.++|||++++++++.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 55678899999999999995 468899999986432 23345788999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
+++ +|.+++.. ....+++.++..++.+|+.||.|||+.+ ++||||+|+||+++.++.+||+|||+++....
T Consensus 107 ~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 107 CLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred CCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 975 77666632 2345899999999999999999999987 99999999999999999999999999876654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=188.08 Aligned_cols=151 Identities=32% Similarity=0.503 Sum_probs=128.2
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLL 422 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 422 (516)
.++|...+.||+|+||.||++.. .+|+.||+|.++... ......+.+|+.++.+++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 35678889999999999999996 468999999986432 22233567899999999999999999998765 46899
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
||||+++ +|.+++... ...+++.++..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+.
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 788777432 356899999999999999999999998 9999999999999999999999999998775
Q ss_pred cC
Q 010186 503 ES 504 (516)
Q Consensus 503 ~~ 504 (516)
..
T Consensus 160 ~~ 161 (309)
T cd07845 160 LP 161 (309)
T ss_pred Cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=188.38 Aligned_cols=150 Identities=31% Similarity=0.518 Sum_probs=126.1
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCe------
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE------ 419 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~------ 419 (516)
++|...+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++++++||||+++++++...+.
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46778899999999999999964 68899999886432 2233456789999999999999999999876543
Q ss_pred --eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCc
Q 010186 420 --KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497 (516)
Q Consensus 420 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 497 (516)
.++||||+++ +|..++.. ....+++.++..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 4999999975 77777643 2346899999999999999999999987 99999999999999999999999999
Q ss_pred ccccccC
Q 010186 498 ARIFAES 504 (516)
Q Consensus 498 a~~~~~~ 504 (516)
++.+...
T Consensus 166 ~~~~~~~ 172 (310)
T cd07865 166 ARAFSLS 172 (310)
T ss_pred cccccCC
Confidence 9877543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.9e-21 Score=192.63 Aligned_cols=149 Identities=32% Similarity=0.541 Sum_probs=126.8
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC--CccchHHHHHHHHHHhcC-CCCCccceeeEEEeC--CeeE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDG--DEKL 421 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~--~~~~ 421 (516)
.++|...+.||+|+||.||+|... +++.+++|++... .......+.+|+.++.++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 356777889999999999999964 6889999988542 233455678899999999 999999999998654 3689
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+||||++ ++|..++.. ..+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+
T Consensus 86 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999997 588888732 26789999999999999999999987 999999999999999999999999999876
Q ss_pred ccC
Q 010186 502 AES 504 (516)
Q Consensus 502 ~~~ 504 (516)
...
T Consensus 158 ~~~ 160 (337)
T cd07852 158 SEL 160 (337)
T ss_pred ccc
Confidence 543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-21 Score=191.40 Aligned_cols=162 Identities=28% Similarity=0.348 Sum_probs=141.1
Q ss_pred HHHhhCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEecc---CCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 010186 344 LNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 419 (516)
Q Consensus 344 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 419 (516)
..+..+.|..-++||+|+||.||-++.. +|+-+|.|++.+ ...+....-++|-.+|.+++.+.||.+--.++..+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 3445567888899999999999999854 688889998864 233445567899999999999999999999999999
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccc
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 499 (516)
++||+..|.||+|.-.+... ....+++..++.++.+|+.||++||+.. ||.|||||+|||||+.|+++|+|+|||.
T Consensus 260 LClVLtlMNGGDLkfHiyn~-g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAv 335 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNH-GNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAV 335 (591)
T ss_pred eEEEEEeecCCceeEEeecc-CCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEE
Confidence 99999999999998888543 3357999999999999999999999987 9999999999999999999999999999
Q ss_pred ccccCCCccC
Q 010186 500 IFAESEGEAN 509 (516)
Q Consensus 500 ~~~~~~~~~~ 509 (516)
.+.+.+...+
T Consensus 336 ei~~g~~~~~ 345 (591)
T KOG0986|consen 336 EIPEGKPIRG 345 (591)
T ss_pred ecCCCCcccc
Confidence 9988776554
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=185.50 Aligned_cols=149 Identities=30% Similarity=0.521 Sum_probs=129.4
Q ss_pred CCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEEEE
Q 010186 351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLLVYE 425 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~E 425 (516)
|...+.||+|+||.||++... +++.+++|++... .......+.+|+++++.++|||++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 455678999999999999965 5889999999764 233456788999999999999999999999988 78999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCC
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 505 (516)
|+++ +|.+++... ...+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+....
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9985 888887432 246899999999999999999999987 9999999999999999999999999998776543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.7e-21 Score=201.33 Aligned_cols=151 Identities=22% Similarity=0.330 Sum_probs=120.5
Q ss_pred HHHHhhCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCC------CCccceeeEEE
Q 010186 343 TLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH------KNLVKLLGFCV 415 (516)
Q Consensus 343 ~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H------~niv~l~g~~~ 415 (516)
++....++|.+.++||+|+||.||++.. .+++.||||+++... .....+..|+.++..++| ++++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 3445678899999999999999999985 467889999996532 233455667777776654 45888888887
Q ss_pred eC-CeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC-CCCCeeeCCCCCCCeEecCCC-----
Q 010186 416 DG-DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDM----- 488 (516)
Q Consensus 416 ~~-~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~iiHrDlk~~NILld~~~----- 488 (516)
.. ...++|||++ +++|.+++. ..+.+++..+..|+.||+.||.|||++ + ||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIM---KHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence 64 4678999988 667877773 335689999999999999999999974 6 99999999999998765
Q ss_pred -----------cEEEcccCccccc
Q 010186 489 -----------NSKISDFGMARIF 501 (516)
Q Consensus 489 -----------~~kl~DFGla~~~ 501 (516)
.+||+|||++...
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~ 298 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDE 298 (467)
T ss_pred ccccccCCCCceEEECCCCccccC
Confidence 4999999988653
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.9e-21 Score=192.40 Aligned_cols=148 Identities=25% Similarity=0.456 Sum_probs=127.5
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEe----CCeeE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVD----GDEKL 421 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~ 421 (516)
++|...+.||+|+||.||++.. .+++.|++|++.... ......+.+|+.+++.++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 5788889999999999999995 468999999987532 2345678889999999999999999998763 34679
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+|+||+. ++|.+++. ....+++.....++.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++.+
T Consensus 85 lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 85 VVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 9999996 58888883 3345899999999999999999999987 999999999999999999999999999876
Q ss_pred cc
Q 010186 502 AE 503 (516)
Q Consensus 502 ~~ 503 (516)
..
T Consensus 158 ~~ 159 (334)
T cd07855 158 SS 159 (334)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.6e-21 Score=207.24 Aligned_cols=159 Identities=33% Similarity=0.480 Sum_probs=137.2
Q ss_pred HHHHhhCCCCCCceeeecCcEeEEEEEec----C----CcEEEEEEecc-CCccchHHHHHHHHHHhcC-CCCCccceee
Q 010186 343 TLNLATSNFSDSNILGQGGFGPVYKGVLS----D----GKEVAVKRLSS-CSEQGTAEFTNEVLLILKL-QHKNLVKLLG 412 (516)
Q Consensus 343 ~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~----~----g~~vavK~l~~-~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g 412 (516)
.+++..+++...+.||+|.||.|++|... . ...||||.++. ....+.+.+..|+++|+.+ .|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 55666667777779999999999999843 1 45789999986 3445678899999999999 7999999999
Q ss_pred EEEeCCeeEEEEEccCCCChhHHhcCCC-------C----C--CCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCC
Q 010186 413 FCVDGDEKLLVYEFMPNGSLDAILFDPR-------K----R--GILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKA 479 (516)
Q Consensus 413 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-------~----~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~ 479 (516)
+|.+.+..++|+||++.|+|.++|...+ . . ..++..+.+.++.||+.||+||++.. +|||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999999999999999999999996544 0 0 24889999999999999999999986 99999999
Q ss_pred CCeEecCCCcEEEcccCcccccccC
Q 010186 480 SNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 480 ~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
+||||.++..+||+||||||.....
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~ 471 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNK 471 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCC
Confidence 9999999999999999999965443
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2e-20 Score=185.34 Aligned_cols=149 Identities=27% Similarity=0.440 Sum_probs=125.4
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
++|...+.||+|++|.||++... +++.|++|.+.... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 45777889999999999999964 68899999886532 2334578899999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC-CCcEEEcccCcccccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARIFA 502 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~-~~~~kl~DFGla~~~~ 502 (516)
|+++ +|.+++.. .....+++.....++.||+.||.|||+.+ ++||||+|+||+++. ++.+||+|||+++...
T Consensus 82 ~~~~-~l~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLDL-DLKKHMDS-SPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred cccc-cHHHHHHh-CCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 9964 77776632 22334678888899999999999999987 999999999999985 5679999999998654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.1e-22 Score=179.17 Aligned_cols=156 Identities=22% Similarity=0.479 Sum_probs=132.9
Q ss_pred ccchHHHHHhh---CCCCCCceeeecCcEeEEEEE-ecCCcEEEEEEeccCCccchHHHHHHHHHHhcCC-CCCccceee
Q 010186 338 FIDLETLNLAT---SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLG 412 (516)
Q Consensus 338 ~~~~~~l~~~~---~~f~~~~~Lg~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g 412 (516)
++++|...+.+ ++|++.+++|+|.++.||.|. ..+.++++||++++. ..+.+.+|+.+|..|. ||||++|++
T Consensus 24 YWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~D 100 (338)
T KOG0668|consen 24 YWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLD 100 (338)
T ss_pred hcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhh
Confidence 45666555444 457778899999999999999 567889999999874 3467899999999995 999999999
Q ss_pred EEEeCCe--eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC-c
Q 010186 413 FCVDGDE--KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-N 489 (516)
Q Consensus 413 ~~~~~~~--~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~-~ 489 (516)
+..++.. .-||+||+.+.+...+. ..|+..++..++.++++||.|+|+.| |+|||+||.|++||... .
T Consensus 101 iV~Dp~SktpaLiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rk 171 (338)
T KOG0668|consen 101 IVKDPESKTPSLIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRK 171 (338)
T ss_pred hhcCccccCchhHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhce
Confidence 9987654 57999999999887665 45788889999999999999999998 99999999999999764 6
Q ss_pred EEEcccCcccccccCC
Q 010186 490 SKISDFGMARIFAESE 505 (516)
Q Consensus 490 ~kl~DFGla~~~~~~~ 505 (516)
++|+|+|||.++.+..
T Consensus 172 LrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 172 LRLIDWGLAEFYHPGK 187 (338)
T ss_pred eeeeecchHhhcCCCc
Confidence 9999999999887654
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.1e-20 Score=180.59 Aligned_cols=152 Identities=25% Similarity=0.426 Sum_probs=133.9
Q ss_pred CCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
+|...+.||.|+||.||++... +++.+++|++.... ......+.+|+++++.++|||++++.+.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4667788999999999999964 68899999987543 24566789999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 427 MPNGSLDAILFDPR-KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 427 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
+++++|.+++.... ....+++.....++.+++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999885422 2367899999999999999999999987 999999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=184.36 Aligned_cols=147 Identities=29% Similarity=0.468 Sum_probs=127.7
Q ss_pred CCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 351 FSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
|+..+.||+|++|.||++.. .+|..|++|++.... ......+.+|+++++.++|||++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 45668899999999999985 478999999986532 223457889999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
+ ++|.+++... ....+++..+..++.|+++||.|||+.+ ++||||+|+||+++.++.+||+|||+++.+.
T Consensus 81 ~-~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~ 150 (283)
T cd07835 81 D-LDLKKYMDSS-PLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFG 150 (283)
T ss_pred C-cCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence 5 6898888432 2246899999999999999999999987 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=182.07 Aligned_cols=142 Identities=25% Similarity=0.366 Sum_probs=120.1
Q ss_pred ceeeecCcEeEEEEEe-cCCcEEEEEEeccCCc---cchHHHHHHHHHH-hcCCCCCccceeeEEEeCCeeEEEEEccCC
Q 010186 355 NILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSE---QGTAEFTNEVLLI-LKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~Ei~~l-~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 429 (516)
+.||+|+||.||++.. .+++.||+|.+.+... .....+..|..++ ...+|+|++++++.+...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999985 4688999999865321 2223445555444 455899999999999999999999999999
Q ss_pred CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
++|.+++. ....+++..+..++.||+.||.|||+.+ ++||||+|+||++++++.+||+|||+++...
T Consensus 82 ~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 82 GDCASLIK---TLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 99999984 3346889999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=190.29 Aligned_cols=155 Identities=29% Similarity=0.432 Sum_probs=130.3
Q ss_pred hHHHHHhhCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 010186 341 LETLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG 417 (516)
Q Consensus 341 ~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 417 (516)
..++...+++|...+.||+|+||.||++.. .+++.||+|++... +....+.+.+|+.++.+++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 345556778899999999999999999984 57889999998753 222345688999999999999999999988643
Q ss_pred ------CeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEE
Q 010186 418 ------DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSK 491 (516)
Q Consensus 418 ------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~k 491 (516)
...++++|++ +++|.+++. ...+++..+..++.||++||.|||+.+ ++||||||+||++++++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 2367888876 789988873 235889999999999999999999987 99999999999999999999
Q ss_pred EcccCccccccc
Q 010186 492 ISDFGMARIFAE 503 (516)
Q Consensus 492 l~DFGla~~~~~ 503 (516)
|+|||+++....
T Consensus 161 l~dfg~~~~~~~ 172 (345)
T cd07877 161 ILDFGLARHTDD 172 (345)
T ss_pred Eecccccccccc
Confidence 999999987543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=190.10 Aligned_cols=149 Identities=26% Similarity=0.484 Sum_probs=127.7
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCC-----ee
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD-----EK 420 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~ 420 (516)
++|...+.||+|+||.||++.. .+++.|+||.+... .......+.+|+.++..++|+||+++++++.... ..
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 4678889999999999999995 46899999998652 2334556788999999999999999999886543 47
Q ss_pred EEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
++|+||+. ++|.+++. ....+++.....++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 85 YIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 99999996 68888873 3456899999999999999999999987 99999999999999999999999999987
Q ss_pred cccC
Q 010186 501 FAES 504 (516)
Q Consensus 501 ~~~~ 504 (516)
....
T Consensus 158 ~~~~ 161 (337)
T cd07858 158 TSEK 161 (337)
T ss_pred cCCC
Confidence 6543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=190.66 Aligned_cols=148 Identities=30% Similarity=0.424 Sum_probs=125.7
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCC------
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD------ 418 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 418 (516)
.++|...+.||+|+||.||++.. .+++.||+|.+... +......+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 46788889999999999999995 47899999998642 2334456788999999999999999999886442
Q ss_pred eeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcc
Q 010186 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (516)
Q Consensus 419 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 498 (516)
..++||||+++ +|.+.+.. .+++.....++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 95 DVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred cEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccc
Confidence 46999999964 77777632 2788899999999999999999987 999999999999999999999999999
Q ss_pred cccccC
Q 010186 499 RIFAES 504 (516)
Q Consensus 499 ~~~~~~ 504 (516)
+.....
T Consensus 166 ~~~~~~ 171 (353)
T cd07850 166 RTAGTS 171 (353)
T ss_pred eeCCCC
Confidence 876543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-21 Score=172.48 Aligned_cols=161 Identities=24% Similarity=0.386 Sum_probs=134.0
Q ss_pred hHHHHHhhCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEecc-CCccchHHHHHHHHHHhcC-CCCCccceeeEEEeC
Q 010186 341 LETLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSS-CSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDG 417 (516)
Q Consensus 341 ~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~-~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 417 (516)
.+.++++.+.+.....||+|++|.|-+-++ .+|+..|+|++.. ...+.+++.++|+++..+- ..|.+|+++|.....
T Consensus 38 ~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re 117 (282)
T KOG0984|consen 38 DRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE 117 (282)
T ss_pred cCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc
Confidence 334556666666677899999999988874 5799999999975 4567778889999887665 899999999999999
Q ss_pred CeeEEEEEccCCCChhHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccC
Q 010186 418 DEKLLVYEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496 (516)
Q Consensus 418 ~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 496 (516)
...|+.||.|. .+|+.+..+- ..++.+++.-.-+|+..|..||.|||++- .+||||+||+||||+.+|++||||||
T Consensus 118 gdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFG 194 (282)
T KOG0984|consen 118 GDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFG 194 (282)
T ss_pred ccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccc
Confidence 99999999994 4777664321 35567888888899999999999999864 69999999999999999999999999
Q ss_pred cccccccC
Q 010186 497 MARIFAES 504 (516)
Q Consensus 497 la~~~~~~ 504 (516)
.+..+.++
T Consensus 195 IsG~L~dS 202 (282)
T KOG0984|consen 195 ISGYLVDS 202 (282)
T ss_pred cceeehhh
Confidence 99877654
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-20 Score=188.92 Aligned_cols=143 Identities=29% Similarity=0.433 Sum_probs=124.1
Q ss_pred CCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccc--------------hHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 010186 353 DSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQG--------------TAEFTNEVLLILKLQHKNLVKLLGFCVDG 417 (516)
Q Consensus 353 ~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~--------------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 417 (516)
..+.||.|+||.||++... +++.||+|.++...... ...+.+|++++..++||||+++++++...
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 3567999999999999954 68999999986532211 12478999999999999999999999999
Q ss_pred CeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCc
Q 010186 418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497 (516)
Q Consensus 418 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 497 (516)
+..++||||++ |+|.+++. ....+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred CcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCccc
Confidence 99999999997 58888883 3345889999999999999999999987 99999999999999999999999999
Q ss_pred ccccc
Q 010186 498 ARIFA 502 (516)
Q Consensus 498 a~~~~ 502 (516)
++.+.
T Consensus 166 ~~~~~ 170 (335)
T PTZ00024 166 ARRYG 170 (335)
T ss_pred eeecc
Confidence 98765
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=181.69 Aligned_cols=152 Identities=29% Similarity=0.493 Sum_probs=132.2
Q ss_pred CCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
+|...+.||+|+||.||++.. .+++.+++|.+... ......++.+|+++++.++|+||+++++.+......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 366778899999999999984 46889999998753 234456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 427 MPNGSLDAILFDPR-KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 427 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 99999999874321 2356889999999999999999999988 999999999999999999999999999877554
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.3e-20 Score=188.17 Aligned_cols=150 Identities=29% Similarity=0.442 Sum_probs=128.4
Q ss_pred HhhCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEe-CCeeE
Q 010186 346 LATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD-GDEKL 421 (516)
Q Consensus 346 ~~~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~ 421 (516)
..+++|...+.||+|+||.||++.. .+++.|++|++.+. .....+.+.+|++++..++||||+++.+++.. .+..+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 4567899999999999999999984 47899999988642 22345678899999999999999999999876 45789
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+|+||+ +++|..++. ...+++.....++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++..
T Consensus 87 lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 87 FVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 999998 568888873 235788888899999999999999987 999999999999999999999999999865
Q ss_pred cc
Q 010186 502 AE 503 (516)
Q Consensus 502 ~~ 503 (516)
..
T Consensus 159 ~~ 160 (328)
T cd07856 159 DP 160 (328)
T ss_pred CC
Confidence 43
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.8e-20 Score=182.81 Aligned_cols=146 Identities=24% Similarity=0.373 Sum_probs=122.6
Q ss_pred CCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC-CccchHHHHHHHHHHhcCC-CCCccceeeEEEeC--CeeEEEEE
Q 010186 351 FSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDG--DEKLLVYE 425 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E 425 (516)
|...+.||+|+||.||++.. .+++.+++|+++.. .........+|+.++.++. |+||+++++++.++ +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 44567899999999999995 46889999998753 2223334567888999885 99999999999987 88999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
|+++ +|.+++.. ....+++.++..++.||+.||.|||+.+ ++||||+|+||+++. +.+||+|||+++.+..
T Consensus 81 ~~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 81 LMDM-NLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred cCCc-cHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 9974 77776643 2346899999999999999999999987 999999999999999 9999999999987643
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.7e-20 Score=186.92 Aligned_cols=147 Identities=29% Similarity=0.427 Sum_probs=122.9
Q ss_pred CCCCCceeeecCcEeEEEEEec-C--CcEEEEEEeccC--CccchHHHHHHHHHHhcC-CCCCccceeeEEEeC----Ce
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS-D--GKEVAVKRLSSC--SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDG----DE 419 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~-~--g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~----~~ 419 (516)
+|...+.||+|+||.||++... . +..+|+|++... .....+.+.+|+.++.++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 3566788999999999999954 3 778999998642 222355688999999999 599999999876533 34
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccc
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 499 (516)
.++++||++ ++|.+++. ....+++..+..++.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 688899886 58888873 3456899999999999999999999988 9999999999999999999999999998
Q ss_pred cccc
Q 010186 500 IFAE 503 (516)
Q Consensus 500 ~~~~ 503 (516)
.+..
T Consensus 154 ~~~~ 157 (332)
T cd07857 154 GFSE 157 (332)
T ss_pred eccc
Confidence 7654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.1e-20 Score=184.24 Aligned_cols=151 Identities=26% Similarity=0.468 Sum_probs=126.1
Q ss_pred hhCCCCCCceeeecCcEeEEEEEecC-CcEEEEEEeccCC-ccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEE
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCS-EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 423 (516)
..++|...+.||+|+||.||++...+ ++.||||.++... ......+..|+.++.+. .||||+++++++......+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34567778899999999999999764 8899999997532 23345677788777666 599999999999999999999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC-CCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
|||+++ +|.+++.. ....+++..+..++.+|++||.|||+. + ++||||+|+||++++++.+||+|||+++.+.
T Consensus 93 ~e~~~~-~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 93 MELMST-CLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eeccCc-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 999854 77766633 234689999999999999999999974 5 9999999999999999999999999998764
Q ss_pred c
Q 010186 503 E 503 (516)
Q Consensus 503 ~ 503 (516)
.
T Consensus 167 ~ 167 (296)
T cd06618 167 D 167 (296)
T ss_pred C
Confidence 3
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.3e-20 Score=178.91 Aligned_cols=145 Identities=22% Similarity=0.315 Sum_probs=118.8
Q ss_pred CCCCCCcee--eecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNIL--GQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~L--g~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...+.+ |+|+||.||++.. .++..+++|.+........ |+.....+ +||||+++++.+...+..++||
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~ 88 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIM 88 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEE
Confidence 455555555 9999999999995 4678899998865321111 22222222 7999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC-cEEEcccCccccccc
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-NSKISDFGMARIFAE 503 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~-~~kl~DFGla~~~~~ 503 (516)
||+++++|.+++.. ...+++.++..++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||+++....
T Consensus 89 e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 89 DYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred EcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence 99999999999843 237899999999999999999999988 99999999999999998 999999999987654
Q ss_pred C
Q 010186 504 S 504 (516)
Q Consensus 504 ~ 504 (516)
.
T Consensus 163 ~ 163 (267)
T PHA03390 163 P 163 (267)
T ss_pred C
Confidence 3
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=2e-20 Score=188.51 Aligned_cols=148 Identities=29% Similarity=0.474 Sum_probs=129.7
Q ss_pred CCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeCC-----eeE
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD-----EKL 421 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~ 421 (516)
+|...+.||+|+||.||++... +++.+++|++.... ....+.+.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4677889999999999999964 58899999987633 345567999999999999999999999998775 789
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+||||++ ++|.+++. ....+++..+..++.+|+.||.|||+.+ ++||||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIK---SPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999998 47888874 3347899999999999999999999988 999999999999999999999999999877
Q ss_pred ccC
Q 010186 502 AES 504 (516)
Q Consensus 502 ~~~ 504 (516)
...
T Consensus 154 ~~~ 156 (330)
T cd07834 154 DPD 156 (330)
T ss_pred ccc
Confidence 654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.8e-21 Score=211.15 Aligned_cols=151 Identities=32% Similarity=0.474 Sum_probs=132.4
Q ss_pred hCCCCCCceeeecCcEeEEEEE-ecCCcEEEEEEecc--CCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~-~~~g~~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
+-+|+.+..||.|.||.||.+. .++|+..|+|-++- ......+...+|+.++..++|||+|+++|+=.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 3467788999999999999999 66799999998764 33445667889999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
|||++|+|.+.+. ....+++.-...+..|++.|+.|||+++ ||||||||.||+||.+|.+|++|||.|+.+..+
T Consensus 1314 EyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 9999999999983 3334555556678899999999999998 999999999999999999999999999988765
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.1e-20 Score=182.70 Aligned_cols=148 Identities=32% Similarity=0.453 Sum_probs=126.9
Q ss_pred CCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCc-cchHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEEcc
Q 010186 351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE-QGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
|...+.||+|++|.||+|... +++.|++|++..... .......+|+..+.+++ ||||+++++.+..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 456788999999999999975 578899999865322 22334567999999998 999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
+|+|.+++... ....+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||+++....
T Consensus 81 -~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 81 -EGNLYQLMKDR-KGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRS 151 (283)
T ss_pred -CCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence 78888877432 2346899999999999999999999987 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.1e-20 Score=182.53 Aligned_cols=146 Identities=30% Similarity=0.473 Sum_probs=124.9
Q ss_pred CCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 351 FSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
|...+.||+|+||.||+|.. .+++.|++|++.... ......+.+|+++++.++|||++++++++.+.+..|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 45567799999999999995 468899999986432 22345688999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
++ |+|.+++.. ....+++.++..++.||+.+|.|||+.+ ++|+||+|+||+++.++.+||+|||++....
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~ 172 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS 172 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC
Confidence 96 467666632 2346899999999999999999999987 9999999999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-20 Score=189.58 Aligned_cols=150 Identities=27% Similarity=0.399 Sum_probs=127.3
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC--------ccchHHHHHHHHHHhcCC---CCCccceeeEEEe
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--------EQGTAEFTNEVLLILKLQ---HKNLVKLLGFCVD 416 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~ 416 (516)
.+|...+.||+|+||.|+.++.+ +..+|+||.+.+.. ....-..-.||.+|..++ |+||++++.+|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45788899999999999999964 56789999887622 112223567999999997 9999999999999
Q ss_pred CCeeEEEEEcc-CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEccc
Q 010186 417 GDEKLLVYEFM-PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDF 495 (516)
Q Consensus 417 ~~~~~lV~Ey~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 495 (516)
++..||+||-. ++-+|.+++ ..+..+++.++.-|+.||+-|+++||+++ |||||||-+||.+|.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 99999999976 455677777 34566999999999999999999999998 999999999999999999999999
Q ss_pred CcccccccC
Q 010186 496 GMARIFAES 504 (516)
Q Consensus 496 Gla~~~~~~ 504 (516)
|-|......
T Consensus 715 gsaa~~ksg 723 (772)
T KOG1152|consen 715 GSAAYTKSG 723 (772)
T ss_pred cchhhhcCC
Confidence 998776544
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.9e-20 Score=185.02 Aligned_cols=143 Identities=21% Similarity=0.223 Sum_probs=122.4
Q ss_pred ceeeecCcEeEEEEEecCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCCCh
Q 010186 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 432 (516)
+.+|.|+++.||++.. +++.||+|++... +....+.+.+|+++++.++||||+++++++...+..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 4455566666666655 7899999998753 344567899999999999999999999999999999999999999999
Q ss_pred hHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
.+++... ....+++.....++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||.+..+.
T Consensus 87 ~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~ 152 (314)
T cd08216 87 EDLLKTH-FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMI 152 (314)
T ss_pred HHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeec
Confidence 9998543 2345888999999999999999999987 9999999999999999999999999987654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.6e-20 Score=184.72 Aligned_cols=150 Identities=31% Similarity=0.484 Sum_probs=125.9
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeCC------
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD------ 418 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 418 (516)
.++|...++||+|+||.||++... +++.+++|++.... ......+.+|+++++.++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 357888899999999999999954 68899999886532 222346789999999999999999999876543
Q ss_pred --eeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccC
Q 010186 419 --EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496 (516)
Q Consensus 419 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 496 (516)
..++|+||+++ +|...+.. ....+++..+..++.||++||.|||+.+ ++|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 36999999975 56666533 2346899999999999999999999998 9999999999999999999999999
Q ss_pred ccccccc
Q 010186 497 MARIFAE 503 (516)
Q Consensus 497 la~~~~~ 503 (516)
+++....
T Consensus 161 ~~~~~~~ 167 (311)
T cd07866 161 LARPYDG 167 (311)
T ss_pred cchhccC
Confidence 9987654
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.7e-20 Score=183.53 Aligned_cols=148 Identities=32% Similarity=0.499 Sum_probs=126.2
Q ss_pred CCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
|...+.||+|+||.||+|... +++.+++|.+... ......++.+|+++++.++|+|++++++++...+..++|+||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 555678999999999999954 6788999988642 223345688999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
+. |+|.+++.. ....+++..+..++.+++.||.|||+.+ ++||||+|+||+++.++.+||+|||++..+...
T Consensus 97 ~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 97 CL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred cC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 97 577766632 2345889999999999999999999987 999999999999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.8e-20 Score=183.62 Aligned_cols=150 Identities=28% Similarity=0.431 Sum_probs=123.8
Q ss_pred CCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEEc
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
+|...+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. ||||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3445577999999999999954 68899999987532 344567889999999995 99999999999999999999999
Q ss_pred cCCCChhHHhcC--CCCCCCCCHHHHHHHHHHHHHHHHHhHcC-CCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 427 MPNGSLDAILFD--PRKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 427 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
++. ++.++... ......+++.....++.+++.||+|||+. + ++||||||+||++++++.+||+|||+++.+..
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 864 55443211 12235689999999999999999999975 5 99999999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.8e-20 Score=185.78 Aligned_cols=141 Identities=25% Similarity=0.337 Sum_probs=122.0
Q ss_pred eeeec--CcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCC
Q 010186 356 ILGQG--GFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNG 430 (516)
Q Consensus 356 ~Lg~G--~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 430 (516)
.||+| +||+||++.. .+|+.||+|++... .....+.+.+|+.+++.++||||+++++++..++..++|+||++++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999995 47899999998653 2234567899999999999999999999999999999999999999
Q ss_pred ChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 431 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
+|.+++... ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+|++||+.+..
T Consensus 85 ~l~~~l~~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~ 150 (328)
T cd08226 85 SANSLLKTY-FPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYS 150 (328)
T ss_pred CHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhh
Confidence 999988542 2235889999999999999999999987 99999999999999999999999986543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.3e-20 Score=187.22 Aligned_cols=146 Identities=32% Similarity=0.507 Sum_probs=125.9
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeC----------
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG---------- 417 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~---------- 417 (516)
.+|...+.||.|+||.||++.. .+++.|++|.+........+.+.+|++++++++||||+++++.+...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 5788889999999999999995 46889999998766556677899999999999999999999876544
Q ss_pred ----CeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC-CCcEEE
Q 010186 418 ----DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKI 492 (516)
Q Consensus 418 ----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~-~~~~kl 492 (516)
...++|+||++ ++|.+++. ...+++.....++.||+.||.|||+.+ ++||||||+||+++. +..+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 35789999997 58888773 235889999999999999999999987 999999999999975 557899
Q ss_pred cccCcccccc
Q 010186 493 SDFGMARIFA 502 (516)
Q Consensus 493 ~DFGla~~~~ 502 (516)
+|||+++.+.
T Consensus 157 ~dfg~~~~~~ 166 (342)
T cd07854 157 GDFGLARIVD 166 (342)
T ss_pred CCcccceecC
Confidence 9999998764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.1e-22 Score=181.51 Aligned_cols=150 Identities=31% Similarity=0.575 Sum_probs=123.3
Q ss_pred CCCCceeeecCcEeEEEEEec-CCcEEEEEEecc--CCccchHHHHHHHHHHhcCCCCCccceeeEEEeC--------Ce
Q 010186 351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--------DE 419 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--------~~ 419 (516)
|....+||+|.||.||+++.. +|+.||+|++-- .....-..-.+|+++|..++|+|++.+++.|... ..
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 344567999999999999954 577888886532 2233345568999999999999999999988532 34
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccc
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 499 (516)
.|||+++++. +|.-+|.+ ....++..++..++.++..||.|+|... |+|||+||.|+||+.++.+||+|||++|
T Consensus 99 ~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred eeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccccc
Confidence 7999999987 77777743 3356888999999999999999999887 9999999999999999999999999999
Q ss_pred ccccCCC
Q 010186 500 IFAESEG 506 (516)
Q Consensus 500 ~~~~~~~ 506 (516)
.+...+.
T Consensus 173 ~fs~~~n 179 (376)
T KOG0669|consen 173 AFSTSKN 179 (376)
T ss_pred ceecccc
Confidence 8876554
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=7e-20 Score=176.57 Aligned_cols=142 Identities=30% Similarity=0.408 Sum_probs=126.0
Q ss_pred eeecCcEeEEEEEec-CCcEEEEEEeccCCc---cchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCCCh
Q 010186 357 LGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE---QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432 (516)
Q Consensus 357 Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 432 (516)
||+|+||.||++... +++.+++|.+..... .....+.+|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999965 588999999875322 2455789999999999999999999999999999999999999999
Q ss_pred hHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
.+++.. ...+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 146 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSE 146 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence 999843 336899999999999999999999987 999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.3e-22 Score=181.35 Aligned_cols=150 Identities=29% Similarity=0.472 Sum_probs=125.2
Q ss_pred CceeeecCcEeEEEEE-ecCCcEEEEEEecc--CCccchHHHHHHHHHHhcCCCCCccceeeEEEeCC-----eeEEEEE
Q 010186 354 SNILGQGGFGPVYKGV-LSDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD-----EKLLVYE 425 (516)
Q Consensus 354 ~~~Lg~G~fg~Vy~~~-~~~g~~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~lV~E 425 (516)
.+-||-|.||.||..+ -++|+.|+.|++.. .+-...+.+.+|++++..++|.|+...++...-.+ +.|++.|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 4679999999999998 45899999998864 23334567889999999999999999998876543 4678888
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCC
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 505 (516)
.| ..+|..++. ..+.++...+.-+..||++||+|||+.+ |.||||||.|.|++++-.+||+||||||.-..++
T Consensus 138 Lm-QSDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 138 LM-QSDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HH-Hhhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhh
Confidence 88 447888874 3456888888889999999999999998 9999999999999999999999999999877666
Q ss_pred CccCc
Q 010186 506 GEANT 510 (516)
Q Consensus 506 ~~~~~ 510 (516)
....|
T Consensus 211 ~~hMT 215 (449)
T KOG0664|consen 211 RLNMT 215 (449)
T ss_pred hhhhH
Confidence 54443
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=178.67 Aligned_cols=149 Identities=32% Similarity=0.505 Sum_probs=124.1
Q ss_pred CCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHhcC---CCCCccceeeEEEeCCe-----
Q 010186 351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKL---QHKNLVKLLGFCVDGDE----- 419 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~----- 419 (516)
|...+.||+|+||.||++... +++.+++|+++... ......+.+|+.++.++ +||||+++++.+...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 456688999999999999975 48999999997422 22234566788777665 69999999999998776
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccc
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 499 (516)
.+++|||+++ +|.+++... ....+++..+..++.||++||.|||+.+ ++|+||+|+||+++.++.+||+|||+++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 788877432 2235899999999999999999999987 9999999999999999999999999998
Q ss_pred ccccC
Q 010186 500 IFAES 504 (516)
Q Consensus 500 ~~~~~ 504 (516)
.+...
T Consensus 156 ~~~~~ 160 (287)
T cd07838 156 IYSFE 160 (287)
T ss_pred eccCC
Confidence 87543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.9e-20 Score=180.42 Aligned_cols=148 Identities=32% Similarity=0.490 Sum_probs=129.2
Q ss_pred CCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
|...+.||+|++|.||++... +++.+++|.+.... ....+.+..|+.+++.++|+|++++++++...+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 345678999999999999965 58999999987642 334567889999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
+ ++|.+++... ...+++..+..++.+++.||.|||+.+ ++||||+|+||++++++.+||+|||+++.+...
T Consensus 81 ~-~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~ 151 (282)
T cd07829 81 D-MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIP 151 (282)
T ss_pred C-cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCC
Confidence 8 5899988532 146899999999999999999999987 999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=180.23 Aligned_cols=150 Identities=21% Similarity=0.289 Sum_probs=111.1
Q ss_pred hhCCCCCCceeeecCcEeEEEEEecC----CcEEEEEEeccCCccch-----------HHHHHHHHHHhcCCCCCcccee
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLSD----GKEVAVKRLSSCSEQGT-----------AEFTNEVLLILKLQHKNLVKLL 411 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~----g~~vavK~l~~~~~~~~-----------~~~~~Ei~~l~~l~H~niv~l~ 411 (516)
..++|.+.++||+|+||.||+|...+ +..+++|.......... .....+...+..++|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 34678889999999999999999654 34556665432211110 1122333455677999999999
Q ss_pred eEEEeCC----eeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCC
Q 010186 412 GFCVDGD----EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD 487 (516)
Q Consensus 412 g~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~ 487 (516)
+.+.... ..++++|++.. ++.+.+.. ....++.....++.|++.||.|||+.+ ++||||||+|||++.+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 9776543 34678887644 55555522 223568888999999999999999987 9999999999999999
Q ss_pred CcEEEcccCccccccc
Q 010186 488 MNSKISDFGMARIFAE 503 (516)
Q Consensus 488 ~~~kl~DFGla~~~~~ 503 (516)
+.+||+|||+|+.+..
T Consensus 163 ~~~~l~DFGla~~~~~ 178 (294)
T PHA02882 163 NRGYIIDYGIASHFII 178 (294)
T ss_pred CcEEEEEcCCceeecc
Confidence 9999999999988754
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.5e-20 Score=180.23 Aligned_cols=148 Identities=30% Similarity=0.487 Sum_probs=128.5
Q ss_pred CCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCc--cchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE--QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
|...+.||+|++|.||++... +++.+++|++..... .....+.+|+.++++++|+||+++++.+..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 345678999999999999964 688999999875322 24567889999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
++ +|.+++.. ....+++..+..++.+|+.||.|||+.+ ++|+||||+||+++.++.+||+|||.+..+...
T Consensus 81 ~~-~l~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 81 DT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred CC-CHHHHHHh--hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence 76 78777743 2256899999999999999999999988 999999999999999999999999999877654
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-19 Score=183.49 Aligned_cols=146 Identities=31% Similarity=0.481 Sum_probs=124.2
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCC------
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD------ 418 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 418 (516)
.++|...+.||+|+||.||+|.. .+++.||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 35788889999999999999995 46899999998652 2233456889999999999999999999987543
Q ss_pred eeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcc
Q 010186 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (516)
Q Consensus 419 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 498 (516)
..++|+||++. +|..+. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999964 676655 134889999999999999999999987 999999999999999999999999999
Q ss_pred cccc
Q 010186 499 RIFA 502 (516)
Q Consensus 499 ~~~~ 502 (516)
+...
T Consensus 165 ~~~~ 168 (342)
T cd07879 165 RHAD 168 (342)
T ss_pred cCCC
Confidence 8754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.2e-20 Score=177.86 Aligned_cols=150 Identities=28% Similarity=0.395 Sum_probs=124.0
Q ss_pred CCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC-----CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-----SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 423 (516)
+|...+.||+|+||.||++... .+..+++|.++.. .......+..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4677789999999999999854 3445556655431 222344577899999999999999999999999999999
Q ss_pred EEccCCCChhHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 424 YEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
+||+++++|.+++... .....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++ +.+||+|||+++.+.
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999887432 23456899999999999999999999987 999999999999975 569999999998764
Q ss_pred c
Q 010186 503 E 503 (516)
Q Consensus 503 ~ 503 (516)
.
T Consensus 157 ~ 157 (260)
T cd08222 157 G 157 (260)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.8e-19 Score=166.84 Aligned_cols=139 Identities=19% Similarity=0.233 Sum_probs=107.4
Q ss_pred CCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcC-----CCCCccceeeEEEeCC---e-eEE
Q 010186 352 SDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-----QHKNLVKLLGFCVDGD---E-KLL 422 (516)
Q Consensus 352 ~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-----~H~niv~l~g~~~~~~---~-~~l 422 (516)
...+.||+|+||.||. ...++.. +||++........+.+.+|+.+++.+ .||||++++|++.++. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457899999999996 2223444 68888765445567899999999999 5799999999998864 3 337
Q ss_pred EEEc--cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHH-HHhHcCCCCCeeeCCCCCCCeEecC----CCcEEEccc
Q 010186 423 VYEF--MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM-LYLHEDSRLRIVHRDLKASNVLLDS----DMNSKISDF 495 (516)
Q Consensus 423 V~Ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l-~yLH~~~~~~iiHrDlk~~NILld~----~~~~kl~DF 495 (516)
|+|| +++|+|.+++.+ ..+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 668999999943 235544 35678888888 8999998 999999999999974 347999994
Q ss_pred Cccccc
Q 010186 496 GMARIF 501 (516)
Q Consensus 496 Gla~~~ 501 (516)
+-++.+
T Consensus 154 ~G~~~~ 159 (210)
T PRK10345 154 IGESTF 159 (210)
T ss_pred CCCcce
Confidence 444443
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.1e-20 Score=184.96 Aligned_cols=148 Identities=30% Similarity=0.471 Sum_probs=127.6
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCe-----
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE----- 419 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 419 (516)
.++|...+.||+|++|.||++... +++.|++|++... +......+.+|+.+++.++||||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 457888899999999999999964 5789999988642 22334567889999999999999999998876554
Q ss_pred -eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcc
Q 010186 420 -KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (516)
Q Consensus 420 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 498 (516)
.++|+||+ +++|.+++.. ..+++..+..++.||++||.|||+.+ ++||||||+||++++++.+||+|||++
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999998 5699888832 46899999999999999999999987 999999999999999999999999999
Q ss_pred ccccc
Q 010186 499 RIFAE 503 (516)
Q Consensus 499 ~~~~~ 503 (516)
+....
T Consensus 166 ~~~~~ 170 (343)
T cd07851 166 RHTDD 170 (343)
T ss_pred ccccc
Confidence 87654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-19 Score=173.05 Aligned_cols=133 Identities=23% Similarity=0.224 Sum_probs=115.3
Q ss_pred cCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCCChhHHhcC
Q 010186 360 GGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD 438 (516)
Q Consensus 360 G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 438 (516)
|.+|.||++.. .+++.+|+|++...+ .+.+|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999995 578899999997632 234555666667899999999999999999999999999999998843
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 439 PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 439 ~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
...+++.....++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++.+..
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~ 137 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVED 137 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccc
Confidence 345899999999999999999999987 99999999999999999999999998876543
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-20 Score=181.68 Aligned_cols=163 Identities=27% Similarity=0.320 Sum_probs=134.0
Q ss_pred HhhCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCee
Q 010186 346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEK 420 (516)
Q Consensus 346 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 420 (516)
+...+|....+||+|+||+|-++.-+ +.+.+|||++++. .....+--+.|-++|+.. +-|.+++|+.++..-+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 34457888899999999999999854 4567899999863 223344456777888777 568899999999999999
Q ss_pred EEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
|.||||+.+|+|...++ .-+.+.+..+..++.+|+-||-|||+++ ||.||||..|||||.+|++||+|||+++.
T Consensus 426 yFVMEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred eeEEEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccc
Confidence 99999999999987773 4456788889999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCccCccceecC
Q 010186 501 FAESEGEANTVRIVGT 516 (516)
Q Consensus 501 ~~~~~~~~~~~~~~GT 516 (516)
---+.. .|.+++||
T Consensus 500 ni~~~~--TTkTFCGT 513 (683)
T KOG0696|consen 500 NIFDGV--TTKTFCGT 513 (683)
T ss_pred cccCCc--ceeeecCC
Confidence 543332 23347787
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.6e-21 Score=176.72 Aligned_cols=152 Identities=30% Similarity=0.427 Sum_probs=123.8
Q ss_pred CCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC-CccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEEc
Q 010186 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
+.+....||.|.||+|+|-.+ +.|+..|||++... ...++++++.|.+...+- +.||||+++|.+..++..|+.||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 334456699999999999885 46899999999764 346778899998876655 789999999999999999999999
Q ss_pred cCCCChhHHhcC--CCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 427 MPNGSLDAILFD--PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 427 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
|. .+|+.+... ...+..+++...-+|..-...||.||-+.- .|||||+||+|||||..|.+||||||++..+.++
T Consensus 145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 94 466655321 123345778777788888899999998764 6999999999999999999999999999877543
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.8e-20 Score=173.57 Aligned_cols=146 Identities=29% Similarity=0.402 Sum_probs=121.2
Q ss_pred CCCCC-CceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcC-CCCCccceeeEEEeC----CeeE
Q 010186 349 SNFSD-SNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDG----DEKL 421 (516)
Q Consensus 349 ~~f~~-~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~----~~~~ 421 (516)
++|.+ -++||-|-.|+|..+.. .+++.+|+|++.. ....++|+++.-.. .|||||+++++++.. .-++
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL 135 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLL 135 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence 34433 36799999999999985 4788999998864 23457888876655 799999999998753 3467
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC---CCcEEEcccCcc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMA 498 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~---~~~~kl~DFGla 498 (516)
+|||.|+||.|.+.+.+ +....++++++-.|+.||..|+.|||+.. |.||||||+|+|... |-.+||+|||+|
T Consensus 136 iVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 136 IVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccc
Confidence 89999999999988854 45567999999999999999999999998 999999999999964 346899999999
Q ss_pred ccccc
Q 010186 499 RIFAE 503 (516)
Q Consensus 499 ~~~~~ 503 (516)
+.-..
T Consensus 212 K~t~~ 216 (400)
T KOG0604|consen 212 KETQE 216 (400)
T ss_pred cccCC
Confidence 98664
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.4e-21 Score=187.96 Aligned_cols=158 Identities=28% Similarity=0.365 Sum_probs=137.6
Q ss_pred CCCCCceeeecCcEeEEEEEecCCc-EEEEEEecc---CCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 350 NFSDSNILGQGGFGPVYKGVLSDGK-EVAVKRLSS---CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~~g~-~vavK~l~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
++.....||-|+||.|=++...... .+|+|++++ .+....+....|-.+|...+.|.||+|+..+.+....||+||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 4445566999999999998864333 478888876 344556678899999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCC
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 505 (516)
-|-||.|+.+| +.++.++......++..+.+|++|||+++ ||.|||||+|.|||.+|-+||.|||+|+.+..++
T Consensus 501 aClGGElWTiL---rdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 501 ACLGGELWTIL---RDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hhcCchhhhhh---hhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 99999999999 56677888999999999999999999998 9999999999999999999999999999998775
Q ss_pred CccCccceecC
Q 010186 506 GEANTVRIVGT 516 (516)
Q Consensus 506 ~~~~~~~~~GT 516 (516)
. |-+++||
T Consensus 575 K---TwTFcGT 582 (732)
T KOG0614|consen 575 K---TWTFCGT 582 (732)
T ss_pred c---eeeecCC
Confidence 3 4458887
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.5e-19 Score=172.67 Aligned_cols=164 Identities=24% Similarity=0.432 Sum_probs=142.5
Q ss_pred cchHHHHHhhCCCCCCceeeecCcEeEEEEEec------CCcEEEEEEecc-CCccchHHHHHHHHHHhcCCCCCcccee
Q 010186 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLL 411 (516)
Q Consensus 339 ~~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~------~g~~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~H~niv~l~ 411 (516)
-...++.+...++....++.+|.||.||+|.|. +.+.|.||.++. .+.-+...++.|-.++..+.|||+.++.
T Consensus 274 ~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~ 353 (563)
T KOG1024|consen 274 RRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVL 353 (563)
T ss_pred hhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCcccee
Confidence 346778888889999999999999999999764 345778888865 4555677899999999999999999999
Q ss_pred eEEEeC-CeeEEEEEccCCCChhHHhc-----CCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEec
Q 010186 412 GFCVDG-DEKLLVYEFMPNGSLDAILF-----DPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD 485 (516)
Q Consensus 412 g~~~~~-~~~~lV~Ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld 485 (516)
+++.+. +..+++|.++.-|+|..||. ++...+.++..+...++.|++.||+|||+++ +||.||.++|++||
T Consensus 354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVID 430 (563)
T ss_pred EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceeh
Confidence 998764 56899999999999999997 5555567888999999999999999999998 99999999999999
Q ss_pred CCCcEEEcccCcccccccCC
Q 010186 486 SDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 486 ~~~~~kl~DFGla~~~~~~~ 505 (516)
+..++||+|=.|+|.+.+.+
T Consensus 431 d~LqVkltDsaLSRDLFP~D 450 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGD 450 (563)
T ss_pred hheeEEeccchhccccCccc
Confidence 99999999999999876543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=164.98 Aligned_cols=149 Identities=36% Similarity=0.498 Sum_probs=131.7
Q ss_pred CCCCceeeecCcEeEEEEEecC-CcEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccC
Q 010186 351 FSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQ-GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 428 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 428 (516)
|...+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+.+++|+|++++++.+......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 3456789999999999999765 889999999765444 56789999999999999999999999999999999999999
Q ss_pred CCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
+++|.+++..... .+++.....++.+++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++..+...
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence 9999999843221 1789999999999999999999987 999999999999999999999999999887654
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-19 Score=181.84 Aligned_cols=166 Identities=25% Similarity=0.332 Sum_probs=137.8
Q ss_pred HHHhhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEecc--CCccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCee
Q 010186 344 LNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEK 420 (516)
Q Consensus 344 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~--~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 420 (516)
+.+....|++.++||.||.+.||++...+.+.+|+|++.. .+.+...-|.+|+.+|.+| .|.+|++|++|-..++.+
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 3445566888899999999999999988888888887753 5566678899999999999 699999999999999999
Q ss_pred EEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
||||||= .-+|..+|.+... ....| .+..+..|++.++.++|+++ |||.||||.|+|+ -.|.+||+|||+|..
T Consensus 436 YmvmE~G-d~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLl-VkG~LKLIDFGIA~a 508 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLL-VKGRLKLIDFGIANA 508 (677)
T ss_pred EEEeecc-cccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEE-EeeeEEeeeechhcc
Confidence 9999975 5589999954322 22224 67789999999999999998 9999999999999 458999999999999
Q ss_pred cccCCCccCccceecC
Q 010186 501 FAESEGEANTVRIVGT 516 (516)
Q Consensus 501 ~~~~~~~~~~~~~~GT 516 (516)
+..+.+......-+||
T Consensus 509 I~~DTTsI~kdsQvGT 524 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGT 524 (677)
T ss_pred cCccccceeeccccCc
Confidence 9888766555455666
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-19 Score=171.19 Aligned_cols=161 Identities=23% Similarity=0.304 Sum_probs=137.6
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEecc---CCccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSS---CSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~---~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 422 (516)
-++|....+||+|+|.+|..+++. +.+.+|+|++++ .+.........|-.+.... +||.+|.|..++.....+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 356788899999999999999954 577889999876 3455667788888888877 89999999999999999999
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
|.||+++|+|.-.. ..+..|+++.+..+..+|.-||.|||+.+ ||.||||..|||||.++++||.|+|+++.--
T Consensus 329 vieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999997665 45567999999999999999999999998 9999999999999999999999999998754
Q ss_pred cCCCccCccceecC
Q 010186 503 ESEGEANTVRIVGT 516 (516)
Q Consensus 503 ~~~~~~~~~~~~GT 516 (516)
.+-. -|++++||
T Consensus 403 ~~gd--~tstfcgt 414 (593)
T KOG0695|consen 403 GPGD--TTSTFCGT 414 (593)
T ss_pred CCCc--ccccccCC
Confidence 3322 24458887
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.4e-19 Score=167.00 Aligned_cols=149 Identities=27% Similarity=0.460 Sum_probs=124.9
Q ss_pred CceeeecCcEeEEEEEec-CCcEEEEEEecc-CCccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEEccCCC
Q 010186 354 SNILGQGGFGPVYKGVLS-DGKEVAVKRLSS-CSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNG 430 (516)
Q Consensus 354 ~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~-~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~g 430 (516)
...||.|.-|.|++.+.+ +|..+|||.+.+ .+..+.+.++..++++.+- ..|.||+.+|+|..+...++.||.|. .
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~ 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-T 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-H
Confidence 345999999999999964 588999999976 4556677788888877665 58999999999999999999999884 3
Q ss_pred ChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCCCc
Q 010186 431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (516)
Q Consensus 431 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 507 (516)
-++.++. +..+++++...-++...+.+||.||-++. +|||||+||+|||+|+.|++||||||++..+.++..+
T Consensus 176 C~ekLlk--rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh 248 (391)
T KOG0983|consen 176 CAEKLLK--RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH 248 (391)
T ss_pred HHHHHHH--HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc
Confidence 4566663 34566888888899999999999999875 6999999999999999999999999999888766543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.5e-19 Score=189.99 Aligned_cols=150 Identities=23% Similarity=0.279 Sum_probs=106.2
Q ss_pred hhCCCCCCceeeecCcEeEEEEEec-C----CcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeE------EE
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLS-D----GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF------CV 415 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~----g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~------~~ 415 (516)
..++|...+.||+|+||.||+|... + +..||+|++..... .+...+| .+....+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4567888999999999999999964 4 68999998865321 1112222 1222223333322221 23
Q ss_pred eCCeeEEEEEccCCCChhHHhcCCCCC-----------------CCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCC
Q 010186 416 DGDEKLLVYEFMPNGSLDAILFDPRKR-----------------GILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLK 478 (516)
Q Consensus 416 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk 478 (516)
.....+||+||+++++|.+++...... ....+..+..++.||+.||.|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 556789999999999999888532110 01122345678999999999999987 9999999
Q ss_pred CCCeEecC-CCcEEEcccCccccccc
Q 010186 479 ASNVLLDS-DMNSKISDFGMARIFAE 503 (516)
Q Consensus 479 ~~NILld~-~~~~kl~DFGla~~~~~ 503 (516)
|+|||+++ ++.+||+|||+|+.+..
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~ 308 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRV 308 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccc
Confidence 99999986 57999999999987643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.4e-20 Score=189.22 Aligned_cols=161 Identities=25% Similarity=0.436 Sum_probs=140.2
Q ss_pred hCCCCCCceeeecCcEeEEEEE-ecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
.++|.....+|.|.+|.|||++ ...++..|+|+++-.......-...|+-+++..+||||+.++|-+...+..|+.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 3456677889999999999999 567899999999876666677788999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCCC
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 506 (516)
+.+|+|+++.+ .-+++++.+...+.++.++||+|||+.+ -+|||||-.|||+++.+.+|++|||.+..+...-.
T Consensus 94 cgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati~ 167 (829)
T KOG0576|consen 94 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATIA 167 (829)
T ss_pred cCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhhh
Confidence 99999999874 4467889999999999999999999998 89999999999999999999999999988875433
Q ss_pred ccCccceecC
Q 010186 507 EANTVRIVGT 516 (516)
Q Consensus 507 ~~~~~~~~GT 516 (516)
+.. .++||
T Consensus 168 Krk--sfiGt 175 (829)
T KOG0576|consen 168 KRK--SFIGT 175 (829)
T ss_pred hhh--cccCC
Confidence 322 35665
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.9e-19 Score=158.67 Aligned_cols=152 Identities=22% Similarity=0.367 Sum_probs=126.3
Q ss_pred hCCCCCCceeeecCcEeEEEEE-ecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCC-CCccceeeEEEeCCeeEEEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH-KNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 425 (516)
.++|...++||.|+||.+|.|. +.+|++||+|.-... .....+.-|.++...|+| ..|..+..+..+.+...||||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4568888999999999999999 678999999976542 233457788999999965 678888888888888999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC---CCcEEEcccCcccccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFA 502 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~---~~~~kl~DFGla~~~~ 502 (516)
.+ |.+|+++..-- ...++.++++.++.|++.-++|+|.++ +|||||||+|+|+.- ..++.|+|||||+.+-
T Consensus 92 LL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 87 77998887432 234788899999999999999999998 999999999999954 4578999999999987
Q ss_pred cCCCc
Q 010186 503 ESEGE 507 (516)
Q Consensus 503 ~~~~~ 507 (516)
+.++.
T Consensus 166 d~~t~ 170 (341)
T KOG1163|consen 166 DIRTR 170 (341)
T ss_pred ccccc
Confidence 66543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.1e-19 Score=184.48 Aligned_cols=158 Identities=32% Similarity=0.448 Sum_probs=124.1
Q ss_pred CCCCceeeecCcEe-EEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEEccC
Q 010186 351 FSDSNILGQGGFGP-VYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMP 428 (516)
Q Consensus 351 f~~~~~Lg~G~fg~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~ 428 (516)
|...+++|.|..|+ ||+|.. +|++||||++-. ....-..+|+..|..= +|||||++++.=.+....|+..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 55667899999875 799998 688999999864 2233457899988776 89999999999888899999999995
Q ss_pred CCChhHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC---C--CcEEEcccCcccccc
Q 010186 429 NGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---D--MNSKISDFGMARIFA 502 (516)
Q Consensus 429 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~---~--~~~kl~DFGla~~~~ 502 (516)
. +|++++... ...........+.+..|+++||++||+.+ ||||||||.||||+. + .+++|+|||+++.+.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 4 999998653 11111222556788999999999999987 999999999999976 3 479999999999998
Q ss_pred cCCCccC-ccceecC
Q 010186 503 ESEGEAN-TVRIVGT 516 (516)
Q Consensus 503 ~~~~~~~-~~~~~GT 516 (516)
.+++.-. .....||
T Consensus 663 ~~~sS~~r~s~~sGt 677 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGT 677 (903)
T ss_pred CCcchhhcccCCCCc
Confidence 7765432 2334554
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.3e-18 Score=156.71 Aligned_cols=143 Identities=38% Similarity=0.623 Sum_probs=126.7
Q ss_pred eeecCcEeEEEEEecC-CcEEEEEEeccCCcc-chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCCChhH
Q 010186 357 LGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQ-GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDA 434 (516)
Q Consensus 357 Lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 434 (516)
||+|.+|.||++...+ ++++++|++...... ..+.+.+|+..++.++|++|+++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 899999999764332 35679999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC-CCcEEEcccCcccccccC
Q 010186 435 ILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARIFAES 504 (516)
Q Consensus 435 ~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~-~~~~kl~DFGla~~~~~~ 504 (516)
++.... ..+++..+..++.++++++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD 146 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence 984321 46889999999999999999999997 999999999999999 899999999999877554
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.1e-18 Score=163.54 Aligned_cols=145 Identities=21% Similarity=0.204 Sum_probs=112.6
Q ss_pred CCCCCceeeecCcEeEEEEE--ecCCcEEEEEEeccCCcc------------------------chHHHHHHHHHHhcCC
Q 010186 350 NFSDSNILGQGGFGPVYKGV--LSDGKEVAVKRLSSCSEQ------------------------GTAEFTNEVLLILKLQ 403 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~--~~~g~~vavK~l~~~~~~------------------------~~~~~~~Ei~~l~~l~ 403 (516)
-|.+.+.||+|+||.||+|. ..+|+.||+|++...... ....+..|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46778999999999999998 568999999998753210 0123568999999997
Q ss_pred CC--CccceeeEEEeCCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCC
Q 010186 404 HK--NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASN 481 (516)
Q Consensus 404 H~--niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~N 481 (516)
+. .+.+.+++ ...++||||+++.+|..... ....+...+...++.||+.+|.+||+.+ +++||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhh
Confidence 53 33444442 23589999999988876542 2234556667889999999999999885 49999999999
Q ss_pred eEecCCCcEEEcccCcccccccC
Q 010186 482 VLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 482 ILld~~~~~kl~DFGla~~~~~~ 504 (516)
|+++ +++++|+|||+++.....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELDHP 201 (237)
T ss_pred EEEE-CCCEEEEEChhhhccCCc
Confidence 9999 889999999999876554
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.3e-18 Score=159.15 Aligned_cols=136 Identities=18% Similarity=0.288 Sum_probs=114.6
Q ss_pred ceeeecCcEeEEEEEecCCcEEEEEEeccCCcc--------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQ--------GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~--------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
+.||+|++|.||+|.. +|..+++|+....... ....+.+|+.++..++|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5699999999999988 6778999976542211 123578899999999999998888887788889999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
+++++|.+++... .+ ....++.+++.+|.++|+.+ ++|+|++|.|||++ ++.++|+|||+++...
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~ 145 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence 9999999988421 12 77889999999999999988 99999999999999 7899999999998643
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.3e-18 Score=160.18 Aligned_cols=143 Identities=14% Similarity=0.167 Sum_probs=116.2
Q ss_pred HhhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccch---HH------HHHHHHHHhcCCCCCccceeeEEEe
Q 010186 346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGT---AE------FTNEVLLILKLQHKNLVKLLGFCVD 416 (516)
Q Consensus 346 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~---~~------~~~Ei~~l~~l~H~niv~l~g~~~~ 416 (516)
+-.++|...++||.|+||.||.... ++..+++|.+.+...... .. +.+|+..+.+++||+|.....++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3467899999999999999999655 577899999975322222 22 6899999999999999999888664
Q ss_pred C--------CeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC
Q 010186 417 G--------DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM 488 (516)
Q Consensus 417 ~--------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~ 488 (516)
. ...+|||||++|.+|.++.. ++. ....+++.+|..+|+.+ ++|||+||+||+++.++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence 3 35789999999999987741 222 24568999999999998 99999999999999988
Q ss_pred cEEEcccCcccccccC
Q 010186 489 NSKISDFGMARIFAES 504 (516)
Q Consensus 489 ~~kl~DFGla~~~~~~ 504 (516)
++|+|||..+...++
T Consensus 173 -i~liDfg~~~~~~e~ 187 (232)
T PRK10359 173 -LRIIDLSGKRCTAQR 187 (232)
T ss_pred -EEEEECCCcccccch
Confidence 999999999877543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.7e-18 Score=158.50 Aligned_cols=146 Identities=20% Similarity=0.199 Sum_probs=113.3
Q ss_pred HHHhhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCcc----------------------chHHHHHHHHHHhc
Q 010186 344 LNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQ----------------------GTAEFTNEVLLILK 401 (516)
Q Consensus 344 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~----------------------~~~~~~~Ei~~l~~ 401 (516)
+......|...+.||+|+||.||++...+|+.|+||++...... ....+..|..++..
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 33333346778899999999999999888999999987542200 01135778888998
Q ss_pred CCCCC--ccceeeEEEeCCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCC
Q 010186 402 LQHKN--LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKA 479 (516)
Q Consensus 402 l~H~n--iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~ 479 (516)
+.|++ ++..++ ....++||||+++++|..+... .....++.+++.++.++|+.+ ++||||||
T Consensus 90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p 153 (198)
T cd05144 90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSE 153 (198)
T ss_pred HHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence 88774 444443 2456899999999999765420 234578899999999999987 99999999
Q ss_pred CCeEecCCCcEEEcccCcccccccCC
Q 010186 480 SNVLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 480 ~NILld~~~~~kl~DFGla~~~~~~~ 505 (516)
+||++++++.++|+|||++..+..+.
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~~~~ 179 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTDHPN 179 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCCCcc
Confidence 99999999999999999998776654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=8e-18 Score=160.54 Aligned_cols=138 Identities=34% Similarity=0.509 Sum_probs=123.6
Q ss_pred CcEeEEEEEec-CCcEEEEEEeccCCccc-hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCCChhHHhcC
Q 010186 361 GFGPVYKGVLS-DGKEVAVKRLSSCSEQG-TAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD 438 (516)
Q Consensus 361 ~fg~Vy~~~~~-~g~~vavK~l~~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 438 (516)
+||.||++... +++.+++|++....... .+.+.+|++.+++++|+||+++++.+......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48999999997654444 67899999999999999999999999999999999999999999999843
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 439 PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 439 ~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
. ..+++.....++.++++++.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~ 140 (244)
T smart00220 81 R---GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPG 140 (244)
T ss_pred c---cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccc
Confidence 2 23889999999999999999999987 999999999999999999999999999887654
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-17 Score=153.15 Aligned_cols=133 Identities=19% Similarity=0.172 Sum_probs=105.7
Q ss_pred CCceeeecCcEeEEEEEecCCcEEEEEEeccCCcc----chHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEEcc
Q 010186 353 DSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQ----GTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 353 ~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~----~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
....|++|+||+||.+.- .+.+++.+.+.....- ....+.+|+++|++++ |+++++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457799999999996655 6778887777653221 1125789999999994 5889999886 4579999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCC-CCCCeEecCCCcEEEcccCccccccc
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDL-KASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDl-k~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
+|.+|...+. . ....++.++.++|.++|+++ |+|||| ||.|||++.++.++|+|||+|.....
T Consensus 81 ~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 81 AGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred cCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 9999865431 0 12357789999999999998 999999 79999999999999999999986543
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.3e-18 Score=179.80 Aligned_cols=138 Identities=22% Similarity=0.319 Sum_probs=112.5
Q ss_pred CCCCCceeeecCcEeEEEEEecCCcEEEEEE-eccC-Cc------cchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 010186 350 NFSDSNILGQGGFGPVYKGVLSDGKEVAVKR-LSSC-SE------QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~-l~~~-~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 421 (516)
.|...++||+|+||.||++.+.+.. +++|+ +.+. .. ...+.+.+|++++..++|++++....+....+..+
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 3455788999999999999875443 44333 2221 11 12346889999999999999998888888878889
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+|||+ +++.++|+|||+++..
T Consensus 413 lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999999998872 35678999999999999988 9999999999999 6789999999999876
Q ss_pred cc
Q 010186 502 AE 503 (516)
Q Consensus 502 ~~ 503 (516)
..
T Consensus 478 ~~ 479 (535)
T PRK09605 478 DL 479 (535)
T ss_pred Cc
Confidence 54
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-17 Score=155.42 Aligned_cols=133 Identities=23% Similarity=0.364 Sum_probs=108.4
Q ss_pred eeeecCcEeEEEEEecCCcEEEEEEeccCCc--c------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 356 ILGQGGFGPVYKGVLSDGKEVAVKRLSSCSE--Q------GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 356 ~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~--~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
.||+|+||.||++.+ ++..+++|....... . ....+.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999996 578899998654221 1 1255778999999999887666665666777789999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
++++|.+++... . ..++.+++.+|.+||+.+ ++|+|++|+||+++ ++.+++.|||+++....
T Consensus 80 ~g~~l~~~~~~~---~-------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~~ 141 (199)
T TIGR03724 80 EGKPLKDVIEEG---N-------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSDE 141 (199)
T ss_pred CCccHHHHHhhc---H-------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCCCc
Confidence 999999887321 0 078999999999999988 99999999999999 89999999999987543
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.2e-17 Score=158.29 Aligned_cols=152 Identities=21% Similarity=0.360 Sum_probs=127.6
Q ss_pred hCCCCCCceeeecCcEeEEEEE-ecCCcEEEEEEeccCCccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 425 (516)
.-+|.++++||+|+||.++.|+ +-++++||||.-... .+..++..|-+..+.| ..++|...+-+-.++..-.||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 3468889999999999999999 668999999976432 2344678888888888 56899998888888888899999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC-----CCcEEEcccCcccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-----DMNSKISDFGMARI 500 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~-----~~~~kl~DFGla~~ 500 (516)
.+ |.+|+++..- -+..++.+.+..++.|++.-++|+|++. +|.|||||+|+||.. ...+.|+|||||+.
T Consensus 105 LL-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 105 LL-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hh-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 87 7799887732 2345899999999999999999999998 999999999999954 34589999999999
Q ss_pred cccCCCc
Q 010186 501 FAESEGE 507 (516)
Q Consensus 501 ~~~~~~~ 507 (516)
+.+.+++
T Consensus 179 YrDp~Tk 185 (449)
T KOG1165|consen 179 YRDPKTK 185 (449)
T ss_pred hcCcccc
Confidence 9877765
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.8e-18 Score=155.72 Aligned_cols=146 Identities=24% Similarity=0.454 Sum_probs=117.8
Q ss_pred CCCCCCceeeecCcEeEEEEEecC-CcEEEEEEeccCCccchHHHHHHHHHHhcC-CCCCccceeeEE-EeCCeeEEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFC-VDGDEKLLVYE 425 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~-~~~~~~~lV~E 425 (516)
+.|.+.+.||+|.||.+-++.++. .+.+++|-+.. ...-+++|.+|..---.| .|.||+.-+++. +..+..+.++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 356777889999999999999764 56788887754 334567898888766666 689999877654 44566778999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEe-cCC-CcEEEcccCcccccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL-DSD-MNSKISDFGMARIFA 502 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILl-d~~-~~~kl~DFGla~~~~ 502 (516)
|+|.|+|.+-+.. ..+-+.....++.|+++|+.|+|++. +||||||.+|||| +.| .++||+|||+.+...
T Consensus 103 ~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred cCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999999877632 34667778899999999999999998 9999999999999 443 489999999998654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1e-17 Score=171.59 Aligned_cols=146 Identities=29% Similarity=0.431 Sum_probs=120.6
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 425 (516)
+..|.....+|.|+|+.|.++.. .+++..+||++.+.. .+-.+|+.++... +||||+++.+.+.++.+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 45566677799999999999984 568889999997642 2234566555555 89999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEe-cCCCcEEEcccCcccccccC
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL-DSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILl-d~~~~~kl~DFGla~~~~~~ 504 (516)
.+.++.+.+-+. ...... .++..|+.+|+.++.|||+++ +|||||||+|||+ ++.++++|+|||.++....+
T Consensus 397 ~l~g~ell~ri~---~~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIR---SKPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHH---hcchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999998766552 222233 777889999999999999998 9999999999999 58999999999999988765
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.3e-16 Score=160.21 Aligned_cols=145 Identities=24% Similarity=0.338 Sum_probs=120.5
Q ss_pred CCCCCceeeecCcEeEEEEEecCC--cEEEEEEeccCCccchHHHHHHHHHHhcCCC----CCccceeeEE-EeCCeeEE
Q 010186 350 NFSDSNILGQGGFGPVYKGVLSDG--KEVAVKRLSSCSEQGTAEFTNEVLLILKLQH----KNLVKLLGFC-VDGDEKLL 422 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~~g--~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H----~niv~l~g~~-~~~~~~~l 422 (516)
+|...++||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 788899999999999999996443 4788887765433333378889999998863 5888888888 46778899
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCC-----CcEEEcccCc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-----MNSKISDFGM 497 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~-----~~~kl~DFGl 497 (516)
||+.+ |.+|.++..... .+.++....+.|+.|++.+|++||+.+ ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99976 789999774433 567999999999999999999999998 9999999999999754 4699999999
Q ss_pred cc
Q 010186 498 AR 499 (516)
Q Consensus 498 a~ 499 (516)
++
T Consensus 174 ar 175 (322)
T KOG1164|consen 174 AR 175 (322)
T ss_pred Cc
Confidence 99
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.68 E-value=6.1e-17 Score=158.25 Aligned_cols=148 Identities=25% Similarity=0.449 Sum_probs=127.9
Q ss_pred HHHHhhCCCCCCceeeecCcEeEEEEEec----CCcEEEEEEeccCCccchHHHHHHHHHHhcC-CCCCccceeeEEEeC
Q 010186 343 TLNLATSNFSDSNILGQGGFGPVYKGVLS----DGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDG 417 (516)
Q Consensus 343 ~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 417 (516)
.+....+.|...++||+|.|+.||+++.. ..+.||+|.+...+. ...+.+|+++|..+ .+.||+++.+++..+
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 34445567888999999999999999843 467899999976443 34589999999999 799999999999999
Q ss_pred CeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCC-CcEEEcccC
Q 010186 418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFG 496 (516)
Q Consensus 418 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~-~~~kl~DFG 496 (516)
+...+|+||+++-...+++.. ++..++..+++.+.+||.++|.++ ||||||||.|+|.+.. ++-.|.|||
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred CeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEech
Confidence 999999999999999988832 667888999999999999999998 9999999999999754 678999999
Q ss_pred ccccc
Q 010186 497 MARIF 501 (516)
Q Consensus 497 la~~~ 501 (516)
||...
T Consensus 179 LA~~~ 183 (418)
T KOG1167|consen 179 LAQRY 183 (418)
T ss_pred hHHHH
Confidence 99743
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.8e-16 Score=136.75 Aligned_cols=136 Identities=23% Similarity=0.244 Sum_probs=115.3
Q ss_pred CceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCC--CCccceeeEEEeCCeeEEEEEccCCCC
Q 010186 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH--KNLVKLLGFCVDGDEKLLVYEFMPNGS 431 (516)
Q Consensus 354 ~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~gs 431 (516)
.+.|++|.++.||++...+ ..+++|....... ...+.+|+..+..++| .++++++++....+..++++||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 4679999999999999754 7899998865432 5678999999999976 589999998888888999999999887
Q ss_pred hhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 432 LDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 432 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
+..+ +......++.+++++|.+||.....+++|+|++|+||++++++.+++.|||+++...
T Consensus 80 ~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 80 LDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred cccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 7543 456677889999999999998654569999999999999998999999999998644
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.9e-16 Score=143.98 Aligned_cols=139 Identities=24% Similarity=0.286 Sum_probs=99.4
Q ss_pred CceeeecCcEeEEEEEecCCcEEEEEEeccCCcc--chHH----------------------HHHHHHHHhcCCCCC--c
Q 010186 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQ--GTAE----------------------FTNEVLLILKLQHKN--L 407 (516)
Q Consensus 354 ~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~--~~~~----------------------~~~Ei~~l~~l~H~n--i 407 (516)
.+.||+|+||.||++...++++||||++.+.... .... ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999878999999998753211 1111 134555565554332 4
Q ss_pred cceeeEEEeCCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHc-CCCCCeeeCCCCCCCeEecC
Q 010186 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-DSRLRIVHRDLKASNVLLDS 486 (516)
Q Consensus 408 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~iiHrDlk~~NILld~ 486 (516)
.+.++. ...++||||++++.+......... .. .+...++.+++.++.++|. .+ ++||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444433 246899999999654321111000 11 5677899999999999998 76 99999999999999
Q ss_pred CCcEEEcccCcccccccC
Q 010186 487 DMNSKISDFGMARIFAES 504 (516)
Q Consensus 487 ~~~~kl~DFGla~~~~~~ 504 (516)
++.++|+|||+++....+
T Consensus 150 ~~~~~liDfg~a~~~~~~ 167 (187)
T cd05119 150 DGKVYIIDVPQAVEIDHP 167 (187)
T ss_pred CCcEEEEECcccccccCc
Confidence 899999999999877654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=3.5e-16 Score=151.04 Aligned_cols=153 Identities=21% Similarity=0.270 Sum_probs=125.3
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCC--C----CccceeeEEEeCCee
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH--K----NLVKLLGFCVDGDEK 420 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H--~----niv~l~g~~~~~~~~ 420 (516)
+++|.+...+|+|.||.|-++.. ..+..||+|+++... ...+.-+-|++++.++.+ | .+|.+.+|+...+..
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 67888899999999999999984 347899999987643 234456779999999932 2 378888999999999
Q ss_pred EEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC--------------
Q 010186 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-------------- 486 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~-------------- 486 (516)
++|+|.+ |-++.+++.. ....+++...+..|+.|+++++.|||+.. ++|-||||+|||+-+
T Consensus 167 Civfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 9999987 6688999843 34457888999999999999999999987 999999999999832
Q ss_pred ------CCcEEEcccCcccccccCCC
Q 010186 487 ------DMNSKISDFGMARIFAESEG 506 (516)
Q Consensus 487 ------~~~~kl~DFGla~~~~~~~~ 506 (516)
+..+||+|||-|+.-.+..+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~hs 267 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHHS 267 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCcc
Confidence 23489999999988766553
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.6e-15 Score=142.72 Aligned_cols=137 Identities=20% Similarity=0.233 Sum_probs=106.2
Q ss_pred Cceee-ecCcEeEEEEEecCCcEEEEEEeccCC-------------ccchHHHHHHHHHHhcCCCCCc--cceeeEEEeC
Q 010186 354 SNILG-QGGFGPVYKGVLSDGKEVAVKRLSSCS-------------EQGTAEFTNEVLLILKLQHKNL--VKLLGFCVDG 417 (516)
Q Consensus 354 ~~~Lg-~G~fg~Vy~~~~~~g~~vavK~l~~~~-------------~~~~~~~~~Ei~~l~~l~H~ni--v~l~g~~~~~ 417 (516)
...|| .|+.|+||+.... +..+++|++.... ......+.+|++++..++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 8999999998874 7789998875311 1223467889999999998875 6777765433
Q ss_pred C----eeEEEEEccCC-CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEE
Q 010186 418 D----EKLLVYEFMPN-GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKI 492 (516)
Q Consensus 418 ~----~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl 492 (516)
. ..++|+||+++ .+|.+++.. ..++.. .+.+|+.+|.+||+.+ |+||||||.|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence 2 23599999997 689888732 234443 3568999999999998 999999999999999899999
Q ss_pred cccCcccccc
Q 010186 493 SDFGMARIFA 502 (516)
Q Consensus 493 ~DFGla~~~~ 502 (516)
+|||.++...
T Consensus 184 IDfg~~~~~~ 193 (239)
T PRK01723 184 IDFDRGELRT 193 (239)
T ss_pred EECCCcccCC
Confidence 9999998755
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.1e-15 Score=151.57 Aligned_cols=135 Identities=26% Similarity=0.349 Sum_probs=110.1
Q ss_pred hCCCCCCceeeecCcEeEEEEE-ecCCcEEEEEEeccCCccchHHHHHHHHHHhcCC-----C---CCccceeeEEEeC-
Q 010186 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-----H---KNLVKLLGFCVDG- 417 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----H---~niv~l~g~~~~~- 417 (516)
.++|...++||-|.|++||++. ..+.+-||+|+.+.. ....+.-+.||++|++++ | ..||+|++.|...
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 3678899999999999999998 456788999998753 234566789999999883 3 3699999999854
Q ss_pred ---CeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCC
Q 010186 418 ---DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD 487 (516)
Q Consensus 418 ---~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~ 487 (516)
.+.+||+|++- -+|..++.. ...+.++...+.+|+.||+.||.|||++. +|||-||||+||||..+
T Consensus 156 pNG~HVCMVfEvLG-dnLLklI~~-s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 156 PNGQHVCMVFEVLG-DNLLKLIKY-SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred CCCcEEEEEehhhh-hHHHHHHHH-hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 46899999984 456555533 34556899999999999999999999986 79999999999999654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.6e-16 Score=147.00 Aligned_cols=144 Identities=31% Similarity=0.423 Sum_probs=113.4
Q ss_pred CCCCCceeeecCcEeEEEEE-ecCCcEEEEEEecc--CCccchHHHHHHHHHHhcCCCCCccceeeEEEeCC------ee
Q 010186 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD------EK 420 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~-~~~g~~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~~ 420 (516)
+|.....++.|.- .|..+. .-.+++|++|++.. ......+.-.+|..++..++|+||++++.++.-.. +.
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 4444555676665 344443 22578999998754 23344556788999999999999999999987543 46
Q ss_pred EEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
|+|||+|.. +|...+. -.++-+....|..|++.|+.|||+.+ |+||||||+||++..+..+||.|||+|+.
T Consensus 97 y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 97 YLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcc
Confidence 999999954 7777664 23667788899999999999999998 99999999999999999999999999986
Q ss_pred ccc
Q 010186 501 FAE 503 (516)
Q Consensus 501 ~~~ 503 (516)
-..
T Consensus 168 e~~ 170 (369)
T KOG0665|consen 168 EDT 170 (369)
T ss_pred cCc
Confidence 443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.8e-14 Score=142.83 Aligned_cols=150 Identities=35% Similarity=0.544 Sum_probs=126.9
Q ss_pred CCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCcc---chHHHHHHHHHHhcCCCC-CccceeeEEEeCCeeEEEEEc
Q 010186 351 FSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQ---GTAEFTNEVLLILKLQHK-NLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~H~-niv~l~g~~~~~~~~~lV~Ey 426 (516)
|...+.||.|+|+.||++... ..+++|.+...... ....+.+|+.++..+.|+ +++++.+.+......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 455678999999999999976 78899988763322 467899999999999888 799999999777778999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC-cEEEcccCcccccccCC
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-NSKISDFGMARIFAESE 505 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~-~~kl~DFGla~~~~~~~ 505 (516)
+.++++.+++........++......+..+++.++.|+|+.+ ++|||+||+||+++... .+++.|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977633211136888999999999999999999998 99999999999999988 79999999998665543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.1e-15 Score=149.19 Aligned_cols=161 Identities=22% Similarity=0.279 Sum_probs=133.6
Q ss_pred chHHHHHhhCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCC------CCCccceee
Q 010186 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ------HKNLVKLLG 412 (516)
Q Consensus 340 ~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~------H~niv~l~g 412 (516)
.+.-.++-.++|.+....|+|-|+.|.+|.. ..|+.||||+|... +...+.=+.|+++|++|+ ..|+++|+.
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 3444455667788888899999999999984 35789999999762 223344568999999995 358999999
Q ss_pred EEEeCCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC-cEE
Q 010186 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-NSK 491 (516)
Q Consensus 413 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~-~~k 491 (516)
.|...++++||+|-+ .-+|.++|.+...+..|....+..++.|+.-||..|-..+ |+|.||||.|||+++.. .+|
T Consensus 502 ~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILK 577 (752)
T ss_pred HhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceee
Confidence 999999999999977 5589999977666777888999999999999999999887 99999999999998765 579
Q ss_pred EcccCcccccccCC
Q 010186 492 ISDFGMARIFAESE 505 (516)
Q Consensus 492 l~DFGla~~~~~~~ 505 (516)
|||||-|....+++
T Consensus 578 LCDfGSA~~~~ene 591 (752)
T KOG0670|consen 578 LCDFGSASFASENE 591 (752)
T ss_pred eccCcccccccccc
Confidence 99999998877665
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=5.2e-15 Score=161.90 Aligned_cols=149 Identities=23% Similarity=0.296 Sum_probs=118.1
Q ss_pred HHHHhhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCC---CCCccceeeEEEeCCe
Q 010186 343 TLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ---HKNLVKLLGFCVDGDE 419 (516)
Q Consensus 343 ~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~ 419 (516)
+.++....|.+.+.||+|+||+||+|...+|+.||+|.-++...-+ |.-=.+++.+|+ -+-|+.+.......+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 4455667788899999999999999998889999999887744322 222223344443 2345555666667788
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC-------CCcEEE
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-------DMNSKI 492 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~-------~~~~kl 492 (516)
.+||+||.+.|+|.+++. ..+.++|...+.++.|+++-++.||..+ |||+||||+|+||.. ..-++|
T Consensus 769 S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred ceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEE
Confidence 899999999999999994 5567999999999999999999999998 999999999999932 235899
Q ss_pred cccCcccc
Q 010186 493 SDFGMARI 500 (516)
Q Consensus 493 ~DFGla~~ 500 (516)
+|||-+--
T Consensus 843 IDfG~siD 850 (974)
T KOG1166|consen 843 IDFGRSID 850 (974)
T ss_pred Eeccccee
Confidence 99998843
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.53 E-value=3e-14 Score=147.98 Aligned_cols=143 Identities=24% Similarity=0.274 Sum_probs=101.0
Q ss_pred CceeeecCcEeEEEEEecCCcEEEEEEeccCCccch----------------------------------------HHHH
Q 010186 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGT----------------------------------------AEFT 393 (516)
Q Consensus 354 ~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~----------------------------------------~~~~ 393 (516)
.+.||.|++|.||+|++.+|+.||||+.++.-.... -+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999999999999999876321110 0244
Q ss_pred HHHHHHhcC----CCCCccceeeEEE-eCCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHH-HHHHhHcC
Q 010186 394 NEVLLILKL----QHKNLVKLLGFCV-DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK-GMLYLHED 467 (516)
Q Consensus 394 ~Ei~~l~~l----~H~niv~l~g~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-~l~yLH~~ 467 (516)
+|...+.++ +|.+-+.+-.++. .....+|||||++|++|.++...... .. ....++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence 455555444 2333333333332 24457999999999999887632111 12 23456666665 46788988
Q ss_pred CCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 468 ~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
+ ++|+|++|.||+++.+++++|.|||+++.+++.
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~ 310 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSEE 310 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence 7 999999999999999999999999999888654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.39 E-value=2e-12 Score=117.14 Aligned_cols=131 Identities=24% Similarity=0.190 Sum_probs=97.7
Q ss_pred ceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCcc-ceeeEEEeCCeeEEEEEccCCCChh
Q 010186 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV-KLLGFCVDGDEKLLVYEFMPNGSLD 433 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~~gsL~ 433 (516)
+.|+.|.++.||+.... +..+++|...+... ....+..|...+..+.+.+++ +++... ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 45889999999999874 77899998765321 234578899999988655544 455443 33468999999998875
Q ss_pred HHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC--CCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 434 AILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS--RLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 434 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
... . ....+..+++++|..||+.+ +..++|+|++|.||+++ ++.++++|||.+..-
T Consensus 80 ~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 80 TED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred ccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 421 1 11235678999999999876 23469999999999999 678999999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.36 E-value=5.8e-13 Score=140.14 Aligned_cols=144 Identities=19% Similarity=0.224 Sum_probs=93.9
Q ss_pred CCCCCceeeecCcEeEEEEEecC-CcEEEEEEeccCCcc----------------------------------chH----
Q 010186 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQ----------------------------------GTA---- 390 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~----------------------------------~~~---- 390 (516)
.|.. +.||.|++|.||++++++ |+.||||++.+.-.. ..+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 3554 679999999999999877 999999999753110 011
Q ss_pred --HHHHHHHHHhcC----CCCCccceeeEEEe-CCeeEEEEEccCCCChhHHhcCCCCC---CCCCHHHHHHHHHHHHHH
Q 010186 391 --EFTNEVLLILKL----QHKNLVKLLGFCVD-GDEKLLVYEFMPNGSLDAILFDPRKR---GILCWRKRTNIVNGIAKG 460 (516)
Q Consensus 391 --~~~~Ei~~l~~l----~H~niv~l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~~ia~~ 460 (516)
+|.+|...+.++ .+.+.+.+-.++.+ ....+|||||++|+.+.++......+ ..+.......++.||
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--- 276 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--- 276 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH---
Confidence 233444333333 23333443344433 45678999999999998753111111 112222233333333
Q ss_pred HHHhHcCCCCCeeeCCCCCCCeEecCCC----cEEEcccCcccccccC
Q 010186 461 MLYLHEDSRLRIVHRDLKASNVLLDSDM----NSKISDFGMARIFAES 504 (516)
Q Consensus 461 l~yLH~~~~~~iiHrDlk~~NILld~~~----~~kl~DFGla~~~~~~ 504 (516)
+..+ ++|+|+||.||+++.++ ++++.|||++..+++.
T Consensus 277 ----f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 277 ----FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred ----HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 3455 99999999999999988 9999999999888654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.6e-12 Score=137.92 Aligned_cols=146 Identities=27% Similarity=0.396 Sum_probs=112.6
Q ss_pred CCCceeeecCcEeEEEEEec-CCcEEEEEEec----cC-C-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 352 SDSNILGQGGFGPVYKGVLS-DGKEVAVKRLS----SC-S-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 352 ~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~----~~-~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
...+++|.|.+|.|+..... ..+....|... +. . ......+..|..+-..+.|||++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35678999999977777632 23333333221 21 1 111222566777778899999998888877777777779
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||+++ +|..++. ....++..++..++.|+..|+.|||+.+ +.|||+|++|++++.++.+||+|||.+..+.-.
T Consensus 401 E~~~~-Dlf~~~~---~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVM---SNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHh---cccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 9998883 3346888999999999999999999998 999999999999999999999999999877543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.26 E-value=6.6e-11 Score=108.64 Aligned_cols=137 Identities=18% Similarity=0.146 Sum_probs=99.6
Q ss_pred ceeeecCcEeEEEEEecC-------CcEEEEEEeccC-------------Cc---------cchHHH----HHHHHHHhc
Q 010186 355 NILGQGGFGPVYKGVLSD-------GKEVAVKRLSSC-------------SE---------QGTAEF----TNEVLLILK 401 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~-------g~~vavK~l~~~-------------~~---------~~~~~~----~~Ei~~l~~ 401 (516)
..||.|.-+.||.|.-.+ +..+|||+.+.. +. ...+.+ ++|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 478999976521 00 011123 378888988
Q ss_pred CC--CCCccceeeEEEeCCeeEEEEEccCCCChhH-HhcCCCCCCCCCHHHHHHHHHHHHHHHHHh-HcCCCCCeeeCCC
Q 010186 402 LQ--HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDA-ILFDPRKRGILCWRKRTNIVNGIAKGMLYL-HEDSRLRIVHRDL 477 (516)
Q Consensus 402 l~--H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~~l~yL-H~~~~~~iiHrDl 477 (516)
+. .-++...+++ ...+|||||+.+..+.. .+. ...++..+...+..++..+|..| |+.+ ++|+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 84 3567777764 56789999998754422 221 12345556677889999999999 7777 999999
Q ss_pred CCCCeEecCCCcEEEcccCccccccc
Q 010186 478 KASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 478 k~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
++.|||++ ++.++|+|||.+-....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCCC
Confidence 99999996 47899999999877654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.25 E-value=4.9e-12 Score=142.26 Aligned_cols=94 Identities=22% Similarity=0.238 Sum_probs=73.0
Q ss_pred cCCC-CCccceeeEE-------EeCCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCe
Q 010186 401 KLQH-KNLVKLLGFC-------VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472 (516)
Q Consensus 401 ~l~H-~niv~l~g~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i 472 (516)
.++| +||.++++++ .+....++++||+ +++|.+++.. ....+++.+++.++.||++||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 3455 5777888877 2334567788987 5599999953 2355899999999999999999999988 9
Q ss_pred eeCCCCCCCeEecC-------------------CCcEEEcccCcccc
Q 010186 473 VHRDLKASNVLLDS-------------------DMNSKISDFGMARI 500 (516)
Q Consensus 473 iHrDlk~~NILld~-------------------~~~~kl~DFGla~~ 500 (516)
+||||||+||||+. ++.+||+|||+++.
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~ 148 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRR 148 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccc
Confidence 99999999999955 44566666666654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.1e-10 Score=110.22 Aligned_cols=143 Identities=20% Similarity=0.269 Sum_probs=110.6
Q ss_pred ceeeecCcEeEEEEEecCCcEEEEEEeccCCc-cchHHHHHHHHHHhcCCC--CCccceeeEEEeCC---eeEEEEEccC
Q 010186 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSE-QGTAEFTNEVLLILKLQH--KNLVKLLGFCVDGD---EKLLVYEFMP 428 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~---~~~lV~Ey~~ 428 (516)
+.|+.|..+.||++...+|+.+++|....... .....+..|.+++..+.+ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 45899999999999987778999998765322 245578999999999965 44677787766543 5689999999
Q ss_pred CCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC----------------------------------------
Q 010186 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS---------------------------------------- 468 (516)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~---------------------------------------- 468 (516)
+.++...+.. ..++..+...++.++++.|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988765421 34677777888888888888888531
Q ss_pred -------------CCCeeeCCCCCCCeEecC--CCcEEEcccCccccc
Q 010186 469 -------------RLRIVHRDLKASNVLLDS--DMNSKISDFGMARIF 501 (516)
Q Consensus 469 -------------~~~iiHrDlk~~NILld~--~~~~kl~DFGla~~~ 501 (516)
+..++|+|++|.||+++. ++.+.|+||+.+..-
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 244799999999999998 667899999988753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=6.7e-12 Score=116.36 Aligned_cols=135 Identities=23% Similarity=0.457 Sum_probs=112.1
Q ss_pred ceeeecCcEeEEEEEecCCcEEEEEEecc--CCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCCCh
Q 010186 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 432 (516)
.+|.+...|..|+|+++ |..+++|++.. .+.....+|..|.-.++-+.||||..++|.|..+....++..|||.|+|
T Consensus 196 tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 44888899999999995 45566677653 3444556788998889999999999999999999999999999999999
Q ss_pred hHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeee-CCCCCCCeEecCCCcEEEc
Q 010186 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH-RDLKASNVLLDSDMNSKIS 493 (516)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH-rDlk~~NILld~~~~~kl~ 493 (516)
...|+. ......+..++.+++.+|++||.|||+.. |++- --|.++.++||++.+++|+
T Consensus 275 ynvlhe-~t~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltaris 333 (448)
T KOG0195|consen 275 YNVLHE-QTSVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARIS 333 (448)
T ss_pred HHHHhc-CccEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhhee
Confidence 999965 33445677899999999999999999986 3444 4688999999999998874
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=4e-12 Score=130.89 Aligned_cols=146 Identities=25% Similarity=0.296 Sum_probs=120.7
Q ss_pred eeeecCcEeEEEEE----ecCCcEEEEEEeccCCcc--chHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEEccC
Q 010186 356 ILGQGGFGPVYKGV----LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYEFMP 428 (516)
Q Consensus 356 ~Lg~G~fg~Vy~~~----~~~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~ 428 (516)
++|+|.||.|+.+. .+.|.-+++|.+++.... .......|..++...+ ||.++++.-.+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37899999999765 335667788888653221 1224567888888886 9999999999999999999999999
Q ss_pred CCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCCCc
Q 010186 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (516)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 507 (516)
+|.|...+ ......++.....+...++-+++++|+.+ ++|||+|++||+++.+|++|+.|||++++.-+.+..
T Consensus 81 gg~lft~l---~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRL---SKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhcc---ccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 99998777 34455777778888899999999999998 999999999999999999999999999988766544
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=4.1e-12 Score=137.32 Aligned_cols=142 Identities=20% Similarity=0.220 Sum_probs=116.1
Q ss_pred CCCCCceeeecCcEeEEEEEecCCcEEEEEEeccC-CccchHHHHHHHHHH--hcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 350 NFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC-SEQGTAEFTNEVLLI--LKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~-~~~~~~~~~~Ei~~l--~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
++...+.||.+.|=+|.+++.++|. |+||++.+. .......|.++++-+ ..++|||++.+..+-....-.|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4566788999999999999998887 888887553 344566666555444 445999999998887777778899999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 499 (516)
+.+ +|.+.+ .-+.-|...+..-|+.|++.||.-+|+.+ |+|+|||.+||||++.+-+.|+||.-=|
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccC
Confidence 865 777777 34456778888899999999999999998 9999999999999999999999997554
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.3e-10 Score=101.70 Aligned_cols=137 Identities=23% Similarity=0.337 Sum_probs=100.9
Q ss_pred ceeeecCcEeEEEEEecCCcEEEEEEeccCC--cc------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCS--EQ------GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~--~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
..+.+|+-+.+|.+.+. |.++.+|.=.+.. .. ....-.+|.+++.+++--.|..-+=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35788999999999774 4445555322211 11 123457889999888655555545556678888999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCCC
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 506 (516)
+++..|.+.+... ...++..|-.-+.-||..+ |+|+||.++||++..+. +.++||||++.-...+.
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~~Ed 146 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSDEVED 146 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccccccHHh
Confidence 9999999888432 2567778888889999998 99999999999997655 99999999986554443
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.3e-09 Score=96.37 Aligned_cols=150 Identities=20% Similarity=0.275 Sum_probs=105.9
Q ss_pred CCceeeecCcEeEEEEEecCCcEEEEEEe-cc-C------CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 353 DSNILGQGGFGPVYKGVLSDGKEVAVKRL-SS-C------SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 353 ~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l-~~-~------~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
....+-+|+-+.|+++.+ .|+...||.= .+ - ..-......+|++.+.++.--.|.--.=++.+.....|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 456789999999999998 4666666632 22 0 1112345778999998875444444344566777788999
Q ss_pred EccCC-CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC---cEEEcccCcccc
Q 010186 425 EFMPN-GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM---NSKISDFGMARI 500 (516)
Q Consensus 425 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~---~~kl~DFGla~~ 500 (516)
||+++ .++.+++...-... ...+....++..|-+.+.-||..+ +||+||..+||+|.+++ .+.++||||+..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 45777764322222 222233678889999999999998 99999999999997655 458999999976
Q ss_pred cccCCCc
Q 010186 501 FAESEGE 507 (516)
Q Consensus 501 ~~~~~~~ 507 (516)
-...+.+
T Consensus 166 s~~~EDK 172 (229)
T KOG3087|consen 166 SRLPEDK 172 (229)
T ss_pred ccCcccc
Confidence 6555444
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.8e-09 Score=104.65 Aligned_cols=147 Identities=24% Similarity=0.339 Sum_probs=93.8
Q ss_pred CCCceeeecCcEeEEEEEec-CCcEEEEEEecc---CCccchHHHHHHHHHHhcCCC----------CCccceeeEEE--
Q 010186 352 SDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQH----------KNLVKLLGFCV-- 415 (516)
Q Consensus 352 ~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~---~~~~~~~~~~~Ei~~l~~l~H----------~niv~l~g~~~-- 415 (516)
..++.||.|+++.||.++.. +++++++|+..- ......+++++|...+..+.+ -.++--++...
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 34578999999999999965 589999998753 223346677777766666443 11221122211
Q ss_pred -------eC---C-----eeEEEEEccCCCChhHHhc---CC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCC
Q 010186 416 -------DG---D-----EKLLVYEFMPNGSLDAILF---DP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD 476 (516)
Q Consensus 416 -------~~---~-----~~~lV~Ey~~~gsL~~~l~---~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrD 476 (516)
.. . ..+++|+-+ .++|.+++. .. .....+...-++.+..|+.+.+++||+.+ ++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecc
Confidence 11 1 125677766 568877652 11 11122334445677799999999999998 99999
Q ss_pred CCCCCeEecCCCcEEEcccCcccccc
Q 010186 477 LKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 477 lk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
|+|+|++++.+|.++|+||+-.....
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g 196 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAG 196 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETT
T ss_pred cceeeEEEcCCCCEEEcChHHHeecC
Confidence 99999999999999999998776543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=9.5e-09 Score=99.64 Aligned_cols=141 Identities=18% Similarity=0.124 Sum_probs=101.6
Q ss_pred ceeeecCcEeEEEEEecCCcEEEEEEeccCCc-----------cchHHHHHHHHHHhcCCCC--CccceeeEEEe-----
Q 010186 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSE-----------QGTAEFTNEVLLILKLQHK--NLVKLLGFCVD----- 416 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~-----------~~~~~~~~Ei~~l~~l~H~--niv~l~g~~~~----- 416 (516)
+++-+.....|.+..+ +|+.+.||+...... .....+.+|...+.++... .++..+++.+.
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4555555555777766 678899997744221 1112477899888888433 34455556543
Q ss_pred CCeeEEEEEccCCC-ChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC-------CC
Q 010186 417 GDEKLLVYEFMPNG-SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-------DM 488 (516)
Q Consensus 417 ~~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~-------~~ 488 (516)
....+||+|++++. +|.+++.... ....+......++.+++..+.-||+.+ ++|+|++++|||++. +.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence 23578999999986 7988874211 233456677789999999999999998 999999999999975 46
Q ss_pred cEEEcccCcccc
Q 010186 489 NSKISDFGMARI 500 (516)
Q Consensus 489 ~~kl~DFGla~~ 500 (516)
.+.|+||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 899999999864
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=7.1e-10 Score=108.26 Aligned_cols=88 Identities=28% Similarity=0.483 Sum_probs=69.9
Q ss_pred CCCCccceeeEEEeC---------------------------CeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHH
Q 010186 403 QHKNLVKLLGFCVDG---------------------------DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN 455 (516)
Q Consensus 403 ~H~niv~l~g~~~~~---------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 455 (516)
+|||||++.+.|.+. ...|+||.-.+. +|..++.. ...+......|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc----CCCchHHHHHHHH
Confidence 699999998876432 235788877655 78888843 2356677788999
Q ss_pred HHHHHHHHhHcCCCCCeeeCCCCCCCeEe--cCCC--cEEEcccCcc
Q 010186 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLL--DSDM--NSKISDFGMA 498 (516)
Q Consensus 456 ~ia~~l~yLH~~~~~~iiHrDlk~~NILl--d~~~--~~kl~DFGla 498 (516)
|+++|+.|||+++ |.|||+|++|||| |+|. ...|+|||++
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCc 392 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCC 392 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEccccee
Confidence 9999999999998 9999999999998 4444 4689999987
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.93 E-value=6.3e-09 Score=95.21 Aligned_cols=127 Identities=25% Similarity=0.310 Sum_probs=83.8
Q ss_pred eEEEEEecCCcEEEEEEeccCC-------------cc-------------chHHHHHHHHHHhcCCCC--CccceeeEEE
Q 010186 364 PVYKGVLSDGKEVAVKRLSSCS-------------EQ-------------GTAEFTNEVLLILKLQHK--NLVKLLGFCV 415 (516)
Q Consensus 364 ~Vy~~~~~~g~~vavK~l~~~~-------------~~-------------~~~~~~~Ei~~l~~l~H~--niv~l~g~~~ 415 (516)
.||.|...+|.++|+|+.+... .. ......+|.+.|.++... ++.+.+.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 4899998889999999765310 00 012467899999999665 56677654
Q ss_pred eCCeeEEEEEccC--CCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHH-hHcCCCCCeeeCCCCCCCeEecCCCcEEE
Q 010186 416 DGDEKLLVYEFMP--NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY-LHEDSRLRIVHRDLKASNVLLDSDMNSKI 492 (516)
Q Consensus 416 ~~~~~~lV~Ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~y-LH~~~~~~iiHrDlk~~NILld~~~~~kl 492 (516)
....|||||++ +..+..+... .++..+...++.+++..+.. +|..+ ++|+||.+.|||++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 24579999999 6555544321 11134456677778776665 46777 9999999999999887 9999
Q ss_pred cccCccccccc
Q 010186 493 SDFGMARIFAE 503 (516)
Q Consensus 493 ~DFGla~~~~~ 503 (516)
+|||.+.....
T Consensus 148 IDf~qav~~~~ 158 (188)
T PF01163_consen 148 IDFGQAVDSSH 158 (188)
T ss_dssp --GTTEEETTS
T ss_pred EecCcceecCC
Confidence 99999876553
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=2.1e-09 Score=110.76 Aligned_cols=100 Identities=35% Similarity=0.569 Sum_probs=90.4
Q ss_pred HhcCCCCCccceeeEEEeCCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCC
Q 010186 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLK 478 (516)
Q Consensus 399 l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk 478 (516)
|+.+.|.|+.+++|.+.++...++|.+|++.|+|.+.+.. ....++|.-...++.+|+.||.|||+.. . ..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i-~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP-I-GYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc-c-eeeeeec
Confidence 3568999999999999999999999999999999999954 4556899999999999999999999864 2 3999999
Q ss_pred CCCeEecCCCcEEEcccCcccccc
Q 010186 479 ASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 479 ~~NILld~~~~~kl~DFGla~~~~ 502 (516)
++|+++|....+||+|||+..+..
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~ 100 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLE 100 (484)
T ss_pred cccceeeeeEEEEechhhhccccc
Confidence 999999999999999999998774
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.75 E-value=7.5e-08 Score=97.64 Aligned_cols=140 Identities=21% Similarity=0.296 Sum_probs=112.9
Q ss_pred EeEEEEE-ecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEe----CCeeEEEEEccCC-CChhHHh
Q 010186 363 GPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD----GDEKLLVYEFMPN-GSLDAIL 436 (516)
Q Consensus 363 g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~Ey~~~-gsL~~~l 436 (516)
.+.||+. ..+|..+++|++.....+.......-++.++++.|+|||++..++.. +..+++||+|.|+ ++|.+..
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 5678888 45899999999954444444445566889999999999999998873 3467899999986 4576655
Q ss_pred cCCC------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 437 FDPR------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 437 ~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
+... .+...++...|.++.|+..||.++|+.| +.-+-|.+++||++.+.+++|+..|...++.++
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 4321 2235788999999999999999999998 888999999999999999999999998888776
Q ss_pred C
Q 010186 505 E 505 (516)
Q Consensus 505 ~ 505 (516)
+
T Consensus 447 ~ 447 (655)
T KOG3741|consen 447 P 447 (655)
T ss_pred C
Confidence 6
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.73 E-value=2.3e-09 Score=115.29 Aligned_cols=150 Identities=27% Similarity=0.384 Sum_probs=118.1
Q ss_pred CCCCCceeeecCcEeEEEEEecC--CcEEEEEEeccCC--ccchHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEE
Q 010186 350 NFSDSNILGQGGFGPVYKGVLSD--GKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~~--g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 424 (516)
.|...+.||+|.|+.|-...... ...+++|.+.... .........|..+-..+. |+|++++++...+.+..++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 34555669999999998887533 3456677665432 233344455777777775 999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhH-cCCCCCeeeCCCCCCCeEecCCC-cEEEcccCcccccc
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH-EDSRLRIVHRDLKASNVLLDSDM-NSKISDFGMARIFA 502 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH-~~~~~~iiHrDlk~~NILld~~~-~~kl~DFGla~~~~ 502 (516)
||..++++...+... .....+......++.|+..++.|+| +.+ +.||||||+|.+++..+ ..|++|||+|..+.
T Consensus 101 ~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred CcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 999999987766311 1114556677789999999999999 777 99999999999999999 99999999998887
Q ss_pred c
Q 010186 503 E 503 (516)
Q Consensus 503 ~ 503 (516)
.
T Consensus 177 ~ 177 (601)
T KOG0590|consen 177 N 177 (601)
T ss_pred c
Confidence 6
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=5.6e-08 Score=101.58 Aligned_cols=123 Identities=19% Similarity=0.222 Sum_probs=100.5
Q ss_pred ecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCCChhHHhcCCCCCCCCCHHH
Q 010186 370 LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRK 449 (516)
Q Consensus 370 ~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~ 449 (516)
..++.+|.|...+..+........+-++.|+.++||||++++...+..+..|||+|-+. .|..++.. +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence 44788898888876555445557788999999999999999999999999999999873 35555522 33555
Q ss_pred HHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 450 RTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 450 ~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
..--+.||+.||.|||+.+ .++|++|.-..|++++.|.+||++|.++....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~ 156 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKAS 156 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccc
Confidence 6667899999999999765 59999999999999999999999999886544
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.4e-07 Score=88.95 Aligned_cols=137 Identities=21% Similarity=0.227 Sum_probs=95.3
Q ss_pred CCCCceeeecCcEeEEEEEecCCcEEEEEEeccC--------------------C--ccchHHHHHHHHHHhcCCCC--C
Q 010186 351 FSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC--------------------S--EQGTAEFTNEVLLILKLQHK--N 406 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~--------------------~--~~~~~~~~~Ei~~l~~l~H~--n 406 (516)
..+++.||.|.-+.||.|..+.|.+++||.=+.. + ........+|.+.|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4567889999999999999989999999953210 0 00122356788888888544 6
Q ss_pred ccceeeEEEeCCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC
Q 010186 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS 486 (516)
Q Consensus 407 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~ 486 (516)
|.+-+++ +...+||||+++-.|...- ++.+..-.++..|+.-+.-+-..+ +||+|+.+-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 6666554 5668999999997765432 122333344444444444444445 999999999999999
Q ss_pred CCcEEEcccCcccccc
Q 010186 487 DMNSKISDFGMARIFA 502 (516)
Q Consensus 487 ~~~~kl~DFGla~~~~ 502 (516)
|+.++++||=-+-...
T Consensus 238 dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 238 DGDIVVIDWPQAVPIS 253 (304)
T ss_pred CCCEEEEeCcccccCC
Confidence 9999999997654433
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.63 E-value=2.8e-07 Score=86.25 Aligned_cols=108 Identities=21% Similarity=0.269 Sum_probs=84.5
Q ss_pred hHHHHHHHHHHhcCCC--CCccceeeEEEeCC----eeEEEEEccCCC-ChhHHhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 010186 389 TAEFTNEVLLILKLQH--KNLVKLLGFCVDGD----EKLLVYEFMPNG-SLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461 (516)
Q Consensus 389 ~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~----~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l 461 (516)
.....+|...+..+.. -.+++.+++.+... ..+||+|++++. +|.+++... ..++......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHHH
Confidence 3457788888777743 34556667666532 458999999985 799988431 1255667788999999999
Q ss_pred HHhHcCCCCCeeeCCCCCCCeEecCCC---cEEEcccCcccccc
Q 010186 462 LYLHEDSRLRIVHRDLKASNVLLDSDM---NSKISDFGMARIFA 502 (516)
Q Consensus 462 ~yLH~~~~~~iiHrDlk~~NILld~~~---~~kl~DFGla~~~~ 502 (516)
.-||+.+ |+|+|++++|||++.+. .+.++||+-++...
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999998 99999999999998887 89999999887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.7e-06 Score=79.83 Aligned_cols=140 Identities=19% Similarity=0.126 Sum_probs=102.8
Q ss_pred eeecCcEeEEEEEecCCcEEEEEEecc---CC---ccchHHHHHHHHHHhcCCC--CCccceeeEEEeC----CeeEEEE
Q 010186 357 LGQGGFGPVYKGVLSDGKEVAVKRLSS---CS---EQGTAEFTNEVLLILKLQH--KNLVKLLGFCVDG----DEKLLVY 424 (516)
Q Consensus 357 Lg~G~fg~Vy~~~~~~g~~vavK~l~~---~~---~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~----~~~~lV~ 424 (516)
-++||.+.|++-.+. |..+-+|+-.. .+ +-....|.+|...|..+.. -.+.+....-... -..+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 467899999998774 45788887652 11 2356789999999998843 3344544222111 1357999
Q ss_pred EccCC-CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCc--EEEcccCccccc
Q 010186 425 EFMPN-GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN--SKISDFGMARIF 501 (516)
Q Consensus 425 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~--~kl~DFGla~~~ 501 (516)
|-+++ -+|.+++.+. ...+.+...+..+..+|++.+.-||+.+ +.|+|+.++||+++.++. ++++||.-++..
T Consensus 105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR 180 (216)
T ss_pred EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence 97764 5688887432 2234567778899999999999999998 999999999999986666 999999877653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.8e-07 Score=96.79 Aligned_cols=142 Identities=18% Similarity=0.229 Sum_probs=91.2
Q ss_pred ceeeecCcEeEEEEEecCCcEEEEEEeccCCccch------------------------------H----------HHHH
Q 010186 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGT------------------------------A----------EFTN 394 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~------------------------------~----------~~~~ 394 (516)
+-|+.++-|.||+|++++|+.||||+..+.-.... + ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 56899999999999999999999998765211100 0 1233
Q ss_pred HHHHHhcC----CCCCccceeeEEE-eCCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHH-HHHhHcCC
Q 010186 395 EVLLILKL----QHKNLVKLLGFCV-DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG-MLYLHEDS 468 (516)
Q Consensus 395 Ei~~l~~l----~H~niv~l~g~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~-l~yLH~~~ 468 (516)
|..-+.++ ++..-+++=.+++ -.....|+|||++|-.+.++..... ..++.+. ++..++++ +..+-..+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~---ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKE---LAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHH---HHHHHHHHHHHHHHhcC
Confidence 33333333 2222222223333 3567789999999999988753222 2234333 33322222 22222235
Q ss_pred CCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 469 ~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
++|.|.+|.||+++.++++.+.|||+...+++.
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 999999999999999999999999999887654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.44 E-value=9.4e-08 Score=98.87 Aligned_cols=149 Identities=23% Similarity=0.231 Sum_probs=117.4
Q ss_pred HhhCCCCCCceeeecCcEeEEEEEec--CCcEEEEEEeccCCccchHH--HHHHHHHHhcC-CCCCccceeeEEEeCCee
Q 010186 346 LATSNFSDSNILGQGGFGPVYKGVLS--DGKEVAVKRLSSCSEQGTAE--FTNEVLLILKL-QHKNLVKLLGFCVDGDEK 420 (516)
Q Consensus 346 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~--~g~~vavK~l~~~~~~~~~~--~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 420 (516)
....+|.....||.|.|+.|++...+ ++..+++|.+.+.......+ -..|+.+...+ .|.++++....+......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34457888899999999999998743 57788998876533222222 24566666655 688899888888887888
Q ss_pred EEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCC-CcEEEcccCccc
Q 010186 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGMAR 499 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~-~~~kl~DFGla~ 499 (516)
|+=.||++++++.... .....+.+..++.+..+++.++.++|+.. ++|+|+||+||++..+ +..++.|||++.
T Consensus 342 ~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 8999999999987655 23345777888999999999999999887 9999999999999876 788999999986
Q ss_pred c
Q 010186 500 I 500 (516)
Q Consensus 500 ~ 500 (516)
.
T Consensus 416 ~ 416 (524)
T KOG0601|consen 416 R 416 (524)
T ss_pred c
Confidence 3
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.4e-06 Score=80.04 Aligned_cols=140 Identities=15% Similarity=0.205 Sum_probs=85.6
Q ss_pred ceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCC--ccceeeEEEeCCeeEEEEEccCCCC-
Q 010186 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN--LVKLLGFCVDGDEKLLVYEFMPNGS- 431 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~~~~~~lV~Ey~~~gs- 431 (516)
..|++|..+.||+. .+..+++|...+.. ......+|.+++..+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 46899999999984 24567778775422 3445788999998885433 4677888877788889999999964
Q ss_pred hhHHh---------------------cCCC-CCCCCCH--HHHHHHHH-------HHHH-HHHHhHc-CCCCCeeeCCCC
Q 010186 432 LDAIL---------------------FDPR-KRGILCW--RKRTNIVN-------GIAK-GMLYLHE-DSRLRIVHRDLK 478 (516)
Q Consensus 432 L~~~l---------------------~~~~-~~~~l~~--~~~~~i~~-------~ia~-~l~yLH~-~~~~~iiHrDlk 478 (516)
+...+ +... ....++. ......+. .+.. ...+|.. ...+.++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 22111 1100 0101110 00000000 0111 1222221 123457999999
Q ss_pred CCCeEecCCCcEEEcccCcccc
Q 010186 479 ASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 479 ~~NILld~~~~~kl~DFGla~~ 500 (516)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.38 E-value=3.2e-07 Score=94.97 Aligned_cols=151 Identities=24% Similarity=0.274 Sum_probs=118.8
Q ss_pred CCCCCCceeee--cCcEeEEEEEe---cCCcEEEEEEecc--CCccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCee
Q 010186 349 SNFSDSNILGQ--GGFGPVYKGVL---SDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEK 420 (516)
Q Consensus 349 ~~f~~~~~Lg~--G~fg~Vy~~~~---~~g~~vavK~l~~--~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 420 (516)
..|...+.+|. |.+|.+|.+.. .++..+|+|+-+. ........=.+|.....++ .|+|.++....+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34556677999 99999999986 3577889987443 2223333345666666677 699999999999999999
Q ss_pred EEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHH----HHHHhHcCCCCCeeeCCCCCCCeEecCC-CcEEEccc
Q 010186 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK----GMLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDF 495 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----~l~yLH~~~~~~iiHrDlk~~NILld~~-~~~kl~DF 495 (516)
++-+|++. .+|..+... ....++....+.+..+..+ ||.++|+.. ++|-|+||.||++.++ ...++.||
T Consensus 194 fiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 99999885 677777643 3334667777888888888 999999988 9999999999999999 88999999
Q ss_pred CcccccccCC
Q 010186 496 GMARIFAESE 505 (516)
Q Consensus 496 Gla~~~~~~~ 505 (516)
|+...+.+..
T Consensus 268 ~~v~~i~~~~ 277 (524)
T KOG0601|consen 268 GLVSKISDGN 277 (524)
T ss_pred ceeEEccCCc
Confidence 9999887654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.34 E-value=8.3e-07 Score=80.56 Aligned_cols=62 Identities=23% Similarity=0.119 Sum_probs=53.8
Q ss_pred CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
|+|.+++.. .+..++|.+++.++.||+.||.|||+++ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~ 62 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE 62 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc
Confidence 688888843 2446999999999999999999999875 999999999999999 9999876554
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.33 E-value=6.2e-06 Score=79.34 Aligned_cols=140 Identities=16% Similarity=0.136 Sum_probs=86.1
Q ss_pred eeecCc-EeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEEccCCCChhH
Q 010186 357 LGQGGF-GPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDA 434 (516)
Q Consensus 357 Lg~G~f-g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 434 (516)
|..|.. ..||+.... +..+.+|+..... ...+..|++++..+ .+--+.+++++....+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 445555 778998764 4678888775432 34577899888888 34456678887777667899999999988764
Q ss_pred Hhc-------------------CCCC-CCCCCH--HHHHHHHH--------------------HHHHHHHHhHc----CC
Q 010186 435 ILF-------------------DPRK-RGILCW--RKRTNIVN--------------------GIAKGMLYLHE----DS 468 (516)
Q Consensus 435 ~l~-------------------~~~~-~~~l~~--~~~~~i~~--------------------~ia~~l~yLH~----~~ 468 (516)
... .... ...... ........ .+...+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 321 0000 001110 00000000 01111222211 12
Q ss_pred CCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 469 ~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
.+.++|+|+.|.|||++.+..+.|+||+.+..
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 35599999999999999987789999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.31 E-value=8.6e-06 Score=75.52 Aligned_cols=140 Identities=15% Similarity=0.156 Sum_probs=90.0
Q ss_pred HhhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHH---------HHHHHHHHhcCCC---CCccceeeE
Q 010186 346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAE---------FTNEVLLILKLQH---KNLVKLLGF 413 (516)
Q Consensus 346 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~---------~~~Ei~~l~~l~H---~niv~l~g~ 413 (516)
+..++|...+++-......|.+-.. +|....+|...+......+. ..+++..+.+++. .....++-+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 3446677777777777666666665 56888888776532222222 2233443444422 222232222
Q ss_pred EE-----eCCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC
Q 010186 414 CV-----DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM 488 (516)
Q Consensus 414 ~~-----~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~ 488 (516)
.+ .....+|+|||++|-.|.++.. +++ .+...|.+.|.-||+.| +.|+|.+|.|++++.+
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~- 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN- 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-
Confidence 22 2234579999999988866541 222 24566778899999998 9999999999999854
Q ss_pred cEEEcccCccccc
Q 010186 489 NSKISDFGMARIF 501 (516)
Q Consensus 489 ~~kl~DFGla~~~ 501 (516)
.++++||+..+..
T Consensus 172 ~i~iID~~~k~~~ 184 (229)
T PF06176_consen 172 GIRIIDTQGKRMS 184 (229)
T ss_pred cEEEEECcccccc
Confidence 4999999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.28 E-value=4.3e-06 Score=87.71 Aligned_cols=143 Identities=17% Similarity=0.216 Sum_probs=91.0
Q ss_pred ceeeecCcEeEEEEEecCCcEEEEEEeccCCccc-------------------------------------hHHHHHHHH
Q 010186 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQG-------------------------------------TAEFTNEVL 397 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~-------------------------------------~~~~~~Ei~ 397 (516)
+.|+.-+.|.||++++++|+.||||+-++.-... .-+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5699999999999999999999999865421110 002333433
Q ss_pred HHhc----CCCCCc---cceeeEEEe-CCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCC
Q 010186 398 LILK----LQHKNL---VKLLGFCVD-GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469 (516)
Q Consensus 398 ~l~~----l~H~ni---v~l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~ 469 (516)
-..+ +.|-+. |.+=.++++ .....|+||||+|..+.+...- ....++..+...-+.+...-+-+-| |
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~~~l~~~~~~qIf~~--G- 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI--DKRGISPHDILNKLVEAYLEQIFKT--G- 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH--HHcCCCHHHHHHHHHHHHHHHHHhc--C-
Confidence 3322 334441 112222222 3467899999999988765421 1223555554444444333333333 4
Q ss_pred CCeeeCCCCCCCeEecC----CCcEEEcccCcccccccC
Q 010186 470 LRIVHRDLKASNVLLDS----DMNSKISDFGMARIFAES 504 (516)
Q Consensus 470 ~~iiHrDlk~~NILld~----~~~~kl~DFGla~~~~~~ 504 (516)
++|.|-+|.||+++. +..+.+-|||+.+.+.+.
T Consensus 322 --ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 322 --FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred --CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 999999999999984 668999999999877644
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.27 E-value=6.5e-07 Score=97.78 Aligned_cols=111 Identities=27% Similarity=0.396 Sum_probs=75.3
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
..+|...+.|..|++|.||...++ ..+.+|+|+-+. + -+.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~-----lilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-N-----LILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccccc-c-----hhhhc--cccccCCccee------------------
Confidence 356777899999999999999865 356778743221 1 01110 22222333332
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
|+-...+. .-+.++. +++.+++|||+.+ |+|||+||+|.||+.-|++|+.||||++..
T Consensus 136 ---gDc~tllk---~~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 ---GDCATLLK---NIGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred ---chhhhhcc---cCCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhh
Confidence 44444442 2233332 2278999999998 999999999999999999999999999864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.25 E-value=2.3e-07 Score=94.43 Aligned_cols=81 Identities=26% Similarity=0.363 Sum_probs=72.1
Q ss_pred eeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcc
Q 010186 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (516)
Q Consensus 419 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 498 (516)
..|+.|+++...+|.+++..++.....++.....++.|++.|++| ++ .+|||+||.||....+..+||.||||.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 368999999999999999766666778899999999999999999 55 999999999999999999999999999
Q ss_pred cccccCC
Q 010186 499 RIFAESE 505 (516)
Q Consensus 499 ~~~~~~~ 505 (516)
.......
T Consensus 404 ts~~~~~ 410 (516)
T KOG1033|consen 404 TSQDKDE 410 (516)
T ss_pred eecccCC
Confidence 7766554
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.6e-05 Score=75.48 Aligned_cols=144 Identities=20% Similarity=0.221 Sum_probs=85.2
Q ss_pred ceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCC--CccceeeEEEeC---CeeEEEEEccCC
Q 010186 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHK--NLVKLLGFCVDG---DEKLLVYEFMPN 429 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~~~~~---~~~~lV~Ey~~~ 429 (516)
+.|+.|..+.||+....+ ..+++|..... .....+.+|..++..+... .+.+++...... ...+++||++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 568999999999999876 68999987653 3456778888888887433 456777655433 346899999999
Q ss_pred CChhH----------------Hh---cCC-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHhHc-
Q 010186 430 GSLDA----------------IL---FDP-RKRGILCWRK---------RTNI------------VNGIAK-GMLYLHE- 466 (516)
Q Consensus 430 gsL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~~ia~-~l~yLH~- 466 (516)
..+.. .+ +.. .....+.+.. .... ...+.+ .+..+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 88877 11 010 0111111110 0000 111222 2333332
Q ss_pred ---CCCCCeeeCCCCCCCeEec-CCCcEEEcccCccccc
Q 010186 467 ---DSRLRIVHRDLKASNVLLD-SDMNSKISDFGMARIF 501 (516)
Q Consensus 467 ---~~~~~iiHrDlk~~NILld-~~~~~kl~DFGla~~~ 501 (516)
..+..++|+|+.|.|||++ +++.+-|+||+.+..-
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 2345699999999999999 6666689999987653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.20 E-value=8.4e-07 Score=85.22 Aligned_cols=95 Identities=25% Similarity=0.416 Sum_probs=79.7
Q ss_pred HHhcCCCCCccceeeEEEeCC-----eeEEEEEccCCCChhHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCC
Q 010186 398 LILKLQHKNLVKLLGFCVDGD-----EKLLVYEFMPNGSLDAILFDPR-KRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471 (516)
Q Consensus 398 ~l~~l~H~niv~l~g~~~~~~-----~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ 471 (516)
-|-.+-|.|||+++.++.+.. +..++.|||+.|++..+|+..+ ....+..+...++..||..||.|||+.. |+
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Cc
Confidence 344567999999999987543 4678999999999999996433 3345777888899999999999999975 78
Q ss_pred eeeCCCCCCCeEecCCCcEEEc
Q 010186 472 IVHRDLKASNVLLDSDMNSKIS 493 (516)
Q Consensus 472 iiHrDlk~~NILld~~~~~kl~ 493 (516)
++|+++.-+-|++..++-+||.
T Consensus 199 iihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred cccCCcchhheeecCCceEEec
Confidence 9999999999999999988874
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.7e-05 Score=74.48 Aligned_cols=137 Identities=23% Similarity=0.267 Sum_probs=89.5
Q ss_pred eeeecCcEeEEEEEecCCcEEEEEEeccCCccch------------------------HHHHHHHHHHhcC--CCCCccc
Q 010186 356 ILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGT------------------------AEFTNEVLLILKL--QHKNLVK 409 (516)
Q Consensus 356 ~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~------------------------~~~~~Ei~~l~~l--~H~niv~ 409 (516)
.|.+|.-+.||+|.-.++..+|||+.+....... .+-..|..-|.++ .+-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 3556777889999987899999998864221110 1223455555554 2333333
Q ss_pred eeeEEEeCCeeEEEEEccCCCChh-HHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC
Q 010186 410 LLGFCVDGDEKLLVYEFMPNGSLD-AILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM 488 (516)
Q Consensus 410 l~g~~~~~~~~~lV~Ey~~~gsL~-~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~ 488 (516)
-+++. ...|||||+....+- -.| ....+..++...+..++.+.|.-|-... ++||+||..=|||+. ++
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH-DG 203 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE-CC
Confidence 33332 347999999664211 111 1223344467778888888888887733 499999999999999 89
Q ss_pred cEEEcccCccccccc
Q 010186 489 NSKISDFGMARIFAE 503 (516)
Q Consensus 489 ~~kl~DFGla~~~~~ 503 (516)
.+.|+|||-|-....
T Consensus 204 ~p~iID~~QaV~~~h 218 (268)
T COG1718 204 EPYIIDVSQAVTIDH 218 (268)
T ss_pred eEEEEECccccccCC
Confidence 999999998866553
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.17 E-value=7.6e-06 Score=75.17 Aligned_cols=106 Identities=25% Similarity=0.250 Sum_probs=83.1
Q ss_pred HHHHHHHhcCCC-CCccceeeEEEeCCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCC
Q 010186 393 TNEVLLILKLQH-KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471 (516)
Q Consensus 393 ~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ 471 (516)
.+|..++..+++ +++++++|.| ..++|.||.+.+++......-.....-+|..+.+|+.++++.+++|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357788888876 6999999999 34789999998766422100011123689999999999999999999865555
Q ss_pred eeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 472 iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
+...|++++|+-+++++++|+.|...+-...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 8889999999999999999999998775443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.04 E-value=6.5e-05 Score=84.96 Aligned_cols=79 Identities=16% Similarity=0.357 Sum_probs=57.2
Q ss_pred CceeeecCcEeEEEEEecCC---cEEEEEEeccCC-ccchHHHHHHHHHHhcCC-CCCc--cceeeEEEeC---CeeEEE
Q 010186 354 SNILGQGGFGPVYKGVLSDG---KEVAVKRLSSCS-EQGTAEFTNEVLLILKLQ-HKNL--VKLLGFCVDG---DEKLLV 423 (516)
Q Consensus 354 ~~~Lg~G~fg~Vy~~~~~~g---~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV 423 (516)
.+.++.|.+..+|+....++ ..+++|+..... ......+.+|.++++.+. |+++ .+.++++.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 45688899999999876554 366777654422 123456889999999995 6654 7888888764 457899
Q ss_pred EEccCCCCh
Q 010186 424 YEFMPNGSL 432 (516)
Q Consensus 424 ~Ey~~~gsL 432 (516)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998653
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.03 E-value=0.00011 Score=68.00 Aligned_cols=135 Identities=21% Similarity=0.319 Sum_probs=91.4
Q ss_pred CCceeeecCcEeEEEEEecCCcEEEEEEeccCC----------------ccchHHHHHHHHHHhcCC------CCCccce
Q 010186 353 DSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCS----------------EQGTAEFTNEVLLILKLQ------HKNLVKL 410 (516)
Q Consensus 353 ~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~----------------~~~~~~~~~Ei~~l~~l~------H~niv~l 410 (516)
....||+|+.-.||.- ++.....||+..+.. .....+..+|+.-...+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 3467999999999974 345567888876644 223456677776666555 7889999
Q ss_pred eeEEEeCCeeEEEEEccCC------CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEe
Q 010186 411 LGFCVDGDEKLLVYEFMPN------GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL 484 (516)
Q Consensus 411 ~g~~~~~~~~~lV~Ey~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILl 484 (516)
+|+.+.+.-.-+|+|.+-+ -+|.+++. .+.++. .....+.+. ..||-+.. |+.+|++|.||++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~L~~f---~~~l~~~~---Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQALDEF---KRYLLDHH---IVIRDLNPHNIVV 151 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHHHHHH---HHHHHHcC---CeecCCCcccEEE
Confidence 9999999888999987642 34666662 233554 333444444 34555555 9999999999999
Q ss_pred cCC---C-cEEEcc-cCcccc
Q 010186 485 DSD---M-NSKISD-FGMARI 500 (516)
Q Consensus 485 d~~---~-~~kl~D-FGla~~ 500 (516)
... . .+.|+| ||-...
T Consensus 152 ~~~~~~~~~lvlIDG~G~~~~ 172 (199)
T PF10707_consen 152 QRRDSGEFRLVLIDGLGEKEL 172 (199)
T ss_pred EecCCCceEEEEEeCCCCccc
Confidence 532 2 577777 564443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00015 Score=71.81 Aligned_cols=77 Identities=12% Similarity=0.106 Sum_probs=56.6
Q ss_pred CCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCC---CCccceeeEEEeC---CeeEEEEEc
Q 010186 353 DSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH---KNLVKLLGFCVDG---DEKLLVYEF 426 (516)
Q Consensus 353 ~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H---~niv~l~g~~~~~---~~~~lV~Ey 426 (516)
..+.|+.|..+.||+....++ .+.+|..+.. .....|..|.+.++.+.. ..+.++++++... +..+||||+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 345699999999999876555 4666664321 123578999999988843 4688899888653 568999999
Q ss_pred cCCCCh
Q 010186 427 MPNGSL 432 (516)
Q Consensus 427 ~~~gsL 432 (516)
++++++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998765
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.88 E-value=8.5e-05 Score=71.01 Aligned_cols=73 Identities=16% Similarity=0.260 Sum_probs=44.9
Q ss_pred ceeeecCcE-eEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCC---CccceeeEEEeCC---eeEEEEEcc
Q 010186 355 NILGQGGFG-PVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHK---NLVKLLGFCVDGD---EKLLVYEFM 427 (516)
Q Consensus 355 ~~Lg~G~fg-~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~---niv~l~g~~~~~~---~~~lV~Ey~ 427 (516)
+.|+.|+.. .||+. +..+++|.... ......+.+|.+++..+... .+.+.++.....+ ..+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 346766665 58874 23466675443 22345788999999877432 3444554433322 348999999
Q ss_pred CCCChh
Q 010186 428 PNGSLD 433 (516)
Q Consensus 428 ~~gsL~ 433 (516)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 997774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00027 Score=67.38 Aligned_cols=141 Identities=19% Similarity=0.240 Sum_probs=81.1
Q ss_pred ceeeecCcEeEEEEEecC--CcEEEEEEeccCCccchHHHHHHHHHHhcCCCCC-ccceeeEEEeCCeeEEEEEccCCCC
Q 010186 355 NILGQGGFGPVYKGVLSD--GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN-LVKLLGFCVDGDEKLLVYEFMPNGS 431 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~--g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~Ey~~~gs 431 (516)
+.|..|-...+|+....+ +..+++|+...... ....-.+|+.++..+...+ .+++++... ..+||||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 456778788999988654 67888887654322 2223457888888884333 344544332 248999999877
Q ss_pred hhHH-----------------hcCCCCC--------CCC-CHHHHHHHHH----------------------HHHHHHHH
Q 010186 432 LDAI-----------------LFDPRKR--------GIL-CWRKRTNIVN----------------------GIAKGMLY 463 (516)
Q Consensus 432 L~~~-----------------l~~~~~~--------~~l-~~~~~~~i~~----------------------~ia~~l~y 463 (516)
+... ++..... ... .+.....+.. .+..-+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6321 0110100 011 1222111111 11111111
Q ss_pred ----hHcC-CCCCeeeCCCCCCCeEecC-CCcEEEcccCcccc
Q 010186 464 ----LHED-SRLRIVHRDLKASNVLLDS-DMNSKISDFGMARI 500 (516)
Q Consensus 464 ----LH~~-~~~~iiHrDlk~~NILld~-~~~~kl~DFGla~~ 500 (516)
+... ....++|+|+.+.|||+++ ++.+.|+||..|..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 1111 2345999999999999998 57899999998864
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00024 Score=63.28 Aligned_cols=128 Identities=20% Similarity=0.212 Sum_probs=85.6
Q ss_pred CceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccc-eeeEEEeCCeeEEEEEccCCCCh
Q 010186 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVK-LLGFCVDGDEKLLVYEFMPNGSL 432 (516)
Q Consensus 354 ~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~-l~g~~~~~~~~~lV~Ey~~~gsL 432 (516)
.+.|++|++|.||++.+. |..+|+|.-... .....+..|.+++..++-.++.+ ++.+- +.++.|||+.|-.|
T Consensus 27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L 99 (201)
T COG2112 27 EKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPL 99 (201)
T ss_pred hhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcch
Confidence 467999999999999995 558888876653 34567899999998887666543 44432 33456999999888
Q ss_pred hHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCC-CCCeEecCCCcEEEcccCccccc
Q 010186 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLK-ASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk-~~NILld~~~~~kl~DFGla~~~ 501 (516)
.+.-.. .+.+.... ++..---|...+ |-|..|. |...+|-.+..+.|+||.-|+.-
T Consensus 100 ~~~~~~------~~rk~l~~----vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 100 GKLEIG------GDRKHLLR----VLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhhc------ccHHHHHH----HHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 765421 12223232 333322222224 8888886 55566656669999999998743
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00021 Score=69.18 Aligned_cols=138 Identities=16% Similarity=0.094 Sum_probs=79.0
Q ss_pred eeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCc-cceeeEEEeCCeeEEEEEccCCCChhHH
Q 010186 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVYEFMPNGSLDAI 435 (516)
Q Consensus 357 Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gsL~~~ 435 (516)
+..|-...+|+... ++..+++|...+..........+|.++++.+....+ .++++.. ..++|+||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCcccccc
Confidence 45577788998874 567788887654322221245788888888854333 3444443 24799999998776421
Q ss_pred -----------------hcCCC-CCCCCCHHHH-HHHHHH---------HHHHHHHhHcC-----CCCCeeeCCCCCCCe
Q 010186 436 -----------------LFDPR-KRGILCWRKR-TNIVNG---------IAKGMLYLHED-----SRLRIVHRDLKASNV 482 (516)
Q Consensus 436 -----------------l~~~~-~~~~l~~~~~-~~i~~~---------ia~~l~yLH~~-----~~~~iiHrDlk~~NI 482 (516)
++... ....++.... ..+..+ +..-+..+-.. .+..++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 11111 1112222111 111111 11112222111 134589999999999
Q ss_pred EecCCCcEEEcccCcccc
Q 010186 483 LLDSDMNSKISDFGMARI 500 (516)
Q Consensus 483 Lld~~~~~kl~DFGla~~ 500 (516)
++++++ ++|+||+.|..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999877 78999998865
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00046 Score=63.39 Aligned_cols=125 Identities=26% Similarity=0.379 Sum_probs=89.0
Q ss_pred CCCCCCceeeecCc-EeEEEEEecCCcEEEEEEecc---C---------Cc---------cchHHHHHHHHHHhcCC---
Q 010186 349 SNFSDSNILGQGGF-GPVYKGVLSDGKEVAVKRLSS---C---------SE---------QGTAEFTNEVLLILKLQ--- 403 (516)
Q Consensus 349 ~~f~~~~~Lg~G~f-g~Vy~~~~~~g~~vavK~l~~---~---------~~---------~~~~~~~~Ei~~l~~l~--- 403 (516)
.+++..+.||.|.- |.||++.+ +|+.+|+|.... . .. .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67777899999999 99999999 678999998321 0 00 12335889999888884
Q ss_pred CCCc--cceeeEEEeCC------------------eeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 010186 404 HKNL--VKLLGFCVDGD------------------EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463 (516)
Q Consensus 404 H~ni--v~l~g~~~~~~------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~y 463 (516)
+.++ |+.+||..-.. ...||.||++... .++. .-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHH
Confidence 4456 89999874321 1246777765533 1222 235567777889
Q ss_pred hHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcc
Q 010186 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (516)
Q Consensus 464 LH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 498 (516)
+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99988 999999999976 3578899864
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.0022 Score=65.70 Aligned_cols=75 Identities=17% Similarity=0.188 Sum_probs=53.7
Q ss_pred ceeeecCcEeEEEEEecCC-cEEEEEEeccC-----C--ccchHHHHHHHHHHhcCC---CCCccceeeEEEeCCeeEEE
Q 010186 355 NILGQGGFGPVYKGVLSDG-KEVAVKRLSSC-----S--EQGTAEFTNEVLLILKLQ---HKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~g-~~vavK~l~~~-----~--~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV 423 (516)
+.||.|.+..||+....+| +.+.||.-.+. . ....+.+..|.+.|..+. ..++++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 4689999999999998776 58999985431 1 123456677877777762 3457777766 44567899
Q ss_pred EEccCCCC
Q 010186 424 YEFMPNGS 431 (516)
Q Consensus 424 ~Ey~~~gs 431 (516)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998754
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0017 Score=64.27 Aligned_cols=143 Identities=17% Similarity=0.127 Sum_probs=84.8
Q ss_pred CceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCC--CccceeeE------EEeCCeeEEEEE
Q 010186 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHK--NLVKLLGF------CVDGDEKLLVYE 425 (516)
Q Consensus 354 ~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~------~~~~~~~~lV~E 425 (516)
.+.|..|....+|+....+ ..+++|+... ........|+.++..+.+. .+.+.+.. ....+..++|+|
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 3457777778899887644 4688887754 2334566788877777432 24444431 233456789999
Q ss_pred ccCCCChhH----Hh----------c----CCC----CCCCCCHHHHH----------HHHHHHHHHHHHhHc----CCC
Q 010186 426 FMPNGSLDA----IL----------F----DPR----KRGILCWRKRT----------NIVNGIAKGMLYLHE----DSR 469 (516)
Q Consensus 426 y~~~gsL~~----~l----------~----~~~----~~~~l~~~~~~----------~i~~~ia~~l~yLH~----~~~ 469 (516)
|++|..+.. .. + ... ......|.... .....+...+.++.+ ..+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999877532 00 0 000 00111222211 011123344455543 123
Q ss_pred CCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 470 ~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
..++|+|+.|.|||++++..+.|.||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4599999999999999987789999998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0068 Score=60.39 Aligned_cols=143 Identities=18% Similarity=0.201 Sum_probs=81.0
Q ss_pred CceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCC--CccceeeE------EEeCCeeEEEEE
Q 010186 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHK--NLVKLLGF------CVDGDEKLLVYE 425 (516)
Q Consensus 354 ~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~------~~~~~~~~lV~E 425 (516)
.+.++.|....+|+....+| .+++|+..... ..+....|++++..|... .+.+.+.. ....+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 34567777788998876545 56778765421 233455666666666322 23444432 122456789999
Q ss_pred ccCCCChhH-----------H---hcCC-C---CC-----CCCCHHHHH------------HHHHHHHHHHHHhHc----
Q 010186 426 FMPNGSLDA-----------I---LFDP-R---KR-----GILCWRKRT------------NIVNGIAKGMLYLHE---- 466 (516)
Q Consensus 426 y~~~gsL~~-----------~---l~~~-~---~~-----~~l~~~~~~------------~i~~~ia~~l~yLH~---- 466 (516)
|++|..+.. . ++.. . .. ..-.|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 999865421 0 1100 0 00 001121111 011223345555542
Q ss_pred CCCCCeeeCCCCCCCeEecCCCcEEEcccCccc
Q 010186 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (516)
Q Consensus 467 ~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 499 (516)
..+..++|+|+++.||+++.++.+.|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 223569999999999999988877899999884
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0081 Score=60.16 Aligned_cols=141 Identities=18% Similarity=0.203 Sum_probs=75.4
Q ss_pred ceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCC--CCccceee------EEEeCCeeEEEEEc
Q 010186 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH--KNLVKLLG------FCVDGDEKLLVYEF 426 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g------~~~~~~~~~lV~Ey 426 (516)
+.|..|....+|+....+| .+++|+.... ..+....|+.++..|.. -.+.+.+. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4466677778999876555 6788876521 22333445555554421 12333332 12234567899999
Q ss_pred cCCCChhH-----------Hh---cCC-C-------CCCCCCH-HHHHH------------HHHH-HHHHHHHhHcC---
Q 010186 427 MPNGSLDA-----------IL---FDP-R-------KRGILCW-RKRTN------------IVNG-IAKGMLYLHED--- 467 (516)
Q Consensus 427 ~~~gsL~~-----------~l---~~~-~-------~~~~l~~-~~~~~------------i~~~-ia~~l~yLH~~--- 467 (516)
++|..+.. .+ +.. . ....+.| .+... ...+ +...+..+.+.
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 99875421 11 100 0 0011112 21111 1111 11122333211
Q ss_pred -CCCCeeeCCCCCCCeEecCCCcEEEcccCccc
Q 010186 468 -SRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (516)
Q Consensus 468 -~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 499 (516)
-+..++|+|+.|.|||++.+...-|+||+.+.
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 23469999999999999876666899999875
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0055 Score=60.01 Aligned_cols=32 Identities=28% Similarity=0.499 Sum_probs=26.7
Q ss_pred CCeeeCCCCCCCeEecCCCc-EEEcccCccccc
Q 010186 470 LRIVHRDLKASNVLLDSDMN-SKISDFGMARIF 501 (516)
Q Consensus 470 ~~iiHrDlk~~NILld~~~~-~kl~DFGla~~~ 501 (516)
+.++|+|++|.|||++++++ .-|.||+.+..-
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 45899999999999997555 469999988754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0089 Score=59.33 Aligned_cols=140 Identities=24% Similarity=0.323 Sum_probs=82.1
Q ss_pred eeeecCcEeEEEEEecC-------CcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCc-cceeeEEEeCCeeEEEEEcc
Q 010186 356 ILGQGGFGPVYKGVLSD-------GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 356 ~Lg~G~fg~Vy~~~~~~-------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~ 427 (516)
.|..|-.-.+|+....+ ++.+++|+..... .......+|.+++..+....+ .++++.+. ..+|+||+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~i 79 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEFI 79 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhee
Confidence 35556666888887654 4788888865532 233456788888887743333 35555543 24689999
Q ss_pred CCCChhHH-h----------------cCCCCCC------CCC--HHHHHH--------------------------HHHH
Q 010186 428 PNGSLDAI-L----------------FDPRKRG------ILC--WRKRTN--------------------------IVNG 456 (516)
Q Consensus 428 ~~gsL~~~-l----------------~~~~~~~------~l~--~~~~~~--------------------------i~~~ 456 (516)
+|..+... + +...... ..+ |..... +...
T Consensus 80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (302)
T cd05156 80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED 159 (302)
T ss_pred CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence 98776431 1 1100000 010 111100 1112
Q ss_pred HHHHHHHhHc------CCCCCeeeCCCCCCCeEecCC----CcEEEcccCcccc
Q 010186 457 IAKGMLYLHE------DSRLRIVHRDLKASNVLLDSD----MNSKISDFGMARI 500 (516)
Q Consensus 457 ia~~l~yLH~------~~~~~iiHrDlk~~NILld~~----~~~kl~DFGla~~ 500 (516)
+..-+.+|.. ..+..++|+|+.+.|||++++ +.++|+||..|..
T Consensus 160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 2223334432 234569999999999999985 8899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0063 Score=61.64 Aligned_cols=141 Identities=21% Similarity=0.272 Sum_probs=80.8
Q ss_pred eeeecCcEeEEEEEecC-----CcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCcc-ceeeEEEeCCeeEEEEEccCC
Q 010186 356 ILGQGGFGPVYKGVLSD-----GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV-KLLGFCVDGDEKLLVYEFMPN 429 (516)
Q Consensus 356 ~Lg~G~fg~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~~ 429 (516)
.|-.|-.-.+|+....+ ++.+.+|+..+...... .-.+|..++..+...++. ++++.+..+ .|+||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 34456667888877532 36788887765443332 236788888888544443 456655332 68999988
Q ss_pred CChhHH-----------------hcCCC--CCC-CCCHHHHHHHHHH-----------------HHHHHHHh----Hc-C
Q 010186 430 GSLDAI-----------------LFDPR--KRG-ILCWRKRTNIVNG-----------------IAKGMLYL----HE-D 467 (516)
Q Consensus 430 gsL~~~-----------------l~~~~--~~~-~l~~~~~~~i~~~-----------------ia~~l~yL----H~-~ 467 (516)
.+|... ++... ... ...|.+...+..+ +..-+..| .. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 776421 11111 001 1112222222211 11112222 22 2
Q ss_pred CCCCeeeCCCCCCCeEecC-CCcEEEcccCccccc
Q 010186 468 SRLRIVHRDLKASNVLLDS-DMNSKISDFGMARIF 501 (516)
Q Consensus 468 ~~~~iiHrDlk~~NILld~-~~~~kl~DFGla~~~ 501 (516)
.+..++|+|+++.|||+++ ++.++|+||..|..-
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 2345899999999999986 468999999988653
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0092 Score=58.61 Aligned_cols=73 Identities=23% Similarity=0.315 Sum_probs=48.1
Q ss_pred CceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcC---CCCCccceeeEEEeCCeeEEEEEccCCC
Q 010186 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL---QHKNLVKLLGFCVDGDEKLLVYEFMPNG 430 (516)
Q Consensus 354 ~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~~~lV~Ey~~~g 430 (516)
.+.++.|....+|+.. .+++.+.||.-.. .....|..|.+-|+.| .--.+++.+++....+..+||+||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 3568888889999877 5778899997752 3345688888888777 3456778999988888889999999877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.012 Score=58.53 Aligned_cols=139 Identities=21% Similarity=0.221 Sum_probs=94.7
Q ss_pred ceeeecCcEeEEEEEecCCcEEEEEEeccC------Cc----------------cc----hHHHHHHHHHHhcCCCCCcc
Q 010186 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSC------SE----------------QG----TAEFTNEVLLILKLQHKNLV 408 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~------~~----------------~~----~~~~~~Ei~~l~~l~H~niv 408 (516)
..|..|.-+-||.++-.+|..+|||+.+.. .. .. ..+...|++-|++++...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 468889999999999999999999987531 00 00 11345677778777655443
Q ss_pred ceeeEEEeCCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC
Q 010186 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM 488 (516)
Q Consensus 409 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~ 488 (516)
.---... ....|||+|+..-.. ....-....++...+..+-.+++.-|.-|-+.+ ++||.||.-=|+|+ .+|
T Consensus 230 ~PePIlL--k~hVLVM~FlGrdgw---~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly-hdG 301 (520)
T KOG2270|consen 230 CPEPILL--KNHVLVMEFLGRDGW---AAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY-HDG 301 (520)
T ss_pred CCCceee--ecceEeeeeccCCCC---cCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-ECC
Confidence 2111111 134699999863222 111123345777778888888888888888776 69999999999999 568
Q ss_pred cEEEcccCccccc
Q 010186 489 NSKISDFGMARIF 501 (516)
Q Consensus 489 ~~kl~DFGla~~~ 501 (516)
.+.|+|.+-+-..
T Consensus 302 ~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 302 KLYIIDVSQSVEH 314 (520)
T ss_pred EEEEEEccccccC
Confidence 8999998876544
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.0027 Score=61.94 Aligned_cols=130 Identities=17% Similarity=0.167 Sum_probs=86.9
Q ss_pred CCCCceeeecCcEeEEEEEecCCcEEEEEEecc------------------CCccc----hHHHHHHHHHHhcCC-C-CC
Q 010186 351 FSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSS------------------CSEQG----TAEFTNEVLLILKLQ-H-KN 406 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~------------------~~~~~----~~~~~~Ei~~l~~l~-H-~n 406 (516)
++.++.||-|.-+.||.+-..+|++.++|.=.. .+..+ .-....|...|+.|. | --
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 567889999999999999998899988883211 00000 112345667777763 2 22
Q ss_pred ccceeeEEEeCCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC
Q 010186 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS 486 (516)
Q Consensus 407 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~ 486 (516)
|.+-++ .+..++|||++.+-.|...-+- ..... +...+..-+.-|..+| +||+|..-=||+|++
T Consensus 174 VPkpiD----~~RH~Vvmelv~g~Pl~~v~~v------~d~~~---ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 174 VPKPID----HNRHCVVMELVDGYPLRQVRHV------EDPPT---LYDDLMGLIVRLANHG---LIHGDFNEFNIMVKD 237 (465)
T ss_pred CCCccc----ccceeeHHHhhcccceeeeeec------CChHH---HHHHHHHHHHHHHHcC---ceecccchheeEEec
Confidence 334343 3567899999988887654311 11222 3333344455666667 999999999999999
Q ss_pred CCcEEEcccC
Q 010186 487 DMNSKISDFG 496 (516)
Q Consensus 487 ~~~~kl~DFG 496 (516)
+..++++||=
T Consensus 238 d~~i~vIDFP 247 (465)
T KOG2268|consen 238 DDKIVVIDFP 247 (465)
T ss_pred CCCEEEeech
Confidence 9999999995
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.053 Score=55.62 Aligned_cols=73 Identities=14% Similarity=0.139 Sum_probs=47.9
Q ss_pred CceeeecCcEeEEEEEecCCcEEEEEEeccC----Cc---cchHHHHHHHHHHhcCC---CCCccceeeEEEeCCeeEEE
Q 010186 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSC----SE---QGTAEFTNEVLLILKLQ---HKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 354 ~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~----~~---~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV 423 (516)
.+.||.|..-.||+... ++..++||+-.+. +. .....-..|.+.|..+. ..++++++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 35689999999999876 4557889976521 11 12233334455555442 357888888876 456889
Q ss_pred EEccCC
Q 010186 424 YEFMPN 429 (516)
Q Consensus 424 ~Ey~~~ 429 (516)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.031 Score=55.43 Aligned_cols=129 Identities=16% Similarity=0.283 Sum_probs=76.2
Q ss_pred CcEEEEEEecc--CCccchHHHHHHHHHHhcCCC--CCccceeeEEEeCC--eeEEEEEccCCCChhHHhc---------
Q 010186 373 GKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQH--KNLVKLLGFCVDGD--EKLLVYEFMPNGSLDAILF--------- 437 (516)
Q Consensus 373 g~~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~--~~~lV~Ey~~~gsL~~~l~--------- 437 (516)
+++.+++ ..+ ..........+|..+|+.+.- .-+.+.++.|.++. ..|.||||++|..+...+.
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~ 126 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFA 126 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHH
Confidence 6777777 321 222344556778888887743 34456677777766 6799999998843321110
Q ss_pred ------------CC--------------CCCCCCCHHHHHHH--------HHHHHHHHHHhHcC-----CCCCeeeCCCC
Q 010186 438 ------------DP--------------RKRGILCWRKRTNI--------VNGIAKGMLYLHED-----SRLRIVHRDLK 478 (516)
Q Consensus 438 ------------~~--------------~~~~~l~~~~~~~i--------~~~ia~~l~yLH~~-----~~~~iiHrDlk 478 (516)
.- ...+...|...... .-....-..||+.+ +++.++|+|+.
T Consensus 127 ~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~ 206 (321)
T COG3173 127 LDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYR 206 (321)
T ss_pred HHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcc
Confidence 00 00000112111110 01122334555544 34569999999
Q ss_pred CCCeEecCCCcEEEcccCcccccc
Q 010186 479 ASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 479 ~~NILld~~~~~kl~DFGla~~~~ 502 (516)
+.|++++.+..+=+.||+++.+-+
T Consensus 207 ~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 207 PGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred cCCEEEeCCCeeEEEeccccccCC
Confidence 999999998889999999987644
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.034 Score=56.03 Aligned_cols=79 Identities=15% Similarity=0.154 Sum_probs=48.6
Q ss_pred eeeecCcEeEEEEEecCC-cEEEEEEeccC------C-ccchHHHHHHHHHHhcCC--CC-CccceeeEEEeCCeeEEEE
Q 010186 356 ILGQGGFGPVYKGVLSDG-KEVAVKRLSSC------S-EQGTAEFTNEVLLILKLQ--HK-NLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 356 ~Lg~G~fg~Vy~~~~~~g-~~vavK~l~~~------~-~~~~~~~~~Ei~~l~~l~--H~-niv~l~g~~~~~~~~~lV~ 424 (516)
.||.|..-.||++..++| +.|+||.-.+. + .-..+...-|.+.|.... -| .+++++. .+++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 478999999999997654 58999975431 1 122334455666665542 23 4555543 3555667999
Q ss_pred EccCCCC-hhHHh
Q 010186 425 EFMPNGS-LDAIL 436 (516)
Q Consensus 425 Ey~~~gs-L~~~l 436 (516)
|+++... |...|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 9996544 43444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.00052 Score=75.78 Aligned_cols=148 Identities=16% Similarity=0.202 Sum_probs=99.1
Q ss_pred hhCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEecc---CCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 422 (516)
..+.+.+.+-+..|.++.++...-. .|...+.|.... ......+....+-.++-..+||-+++..--+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3445666667888999988876632 232223332221 111122223333333333455666655544556778899
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
+++|..+++|...|+.. +..+.+-.......+.++++|||... ++|||++|.|+|+..++..++.|||+.+.
T Consensus 882 ~~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred hhHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccc
Confidence 99999999998888543 34555555666777889999999875 89999999999999999999999995544
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.14 Score=50.88 Aligned_cols=30 Identities=23% Similarity=0.329 Sum_probs=25.7
Q ss_pred CCCeeeCCCCCCCeEecCCCcEEEcccCccc
Q 010186 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (516)
Q Consensus 469 ~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 499 (516)
+..++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 346999999999999987 678999999664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.012 Score=55.21 Aligned_cols=30 Identities=33% Similarity=0.536 Sum_probs=21.6
Q ss_pred CeeeCCCCCCCeEe-cCCCcEEEcccCcccc
Q 010186 471 RIVHRDLKASNVLL-DSDMNSKISDFGMARI 500 (516)
Q Consensus 471 ~iiHrDlk~~NILl-d~~~~~kl~DFGla~~ 500 (516)
.+.|+|+.|.|||+ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48999999999999 8899999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.062 Score=54.13 Aligned_cols=139 Identities=16% Similarity=0.230 Sum_probs=77.4
Q ss_pred eeecCcEeEEEEEecC----CcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCcc-ceeeEEEeCCeeEEEEEccCCCC
Q 010186 357 LGQGGFGPVYKGVLSD----GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV-KLLGFCVDGDEKLLVYEFMPNGS 431 (516)
Q Consensus 357 Lg~G~fg~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~~gs 431 (516)
|..|-.-.+|+....+ +..+.+|+..+.... .-.-.+|..+++.+...++. ++++++. ++ +|.||+++..
T Consensus 22 l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~~ 96 (330)
T PLN02421 22 ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINART 96 (330)
T ss_pred eCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCCC
Confidence 4446666788876543 237888877654332 22346788888888655553 5565552 22 5899998776
Q ss_pred hhHH-----------------hcCCC--CCC-CCCHHHHHHHHHH----------------------HHHHHH----HhH
Q 010186 432 LDAI-----------------LFDPR--KRG-ILCWRKRTNIVNG----------------------IAKGML----YLH 465 (516)
Q Consensus 432 L~~~-----------------l~~~~--~~~-~l~~~~~~~i~~~----------------------ia~~l~----yLH 465 (516)
|..- ++... ... ...|.....+..+ +..-+. ++.
T Consensus 97 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~ 176 (330)
T PLN02421 97 LTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITD 176 (330)
T ss_pred CChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhc
Confidence 5321 11111 011 1123222222211 111111 221
Q ss_pred c-CCCCCeeeCCCCCCCeEecC-CCcEEEcccCcccc
Q 010186 466 E-DSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARI 500 (516)
Q Consensus 466 ~-~~~~~iiHrDlk~~NILld~-~~~~kl~DFGla~~ 500 (516)
. ..+.-+.|.|+.+.|||+++ ++.++++||+.|..
T Consensus 177 ~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 177 SLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred cCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 12234899999999999975 57899999998754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.0017 Score=68.34 Aligned_cols=136 Identities=18% Similarity=0.107 Sum_probs=91.6
Q ss_pred CCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCC-ccceeeEEEeCCeeEEEEEccCCC-
Q 010186 353 DSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN-LVKLLGFCVDGDEKLLVYEFMPNG- 430 (516)
Q Consensus 353 ~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~Ey~~~g- 430 (516)
..+-++++..++++|.+-...+...++.+.. .....-++++|.+++||| .++.++-+..++..+++++++..+
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeecc-----chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 3345788999999998743333333554432 144567899999999999 777777666677789999999877
Q ss_pred C-hhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 431 S-LDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 431 s-L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
+ ..... ...-.+...+...+.+.-+++++|||+.. -+||| ||+..+ ...|..||+....++..
T Consensus 321 s~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 321 SSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred cccccCC---hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence 2 21111 11111223334445666778999999864 58998 776654 78899999998877654
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.11 Score=52.12 Aligned_cols=136 Identities=24% Similarity=0.316 Sum_probs=78.7
Q ss_pred CcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCC------ccceeeE----EEeCCeeEEEEEccCCC
Q 010186 361 GFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN------LVKLLGF----CVDGDEKLLVYEFMPNG 430 (516)
Q Consensus 361 ~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n------iv~l~g~----~~~~~~~~lV~Ey~~~g 430 (516)
.--.+|+....+|.. ++|+..+. ....++..|+..+..+.-.. +..+=|- ...+...+-++||++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 345688888777766 77877664 34455666777776662111 2332222 11223677899999998
Q ss_pred ChhH-H-----------h-------cC-----CCCCCCCCHHH-------------HHHHHHHHHHHHHHhHcC------
Q 010186 431 SLDA-I-----------L-------FD-----PRKRGILCWRK-------------RTNIVNGIAKGMLYLHED------ 467 (516)
Q Consensus 431 sL~~-~-----------l-------~~-----~~~~~~l~~~~-------------~~~i~~~ia~~l~yLH~~------ 467 (516)
.+.. . + .. +.......|.. ......++...+..+.+.
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 8872 1 0 00 00111233331 001223344444444432
Q ss_pred -CCCCeeeCCCCCCCeEecCCCc-EEEcccCccc
Q 010186 468 -SRLRIVHRDLKASNVLLDSDMN-SKISDFGMAR 499 (516)
Q Consensus 468 -~~~~iiHrDlk~~NILld~~~~-~kl~DFGla~ 499 (516)
.+..+||+|+.|.||++|.+.. +.+.||+-+.
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1122899999999999999885 8999999775
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.052 Score=54.08 Aligned_cols=71 Identities=18% Similarity=0.214 Sum_probs=55.0
Q ss_pred eeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcc
Q 010186 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (516)
Q Consensus 419 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 498 (516)
..|++|++. +++|..+ ....|++...++.+-+.-+.-+..+- +.=|||+.-.||||| +|++.|+||-++
T Consensus 300 y~yl~~kdh-gt~is~i-------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 300 YLYLHFKDH-GTPISII-------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred EEEEEEecC-Cceeeee-------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeee
Confidence 356777764 4455322 22458899999998887777776654 799999999999999 999999999999
Q ss_pred cc
Q 010186 499 RI 500 (516)
Q Consensus 499 ~~ 500 (516)
|+
T Consensus 369 Rl 370 (488)
T COG5072 369 RL 370 (488)
T ss_pred ec
Confidence 94
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.13 Score=51.32 Aligned_cols=32 Identities=28% Similarity=0.364 Sum_probs=28.4
Q ss_pred CCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 469 ~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
+..++|+|+.+.|||++.++.+.|+||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 44699999999999999999999999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.29 E-value=0.23 Score=46.61 Aligned_cols=74 Identities=22% Similarity=0.265 Sum_probs=50.5
Q ss_pred eeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcC---CCCCccceeeEEEeCCeeEEEEEccCCCCh
Q 010186 356 ILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL---QHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432 (516)
Q Consensus 356 ~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 432 (516)
.+.-|..-..|.... +..++.||+-.. .....|..|+.-|..+ +--++.+.+.+-...+..|||+||++-|.+
T Consensus 23 ~v~gG~inea~~v~d-g~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~ 98 (286)
T COG3001 23 EVSGGDINEAWRLRD-GTDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL 98 (286)
T ss_pred ccCCccccceeEeec-CCcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence 344444444444332 456788886432 3456788887766666 445688888888899999999999998777
Q ss_pred h
Q 010186 433 D 433 (516)
Q Consensus 433 ~ 433 (516)
+
T Consensus 99 d 99 (286)
T COG3001 99 D 99 (286)
T ss_pred C
Confidence 5
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.28 E-value=0.32 Score=48.89 Aligned_cols=70 Identities=17% Similarity=0.137 Sum_probs=43.4
Q ss_pred cEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCC--CCccc---eee--EEEeCCeeEEEEEccCCCCh
Q 010186 362 FGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH--KNLVK---LLG--FCVDGDEKLLVYEFMPNGSL 432 (516)
Q Consensus 362 fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H--~niv~---l~g--~~~~~~~~~lV~Ey~~~gsL 432 (516)
--.||+....++..+++|+..+. ......+..|++.+..|.. -.++. .-| ....++..+.|+++++|...
T Consensus 38 eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 38 ENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 35689888777888999987542 2244566777777766622 11222 222 22334567889999987654
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.25 E-value=0.23 Score=57.64 Aligned_cols=140 Identities=21% Similarity=0.262 Sum_probs=75.2
Q ss_pred eeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcC-------CCCCcccee-e----EEEe-CC--ee
Q 010186 356 ILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-------QHKNLVKLL-G----FCVD-GD--EK 420 (516)
Q Consensus 356 ~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-------~H~niv~l~-g----~~~~-~~--~~ 420 (516)
.|+ |..-.+|+....+|..+++|+..+.. .......|...|..| .-|.+++-. | .... .+ ..
T Consensus 32 ~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~ 108 (1013)
T PRK06148 32 PLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL 108 (1013)
T ss_pred ecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence 343 34566788887778889999987642 222334444555444 223333221 1 1111 12 35
Q ss_pred EEEEEccCCCChhHHhc------------------------CCCCCCCCCHHH-----------------HHHHHHHHHH
Q 010186 421 LLVYEFMPNGSLDAILF------------------------DPRKRGILCWRK-----------------RTNIVNGIAK 459 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~------------------------~~~~~~~l~~~~-----------------~~~i~~~ia~ 459 (516)
+-+++|++|..+.+... .+.....+.|.. ...++.++..
T Consensus 109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~ 188 (1013)
T PRK06148 109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA 188 (1013)
T ss_pred EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence 67899999987754110 000011122211 1122222322
Q ss_pred HHH-----HhHcCCCCCeeeCCCCCCCeEecCCC--cEE-EcccCccc
Q 010186 460 GML-----YLHEDSRLRIVHRDLKASNVLLDSDM--NSK-ISDFGMAR 499 (516)
Q Consensus 460 ~l~-----yLH~~~~~~iiHrDlk~~NILld~~~--~~k-l~DFGla~ 499 (516)
... .+.+ -+..+||+|+.+.|||++.+. ++. |+|||.+.
T Consensus 189 ~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 189 RFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 221 1222 234599999999999999875 554 99999774
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.10 E-value=0.084 Score=53.44 Aligned_cols=61 Identities=18% Similarity=0.049 Sum_probs=39.2
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS 486 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~ 486 (516)
..|+-+|+++-++..++.. ...+++...+++.--.+|+.-+---. .++|.|+.|.||++.-
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~----~~~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKW----KSQPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhhc----ccChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEEe
Confidence 3577788889888888832 22344445555554555544332221 2999999999999953
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=94.72 E-value=0.18 Score=48.43 Aligned_cols=75 Identities=20% Similarity=0.185 Sum_probs=53.9
Q ss_pred ceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHH---HHHhcCCCCCccceeeEEEeCCeeEEEEEcc-CCC
Q 010186 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEV---LLILKLQHKNLVKLLGFCVDGDEKLLVYEFM-PNG 430 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei---~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~-~~g 430 (516)
..+..|..+.|+.++..+|+++++|+..+... +..|. ..|...+-...|++++.- .+...|++|.+ ++.
T Consensus 8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~-----~~~E~~g~~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g~ 80 (253)
T PF04655_consen 8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAE-----AEHEARGEAALRWWNGRGAVRLLAAD--PERGALLLERLDPGR 80 (253)
T ss_pred CCCCCCcceEEEEEEcCCCCeEEEEecCCccc-----chhhhhHHhHhheeCCCCceeeeccc--cccchhhhhhccCCC
Confidence 34667889999999988999999998875332 22333 447777777888988753 34567899998 555
Q ss_pred ChhHHh
Q 010186 431 SLDAIL 436 (516)
Q Consensus 431 sL~~~l 436 (516)
+|.+..
T Consensus 81 ~L~~~~ 86 (253)
T PF04655_consen 81 SLASLP 86 (253)
T ss_pred chhhcc
Confidence 776554
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.48 E-value=0.32 Score=49.97 Aligned_cols=73 Identities=19% Similarity=0.302 Sum_probs=43.9
Q ss_pred eeeecCcEeEEEEEecCC--cE-----EEEEEeccCCccchHHHHHHHHHHhcCCCCCcc-ceeeEEEeCCeeEEEEEcc
Q 010186 356 ILGQGGFGPVYKGVLSDG--KE-----VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV-KLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 356 ~Lg~G~fg~Vy~~~~~~g--~~-----vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~ 427 (516)
.|..|-...+|++...++ .. |.++........ .-+-.+|+++++.+...++. ++++.+. .++|+||+
T Consensus 57 ~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l-~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~efI 131 (383)
T PTZ00384 57 KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSL-VIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEWV 131 (383)
T ss_pred EeCCcccceEEEEEecCCCCCccccceEEEEeccCCCce-EeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEEe
Confidence 455577788999875433 12 444432222111 12235788899988665555 4555543 36999999
Q ss_pred CCCChh
Q 010186 428 PNGSLD 433 (516)
Q Consensus 428 ~~gsL~ 433 (516)
+|..|.
T Consensus 132 eGr~l~ 137 (383)
T PTZ00384 132 EGNTMG 137 (383)
T ss_pred ccccCC
Confidence 998774
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.34 E-value=0.18 Score=47.03 Aligned_cols=101 Identities=15% Similarity=0.170 Sum_probs=64.4
Q ss_pred EEEEEeccCCcc-chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHH
Q 010186 376 VAVKRLSSCSEQ-GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV 454 (516)
Q Consensus 376 vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~ 454 (516)
..+|++....-. ...-|.++.+++++++ .|++|..- .....-+++|+|-.... ++ ..++
T Consensus 88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------------~~----~N~i 147 (308)
T PF07387_consen 88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------------NF----SNFI 147 (308)
T ss_pred hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------------ch----hHHH
Confidence 455666543333 3456788888888775 45665521 22345588898733111 11 1122
Q ss_pred HHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCc
Q 010186 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497 (516)
Q Consensus 455 ~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 497 (516)
.-=.+.|.-.|+.. ...+|+|-.|+||+-|+.|-+||.|=+.
T Consensus 148 ~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 148 TAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence 21246677788643 4699999999999999999999999764
|
The function of this family is unknown. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.21 E-value=0.23 Score=50.81 Aligned_cols=74 Identities=19% Similarity=0.153 Sum_probs=47.4
Q ss_pred ceeeecCcEeEEEEEecC-CcEEEEEEecc---CC---ccchHHHHHHHHHHhcCC--CC-CccceeeEEEeCCeeEEEE
Q 010186 355 NILGQGGFGPVYKGVLSD-GKEVAVKRLSS---CS---EQGTAEFTNEVLLILKLQ--HK-NLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~-g~~vavK~l~~---~~---~~~~~~~~~Ei~~l~~l~--H~-niv~l~g~~~~~~~~~lV~ 424 (516)
+.||.|.-.-||++...+ ++.|+||.-.+ .. .-..++..-|.+.|+... -| .+++++.+ +++...+||
T Consensus 35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~vM 112 (409)
T PRK12396 35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCVM 112 (409)
T ss_pred eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHHH
Confidence 568999999999999743 56899997543 11 122344555666666542 23 45555543 555667999
Q ss_pred EccCCC
Q 010186 425 EFMPNG 430 (516)
Q Consensus 425 Ey~~~g 430 (516)
|+++..
T Consensus 113 EdL~~~ 118 (409)
T PRK12396 113 EDLSDH 118 (409)
T ss_pred HhCccc
Confidence 999653
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.38 E-value=0.56 Score=47.77 Aligned_cols=134 Identities=16% Similarity=0.168 Sum_probs=82.8
Q ss_pred CCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcC-CCCCccceeeEE----E--e-CCeeEEEE
Q 010186 353 DSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFC----V--D-GDEKLLVY 424 (516)
Q Consensus 353 ~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~----~--~-~~~~~lV~ 424 (516)
.+..||+|+-+.+|---.- +.. +.|+..........+ .+..|... .||-+..-+.|= . + +...-++|
T Consensus 15 ~gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchh-hch-hheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 4567999999999964311 112 335554322222222 23334444 566443312111 0 1 12245677
Q ss_pred EccCCCC-hhHHhc---CCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcc
Q 010186 425 EFMPNGS-LDAILF---DPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD 494 (516)
Q Consensus 425 Ey~~~gs-L~~~l~---~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~D 494 (516)
..+++.. +..++. ..+......|.-.+..++.++.+..-||+.+ .+-+|+.++|+|+.++..+.|.|
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVd 160 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVD 160 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEc
Confidence 7776653 333332 1123345789999999999999999999998 89999999999999888888766
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=93.06 E-value=0.8 Score=45.08 Aligned_cols=32 Identities=28% Similarity=0.413 Sum_probs=26.6
Q ss_pred CeeeCCCCCCCeEecCC--C---cEEEcccCcccccc
Q 010186 471 RIVHRDLKASNVLLDSD--M---NSKISDFGMARIFA 502 (516)
Q Consensus 471 ~iiHrDlk~~NILld~~--~---~~kl~DFGla~~~~ 502 (516)
-++|+|+++.|||...+ + .+++.||-+++.-.
T Consensus 216 vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~g~ 252 (294)
T PF02958_consen 216 VLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARYGS 252 (294)
T ss_pred EEEcCccCHHhEeEccccccccccceeeccccccCCC
Confidence 49999999999999654 3 69999999987643
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 516 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-36 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-35 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-29 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-29 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-29 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-28 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-26 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-26 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-16 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 9e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 9e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-11 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-11 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-11 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-11 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-11 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 7e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 9e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-08 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-08 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 9e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-06 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 9e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 9e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-05 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-05 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-05 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-05 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-04 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-04 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 4e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 4e-04 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-04 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-04 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-04 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 8e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 8e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 280 bits (719), Expect = 3e-91
Identities = 77/186 (41%), Positives = 107/186 (57%), Gaps = 14/186 (7%)
Query: 341 LETLNLATSNFSD------SNILGQGGFGPVYKGVLSDGKEVAVKRLSSC----SEQGTA 390
L T+NF + N +G+GGFG VYKG + + VAVK+L++ +E+
Sbjct: 17 FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQ 75
Query: 391 EFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKR 450
+F E+ ++ K QH+NLV+LLGF DGD+ LVY +MPNGSL L L W R
Sbjct: 76 QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
I G A G+ +LHE+ +HRD+K++N+LLD +KISDFG+AR + T
Sbjct: 136 CKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192
Query: 511 VRIVGT 516
RIVGT
Sbjct: 193 SRIVGT 198
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 273 bits (700), Expect = 3e-88
Identities = 78/178 (43%), Positives = 112/178 (62%), Gaps = 3/178 (1%)
Query: 341 LETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGT-AEFTNEVLLI 399
L L +A+ NFS+ NILG+GGFG VYKG L+DG VAVKRL QG +F EV +I
Sbjct: 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMI 81
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRK-RGILCWRKRTNIVNGIA 458
H+NL++L GFC+ E+LLVY +M NGS+ + L + + + L W KR I G A
Sbjct: 82 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 141
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
+G+ YLH+ +I+HRD+KA+N+LLD + + + DFG+A++ + T + GT
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 256 bits (657), Expect = 6e-82
Identities = 69/177 (38%), Positives = 105/177 (59%), Gaps = 4/177 (2%)
Query: 341 LETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLIL 400
L L AT+NF ++G G FG VYKGVL DG +VA+KR + S QG EF E+ +
Sbjct: 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 401 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAK 459
+H +LV L+GFC + +E +L+Y++M NG+L L+ + W +R I G A+
Sbjct: 91 FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
G+ YLH + I+HRD+K+ N+LLD + KI+DFG+++ E + + + GT
Sbjct: 151 GLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGT 204
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 2e-63
Identities = 54/189 (28%), Positives = 90/189 (47%), Gaps = 17/189 (8%)
Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLL 398
+ E L + + +G FG V+K L + VAVK +Q + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 399 ILKLQHKNLVKLLGFCVDGD----EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV 454
+ ++H+N+++ +G G + L+ F GSL L K ++ W + +I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127
Query: 455 NGIAKGMLYLHED-------SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
+A+G+ YLHED + I HRD+K+ NVLL +++ + I+DFG+A F +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 508 ANTVRIVGT 516
+T VGT
Sbjct: 188 GDTHGQVGT 196
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 3e-55
Identities = 56/197 (28%), Positives = 86/197 (43%), Gaps = 27/197 (13%)
Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNE--V 396
+L N ++G+G +G VYKG L D + VAVK S + Q F NE +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 397 LLILKLQHKNLVKLLGFCVDGD-----EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT 451
+ ++H N+ + + E LLV E+ PNGSL L W
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSC 114
Query: 452 NIVNGIAKGMLYLHED------SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES- 504
+ + + +G+ YLH + + I HRDL + NVL+ +D ISDFG++ +
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 505 -----EGEANTVRIVGT 516
E + + VGT
Sbjct: 175 LVRPGEEDNAAISEVGT 191
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 6e-50
Identities = 57/187 (30%), Positives = 90/187 (48%), Gaps = 13/187 (6%)
Query: 332 LKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRL--SSCSEQGT 389
+ D I LN+ +G G FG V++ G +VAVK L +
Sbjct: 27 MDGDDMDIPWCDLNI-------KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERV 78
Query: 390 AEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRK 449
EF EV ++ +L+H N+V +G +V E++ GSL +L R L R+
Sbjct: 79 NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR 138
Query: 450 RTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509
R ++ +AKGM YLH IVHR+LK+ N+L+D K+ DFG++R+ ++ +
Sbjct: 139 RLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLS 195
Query: 510 TVRIVGT 516
+ GT
Sbjct: 196 SKSAAGT 202
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-48
Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 6/159 (3%)
Query: 355 NILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
+LG+G FG K G+ + +K L E+ F EV ++ L+H N++K +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
+ E++ G+L I+ + W +R + IA GM YLH + I+
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLH---SMNII 130
Query: 474 HRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR 512
HRDL + N L+ + N ++DFG+AR+ + + + +R
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 6e-47
Identities = 48/163 (29%), Positives = 75/163 (46%), Gaps = 13/163 (7%)
Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLL 398
ID + + + ++G+G FG V K K+VA+K++ S E F E+
Sbjct: 5 IDYKEIEV-------EEVVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQ 54
Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIA 458
+ ++ H N+VKL G C++ LV E+ GSL +L + +
Sbjct: 55 LSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARI 500
+G+ YLH ++HRDLK N+LL + KI DFG A
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 5e-46
Identities = 43/178 (24%), Positives = 74/178 (41%), Gaps = 15/178 (8%)
Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRL--SSCSEQGTAEFTNEV 396
ID + LN L + G ++KG G ++ VK L S + + +F E
Sbjct: 7 IDFKQLNF-------LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEEC 58
Query: 397 LLILKLQHKNLVKLLGFCVDGDEKLL--VYEFMPNGSLDAILFDPRKRGILCWRKRTNIV 454
+ H N++ +LG C + +MP GSL +L + ++ +
Sbjct: 59 PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF-VVDQSQAVKFA 117
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR 512
+A+GM +LH L I L + +V++D DM ++IS + F +S G
Sbjct: 118 LDMARGMAFLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF-QSPGRMYAPA 173
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 3e-45
Identities = 58/184 (31%), Positives = 86/184 (46%), Gaps = 24/184 (13%)
Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTA----EFTN 394
ID L L I+G GGFG VY+ G EVAVK ++ +
Sbjct: 4 IDFAELTLE-------EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQ 55
Query: 395 EVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV 454
E L L+H N++ L G C+ LV EF G L+ +L R + N
Sbjct: 56 EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWA 111
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS--------KISDFGMARIFAESEG 506
IA+GM YLH+++ + I+HRDLK+SN+L+ + + KI+DFG+AR + +
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK 171
Query: 507 EANT 510
+
Sbjct: 172 MSAA 175
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-44
Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 19/197 (9%)
Query: 323 QHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRL- 381
H + A D+ I + + +G G FG VYKG +VAVK L
Sbjct: 5 HHHHHHGSRDAADDWEIPDGQITVG-------QRIGSGSFGTVYKGKWHG--DVAVKMLN 55
Query: 382 -SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDP 439
++ + Q F NEV ++ K +H N++ +G+ +L +V ++ SL L
Sbjct: 56 VTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQLAIVTQWCEGSSLYHHLHAS 113
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+ +K +I A+GM YLH I+HRDLK++N+ L D KI DFG+A
Sbjct: 114 ETK--FEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT 168
Query: 500 IFAESEGEANTVRIVGT 516
+ G ++ G+
Sbjct: 169 EKSRWSGSHQFEQLSGS 185
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-44
Identities = 52/179 (29%), Positives = 83/179 (46%), Gaps = 25/179 (13%)
Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTA------- 390
+ + +G+GGFG V+KG + D VA+K L +G
Sbjct: 16 LADNEIEY-------EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ 68
Query: 391 EFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKR 450
EF EV ++ L H N+VKL G + +V EF+P G L L D + W +
Sbjct: 69 EFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHP--IKWSVK 124
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-----DMNSKISDFGMARIFAES 504
++ IA G+ Y+ + IVHRDL++ N+ L S + +K++DFG+++ S
Sbjct: 125 LRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS 182
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 5e-44
Identities = 48/187 (25%), Positives = 81/187 (43%), Gaps = 17/187 (9%)
Query: 326 QGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRL--SS 383
+ + Q++ I E L + ++G+G FG VY G EVA++ +
Sbjct: 17 KASQTSIFLQEWDIPFEQLEI-------GELIGKGRFGQVYHGRWHG--EVAIRLIDIER 67
Query: 384 CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRG 443
+E F EV+ + +H+N+V +G C+ ++ +L +++ D +
Sbjct: 68 DNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV- 126
Query: 444 ILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503
L K I I KGM YLH I+H+DLK+ NV D + I+DFG+ I
Sbjct: 127 -LDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181
Query: 504 SEGEANT 510
+
Sbjct: 182 LQAGRRE 188
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 9e-42
Identities = 45/175 (25%), Positives = 78/175 (44%), Gaps = 21/175 (12%)
Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNE--VLLILKLQHKNLVKLLG 412
+G+G +G V++G G+ VAVK SS + + E + + L+H+N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 413 FCVDGDEK----LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
+ L+ + GSL L + L IV IA G+ +LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 469 RLR-----IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI--VGT 516
I HRDLK+ N+L+ + I+D G+A + ++S + + VGT
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 1e-41
Identities = 43/191 (22%), Positives = 78/191 (40%), Gaps = 28/191 (14%)
Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNE--V 396
+ + + +G+G +G V+ G G++VAVK + A + E +
Sbjct: 34 TIAKQIQM-------VKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEI 82
Query: 397 LLILKLQHKNLVKLLGFCVDGDEK----LLVYEFMPNGSLDAILFDPRKRGILCWRKRTN 452
+ ++H+N++ + + G L+ ++ NGSL L K L +
Sbjct: 83 YQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLK 138
Query: 453 IVNGIAKGMLYLHEDSRLR-----IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
+ G+ +LH + I HRDLK+ N+L+ + I+D G+A F E
Sbjct: 139 LAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNE 198
Query: 508 ANTVRI--VGT 516
+ VGT
Sbjct: 199 VDIPPNTRVGT 209
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-40
Identities = 50/152 (32%), Positives = 70/152 (46%), Gaps = 9/152 (5%)
Query: 357 LGQGGFGPVYKGVL-SDGKEVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
+G+G FG V+ G L +D VAVK + A+F E ++ + H N+V+L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRG-ILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
+V E + G L R G L + +V A GM YL +
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLES---KCCI 235
Query: 474 HRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
HRDL A N L+ KISDFGM+R A+
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGV 267
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-39
Identities = 52/162 (32%), Positives = 82/162 (50%), Gaps = 12/162 (7%)
Query: 355 NILGQGGFGPVYKGVLSDGKE-----VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLV 408
+LG G FG VYKG+ E VA+K L + S + E +E ++ + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
+LLG C+ L+ + MP G L + + + + + N IAKGM YL
Sbjct: 81 RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYL---E 134
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
R+VHRDL A NVL+ + + KI+DFG+A++ E E +
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-39
Identities = 49/158 (31%), Positives = 79/158 (50%), Gaps = 12/158 (7%)
Query: 355 NILGQGGFGPVYKGVL-----SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVK 409
LG+G FG V + G+ VAVK+L +E+ +F E+ ++ LQH N+VK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 410 LLGFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
G C + L+ E++P GSL L + + + K + I KGM YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT- 132
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
R +HRDL N+L++++ KI DFG+ ++ + +
Sbjct: 133 --KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 4e-39
Identities = 49/158 (31%), Positives = 79/158 (50%), Gaps = 12/158 (7%)
Query: 355 NILGQGGFGPVYKGVL-----SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVK 409
LG+G FG V + G+ VAVK+L +E+ +F E+ ++ LQH N+VK
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 410 LLGFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
G C + L+ E++P GSL L + + + K + I KGM YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT- 163
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
R +HRDL N+L++++ KI DFG+ ++ + +
Sbjct: 164 --KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 9e-39
Identities = 45/175 (25%), Positives = 77/175 (44%), Gaps = 21/175 (12%)
Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNE--VLLILKLQHKNLVKLLG 412
+G+G FG V++G G+EVAVK SS E+ + E + + L+H+N++ +
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIA 103
Query: 413 FCVDGDEK----LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED- 467
+ LV ++ +GSL L R + + A G+ +LH +
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 468 ----SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI--VGT 516
+ I HRDLK+ N+L+ + I+D G+A + + VGT
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 9e-39
Identities = 50/160 (31%), Positives = 75/160 (46%), Gaps = 12/160 (7%)
Query: 355 NILGQGGFGPVYKGVL-----SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVK 409
+ LG+G FG V + G VAVK+L +F E+ ++ L +VK
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 410 LLGFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
G + LV E++P+G L L R R L + + I KGM YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS- 145
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
R VHRDL A N+L++S+ + KI+DFG+A++ +
Sbjct: 146 --RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY 183
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-38
Identities = 49/179 (27%), Positives = 81/179 (45%), Gaps = 16/179 (8%)
Query: 333 KAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE----VAVKRL-SSCSEQ 387
+ +D I E + ++G+G FG VY G D + A+K L Q
Sbjct: 10 EVKDVLIPHERVVT-----HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ 64
Query: 388 GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE-KLLVYEFMPNGSLDAILFDPRKRGILC 446
F E LL+ L H N++ L+G + + ++ +M +G L + P++
Sbjct: 65 QVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN--PT 122
Query: 447 WRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
+ + +A+GM YL + + VHRDL A N +LD K++DFG+AR + E
Sbjct: 123 VKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-38
Identities = 45/151 (29%), Positives = 69/151 (45%), Gaps = 6/151 (3%)
Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
LG G FG V G +VA+K + S EF E +++ L H+ LV+L G C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
++ E+M NG L L R ++ + + + M YL + +H
Sbjct: 89 TKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLH 143
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESE 505
RDL A N L++ K+SDFG++R + E
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-38
Identities = 54/161 (33%), Positives = 84/161 (52%), Gaps = 10/161 (6%)
Query: 355 NILGQGGFGPVYKGVLSDGKE----VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
I+G G G V G L + VA+K L + +E+ +F +E ++ + H N+++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
L G G ++V E+M NGSLD L + + ++ G+ GM YL S
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--FTIMQLVGMLRGVGAGMRYL---SD 169
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
L VHRDL A NVL+DS++ K+SDFG++R+ + A T
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT 210
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-38
Identities = 51/181 (28%), Positives = 84/181 (46%), Gaps = 18/181 (9%)
Query: 332 LKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGK---EVAVKRL--SSCSE 386
++ ++ ++D + L L LG G FG V KG K VAVK L +
Sbjct: 6 IRPKEVYLDRKLLTLEDK------ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP 59
Query: 387 QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILC 446
E E ++ +L + +V+++G C + + +LV E G L+ L ++ +
Sbjct: 60 ALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVK 115
Query: 447 WRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506
+ +V+ ++ GM YL VHRDL A NVLL + +KISDFG+++ E
Sbjct: 116 DKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172
Query: 507 E 507
Sbjct: 173 Y 173
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-38
Identities = 52/163 (31%), Positives = 77/163 (47%), Gaps = 21/163 (12%)
Query: 355 NILGQGGFGPVYKGVLSDGKE------VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
LG+G FG V+ + VAVK L SE +F E L+ LQH+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAIL------------FDPRKRGILCWRKRTNIVNG 456
+ G C +G L+V+E+M +G L+ L + G L + + +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+A GM+YL + L VHRDL N L+ + KI DFGM+R
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-38
Identities = 50/177 (28%), Positives = 80/177 (45%), Gaps = 16/177 (9%)
Query: 335 QDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE---VAVKRL-SSCSEQGTA 390
+ F+ + L + LG G FG V +GV K+ VA+K L + T
Sbjct: 2 KKLFLKRDNLLI------ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE 55
Query: 391 EFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKR 450
E E ++ +L + +V+L+G C + +LV E G L L R+ +
Sbjct: 56 EMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNV 112
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
+++ ++ GM YL VHRDL A NVLL + +KISDFG+++ +
Sbjct: 113 AELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-38
Identities = 48/152 (31%), Positives = 74/152 (48%), Gaps = 8/152 (5%)
Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
+G G FG V+ G + +VA+K + + +F E +++KL H LV+L G C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRK-RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
++ LV EFM +G L L R RG+ + + +GM YL ++
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAYL---EEACVI 126
Query: 474 HRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
HRDL A N L+ + K+SDFGM R + +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-38
Identities = 46/167 (27%), Positives = 74/167 (44%), Gaps = 21/167 (12%)
Query: 356 ILGQGGFGPVYKGVLSDGK--------EVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL 407
LGQG F ++KGV + EV +K L + F ++ KL HK+L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
V G CV GDE +LV EF+ GSLD L + + + + + +A M +L
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAAMHFL--- 129
Query: 468 SRLRIVHRDLKASNVLLDSDMNS--------KISDFGMARIFAESEG 506
++H ++ A N+LL + + K+SD G++ +
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI 176
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-38
Identities = 51/159 (32%), Positives = 78/159 (49%), Gaps = 13/159 (8%)
Query: 355 NILGQGGFGPVYKGVL-----SDGKEVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLV 408
LG+G FG V + G++VAVK L A+ E+ ++ L H+N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 409 KLLGFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
K G C + L+ EF+P+GSL L P+ + + +++ I KGM YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
+ VHRDL A NVL++S+ KI DFG+ + +
Sbjct: 145 ---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-38
Identities = 51/179 (28%), Positives = 78/179 (43%), Gaps = 16/179 (8%)
Query: 333 KAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE----VAVKRL-SSCSEQ 387
Q I +L + + ++G+G FG VY G L D AVK L
Sbjct: 14 AVQHVVIGPSSLIV-----HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG 68
Query: 388 GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL-VYEFMPNGSLDAILFDPRKRGILC 446
++F E +++ H N++ LLG C+ + L V +M +G L + +
Sbjct: 69 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PT 126
Query: 447 WRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
+ +AKGM YL + VHRDL A N +LD K++DFG+AR + E
Sbjct: 127 VKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 6e-38
Identities = 50/161 (31%), Positives = 85/161 (52%), Gaps = 11/161 (6%)
Query: 356 ILGQGGFGPVYKGVLSDGKE-----VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
++G G FG VYKG+L VA+K L + +E+ +F E ++ + H N+++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
L G +++ E+M NG+LD L + + ++ GIA GM YL +
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMKYL---AN 165
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
+ VHRDL A N+L++S++ K+SDFG++R+ + T
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 206
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 9e-38
Identities = 53/162 (32%), Positives = 80/162 (49%), Gaps = 22/162 (13%)
Query: 357 LGQGGFGPVYKGVLSDGKE------VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
LG+G FG V+ + VAVK L + +F E L+ LQH+++VK
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAIL-------------FDPRKRGILCWRKRTNIVNGI 457
G C DGD ++V+E+M +G L+ L + +G L + +I + I
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
A GM+YL + VHRDL N L+ +++ KI DFGM+R
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-37
Identities = 51/151 (33%), Positives = 70/151 (46%), Gaps = 8/151 (5%)
Query: 356 ILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
LG G FG V G +VAVK + S EF E ++KL H LVK G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRG-ILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
+V E++ NG L L R G L + + + +GM +L + +H
Sbjct: 74 KEYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIH 127
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESE 505
RDL A N L+D D+ K+SDFGM R + +
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 52/159 (32%), Positives = 74/159 (46%), Gaps = 15/159 (9%)
Query: 355 NILGQGGFGPVYKGVL-----SDGKEVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLV 408
LG+G FG V G+ VAVK L + Q + + E+ ++ L H++++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 409 KLLGFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
K G C D LV E++P GSL L + + + I +GM YLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHS-IGLAQLLLFAQQICEGMAYLHA 152
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
+HRDL A NVLLD+D KI DFG+A+ E
Sbjct: 153 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 52/162 (32%), Positives = 82/162 (50%), Gaps = 12/162 (7%)
Query: 355 NILGQGGFGPVYKGVLSDGKE-----VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLV 408
+LG G FG VYKG+ E VA+K L + S + E +E ++ + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
+LLG C+ L+ + MP G L + + + + + N IAKGM YL
Sbjct: 81 RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYL---E 134
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
R+VHRDL A NVL+ + + KI+DFG+A++ E E +
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 53/160 (33%), Positives = 83/160 (51%), Gaps = 12/160 (7%)
Query: 355 NILGQGGFGPVYKGVLSDGKE----VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
++G G FG V G L + VA+K L +E+ +F E ++ + H N+++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRK-RGILCWRKRTNIVNGIAKGMLYLHEDS 468
L G ++V E+M NGSLD+ L RK + ++ GIA GM YL S
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYL---S 164
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508
+ VHRDL A N+L++S++ K+SDFG+ R+ + A
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA 204
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-37
Identities = 52/165 (31%), Positives = 71/165 (43%), Gaps = 23/165 (13%)
Query: 355 NILGQGGFGPVYKGVLSDGKE------VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNL 407
LG+ FG VYKG L VA+K L EF +E +L +LQH N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAIL-------------FDPRKRGILCWRKRTNIV 454
V LLG +++ + +G L L D + L ++V
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
IA GM YL S +VH+DL NVL+ +N KISD G+ R
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-37
Identities = 50/179 (27%), Positives = 79/179 (44%), Gaps = 16/179 (8%)
Query: 333 KAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE----VAVKRL-SSCSEQ 387
Q I +L + + ++G+G FG VY G L D AVK L
Sbjct: 78 AVQHVVIGPSSLIV-----HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG 132
Query: 388 GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL-VYEFMPNGSLDAILFDPRKRGILC 446
++F E +++ H N++ LLG C+ + L V +M +G L + +
Sbjct: 133 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PT 190
Query: 447 WRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
+ +AKGM +L + + VHRDL A N +LD K++DFG+AR + E
Sbjct: 191 VKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 6e-37
Identities = 54/183 (29%), Positives = 77/183 (42%), Gaps = 20/183 (10%)
Query: 332 LKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVL--SDGKE--VAVKRL---SSC 384
L++ I + L L LG G FG V +G GK VAVK L
Sbjct: 8 LQSLTCLIGEKDLRL-------LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS 60
Query: 385 SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI 444
+ +F EV + L H+NL++L G + +V E P GSL L +
Sbjct: 61 QPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGH-- 117
Query: 445 LCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504
+ +A+GM YL R +HRDL A N+LL + KI DFG+ R ++
Sbjct: 118 FLLGTLSRYAVQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174
Query: 505 EGE 507
+
Sbjct: 175 DDH 177
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-37
Identities = 45/179 (25%), Positives = 78/179 (43%), Gaps = 18/179 (10%)
Query: 332 LKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE----VAVKRL-SSCSE 386
+D+ I E + L +G+G FG V++G+ + VA+K + S+
Sbjct: 5 SSTRDYEIQRERIEL-------GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD 57
Query: 387 QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILC 446
+F E L + + H ++VKL+G + ++ E G L + L + L
Sbjct: 58 SVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS--LD 114
Query: 447 WRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
++ + YL R VHRD+ A NVL+ S+ K+ DFG++R +S
Sbjct: 115 LASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-36
Identities = 52/190 (27%), Positives = 86/190 (45%), Gaps = 16/190 (8%)
Query: 322 YQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE---VAV 378
++ +LK + F+ + L +A LG G FG V +GV K+ VA+
Sbjct: 315 FESPFSDPEELKDKKLFLKRDNLLIA------DIELGCGNFGSVRQGVYRMRKKQIDVAI 368
Query: 379 KRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILF 437
K L + T E E ++ +L + +V+L+G C + +LV E G L L
Sbjct: 369 KVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV 427
Query: 438 DPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497
R+ + +++ ++ GM YL VHR+L A NVLL + +KISDFG+
Sbjct: 428 GKREE--IPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGL 482
Query: 498 ARIFAESEGE 507
++ +
Sbjct: 483 SKALGADDSY 492
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-36
Identities = 55/157 (35%), Positives = 77/157 (49%), Gaps = 12/157 (7%)
Query: 355 NILGQGGFGPVYKGVLSDGKE-----VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLV 408
+LG G FG V+KGV E V +K + Q T+ +L I L H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
+LLG C G LV +++P GSL + RG L + N IAKGM YL
Sbjct: 79 RLLGLCP-GSSLQLVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYL---E 132
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
+VHR+L A NVLL S +++DFG+A + +
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-36
Identities = 47/152 (30%), Positives = 74/152 (48%), Gaps = 6/152 (3%)
Query: 355 NILGQGGFGPVYKGVLSDGK-EVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
+ LG G +G VY+GV VAVK L + + EF E ++ +++H NLV+LLG
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
C ++ EFM G+L L + R + + I+ M YL + +
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYL---EKKNFI 133
Query: 474 HRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
HRDL A N L+ + K++DFG++R+
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-36
Identities = 51/159 (32%), Positives = 72/159 (45%), Gaps = 17/159 (10%)
Query: 355 NILGQGGFGPVYKGVLSDGKE------VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNL 407
LGQG FG VY+GV + VA+K + + S + EF NE ++ + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAIL-------FDPRKRGILCWRKRTNIVNGIAKG 460
V+LLG G L++ E M G L + L + K + IA G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
M YL+ + VHRDL A N ++ D KI DFGM R
Sbjct: 151 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-36
Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 11/155 (7%)
Query: 356 ILGQGGFGPVYKGVLSDGKE----VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
ILG+G FG VY+GV ++ K VAVK C+ +F +E +++ L H ++VKL
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
+G + + ++ E P G L L + L I K M YL +
Sbjct: 79 IGII-EEEPTWIIMELYPYGELGHYLERNKNS--LKVLTLVLYSLQICKAMAYL---ESI 132
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
VHRD+ N+L+ S K+ DFG++R + +
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-36
Identities = 52/193 (26%), Positives = 86/193 (44%), Gaps = 17/193 (8%)
Query: 321 HYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE----V 376
H+ H +++ LE + + + ILG+G FG V +G L V
Sbjct: 6 HHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKV 65
Query: 377 AVKRL--SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD-----EKLLVYEFMPN 429
AVK + + S++ EF +E + H N+++LLG C++ + +++ FM
Sbjct: 66 AVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKY 125
Query: 430 GSLDAILFDPRKRG---ILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS 486
G L L R + + + IA GM YL S +HRDL A N +L
Sbjct: 126 GDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRD 182
Query: 487 DMNSKISDFGMAR 499
DM ++DFG+++
Sbjct: 183 DMTVCVADFGLSK 195
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-36
Identities = 48/160 (30%), Positives = 70/160 (43%), Gaps = 18/160 (11%)
Query: 355 NILGQGGFGPVYKGVLSDGKE----VAVKRL--SSCSEQGTAEFTNEVLLILKLQHKNLV 408
+LG+G FG V + L VAVK L + EF E + + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 409 KLLGFCVDGDEK------LLVYEFMPNGSLDAILFDPR---KRGILCWRKRTNIVNGIAK 459
KL+G + K +++ FM +G L A L R L + + IA
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
GM YL S +HRDL A N +L DM ++DFG++R
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-36
Identities = 52/147 (35%), Positives = 74/147 (50%), Gaps = 10/147 (6%)
Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
+G+G FG V G G +VAVK + + + Q F E ++ +L+H NLV+LLG
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNLVQLLGV 82
Query: 414 CVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
V+ L +V E+M GSL L R R +L + + M YL
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYL---EGNNF 138
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMAR 499
VHRDL A NVL+ D +K+SDFG+ +
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-36
Identities = 54/159 (33%), Positives = 75/159 (47%), Gaps = 17/159 (10%)
Query: 355 NILGQGGFGPVYKGVLSDGK------EVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNL 407
LG G FG VY+G +S +VAVK L CSEQ +F E L+I K H+N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR----KRGILCWRKRTNIVNGIAKGMLY 463
V+ +G + + ++ E M G L + L + R + L ++ IA G Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 464 LHEDSRLRIVHRDLKASNVLLD---SDMNSKISDFGMAR 499
L +HRD+ A N LL +KI DFGMAR
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 7e-36
Identities = 46/163 (28%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 355 NILGQGGFGPVYKGVLSDGKE---VAVKRL-SSCSEQGTAEFTNEVLLILKL-QHKNLVK 409
+++G+G FG V K + A+KR+ S+ +F E+ ++ KL H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAIL-------------FDPRKRGILCWRKRTNIVNG 456
LLG C L E+ P+G+L L L ++ +
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+A+GM YL S+ + +HRDL A N+L+ + +KI+DFG++R
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 54/159 (33%), Positives = 75/159 (47%), Gaps = 17/159 (10%)
Query: 355 NILGQGGFGPVYKGVLSDGK------EVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNL 407
LG G FG VY+G +S +VAVK L CSEQ +F E L+I K H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR----KRGILCWRKRTNIVNGIAKGMLY 463
V+ +G + + ++ E M G L + L + R + L ++ IA G Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 464 LHEDSRLRIVHRDLKASNVLLD---SDMNSKISDFGMAR 499
L +HRD+ A N LL +KI DFGMAR
Sbjct: 197 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-35
Identities = 51/151 (33%), Positives = 79/151 (52%), Gaps = 6/151 (3%)
Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
LG G FG V+ G + +VAVK L S F E L+ +LQH+ LV+L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYA-V 76
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
V + ++ E+M NGSL L L K ++ IA+GM ++ +H
Sbjct: 77 VTQEPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFI---EERNYIH 132
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESE 505
RDL+A+N+L+ ++ KI+DFG+AR+ ++E
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNE 163
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 49/173 (28%), Positives = 70/173 (40%), Gaps = 31/173 (17%)
Query: 355 NILGQGGFGPVYKGVLSDGKE------VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNL 407
+G+G FG V++ VAVK L S A+F E L+ + + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG----------- 456
VKLLG C G L++E+M G L+ L +
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 457 ----------IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+A GM YL S + VHRDL N L+ +M KI+DFG++R
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 50/173 (28%), Positives = 76/173 (43%), Gaps = 31/173 (17%)
Query: 355 NILGQGGFGPVYKGVLSDGKE------VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNL 407
LG+G FG V K K VAVK L + S + +E ++ ++ H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG----------- 456
+KL G C LL+ E+ GSL L + RK G + +
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 457 ----------IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
I++GM YL + +++VHRDL A N+L+ KISDFG++R
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 6e-35
Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 6/152 (3%)
Query: 355 NILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
+ LG G +G VY+GV VAVK L + + EF E ++ +++H NLV+LLG
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
C ++ EFM G+L L + ++ + + I+ M YL + +
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYL---EKKNFI 340
Query: 474 HRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
HR+L A N L+ + K++DFG++R+
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-34
Identities = 52/147 (35%), Positives = 74/147 (50%), Gaps = 10/147 (6%)
Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
+G+G FG V G G +VAVK + + + Q F E ++ +L+H NLV+LLG
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNLVQLLGV 254
Query: 414 CVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
V+ L +V E+M GSL L R R +L + + M YL
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYL---EGNNF 310
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMAR 499
VHRDL A NVL+ D +K+SDFG+ +
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 54/237 (22%), Positives = 92/237 (38%), Gaps = 29/237 (12%)
Query: 289 FFATKKITRKRKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLN--- 345
TK+I +R+ T + + + D + A +L
Sbjct: 18 HKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWE 77
Query: 346 LATSNFSDSNILGQGGFGPVYKGVLSDGKE--------VAVKRL-SSCSEQGTAEFTNEV 396
+ LG+G FG V + VAVK L +E+ ++ +E+
Sbjct: 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 137
Query: 397 LLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN 455
++ + +HKN++ LLG C ++ E+ G+L L R G+ +
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 456 G-------------IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+A+GM YL + + +HRDL A NVL+ + KI+DFG+AR
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 46/168 (27%), Positives = 75/168 (44%), Gaps = 26/168 (15%)
Query: 355 NILGQGGFGPVYKGVLSDGKE--------VAVKRL-SSCSEQGTAEFTNEVLLILKL-QH 404
LG+G FG V + VAVK L +E+ ++ +E+ ++ + +H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG-------- 456
KN++ LLG C ++ E+ G+L L R G+ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 457 -----IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+A+GM YL + + +HRDL A NVL+ + KI+DFG+AR
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-34
Identities = 48/154 (31%), Positives = 75/154 (48%), Gaps = 6/154 (3%)
Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
LG G FG V+ + +VAVK + S F E ++ LQH LVKL
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
+ ++ EFM GSL L + K + IA+GM ++ + +H
Sbjct: 253 T-KEPIYIITEFMAKGSLLDFLKS-DEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIH 307
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508
RDL+A+N+L+ + + KI+DFG+AR+ ++E A
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-34
Identities = 49/151 (32%), Positives = 79/151 (52%), Gaps = 6/151 (3%)
Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
LGQG FG V+ G + VA+K L + F E ++ KL+H+ LV+L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
+ + +V E+M GSL L L + ++ IA GM Y+ R+ VH
Sbjct: 249 SE-EPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 303
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESE 505
RDL+A+N+L+ ++ K++DFG+AR+ ++E
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNE 334
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 8e-34
Identities = 49/151 (32%), Positives = 79/151 (52%), Gaps = 6/151 (3%)
Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
LGQG FG V+ G + VA+K L + F E ++ KL+H+ LV+L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
+ + +V E+M GSL L L + ++ IA GM Y+ R+ VH
Sbjct: 332 SE-EPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 386
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESE 505
RDL+A+N+L+ ++ K++DFG+AR+ ++E
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNE 417
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 9e-34
Identities = 49/174 (28%), Positives = 68/174 (39%), Gaps = 26/174 (14%)
Query: 355 NILGQGGFGPVYKGVLSDGKE------VAVKRL-SSCSEQGTAEFTNEVLLILKL-QHKN 406
LG G FG V + + VAVK L S +E+ ++ L H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG---------- 456
+V LLG C G L++ E+ G L L R I + +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 457 -----IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
+AKGM +L + +HRDL A N+LL +KI DFG+AR
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 46/167 (27%), Positives = 71/167 (42%), Gaps = 25/167 (14%)
Query: 355 NILGQGGFGPVYKGVL------SDGKEVAVKRL-SSCSEQGTAEFTNEVLLILKL-QHKN 406
LG+G FG V + + + VAVK L + +E+ +++ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 407 LVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG--------- 456
+V LLG C L ++ EF G+L L R + ++
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 457 ----IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+AKGM +L + + +HRDL A N+LL KI DFG+AR
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-33
Identities = 41/155 (26%), Positives = 73/155 (47%), Gaps = 11/155 (7%)
Query: 356 ILGQGGFGPVYKGVLSDGKE----VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
+G+G FG V++G+ + VA+K + S+ +F E L + + H ++VKL
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
+G + + ++ E G L + L ++ L ++ + YL
Sbjct: 457 IGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---ESK 510
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
R VHRD+ A NVL+ S+ K+ DFG++R +S
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 47/164 (28%), Positives = 71/164 (43%), Gaps = 22/164 (13%)
Query: 355 NILGQGGFGPVYKGVLSDGKE------VAVKRL-SSCSEQGTAEFTNEVLLILKL-QHKN 406
LG G FG V + + VAVK L S+ +E+ ++ L QH+N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSL-----------DAILFDPRKRGILCWRKRTNIVN 455
+V LLG C G L++ E+ G L + R + +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+A+GM +L + +HRD+ A NVLL + +KI DFG+AR
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 58/231 (25%), Positives = 90/231 (38%), Gaps = 41/231 (17%)
Query: 297 RKRKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNI 356
K++ Q+Q+ ++ ++D ++ Y + + DLK + E L +
Sbjct: 3 YKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLK---WEFPRENLEFG-------KV 52
Query: 357 LGQGGFGPVYKGVLSDGKE------VAVKRL-SSCSEQGTAEFTNEVLLILKL-QHKNLV 408
LG G FG V + VAVK L +E+ ++ +L H+N+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG------------ 456
LLG C L++E+ G L L R++ + N
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 457 --------IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+AKGM +L VHRDL A NVL+ KI DFG+AR
Sbjct: 173 DLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 48/166 (28%), Positives = 77/166 (46%), Gaps = 26/166 (15%)
Query: 357 LGQGGFGPVYKGVLSDGK--------EVAVKRL-SSCSEQGTAEFTNEVLLILKL-QHKN 406
LG+G FG V +VAVK L S +E+ ++ +E+ ++ + +HKN
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG---------- 456
++ LLG C ++ E+ G+L L R G+ ++
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 457 ---IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+A+GM YL + + +HRDL A NVL+ D KI+DFG+AR
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-31
Identities = 51/163 (31%), Positives = 80/163 (49%), Gaps = 7/163 (4%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
+LG+G +G VY G LS+ +A+K + + + E+ L L+HKN+V+ LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
+ + E +P GSL A+L + I +G+ YLH++ +IVH
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 475 RDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGT 516
RD+K NVL+++ KISDFG ++ A T GT
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF--TGT 186
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 50/216 (23%), Positives = 83/216 (38%), Gaps = 27/216 (12%)
Query: 315 ANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDS-------NILGQGGFGPVYK 367
A +Q + + + + E L + + +G+G FG V++
Sbjct: 17 AKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHR 76
Query: 368 GV-LSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424
G + AVK RL + E++ L +V L G +G +
Sbjct: 77 MKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGAVREGPWVNIFM 129
Query: 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL 484
E + GSL ++ ++ G L + + +G+ YLH RI+H D+KA NVLL
Sbjct: 130 ELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLL 183
Query: 485 DSDMNS-KISDFGMARIFAESEGEANTVR---IVGT 516
SD + + DFG A + + I GT
Sbjct: 184 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 43/169 (25%), Positives = 80/169 (47%), Gaps = 18/169 (10%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRL---SSCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
+G+G F VY+ L DG VA+K++ + A+ E+ L+ +L H N++K
Sbjct: 40 IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGIL-----CWRKRTNIVNGIAKGMLYLHED 467
++ +E +V E G L ++ +K+ L W + + ++H
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW----KYFVQLCSALEHMHSR 155
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
R++HRD+K +NV + + K+ D G+ R F+ A+++ VGT
Sbjct: 156 ---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGT 199
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-30
Identities = 47/169 (27%), Positives = 76/169 (44%), Gaps = 16/169 (9%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
+G+G F VYKG+ EVA + ++ F E ++ LQH N+V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 413 FCVDGDEK----LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
+ +LV E M +G+L L ++ ++ + + I KG+ +LH +
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 469 RLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGT 516
I+HRDLK N+ + S KI D G+A + S A V +GT
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--FAKAV--IGT 193
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 45/202 (22%), Positives = 85/202 (42%), Gaps = 18/202 (8%)
Query: 321 HYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKR 380
H+ H DL ++ + ++ +S +G GG V++ + + A+K
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSVK--GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKY 59
Query: 381 --LSSCSEQGTAEFTNEVLLILKLQHKNL--VKLLGFCVDGDEKLLVYEFMPNGSLDAIL 436
L Q + NE+ + KLQ + ++L + + +V E N L++ L
Sbjct: 60 VNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL 118
Query: 437 FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496
+K+ + +R + + + + +H+ IVH DLK +N L+ D K+ DFG
Sbjct: 119 ---KKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFG 171
Query: 497 MARIFAESEGEANTVR--IVGT 516
+A + V+ VGT
Sbjct: 172 IANQM--QPDTTSVVKDSQVGT 191
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 40/203 (19%), Positives = 81/203 (39%), Gaps = 21/203 (10%)
Query: 320 FHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAV 378
H+ H DL ++ +++ + +G+G FG DG++ +
Sbjct: 1 MHHHHHHSSGVDLGTENL--YFQSME----KYVRLQKIGEGSFGKAILVKSTEDGRQYVI 54
Query: 379 K--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL 436
K +S S + E EV ++ ++H N+V+ + +V ++ G L +
Sbjct: 55 KEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI 114
Query: 437 FDPRKRGI---LCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKIS 493
+ I + ++H+ +I+HRD+K+ N+ L D ++
Sbjct: 115 NAQKGVLFQEDQILD----WFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLG 167
Query: 494 DFGMARIFAESEGEANTVRIVGT 516
DFG+AR+ + A +GT
Sbjct: 168 DFGIARVLNSTVELARAC--IGT 188
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 40/168 (23%), Positives = 73/168 (43%), Gaps = 16/168 (9%)
Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKR--LSSCSEQGTAEFTNEVLLILKLQHKNL--VKL 410
+G GG V++ + + A+K L Q + NE+ + KLQ + ++L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
+ + +V E N L++ L +K+ + +R + + + + +H+
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ---H 127
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR--IVGT 516
IVH DLK +N L+ D K+ DFG+A + V+ VGT
Sbjct: 128 GIVHSDLKPANFLIV-DGMLKLIDFGIANQM--QPDTTSVVKDSQVGT 172
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 39/168 (23%), Positives = 72/168 (42%), Gaps = 16/168 (9%)
Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKR--LSSCSEQGTAEFTNEVLLILKLQHKNL--VKL 410
+G GG V++ + + A+K L Q + NE+ + KLQ + ++L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
+ + +V E N L++ L +K+ + +R + + + + +H+
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ---H 174
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR--IVGT 516
IVH DLK +N L+ D K+ DFG+A + V+ VG
Sbjct: 175 GIVHSDLKPANFLIV-DGMLKLIDFGIANQM--QPDTTSVVKDSQVGA 219
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-28
Identities = 48/158 (30%), Positives = 74/158 (46%), Gaps = 11/158 (6%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKLLGF 413
ILGQG V++G G A+K ++ S + E ++ KL HKN+VKL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 414 CVDGDEKL--LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
+ + L+ EF P GSL +L +P L + ++ + GM +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NG 132
Query: 472 IVHRDLKASNVLL----DSDMNSKISDFGMARIFAESE 505
IVHR++K N++ D K++DFG AR + E
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 51/173 (29%), Positives = 73/173 (42%), Gaps = 18/173 (10%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
+G G +G K SDGK + K S +E +EV L+ +L+H N+V+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 413 FCVDGDEKLL--VYEFMPNGSLDAILFDPRKRGIL-----CWRKRTNIVNGIAKGMLYLH 465
+D L V E+ G L +++ K R T + + H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK----ECH 128
Query: 466 E--DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
D ++HRDLK +NV LD N K+ DFG+ARI A T VGT
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF--VGT 179
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 48/158 (30%), Positives = 74/158 (46%), Gaps = 11/158 (6%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKLLGF 413
ILGQG V++G G A+K ++ S + E ++ KL HKN+VKL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 414 CVDGDEKL--LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
+ + L+ EF P GSL +L +P L + ++ + GM +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NG 132
Query: 472 IVHRDLKASNVLL----DSDMNSKISDFGMARIFAESE 505
IVHR++K N++ D K++DFG AR + E
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-27
Identities = 42/170 (24%), Positives = 88/170 (51%), Gaps = 10/170 (5%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN 406
++ +GQG G VY + ++ G+EVA+++++ + NE+L++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
+V L + GDE +V E++ GSL ++ + + + + + +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHS 134
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
+ +++HRD+K+ N+LL D + K++DFG + + +T+ VGT
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGT 179
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-27
Identities = 49/185 (26%), Positives = 79/185 (42%), Gaps = 28/185 (15%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL 407
+F + ++G GGFG V+K DGK +KR+ +E + EV + KL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNI 66
Query: 408 VKLLGFCVDGDEKL----------------LVYEFMPNGSLDAILFDPRKRGILCWRKRT 451
V G D + EF G+L+ + + R+ L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125
Query: 452 NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV 511
+ I KG+ Y+H ++++RDLK SN+ L KI DFG+ +++G+
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-KNDGKRTRS 181
Query: 512 RIVGT 516
GT
Sbjct: 182 --KGT 184
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 41/170 (24%), Positives = 70/170 (41%), Gaps = 21/170 (12%)
Query: 343 TLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILK 401
+ + ++ LG+GGF V L DG A+KR+ +Q E E +
Sbjct: 23 MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRL 82
Query: 402 LQHKNLVKLLGFCVD----GDEKLLVYEFMPNGSLDAILFDPRKRG-------ILCWRKR 450
H N+++L+ +C+ E L+ F G+L + + +G IL
Sbjct: 83 FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL----- 137
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500
++ GI +G+ +H HRDLK +N+LL + + D G
Sbjct: 138 -WLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 43/170 (25%), Positives = 80/170 (47%), Gaps = 10/170 (5%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN 406
+G+G G V G++VAVK + +Q NEV+++ QH N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
+V++ + G+E ++ EF+ G+L I+ + L + + + + + YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIV----SQVRLNEEQIATVCEAVLQALAYLHA 159
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
++HRD+K+ ++LL D K+SDFG ++ + ++ VGT
Sbjct: 160 Q---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL--VGT 204
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 46/167 (27%), Positives = 83/167 (49%), Gaps = 8/167 (4%)
Query: 351 FSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVK 409
+ LG G FG VYK G A K + + SE+ ++ E+ ++ H +VK
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
LLG + ++ EF P G++DAI+ L + + + + + +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALNFLHSK-- 136
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
RI+HRDLKA NVL+ + + +++DFG++ ++ + ++ +GT
Sbjct: 137 -RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF--IGT 180
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 24/173 (13%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN 406
S+F + +LGQG FG V K D + A+K++ +E+ + +EV+L+ L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY 63
Query: 407 LVKLLGFCVDGDEKL-------------LVYEFMPNGSL-DAILFDPRKRGILCWRKRT- 451
+V+ ++ + + E+ NG+L D I + R
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI----HSENLNQQRDEYW 119
Query: 452 NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504
+ I + + Y+H I+HRDLK N+ +D N KI DFG+A+ S
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 41/178 (23%), Positives = 72/178 (40%), Gaps = 17/178 (9%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKN 406
++F LG+GGFG V++ D A+KR+ E + EV + KL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 407 LVKLLGFCVDGDE---------KLLVY---EFMPNGSLDAILFDPRKRGILCWRKRTNIV 454
+V+ ++ + K+ +Y + +L + +I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR 512
IA+ + +LH ++HRDLK SN+ D K+ DFG+ + E E +
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 52/195 (26%), Positives = 93/195 (47%), Gaps = 10/195 (5%)
Query: 323 QHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRL 381
+ VQ R+ + + F LG+G +G VYK + G+ VA+K++
Sbjct: 3 ETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV 62
Query: 382 SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRK 441
E E E+ ++ + ++VK G + +V E+ GS+ I+ +
Sbjct: 63 PV--ESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLR 118
Query: 442 RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
L + I+ KG+ YLH R +HRD+KA N+LL+++ ++K++DFG+A
Sbjct: 119 NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175
Query: 502 AESEGEANTVRIVGT 516
++ + NTV +GT
Sbjct: 176 TDTMAKRNTV--IGT 188
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 42/174 (24%), Positives = 76/174 (43%), Gaps = 22/174 (12%)
Query: 347 ATSNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVKRLS--------SCSEQGTAEFT 393
A F +++G+G V + V + G E AVK + E+
Sbjct: 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR 147
Query: 394 NEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRT 451
E ++ ++ H +++ L+ LV++ M G L D + ++ L ++
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLT----EKVALSEKETR 203
Query: 452 NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
+I+ + + + +LH IVHRDLK N+LLD +M ++SDFG + E
Sbjct: 204 SIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE 254
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 48/175 (27%), Positives = 78/175 (44%), Gaps = 23/175 (13%)
Query: 347 ATSNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVKRLS---------SCSEQGTAEF 392
+T F + ILG+G V + + KE AVK + ++
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 393 TNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKR 450
EV ++ K+ H N+++L LV++ M G L D + ++ L ++
Sbjct: 71 LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKET 126
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
I+ + + + LH+ L IVHRDLK N+LLD DMN K++DFG + E
Sbjct: 127 RKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 178
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 42/174 (24%), Positives = 74/174 (42%), Gaps = 16/174 (9%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEV-LLILKLQHKNLV 408
+F ++LG G G + + D ++VAVKR+ + + EV LL +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVI 81
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
+ D + + E +L + +K + ++ G+ +LH
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHS-- 136
Query: 469 RLRIVHRDLKASNVLL-----DSDMNSKISDFGMARIFAESEGEANTVR-IVGT 516
L IVHRDLK N+L+ + + ISDFG+ + A + + GT
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 46/171 (26%), Positives = 75/171 (43%), Gaps = 15/171 (8%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVK-----RLSSCSEQGTAEFTNEVLLILKLQHKNLVK 409
++G+G F V + + G++ AVK + +S T + E + L+H ++V+
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 410 LLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
LL +V+EFM L I+ + ++ + I + + Y H+
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-- 148
Query: 469 RLRIVHRDLKASNVLLDSDMNS---KISDFGMARIFAESEGEANTVRIVGT 516
I+HRD+K VLL S NS K+ FG+A ES A VGT
Sbjct: 149 -NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGT 196
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 6e-25
Identities = 48/171 (28%), Positives = 85/171 (49%), Gaps = 11/171 (6%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHK 405
F+ +G+G FG V+KG+ K VA+K + +E + E+ ++ +
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
+ K G + + ++ E++ GS +L + G L + I+ I KG+ YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH 136
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
+ + +HRD+KA+NVLL K++DFG+A +++ + NT VGT
Sbjct: 137 SE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF--VGT 182
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 1e-24
Identities = 46/161 (28%), Positives = 68/161 (42%), Gaps = 14/161 (8%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKLL-- 411
LG GGFG V + + G++VA+K+ E + E+ ++ KL H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 412 ----GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
D LL E+ G L L L +++ I+ + YLHE
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE- 139
Query: 468 SRLRIVHRDLKASNVLLDSDMNS---KISDFGMARIFAESE 505
RI+HRDLK N++L KI D G A+ + E
Sbjct: 140 --NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 18/169 (10%)
Query: 348 TSNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAEFTNEVLLIL 400
++ FSD LG+G F V + V + G E A K + S + + E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 401 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAK 459
KLQH N+V+L + LV++ + G L + I+ R ++ + I +
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILE 116
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNS---KISDFGMARIFAESE 505
+ Y H IVHR+LK N+LL S K++DFG+A +SE
Sbjct: 117 SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 53/186 (28%), Positives = 85/186 (45%), Gaps = 15/186 (8%)
Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVL 397
IDL L F ++G G +G VYKG + G+ A+K + + E E+
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEIN 72
Query: 398 LILKL-QHKNLVKLLG-----FCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKR 450
++ K H+N+ G D++L LV EF GS+ ++ K L
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWI 131
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
I I +G+ +LH+ +++HRD+K NVLL + K+ DFG++ + G NT
Sbjct: 132 AYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT 188
Query: 511 VRIVGT 516
+GT
Sbjct: 189 F--IGT 192
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-24
Identities = 49/207 (23%), Positives = 80/207 (38%), Gaps = 31/207 (14%)
Query: 312 IGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-L 370
+ + + F + + D + + + S LG G G V
Sbjct: 108 LSLSRNKVFVFFDLTVDDQSVYPKAL----------RDEYIMSKTLGSGACGEVKLAFER 157
Query: 371 SDGKEVAVKRLS--------SCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422
K+VA++ +S + E+ ++ KL H ++K+ F D ++ +
Sbjct: 158 KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYI 216
Query: 423 VYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASN 481
V E M G L D ++ L + + YLHE I+HRDLK N
Sbjct: 217 VLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPEN 269
Query: 482 VLLDS---DMNSKISDFGMARIFAESE 505
VLL S D KI+DFG ++I E+
Sbjct: 270 VLLSSQEEDCLIKITDFGHSKILGETS 296
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 41/177 (23%), Positives = 60/177 (33%), Gaps = 23/177 (12%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKL-QH 404
+F + LG G +G V+K DG+ AVK + A EV K+ QH
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGIL-----CWRKRTNIVNGIAK 459
V+L +G L E SL G W +
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHC---EAWGASLPEAQVW----GYLRDTLL 168
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
+ +LH +VH D+K +N+ L K+ DFG+ + G G
Sbjct: 169 ALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEVQ--EGD 219
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 49/186 (26%), Positives = 79/186 (42%), Gaps = 24/186 (12%)
Query: 342 ETLNLATSNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEV 396
+ L+ + F+D +G G + + + + E AVK + T E+
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT----EEI 66
Query: 397 LLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIV 454
++L+ QH N++ L DG +V E M G L D IL ++ R+ + ++
Sbjct: 67 EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL----RQKFFSEREASAVL 122
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS----KISDFGMARIFAESEGEANT 510
I K + YLH +VHRDLK SN+L + + +I DFG A+ G T
Sbjct: 123 FTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT 179
Query: 511 VRIVGT 516
T
Sbjct: 180 P--CYT 183
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 44/146 (30%), Positives = 68/146 (46%), Gaps = 10/146 (6%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAE-FTNEVLLILKLQHKNLVKLLG 412
LG+GGF ++ + A K + S + E + E+ + L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
F D D +V E SL + ++R L + + I G YLH R R+
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLH---RNRV 136
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMA 498
+HRDLK N+ L+ D+ KI DFG+A
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLA 162
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 54/169 (31%), Positives = 80/169 (47%), Gaps = 18/169 (10%)
Query: 348 TSNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAEFTNEVLLIL 400
F++ +LG+G FG V K +E AVK + +S + T+ EV L+
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 401 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAK 459
KL H N++KL D +V E G L D I+ KR I+ +
Sbjct: 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII----KRKRFSEHDAARIIKQVFS 132
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESE 505
G+ Y+H+ IVHRDLK N+LL+S D + KI DFG++ F ++
Sbjct: 133 GITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 44/146 (30%), Positives = 68/146 (46%), Gaps = 10/146 (6%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAE-FTNEVLLILKLQHKNLVKLLG 412
LG+GGF ++ + A K + S + E + E+ + L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
F D D +V E SL + ++R L + + I G YLH R R+
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLH---RNRV 162
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMA 498
+HRDLK N+ L+ D+ KI DFG+A
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLA 188
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-24
Identities = 59/208 (28%), Positives = 86/208 (41%), Gaps = 22/208 (10%)
Query: 321 HYQHVQGRDNDLKAQDFFIDLET-LNLATSNFSD----SNILGQGGFGPVYKGV-LSDGK 374
H+ H GR+N D + + S+ LG G +G V
Sbjct: 4 HHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHV 63
Query: 375 EVAVKRL--SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432
E A+K + +S S ++ EV ++ L H N++KL F D LV E G L
Sbjct: 64 ERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL 123
Query: 433 -DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DM 488
D I+ R I+ + G+ YLH+ IVHRDLK N+LL+S D
Sbjct: 124 FDEII----HRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDA 176
Query: 489 NSKISDFGMARIFAESEGEANTVRIVGT 516
KI DFG++ +F + +GT
Sbjct: 177 LIKIVDFGLSAVFENQK---KMKERLGT 201
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 9e-24
Identities = 46/191 (24%), Positives = 73/191 (38%), Gaps = 19/191 (9%)
Query: 321 HYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVK 379
H+ H GR+N F LG G FG V+ S G E +K
Sbjct: 4 HHHHSSGRENLYFQGTI----------DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIK 53
Query: 380 RLS-SCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILF 437
++ S+ + E+ ++ L H N++K+ D +V E G L + I+
Sbjct: 54 TINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVS 113
Query: 438 DPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISD 494
+ L ++ + + Y H +VH+DLK N+L KI D
Sbjct: 114 AQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIID 170
Query: 495 FGMARIFAESE 505
FG+A +F E
Sbjct: 171 FGLAELFKSDE 181
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 13/178 (7%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKN 406
++ ++G G V ++VA+KR++ + E E+ + + H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT-----NIVNGIAKGM 461
+V V DE LV + + GS+ I+ +G I+ + +G+
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM-ARIFAESEGEANTVR--IVGT 516
YLH++ +HRD+KA N+LL D + +I+DFG+ A + + N VR VGT
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 44/169 (26%), Positives = 73/169 (43%), Gaps = 18/169 (10%)
Query: 348 TSNFSD-----SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILK 401
+ F D ++LG+G V + L +E AVK + + EV ++ +
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66
Query: 402 LQ-HKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAK 459
Q H+N+++L+ F + D LV+E M GS+ I KR + + +V +A
Sbjct: 67 CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH----KRRHFNELEASVVVQDVAS 122
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLL---DSDMNSKISDFGMARIFAESE 505
+ +LH I HRDLK N+L + KI DF + +
Sbjct: 123 ALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 36/187 (19%), Positives = 64/187 (34%), Gaps = 14/187 (7%)
Query: 340 DLETLNLATSNFSDSNILGQG--GFGPVYKGV-LSDGKEVAVKR--LSSCSEQGTAEFTN 394
+ + + ++G+G V G+ V V+R L +CS +
Sbjct: 16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG 75
Query: 395 EVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV 454
E+ + H N+V + +E +V FM GS ++ + I+
Sbjct: 76 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI-CTHFMDGMNELAIAYIL 134
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI- 513
G+ K + Y+H VHR +KAS++L+ D +S V
Sbjct: 135 QGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDF 191
Query: 514 ----VGT 516
V
Sbjct: 192 PKYSVKV 198
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 47/184 (25%), Positives = 73/184 (39%), Gaps = 25/184 (13%)
Query: 346 LATSNFSD-------SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVL 397
+ S F LG+G F K V + AVK +S E T E+
Sbjct: 1 MKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT---QKEIT 57
Query: 398 LILKLQ-HKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVN 455
+ + H N+VKL D LV E + G L + I K+ + + I+
Sbjct: 58 ALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIK----KKKHFSETEASYIMR 113
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLL---DSDMNSKISDFGMARIFAESEGEANTVR 512
+ + ++H+ + +VHRDLK N+L + ++ KI DFG AR+ T
Sbjct: 114 KLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-- 168
Query: 513 IVGT 516
T
Sbjct: 169 PCFT 172
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 43/182 (23%), Positives = 68/182 (37%), Gaps = 27/182 (14%)
Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEV-LLILKLQHKNLVKLLGF 413
ILG G G V G+ VAVKR+ E+ LL H N+++
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD---IALMEIKLLTESDDHPNVIRYYCS 77
Query: 414 CVDGDEKLLVYEFMPNGSL-DAIL---FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
+ E N +L D + + +++ IA G+ +LH
Sbjct: 78 ETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--- 133
Query: 470 LRIVHRDLKASNVLLDS-------------DMNSKISDFGMARIFAESEGEANTVR--IV 514
L+I+HRDLK N+L+ + ++ ISDFG+ + + T
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193
Query: 515 GT 516
GT
Sbjct: 194 GT 195
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 49/173 (28%), Positives = 78/173 (45%), Gaps = 16/173 (9%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFT---NEVLLILKLQ 403
FSD +G G FG VY + + + VA+K++S +Q ++ EV + KL+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
H N ++ G + LV E+ + D + L + + +G +G+ Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAY 169
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
LH ++HRD+KA N+LL K+ DFG A AN+ VGT
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFG----SASIMAPANSF--VGT 213
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 44/191 (23%), Positives = 79/191 (41%), Gaps = 14/191 (7%)
Query: 323 QHVQGRDNDLKAQDFFIDLETLNLATSNFSD----SNILGQGGFGPVYKGV-LSDGKEVA 377
+ D + + + + + D LG G FG V++ V + G+
Sbjct: 21 PKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFV 80
Query: 378 VKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAIL 436
K +++ NE+ ++ +L H L+ L D E +L+ EF+ G L D I
Sbjct: 81 AKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA 140
Query: 437 FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS--KISD 494
+ + + N + +G+ ++HE IVH D+K N++ ++ S KI D
Sbjct: 141 ---AEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIID 194
Query: 495 FGMARIFAESE 505
FG+A E
Sbjct: 195 FGLATKLNPDE 205
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 4e-23
Identities = 46/170 (27%), Positives = 80/170 (47%), Gaps = 16/170 (9%)
Query: 345 NLATSNFSDS----NILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLI 399
++ T+N + +LG G F V+ GK A+K + + NE+ ++
Sbjct: 1 SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVL 60
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIA 458
K++H+N+V L LV + + G L D IL +RG+ + + ++ +
Sbjct: 61 KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL----ERGVYTEKDASLVIQQVL 116
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNS--KISDFGMARIFAESE 505
+ YLHE IVHRDLK N+L + + NS I+DFG++++
Sbjct: 117 SAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI 163
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 52/186 (27%), Positives = 82/186 (44%), Gaps = 21/186 (11%)
Query: 342 ETLNLATSNFSDS----NILGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAEFTN 394
E + A++ FSD+ LG+G F V + V + G E A K + S + +
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77
Query: 395 EVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNI 453
E + KLQH N+V+L + LV++ + G L + I+ R ++
Sbjct: 78 EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV----AREFYSEADASHC 133
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANT 510
+ I + + Y H IVHR+LK N+LL S K++DFG+A +SE
Sbjct: 134 IQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AW 187
Query: 511 VRIVGT 516
GT
Sbjct: 188 HGFAGT 193
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 61/203 (30%), Positives = 90/203 (44%), Gaps = 27/203 (13%)
Query: 321 HYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVK 379
H+ H GR+N F ++ +LG+G FG V K +E AVK
Sbjct: 4 HHHHSSGRENLYFQGTF----------AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVK 53
Query: 380 RL--SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAIL 436
+ +S + T+ EV L+ KL H N++KL D +V E G L D I+
Sbjct: 54 VINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII 113
Query: 437 FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKIS 493
KR I+ + G+ Y+H+ IVHRDLK N+LL+S D + KI
Sbjct: 114 ----KRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKII 166
Query: 494 DFGMARIFAESEGEANTVRIVGT 516
DFG++ F ++ +GT
Sbjct: 167 DFGLSTCFQQNT---KMKDRIGT 186
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 5e-23
Identities = 45/154 (29%), Positives = 66/154 (42%), Gaps = 10/154 (6%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLGFC 414
L +GGF VY+ + G+E A+KRL S E+ EV + KL H N+V+
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 415 V-------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
G + L+ + G L L RG L I + + ++H
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH-R 154
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
+ I+HRDLK N+LL + K+ DFG A
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-23
Identities = 39/172 (22%), Positives = 73/172 (42%), Gaps = 14/172 (8%)
Query: 342 ETLNLATSNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEV 396
+ + + + D LG G FG V++ + G A K + + E E+
Sbjct: 146 QPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEI 205
Query: 397 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVN 455
+ L+H LV L D +E +++YEFM G L + + + + + +
Sbjct: 206 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMR 262
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS--KISDFGMARIFAESE 505
+ KG+ ++HE VH DLK N++ + ++ K+ DFG+ +
Sbjct: 263 QVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 6e-23
Identities = 52/184 (28%), Positives = 76/184 (41%), Gaps = 26/184 (14%)
Query: 349 SNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVK-----RLSSCSEQGTAE-FTNEVL 397
S D LG G F V K GKE A K RLSS + E EV
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 398 LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNG 456
++ +++H N++ L + + +L+ E + G L D + ++ L + T +
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA----EKESLTEDEATQFLKQ 116
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDS----DMNSKISDFGMARIFAESEGEANTVR 512
I G+ YLH RI H DLK N++L + K+ DFG+A G
Sbjct: 117 ILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKN- 170
Query: 513 IVGT 516
I GT
Sbjct: 171 IFGT 174
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 7e-23
Identities = 51/209 (24%), Positives = 87/209 (41%), Gaps = 27/209 (12%)
Query: 321 HYQHVQGRDNDLKAQDFFIDLETLNLATSNFSD-----SNILGQGGFGPVYKGV-LSDGK 374
H+ H DL ++ + + NF++ S LG+G F V + + S G+
Sbjct: 2 HHHHHHSSGVDLGTENLYFQ------SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQ 55
Query: 375 EVAVK--RLSSCSEQGTAEFTNEVLLILKLQH-KNLVKLLGFCVDGDEKLLVYEFMPNGS 431
E A K + + AE +E+ ++ + ++ L + E +L+ E+ G
Sbjct: 56 EYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGE 115
Query: 432 L-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL---DSD 487
+ L P ++ ++ I +G+ YLH+ IVH DLK N+LL
Sbjct: 116 IFSLCL--PELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPL 170
Query: 488 MNSKISDFGMARIFAESEGEANTVRIVGT 516
+ KI DFGM+R I+GT
Sbjct: 171 GDIKIVDFGMSRKI--GHACELRE-IMGT 196
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 52/162 (32%), Positives = 86/162 (53%), Gaps = 13/162 (8%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQG---TAEFTNEVLLILKL 402
++S F LG G + VYKG+ + G VA+K + SE+G TA E+ L+ +L
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA--IREISLMKEL 60
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPN---GSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
+H+N+V+L ++ LV+EFM N +D+ RG+ + + +
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKY-FQWQLLQ 119
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
G+ + HE+ +I+HRDLK N+L++ K+ DFG+AR F
Sbjct: 120 GLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF 158
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 44/193 (22%), Positives = 69/193 (35%), Gaps = 33/193 (17%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKR--LSSCSEQGTAEFTNEVLLILKL-Q 403
T+ F + +G G FG V+K V DG A+KR EV L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGML 462
H ++V+ + D L+ E+ GSL DAI + R + +++ + +G+
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSD-------------------MNSKISDFGMARIFAE 503
Y+H +VH D+K SN+ + + KI D G
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT---- 182
Query: 504 SEGEANTVRIVGT 516
G
Sbjct: 183 RISSPQVE--EGD 193
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 49/171 (28%), Positives = 82/171 (47%), Gaps = 13/171 (7%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
S + ILG G FG V+K + G ++A K + + + E NE+ ++ +L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
+L ++ +LV E++ G L D I+ + L + I +G+ ++H+
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRII---DESYNLTELDTILFMKQICEGIRHMHQ- 205
Query: 468 SRLRIVHRDLKASNVLLDSDMNS--KISDFGMARIFAESEGEANTVRIVGT 516
+ I+H DLK N+L + KI DFG+AR + E V GT
Sbjct: 206 --MYILHLDLKPENILCVNRDAKQIKIIDFGLARRY--KPREKLKV-NFGT 251
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 50/185 (27%), Positives = 76/185 (41%), Gaps = 26/185 (14%)
Query: 348 TSNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVK----RLSSCSEQGT--AEFTNEV 396
D LG G F V K S G E A K R S S +G E EV
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66
Query: 397 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVN 455
++ ++ H N++ L + + +L+ E + G L D + ++ L + T+ +
Sbjct: 67 SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIK 122
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDS----DMNSKISDFGMARIFAESEGEANTV 511
I G+ YLH +I H DLK N++L + K+ DFG+A +G
Sbjct: 123 QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKN 177
Query: 512 RIVGT 516
I GT
Sbjct: 178 -IFGT 181
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 44/180 (24%), Positives = 80/180 (44%), Gaps = 20/180 (11%)
Query: 348 TSNFSDS----NILGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAEFTNEVLLIL 400
+ F++ LG+G F V + V + G+E A + S + + E +
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65
Query: 401 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAK 459
L+H N+V+L + L+++ + G L + I+ R ++ + I +
Sbjct: 66 LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV----AREYYSEADASHCIQQILE 121
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANTVRIVGT 516
+L+ H+ + +VHR+LK N+LL S K++DFG+A E E +A GT
Sbjct: 122 AVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV-EGEQQAWF-GFAGT 176
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-22
Identities = 48/148 (32%), Positives = 76/148 (51%), Gaps = 13/148 (8%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAE-FTNEVLLILKLQHKNLVKLLG 412
LG+G F VY+ + G EVA+K + + + G + NEV + +L+H ++++L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDP--RKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
+ D + LV E NG + + + + ++ I GMLYLH
Sbjct: 79 YFEDSNYVYLVLEMCHNGEM----NRYLKNRVKPFSENEARHFMHQIITGMLYLH---SH 131
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMA 498
I+HRDL SN+LL +MN KI+DFG+A
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLA 159
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 46/184 (25%), Positives = 79/184 (42%), Gaps = 36/184 (19%)
Query: 348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTN-EVLLILKLQHKN 406
+++ ++G G FG V++ L + EVA+K++ F N E+ ++ ++H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPN 93
Query: 407 LVKLLGF-----CVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG---- 456
+V L F + L LV E++P ++ R + K +
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TV--------YRASRHYAKLKQTMPMLLIK 144
Query: 457 -----IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANT 510
+ + + Y+H + I HRD+K N+LLD K+ DFG A+I GE N
Sbjct: 145 LYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNV 199
Query: 511 VRIV 514
I
Sbjct: 200 SYIC 203
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 35/164 (21%), Positives = 71/164 (43%), Gaps = 14/164 (8%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
LG+G FG V++ V S K K + E+ ++ +H+N++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 416 DGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
+E ++++EF+ + + I L R+ + V+ + + + +LH I H
Sbjct: 72 SMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 475 RDLKASNVLLDSDMNS--KISDFGMARIFAESEGEANTVRIVGT 516
D++ N++ + +S KI +FG AR G+ + +
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRL-LFTA 166
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 38/175 (21%), Positives = 68/175 (38%), Gaps = 33/175 (18%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRL--SSCSEQGTAEFTNEVLL--------------IL 400
L QG F + D K A+K+ S ++ +N + I+
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 401 K-LQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIA 458
++++ + G + DE ++YE+M N S+ +L I +
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSI----LKFDEYFFVLDKNYTCFIPIQVI 153
Query: 459 K--------GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
K Y+H + I HRD+K SN+L+D + K+SDFG + + +
Sbjct: 154 KCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 59/185 (31%), Positives = 85/185 (45%), Gaps = 22/185 (11%)
Query: 344 LNLATSNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVKRLS---SCSEQGTAEFTNE 395
+ +T+ FSD +LG+G FG V G+E AVK +S + E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 396 VLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIV 454
V L+ +L H N++KL F D LV E G L D I+ R I+
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII----SRKRFSEVDAARII 132
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANTV 511
+ G+ Y+H+ +IVHRDLK N+LL+S D N +I DFG++ F S+
Sbjct: 133 RQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMK 186
Query: 512 RIVGT 516
+GT
Sbjct: 187 DKIGT 191
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 47/163 (28%), Positives = 69/163 (42%), Gaps = 21/163 (12%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLS--------SCSEQGTAEFTNEVLLILKLQHKN 406
LG G G V K+VA+K +S + E+ ++ KL H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
++K+ F D ++ +V E M G L D ++ L + + YLH
Sbjct: 77 IIKIKNF-FDAEDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLH 131
Query: 466 EDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESE 505
E I+HRDLK NVLL S D KI+DFG ++I E+
Sbjct: 132 E---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 171
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 3e-22
Identities = 57/219 (26%), Positives = 86/219 (39%), Gaps = 33/219 (15%)
Query: 321 HYQHVQGRDNDLKAQDFFIDLET-LNLATSNFSD----SNILGQGGFGPVYKGV-LSDGK 374
H+ H +L Q I+ + + LG G +G V +
Sbjct: 3 HHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHS 62
Query: 375 EVAVKRLS-------------SCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421
E A+K + E+ E NE+ L+ L H N++KL D
Sbjct: 63 EKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFY 122
Query: 422 LVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKAS 480
LV EF G L + I+ R NI+ I G+ YLH+ IVHRD+K
Sbjct: 123 LVTEFYEGGELFEQII----NRHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPE 175
Query: 481 NVLLDS---DMNSKISDFGMARIFAESEGEANTVRIVGT 516
N+LL++ +N KI DFG++ F++ +GT
Sbjct: 176 NILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGT 211
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 50/185 (27%), Positives = 76/185 (41%), Gaps = 26/185 (14%)
Query: 348 TSNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVK----RLSSCSEQGT--AEFTNEV 396
D LG G F V K S G E A K R S S +G E EV
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 397 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVN 455
++ ++ H N++ L + + +L+ E + G L D + ++ L + T+ +
Sbjct: 67 SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIK 122
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDS----DMNSKISDFGMARIFAESEGEANTV 511
I G+ YLH +I H DLK N++L + K+ DFG+A +G
Sbjct: 123 QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKN 177
Query: 512 RIVGT 516
I GT
Sbjct: 178 -IFGT 181
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-22
Identities = 38/167 (22%), Positives = 67/167 (40%), Gaps = 16/167 (9%)
Query: 348 TSNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL 402
+ + N +G+G +G V V A K++ + F E+ ++ L
Sbjct: 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL 63
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGM 461
H N+++L D + LV E G L + ++ + + I+ + +
Sbjct: 64 DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVV----HKRVFRESDAARIMKDVLSAV 119
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESE 505
Y H+ L + HRDLK N L + D K+ DFG+A F +
Sbjct: 120 AYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 5e-22
Identities = 49/160 (30%), Positives = 78/160 (48%), Gaps = 18/160 (11%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTN--EVLLILKLQHKN 406
+ +G+G +G VYK S G+ VA+KR+ +E T E+ L+ +L H N
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 407 LVKLLGFCVDGDEKLLVYEFMPN---GSLDA--ILFDPRKRGILCWRKRTNIVNGIAKGM 461
+V L+ LV+EFM LD + I ++ + +G+
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQ--------LLRGV 132
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
+ H+ RI+HRDLK N+L++SD K++DFG+AR F
Sbjct: 133 AHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF 169
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 5e-22
Identities = 46/156 (29%), Positives = 79/156 (50%), Gaps = 10/156 (6%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN--EVLLILKLQHKN 406
NF +G+G +G VYK G+ VA+K++ +E T E+ L+ +L H N
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLD-AILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
+VKLL ++ LV+EF+ D D + + + + +G+ + H
Sbjct: 64 IVKLLDVIHTENKLYLVFEFL---HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
R++HRDLK N+L++++ K++DFG+AR F
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 153
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 5e-22
Identities = 51/185 (27%), Positives = 76/185 (41%), Gaps = 26/185 (14%)
Query: 348 TSNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVK----RLSSCSEQGT--AEFTNEV 396
N D LG G F V K S G + A K R + S +G + EV
Sbjct: 6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 397 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVN 455
++ ++QH N++ L + + +L+ E + G L D + ++ L + T +
Sbjct: 66 SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLK 121
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDS----DMNSKISDFGMARIFAESEGEANTV 511
I G+ YLH L+I H DLK N++L KI DFG+A G
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKN 176
Query: 512 RIVGT 516
I GT
Sbjct: 177 -IFGT 180
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 9e-22
Identities = 40/167 (23%), Positives = 74/167 (44%), Gaps = 35/167 (20%)
Query: 357 LGQGGFGPVYKGV---LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
+G+G +G VYK D K+ A+K++ +A E+ L+ +L+H N++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQKV 86
Query: 414 CVD-GDEKL-LVYEFM-------------PNGSLDAILFDPRKRGILCWRKRTNIVNGIA 458
+ D K+ L++++ + + L ++ I
Sbjct: 87 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ--------IL 138
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS----KISDFGMARIF 501
G+ YLH + ++HRDLK +N+L+ + KI+D G AR+F
Sbjct: 139 DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 46/164 (28%), Positives = 77/164 (46%), Gaps = 22/164 (13%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAE---FTN--EVLLILKL 402
+ + LG+G F VYK + + VA+K++ + T E+ L+ +L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 403 QHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGI 457
H N++ LL + LV++FM L+ I+ D I +
Sbjct: 70 SHPNIIGLLD-AFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM------T 121
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
+G+ YLH+ I+HRDLK +N+LLD + K++DFG+A+ F
Sbjct: 122 LQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF 162
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 43/184 (23%), Positives = 78/184 (42%), Gaps = 19/184 (10%)
Query: 342 ETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRL-SSCSEQGTAEFTNEVLLI 399
+ + + D +G+G +G V K V G+ +AVKR+ S+ E+ + ++ ++
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 400 LKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN------ 452
++ +V+ G + + E M + S D K
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGK 129
Query: 453 IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR 512
I K + +L E+ L+I+HRD+K SN+LLD N K+ DFG++ +S +
Sbjct: 130 ITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD-- 185
Query: 513 IVGT 516
G
Sbjct: 186 -AGC 188
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 3e-21
Identities = 43/207 (20%), Positives = 66/207 (31%), Gaps = 50/207 (24%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVK-----RLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
+GQG +G V + A+K ++ + + EV L+ KL H N+ +L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 411 LGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRT------------------ 451
D LV E G L D + C
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 452 ------------------NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS--K 491
NI+ I + YLH I HRD+K N L ++ + K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIK 210
Query: 492 ISDFGMARIFAESEGEANTVR--IVGT 516
+ DFG+++ F + GT
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGT 237
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 3e-21
Identities = 44/155 (28%), Positives = 78/155 (50%), Gaps = 10/155 (6%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTN--EVLLILKLQHKNL 407
+ +G+G +G VYK + G+ A+K++ E T E+ ++ +L+H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLD-AILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
VKL +LV+E + D L D + G+ ++ + + G+ Y H+
Sbjct: 63 VKLYDVIHTKKRLVLVFEHL---DQDLKKLLDVCEGGLESVTAKS-FLLQLLNGIAYCHD 118
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
R++HRDLK N+L++ + KI+DFG+AR F
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAF 150
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 3e-21
Identities = 50/185 (27%), Positives = 82/185 (44%), Gaps = 37/185 (20%)
Query: 348 TSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTN-EVLLILKLQHK 405
+++D+ ++G G FG VY+ L D G+ VA+K++ F N E+ ++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHC 107
Query: 406 NLVKLLGFCVDGDEKL------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG--- 456
N+V+L F EK LV +++P ++ R + + +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TV--------YRVARHYSRAKQTLPVIYV 158
Query: 457 ------IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEAN 509
+ + + Y+H I HRD+K N+LLD D K+ DFG A+ GE N
Sbjct: 159 KLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPN 213
Query: 510 TVRIV 514
I
Sbjct: 214 VSYIC 218
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 3e-21
Identities = 44/162 (27%), Positives = 76/162 (46%), Gaps = 24/162 (14%)
Query: 350 NFSDSNILGQGGFGPVYKG-VLSDGKEVAVKRLSSCSEQG---TAEFTNEVLLILKLQHK 405
+ + LG+G + VYKG VA+K + E+G TA EV L+ L+H
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA--IREVSLLKDLKHA 60
Query: 406 NLVKLLGFCVDGDEKL-LVYEFMPN---GSLD--AILFDPRKRGILCWRKRTNIVNGIAK 459
N+V L ++ L LV+E++ LD + + + ++ + +
Sbjct: 61 NIVTLHDIIH-TEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQ--------LLR 111
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
G+ Y H +++HRDLK N+L++ K++DFG+AR
Sbjct: 112 GLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK 150
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 4e-21
Identities = 45/189 (23%), Positives = 73/189 (38%), Gaps = 48/189 (25%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLS-----------------SCSEQGTAEFTNEVLL 398
+G+G +G V +D A+K LS +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 399 --------ILK-LQHKNLVKLLGFCV---DGDEKL-LVYEFMPNGSLDAILFDPRKRGIL 445
ILK L H N+VKL V ++ L +V+E + G + + L
Sbjct: 81 EQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPL 134
Query: 446 ----CWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
+++ GI YLH +I+HRD+K SN+L+ D + KI+DFG++ F
Sbjct: 135 SEDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 502 AESEGEANT 510
S+ +
Sbjct: 188 KGSDALLSN 196
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 6e-21
Identities = 42/186 (22%), Positives = 72/186 (38%), Gaps = 33/186 (17%)
Query: 348 TSNFSD-----SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILK 401
+D +LG G G V + G++ A+K L + EV +
Sbjct: 23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQ 77
Query: 402 LQ-HKNLVKLLGFCVDGDEK----LLVYEFMPNGSL-DAILFDPRKRGILCW--RKRTNI 453
++V +L + L++ E M G L I +RG + R+ I
Sbjct: 78 ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ----ERGDQAFTEREAAEI 133
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNS--KISDFGMARIFAESEGEANT 510
+ I + +LH I HRD+K N+L S + ++ K++DFG A+ ++ T
Sbjct: 134 MRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQT 188
Query: 511 VRIVGT 516
T
Sbjct: 189 --PCYT 192
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 8e-21
Identities = 43/161 (26%), Positives = 76/161 (47%), Gaps = 21/161 (13%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN--EVLLILKLQHKN 406
+ +G+G +G V+K + VA+KR+ + + E+ L+ +L+HKN
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 407 LVKLLGFCVDGDEKL-LVYEFMPN---GSLD--AILFDPRKRGILCWRKRTNIVNGIAKG 460
+V+L D+KL LV+EF D DP ++ + KG
Sbjct: 63 IVRLHDVLH-SDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ--------LLKG 113
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
+ + H ++HRDLK N+L++ + K+++FG+AR F
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF 151
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 48/164 (29%), Positives = 85/164 (51%), Gaps = 17/164 (10%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN--EVLLILKLQHK 405
S + +GQG FG V+K G++VA+K++ +E+ T E+ ++ L+H+
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76
Query: 406 NLVKLLGFCVDGDEKL--------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGI 457
N+V L+ C LV++F + L +L + + L K ++ +
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIK--RVMQML 133
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
G+ Y+H + +I+HRD+KA+NVL+ D K++DFG+AR F
Sbjct: 134 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF 174
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 1e-20
Identities = 49/182 (26%), Positives = 75/182 (41%), Gaps = 13/182 (7%)
Query: 338 FIDLETLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLS-SCSEQGTAEFTNE 395
+ L +F + LG G G V+K G +A K + + E
Sbjct: 22 TQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRE 81
Query: 396 VLLILK-LQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV 454
L +L +V G E + E M GSLD +L + K +
Sbjct: 82 -LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 137
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
+ KG+ YL E +I+HRD+K SN+L++S K+ DFG++ +S AN+ V
Sbjct: 138 IAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSF--V 191
Query: 515 GT 516
GT
Sbjct: 192 GT 193
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 51/170 (30%), Positives = 80/170 (47%), Gaps = 21/170 (12%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN-----EVLLIL 400
ATS + +G G +G VYK G VA+K + + G EV L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 401 KLQ---HKNLVKLLGFCV----DGDEKL-LVYEFMPNGSLD-AILFDPRKRGILCWRKRT 451
+L+ H N+V+L+ C D + K+ LV+E + D D L
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIK 123
Query: 452 NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
+++ +G+ +LH + IVHRDLK N+L+ S K++DFG+ARI+
Sbjct: 124 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIY 170
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 47/188 (25%), Positives = 82/188 (43%), Gaps = 23/188 (12%)
Query: 321 HYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVK 379
H+ H G D + F +++ + + ++G+G +G V K G+ VA+K
Sbjct: 5 HHHHSSGVDLGTENLYF----QSME----KYENLGLVGEGSYGMVMKCRNKDTGRIVAIK 56
Query: 380 RLSSCSEQGTAEFTN--EVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN---GSLDA 434
+ + + E+ L+ +L+H+NLV LL C LV+EF+ + L+
Sbjct: 57 KFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLE- 115
Query: 435 ILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD 494
L ++ + I G+ + H I+HRD+K N+L+ K+ D
Sbjct: 116 -----LFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCD 167
Query: 495 FGMARIFA 502
FG AR A
Sbjct: 168 FGFARTLA 175
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 44/181 (24%), Positives = 74/181 (40%), Gaps = 29/181 (16%)
Query: 343 TLNLATSNFSD-----SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEV 396
L + + D S +LG G G V + ++ A+K L C + EV
Sbjct: 51 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREV 105
Query: 397 LLILKLQ-HKNLVKLLGFCVDGDEK----LLVYEFMPNGSL-DAILFDPRKRGILCW--R 448
L + ++V+++ + L+V E + G L I RG + R
Sbjct: 106 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTER 161
Query: 449 KRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNS--KISDFGMARIFAESE 505
+ + I+ I + + YLH + I HRD+K N+L S N+ K++DFG A+
Sbjct: 162 EASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218
Query: 506 G 506
Sbjct: 219 S 219
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 42/183 (22%), Positives = 78/183 (42%), Gaps = 20/183 (10%)
Query: 343 TLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRL-SSCSEQGTAEFTNEVLLIL 400
++ + + LG+G +G V K + G+ +AVKR+ ++ + Q ++ + +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 401 KL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRG------ILCWRKRTNI 453
+ V G + + E M + SLD +G IL I
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILG-----KI 114
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
I K + +LH S+L ++HRD+K SNVL+++ K+ DFG++ + +
Sbjct: 115 AVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD-VAKDID-- 169
Query: 514 VGT 516
G
Sbjct: 170 AGC 172
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-20
Identities = 42/146 (28%), Positives = 69/146 (47%), Gaps = 10/146 (6%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAE-FTNEVLLILKLQHKNLVKLLG 412
LG+G FG VY +A+K L + + G EV + L+H N+++L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
+ D L+ E+ P G++ L +K ++ + +A + Y H R+
Sbjct: 77 YFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCH---SKRV 130
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMA 498
+HRD+K N+LL S KI+DFG +
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWS 156
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 44/159 (27%), Positives = 67/159 (42%), Gaps = 24/159 (15%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVK--------RLSSCSEQGTAEFTNEVLLILKLQHKNL 407
LG G FG V+ V KEV VK + + T E+ ++ +++H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-----PRKRGILCWRKRTNIVNGIAKGML 462
+K+L + LV E +G LD LF PR L +V+ +
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSG-LD--LFAFIDRHPRLDEPLASYIFRQLVSAVG---- 144
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
YL I+HRD+K N+++ D K+ DFG A
Sbjct: 145 YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 4e-20
Identities = 38/150 (25%), Positives = 71/150 (47%), Gaps = 9/150 (6%)
Query: 355 NILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN--EVLLILKLQHKNLVKLL 411
+G+G +G V+K G+ VA+K+ + + E+ ++ +L+H NLV LL
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
LV+E+ + ++ L D +RG+ + +I + + + H +
Sbjct: 69 EVFRRKRRLHLVFEYCDH-TVLHEL-DRYQRGVPEHLVK-SITWQTLQAVNFCH---KHN 122
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIF 501
+HRD+K N+L+ K+ DFG AR+
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLL 152
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 4e-20
Identities = 50/164 (30%), Positives = 77/164 (46%), Gaps = 11/164 (6%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
LG GG VY +VA+K + E+ F EV +L H+N+V ++
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
+ D LV E++ +L + G L N N I G+ + H +RI
Sbjct: 79 VDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---DMRI 132
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
VHRD+K N+L+DS+ KI DFG+A+ +E+ T ++GT
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSET-SLTQTNHVLGT 175
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 50/166 (30%), Positives = 74/166 (44%), Gaps = 17/166 (10%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
LG+G VY+ K A+K L ++ E+ ++L+L H N++KL
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 415 VDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
E LV E + G L D I+ ++G R + V I + + YLHE IV
Sbjct: 118 ETPTEISLVLELVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHE---NGIV 170
Query: 474 HRDLKASNVLL---DSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
HRDLK N+L D KI+DFG+++I + GT
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGT 213
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 7e-20
Identities = 45/166 (27%), Positives = 81/166 (48%), Gaps = 19/166 (11%)
Query: 349 SNFSDSNILGQGGFGPVYKG--VLSDGKEVAVKRLSSCSEQGTAEFTN--EVLLILKLQ- 403
+ +G+G +G V+K + + G+ VA+KR+ + + + EV ++ L+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 404 --HKNLVKLL----GFCVDGDEKL-LVYEFMPNGSLD-AILFDPRKRGILCWRKRTNIVN 455
H N+V+L D + KL LV+E + D D + +++
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV---DQDLTTYLDKVPEPGVPTETIKDMMF 127
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
+ +G+ +LH R+VHRDLK N+L+ S K++DFG+ARI+
Sbjct: 128 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 170
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 7e-20
Identities = 42/158 (26%), Positives = 68/158 (43%), Gaps = 24/158 (15%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLS----SCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
LG+G +G V + + AVK L G A E+ L+ +L+HKN+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL- 71
Query: 412 GFCVDGDE---KL-LVYEFMPNGSLDAILFDPRKRGIL----CWRKRTNIVNGIAKGMLY 463
V +E K+ +V E+ G + + D +++G+ Y
Sbjct: 72 -VDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----Y 124
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
LH IVH+D+K N+LL + KIS G+A
Sbjct: 125 LH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 46/165 (27%), Positives = 72/165 (43%), Gaps = 23/165 (13%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN--EVLLILKLQHK 405
+ LG+G +G VYK + + VA+KR+ E+ T EV L+ +LQH+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPN---GSLDA-ILFDPRKRGILCWRKRTNIVNGIAKGM 461
N+++L L++E+ N +D R ++ + G+
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQ--------LINGV 145
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNS-----KISDFGMARIF 501
+ H R +HRDLK N+LL S KI DFG+AR F
Sbjct: 146 NFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 45/160 (28%), Positives = 71/160 (44%), Gaps = 25/160 (15%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN------EVLLILKLQHK--NL 407
LG GGFG VY G+ +SD VA+K + E N EV+L+ K+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-PRKRGIL----CWRKRTNIVNGIAKGML 462
++LL + D +L+ E P D LFD +RG L ++ +
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELARSFFWQVLEAVR---- 163
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGMARIF 501
+ H ++HRD+K N+L+D + K+ DFG +
Sbjct: 164 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 200
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 43/162 (26%), Positives = 69/162 (42%), Gaps = 27/162 (16%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLL-----ILKL-----QHK 405
LG+GGFG V+ G L+D +VA+K + G + ++ V +L H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-PRKRGIL----CWRKRTNIVNGIAKG 460
+++LL + + +LV E D LFD ++G L +V I
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQ-D--LFDYITEKGPLGEGPSRCFFGQVVAAIQ-- 153
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIF 501
+ H +VHRD+K N+L+D K+ DFG +
Sbjct: 154 --HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL 190
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 19/183 (10%), Positives = 39/183 (21%), Gaps = 38/183 (20%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRL---SSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
L G V+ + ++ A+K + S +L ++ +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 412 GFC--------------------------VDGDEKLLVYEFMPNGSL----DAILFDPRK 441
LL+ + L + F
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVF 187
Query: 442 RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
RG + + + L +VH N+ + D + D
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 502 AES 504
Sbjct: 245 GTR 247
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 51/162 (31%), Positives = 69/162 (42%), Gaps = 38/162 (23%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVK-----RLSSCSEQGTAEFTNEVLLILK-LQHKNLVK 409
LG+G +G V V + VAVK R C E E I K L H+N+VK
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC-----INKMLNHENVVK 69
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN----------IVNGIAK 459
G +G+ + L E+ G L FD + ++ G+
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGEL----FD-----RIEPDIGMPEPDAQRFFHQLMAGVV- 119
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
YLH + I HRD+K N+LLD N KISDFG+A +F
Sbjct: 120 ---YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVF 155
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 47/185 (25%), Positives = 73/185 (39%), Gaps = 39/185 (21%)
Query: 348 TSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKL---- 402
F + GQG FG V G G VA+K++ F N L I++
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ-----DPRFRNRELQIMQDLAVL 76
Query: 403 QHKNLVKLL------GFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN 455
H N+V+L G D L +V E++P+ +L R + +R
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TL--------HRCCRNYYRRQVAPP 127
Query: 456 G---------IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESE 505
+ + + LH S + + HRD+K NVL++ + K+ DFG A+ S
Sbjct: 128 PILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL--SP 184
Query: 506 GEANT 510
E N
Sbjct: 185 SEPNV 189
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 4e-19
Identities = 51/162 (31%), Positives = 69/162 (42%), Gaps = 38/162 (23%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVK-----RLSSCSEQGTAEFTNEVLLILK-LQHKNLVK 409
LG+G +G V V + VAVK R C E E I K L H+N+VK
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC-----INKMLNHENVVK 69
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN----------IVNGIAK 459
G +G+ + L E+ G L FD + ++ G+
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGEL----FD-----RIEPDIGMPEPDAQRFFHQLMAGVV- 119
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
YLH + I HRD+K N+LLD N KISDFG+A +F
Sbjct: 120 ---YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVF 155
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-19
Identities = 45/174 (25%), Positives = 74/174 (42%), Gaps = 29/174 (16%)
Query: 342 ETLNLATSNFSD-----SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNE 395
L + + D S +LG G G V + ++ A+K L C + E
Sbjct: 6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARRE 60
Query: 396 VLLILKL-QHKNLVKLLGFCVDGDEK----LLVYEFMPNGSL-DAILFDPRKRGILCW-- 447
V L + Q ++V+++ + L+V E + G L I RG +
Sbjct: 61 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTE 116
Query: 448 RKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNS--KISDFGMA 498
R+ + I+ I + + YLH + I HRD+K N+L S N+ K++DFG A
Sbjct: 117 REASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 40/144 (27%), Positives = 68/144 (47%), Gaps = 10/144 (6%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAE-FTNEVLLILKLQHKNLVKLLG 412
LG+G FG VY + +A+K L S ++G E+ + L+H N++++
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
+ D L+ EF P G L L +K G ++ + +A + Y H ++
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHYCH---ERKV 135
Query: 473 VHRDLKASNVLLDSDMNSKISDFG 496
+HRD+K N+L+ KI+DFG
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFG 159
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 39/195 (20%), Positives = 78/195 (40%), Gaps = 18/195 (9%)
Query: 329 DNDLKAQDF-FIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRL-SSCS 385
+ K + I + ++ + +G G G V+K G +AVK++ S +
Sbjct: 4 GSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN 63
Query: 386 EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR-- 442
++ ++ ++LK +V+ G + + + E M + + +
Sbjct: 64 KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIP 122
Query: 443 -GILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
IL + I K + YL E ++HRD+K SN+LLD K+ DFG++
Sbjct: 123 ERILG-----KMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRL 175
Query: 502 AESEGEANTVRIVGT 516
+ + + + G
Sbjct: 176 VDDKAKDRS---AGC 187
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 21/154 (13%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
+G+G F V + G+EVA+K + + + + EV ++ L H N+VKL
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE- 81
Query: 414 CVDGDEKL-LVYEFMPNGSLDAILFD-PRKRGIL----CWRKRTNIVNGIAKGMLYLHED 467
++ ++ L L+ E+ G + FD G + K IV+ + Y H
Sbjct: 82 VIETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQ----YCH-- 131
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
+ RIVHRDLKA N+LLD+DMN KI+DFG + F
Sbjct: 132 -QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF 164
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 85.0 bits (210), Expect = 4e-18
Identities = 25/180 (13%), Positives = 53/180 (29%), Gaps = 28/180 (15%)
Query: 342 ETLNLATSNFSDSNILGQGGFGPVYKGVLSD------GKEVAVKRLSSCSEQGTAEFTNE 395
L + ++LG+G F VY+ D ++ +K + T
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 396 VLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN--- 452
+ + +K + + +LV E G+L + +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAI---NLYKNTPEKVMPQGLV 174
Query: 453 --IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-----------KISDFGMAR 499
+ + +H+ I+H D+K N +L + + D G +
Sbjct: 175 ISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 22/178 (12%), Positives = 47/178 (26%), Gaps = 37/178 (20%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAE----------------------- 391
+LGQ + G+ V +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 392 -----FTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM-PNGSL----DAILFDPRK 441
F L+ Q K ++++ D + + +L + +L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 442 RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
L R + + + + LH +VH L+ +++LD ++ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 85.5 bits (211), Expect = 4e-18
Identities = 24/178 (13%), Positives = 51/178 (28%), Gaps = 37/178 (20%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGT---AEFTNEVLLILKLQ-------- 403
+LGQ + G+ V + + EVL + L+
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 404 --------------HKNLVKLLGFCVDGDEKLLVYEFM----PNGSL----DAILFDPRK 441
K++ +D + ++ F +L + +L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 442 RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
L R + + + + LH +VH L+ +++LD ++ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 42/170 (24%), Positives = 74/170 (43%), Gaps = 17/170 (10%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQHKNLVKLL- 411
LG GG V+ L D ++VAVK L + F E L H +V +
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 412 -GFCVDGDEKLLVY---EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
G + L Y E++ +L I+ G + ++ ++ + + + H
Sbjct: 80 TG-EAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH-- 133
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE-ANTVRIVGT 516
+ I+HRD+K +N+++ + K+ DFG+AR A+S T ++GT
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 40/164 (24%), Positives = 67/164 (40%), Gaps = 11/164 (6%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSS--CSEQGTAE-FTNEVLLILKLQHKNLVKLLG 412
+G+GG G VY+ + VA+K +S S+ E +LQ ++V +
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD 101
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
F + + + L A+L R++G L + IV I + H
Sbjct: 102 FGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAHAA---GA 155
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
HRD+K N+L+ +D + + DFG+A + VGT
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDE-KLTQLGNTVGT 198
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 3e-17
Identities = 31/151 (20%), Positives = 58/151 (38%), Gaps = 17/151 (11%)
Query: 357 LGQGGFGPVYKGV--LSDGKEVAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKLLGF 413
+ GG G +Y + +G+ V +K L + E + ++ H ++V++ F
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147
Query: 414 CVDGDEKL-----LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
D +V E++ SL L + + I + YLH
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSYLH--- 199
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+ +V+ DLK N++L + K+ D G
Sbjct: 200 SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 6e-17
Identities = 49/159 (30%), Positives = 70/159 (44%), Gaps = 30/159 (18%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAEFTNEVLLILKL-QHKNLVKLLG 412
LG G FG V G G +VAVK L + LKL +H +++KL
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN----------IVNGIAKGML 462
+ +V E++ G L FD +C R I++ +
Sbjct: 79 VISTPTDFFMVMEYVSGGEL----FD-----YICKHGRVEEMEARRLFQQILSAVD---- 125
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
Y H R +VHRDLK NVLLD+ MN+KI+DFG++ +
Sbjct: 126 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 7e-17
Identities = 52/162 (32%), Positives = 76/162 (46%), Gaps = 36/162 (22%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVK-----RLSSCSEQGTAEFTNEVLLILKL-QHKNLVK 409
LG G FG V G G +VAVK ++ S G E+ LKL +H +++K
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR--REIQ-NLKLFRHPHIIK 80
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN----------IVNGIAK 459
L + +V E++ G L FD +C R + I++G+
Sbjct: 81 LYQVISTPSDIFMVMEYVSGGEL----FD-----YICKNGRLDEKESRRLFQQILSGVD- 130
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
Y H R +VHRDLK NVLLD+ MN+KI+DFG++ +
Sbjct: 131 ---YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 8e-17
Identities = 40/178 (22%), Positives = 77/178 (43%), Gaps = 29/178 (16%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEV--------LL 398
+ +++G G +G V + + + VA+K++ F + + +
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIA 104
Query: 399 ILK-LQHKNLVKLLGFCV----DGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTN 452
IL L H ++VK+L + + ++L +V E + + R L
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLF---RTPVYLTELHIKT 160
Query: 453 IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
++ + G+ Y+H S I+HRDLK +N L++ D + K+ DFG+AR E +
Sbjct: 161 LLYNLLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 41/180 (22%), Positives = 67/180 (37%), Gaps = 34/180 (18%)
Query: 348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAE--FTN---------EV 396
S ++ + G +G V GV S+G VA+KR+ + G ++ E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 397 LLILKLQHKNLVKLLG-FCVDGDEKL----LVYEFMPN------GSLDAILFDPRKRGIL 445
L+ H N++ L F + + LV E M ++ +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQ--- 137
Query: 446 CWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
+ I G+ LHE +VHRDL N+LL + + I DF +AR
Sbjct: 138 ------YFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 8e-16
Identities = 19/149 (12%), Positives = 45/149 (30%), Gaps = 16/149 (10%)
Query: 357 LGQGGFGPVYKGVLSD---GKEVAVKRL---SSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
G ++ + D ++VA+ + + E + L + ++ + ++
Sbjct: 39 HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
L L+V E++ GSL + + +A H R
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH---RA 148
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+ S V + D + ++
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPATMP 177
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 41/204 (20%), Positives = 76/204 (37%), Gaps = 51/204 (25%)
Query: 348 TSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTN-EVLLILKLQHK 405
+ +S LG G FG V + + GK A+K++ + N E+ ++ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLDHV 60
Query: 406 NLVKLL-GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRK--------------- 449
N++KL+ F GDE+ + + + +
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 450 --------RTNIVNG--------------IAKGMLYLHEDSRLRIVHRDLKASNVLLDSD 487
++ I +G + + + ++H L I HRD+K N+L++S
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSK 177
Query: 488 MNS-KISDFGMARIFAESEGEANT 510
N+ K+ DFG A+ E +
Sbjct: 178 DNTLKLCDFGSAKKL--IPSEPSV 199
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 49/166 (29%), Positives = 73/166 (43%), Gaps = 37/166 (22%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVK-----RLSSCSEQGTAEFTNEVLLILKL-QHKNLVK 409
LG+G FG V ++VA+K L E E+ LKL +H +++K
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE--REIS-YLKLLRHPHIIK 73
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN----------IVNGIAK 459
L + ++V E+ G L FD + +KR I+ I
Sbjct: 74 LYDVITTPTDIVMVIEYA-GGEL----FD-----YIVEKKRMTEDEGRRFFQQIICAIE- 122
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
Y H R +IVHRDLK N+LLD ++N KI+DFG++ I +
Sbjct: 123 ---YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 43/202 (21%), Positives = 84/202 (41%), Gaps = 30/202 (14%)
Query: 324 HVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS 382
H + + +F ++ +++ N+ +++G+G +G VY + K VA+K+++
Sbjct: 2 HHHHHHSSGRENLYFQGIKNVHV-PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN 60
Query: 383 SCSEQGTAEFTNEV--------LLILK-LQHKNLVKLLG-FCVDGDEKL----LVYEFMP 428
F + + + IL L+ +++L D K +V E
Sbjct: 61 RM-------FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD 113
Query: 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM 488
+ L + + L I+ + G ++HE I+HRDLK +N LL+ D
Sbjct: 114 S-DLKKLF---KTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDC 166
Query: 489 NSKISDFGMARIFAESEGEANT 510
+ K+ DFG+AR +
Sbjct: 167 SVKVCDFGLARTINSEKDTNIV 188
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 6e-15
Identities = 55/177 (31%), Positives = 79/177 (44%), Gaps = 20/177 (11%)
Query: 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS--EQGTAEFTN-EVLLILKLQH 404
+F ILG+G F V + +E A+K L ++ + E ++ +L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 405 KNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILC-WRKR---TNIVNGIAK 459
VKL D DEKL + NG L L RK G R IV+ +
Sbjct: 90 PFFVKLYFTFQD-DEKLYFGLSYAKNGEL---LKYIRKIGSFDETCTRFYTAEIVSALE- 144
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
YLH I+HRDLK N+LL+ DM+ +I+DFG A++ + +A VGT
Sbjct: 145 ---YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 9e-15
Identities = 50/210 (23%), Positives = 80/210 (38%), Gaps = 55/210 (26%)
Query: 316 NDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSD-GK 374
D +F+ + F + + + +G G G V + +
Sbjct: 7 RDNNFYSVEIGD-------STFTVL--------KRYQNLKPIGSGAQGIVCAAYDAILER 51
Query: 375 EVAVKRLSSCSEQGTAEFTN---------EVLLILKLQHKNLVKLLG-FCVDGDEKL--- 421
VA+K+LS F N E++L+ + HKN++ LL F +
Sbjct: 52 NVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104
Query: 422 --LVYEFMPNGSLDAI----LFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
+V E M +L + L R +L + G+ +LH I+HR
Sbjct: 105 VYIVMELMDA-NLCQVIQMELDHERMSYLLY---------QMLCGIKHLHSAG---IIHR 151
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESE 505
DLK SN+++ SD KI DFG+AR S
Sbjct: 152 DLKPSNIVVKSDCTLKILDFGLARTAGTSF 181
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 41/169 (24%), Positives = 80/169 (47%), Gaps = 15/169 (8%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFT-NEVLLILKLQHK 405
+++ + +G+G +G V + VA+K++S Q + T E+ ++L+ +H+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 406 NLVKLLG-FCVDGDEKL----LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
N++ + E++ +V + M L +L K L + I +G
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL----KTQHLSNDHICYFLYQILRG 140
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509
+ Y+H + ++HRDLK SN+LL++ + KI DFG+AR+
Sbjct: 141 LKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 50/209 (23%), Positives = 76/209 (36%), Gaps = 53/209 (25%)
Query: 316 NDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGK 374
D F+ V F + + + +G G G V +
Sbjct: 44 VDNQFYSVEVGD-------STFTVL--------KRYQNLKPIGSGAQGIVCAAYDAVLDR 88
Query: 375 EVAVKRLSSCSEQGTAEFTN---------EVLLILKLQHKNLVKLL------GFCVDGDE 419
VA+K+LS F N E++L+ + HKN++ LL + +
Sbjct: 89 NVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141
Query: 420 KLLVYEFMP---NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD 476
LV E M + L R +L + G+ +LH I+HRD
Sbjct: 142 VYLVMELMDANLCQVIQMELDHERMSYLLY---------QMLCGIKHLHS---AGIIHRD 189
Query: 477 LKASNVLLDSDMNSKISDFGMARIFAESE 505
LK SN+++ SD KI DFG+AR S
Sbjct: 190 LKPSNIVVKSDCTLKILDFGLARTAGTSF 218
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 49/202 (24%), Positives = 78/202 (38%), Gaps = 47/202 (23%)
Query: 319 DFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVA 377
F+ Q V + + + +G G +G V + G++VA
Sbjct: 9 GFYKQDVNK-------TAWEL--------PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVA 53
Query: 378 VKRLSSCSEQGTAEFTN---------EVLLILKLQHKNLVKLL-----GFCVDGDEKL-L 422
+K+LS F + E+LL+ +QH+N++ LL + L
Sbjct: 54 IKKLSRP-------FQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL 106
Query: 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNV 482
V FM L I+ K +V + KG+ Y+H +VHRDLK N+
Sbjct: 107 VMPFMQT-DLQKIM-----GLKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNL 157
Query: 483 LLDSDMNSKISDFGMARIFAES 504
++ D KI DFG+AR
Sbjct: 158 AVNEDCELKILDFGLARHADAE 179
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 36/158 (22%), Positives = 61/158 (38%), Gaps = 30/158 (18%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
+G G FG + VAVK + E++ L+H N+V+ +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER-GAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN----------IVNGIAKGMLYLH 465
++ E+ G L ++ +C R + +++G++ Y H
Sbjct: 87 TPTHLAIIMEYASGGEL----YE-----RICNAGRFSEDEARFFFQQLLSGVS----YCH 133
Query: 466 EDSRLRIVHRDLKASNVLLDSD--MNSKISDFGMARIF 501
++I HRDLK N LLD KI DFG ++
Sbjct: 134 ---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 6e-14
Identities = 48/187 (25%), Positives = 82/187 (43%), Gaps = 42/187 (22%)
Query: 348 TSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTN---------EVL 397
S + D LG GG G V+ V +D K VA+K++ T+ E+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60
Query: 398 LILKLQHKNLVKLL--------------GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRG 443
+I +L H N+VK+ G + + +V E+M L +L ++G
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL----EQG 115
Query: 444 ILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARIFA 502
L + + +G+ Y+H + ++HRDLK +N+ +++ D+ KI DFG+ARI
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172
Query: 503 ESEGEAN 509
Sbjct: 173 PHYSHKG 179
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 6e-14
Identities = 42/170 (24%), Positives = 81/170 (47%), Gaps = 15/170 (8%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFT-NEVLLILKLQHK 405
+S+F ++LG+G +G V G+ VA+K++ + A T E+ ++ +H+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 406 NLVKLLG-FCVDGDEKL----LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
N++ + D E ++ E M L ++ +L + +
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI----STQMLSDDHIQYFIYQTLRA 124
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
+ LH + ++HRDLK SN+L++S+ + K+ DFG+ARI ES + +
Sbjct: 125 VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 8e-14
Identities = 47/173 (27%), Positives = 74/173 (42%), Gaps = 31/173 (17%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN---------EVL 397
+ + D +G G +G V V G +VA+K+L F + E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYRELR 76
Query: 398 LILKLQHKNLVKLLG-FCVDGDEKL-----LVYEFMPNGSLDAILFDPRKRGILCWRKRT 451
L+ ++H+N++ LL F D LV FM L ++ K L +
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM----KHEKLGEDRIQ 131
Query: 452 NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504
+V + KG+ Y+H I+HRDLK N+ ++ D KI DFG+AR
Sbjct: 132 FLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 45/234 (19%), Positives = 75/234 (32%), Gaps = 66/234 (28%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKN 406
++F +G+GGFG V++ D A+KR+ E + EV + KL+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 407 LVKLLGFCVDGD----EKLLVYEFMPNGSLDAILFDPRKRGILCWRKR-----------T 451
+V+ ++ ++ + ++ + S D L P + R
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 452 NIVNGIAKGMLYLH-----------------------EDSRLRI---------------- 472
+ K LY+ L I
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV----------RIVGT 516
+HRDLK SN+ D K+ DFG+ + E E + VGT
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 48/182 (26%), Positives = 79/182 (43%), Gaps = 12/182 (6%)
Query: 341 LETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSS---CSEQGTAEFTNEV 396
LE + F D +LG+GGFG V+ + ++ A K+L+ +G E
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 397 LLILKLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNI-V 454
++ K+ + +V L + + L LV M G + +++ + R
Sbjct: 237 KILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
I G+ +LH+ I++RDLK NVLLD D N +ISD G+A + +
Sbjct: 296 AQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YA 350
Query: 515 GT 516
GT
Sbjct: 351 GT 352
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 50/176 (28%), Positives = 85/176 (48%), Gaps = 28/176 (15%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEV--------LL 398
+ LG+G +G V+K + G+ VAVK++ F N ++
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIM 60
Query: 399 ILKL--QHKNLVKLLG-FCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV 454
IL H+N+V LL D D + LV+++M L A++ + IL + +V
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVI----RANILEPVHKQYVV 115
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
+ K + YLH S ++HRD+K SN+LL+++ + K++DFG++R F N
Sbjct: 116 YQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 52/181 (28%), Positives = 79/181 (43%), Gaps = 13/181 (7%)
Query: 341 LETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSS---CSEQGTAEFTNEV 396
LE + + F +LG+GGFG V + ++ A K+L +G A NE
Sbjct: 176 LERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK 235
Query: 397 LLILKLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN 455
++ K+ + +V L + + + L LV M G L ++ + G R
Sbjct: 236 QILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE 294
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515
I G+ LH RIV+RDLK N+LLD + +ISD G+A E + VG
Sbjct: 295 -ICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKG--RVG 347
Query: 516 T 516
T
Sbjct: 348 T 348
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 9e-13
Identities = 48/201 (23%), Positives = 83/201 (41%), Gaps = 46/201 (22%)
Query: 319 DFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVA 377
F+ Q + + + + + + +G G +G V + G VA
Sbjct: 14 TFYRQELNK-------TIWEVP--------ERYQNLSPVGSGAYGSVCAAFDTKTGLRVA 58
Query: 378 VKRLSSCSEQGTAEFTN---------EVLLILKLQHKNLVKLL-----GFCVDGDEKL-L 422
VK+LS F + E+ L+ ++H+N++ LL ++ + L
Sbjct: 59 VKKLSRP-------FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 111
Query: 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNV 482
V M L+ I+ K L ++ I +G+ Y+H I+HRDLK SN+
Sbjct: 112 VTHLMGA-DLNNIV----KCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNL 163
Query: 483 LLDSDMNSKISDFGMARIFAE 503
++ D KI DFG+AR A+
Sbjct: 164 AVNEDCELKILDFGLARHTAD 184
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 19/176 (10%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSC---SEQGTAEFTNE--VL-LILK 401
++FS I+G+GGFG VY +D ++ A+K L +QG NE +L L+
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 402 LQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
+V + + +KL + + M G L + + G+ I G
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDL---HYHLSQHGVFSEADMRFYAAEIILG 304
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
+ ++H +V+RDLK +N+LLD + +ISD G+A F S+ + + VGT
Sbjct: 305 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF--SKKKPHA--SVGT 353
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 4e-12
Identities = 41/188 (21%), Positives = 83/188 (44%), Gaps = 28/188 (14%)
Query: 338 FIDLETLNLA---TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFT 393
+ D E+ + ++ LG+G + V++ + +++ ++V VK L ++ +
Sbjct: 22 YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIK 78
Query: 394 NEVLLILKLQ-HKNLVKLLGFCVDGDEK--LLVYEFMPNGSLDAI---LFDPRKRGILCW 447
E+ ++ L+ N++ L D + LV+E + N + L D R +
Sbjct: 79 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYM-- 136
Query: 448 RKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEG 506
I K + Y H S I+HRD+K NV++D + ++ D+G+A + G
Sbjct: 137 -------YEILKALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY--HPG 184
Query: 507 EANTVRIV 514
+ VR+
Sbjct: 185 QEYNVRVA 192
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 39/160 (24%), Positives = 61/160 (38%), Gaps = 19/160 (11%)
Query: 355 NILGQGGFGPVYKGVL------SDGKEVAVKRL-SSCSEQGTAEFTNEVLLILKL-QHKN 406
LG+G FG V + + + VAVK L + +E+ +++ + H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 407 LVKLLGFCVDGDEKLLV-YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
+V LLG C L+V EF G+L L KR V KG +
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFRQ 137
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
+ + DLK + S +S S F + ++ E
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 5e-11
Identities = 21/58 (36%), Positives = 29/58 (50%), Gaps = 3/58 (5%)
Query: 442 RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+ L +AKGM +L + + +HRDL A N+LL KI DFG+AR
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 65.7 bits (159), Expect = 7e-12
Identities = 32/204 (15%), Positives = 60/204 (29%), Gaps = 54/204 (26%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRL--------SSCSEQGTAEFTNEV 396
L T +G+G FG V++ + D VA+K + + ++ E E+
Sbjct: 16 CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74
Query: 397 LLILKLQ---------HKNLVKLLGFCV------------------------------DG 417
++ +L + + L
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDL 477
D+ +V EF G + + + +I++ + + LR HRDL
Sbjct: 135 DQLFIVLEFEFGGID----LEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDL 188
Query: 478 KASNVLLDSDMNSKISDFGMARIF 501
NVLL K+ +
Sbjct: 189 HWGNVLLKKTSLKKLHYTLNGKSS 212
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 45/193 (23%), Positives = 82/193 (42%), Gaps = 22/193 (11%)
Query: 333 KAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCS--EQGT 389
+ +D + L + ++ ++G+G FG V ++V A+K LS ++
Sbjct: 53 RYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD 112
Query: 390 AEFTNEVLLIL-KLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCW 447
+ F E I+ +V+L + D L +V E+MP G L ++ +
Sbjct: 113 SAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEK 168
Query: 448 RKR---TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA-RIFAE 503
R +V + +H + +HRD+K N+LLD + K++DFG ++ E
Sbjct: 169 WARFYTAEVVLALD----AIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221
Query: 504 SEGEANTVRIVGT 516
+T VGT
Sbjct: 222 GMVRCDT--AVGT 232
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 6e-11
Identities = 45/178 (25%), Positives = 76/178 (42%), Gaps = 32/178 (17%)
Query: 350 NFSDSNIL---GQGGFGPVYKGVLSDGKEV-AVKRLS--SCSEQGTAEFTNEVLLILK-L 402
NF IL G+G FG V +D K++ A+K ++ C E+ + L I++ L
Sbjct: 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72
Query: 403 QHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK-- 459
+H LV L + +E + +V + + G L L ++ + K
Sbjct: 73 EHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL-----------QQNVHFKEETVKLF 120
Query: 460 ------GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV 511
+ YL RI+HRD+K N+LLD + I+DF +A + + T+
Sbjct: 121 ICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET-QITTM 174
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 46/195 (23%), Positives = 79/195 (40%), Gaps = 24/195 (12%)
Query: 333 KAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCS--EQGT 389
A+ + L+ + L +F ++G+G F V + +V A+K ++ ++G
Sbjct: 45 WAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGE 104
Query: 390 AEFTNEVLLIL-KLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCW 447
E +L + + +L F + L LV E+ G L L K G
Sbjct: 105 VSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDL---LTLLSKFGERIP 160
Query: 448 RKRTN-----IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA-RIF 501
+ IV I +H L VHRD+K N+LLD + +++DFG ++
Sbjct: 161 AEMARFYLAEIVMAID----SVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213
Query: 502 AESEGEANTVRIVGT 516
A+ + VGT
Sbjct: 214 ADGTVRSLVA--VGT 226
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 44/197 (22%), Positives = 81/197 (41%), Gaps = 28/197 (14%)
Query: 333 KAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCS--EQGT 389
A+ F ++ + L +F ++G+G FG V L + +V A+K L+ ++
Sbjct: 58 WAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAE 117
Query: 390 AEFTNEVLLIL-KLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCW 447
E +L K + L + D L LV ++ G L +L
Sbjct: 118 TACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLS---------- 166
Query: 448 RKRTNIVNGIAK--------GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
+ + +A+ + +H+ L VHRD+K N+L+D + + +++DFG
Sbjct: 167 KFEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCL 223
Query: 500 IFAESEGEANTVRIVGT 516
E +G + VGT
Sbjct: 224 KLME-DGTVQSSVAVGT 239
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 47/217 (21%), Positives = 75/217 (34%), Gaps = 43/217 (19%)
Query: 306 QIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPV 365
Q + + DF + N + F + T LG G FG V
Sbjct: 12 QESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDR------IKT--------LGTGSFGRV 57
Query: 366 YKGVLSDGKEV-AVKRLS--SCSEQGTAEFT-NEVLLILKLQHKNLVKLLGFCVDGDEKL 421
+ A+K L + E T NE ++ + LVKL D
Sbjct: 58 MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117
Query: 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK--------GMLYLHEDSRLRIV 473
+V E++ G + + L R+ A+ YLH L ++
Sbjct: 118 MVMEYVAGGEMFSHL-----------RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 474 HRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
+RDLK N+L+D +++DFG A+ +G T
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWT 197
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 4e-10
Identities = 43/171 (25%), Positives = 80/171 (46%), Gaps = 34/171 (19%)
Query: 357 LGQGGFGPVY---KGVLSDGKEV-AVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLVKL 410
LGQG FG V+ K SD +++ A+K L + + E +++++ H +VKL
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 411 LGFCVDGDEKL-LVYEFMPNGSL-----DAILFD-PRKR----GILCWRKRTNIVNGIAK 459
+ + KL L+ +F+ G L ++F + +
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL------------- 137
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
+ +LH L I++RDLK N+LLD + + K++DFG+++ + E +A +
Sbjct: 138 ALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 185
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 39/160 (24%), Positives = 74/160 (46%), Gaps = 23/160 (14%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
+G G FG +Y G ++ G+EVA+K ++ +++ +++ + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ-GGVGIPTIRWCGA 75
Query: 416 DGDEKLLVYEFMPNG-SLDAILFDPRKRGILCWRKRT-NIVNGIAKGML----YLHEDSR 469
+GD ++V E + G SL+ LF+ C RK + V +A M+ Y+H +
Sbjct: 76 EGDYNVMVMELL--GPSLED-LFN------FCSRKFSLKTVLLLADQMISRIEYIHSKN- 125
Query: 470 LRIVHRDLKASNVLLDSDMNSK---ISDFGMARIFAESEG 506
+HRD+K N L+ I DFG+A+ + ++
Sbjct: 126 --FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 40/159 (25%), Positives = 63/159 (39%), Gaps = 29/159 (18%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
+G G FG + G L + VA+K S L + ++ F
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-SGDGIPQVYYFGP 75
Query: 416 DGDEKLLVYEFMPNG-SLDAILFDPRKRGILCWRK---RTNIVNGIAKGML----YLHED 467
G +V E + G SL+ LFD LC R +T V IA ++ Y+H
Sbjct: 76 CGKYNAMVLELL--GPSLED-LFD------LCDRTFSLKT--VLMIAIQLISRMEYVHSK 124
Query: 468 SRLRIVHRDLKASNVLLDSDMNSK-----ISDFGMARIF 501
+ +++RD+K N L+ N I DF +A+ +
Sbjct: 125 N---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 45/172 (26%), Positives = 74/172 (43%), Gaps = 21/172 (12%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCSEQGTAEFTNEV--------LLI 399
++F+ +LG+G FG V E+ AVK L + ++V +L
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK----KDVVIQDDDVECTMVEKRVLA 396
Query: 400 LKLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIA 458
L + L +L C ++L V E++ G L ++ ++ G IA
Sbjct: 397 LPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIA 452
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
G+ +L I++RDLK NV+LDS+ + KI+DFGM + T
Sbjct: 453 IGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT 501
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 41/165 (24%), Positives = 64/165 (38%), Gaps = 23/165 (13%)
Query: 357 LGQGGFGPVYKGVLSDGKEV-AVKRLS--SCSEQGTAEFT-NEVLLILKLQHKNLVKLLG 412
LG+G FG V A+K L + T E ++ +H L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 214
Query: 413 FCVDGDEKL-LVYEFMPNGSL------DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
+ ++L V E+ G L + + + R R I + YLH
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA---------EIVSALDYLH 265
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
S +V+RDLK N++LD D + KI+DFG+ + + T
Sbjct: 266 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 308
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 6e-09
Identities = 45/178 (25%), Positives = 78/178 (43%), Gaps = 37/178 (20%)
Query: 349 SNFSDSNILGQGGFGPVY----KGVLSDGKEVAVKRLS--SCSEQGTAEFT-NEVLLILK 401
+F LG G FG V+ + +G+ A+K L E T +E L++
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 402 LQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK- 459
+ H ++++ G D +++ ++ +++ G L ++L RK N +AK
Sbjct: 63 VTHPFIIRMWGTFQD-AQQIFMIMDYIEGGELFSLL---RKSQRF--------PNPVAKF 110
Query: 460 -------GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
+ YLH I++RDLK N+LLD + + KI+DFG A+ T
Sbjct: 111 YAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK---YVPDVTYT 162
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 8e-09
Identities = 48/167 (28%), Positives = 70/167 (41%), Gaps = 27/167 (16%)
Query: 357 LGQGGFGPVYKGVLSDGKEV-AVKRLS--SCSEQGTAEFT---NEVLLILKLQHKNLVKL 410
+G+G FG V + AVK L + ++ + VLL ++H LV L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLL-KNVKHPFLVGL 104
Query: 411 LGFCVDGDEKL-LVYEFMPNGSL-----DAILFD-PRKRGILCWRKRTNIVNGIAKGMLY 463
F +KL V +++ G L F PR R IA + Y
Sbjct: 105 H-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA---------EIASALGY 154
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
LH L IV+RDLK N+LLDS + ++DFG+ + E +T
Sbjct: 155 LHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST 198
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 40/162 (24%), Positives = 62/162 (38%), Gaps = 18/162 (11%)
Query: 357 LGQGGFGPVYKGVLSDGKEV-AVKRLS--SCSEQGTAEFT---NEVLLILKLQHKNLVKL 410
LG+G FG V A+K L + T + VL +H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ--NTRHPFLTAL 70
Query: 411 LGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNI-VNGIAKGMLYLHEDS 468
+ ++L V E+ G L F + + +R I + YLH
Sbjct: 71 K-YAFQTHDRLCFVMEYANGGEL---FFHLSRERVFT-EERARFYGAEIVSALEYLHS-- 123
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
+V+RD+K N++LD D + KI+DFG+ + T
Sbjct: 124 -RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 164
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 44/160 (27%), Positives = 67/160 (41%), Gaps = 13/160 (8%)
Query: 357 LGQGGFGPVYKGVLSDGKEV-AVKRLS--SCSEQGTAEFTNEVLLILKLQHKN--LVKLL 411
LG+G FG V+ + A+K L E T +L L ++ L +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 412 GFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
E L V E++ G L ++ + + T I G+ +LH
Sbjct: 85 -CTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQFLHS---K 137
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
IV+RDLK N+LLD D + KI+DFGM + + + NT
Sbjct: 138 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT 177
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 44/158 (27%), Positives = 74/158 (46%), Gaps = 29/158 (18%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV-KLLGFC 414
+G G FG +Y G + +EVA+K + ++ + E + LQ + + F
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGIPNVRWFG 72
Query: 415 VDGDEKLLVYEFMPNG-SLDAILFDPRKRGILCWRK---RTNIVNGIAKGML----YLHE 466
V+GD +LV + + G SL+ LF+ C RK +T V +A M+ ++H
Sbjct: 73 VEGDYNVLVMDLL--GPSLED-LFN------FCSRKLSLKT--VLMLADQMINRVEFVHS 121
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSK---ISDFGMARIF 501
S +HRD+K N L+ + I DFG+A+ +
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 2e-08
Identities = 47/167 (28%), Positives = 71/167 (42%), Gaps = 27/167 (16%)
Query: 357 LGQGGFGPVYKGVLSDGKEV-AVKRLS--SCSEQGTAEFT---NEVLLILKLQHKNLVKL 410
LG+G FG V + + ++ AVK L + E T +L L H L +L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS-LARNHPFLTQL 89
Query: 411 LGFCVDGDEKL-LVYEFMPNGSL-----DAILFD-PRKRGILCWRKRTNIVNGIAKGMLY 463
C ++L V EF+ G L + FD R R I +++
Sbjct: 90 F-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA---------EIISALMF 139
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
LH+ I++RDLK NVLLD + + K++DFGM + + T
Sbjct: 140 LHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT 183
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 55.2 bits (134), Expect = 2e-08
Identities = 37/175 (21%), Positives = 71/175 (40%), Gaps = 40/175 (22%)
Query: 357 LGQGGFGPVY---KGVLSDGKEV-AVKRLSS---CSEQGTAEFT---NEVLLILKLQHKN 406
LG+GG+G V+ K ++ ++ A+K L T +L +++H
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE--EVKHPF 82
Query: 407 LVKLLGFCVDGDEKL-LVYEFMPNGSL------DAILFDPRKR----GILCWRKRTNIVN 455
+V L+ + KL L+ E++ G L + I + I
Sbjct: 83 IVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISM--------- 132
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
+ +LH+ I++RDLK N++L+ + K++DFG+ + +T
Sbjct: 133 ----ALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT 180
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 43/159 (27%), Positives = 71/159 (44%), Gaps = 29/159 (18%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
+G+G FG +++G L + ++VA+K S+ +L + + F
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLA-GCTGIPNVYYFGQ 76
Query: 416 DGDEKLLVYEFMPNG-SLDAILFDPRKRGILCWRK---RTNIVNGIAKGML----YLHED 467
+G +LV + + G SL+ L D LC RK +T V AK ML +HE
Sbjct: 77 EGLHNVLVIDLL--GPSLED-LLD------LCGRKFSVKT--VAMAAKQMLARVQSIHEK 125
Query: 468 SRLRIVHRDLKASNVLLDSDMNSK-----ISDFGMARIF 501
S +V+RD+K N L+ + + DFGM + +
Sbjct: 126 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 40/163 (24%), Positives = 72/163 (44%), Gaps = 17/163 (10%)
Query: 356 ILGQGGFGPVYKGVLSDGKEV-AVKRLS--SCSEQGTAEFT---NEVLLILKLQHKNLVK 409
++G+G + V L + A+K + ++ ++ V H LV
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE-QASNHPFLVG 74
Query: 410 LLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG-IAKGMLYLHED 467
L C + +L V E++ G L +F +++ L + + I+ + YLHE
Sbjct: 75 LH-SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLP-EEHARFYSAEISLALNYLHE- 128
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
I++RDLK NVLLDS+ + K++D+GM + +T
Sbjct: 129 --RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 169
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 46/161 (28%), Positives = 68/161 (42%), Gaps = 15/161 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKEV-AVKRLS--SCSEQGTAEFT---NEVLLILKLQHKNLVKL 410
LG+G FG V E+ AVK L + E T VL L + L +L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA-LPGKPPFLTQL 86
Query: 411 LGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
C ++L V E++ G L ++ ++ G IA G+ +L
Sbjct: 87 H-SCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS--- 139
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
I++RDLK NV+LDS+ + KI+DFGM + T
Sbjct: 140 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT 180
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 32/175 (18%), Positives = 66/175 (37%), Gaps = 37/175 (21%)
Query: 357 LGQGGFGPVYKGV---------LSDGKEVAVKRLSS----CSEQGTAEFTNEVLLILKLQ 403
+ G +Y+ ++ ++K + +EQ + + L + K +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 404 HKNLVKLLGF-------CVDGDEKLLVYEFMPNG-SLDAILFDPRKRGILCWRKRTNIVN 455
LL + LV + G SL + D + +L +R+ V
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQS-ALDVSPKHVLS--ERS--VL 162
Query: 456 GIAKGML----YLHEDSRLRIVHRDLKASNVLLDSDMNSKI--SDFGMARIFAES 504
+A +L +LHE+ VH ++ A N+ +D + S++ + +G A + S
Sbjct: 163 QVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPS 214
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 39/163 (23%), Positives = 72/163 (44%), Gaps = 17/163 (10%)
Query: 356 ILGQGGFGPVYKGVLSDGKEV-AVKRLS--SCSEQGTAEFT---NEVLLILKLQHKNLVK 409
++G+G + V L + A++ + ++ ++ V H LV
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFE-QASNHPFLVG 117
Query: 410 LLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG-IAKGMLYLHED 467
L C + +L V E++ G L +F +++ L + + I+ + YLHE
Sbjct: 118 LH-SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLP-EEHARFYSAEISLALNYLHE- 171
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
I++RDLK NVLLDS+ + K++D+GM + +T
Sbjct: 172 --RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 212
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 5e-08
Identities = 45/166 (27%), Positives = 76/166 (45%), Gaps = 20/166 (12%)
Query: 357 LGQGGFGPVY---KGVLSDGKEV-AVKRLSS---CSEQGTAEFTNEVLLILKLQHKN--L 407
LG G +G V+ K D ++ A+K L + T E T +L+ ++ L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 408 VKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG-IAKGMLYLH 465
V L + + KL L+ +++ G L +R I G I + +LH
Sbjct: 122 VTLH-YAFQTETKLHLILDYINGGEL---FTHLSQRERFT-EHEVQIYVGEIVLALEHLH 176
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE-ANT 510
+ L I++RD+K N+LLDS+ + ++DFG+++ F E E A
Sbjct: 177 K---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD 219
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 42/168 (25%), Positives = 70/168 (41%), Gaps = 33/168 (19%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRL-SSCSEQGTAEFTNEVLLILK---------LQH 404
LG G F V+ + + VA+K + AE ++L + +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 405 KNLVKLLG-FCVDGDEKL---LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
+++KLL F G + +V+E + +L A++ RGI V I+K
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGI-----PLIYVKQISKQ 139
Query: 461 ML----YLHEDSRLRIVHRDLKASNVLLDSDMNS------KISDFGMA 498
+L Y+H R I+H D+K NVL++ + KI+D G A
Sbjct: 140 LLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 37/181 (20%), Positives = 65/181 (35%), Gaps = 45/181 (24%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSC-----------SEQGTAEFTNEVLLILKLQHK 405
+GQGGFG +Y ++ + V +E + + I K
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 406 NLVKLLGFCV-----DGDEKLLVYEFM------PNGSLDAILFDPRKRGILCWRK---RT 451
+K LG D+ Y FM L +++ ++ +T
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS--DLQK-IYE------ANAKRFSRKT 153
Query: 452 NIVNGIAKGML----YLHEDSRLRIVHRDLKASNVLLDSDMNSKI--SDFGMARIFAESE 505
V ++ +L Y+HE VH D+KASN+LL+ ++ D+G+A +
Sbjct: 154 --VLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
Query: 506 G 506
Sbjct: 209 V 209
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.6 bits (120), Expect = 1e-06
Identities = 83/558 (14%), Positives = 152/558 (27%), Gaps = 185/558 (33%)
Query: 19 HDLAFGDS---PPYNICSTSTAGSARASTIDDNLQNVLTSLASNANAAKFSNASFGNDSD 75
D + D+ YN+ R L+ L L N
Sbjct: 116 RDRLYNDNQVFAKYNVS--------RLQPYL-KLRQALLELRPAKNVL------------ 154
Query: 76 RVYGLYM------CLNYISAETCNDCITTASQDISKLCPNKTEAIVW------------- 116
+ G + + + + C + K I W
Sbjct: 155 -IDG--VLGSGKTWV---ALDVCLS------YKVQCKMDFK---IFWLNLKNCNSPETVL 199
Query: 117 EEVCQLRY-AYQNFFGQLDVSGNIP-----------------KYNR-L----NISEPE-- 151
E + +L Y N+ + D S NI Y L N+ +
Sbjct: 200 EMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW 259
Query: 152 -------------RYRSVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCT- 197
R++ V + + T +S + T + L++
Sbjct: 260 NAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHH-------SMTLTPDEVKSLLLKYLD 312
Query: 198 ---KDLPADDCITCLHNATADILSCCYFSRGARL---LSRNCYLRYELYAFYKGATEPSI 251
+DLP + T + + L+ ++ E S+
Sbjct: 313 CRPQDLPREVL-------TTNPRRLSII--AESIRDGLATWDNWKHVNCDKLTTIIESSL 363
Query: 252 LAGNQASGGGKQRKMWMIIVL---ASVVALLLVVFASTGYFFATKKITRK--RKGTARKQ 306
N ++ + V A + +LL + + K + KQ
Sbjct: 364 ---NVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQ 420
Query: 307 -----IQLH------KIGDANDTDFH------YQHVQGRDNDLKAQDFFIDLETLNLATS 349
I + K+ N+ H Y + D+D D
Sbjct: 421 PKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSD----DLIPPYL------D 470
Query: 350 NFSDSNI------LGQGGFGPVYKGVLSDGKEVAVK-RLSSCSEQGTAEFTNEVLLILKL 402
+ S+I + +++ V D + + K R S + + N L LK
Sbjct: 471 QYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILN-TLQQLKF 529
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL-FDPRKRGILCWRKRTNIVNGIA--- 458
+ D D K YE + ++AIL F P+ L K T+++ IA
Sbjct: 530 YKP-------YICDNDPK---YERL----VNAILDFLPKIEENLICSKYTDLLR-IALMA 574
Query: 459 -KGMLYLHEDSRLRIVHR 475
++ E++ + V R
Sbjct: 575 EDEAIF--EEA-HKQVQR 589
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 32/176 (18%), Positives = 61/176 (34%), Gaps = 40/176 (22%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV------- 408
+G GGFG +Y + ++ A + Q +E+ ++ K+ +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARH-VVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 409 --------KLLGF----CVDGDEKLLVYEFMPNG-SLDAILFDPRKRGILCWRKRTNIVN 455
G + +V E + G L I V
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFKKST-------VL 154
Query: 456 GIAKGML----YLHEDSRLRIVHRDLKASNVLLDSDMNSKI--SDFGMARIFAESE 505
+ ML Y+HE+ VH D+KA+N+LL ++ +D+G++ + +
Sbjct: 155 QLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 48/230 (20%), Positives = 87/230 (37%), Gaps = 55/230 (23%)
Query: 290 FATKKITRKRKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATS 349
T+ + + + +K+ +++ G +D ++ Y G E
Sbjct: 13 LGTENLYFQSMSSHKKERKVYNDG-YDDDNYDYIVKNG--------------EKWM---D 54
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVK---RLSSCSEQGTAEFTNEVLLILKLQ-- 403
+ +++G+G FG V K + + VA+K + Q E +L ++
Sbjct: 55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEV--RLLELMNKHDT 112
Query: 404 --HKNLVKLLGF-------CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV 454
+V L C LV+E + + +L +L + RG+ N+
Sbjct: 113 EMKYYIVHLKRHFMFRNHLC-------LVFEML-SYNLYDLLRNTNFRGV-----SLNLT 159
Query: 455 NGIAKGML----YLHEDSRLRIVHRDLKASNVLLDSDMNS--KISDFGMA 498
A+ M +L L I+H DLK N+LL + S KI DFG +
Sbjct: 160 RKFAQQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 41/178 (23%), Positives = 70/178 (39%), Gaps = 32/178 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRL-SSCSEQGTAEFTNEVLLILK------LQHKNLV 408
LG G F V+ + K VA+K + S+ TA +L ++ + +V
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104
Query: 409 KLLG-FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN-------IVNGIAKG 460
+LL F + G NG+ ++F+ +L W ++N V I +
Sbjct: 105 QLLDDFKISG----------VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQ 154
Query: 461 ML----YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
+L YLH ++ RI+H D+K N+LL + A + S + V
Sbjct: 155 VLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 42/168 (25%), Positives = 67/168 (39%), Gaps = 47/168 (27%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQ----HKNL 407
++G+G FG V K + VA+K + + Q E +L L+ Q N+
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEI--RILEHLRKQDKDNTMNV 161
Query: 408 VKLLGF-------CVDGDEKLL---VYEFMPNG-----SLDAILFDPRKRGILCWRKRTN 452
+ +L C+ + LL +YE + SL + RK
Sbjct: 162 IHMLENFTFRNHICMTFE--LLSMNLYELIKKNKFQGFSLPLV------------RK--- 204
Query: 453 IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS--KISDFGMA 498
+ I + + LH + RI+H DLK N+LL S K+ DFG +
Sbjct: 205 FAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 516 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.97 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.96 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.96 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.96 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.95 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.95 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.95 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.95 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.95 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.95 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.95 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.95 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.95 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.95 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.95 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.94 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.94 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.94 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.94 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.94 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.94 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.94 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.94 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.94 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.94 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.94 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.94 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.94 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.94 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.94 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.94 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.94 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.94 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.94 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.94 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.94 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.94 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.94 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.94 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.94 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.94 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.94 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.94 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.94 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.94 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.94 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.94 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.94 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.94 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.94 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.93 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.93 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.93 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.93 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.93 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.93 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.93 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.93 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.93 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.93 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.93 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.93 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.93 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.93 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.93 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.93 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.93 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.93 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.93 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.93 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.93 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.93 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.93 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.93 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.93 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.93 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.93 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.93 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.93 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.93 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.93 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.93 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.93 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.93 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.93 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.93 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.93 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.93 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.93 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.93 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.93 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.93 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.93 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.93 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.93 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.93 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.93 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.93 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.93 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.93 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.93 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.93 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.93 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.93 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.93 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.92 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.92 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.92 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.92 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.92 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.92 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.92 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.92 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.92 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.92 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.92 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.92 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.92 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.92 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.92 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.92 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.92 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.92 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.92 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.92 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.92 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.92 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.92 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.92 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.92 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.92 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.92 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.92 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.92 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.92 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.92 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.92 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.92 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.92 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.92 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.92 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.92 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.92 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.92 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.92 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.92 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.92 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.92 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.92 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.92 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.92 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.92 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.92 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.92 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.92 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.92 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.92 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.92 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.92 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.92 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.91 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.91 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.91 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.91 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.91 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.91 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.91 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.91 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.91 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.91 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.91 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.91 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.91 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.91 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.91 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.91 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.91 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.91 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.91 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.91 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.91 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.91 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.91 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.91 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.91 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.91 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.91 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.91 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.91 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.91 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.91 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.91 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.91 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.91 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.91 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.91 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.91 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.91 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.91 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.91 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.91 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.91 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.91 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.9 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.9 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.9 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.9 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.9 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.9 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.9 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.9 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.9 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.9 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.9 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.9 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.9 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.9 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.9 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.9 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.9 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.9 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.9 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.9 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.89 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.89 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.89 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.89 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.89 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.89 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.89 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.89 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.89 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.89 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.89 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.88 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.88 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.87 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.87 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.87 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.82 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.81 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.37 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.07 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.74 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.63 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.61 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.53 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.52 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.42 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.34 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.06 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.06 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.01 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.86 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.68 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.43 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.4 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.36 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.33 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.21 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.21 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.15 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.88 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.86 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.49 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.3 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.53 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 84.77 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 83.44 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 83.22 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=297.22 Aligned_cols=166 Identities=33% Similarity=0.507 Sum_probs=141.5
Q ss_pred hCCCCCCceeeecCcEeEEEEEec------CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 421 (516)
.++|...+.||+|+||+||+|++. +++.||||+++..+....++|.+|+++|++++|||||+++|+|.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 345677789999999999999864 47789999998877677788999999999999999999999999999999
Q ss_pred EEEEccCCCChhHHhcCC----------CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEE
Q 010186 422 LVYEFMPNGSLDAILFDP----------RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSK 491 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~----------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~k 491 (516)
|||||+++|+|.++|... .....++|.+++.|+.||++||.|||+++ ||||||||+||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 999999999999999542 23357999999999999999999999987 99999999999999999999
Q ss_pred EcccCcccccccCCCccCccceecC
Q 010186 492 ISDFGMARIFAESEGEANTVRIVGT 516 (516)
Q Consensus 492 l~DFGla~~~~~~~~~~~~~~~~GT 516 (516)
|+|||+|+.....+....+....||
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt 193 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLP 193 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEEC
T ss_pred ECCcccceecCCCCceeecCceecC
Confidence 9999999987665443333334554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=298.55 Aligned_cols=165 Identities=32% Similarity=0.491 Sum_probs=133.7
Q ss_pred CCCCCCceeeecCcEeEEEEEec------CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 422 (516)
++|...++||+|+||.||+|++. +++.||||+++..+....++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45666788999999999999864 478899999988777777889999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcE
Q 010186 423 VYEFMPNGSLDAILFDPRK------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS 490 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~ 490 (516)
||||+++|+|.+++..... ...++|.+++.|+.||++||.|||+.+ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999865322 246999999999999999999999987 9999999999999999999
Q ss_pred EEcccCcccccccCCCccCccceecC
Q 010186 491 KISDFGMARIFAESEGEANTVRIVGT 516 (516)
Q Consensus 491 kl~DFGla~~~~~~~~~~~~~~~~GT 516 (516)
||+|||+|+.+...+....+.+..||
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt 223 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLP 223 (329)
T ss_dssp EECCCC----------------CCCC
T ss_pred EEcccccceeccCCCcceecCccccc
Confidence 99999999988665443333345555
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=293.42 Aligned_cols=164 Identities=30% Similarity=0.411 Sum_probs=138.4
Q ss_pred CCCCCceeeecCcEeEEEEEec------CCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 422 (516)
++...++||+|+||+||+|.+. +++.||||+++.. +....++|.+|+.++++++|||||+++|+|.+++..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3445678999999999999863 4678999999753 33456789999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCc
Q 010186 423 VYEFMPNGSLDAILFDPRK-------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN 489 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~ 489 (516)
||||+++|+|.++|..... ...++|.+++.|+.||++||.|||+++ ||||||||+||||++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 9999999999999964321 246899999999999999999999987 999999999999999999
Q ss_pred EEEcccCcccccccCCCccCccceecC
Q 010186 490 SKISDFGMARIFAESEGEANTVRIVGT 516 (516)
Q Consensus 490 ~kl~DFGla~~~~~~~~~~~~~~~~GT 516 (516)
+||+|||+|+.+...+....+....||
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt 210 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLP 210 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBC
T ss_pred EEECCcccceeccCCCceeEecccccC
Confidence 999999999988665443333344555
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=289.56 Aligned_cols=162 Identities=30% Similarity=0.421 Sum_probs=144.6
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...++||+|+||+||+++. .+|+.||||++.+. +....+.+.+|+++|++++|||||++++++.+++..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 3588889999999999999995 57899999999752 3345678999999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||+++|+|.+++. ..+.+++.++..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+..+
T Consensus 112 Ey~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999984 3457999999999999999999999998 999999999999999999999999999998766
Q ss_pred CCccCccceecC
Q 010186 505 EGEANTVRIVGT 516 (516)
Q Consensus 505 ~~~~~~~~~~GT 516 (516)
.....+..++||
T Consensus 186 ~~~~~~~~~~GT 197 (311)
T 4aw0_A 186 SKQARANSFVGT 197 (311)
T ss_dssp TTCCCBCCCCSC
T ss_pred CCcccccCcccC
Confidence 555555567887
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=289.25 Aligned_cols=163 Identities=31% Similarity=0.498 Sum_probs=132.9
Q ss_pred HhhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 010186 346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 346 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 423 (516)
+..+++...++||+|+||+||+|++.+ .||||+++.. +....+.|.+|+.++++++|||||+++|++.+ +..+||
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 445667778999999999999999753 6999998753 34456789999999999999999999998865 568999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
|||+++|+|.+++.. ....++|.+++.|+.||++||.|||+++ ||||||||+||||++++.+||+|||+|+....
T Consensus 110 mEy~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 110 TQWCEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EECCSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEcCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 999999999999954 3346999999999999999999999987 99999999999999999999999999998865
Q ss_pred CCCccCccceecC
Q 010186 504 SEGEANTVRIVGT 516 (516)
Q Consensus 504 ~~~~~~~~~~~GT 516 (516)
......+..++||
T Consensus 185 ~~~~~~~~~~~GT 197 (307)
T 3omv_A 185 WSGSQQVEQPTGS 197 (307)
T ss_dssp ---------CCCC
T ss_pred CCcceeecccccC
Confidence 5444334446676
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=290.78 Aligned_cols=159 Identities=28% Similarity=0.450 Sum_probs=142.3
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
+.|...++||+|+||.||+|+.. +|+.||||++...+....+.+.+|+++|+.++|||||++++++.+++..||||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 45778889999999999999964 79999999998766666778999999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCCCc
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 507 (516)
++|+|.+++.. ..+++.++..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+..+...
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 99999999843 45899999999999999999999998 999999999999999999999999999988765443
Q ss_pred cCccceecC
Q 010186 508 ANTVRIVGT 516 (516)
Q Consensus 508 ~~~~~~~GT 516 (516)
.. .++||
T Consensus 227 ~~--~~~GT 233 (346)
T 4fih_A 227 RK--SLVGT 233 (346)
T ss_dssp BC--CCCSC
T ss_pred cc--ccccC
Confidence 32 36777
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=290.44 Aligned_cols=152 Identities=22% Similarity=0.388 Sum_probs=131.1
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
++|...+.||+|+||+||+++. .+|+.||||++... +....+.|.+|+++|++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5788899999999999999995 47999999999753 33456789999999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
|+++|+|.+++.. .....+++.++..|+.||+.||.|||+++ ||||||||+||||++++.+||+|||+|+.+...
T Consensus 104 y~~gg~L~~~i~~-~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999853 23446789999999999999999999998 999999999999999999999999999987654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=292.10 Aligned_cols=159 Identities=29% Similarity=0.455 Sum_probs=143.1
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
+.|...++||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|+.++|||||++++++.+++..|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 5688889999999999999996 469999999998766666778999999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCCCc
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 507 (516)
++|+|.+++.. ..+++.++..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+......
T Consensus 231 ~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 303 (423)
T 4fie_A 231 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 303 (423)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred CCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence 99999999842 35899999999999999999999998 999999999999999999999999999988765443
Q ss_pred cCccceecC
Q 010186 508 ANTVRIVGT 516 (516)
Q Consensus 508 ~~~~~~~GT 516 (516)
.. .++||
T Consensus 304 ~~--~~~GT 310 (423)
T 4fie_A 304 RK--SLVGT 310 (423)
T ss_dssp BC--CCEEC
T ss_pred cc--ccccC
Confidence 32 36787
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=286.42 Aligned_cols=177 Identities=27% Similarity=0.374 Sum_probs=149.3
Q ss_pred cccchHHHHHhhCCCCCCceeeecCcEeEEEEEecC------CcEEEEEEeccCC-ccchHHHHHHHHHHhcCCC-CCcc
Q 010186 337 FFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSD------GKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQH-KNLV 408 (516)
Q Consensus 337 ~~~~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H-~niv 408 (516)
+.++..++++..++|...+.||+|+||+||+|.+.. ++.||||+++... ....+.|.+|+++|.+++| ||||
T Consensus 52 lp~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV 131 (353)
T 4ase_A 52 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131 (353)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEE
Confidence 445667788888999999999999999999998542 3579999997643 3446679999999999965 8999
Q ss_pred ceeeEEEeC-CeeEEEEEccCCCChhHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeee
Q 010186 409 KLLGFCVDG-DEKLLVYEFMPNGSLDAILFDPR-------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474 (516)
Q Consensus 409 ~l~g~~~~~-~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH 474 (516)
+++|+|.+. +..+||||||++|+|.++|.... ....++|.+++.++.||++||.|||+++ |||
T Consensus 132 ~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiH 208 (353)
T 4ase_A 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIH 208 (353)
T ss_dssp CEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred EEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eec
Confidence 999999775 56899999999999999995422 1345899999999999999999999998 999
Q ss_pred CCCCCCCeEecCCCcEEEcccCcccccccCCCccCccceecC
Q 010186 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516 (516)
Q Consensus 475 rDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~GT 516 (516)
|||||+||||++++.+||+|||+|+.+..+.....+....||
T Consensus 209 RDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt 250 (353)
T 4ase_A 209 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 250 (353)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEEC
T ss_pred CccCccceeeCCCCCEEECcchhhhhcccCCCceeecccccc
Confidence 999999999999999999999999988766554444455665
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=274.54 Aligned_cols=157 Identities=29% Similarity=0.424 Sum_probs=132.2
Q ss_pred CCCceeeecCcEeEEEEEec-CCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEe----CCeeEEEE
Q 010186 352 SDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD----GDEKLLVY 424 (516)
Q Consensus 352 ~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 424 (516)
...++||+|+||.||+|... ++..||+|++... .....+.|.+|++++++++|||||++++++.. ++..||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 44567999999999999964 6889999999652 33456679999999999999999999999875 24579999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC-CCcEEEcccCccccccc
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARIFAE 503 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~-~~~~kl~DFGla~~~~~ 503 (516)
||+++|+|.+++. ....+++..+..++.||+.||.|||+++ ++||||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999994 3457999999999999999999999875 46999999999999985 78999999999986543
Q ss_pred CCCccCccceecC
Q 010186 504 SEGEANTVRIVGT 516 (516)
Q Consensus 504 ~~~~~~~~~~~GT 516 (516)
.. +..++||
T Consensus 185 ~~----~~~~~GT 193 (290)
T 3fpq_A 185 SF----AKAVIGT 193 (290)
T ss_dssp TS----BEESCSS
T ss_pred Cc----cCCcccC
Confidence 32 2335676
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=275.75 Aligned_cols=153 Identities=25% Similarity=0.382 Sum_probs=126.1
Q ss_pred CCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCC---------
Q 010186 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD--------- 418 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--------- 418 (516)
+|...+.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 477789999999999999995 478999999997533 334567999999999999999999999987654
Q ss_pred ---eeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEccc
Q 010186 419 ---EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDF 495 (516)
Q Consensus 419 ---~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 495 (516)
..||||||+++|+|.+++.........++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccC
Confidence 26899999999999999965444445667778999999999999999998 999999999999999999999999
Q ss_pred CcccccccCC
Q 010186 496 GMARIFAESE 505 (516)
Q Consensus 496 Gla~~~~~~~ 505 (516)
|+|+.+..+.
T Consensus 163 Gla~~~~~~~ 172 (299)
T 4g31_A 163 GLVTAMDQDE 172 (299)
T ss_dssp CCC-------
T ss_pred ccceecCCCc
Confidence 9999887654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-33 Score=270.30 Aligned_cols=150 Identities=29% Similarity=0.493 Sum_probs=125.5
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...+.||+|+||.||++.. .+|+.||||++.+. .....+.+.+|++++++++|||||++++++.+++..||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5788899999999999999995 57999999999753 2334567999999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||+ +|+|.+++. ..+.+++.++..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+...+.
T Consensus 93 Ey~-~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHH---HSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 678988884 3456999999999999999999999998 999999999999999999999999999887654
Q ss_pred C
Q 010186 505 E 505 (516)
Q Consensus 505 ~ 505 (516)
.
T Consensus 166 ~ 166 (275)
T 3hyh_A 166 N 166 (275)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-34 Score=279.66 Aligned_cols=160 Identities=27% Similarity=0.344 Sum_probs=130.8
Q ss_pred CCCCCCceeeecCcEeEEEEEec----CCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS----DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~----~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 422 (516)
++|...+.||+|+||+||+++.. +++.||||++++. .......+.+|+++|++++|||||++++++.+++..||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46788899999999999999852 4678999999753 22344578899999999999999999999999999999
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
||||+++|+|.+++. ..+.+++.++..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999984 3456999999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCccCccceecC
Q 010186 503 ESEGEANTVRIVGT 516 (516)
Q Consensus 503 ~~~~~~~~~~~~GT 516 (516)
+...... .++||
T Consensus 178 ~~~~~~~--~~~GT 189 (304)
T 3ubd_A 178 DHEKKAY--SFCGT 189 (304)
T ss_dssp ---CCCC--SCCCC
T ss_pred CCCcccc--ccccC
Confidence 5544332 35676
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=278.58 Aligned_cols=157 Identities=27% Similarity=0.339 Sum_probs=132.1
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
+.|...++||+|+||.||+++. .+|+.||||+++... ...+|+.+++.++|||||++++++.+++..||||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 4567778999999999999995 468999999997532 2257999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC-cEEEcccCcccccccCCC
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-NSKISDFGMARIFAESEG 506 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~-~~kl~DFGla~~~~~~~~ 506 (516)
++|+|.+++. ..+.+++.++..++.||+.||.|||+++ ||||||||+||||+.++ .+||+|||+|+.+..+..
T Consensus 133 ~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999999994 3457999999999999999999999998 99999999999999987 699999999998865432
Q ss_pred c---cCccceecC
Q 010186 507 E---ANTVRIVGT 516 (516)
Q Consensus 507 ~---~~~~~~~GT 516 (516)
. .....++||
T Consensus 207 ~~~~~~~~~~~GT 219 (336)
T 4g3f_A 207 GKSLLTGDYIPGT 219 (336)
T ss_dssp -------CCCCCC
T ss_pred ccceecCCccccC
Confidence 1 122336777
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-33 Score=275.79 Aligned_cols=161 Identities=27% Similarity=0.372 Sum_probs=129.0
Q ss_pred CCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCC----eeEEEEE
Q 010186 350 NFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD----EKLLVYE 425 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lV~E 425 (516)
++...++||+|+||.||+|++ +|+.||||+++.... ....++.|+..+.+++|||||+++|++.+++ ..+||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 355678899999999999998 689999999975321 1222345666667889999999999998754 5799999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC-----CCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED-----SRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-----~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
|+++|+|.+++.. ..++|..+..++.|+++||.|||++ ..++||||||||+|||||+++++||+|||+|+.
T Consensus 82 y~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 82 YHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 9999999999943 3589999999999999999999987 234699999999999999999999999999998
Q ss_pred cccCCCcc--CccceecC
Q 010186 501 FAESEGEA--NTVRIVGT 516 (516)
Q Consensus 501 ~~~~~~~~--~~~~~~GT 516 (516)
........ .+...+||
T Consensus 158 ~~~~~~~~~~~~~~~~GT 175 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGT 175 (303)
T ss_dssp EETTTTEESCC-----CC
T ss_pred ccCCCCceeeeccccccc
Confidence 87654332 22335666
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=266.85 Aligned_cols=161 Identities=24% Similarity=0.427 Sum_probs=134.0
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeC------Ce
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG------DE 419 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~ 419 (516)
++|...+.||+|+||.||+|.. .+|+.||||+++.. .....+.+.+|+++|+.++|||||++++++... +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 4688889999999999999995 57999999999753 233456788999999999999999999997643 56
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccc
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 499 (516)
.||||||++ |+|.+++. ..+.+++.++..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+
T Consensus 134 ~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 899999996 67988884 4567999999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCC--ccCccceecC
Q 010186 500 IFAESEG--EANTVRIVGT 516 (516)
Q Consensus 500 ~~~~~~~--~~~~~~~~GT 516 (516)
.+..... ......++||
T Consensus 207 ~~~~~~~~~~~~~~~~~GT 225 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVAT 225 (398)
T ss_dssp CC-------CCCCCSSCCC
T ss_pred ecccCccccccccccceeC
Confidence 8754432 1222346676
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.96 E-value=5.6e-30 Score=273.93 Aligned_cols=158 Identities=30% Similarity=0.380 Sum_probs=134.9
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC---CccchHHHHH---HHHHHhcCCCCCccceeeEEEeCCeeE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTN---EVLLILKLQHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~---Ei~~l~~l~H~niv~l~g~~~~~~~~~ 421 (516)
++|...++||+|+||.||+++. .+|+.||||++.+. .........+ ++.++..++|||||++++++.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 5688899999999999999995 46899999999652 1222233334 466777889999999999999999999
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
|||||++||+|.+++. ..+.+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+
T Consensus 269 lVmEy~~GGdL~~~l~---~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 9999999999999994 3456999999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCccCccceecC
Q 010186 502 AESEGEANTVRIVGT 516 (516)
Q Consensus 502 ~~~~~~~~~~~~~GT 516 (516)
..... ..++||
T Consensus 343 ~~~~~----~t~~GT 353 (689)
T 3v5w_A 343 SKKKP----HASVGT 353 (689)
T ss_dssp SSCCC----CSCCSC
T ss_pred CCCCC----CCccCC
Confidence 65432 235777
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=255.76 Aligned_cols=147 Identities=21% Similarity=0.332 Sum_probs=131.3
Q ss_pred hhCCCCCCceeeecCcEeEEEEEec----CCcEEEEEEeccCCccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeE
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLS----DGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 421 (516)
..++|...++||+|+||.||+|+.+ +++.||+|++.+. .....+.+|+++|..+ +||||+++++++.+.+..|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 4578999999999999999999843 4678999998753 3345688999999998 6999999999999999999
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCC-CcEEEcccCcccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGMARI 500 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~-~~~kl~DFGla~~ 500 (516)
|||||+++|+|.+++. .+++.++..++.||+.||.|||+++ |+||||||+||||+.+ +.+||+|||+|+.
T Consensus 97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 9999999999999982 3899999999999999999999998 9999999999999877 7999999999987
Q ss_pred cccC
Q 010186 501 FAES 504 (516)
Q Consensus 501 ~~~~ 504 (516)
+.+.
T Consensus 168 ~~~~ 171 (361)
T 4f9c_A 168 THDT 171 (361)
T ss_dssp CTTC
T ss_pred cCCc
Confidence 6544
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-29 Score=268.81 Aligned_cols=152 Identities=26% Similarity=0.430 Sum_probs=137.6
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
++|.+.+.||+|+||.||++.. .+|+.||+|++........+.+.+|+.+|+.++|||||++++++.+.+..||||||+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 5788899999999999999995 478999999998766566778999999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCC--CcEEEcccCcccccccCC
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD--MNSKISDFGMARIFAESE 505 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~--~~~kl~DFGla~~~~~~~ 505 (516)
++|+|.+++.. ....+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 237 ~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 237 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred CCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999998843 3456999999999999999999999998 9999999999999864 799999999999987554
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=243.85 Aligned_cols=162 Identities=41% Similarity=0.725 Sum_probs=145.0
Q ss_pred chHHHHHhhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 010186 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 419 (516)
Q Consensus 340 ~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 419 (516)
.+.++...+++|...+.||+|+||.||++...+++.||||++........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 34455567789999999999999999999988899999999987666667889999999999999999999999999999
Q ss_pred eEEEEEccCCCChhHHhcCCCC-CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcc
Q 010186 420 KLLVYEFMPNGSLDAILFDPRK-RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 498 (516)
.++||||+++|+|.+++..... ...+++.+++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence 9999999999999999854322 235899999999999999999999998 999999999999999999999999999
Q ss_pred cccccC
Q 010186 499 RIFAES 504 (516)
Q Consensus 499 ~~~~~~ 504 (516)
+.....
T Consensus 187 ~~~~~~ 192 (321)
T 2qkw_B 187 KKGTEL 192 (321)
T ss_dssp EECSSS
T ss_pred cccccc
Confidence 876543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-27 Score=234.03 Aligned_cols=152 Identities=25% Similarity=0.479 Sum_probs=138.1
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
.++|...+.||+|+||.||++.. .+++.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 45788899999999999999994 57899999999765556677899999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCCC
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 506 (516)
+++|+|.+++.. ..+++.++..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+.....
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 999999999843 35899999999999999999999998 99999999999999999999999999988765543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.6e-27 Score=235.53 Aligned_cols=148 Identities=27% Similarity=0.442 Sum_probs=135.4
Q ss_pred CCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCC
Q 010186 351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 429 (516)
|...+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 555678999999999999965 7999999999876666778899999999999999999999999999999999999999
Q ss_pred CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCC
Q 010186 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 505 (516)
++|.+++.. ..+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+....
T Consensus 127 ~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 195 (321)
T 2c30_A 127 GALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 195 (321)
T ss_dssp CBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCc
Confidence 999999842 35899999999999999999999997 9999999999999999999999999998876543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-28 Score=251.13 Aligned_cols=163 Identities=23% Similarity=0.299 Sum_probs=143.6
Q ss_pred cchHHHHHhhCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEE
Q 010186 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414 (516)
Q Consensus 339 ~~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 414 (516)
..+.++.+..++|...++||+|+||.||+++.. +++.||+|++.+. .......+.+|+.++..++||||+++++++
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 356677778889999999999999999999975 5789999999752 223344589999999999999999999999
Q ss_pred EeCCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcc
Q 010186 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD 494 (516)
Q Consensus 415 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~D 494 (516)
.+.+..+|||||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcc
Confidence 999999999999999999999954 2356999999999999999999999998 99999999999999999999999
Q ss_pred cCcccccccCCC
Q 010186 495 FGMARIFAESEG 506 (516)
Q Consensus 495 FGla~~~~~~~~ 506 (516)
||+|+.+..+..
T Consensus 219 FGla~~~~~~~~ 230 (437)
T 4aw2_A 219 FGSCLKLMEDGT 230 (437)
T ss_dssp CTTCEECCTTSC
T ss_pred hhhhhhcccCCC
Confidence 999988765543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-27 Score=238.13 Aligned_cols=169 Identities=44% Similarity=0.770 Sum_probs=147.8
Q ss_pred cccchHHHHHhhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEE
Q 010186 337 FFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415 (516)
Q Consensus 337 ~~~~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 415 (516)
..+++.++....++|...+.||+|+||.||++...+++.||||++.... ......+.+|++++..++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 3567889999999999999999999999999998889999999997633 233447899999999999999999999999
Q ss_pred eCCeeEEEEEccCCCChhHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcc
Q 010186 416 DGDEKLLVYEFMPNGSLDAILFDPR-KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD 494 (516)
Q Consensus 416 ~~~~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~D 494 (516)
..+..++||||+++|+|.+++.... ....+++..+..++.||+.||.|||+...++++||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 9999999999999999999986543 334599999999999999999999998223399999999999999999999999
Q ss_pred cCcccccccCC
Q 010186 495 FGMARIFAESE 505 (516)
Q Consensus 495 FGla~~~~~~~ 505 (516)
||+++.+....
T Consensus 178 fg~~~~~~~~~ 188 (326)
T 3uim_A 178 FGLAKLMDYKD 188 (326)
T ss_dssp CSSCEECCSSS
T ss_pred CccccccCccc
Confidence 99999876544
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-27 Score=235.67 Aligned_cols=153 Identities=29% Similarity=0.551 Sum_probs=137.4
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
.++|...++||+|+||.||++... +++.||+|++...+....+.|.+|++++.+++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 356777899999999999999964 6899999999776667778899999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCC
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 505 (516)
+++|+|.+++.. ....+++.++..++.||++||.|||+.+ ++||||||+|||++.++.+||+|||+++.+....
T Consensus 89 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHH--CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999954 2456899999999999999999999998 9999999999999999999999999998875443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-27 Score=237.73 Aligned_cols=151 Identities=31% Similarity=0.477 Sum_probs=135.9
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
.++|...+.||+|+||.||++.. .+|+.||||++... +....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35788889999999999999996 57999999999653 3345667899999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||+++|+|.+++.. .+.+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 94 e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999998843 346899999999999999999999998 999999999999999999999999999877654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.4e-27 Score=230.86 Aligned_cols=164 Identities=43% Similarity=0.715 Sum_probs=145.5
Q ss_pred ccchHHHHHhhCCCCCC------ceeeecCcEeEEEEEecCCcEEEEEEeccC----CccchHHHHHHHHHHhcCCCCCc
Q 010186 338 FIDLETLNLATSNFSDS------NILGQGGFGPVYKGVLSDGKEVAVKRLSSC----SEQGTAEFTNEVLLILKLQHKNL 407 (516)
Q Consensus 338 ~~~~~~l~~~~~~f~~~------~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~----~~~~~~~~~~Ei~~l~~l~H~ni 407 (516)
.+.++++...+++|... +.||+|+||.||+|.. +++.||||++... .....+.+.+|+.+++.++||||
T Consensus 14 ~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 92 (307)
T 2nru_A 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL 92 (307)
T ss_dssp ECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTB
T ss_pred cccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCe
Confidence 46778888888888877 8999999999999997 6889999998652 22335679999999999999999
Q ss_pred cceeeEEEeCCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCC
Q 010186 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD 487 (516)
Q Consensus 408 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~ 487 (516)
+++++++.+.+..++||||+++++|.+++........+++..+..++.||+.||.|||+.+ ++||||||+|||++.+
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~ 169 (307)
T 2nru_A 93 VELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEA 169 (307)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTT
T ss_pred EEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCC
Confidence 9999999999999999999999999999865444567999999999999999999999998 9999999999999999
Q ss_pred CcEEEcccCcccccccCC
Q 010186 488 MNSKISDFGMARIFAESE 505 (516)
Q Consensus 488 ~~~kl~DFGla~~~~~~~ 505 (516)
+.+||+|||+++......
T Consensus 170 ~~~kl~Dfg~~~~~~~~~ 187 (307)
T 2nru_A 170 FTAKISDFGLARASEKFA 187 (307)
T ss_dssp CCEEECCCTTCEECCSCS
T ss_pred CcEEEeeccccccccccc
Confidence 999999999998776543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-27 Score=236.06 Aligned_cols=151 Identities=29% Similarity=0.424 Sum_probs=132.9
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
++|...+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 56888899999999999999965 78999999986532 23346789999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCC
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 505 (516)
+++|+|.+++. ....+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 87 ~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 87 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 99999999984 3456999999999999999999999998 9999999999999999999999999998876443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-27 Score=237.98 Aligned_cols=149 Identities=26% Similarity=0.330 Sum_probs=134.0
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...+.||+|+||.||++... +|+.||+|++++. .......+.+|+.+++.++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 56788899999999999999964 6899999999752 3345667899999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
||+++|+|..++. ....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 85 E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 85 EYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 9999999999884 3356899999999999999999999998 99999999999999999999999999987543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=246.63 Aligned_cols=159 Identities=23% Similarity=0.299 Sum_probs=140.5
Q ss_pred chHHHHHhhCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEE
Q 010186 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415 (516)
Q Consensus 340 ~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 415 (516)
.+.++....++|...++||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.++..++||||+++++++.
T Consensus 60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 34566677788999999999999999999965 5889999999652 2234456889999999999999999999999
Q ss_pred eCCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEccc
Q 010186 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDF 495 (516)
Q Consensus 416 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 495 (516)
+.+..||||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+||
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecc
Confidence 99999999999999999999843 35899999999999999999999998 999999999999999999999999
Q ss_pred CcccccccCC
Q 010186 496 GMARIFAESE 505 (516)
Q Consensus 496 Gla~~~~~~~ 505 (516)
|+++.+....
T Consensus 213 G~a~~~~~~~ 222 (410)
T 3v8s_A 213 GTCMKMNKEG 222 (410)
T ss_dssp TTCEECCTTS
T ss_pred ceeEeeccCC
Confidence 9998876543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.5e-27 Score=235.01 Aligned_cols=154 Identities=24% Similarity=0.378 Sum_probs=133.9
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCe-------
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE------- 419 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~------- 419 (516)
++|...+.||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 45777899999999999999975 78999999997533 3345779999999999999999999999876542
Q ss_pred --------------------------------------------------eEEEEEccCCCChhHHhcCCCCCCCCCHHH
Q 010186 420 --------------------------------------------------KLLVYEFMPNGSLDAILFDPRKRGILCWRK 449 (516)
Q Consensus 420 --------------------------------------------------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~ 449 (516)
.++||||+++++|.+++.........++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 799999999999999997655555677888
Q ss_pred HHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCC
Q 010186 450 RTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 450 ~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 505 (516)
++.++.||+.||.|||+++ ++||||||+||||+.++.+||+|||+++.+....
T Consensus 166 ~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~ 218 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 218 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC-
T ss_pred HHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccch
Confidence 9999999999999999998 9999999999999999999999999999886653
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-27 Score=246.20 Aligned_cols=162 Identities=21% Similarity=0.274 Sum_probs=142.9
Q ss_pred cchHHHHHhhCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEE
Q 010186 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414 (516)
Q Consensus 339 ~~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 414 (516)
..++++.+..++|...++||+|+||.||++... +|+.||+|++.+. .....+.+.+|+.++..++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 345666777889999999999999999999964 7899999999752 223455689999999999999999999999
Q ss_pred EeCCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcc
Q 010186 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD 494 (516)
Q Consensus 415 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~D 494 (516)
.+.+..||||||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSK--FGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHH--HSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEee
Confidence 999999999999999999999853 2246899999999999999999999998 99999999999999999999999
Q ss_pred cCcccccccCC
Q 010186 495 FGMARIFAESE 505 (516)
Q Consensus 495 FGla~~~~~~~ 505 (516)
||+++.+..+.
T Consensus 206 FGla~~~~~~~ 216 (412)
T 2vd5_A 206 FGSCLKLRADG 216 (412)
T ss_dssp CTTCEECCTTS
T ss_pred chhheeccCCC
Confidence 99999876544
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-27 Score=240.21 Aligned_cols=156 Identities=29% Similarity=0.489 Sum_probs=135.7
Q ss_pred hhCCCCCCceeeecCcEeEEEEEec--------CCcEEEEEEeccC-CccchHHHHHHHHHHhcC-CCCCccceeeEEEe
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLS--------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVD 416 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 416 (516)
..++|...+.||+|+||.||++... ++..||||+++.. .....+.+.+|+.+++.+ +||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3467888899999999999999852 3457999999764 334466799999999999 89999999999999
Q ss_pred CCeeEEEEEccCCCChhHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeE
Q 010186 417 GDEKLLVYEFMPNGSLDAILFDPRK-------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVL 483 (516)
Q Consensus 417 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIL 483 (516)
.+..++||||+++|+|.+++..... ...+++.+++.++.||+.||.|||+++ |+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence 9999999999999999999864321 245899999999999999999999998 999999999999
Q ss_pred ecCCCcEEEcccCcccccccCC
Q 010186 484 LDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 484 ld~~~~~kl~DFGla~~~~~~~ 505 (516)
|+.++.+||+|||+++.+....
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~ 257 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNID 257 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCC
T ss_pred ECCCCCEEEccccCCcccCccc
Confidence 9999999999999999776543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-27 Score=236.21 Aligned_cols=162 Identities=32% Similarity=0.533 Sum_probs=133.4
Q ss_pred hHHHHHhhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 010186 341 LETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD 418 (516)
Q Consensus 341 ~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 418 (516)
...+.+..++|...+.||+|+||.||++.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 344445567788899999999999999987 68899999987532 334567999999999999999999999999999
Q ss_pred eeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcc
Q 010186 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (516)
Q Consensus 419 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 498 (516)
..++||||+++|+|.+++........+++..++.++.||+.||.|||+.+ ++|+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 99999999999999999965333335899999999999999999999875 35999999999999999999999999999
Q ss_pred cccccC
Q 010186 499 RIFAES 504 (516)
Q Consensus 499 ~~~~~~ 504 (516)
+.....
T Consensus 187 ~~~~~~ 192 (309)
T 3p86_A 187 RLKAST 192 (309)
T ss_dssp ------
T ss_pred cccccc
Confidence 865543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.7e-27 Score=238.44 Aligned_cols=152 Identities=27% Similarity=0.362 Sum_probs=133.6
Q ss_pred hhCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeE
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 421 (516)
..++|...++||+|+||.||+++.. +++.||+|++++. .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 4467888999999999999999964 6899999999752 234556788999999988 7999999999999999999
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+||||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999998843 356899999999999999999999998 999999999999999999999999999875
Q ss_pred ccC
Q 010186 502 AES 504 (516)
Q Consensus 502 ~~~ 504 (516)
...
T Consensus 175 ~~~ 177 (353)
T 3txo_A 175 ICN 177 (353)
T ss_dssp CC-
T ss_pred ccC
Confidence 433
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-27 Score=239.89 Aligned_cols=166 Identities=28% Similarity=0.443 Sum_probs=142.6
Q ss_pred cccchHHHHHhhCCCCCCceeeecCcEeEEEEEe------cCCcEEEEEEeccC-CccchHHHHHHHHHHhcC-CCCCcc
Q 010186 337 FFIDLETLNLATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLV 408 (516)
Q Consensus 337 ~~~~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~------~~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv 408 (516)
..++...+++..++|...+.||+|+||.||++.+ .+++.||||+++.. .....+.+.+|++++.++ +||||+
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv 89 (359)
T 3vhe_A 10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89 (359)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence 3456777888889999999999999999999973 24578999999763 334456799999999999 899999
Q ss_pred ceeeEEEeCCe-eEEEEEccCCCChhHHhcCCCC----------------------------------------------
Q 010186 409 KLLGFCVDGDE-KLLVYEFMPNGSLDAILFDPRK---------------------------------------------- 441 (516)
Q Consensus 409 ~l~g~~~~~~~-~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------- 441 (516)
++++++.+.+. .++||||+++|+|.+++.....
T Consensus 90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 99999988654 8999999999999999865332
Q ss_pred -----------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 442 -----------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 442 -----------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 122899999999999999999999998 999999999999999999999999999977554
Q ss_pred C
Q 010186 505 E 505 (516)
Q Consensus 505 ~ 505 (516)
.
T Consensus 247 ~ 247 (359)
T 3vhe_A 247 P 247 (359)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-27 Score=196.51 Aligned_cols=100 Identities=24% Similarity=0.457 Sum_probs=90.4
Q ss_pred CcccCCCCCCCCCCCChHHHHHHHHHHHhhhccccc--CCcccccC-CCCCeEEEEEeecCCCChhhhHHHHHHHHHHHh
Q 010186 28 PYNICSTSTAGSARASTIDDNLQNVLTSLASNANAA--KFSNASFG-NDSDRVYGLYMCLNYISAETCNDCITTASQDIS 104 (516)
Q Consensus 28 ~~~~c~~~~~~~~~~s~~~~nl~~l~~~l~~~~~~~--~f~~~~~g-~~~~~vyg~~~C~~d~~~~~C~~Cl~~a~~~~~ 104 (516)
.++.|++ ++|+++|+|++||+.||++|+++++.+ +|++...| .++++||||+|||+|+++++|+.||+.|++++.
T Consensus 6 v~~~Cn~--~~~t~~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~~ 83 (108)
T 3a2e_A 6 VSSACNT--QKIPSGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRIF 83 (108)
T ss_dssp EEEEECS--SBCCTTCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTHH
T ss_pred eeeecCC--CccCCCChHHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHHH
Confidence 4568965 699999999999999999999998866 45555555 466999999999999999999999999999999
Q ss_pred HhCCCCccceEEcCceEEEEeeccc
Q 010186 105 KLCPNKTEAIVWEEVCQLRYAYQNF 129 (516)
Q Consensus 105 ~~C~~~~~a~~~~~~C~~ry~~~~f 129 (516)
+.||++++|+||+|.|+||||+++|
T Consensus 84 ~~C~~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 84 SICNNAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp HHTTSBSSEEEEETTEEEEEESSCC
T ss_pred HHCCCCceEEEECCCEEEEEeCCcC
Confidence 9999999999999999999999998
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-26 Score=233.83 Aligned_cols=151 Identities=26% Similarity=0.387 Sum_probs=134.6
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCc------cchHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE------QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK 420 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 420 (516)
.++|...+.||+|+||.||++... +|+.||+|++++... ...+.+.+|+.++..++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 356788899999999999999964 689999999976322 1356799999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC----cEEEcccC
Q 010186 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM----NSKISDFG 496 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~----~~kl~DFG 496 (516)
++||||+++|+|.+++. ....+++.++..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999994 3457999999999999999999999998 99999999999998877 79999999
Q ss_pred cccccccC
Q 010186 497 MARIFAES 504 (516)
Q Consensus 497 la~~~~~~ 504 (516)
+++.+...
T Consensus 165 ~a~~~~~~ 172 (361)
T 2yab_A 165 LAHEIEDG 172 (361)
T ss_dssp SCEECCTT
T ss_pred CceEcCCC
Confidence 99987654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-27 Score=236.90 Aligned_cols=161 Identities=31% Similarity=0.519 Sum_probs=135.6
Q ss_pred hhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCC----eeEE
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD----EKLL 422 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~l 422 (516)
..++|...++||+|+||.||+|... ++.||||++.... .....+..|+.++.+++||||+++++++.... ..++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 4567888899999999999999874 7899999996532 33445677999999999999999999998754 3699
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC----------CCCCeeeCCCCCCCeEecCCCcEEE
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED----------SRLRIVHRDLKASNVLLDSDMNSKI 492 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~----------~~~~iiHrDlk~~NILld~~~~~kl 492 (516)
||||+++|+|.+++.. ..+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||
T Consensus 100 v~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEE
T ss_pred EEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEE
Confidence 9999999999999943 3489999999999999999999998 6 999999999999999999999
Q ss_pred cccCcccccccCCCccCccceecC
Q 010186 493 SDFGMARIFAESEGEANTVRIVGT 516 (516)
Q Consensus 493 ~DFGla~~~~~~~~~~~~~~~~GT 516 (516)
+|||+++.+.............||
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt 196 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGT 196 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCC
T ss_pred ccCCcccccccccCccccccCccC
Confidence 999999887765543333333444
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.7e-27 Score=240.22 Aligned_cols=150 Identities=24% Similarity=0.313 Sum_probs=131.4
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 422 (516)
.++|...++||+|+||.||+++.. +++.||+|++++. .....+.+.+|..++.++ +||||+++++++.+.+..+|
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 456888899999999999999965 5789999999753 233455688999999887 89999999999999999999
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
||||+++|+|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 999999999999884 3356999999999999999999999998 9999999999999999999999999998744
Q ss_pred c
Q 010186 503 E 503 (516)
Q Consensus 503 ~ 503 (516)
.
T Consensus 205 ~ 205 (396)
T 4dc2_A 205 R 205 (396)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.9e-27 Score=235.67 Aligned_cols=154 Identities=26% Similarity=0.356 Sum_probs=134.3
Q ss_pred HHhhCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCe
Q 010186 345 NLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDE 419 (516)
Q Consensus 345 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 419 (516)
.+..++|...+.||+|+||.||+++.. +++.||+|++++. .....+.+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345577888999999999999999964 6889999999753 234556788899999876 99999999999999999
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccc
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 499 (516)
.++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 9999999999999999843 346899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccC
Q 010186 500 IFAES 504 (516)
Q Consensus 500 ~~~~~ 504 (516)
.....
T Consensus 167 ~~~~~ 171 (345)
T 1xjd_A 167 ENMLG 171 (345)
T ss_dssp CCCCT
T ss_pred hcccC
Confidence 76443
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.3e-27 Score=229.50 Aligned_cols=151 Identities=30% Similarity=0.438 Sum_probs=133.3
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 423 (516)
.++|...+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 35688889999999999999995 468899999986432 23356789999999999999999999999999999999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
|||+++++|.+++. ..+.+++.++..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+..
T Consensus 90 ~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999984 3346899999999999999999999998 99999999999999999999999999988754
Q ss_pred C
Q 010186 504 S 504 (516)
Q Consensus 504 ~ 504 (516)
.
T Consensus 164 ~ 164 (294)
T 4eqm_A 164 T 164 (294)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.4e-27 Score=239.06 Aligned_cols=155 Identities=17% Similarity=0.231 Sum_probs=133.9
Q ss_pred HHHHhhCCCCCCceeeecCcEeEEEEE------ecCCcEEEEEEeccCCccchHHHHHHHHHHhcCC---CCCccceeeE
Q 010186 343 TLNLATSNFSDSNILGQGGFGPVYKGV------LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ---HKNLVKLLGF 413 (516)
Q Consensus 343 ~l~~~~~~f~~~~~Lg~G~fg~Vy~~~------~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~ 413 (516)
++++..++|...++||+|+||.||+|. ..+++.||+|++... ...++..|++++..++ |+||++++++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 334556778889999999999999994 456889999999753 4557888888888886 9999999999
Q ss_pred EEeCCeeEEEEEccCCCChhHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC-----
Q 010186 414 CVDGDEKLLVYEFMPNGSLDAILFDP--RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS----- 486 (516)
Q Consensus 414 ~~~~~~~~lV~Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~----- 486 (516)
+...+..+|||||+++|+|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+||||+.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCc
Confidence 99999999999999999999998531 13456999999999999999999999988 999999999999998
Q ss_pred ------CCcEEEcccCccccccc
Q 010186 487 ------DMNSKISDFGMARIFAE 503 (516)
Q Consensus 487 ------~~~~kl~DFGla~~~~~ 503 (516)
++.+||+|||+|+.+..
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~ 235 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKL 235 (365)
T ss_dssp ------CTTEEECCCTTCEEGGG
T ss_pred cccccccCCEEEeeCchhhhhhc
Confidence 89999999999987653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=5.7e-27 Score=239.00 Aligned_cols=154 Identities=33% Similarity=0.584 Sum_probs=128.9
Q ss_pred hhCCCCCCceeeecCcEeEEEEEec----CCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLS----DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 421 (516)
..++|...+.||+|+||.||+|... ++..||||+++.. .....+.|.+|+.++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 3457888999999999999999864 5678999999763 3345667999999999999999999999999999999
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+||||+++|+|.+++.. ....+++.+++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 123 lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999954 3346899999999999999999999998 999999999999999999999999999987
Q ss_pred ccCC
Q 010186 502 AESE 505 (516)
Q Consensus 502 ~~~~ 505 (516)
....
T Consensus 198 ~~~~ 201 (373)
T 2qol_A 198 EDDP 201 (373)
T ss_dssp ----
T ss_pred ccCC
Confidence 6543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.4e-27 Score=232.89 Aligned_cols=154 Identities=34% Similarity=0.575 Sum_probs=134.9
Q ss_pred hhCCCCCCceeeecCcEeEEEEEec----CCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLS----DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 421 (516)
..++|...+.||+|+||.||+|... .+..||||+++.. .....+.|.+|+.++..++||||+++++++.+.+..+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 3456788899999999999999964 3456999999763 3445667999999999999999999999999999999
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+||||+++|+|.+++.. ....+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 127 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999954 3346999999999999999999999998 999999999999999999999999999987
Q ss_pred ccCC
Q 010186 502 AESE 505 (516)
Q Consensus 502 ~~~~ 505 (516)
....
T Consensus 202 ~~~~ 205 (325)
T 3kul_A 202 EDDP 205 (325)
T ss_dssp C---
T ss_pred ccCc
Confidence 6543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.4e-27 Score=237.79 Aligned_cols=150 Identities=23% Similarity=0.348 Sum_probs=134.8
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...+.||+|+||.||++... +++.||+|++.+. .......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 46778899999999999999954 5889999998652 2345677899999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 95 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999999843 456999999999999999999999998 999999999999999999999999999887544
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=231.68 Aligned_cols=149 Identities=26% Similarity=0.401 Sum_probs=133.9
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...+.||+|+||.||++... +|+.||+|++++. .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 46778899999999999999964 6899999999752 2245667889999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
||+++|+|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 86 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 9999999999984 3456899999999999999999999998 99999999999999999999999999987654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=234.17 Aligned_cols=149 Identities=25% Similarity=0.313 Sum_probs=132.3
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 423 (516)
++|...+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 45777899999999999999964 6889999999753 233455688999999988 899999999999999999999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 999999999998842 346899999999999999999999998 99999999999999999999999999987543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=5.8e-27 Score=235.63 Aligned_cols=161 Identities=34% Similarity=0.516 Sum_probs=139.8
Q ss_pred hHHHHHhhCCCCCCceeeecCcEeEEEEEec------CCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeE
Q 010186 341 LETLNLATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGF 413 (516)
Q Consensus 341 ~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~ 413 (516)
+..+....++|...+.||+|+||.||++... +++.||+|+++.. .....+.+.+|+.++++++||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3445566788999999999999999999964 3478999999764 33345679999999999999999999999
Q ss_pred EEeCCeeEEEEEccCCCChhHHhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCe
Q 010186 414 CVDGDEKLLVYEFMPNGSLDAILFDPRK---------------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472 (516)
Q Consensus 414 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i 472 (516)
+.+.+..++||||+++|+|.+++..... ...+++.+++.++.||++||.|||+++ |
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---i 195 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 195 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 9999999999999999999999854221 256899999999999999999999998 9
Q ss_pred eeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 473 iHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
+||||||+|||++.++.+||+|||+++.+...
T Consensus 196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 227 (343)
T 1luf_A 196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227 (343)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGG
T ss_pred ecCCCCcceEEECCCCeEEEeecCCCcccccC
Confidence 99999999999999999999999999876543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=227.61 Aligned_cols=150 Identities=29% Similarity=0.437 Sum_probs=128.3
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCc--------------------------cchHHHHHHHHHHh
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSE--------------------------QGTAEFTNEVLLIL 400 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~--------------------------~~~~~~~~Ei~~l~ 400 (516)
.++|...+.||+|+||.||++.. .+++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 35688889999999999999995 4688999999865321 12356899999999
Q ss_pred cCCCCCccceeeEEEe--CCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCC
Q 010186 401 KLQHKNLVKLLGFCVD--GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLK 478 (516)
Q Consensus 401 ~l~H~niv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk 478 (516)
+++||||+++++++.+ .+..++||||+++++|.+++ ....+++.++..++.||+.||.|||+.+ ++|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 56789999999999998765 3346999999999999999999999998 9999999
Q ss_pred CCCeEecCCCcEEEcccCcccccccC
Q 010186 479 ASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 479 ~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
|+|||++.++.+||+|||+++.+...
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~ 190 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGS 190 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSS
T ss_pred HHHEEECCCCCEEEecCCCccccccc
Confidence 99999999999999999999887654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=232.35 Aligned_cols=151 Identities=26% Similarity=0.412 Sum_probs=124.8
Q ss_pred hCCCCCCceeeecCcEeEEEEEe----cCCcEEEEEEeccCC----ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL----SDGKEVAVKRLSSCS----EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 419 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 419 (516)
.++|...+.||+|+||.||++.. .+++.||+|++++.. ......+.+|+.+++.++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35678889999999999999996 478999999997632 2345568899999999999999999999999999
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccc
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 499 (516)
.++||||+++++|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLE---REGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999884 2346889999999999999999999998 9999999999999999999999999998
Q ss_pred ccccC
Q 010186 500 IFAES 504 (516)
Q Consensus 500 ~~~~~ 504 (516)
.....
T Consensus 170 ~~~~~ 174 (327)
T 3a62_A 170 ESIHD 174 (327)
T ss_dssp -----
T ss_pred ccccC
Confidence 75433
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.5e-27 Score=240.98 Aligned_cols=154 Identities=32% Similarity=0.489 Sum_probs=136.0
Q ss_pred HHhhCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 010186 345 NLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 345 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 422 (516)
.+..++|...+.||+|+||.||+|... +++.||||+++.. .....+.|.+|++++++++||||+++++++...+..++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 344567788899999999999999975 7899999998753 23345578999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
||||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 190 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp EEECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 9999999999999853 2345899999999999999999999998 9999999999999999999999999998754
Q ss_pred c
Q 010186 503 E 503 (516)
Q Consensus 503 ~ 503 (516)
+
T Consensus 265 ~ 265 (377)
T 3cbl_A 265 D 265 (377)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=232.80 Aligned_cols=159 Identities=31% Similarity=0.480 Sum_probs=136.0
Q ss_pred HHHhhCCCCCCceeeecCcEeEEEEEe------cCCcEEEEEEeccC-CccchHHHHHHHHHHhcC-CCCCccceeeEEE
Q 010186 344 LNLATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCV 415 (516)
Q Consensus 344 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~------~~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~ 415 (516)
+++..++|...+.||+|+||.||++.. .++..||+|++... .....+.+.+|+.++.++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 445667888999999999999999995 24568999999753 334567899999999999 9999999999999
Q ss_pred eCCeeEEEEEccCCCChhHHhcCCCCC--------------------CCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeC
Q 010186 416 DGDEKLLVYEFMPNGSLDAILFDPRKR--------------------GILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475 (516)
Q Consensus 416 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHr 475 (516)
..+..++||||+++|+|.+++...... ..+++..++.++.||+.||.|||+.+ |+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 999999999999999999999653321 34899999999999999999999998 9999
Q ss_pred CCCCCCeEecCCCcEEEcccCcccccccCC
Q 010186 476 DLKASNVLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 476 Dlk~~NILld~~~~~kl~DFGla~~~~~~~ 505 (516)
||||+||||+.++.+||+|||+++.+....
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~ 226 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDS 226 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCT
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCc
Confidence 999999999999999999999999876554
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.8e-27 Score=230.90 Aligned_cols=158 Identities=33% Similarity=0.492 Sum_probs=137.1
Q ss_pred HHhhCCCCCCceeeecCcEeEEEEEe------cCCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 010186 345 NLATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG 417 (516)
Q Consensus 345 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~------~~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 417 (516)
....++|...+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+++++.++||||+++++++.+.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 34556788889999999999999985 24578999999753 334567799999999999999999999999999
Q ss_pred CeeEEEEEccCCCChhHHhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCC
Q 010186 418 DEKLLVYEFMPNGSLDAILFDPRK---------------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD 476 (516)
Q Consensus 418 ~~~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrD 476 (516)
+..++||||+++++|.+++..... ...+++.+++.++.||+.||.|||+++ ++|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccc
Confidence 999999999999999999864322 234899999999999999999999998 99999
Q ss_pred CCCCCeEecCCCcEEEcccCcccccccCC
Q 010186 477 LKASNVLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 477 lk~~NILld~~~~~kl~DFGla~~~~~~~ 505 (516)
|||+|||+++++.+||+|||+++.+....
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~ 204 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEED 204 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTS
T ss_pred cchheEEEcCCCCEEEccccccccccccc
Confidence 99999999999999999999998775543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=224.42 Aligned_cols=151 Identities=32% Similarity=0.573 Sum_probs=135.9
Q ss_pred hhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
..++|...+.||+|+||.||++...+++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 345677789999999999999998889999999997633 3456799999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 87 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 87 MEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp CTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CCCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccc
Confidence 999999999954 3346899999999999999999999998 99999999999999999999999999987654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-26 Score=228.53 Aligned_cols=154 Identities=32% Similarity=0.458 Sum_probs=135.5
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCC--eeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD--EKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 424 (516)
++|...++||+|+||.||++... +++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 46778899999999999999965 58999999997533 344677889999999999999999999998765 679999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEe----cCCCcEEEcccCcccc
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL----DSDMNSKISDFGMARI 500 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILl----d~~~~~kl~DFGla~~ 500 (516)
||+++++|.+++........+++.+++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999966544455999999999999999999999998 9999999999999 7888899999999998
Q ss_pred cccCC
Q 010186 501 FAESE 505 (516)
Q Consensus 501 ~~~~~ 505 (516)
+....
T Consensus 166 ~~~~~ 170 (319)
T 4euu_A 166 LEDDE 170 (319)
T ss_dssp CCTTC
T ss_pred cCCCC
Confidence 76554
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-26 Score=233.28 Aligned_cols=149 Identities=26% Similarity=0.315 Sum_probs=134.0
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...+.||+|+||.||++... +|+.||+|++.+. .....+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 46778899999999999999964 6899999999652 2345667899999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
||+++|+|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 121 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999843 345899999999999999999999998 99999999999999999999999999987754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.7e-26 Score=227.87 Aligned_cols=150 Identities=27% Similarity=0.389 Sum_probs=133.8
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCc------cchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE------QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 421 (516)
++|...+.||+|+||.||++... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45777899999999999999964 689999999875322 23567999999999999999999999999999999
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC----cEEEcccCc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM----NSKISDFGM 497 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~----~~kl~DFGl 497 (516)
+||||+++++|.+++. ....+++.++..++.||+.||.|||+.+ ++||||||+|||++.++ .+||+|||+
T Consensus 91 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 91 LILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 9999999999999994 3456999999999999999999999998 99999999999999887 899999999
Q ss_pred ccccccC
Q 010186 498 ARIFAES 504 (516)
Q Consensus 498 a~~~~~~ 504 (516)
++.+...
T Consensus 165 a~~~~~~ 171 (326)
T 2y0a_A 165 AHKIDFG 171 (326)
T ss_dssp CEECCTT
T ss_pred CeECCCC
Confidence 9987644
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-26 Score=233.52 Aligned_cols=151 Identities=26% Similarity=0.302 Sum_probs=133.9
Q ss_pred hhCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeE
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 421 (516)
..++|...+.||+|+||.||++... +++.||+|++++. .....+.+..|..++..+ +||||+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 4467888999999999999999975 4789999999753 234566788999999988 8999999999999999999
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+||||+++|+|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999842 346899999999999999999999998 999999999999999999999999999875
Q ss_pred cc
Q 010186 502 AE 503 (516)
Q Consensus 502 ~~ 503 (516)
..
T Consensus 172 ~~ 173 (353)
T 2i0e_A 172 IW 173 (353)
T ss_dssp CC
T ss_pred cc
Confidence 43
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=236.60 Aligned_cols=158 Identities=31% Similarity=0.478 Sum_probs=137.1
Q ss_pred HHhhCCCCCCceeeecCcEeEEEEEec--------CCcEEEEEEeccC-CccchHHHHHHHHHHhcC-CCCCccceeeEE
Q 010186 345 NLATSNFSDSNILGQGGFGPVYKGVLS--------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFC 414 (516)
Q Consensus 345 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~ 414 (516)
++..++|...+.||+|+||.||++... .+..||||+++.. .......+.+|+++++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 345567888899999999999999852 2357999999763 334457799999999999 999999999999
Q ss_pred EeCCeeEEEEEccCCCChhHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCC
Q 010186 415 VDGDEKLLVYEFMPNGSLDAILFDPRK-------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASN 481 (516)
Q Consensus 415 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~N 481 (516)
...+..++||||+++|+|.+++..... ...+++.+++.++.||+.||.|||+.+ |+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcce
Confidence 999999999999999999999854321 245899999999999999999999998 9999999999
Q ss_pred eEecCCCcEEEcccCcccccccCC
Q 010186 482 VLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 482 ILld~~~~~kl~DFGla~~~~~~~ 505 (516)
|||+.++.+||+|||+++.+....
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~ 245 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHID 245 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCC
T ss_pred EEEcCCCcEEEcccCccccccccc
Confidence 999999999999999999876543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=5.2e-26 Score=227.12 Aligned_cols=151 Identities=21% Similarity=0.313 Sum_probs=134.4
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
++|...+.||+|+||.||++... +++.+|+|.+... ......+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 56788899999999999999964 6889999998753 334567899999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC--CCcEEEcccCcccccccCC
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS--DMNSKISDFGMARIFAESE 505 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~--~~~~kl~DFGla~~~~~~~ 505 (516)
++|+|.+++.. ....+++.++..++.||+.||.|||+.+ ++||||||+|||++. ++.+||+|||+++.+....
T Consensus 84 ~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 84 SGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 99999999843 2346899999999999999999999998 999999999999987 7899999999999876543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.94 E-value=4e-26 Score=224.48 Aligned_cols=150 Identities=27% Similarity=0.412 Sum_probs=130.5
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
++|...+.||+|+||.||++... +++.||+|++.... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46778899999999999999964 68899999997532 2334678899999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
|++++.+..+. .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 82 ~~~~~l~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCCCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 99875444444 23456999999999999999999999998 999999999999999999999999999887543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=232.04 Aligned_cols=162 Identities=31% Similarity=0.511 Sum_probs=125.0
Q ss_pred hHHHHHhhCCCCCCceeeecCcEeEEEEEecC-C---cEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEE
Q 010186 341 LETLNLATSNFSDSNILGQGGFGPVYKGVLSD-G---KEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414 (516)
Q Consensus 341 ~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~-g---~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 414 (516)
++++.+..++|...+.||+|+||.||++.... + ..||||+++.. .....+.+.+|+.++++++||||+++++++
T Consensus 15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence 44455667789999999999999999999643 3 27999999753 344567899999999999999999999999
Q ss_pred EeCCee------EEEEEccCCCChhHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEec
Q 010186 415 VDGDEK------LLVYEFMPNGSLDAILFDPR---KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD 485 (516)
Q Consensus 415 ~~~~~~------~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld 485 (516)
...... ++||||+++|+|.+++.... ....+++.++..++.||+.||.|||+.+ ++||||||+|||++
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~ 171 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLA 171 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEc
Confidence 887665 99999999999999884322 2235899999999999999999999998 99999999999999
Q ss_pred CCCcEEEcccCcccccccCC
Q 010186 486 SDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 486 ~~~~~kl~DFGla~~~~~~~ 505 (516)
.++.+||+|||+++.+....
T Consensus 172 ~~~~~kl~Dfg~a~~~~~~~ 191 (323)
T 3qup_A 172 EDMTVCVADFGLSRKIYSGD 191 (323)
T ss_dssp TTSCEEECCCCC--------
T ss_pred CCCCEEEeeccccccccccc
Confidence 99999999999998875543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=243.31 Aligned_cols=156 Identities=29% Similarity=0.491 Sum_probs=137.9
Q ss_pred HHHHHhhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 010186 342 ETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 342 ~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 421 (516)
..+++..++|...+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+.++++++||||+++++++. .+..+
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 34456667788899999999999999999888999999998643 45778999999999999999999999986 56789
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+||||+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+
T Consensus 259 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp EEECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 999999999999999532 2235789999999999999999999998 999999999999999999999999999987
Q ss_pred cc
Q 010186 502 AE 503 (516)
Q Consensus 502 ~~ 503 (516)
..
T Consensus 335 ~~ 336 (454)
T 1qcf_A 335 ED 336 (454)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.93 E-value=4.8e-26 Score=231.22 Aligned_cols=152 Identities=30% Similarity=0.449 Sum_probs=134.2
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
.++|...+.||+|+||.||++... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 356888899999999999999964 6899999999753 3344567899999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC---cEEEcccCccccc
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM---NSKISDFGMARIF 501 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~---~~kl~DFGla~~~ 501 (516)
||+++|+|.+++. ....+++.++..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++.+
T Consensus 108 e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 108 DLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp CCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 9999999998884 3456899999999999999999999998 99999999999998654 5999999999887
Q ss_pred ccCC
Q 010186 502 AESE 505 (516)
Q Consensus 502 ~~~~ 505 (516)
....
T Consensus 182 ~~~~ 185 (362)
T 2bdw_A 182 NDSE 185 (362)
T ss_dssp TTCC
T ss_pred cCCc
Confidence 6543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-26 Score=223.19 Aligned_cols=154 Identities=32% Similarity=0.480 Sum_probs=137.4
Q ss_pred HhhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 346 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
+..++|...+.||+|+||.||++...++..||+|++.... ...+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 3456788889999999999999999888899999997643 345679999999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCC
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 505 (516)
|+++++|.+++.. ....+++.++..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 84 YISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred ccCCCcHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 9999999999843 2345899999999999999999999998 9999999999999999999999999998775543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.4e-26 Score=226.58 Aligned_cols=150 Identities=31% Similarity=0.474 Sum_probs=131.1
Q ss_pred CCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
++|...+.||+|+||.||++...+++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 100 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF 100 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence 5677889999999999999998889999999997532 22346789999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
+++ +|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 101 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 101 MEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 985 77777643 3345899999999999999999999998 999999999999999999999999999887543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-26 Score=229.06 Aligned_cols=152 Identities=32% Similarity=0.539 Sum_probs=131.9
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-----cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeC--Cee
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-----SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEK 420 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 420 (516)
.++|...+.||+|+||.||++.+ .+++.||||++........+.+.+|++++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 45677889999999999999984 36889999999876666677899999999999999999999998654 458
Q ss_pred EEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
++||||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999998542 345899999999999999999999998 99999999999999999999999999998
Q ss_pred cccC
Q 010186 501 FAES 504 (516)
Q Consensus 501 ~~~~ 504 (516)
+...
T Consensus 164 ~~~~ 167 (295)
T 3ugc_A 164 LPQD 167 (295)
T ss_dssp ----
T ss_pred ccCC
Confidence 7654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=245.09 Aligned_cols=156 Identities=29% Similarity=0.498 Sum_probs=138.4
Q ss_pred HHHhhCCCCCCceeeecCcEeEEEEEecC-CcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 010186 344 LNLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 344 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 422 (516)
+++..++|...+.||+|+||.||+|.+.. +..||||+++... ...+.|.+|+.+|++++||||+++++++...+..+|
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 34455667888999999999999999764 8899999997643 356789999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
||||+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 294 v~E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 294 ITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp EEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EEEccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceecc
Confidence 99999999999999542 3346899999999999999999999998 9999999999999999999999999999875
Q ss_pred cC
Q 010186 503 ES 504 (516)
Q Consensus 503 ~~ 504 (516)
.+
T Consensus 370 ~~ 371 (495)
T 1opk_A 370 GD 371 (495)
T ss_dssp TC
T ss_pred CC
Confidence 43
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-26 Score=243.65 Aligned_cols=156 Identities=29% Similarity=0.398 Sum_probs=137.7
Q ss_pred HhhCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 010186 346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 346 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 421 (516)
+..++|...++||+|+||.||++... +|+.||+|++.+. .......+.+|+.++..++||||+++++++.+.+..+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 34466888899999999999999964 7899999999652 2334567899999999999999999999999999999
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+||||+++|+|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+
T Consensus 261 lVmEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EEECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceec
Confidence 999999999999988543 2345899999999999999999999998 999999999999999999999999999987
Q ss_pred ccCC
Q 010186 502 AESE 505 (516)
Q Consensus 502 ~~~~ 505 (516)
....
T Consensus 337 ~~~~ 340 (576)
T 2acx_A 337 PEGQ 340 (576)
T ss_dssp CTTC
T ss_pred ccCc
Confidence 6543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=9.4e-26 Score=230.87 Aligned_cols=152 Identities=26% Similarity=0.381 Sum_probs=135.4
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
++|...+.||+|+||.||++... +++.||+|++..........+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 56888899999999999999964 68899999997655555667999999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC--CCcEEEcccCcccccccCC
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS--DMNSKISDFGMARIFAESE 505 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~--~~~~kl~DFGla~~~~~~~ 505 (516)
++|+|.+++.. ....+++.++..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+....
T Consensus 131 ~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 131 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999998843 3346899999999999999999999998 999999999999974 4679999999999876543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.3e-26 Score=237.90 Aligned_cols=150 Identities=31% Similarity=0.510 Sum_probs=135.2
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...+.||+|+||.||+|... +|+.||||++.+. .......+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56778899999999999999965 7999999999753 2234567899999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||+++|+|.+++. ..+.+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 96 E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 9999999999984 3456999999999999999999999998 999999999999999999999999999987654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-26 Score=229.91 Aligned_cols=149 Identities=27% Similarity=0.450 Sum_probs=132.2
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...+.||+|+||.||++.. .+++.||+|++... .......+.+|+.+++.++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5688889999999999999995 57899999998652 2233567899999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||+ +|+|.+++.. ...+++.++..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 89 E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp CCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred ECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999 6788887742 346899999999999999999999998 999999999999999999999999999877654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-26 Score=230.36 Aligned_cols=154 Identities=25% Similarity=0.390 Sum_probs=133.0
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC-----CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-----SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 422 (516)
++|...+.||+|+||.||++.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4677889999999999999995 46899999998642 12246779999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCc---EEEcccCcc
Q 010186 423 VYEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN---SKISDFGMA 498 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~---~kl~DFGla 498 (516)
||||+++++|.+.+... .....+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999998776432 22345899999999999999999999998 999999999999987654 999999999
Q ss_pred cccccCC
Q 010186 499 RIFAESE 505 (516)
Q Consensus 499 ~~~~~~~ 505 (516)
+.+....
T Consensus 181 ~~~~~~~ 187 (351)
T 3c0i_A 181 IQLGESG 187 (351)
T ss_dssp EECCTTS
T ss_pred eEecCCC
Confidence 8876543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.1e-26 Score=224.05 Aligned_cols=153 Identities=29% Similarity=0.487 Sum_probs=134.3
Q ss_pred HHhhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 345 NLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 345 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++..++|...+.||+|+||.||++...++..||+|++.... ...+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 34456788889999999999999999888899999997643 34567999999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
||+++++|.+++.. ....+++.++..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+..
T Consensus 99 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 99 EYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp CCCTTCBHHHHHHC--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred eccCCCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999999954 2345899999999999999999999998 99999999999999999999999999987643
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-26 Score=228.94 Aligned_cols=158 Identities=28% Similarity=0.495 Sum_probs=136.1
Q ss_pred HHhhCCCCCCceeeecCcEeEEEEEec--------CCcEEEEEEeccC-CccchHHHHHHHHHHhcC-CCCCccceeeEE
Q 010186 345 NLATSNFSDSNILGQGGFGPVYKGVLS--------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFC 414 (516)
Q Consensus 345 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~ 414 (516)
.+..++|...+.||+|+||.||++... ++..||+|++... .....+.+.+|+.+++++ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 345677888999999999999999863 4678999999753 334566799999999999 999999999999
Q ss_pred EeCCeeEEEEEccCCCChhHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCC
Q 010186 415 VDGDEKLLVYEFMPNGSLDAILFDPRK-------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASN 481 (516)
Q Consensus 415 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~N 481 (516)
...+..++||||+++|+|.+++..... ...+++.+++.++.||+.||.|||+.+ ++||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccce
Confidence 999999999999999999999965332 234899999999999999999999998 9999999999
Q ss_pred eEecCCCcEEEcccCcccccccCC
Q 010186 482 VLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 482 ILld~~~~~kl~DFGla~~~~~~~ 505 (516)
||++.++.+||+|||+++.+....
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~ 211 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNID 211 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTS
T ss_pred EEEcCCCCEEEccccccccccccc
Confidence 999999999999999998776543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=241.60 Aligned_cols=152 Identities=26% Similarity=0.315 Sum_probs=125.4
Q ss_pred hhCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 422 (516)
..++|...++||+|+||.||++.. .+|+.||||++.+. .......+.+|+.++..++||||+++++++...+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 346788899999999999999995 46899999999752 33455678899999999999999999999999999999
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHc-CCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||+ .+ |+||||||+||||+.++.+||+|||+|+..
T Consensus 226 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 226 VMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EEeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 9999999999998843 3468999999999999999999998 77 999999999999999999999999999875
Q ss_pred ccC
Q 010186 502 AES 504 (516)
Q Consensus 502 ~~~ 504 (516)
...
T Consensus 300 ~~~ 302 (446)
T 4ejn_A 300 IKD 302 (446)
T ss_dssp CC-
T ss_pred cCC
Confidence 443
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-26 Score=234.11 Aligned_cols=151 Identities=27% Similarity=0.331 Sum_probs=123.8
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC---ccchHHHHHHHHH-HhcCCCCCccceeeEEEeCCeeEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLL-ILKLQHKNLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~l 422 (516)
.++|...+.||+|+||.||+++.. +++.||+|++.+.. ......+..|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 356788899999999999999965 57899999997532 2334456777776 567899999999999999999999
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999998843 346889999999999999999999998 9999999999999999999999999998754
Q ss_pred cC
Q 010186 503 ES 504 (516)
Q Consensus 503 ~~ 504 (516)
..
T Consensus 191 ~~ 192 (373)
T 2r5t_A 191 EH 192 (373)
T ss_dssp CC
T ss_pred cC
Confidence 43
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-26 Score=227.62 Aligned_cols=160 Identities=31% Similarity=0.445 Sum_probs=138.5
Q ss_pred HHHhhCCCCCCceeeecCcEeEEEEEe------cCCcEEEEEEeccCC-ccchHHHHHHHHHHhcC-CCCCccceeeEEE
Q 010186 344 LNLATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKL-QHKNLVKLLGFCV 415 (516)
Q Consensus 344 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~ 415 (516)
+++..++|...+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++.++ +||||+++++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 344567788899999999999999984 346789999997643 23457799999999999 9999999999999
Q ss_pred eCCeeEEEEEccCCCChhHHhcCCCC---------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCC
Q 010186 416 DGDEKLLVYEFMPNGSLDAILFDPRK---------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKAS 480 (516)
Q Consensus 416 ~~~~~~lV~Ey~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~ 480 (516)
..+..++||||+++|+|.+++..... ...+++.+++.++.||+.||.|||+.+ ++||||||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~ 174 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR 174 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccc
Confidence 99999999999999999999854321 225899999999999999999999998 999999999
Q ss_pred CeEecCCCcEEEcccCcccccccCCC
Q 010186 481 NVLLDSDMNSKISDFGMARIFAESEG 506 (516)
Q Consensus 481 NILld~~~~~kl~DFGla~~~~~~~~ 506 (516)
|||++.++.+||+|||+++.+.....
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~ 200 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSN 200 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTT
T ss_pred eEEEcCCCCEEEcccccccccccccc
Confidence 99999999999999999998765543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=236.32 Aligned_cols=153 Identities=36% Similarity=0.560 Sum_probs=132.4
Q ss_pred hCCCCCCceeeecCcEeEEEEEec------CCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK 420 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 420 (516)
.++|...+.||+|+||.||+|.+. +++.||||+++.. .......+.+|+.++.+++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 456778899999999999999953 4668999999653 344556789999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHhcCCC----CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC---cEEEc
Q 010186 421 LLVYEFMPNGSLDAILFDPR----KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM---NSKIS 493 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~---~~kl~ 493 (516)
++||||+++|+|.+++.... ....+++.+++.++.||++||.|||+.+ |+||||||+||||+.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999985422 2245899999999999999999999998 99999999999999554 59999
Q ss_pred ccCccccccc
Q 010186 494 DFGMARIFAE 503 (516)
Q Consensus 494 DFGla~~~~~ 503 (516)
|||+++.+..
T Consensus 227 DFG~a~~~~~ 236 (367)
T 3l9p_A 227 DFGMARDIYR 236 (367)
T ss_dssp CCHHHHHHHH
T ss_pred CCcccccccc
Confidence 9999987643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.93 E-value=5e-26 Score=223.38 Aligned_cols=149 Identities=28% Similarity=0.466 Sum_probs=132.6
Q ss_pred CCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
++|...+.||+|+||.||++...+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 4677889999999999999998889999999996532 23356789999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
+++ +|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (288)
T ss_dssp CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence 986 88888753 2356899999999999999999999998 99999999999999999999999999987653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-26 Score=230.00 Aligned_cols=151 Identities=25% Similarity=0.397 Sum_probs=128.4
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCe----
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE---- 419 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~---- 419 (516)
.++|...+.||+|+||.||++.. .+++.||||++.... ......+.+|+.++.+++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 35688889999999999999995 578999999997632 2334578999999999999999999999886543
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccc
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 499 (516)
.++||||+++++|.+++.. ...+++.+++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 3999999999999999843 346899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccC
Q 010186 500 IFAES 504 (516)
Q Consensus 500 ~~~~~ 504 (516)
.+...
T Consensus 165 ~~~~~ 169 (311)
T 3ork_A 165 AIADS 169 (311)
T ss_dssp -----
T ss_pred ccccc
Confidence 87654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.5e-26 Score=219.87 Aligned_cols=152 Identities=24% Similarity=0.416 Sum_probs=136.3
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
.++|...+.||+|+||.||++... ++..+|+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 346788899999999999999964 5778999999876566678899999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEe---cCCCcEEEcccCccccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL---DSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILl---d~~~~~kl~DFGla~~~~~ 503 (516)
+++++|.+++.. ...+++.++..++.||+.||.|||+.+ ++||||||+|||+ +.++.+||+|||+++.+..
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 999999988843 345899999999999999999999998 9999999999999 7889999999999988765
Q ss_pred CC
Q 010186 504 SE 505 (516)
Q Consensus 504 ~~ 505 (516)
..
T Consensus 162 ~~ 163 (277)
T 3f3z_A 162 GK 163 (277)
T ss_dssp TS
T ss_pred cc
Confidence 43
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.93 E-value=9.1e-26 Score=239.65 Aligned_cols=155 Identities=28% Similarity=0.393 Sum_probs=137.3
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 423 (516)
.++|...++||+|+||.||+++.. +|+.||+|++.+. .......+.+|++++++++||||+++++++...+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 356788899999999999999964 6899999999652 223456789999999999999999999999999999999
Q ss_pred EEccCCCChhHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 424 YEFMPNGSLDAILFDPR-KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
|||+++|+|..++.... ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999886432 2456999999999999999999999998 9999999999999999999999999999876
Q ss_pred cCC
Q 010186 503 ESE 505 (516)
Q Consensus 503 ~~~ 505 (516)
...
T Consensus 341 ~~~ 343 (543)
T 3c4z_A 341 AGQ 343 (543)
T ss_dssp TTC
T ss_pred CCC
Confidence 554
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.6e-26 Score=236.61 Aligned_cols=152 Identities=24% Similarity=0.372 Sum_probs=132.4
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
.++|...+.||+|+||.||++.. .+|+.+|+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 45678889999999999999985 478999999987532 334567899999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEec---CCCcEEEcccCccccc
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD---SDMNSKISDFGMARIF 501 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld---~~~~~kl~DFGla~~~ 501 (516)
||+++|+|.+.+.. ...+++.++..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.+
T Consensus 90 E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 90 DLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp CCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 99999999888843 356899999999999999999999998 99999999999998 4578999999999887
Q ss_pred ccCC
Q 010186 502 AESE 505 (516)
Q Consensus 502 ~~~~ 505 (516)
....
T Consensus 164 ~~~~ 167 (444)
T 3soa_A 164 EGEQ 167 (444)
T ss_dssp CTTC
T ss_pred cCCC
Confidence 6544
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.93 E-value=5.6e-27 Score=235.49 Aligned_cols=148 Identities=21% Similarity=0.325 Sum_probs=124.0
Q ss_pred hCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCC--------ccchHHHHHHHHHHhcCC---------CCCccce
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCS--------EQGTAEFTNEVLLILKLQ---------HKNLVKL 410 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l~---------H~niv~l 410 (516)
.++|...+.||+|+||.||+++. +|+.||||++.... ....+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45677789999999999999998 78999999997532 223477899999998885 7777777
Q ss_pred eeEEE-----------------e-------------CCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 010186 411 LGFCV-----------------D-------------GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460 (516)
Q Consensus 411 ~g~~~-----------------~-------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~ 460 (516)
.+.+. + .+..+|||||+++|++.+.+.. ..+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 76643 2 6789999999999976555522 458999999999999999
Q ss_pred HHHhH-cCCCCCeeeCCCCCCCeEecCCC--------------------cEEEcccCccccccc
Q 010186 461 MLYLH-EDSRLRIVHRDLKASNVLLDSDM--------------------NSKISDFGMARIFAE 503 (516)
Q Consensus 461 l~yLH-~~~~~~iiHrDlk~~NILld~~~--------------------~~kl~DFGla~~~~~ 503 (516)
|.||| +.+ |+||||||+||||+.++ .+||+|||+|+.+..
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~ 234 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD 234 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC
Confidence 99999 887 99999999999999887 899999999998764
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.93 E-value=6.3e-26 Score=237.09 Aligned_cols=152 Identities=33% Similarity=0.487 Sum_probs=133.7
Q ss_pred HHhhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCC-eeEEE
Q 010186 345 NLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD-EKLLV 423 (516)
Q Consensus 345 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV 423 (516)
++..++|...+.||+|+||.||+|... ++.||||+++... ..+.|.+|+.++++++||||+++++++.+.+ ..++|
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 345567888899999999999999984 7899999997643 5678999999999999999999999988765 78999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
|||+++|+|.+++... ....+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||+++....
T Consensus 266 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EECCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 9999999999999542 2334789999999999999999999998 99999999999999999999999999986543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.9e-26 Score=230.93 Aligned_cols=147 Identities=30% Similarity=0.434 Sum_probs=126.8
Q ss_pred CceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCCCCh
Q 010186 354 SNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432 (516)
Q Consensus 354 ~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 432 (516)
.+.||+|+||.||++.. .+|+.||+|+++.......+.+.+|++++.+++||||+++++++...+..+|||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56799999999999995 46899999999876556677899999999999999999999999999999999999999999
Q ss_pred hHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEe--cCCCcEEEcccCcccccccCC
Q 010186 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL--DSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILl--d~~~~~kl~DFGla~~~~~~~ 505 (516)
.+++.. ....+++.++..++.||++||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 174 ~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 174 FDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp HHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred HHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 888743 2346899999999999999999999998 9999999999999 667899999999999876543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-25 Score=220.60 Aligned_cols=148 Identities=29% Similarity=0.435 Sum_probs=127.0
Q ss_pred hCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhc--CCCCCccceeeEEEeC----CeeE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILK--LQHKNLVKLLGFCVDG----DEKL 421 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~----~~~~ 421 (516)
.++|...+.||+|+||.||+|.. +++.||||++.. .....+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 45788889999999999999998 689999999865 234556667776665 7999999999997653 4578
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhH--------cCCCCCeeeCCCCCCCeEecCCCcEEEc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH--------EDSRLRIVHRDLKASNVLLDSDMNSKIS 493 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH--------~~~~~~iiHrDlk~~NILld~~~~~kl~ 493 (516)
+||||+++|+|.+++. ...+++..++.++.||+.||.||| +.+ ++||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 9999999999999993 346899999999999999999999 666 9999999999999999999999
Q ss_pred ccCcccccccCCC
Q 010186 494 DFGMARIFAESEG 506 (516)
Q Consensus 494 DFGla~~~~~~~~ 506 (516)
|||+++.......
T Consensus 156 Dfg~a~~~~~~~~ 168 (301)
T 3q4u_A 156 DLGLAVMHSQSTN 168 (301)
T ss_dssp CCTTCEEEETTTT
T ss_pred eCCCeeecccccc
Confidence 9999988765543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=218.70 Aligned_cols=150 Identities=29% Similarity=0.425 Sum_probs=134.3
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
++|...+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 45778899999999999999965 68999999986532 33456789999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
+++++|.+++. ....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+...
T Consensus 87 ~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 87 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 99999999884 3456899999999999999999999998 999999999999999999999999999876543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.3e-26 Score=225.81 Aligned_cols=166 Identities=29% Similarity=0.490 Sum_probs=131.6
Q ss_pred ccccchHHHHHhhCCCCCCceeeecCcEeEEEEEec----CCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccc
Q 010186 336 DFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLS----DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVK 409 (516)
Q Consensus 336 ~~~~~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~----~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~ 409 (516)
+....++++.+..++|...+.||+|+||.||++... ++..||+|++... .....+.+.+|+.++++++||||++
T Consensus 21 el~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 100 (313)
T 3brb_A 21 ELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100 (313)
T ss_dssp ---CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred hhhhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeee
Confidence 344456667777888999999999999999999854 3458999998753 3344567999999999999999999
Q ss_pred eeeEEEeCCe-----eEEEEEccCCCChhHHhcCC---CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCC
Q 010186 410 LLGFCVDGDE-----KLLVYEFMPNGSLDAILFDP---RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASN 481 (516)
Q Consensus 410 l~g~~~~~~~-----~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~N 481 (516)
+++++...+. .++||||+++++|.+++... .....+++..++.++.||++||.|||+.+ ++||||||+|
T Consensus 101 ~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~N 177 (313)
T 3brb_A 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARN 177 (313)
T ss_dssp CCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGG
T ss_pred eeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcce
Confidence 9999987653 49999999999999988432 23456999999999999999999999998 9999999999
Q ss_pred eEecCCCcEEEcccCcccccccC
Q 010186 482 VLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 482 ILld~~~~~kl~DFGla~~~~~~ 504 (516)
||++.++.+||+|||+++.+...
T Consensus 178 Ili~~~~~~kl~Dfg~~~~~~~~ 200 (313)
T 3brb_A 178 CMLRDDMTVCVADFGLSKKIYSG 200 (313)
T ss_dssp EEECTTSCEEECSCSCC------
T ss_pred EEEcCCCcEEEeecCcceecccc
Confidence 99999999999999999877543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=5.7e-26 Score=225.58 Aligned_cols=165 Identities=28% Similarity=0.441 Sum_probs=141.1
Q ss_pred ccchHHHHHhhCCCCCCceeeecCcEeEEEEEe------cCCcEEEEEEeccCC-ccchHHHHHHHHHHhcC-CCCCccc
Q 010186 338 FIDLETLNLATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKL-QHKNLVK 409 (516)
Q Consensus 338 ~~~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~ 409 (516)
.++...+....++|...+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++.++ +||||++
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 345667777788999999999999999999984 346789999997633 33456789999999999 7999999
Q ss_pred eeeEEEeCC-eeEEEEEccCCCChhHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeC
Q 010186 410 LLGFCVDGD-EKLLVYEFMPNGSLDAILFDPRK-------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475 (516)
Q Consensus 410 l~g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHr 475 (516)
+++++...+ ..++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ ++||
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~ 172 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR 172 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccc
Confidence 999998755 48999999999999999965332 223889999999999999999999998 9999
Q ss_pred CCCCCCeEecCCCcEEEcccCcccccccCC
Q 010186 476 DLKASNVLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 476 Dlk~~NILld~~~~~kl~DFGla~~~~~~~ 505 (516)
||||+|||++.++.+||+|||+++.+....
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 202 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDP 202 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCT
T ss_pred cCccceEEECCCCCEEECCCccccccccCc
Confidence 999999999999999999999998876544
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-26 Score=229.29 Aligned_cols=160 Identities=34% Similarity=0.546 Sum_probs=138.2
Q ss_pred HHHHHhhCCCCCCceeeecCcEeEEEEEec------CCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEE
Q 010186 342 ETLNLATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414 (516)
Q Consensus 342 ~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 414 (516)
+++++..++|...+.||+|+||.||+|... +++.||+|++... .......+.+|+.+++.++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 345566778889999999999999999854 3678999999753 233456789999999999999999999999
Q ss_pred EeCCeeEEEEEccCCCChhHHhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCC
Q 010186 415 VDGDEKLLVYEFMPNGSLDAILFDPR-------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD 487 (516)
Q Consensus 415 ~~~~~~~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~ 487 (516)
.+.+..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+++ ++||||||+|||++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCC
Confidence 99999999999999999999885311 1245789999999999999999999998 9999999999999999
Q ss_pred CcEEEcccCcccccccC
Q 010186 488 MNSKISDFGMARIFAES 504 (516)
Q Consensus 488 ~~~kl~DFGla~~~~~~ 504 (516)
+.+||+|||+++.+...
T Consensus 175 ~~~kl~Dfg~~~~~~~~ 191 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYET 191 (322)
T ss_dssp CCEEECCTTCCCGGGGG
T ss_pred CeEEECcCccccccccc
Confidence 99999999999877544
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.9e-25 Score=221.22 Aligned_cols=153 Identities=31% Similarity=0.476 Sum_probs=120.3
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
.++|...+.||+|+||.||++.. .+++.||+|+++... ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 35688889999999999999995 468999999997533 3345678999999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCC---CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 426 FMPNGSLDAILFDP---RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 426 y~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
|++ |+|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 5898877422 12245899999999999999999999998 9999999999999999999999999998875
Q ss_pred cC
Q 010186 503 ES 504 (516)
Q Consensus 503 ~~ 504 (516)
..
T Consensus 160 ~~ 161 (317)
T 2pmi_A 160 IP 161 (317)
T ss_dssp SC
T ss_pred CC
Confidence 43
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.9e-26 Score=229.72 Aligned_cols=160 Identities=31% Similarity=0.487 Sum_probs=137.3
Q ss_pred HHHHhhCCCCCCceeeecCcEeEEEEEecC-C-----cEEEEEEeccCC-ccchHHHHHHHHHHhcC-CCCCccceeeEE
Q 010186 343 TLNLATSNFSDSNILGQGGFGPVYKGVLSD-G-----KEVAVKRLSSCS-EQGTAEFTNEVLLILKL-QHKNLVKLLGFC 414 (516)
Q Consensus 343 ~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~-g-----~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~ 414 (516)
.+++..++|...+.||+|+||.||++.... + ..||+|.+.... ....+.+.+|+.++..+ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 345566788999999999999999999642 2 479999997643 34456799999999999 899999999999
Q ss_pred EeCCeeEEEEEccCCCChhHHhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeE
Q 010186 415 VDGDEKLLVYEFMPNGSLDAILFDPR-----------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVL 483 (516)
Q Consensus 415 ~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIL 483 (516)
...+..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ ++||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence 99999999999999999999885321 1345899999999999999999999998 999999999999
Q ss_pred ecCCCcEEEcccCcccccccCC
Q 010186 484 LDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 484 ld~~~~~kl~DFGla~~~~~~~ 505 (516)
++.++.+||+|||+++.+....
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~ 218 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDS 218 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCT
T ss_pred ECCCCeEEECcccccccccccc
Confidence 9999999999999999776543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=220.52 Aligned_cols=152 Identities=32% Similarity=0.451 Sum_probs=133.4
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
+++....+||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3455567899999999999995 568899999998766666778999999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC-CCcEEEcccCccccccc
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARIFAE 503 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~-~~~~kl~DFGla~~~~~ 503 (516)
++++|.+++........+++..+..++.||+.||.|||+.+ ++||||||+|||++. ++.+||+|||+++.+..
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 99999999865444456778999999999999999999998 999999999999987 89999999999987754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=5.4e-26 Score=227.50 Aligned_cols=153 Identities=33% Similarity=0.598 Sum_probs=127.8
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCc----EEEEEEecc-CCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGK----EVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~----~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 421 (516)
.++|...++||+|+||.||+|... +++ +|++|.+.. ......+.|.+|+.++++++||||+++++++..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 346777899999999999999953 444 468888754 33455678999999999999999999999998764 78
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+|+||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 93 ~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHH--STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 99999999999999854 2356899999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCC
Q 010186 502 AESEG 506 (516)
Q Consensus 502 ~~~~~ 506 (516)
.....
T Consensus 168 ~~~~~ 172 (327)
T 3poz_A 168 GAEEK 172 (327)
T ss_dssp TTTCC
T ss_pred cCCcc
Confidence 65543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.93 E-value=9.7e-26 Score=228.88 Aligned_cols=148 Identities=24% Similarity=0.330 Sum_probs=129.7
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
.++|...+.||+|+||.||++... +++.||+|++.... ...+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 457888899999999999999965 78999999997633 3346789999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCc--EEEcccCcccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN--SKISDFGMARIFA 502 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~--~kl~DFGla~~~~ 502 (516)
+++|+|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++...
T Consensus 98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 999999998842 346899999999999999999999998 999999999999987765 9999999998543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.4e-26 Score=226.71 Aligned_cols=153 Identities=37% Similarity=0.575 Sum_probs=130.7
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcE----EEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKE----VAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~----vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 421 (516)
.++|...+.||+|+||.||+|... +++. |++|.+... .......+.+|+.++++++||||+++++++. .+..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 346777899999999999999954 4443 788877543 2344567889999999999999999999886 45689
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+||||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 91 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHS--SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHH--ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 99999999999999854 2356899999999999999999999998 999999999999999999999999999988
Q ss_pred ccCCC
Q 010186 502 AESEG 506 (516)
Q Consensus 502 ~~~~~ 506 (516)
.....
T Consensus 166 ~~~~~ 170 (325)
T 3kex_A 166 PPDDK 170 (325)
T ss_dssp CCCTT
T ss_pred Ccccc
Confidence 65543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-26 Score=230.63 Aligned_cols=152 Identities=23% Similarity=0.321 Sum_probs=131.1
Q ss_pred hhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCC--CCccceeeEEEeCCeeEE
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQH--KNLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~l 422 (516)
..++|...+.||+|+||.||++...+++.||||++... .....+.+.+|+.++..++| |||+++++++...+..++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 45668888999999999999999888999999998753 33445779999999999976 999999999999999999
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
||| +.+++|.+++.. ...+++.++..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+.
T Consensus 87 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999 568899999843 456899999999999999999999998 99999999999997 6789999999999886
Q ss_pred cCCC
Q 010186 503 ESEG 506 (516)
Q Consensus 503 ~~~~ 506 (516)
....
T Consensus 159 ~~~~ 162 (343)
T 3dbq_A 159 PDTT 162 (343)
T ss_dssp ----
T ss_pred cccc
Confidence 5543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-26 Score=240.01 Aligned_cols=155 Identities=30% Similarity=0.516 Sum_probs=133.3
Q ss_pred HHHhhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 010186 344 LNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 344 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 423 (516)
+++..++|...+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+.++++++||||+++++++.+ +..++|
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv 256 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence 344556788889999999999999999888899999997643 345789999999999999999999999876 678999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
|||+++|+|.+++... ....+++.+++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||+++.+..
T Consensus 257 ~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp ECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred ehhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 9999999999999421 2245899999999999999999999998 99999999999999999999999999998764
Q ss_pred C
Q 010186 504 S 504 (516)
Q Consensus 504 ~ 504 (516)
.
T Consensus 333 ~ 333 (452)
T 1fmk_A 333 N 333 (452)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=231.59 Aligned_cols=155 Identities=32% Similarity=0.456 Sum_probs=135.2
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCC--eeEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD--EKLLV 423 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV 423 (516)
.++|...++||+|+||.||++... +++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 346778899999999999999965 58999999997533 344677889999999999999999999998765 67999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEe----cCCCcEEEcccCccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL----DSDMNSKISDFGMAR 499 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILl----d~~~~~kl~DFGla~ 499 (516)
|||+++|+|.+++........+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999965444445999999999999999999999998 9999999999999 777889999999999
Q ss_pred ccccCC
Q 010186 500 IFAESE 505 (516)
Q Consensus 500 ~~~~~~ 505 (516)
.+....
T Consensus 165 ~~~~~~ 170 (396)
T 4eut_A 165 ELEDDE 170 (396)
T ss_dssp ECCCGG
T ss_pred EccCCC
Confidence 876543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=225.25 Aligned_cols=150 Identities=23% Similarity=0.302 Sum_probs=132.8
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 425 (516)
.++|...+.||+|+||.||++.. .+++.||||++.... ..+.+.+|+.+++.+ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 45788889999999999999995 578999999987532 334689999999999 99999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCc-----EEEcccCcccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN-----SKISDFGMARI 500 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~-----~kl~DFGla~~ 500 (516)
|+ +++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998532 456999999999999999999999998 999999999999998887 99999999998
Q ss_pred cccCC
Q 010186 501 FAESE 505 (516)
Q Consensus 501 ~~~~~ 505 (516)
+....
T Consensus 160 ~~~~~ 164 (330)
T 2izr_A 160 YIDPE 164 (330)
T ss_dssp SBCTT
T ss_pred eecCC
Confidence 76544
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-25 Score=221.36 Aligned_cols=149 Identities=26% Similarity=0.385 Sum_probs=129.7
Q ss_pred CCCCC-CceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEE
Q 010186 349 SNFSD-SNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 349 ~~f~~-~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 425 (516)
+.|.. .+.||+|+||.||++.. .+++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 34555 36799999999999994 57899999999876666677899999999985 79999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCc---EEEcccCcccccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN---SKISDFGMARIFA 502 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~---~kl~DFGla~~~~ 502 (516)
|+++|+|.+++.. ...+++.++..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++.+.
T Consensus 92 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999843 346899999999999999999999998 999999999999988776 9999999998765
Q ss_pred c
Q 010186 503 E 503 (516)
Q Consensus 503 ~ 503 (516)
.
T Consensus 166 ~ 166 (316)
T 2ac3_A 166 L 166 (316)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.3e-26 Score=236.77 Aligned_cols=149 Identities=24% Similarity=0.445 Sum_probs=121.9
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeC-----Cee
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-----DEK 420 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~ 420 (516)
++|...++||+|+||.||++... +++.||||++... +....+.+.+|+.+++.++||||+++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 57888999999999999999854 7899999999652 334456789999999999999999999998543 468
Q ss_pred EEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
|+||||++ ++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+.
T Consensus 133 ~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 133 YVVLEIAD-SDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEECCCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEeccc-cchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchh
Confidence 99999984 68988884 3456999999999999999999999998 99999999999999999999999999998
Q ss_pred cccC
Q 010186 501 FAES 504 (516)
Q Consensus 501 ~~~~ 504 (516)
+...
T Consensus 206 ~~~~ 209 (458)
T 3rp9_A 206 VDYP 209 (458)
T ss_dssp TTSC
T ss_pred ccCc
Confidence 7643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-25 Score=226.44 Aligned_cols=149 Identities=32% Similarity=0.472 Sum_probs=121.2
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
.++|...+.||+|+||.||++... +++.||||++.... ..+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 456888899999999999999975 57899999997632 345688999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC---CCcEEEcccCccccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAE 503 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~---~~~~kl~DFGla~~~~~ 503 (516)
+++|+|.+++. ....+++.++..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++....
T Consensus 130 ~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 130 VTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred CCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 99999999984 3456899999999999999999999998 999999999999975 88999999999987754
Q ss_pred C
Q 010186 504 S 504 (516)
Q Consensus 504 ~ 504 (516)
.
T Consensus 204 ~ 204 (349)
T 2w4o_A 204 Q 204 (349)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=4.5e-26 Score=230.80 Aligned_cols=151 Identities=27% Similarity=0.361 Sum_probs=133.7
Q ss_pred CCCCCCceeeecCcEeEEEEEe----cCCcEEEEEEeccCC----ccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCe
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL----SDGKEVAVKRLSSCS----EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDE 419 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 419 (516)
++|...+.||+|+||.||++.. .+++.||||+++... ....+.+.+|+.++..+ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5678889999999999999996 478999999987532 23456688899999999 79999999999999999
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccc
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 499 (516)
.++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 9999999999999999843 346899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCC
Q 010186 500 IFAESE 505 (516)
Q Consensus 500 ~~~~~~ 505 (516)
.+....
T Consensus 208 ~~~~~~ 213 (355)
T 1vzo_A 208 EFVADE 213 (355)
T ss_dssp ECCGGG
T ss_pred ecccCC
Confidence 775443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-25 Score=221.82 Aligned_cols=150 Identities=23% Similarity=0.356 Sum_probs=132.9
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
++|...+.||+|+||.||++... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 46788899999999999999964 58999999986532 2235668899999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
|+++++|..++. ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+...
T Consensus 83 ~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999999999884 3356899999999999999999999998 999999999999999999999999999887643
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9e-26 Score=221.34 Aligned_cols=151 Identities=32% Similarity=0.491 Sum_probs=133.9
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CC-------cEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DG-------KEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 419 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g-------~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 419 (516)
.++|...+.||+|+||.||++... ++ ..||+|++........+.+.+|+.++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 456778899999999999999854 23 4799999987666677889999999999999999999999999999
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCc--------EE
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN--------SK 491 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~--------~k 491 (516)
.++||||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999953 2334899999999999999999999998 999999999999998887 99
Q ss_pred EcccCccccccc
Q 010186 492 ISDFGMARIFAE 503 (516)
Q Consensus 492 l~DFGla~~~~~ 503 (516)
|+|||+++....
T Consensus 162 l~Dfg~~~~~~~ 173 (289)
T 4fvq_A 162 LSDPGISITVLP 173 (289)
T ss_dssp ECCCCSCTTTSC
T ss_pred eccCcccccccC
Confidence 999999976643
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=217.95 Aligned_cols=154 Identities=35% Similarity=0.534 Sum_probs=125.7
Q ss_pred hhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCC----ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCS----EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 422 (516)
..++|...+.||+|+||.||++.. .++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred chhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 345788889999999999999997 48899999986532 2335679999999999999999999999999999999
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC--------CCcEEEcc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS--------DMNSKISD 494 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~--------~~~~kl~D 494 (516)
||||+++++|.+++. ...+++..+..++.|++.||.|||+++..+++||||||+|||++. ++.+||+|
T Consensus 84 v~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 84 VMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EEECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999999983 346899999999999999999999987666999999999999986 67899999
Q ss_pred cCcccccccCC
Q 010186 495 FGMARIFAESE 505 (516)
Q Consensus 495 FGla~~~~~~~ 505 (516)
||+++.+....
T Consensus 160 fg~~~~~~~~~ 170 (271)
T 3dtc_A 160 FGLAREWHRTT 170 (271)
T ss_dssp CCC--------
T ss_pred CCccccccccc
Confidence 99998765443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-25 Score=222.66 Aligned_cols=142 Identities=28% Similarity=0.389 Sum_probs=125.6
Q ss_pred CceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEEccCCCC
Q 010186 354 SNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYEFMPNGS 431 (516)
Q Consensus 354 ~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gs 431 (516)
.+.||+|+||.||++... +++.||||++.+ .....+.+|+.++..+. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999964 689999999965 34567889999999996 9999999999999999999999999999
Q ss_pred hhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC---cEEEcccCcccccccC
Q 010186 432 LDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM---NSKISDFGMARIFAES 504 (516)
Q Consensus 432 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~---~~kl~DFGla~~~~~~ 504 (516)
|.+++.. ...+++.++..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++.....
T Consensus 93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 9999843 456999999999999999999999998 99999999999997765 8999999999876544
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-25 Score=218.49 Aligned_cols=154 Identities=33% Similarity=0.548 Sum_probs=134.8
Q ss_pred HHhhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 345 NLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 345 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++..++|...+.||+|+||.||++...++..||+|.+.... ...+.+.+|+++++.++||||+++++++. .+..++||
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 86 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIIT 86 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEE
Confidence 34456788889999999999999998888899999997633 34678999999999999999999999976 45689999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||+++++|.+++... ....+++.++..++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++.+...
T Consensus 87 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 87 EYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp ECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred ecCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 999999999998431 1226899999999999999999999998 999999999999999999999999999887654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-25 Score=221.72 Aligned_cols=150 Identities=27% Similarity=0.395 Sum_probs=133.9
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCc------cchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE------QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 421 (516)
++|...+.||+|+||.||++... +|+.||+|++..... ...+.+.+|+.++..++||||+++++++.+.+..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 45778899999999999999964 689999999975322 13567999999999999999999999999999999
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC----cEEEcccCc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM----NSKISDFGM 497 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~----~~kl~DFGl 497 (516)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++ .+||+|||+
T Consensus 92 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 99999999999999943 456899999999999999999999998 99999999999999887 799999999
Q ss_pred ccccccC
Q 010186 498 ARIFAES 504 (516)
Q Consensus 498 a~~~~~~ 504 (516)
++.+...
T Consensus 166 ~~~~~~~ 172 (321)
T 2a2a_A 166 AHEIEDG 172 (321)
T ss_dssp CEECCTT
T ss_pred ceecCcc
Confidence 9887654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=9.4e-26 Score=226.62 Aligned_cols=152 Identities=27% Similarity=0.397 Sum_probs=134.3
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC--------ccchHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS--------EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD 418 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 418 (516)
.++|...+.||+|+||.||++.. .+++.||||++.... ......+.+|+.++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 45788889999999999999994 578899999997632 123456889999999999999999999999999
Q ss_pred eeEEEEEccCCC-ChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCc
Q 010186 419 EKLLVYEFMPNG-SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497 (516)
Q Consensus 419 ~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 497 (516)
..++||||+.+| +|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeeccc
Confidence 999999999877 9999884 3446999999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCC
Q 010186 498 ARIFAESE 505 (516)
Q Consensus 498 a~~~~~~~ 505 (516)
++.+....
T Consensus 177 a~~~~~~~ 184 (335)
T 3dls_A 177 AAYLERGK 184 (335)
T ss_dssp CEECCTTC
T ss_pred ceECCCCC
Confidence 98876543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-25 Score=227.83 Aligned_cols=152 Identities=21% Similarity=0.275 Sum_probs=134.9
Q ss_pred hhCCCCCCceeeec--CcEeEEEEEec-CCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 010186 347 ATSNFSDSNILGQG--GFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G--~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 421 (516)
..++|...++||+| +||.||++... +++.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 34568888999999 99999999965 6899999999753 2344567889999999999999999999999999999
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+||||+++|+|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++..+
T Consensus 103 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999998542 2345899999999999999999999998 999999999999999999999999998765
Q ss_pred c
Q 010186 502 A 502 (516)
Q Consensus 502 ~ 502 (516)
.
T Consensus 179 ~ 179 (389)
T 3gni_B 179 I 179 (389)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=217.64 Aligned_cols=151 Identities=32% Similarity=0.557 Sum_probs=135.6
Q ss_pred hhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
..++|...+.||+|+||.||++...+++.||+|++.... ...+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 345677889999999999999998888999999997643 3456899999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
+++++|.+++.. ....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 85 ~~~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 85 MEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp CTTCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CCCCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccc
Confidence 999999999853 2346899999999999999999999998 99999999999999999999999999987643
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-26 Score=243.52 Aligned_cols=154 Identities=31% Similarity=0.518 Sum_probs=135.9
Q ss_pred HHHhhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 010186 344 LNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 344 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 423 (516)
+++..++|...++||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|++++||||+++++++.+ +..+||
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 445566788889999999999999999888899999997643 345789999999999999999999999876 678999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
|||+++|+|.+++... ....+++.+++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 340 ~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp ECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred eehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 9999999999999421 2245899999999999999999999998 99999999999999999999999999987753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.4e-25 Score=217.12 Aligned_cols=150 Identities=33% Similarity=0.539 Sum_probs=133.7
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 4577889999999999999996 57899999999652 2233567899999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
||+++++|.+++.. ....+++..+..++.||++||.|||+.+ ++||||||+||+++.++.+||+|||+++.+..
T Consensus 91 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 91 EMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp ECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999853 2356899999999999999999999998 99999999999999999999999999987654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-25 Score=220.85 Aligned_cols=152 Identities=33% Similarity=0.536 Sum_probs=131.3
Q ss_pred CCCCCCceeeecCcEeEEEEEe-----cCCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeC--Cee
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-----SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEK 420 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-----~~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 420 (516)
+.|...+.||+|+||.||++.+ .+++.||+|++... .....+.+.+|+.++..++||||+++++++... +..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4567788999999999999984 36889999999753 334567899999999999999999999999876 568
Q ss_pred EEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 999999999999999843 2345899999999999999999999998 99999999999999999999999999988
Q ss_pred cccCC
Q 010186 501 FAESE 505 (516)
Q Consensus 501 ~~~~~ 505 (516)
+....
T Consensus 176 ~~~~~ 180 (302)
T 4e5w_A 176 IETDK 180 (302)
T ss_dssp CCTTC
T ss_pred ccCCC
Confidence 76543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=232.90 Aligned_cols=150 Identities=26% Similarity=0.469 Sum_probs=130.6
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeC-----Ce
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-----DE 419 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 419 (516)
.++|...+.||+|+||.||++.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 35788899999999999999995 46889999999753 333456789999999999999999999999876 56
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccc
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 499 (516)
.|+||||++ ++|.+++. ....+++..+..++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+|+
T Consensus 105 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999987 59999884 3456999999999999999999999998 9999999999999999999999999999
Q ss_pred ccccC
Q 010186 500 IFAES 504 (516)
Q Consensus 500 ~~~~~ 504 (516)
.+...
T Consensus 178 ~~~~~ 182 (432)
T 3n9x_A 178 TINSE 182 (432)
T ss_dssp EC---
T ss_pred ccccc
Confidence 87654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-25 Score=222.60 Aligned_cols=150 Identities=27% Similarity=0.276 Sum_probs=127.1
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC--CccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...++||+|+||.||+|... +++.||||++... .......+..|+..+.++ +||||+++++++.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 56888899999999999999965 7899999998653 223344555666666555 9999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||+ +++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 137 e~~-~~~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEA--WGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHH--HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 6688887743 2346999999999999999999999998 999999999999999999999999999877544
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-25 Score=220.19 Aligned_cols=151 Identities=33% Similarity=0.522 Sum_probs=124.5
Q ss_pred HHhhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 010186 345 NLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 345 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 422 (516)
++..++|...+.||+|+||.||++... ..||+|+++.. .....+.|.+|+.+++.++||||++++++. .....++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 345677888999999999999999864 35999998753 334456799999999999999999999965 5566899
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
||||+++++|.+++.. ....+++.+++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 97 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EEECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEEecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccc
Confidence 9999999999999853 3456899999999999999999999998 9999999999999999999999999998765
Q ss_pred c
Q 010186 503 E 503 (516)
Q Consensus 503 ~ 503 (516)
.
T Consensus 172 ~ 172 (289)
T 3og7_A 172 R 172 (289)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.3e-25 Score=218.07 Aligned_cols=149 Identities=27% Similarity=0.422 Sum_probs=133.1
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...+.||+|+||.||++... +++.+|+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 46777899999999999999965 5788999998653 2334567899999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
||+++++|.+++. ....+++.++..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+..
T Consensus 95 e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 95 ELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp ECCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 9999999999884 2346899999999999999999999998 99999999999999999999999999987753
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-25 Score=223.18 Aligned_cols=150 Identities=27% Similarity=0.414 Sum_probs=133.6
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...+.||+|+||.||++... +++.+|+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 46777899999999999999964 5789999998653 2344567899999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||+++++|.+++.. ...+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 121 e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 121 ELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp CCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred ecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 99999999998842 346899999999999999999999998 999999999999999999999999999887543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=7e-26 Score=222.00 Aligned_cols=158 Identities=30% Similarity=0.487 Sum_probs=139.5
Q ss_pred HHHHhhCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 010186 343 TLNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 343 ~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 421 (516)
.+++..++|...+.||+|+||.||++... ++..||+|++... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 34456677888899999999999999965 4889999999753 345678999999999999999999999999999999
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+||||+++++|.+++... ....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++..
T Consensus 86 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EEEECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEEEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 999999999999998542 3456899999999999999999999998 999999999999999999999999999887
Q ss_pred ccCC
Q 010186 502 AESE 505 (516)
Q Consensus 502 ~~~~ 505 (516)
....
T Consensus 162 ~~~~ 165 (288)
T 3kfa_A 162 TGDT 165 (288)
T ss_dssp CSSS
T ss_pred cCCc
Confidence 6543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-25 Score=226.13 Aligned_cols=157 Identities=26% Similarity=0.348 Sum_probs=132.8
Q ss_pred HHHhhCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC-----CccchHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 010186 344 LNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-----SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG 417 (516)
Q Consensus 344 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 417 (516)
+....++|...+.||+|+||.||++.. .+++.||+|++... .....+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 334556788899999999999999996 46889999998642 334567899999999999999999999999999
Q ss_pred CeeEEEEEccCCCChhHHhcCCC-------------------------------------CCCCCCHHHHHHHHHHHHHH
Q 010186 418 DEKLLVYEFMPNGSLDAILFDPR-------------------------------------KRGILCWRKRTNIVNGIAKG 460 (516)
Q Consensus 418 ~~~~lV~Ey~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~~ 460 (516)
+..++||||+++|+|.+++.... ....+++..+..++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999884100 01224567788999999999
Q ss_pred HHHhHcCCCCCeeeCCCCCCCeEecCCC--cEEEcccCccccccc
Q 010186 461 MLYLHEDSRLRIVHRDLKASNVLLDSDM--NSKISDFGMARIFAE 503 (516)
Q Consensus 461 l~yLH~~~~~~iiHrDlk~~NILld~~~--~~kl~DFGla~~~~~ 503 (516)
|.|||+.+ |+||||||+|||++.++ .+||+|||+++.+..
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~ 222 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYK 222 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGG
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccc
Confidence 99999998 99999999999998776 899999999997754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.1e-25 Score=216.21 Aligned_cols=150 Identities=29% Similarity=0.480 Sum_probs=135.0
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
+.|...+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 4577789999999999999985 468899999997533 34567899999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCC
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 505 (516)
+++++|.+++. ...+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+....
T Consensus 102 ~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 102 LGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 99999999983 246899999999999999999999998 9999999999999999999999999998876543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-25 Score=218.85 Aligned_cols=154 Identities=26% Similarity=0.400 Sum_probs=131.2
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
++|...+.||+|+||.||++.. .++..+|+|++... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 4577789999999999999996 46889999998763 334567899999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEe---cCCCcEEEcccCcccccc
Q 010186 427 MPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL---DSDMNSKISDFGMARIFA 502 (516)
Q Consensus 427 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILl---d~~~~~kl~DFGla~~~~ 502 (516)
+++|+|.+++... .....+++..+..++.||+.||.|||+.+ ++||||||+|||+ +.++.+||+|||+++.+.
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999998887432 12356899999999999999999999998 9999999999999 456789999999998776
Q ss_pred cCC
Q 010186 503 ESE 505 (516)
Q Consensus 503 ~~~ 505 (516)
...
T Consensus 179 ~~~ 181 (285)
T 3is5_A 179 SDE 181 (285)
T ss_dssp ---
T ss_pred Ccc
Confidence 543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.2e-25 Score=229.63 Aligned_cols=151 Identities=29% Similarity=0.416 Sum_probs=127.8
Q ss_pred hhCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC--------ccchHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS--------EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG 417 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 417 (516)
..++|...+.||+|+||.||++.. .+++.||||++.+.. ......+.+|+.++++++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 457899999999999999999995 468899999986521 122345889999999999999999999975 4
Q ss_pred CeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCC---CcEEEcc
Q 010186 418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD---MNSKISD 494 (516)
Q Consensus 418 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~---~~~kl~D 494 (516)
+..++||||+++|+|.+++. ....+++.++..++.||+.||.|||+.+ |+||||||+|||++.+ ..+||+|
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred CceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEee
Confidence 56899999999999998884 3456999999999999999999999998 9999999999999754 4599999
Q ss_pred cCcccccccC
Q 010186 495 FGMARIFAES 504 (516)
Q Consensus 495 FGla~~~~~~ 504 (516)
||+++.+...
T Consensus 286 FG~a~~~~~~ 295 (419)
T 3i6u_A 286 FGHSKILGET 295 (419)
T ss_dssp SSTTTSCC--
T ss_pred cccceecCCC
Confidence 9999987643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-25 Score=223.39 Aligned_cols=153 Identities=31% Similarity=0.476 Sum_probs=135.1
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-----cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEe--CCee
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-----SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD--GDEK 420 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~ 420 (516)
.++|...+.||+|+||.||++.+ .+++.||||++........+.+.+|++++++++||||+++++++.. ....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 35677889999999999999984 3678999999987666667789999999999999999999999874 4568
Q ss_pred EEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 999999999999999853 2345899999999999999999999998 99999999999999999999999999998
Q ss_pred cccCC
Q 010186 501 FAESE 505 (516)
Q Consensus 501 ~~~~~ 505 (516)
+....
T Consensus 177 ~~~~~ 181 (327)
T 3lxl_A 177 LPLDK 181 (327)
T ss_dssp CCTTC
T ss_pred cccCC
Confidence 75443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.3e-25 Score=243.72 Aligned_cols=163 Identities=26% Similarity=0.300 Sum_probs=138.3
Q ss_pred HhhCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCee
Q 010186 346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEK 420 (516)
Q Consensus 346 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 420 (516)
+..++|...++||+|+||.||++... +++.||||++++. .....+.+..|..++..+ +||+|+++++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 44567888999999999999999964 6789999999752 234566788999999988 799999999999999999
Q ss_pred EEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
||||||+++|+|..++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+.
T Consensus 418 ~lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeec
Confidence 999999999999999843 346899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCccCccceecC
Q 010186 501 FAESEGEANTVRIVGT 516 (516)
Q Consensus 501 ~~~~~~~~~~~~~~GT 516 (516)
....... +..++||
T Consensus 492 ~~~~~~~--~~~~~GT 505 (674)
T 3pfq_A 492 NIWDGVT--TKTFCGT 505 (674)
T ss_dssp CCCTTCC--BCCCCSC
T ss_pred cccCCcc--cccccCC
Confidence 5443322 2234555
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-25 Score=228.58 Aligned_cols=151 Identities=23% Similarity=0.320 Sum_probs=129.8
Q ss_pred hCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccC--CccchHHHHHHHHHHhcCC--CCCccceeeEEEeCCeeEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQ--HKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV 423 (516)
..+|...+.||+|+||.||++...+++.||||++... .....+.+.+|+.++..++ ||||+++++++...+..+||
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 3458888999999999999999878999999998653 3345678999999999996 59999999999999999999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
|| +.+++|.+++.. ...+++.++..++.||+.||.|||+.+ |+||||||+||||+ ++.+||+|||+++.+..
T Consensus 135 ~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 678899999853 346889999999999999999999998 99999999999995 58999999999998865
Q ss_pred CCC
Q 010186 504 SEG 506 (516)
Q Consensus 504 ~~~ 506 (516)
...
T Consensus 207 ~~~ 209 (390)
T 2zmd_A 207 DTT 209 (390)
T ss_dssp ---
T ss_pred CCc
Confidence 543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.9e-25 Score=215.51 Aligned_cols=152 Identities=30% Similarity=0.452 Sum_probs=133.7
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
.++|...+.||+|+||.||++... +++.||+|++... +....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467888899999999999999964 6889999998653 3344567899999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCc---EEEcccCccccc
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN---SKISDFGMARIF 501 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~---~kl~DFGla~~~ 501 (516)
||+++++|.+.+.. ...+++..+..++.||+.||.|||+.+ ++||||||+||+++.++. +||+|||+++..
T Consensus 85 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999999888742 356899999999999999999999998 999999999999987665 999999999877
Q ss_pred ccCC
Q 010186 502 AESE 505 (516)
Q Consensus 502 ~~~~ 505 (516)
....
T Consensus 159 ~~~~ 162 (284)
T 3kk8_A 159 NDSE 162 (284)
T ss_dssp CSSC
T ss_pred ccCc
Confidence 6544
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-25 Score=225.33 Aligned_cols=151 Identities=31% Similarity=0.482 Sum_probs=131.5
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
+.|...+.||+|+||.||++.. .+++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 3477788999999999999995 578999999997532 223457899999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||++ |+|.+++.. ....+++.++..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 134 e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9998 577776632 2356899999999999999999999998 999999999999999999999999999887654
Q ss_pred C
Q 010186 505 E 505 (516)
Q Consensus 505 ~ 505 (516)
.
T Consensus 208 ~ 208 (348)
T 1u5q_A 208 N 208 (348)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.3e-25 Score=216.66 Aligned_cols=156 Identities=26% Similarity=0.395 Sum_probs=134.1
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC--CccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 423 (516)
.++|...+.||+|+||.||++... +++.||+|++... .......+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 356778899999999999999965 7899999999753 334456788999999999 999999999999999999999
Q ss_pred EEccCCCChhHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC----------------
Q 010186 424 YEFMPNGSLDAILFDPR-KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---------------- 486 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~---------------- 486 (516)
|||+++++|.+++.... ....+++.++..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999985321 1256899999999999999999999998 999999999999984
Q ss_pred ---CCcEEEcccCcccccccCCC
Q 010186 487 ---DMNSKISDFGMARIFAESEG 506 (516)
Q Consensus 487 ---~~~~kl~DFGla~~~~~~~~ 506 (516)
...+||+|||+++.......
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~~ 189 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQV 189 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSCC
T ss_pred cCCceEEEEcccccccccCCccc
Confidence 44799999999988765543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=220.12 Aligned_cols=153 Identities=27% Similarity=0.464 Sum_probs=124.2
Q ss_pred HhhCCCCCCceeeecCcEeEEEEEecC----CcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 010186 346 LATSNFSDSNILGQGGFGPVYKGVLSD----GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK 420 (516)
Q Consensus 346 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 420 (516)
+..++|...+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.++++++||||+++++++ ..+..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCcc
Confidence 345678888999999999999998642 457999998763 334456799999999999999999999997 45678
Q ss_pred EEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
++||||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccc
Confidence 999999999999999853 2346899999999999999999999998 99999999999999999999999999988
Q ss_pred cccC
Q 010186 501 FAES 504 (516)
Q Consensus 501 ~~~~ 504 (516)
+...
T Consensus 166 ~~~~ 169 (281)
T 1mp8_A 166 MEDS 169 (281)
T ss_dssp ----
T ss_pred cCcc
Confidence 7544
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.92 E-value=7.6e-25 Score=214.06 Aligned_cols=150 Identities=27% Similarity=0.413 Sum_probs=132.4
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCc------cchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE------QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 421 (516)
++|...+.||+|+||.||++... +++.||+|.++.... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 45778899999999999999965 689999999875321 23677999999999999999999999999999999
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC----cEEEcccCc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM----NSKISDFGM 497 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~----~~kl~DFGl 497 (516)
+||||+++++|.+++.. ...+++.++..++.||+.||.|||+.+ ++||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999999842 346899999999999999999999998 99999999999998877 899999999
Q ss_pred ccccccC
Q 010186 498 ARIFAES 504 (516)
Q Consensus 498 a~~~~~~ 504 (516)
++.+...
T Consensus 159 ~~~~~~~ 165 (283)
T 3bhy_A 159 AHKIEAG 165 (283)
T ss_dssp CEECC--
T ss_pred ceeccCC
Confidence 9877543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.92 E-value=6.9e-25 Score=222.94 Aligned_cols=156 Identities=26% Similarity=0.434 Sum_probs=136.7
Q ss_pred HHHhhCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCc--------cchHHHHHHHHHHhcC-CCCCccceeeE
Q 010186 344 LNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE--------QGTAEFTNEVLLILKL-QHKNLVKLLGF 413 (516)
Q Consensus 344 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--------~~~~~~~~Ei~~l~~l-~H~niv~l~g~ 413 (516)
.....++|...+.||+|+||.||++... +|+.||||++..... ...+.+.+|+.++.++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3344567888899999999999999975 799999999875331 1145678999999999 89999999999
Q ss_pred EEeCCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEc
Q 010186 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKIS 493 (516)
Q Consensus 414 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~ 493 (516)
+......++||||+++++|.+++. ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLT---EKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEE
Confidence 999999999999999999999984 2346899999999999999999999998 9999999999999999999999
Q ss_pred ccCcccccccCC
Q 010186 494 DFGMARIFAESE 505 (516)
Q Consensus 494 DFGla~~~~~~~ 505 (516)
|||+++.+....
T Consensus 243 DfG~~~~~~~~~ 254 (365)
T 2y7j_A 243 DFGFSCHLEPGE 254 (365)
T ss_dssp CCTTCEECCTTC
T ss_pred ecCcccccCCCc
Confidence 999998876543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=3.4e-25 Score=216.28 Aligned_cols=151 Identities=27% Similarity=0.413 Sum_probs=131.5
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 423 (516)
.++|...+.||+|+||.||++... +++.||+|++... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 356778899999999999999854 5779999998652 223356789999999999999999999999999999999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 999999999998843 345899999999999999999999987 99999999999999999999999999976544
Q ss_pred C
Q 010186 504 S 504 (516)
Q Consensus 504 ~ 504 (516)
.
T Consensus 162 ~ 162 (279)
T 3fdn_A 162 S 162 (279)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.8e-25 Score=238.79 Aligned_cols=151 Identities=32% Similarity=0.545 Sum_probs=129.5
Q ss_pred CCCCCCc-eeeecCcEeEEEEEec---CCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 010186 349 SNFSDSN-ILGQGGFGPVYKGVLS---DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 349 ~~f~~~~-~Lg~G~fg~Vy~~~~~---~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 423 (516)
+++...+ .||+|+||.||+|.+. ++..||||+++.. .....+.|.+|+++|++++||||+++++++.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3333334 7999999999999864 4567999999764 33456789999999999999999999999976 568999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
|||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 414 ~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 999999999999953 3456999999999999999999999998 99999999999999999999999999998754
Q ss_pred CC
Q 010186 504 SE 505 (516)
Q Consensus 504 ~~ 505 (516)
..
T Consensus 489 ~~ 490 (613)
T 2ozo_A 489 DD 490 (613)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.8e-25 Score=226.66 Aligned_cols=148 Identities=30% Similarity=0.561 Sum_probs=122.4
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCC-CCCccceeeEEEeCC--eeE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGD--EKL 421 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~--~~~ 421 (516)
.++|...+.||+|+||.||++.. .+|+.||||++... .......+.+|+.++..+. ||||+++++++...+ ..|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 46788889999999999999995 47899999998652 3344567889999999996 999999999998654 689
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+||||++ ++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 88 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 9999998 589888843 36889999999999999999999998 999999999999999999999999999876
Q ss_pred cc
Q 010186 502 AE 503 (516)
Q Consensus 502 ~~ 503 (516)
..
T Consensus 160 ~~ 161 (388)
T 3oz6_A 160 VN 161 (388)
T ss_dssp SS
T ss_pred cc
Confidence 54
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4.6e-25 Score=222.14 Aligned_cols=148 Identities=28% Similarity=0.457 Sum_probs=128.1
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 425 (516)
.++|...+.||+|+||.||++... +++.||+|++.+... .+.+|++++.++ +||||+++++++.+++..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 356788899999999999999964 688999999976432 345788888887 89999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCC----CcEEEcccCccccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD----MNSKISDFGMARIF 501 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~----~~~kl~DFGla~~~ 501 (516)
|+++|+|.+++.. ...+++.++..++.||+.||.|||+.+ |+||||||+|||+.++ +.+||+|||+++.+
T Consensus 97 ~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999998843 356899999999999999999999998 9999999999998543 35999999999987
Q ss_pred ccCC
Q 010186 502 AESE 505 (516)
Q Consensus 502 ~~~~ 505 (516)
....
T Consensus 171 ~~~~ 174 (342)
T 2qr7_A 171 RAEN 174 (342)
T ss_dssp BCTT
T ss_pred cCCC
Confidence 6554
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=216.70 Aligned_cols=148 Identities=35% Similarity=0.521 Sum_probs=130.7
Q ss_pred CCCCceeeecCcEeEEEEEec-----CCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEE
Q 010186 351 FSDSNILGQGGFGPVYKGVLS-----DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLL 422 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~~-----~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 422 (516)
|...+.||+|+||.||++.+. +++.||||++.... ....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 467789999999999998753 67899999997643 34466799999999999999999999999884 57899
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
||||+++|+|.+++.. ..+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+.
T Consensus 113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 9999999999999943 34899999999999999999999998 9999999999999999999999999999876
Q ss_pred cCC
Q 010186 503 ESE 505 (516)
Q Consensus 503 ~~~ 505 (516)
...
T Consensus 186 ~~~ 188 (318)
T 3lxp_A 186 EGH 188 (318)
T ss_dssp TTC
T ss_pred ccc
Confidence 543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=6.6e-25 Score=221.37 Aligned_cols=151 Identities=30% Similarity=0.466 Sum_probs=127.3
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCc-----cchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE-----QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 421 (516)
.++|...+.||+|+||.||++... +|+.||||++..... .....+.+|+.++..++||||+++++++.+.+..+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 467888999999999999999964 689999999875221 12346889999999999999999999999999999
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+||||+++ +|..++.. ....+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 89 lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp EEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred EEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 99999986 88888743 3346888999999999999999999998 999999999999999999999999999987
Q ss_pred ccC
Q 010186 502 AES 504 (516)
Q Consensus 502 ~~~ 504 (516)
...
T Consensus 163 ~~~ 165 (346)
T 1ua2_A 163 GSP 165 (346)
T ss_dssp TSC
T ss_pred cCC
Confidence 543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=5.5e-25 Score=219.95 Aligned_cols=154 Identities=31% Similarity=0.536 Sum_probs=135.2
Q ss_pred hhCCCCCCceeeecCcEeEEEEEe-----cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCC--e
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVL-----SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD--E 419 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~ 419 (516)
..++|...+.||+|+||.||++.. .+++.||+|++........+.+.+|++++++++||||+++++++...+ .
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 345677889999999999999984 368899999998766666778999999999999999999999987654 6
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccc
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 499 (516)
.++||||+++++|.+++... ...+++.+++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eEEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 89999999999999998542 345899999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCC
Q 010186 500 IFAESE 505 (516)
Q Consensus 500 ~~~~~~ 505 (516)
.+....
T Consensus 194 ~~~~~~ 199 (326)
T 2w1i_A 194 VLPQDK 199 (326)
T ss_dssp ECCSSC
T ss_pred hccccc
Confidence 876543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=6e-25 Score=215.53 Aligned_cols=150 Identities=33% Similarity=0.555 Sum_probs=130.5
Q ss_pred CCCCCCc-eeeecCcEeEEEEEec---CCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 010186 349 SNFSDSN-ILGQGGFGPVYKGVLS---DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 349 ~~f~~~~-~Lg~G~fg~Vy~~~~~---~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 423 (516)
++|...+ .||+|+||.||++... ++..||+|+++.. .....+.+.+|++++..++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3444444 8999999999999853 5778999999764 334567799999999999999999999999 55678999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
|||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+..
T Consensus 88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999853 3456899999999999999999999998 99999999999999999999999999988754
Q ss_pred C
Q 010186 504 S 504 (516)
Q Consensus 504 ~ 504 (516)
.
T Consensus 163 ~ 163 (287)
T 1u59_A 163 D 163 (287)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=3.8e-25 Score=221.98 Aligned_cols=153 Identities=34% Similarity=0.612 Sum_probs=129.0
Q ss_pred hhCCCCCCceeeecCcEeEEEEEecC-----CcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLSD-----GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK 420 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~-----g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 420 (516)
..++|...+.||+|+||.||+|.... +..||+|++... .......+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 34567778999999999999998642 236999999753 333456799999999999999999999999999999
Q ss_pred EEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
++||||+++|+|.+++.. ....+++.+++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 122 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 122 MIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999999853 3356899999999999999999999998 99999999999999999999999999988
Q ss_pred cccC
Q 010186 501 FAES 504 (516)
Q Consensus 501 ~~~~ 504 (516)
+...
T Consensus 197 ~~~~ 200 (333)
T 1mqb_A 197 LEDD 200 (333)
T ss_dssp ----
T ss_pred hccc
Confidence 7654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=8.5e-25 Score=215.24 Aligned_cols=148 Identities=30% Similarity=0.484 Sum_probs=128.5
Q ss_pred CCCCceeeecCcEeEEEEEec-CC---cEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCee-EEEE
Q 010186 351 FSDSNILGQGGFGPVYKGVLS-DG---KEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK-LLVY 424 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~~-~g---~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~-~lV~ 424 (516)
|...++||+|+||.||+|... ++ ..+|+|.+... .....+.+.+|+.+++.++||||+++++++.+.+.. ++||
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 445688999999999999853 22 37999998763 334567899999999999999999999999876665 9999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
||+.+|+|.+++.. ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+..
T Consensus 103 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 103 PYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp CCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred ecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 99999999999954 3456899999999999999999999998 99999999999999999999999999987644
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=218.13 Aligned_cols=152 Identities=25% Similarity=0.411 Sum_probs=127.3
Q ss_pred HhhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcC--CCCCccceeeEEEeC----Ce
Q 010186 346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL--QHKNLVKLLGFCVDG----DE 419 (516)
Q Consensus 346 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l--~H~niv~l~g~~~~~----~~ 419 (516)
...++|...+.||+|+||.||++... ++.||||++... ....+..|.+++..+ +||||+++++++... ..
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 34567889999999999999999984 899999998642 334455666666554 999999999999987 67
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC-----CCCeeeCCCCCCCeEecCCCcEEEcc
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS-----RLRIVHRDLKASNVLLDSDMNSKISD 494 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-----~~~iiHrDlk~~NILld~~~~~kl~D 494 (516)
.++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+.. +++++||||||+|||++.++.+||+|
T Consensus 110 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp EEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred eEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 8999999999999999943 35899999999999999999999871 12399999999999999999999999
Q ss_pred cCcccccccCC
Q 010186 495 FGMARIFAESE 505 (516)
Q Consensus 495 FGla~~~~~~~ 505 (516)
||+++.+....
T Consensus 186 fg~a~~~~~~~ 196 (337)
T 3mdy_A 186 LGLAVKFISDT 196 (337)
T ss_dssp CTTCEECC---
T ss_pred CCCceeecccc
Confidence 99998775543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.1e-25 Score=213.42 Aligned_cols=151 Identities=29% Similarity=0.469 Sum_probs=134.6
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 423 (516)
.++|...+.||+|+||.||++... +++.||+|++... +....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 357888899999999999999965 7899999998652 233456789999999999999999999999999999999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999843 345899999999999999999999998 99999999999999999999999999988754
Q ss_pred C
Q 010186 504 S 504 (516)
Q Consensus 504 ~ 504 (516)
.
T Consensus 164 ~ 164 (276)
T 2h6d_A 164 G 164 (276)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.5e-25 Score=221.39 Aligned_cols=160 Identities=28% Similarity=0.402 Sum_probs=132.8
Q ss_pred cchHHHHHhhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCcc-----------chHHHHHHHHHHhcCCCCCc
Q 010186 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQ-----------GTAEFTNEVLLILKLQHKNL 407 (516)
Q Consensus 339 ~~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~-----------~~~~~~~Ei~~l~~l~H~ni 407 (516)
....++....++|...+.||+|+||.||++...+|+.||||++...... ..+.+.+|++++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 3456777888999999999999999999999888999999998652211 13678999999999999999
Q ss_pred cceeeEEEeC-----CeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCe
Q 010186 408 VKLLGFCVDG-----DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNV 482 (516)
Q Consensus 408 v~l~g~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NI 482 (516)
+++++++... ...++||||++ |+|.+++.. ....+++..+..++.||+.||.|||+.+ ++||||||+||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 165 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI 165 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence 9999998643 35799999998 577777743 3456899999999999999999999998 99999999999
Q ss_pred EecCCCcEEEcccCcccccccC
Q 010186 483 LLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 483 Lld~~~~~kl~DFGla~~~~~~ 504 (516)
|++.++.+||+|||+++.....
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~ 187 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTAD 187 (362)
T ss_dssp EECTTCCEEECCTTC-------
T ss_pred EEcCCCCEEEEecCcccccccc
Confidence 9999999999999999865543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-24 Score=214.58 Aligned_cols=153 Identities=31% Similarity=0.490 Sum_probs=127.9
Q ss_pred hhCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC-----ccchHHHHHHHHHHhcC---CCCCccceeeEEEeC
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS-----EQGTAEFTNEVLLILKL---QHKNLVKLLGFCVDG 417 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~ 417 (516)
..++|...+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.+++.+ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 457899999999999999999995 578999999986422 12234677888887776 499999999999876
Q ss_pred C-----eeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEE
Q 010186 418 D-----EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKI 492 (516)
Q Consensus 418 ~-----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl 492 (516)
. ..++||||++ ++|.+++... ....+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 4789999997 5999988543 3344899999999999999999999998 999999999999999999999
Q ss_pred cccCcccccccC
Q 010186 493 SDFGMARIFAES 504 (516)
Q Consensus 493 ~DFGla~~~~~~ 504 (516)
+|||+++.+...
T Consensus 162 ~Dfg~a~~~~~~ 173 (308)
T 3g33_A 162 ADFGLARIYSYQ 173 (308)
T ss_dssp CSCSCTTTSTTC
T ss_pred eeCccccccCCC
Confidence 999999877544
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=7.7e-25 Score=215.75 Aligned_cols=151 Identities=31% Similarity=0.519 Sum_probs=129.7
Q ss_pred CCCCCCceeeecCcEeEEEEEecC----CcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEe-CCeeEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLSD----GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD-GDEKLL 422 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~l 422 (516)
.+|...++||+|+||.||+|...+ ...+++|.+... .....+.+.+|+.++++++||||+++++++.. ++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 456778899999999999998542 235899998763 33456779999999999999999999999754 457899
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
||||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+.
T Consensus 105 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence 9999999999999954 3456899999999999999999999998 9999999999999999999999999998775
Q ss_pred cC
Q 010186 503 ES 504 (516)
Q Consensus 503 ~~ 504 (516)
..
T Consensus 180 ~~ 181 (298)
T 3f66_A 180 DK 181 (298)
T ss_dssp CG
T ss_pred cc
Confidence 43
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.1e-25 Score=218.43 Aligned_cols=154 Identities=25% Similarity=0.371 Sum_probs=133.7
Q ss_pred HhhCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEe----CCee
Q 010186 346 LATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD----GDEK 420 (516)
Q Consensus 346 ~~~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~ 420 (516)
+..++|...+.||+|+||.||++.. .+++.||+|++........+.+.+|+++++.++||||+++++++.. ....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 4556788899999999999999996 5789999999977666667789999999999999999999999973 3468
Q ss_pred EEEEEccCCCChhHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccc
Q 010186 421 LLVYEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 499 (516)
++||||+++|+|.+++... .....+++.+++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 9999999999999888532 13456899999999999999999999998 9999999999999999999999999987
Q ss_pred ccc
Q 010186 500 IFA 502 (516)
Q Consensus 500 ~~~ 502 (516)
...
T Consensus 183 ~~~ 185 (317)
T 2buj_A 183 QAC 185 (317)
T ss_dssp ESC
T ss_pred hcc
Confidence 653
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5e-25 Score=220.76 Aligned_cols=150 Identities=29% Similarity=0.479 Sum_probs=129.0
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
++|...+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 46777899999999999999964 58999999986532 2234568899999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
|+++++|..++.. ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+...
T Consensus 105 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 105 FVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp CCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999999988742 345899999999999999999999998 999999999999999999999999999876543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.4e-25 Score=231.39 Aligned_cols=148 Identities=29% Similarity=0.414 Sum_probs=124.3
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeC------C
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG------D 418 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~ 418 (516)
.++|...+.||+|+||.||++.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46788899999999999999985 46889999999753 334466789999999999999999999999755 3
Q ss_pred eeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcc
Q 010186 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (516)
Q Consensus 419 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 498 (516)
..+|||||++++ |.+.+. ..+++.++..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 569999999875 555552 23889999999999999999999998 999999999999999999999999999
Q ss_pred cccccC
Q 010186 499 RIFAES 504 (516)
Q Consensus 499 ~~~~~~ 504 (516)
+.....
T Consensus 212 ~~~~~~ 217 (464)
T 3ttj_A 212 RTAGTS 217 (464)
T ss_dssp -----C
T ss_pred eecCCC
Confidence 887654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-24 Score=214.58 Aligned_cols=152 Identities=30% Similarity=0.422 Sum_probs=133.9
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCc---------cchHHHHHHHHHHhcCC-CCCccceeeEEEe
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE---------QGTAEFTNEVLLILKLQ-HKNLVKLLGFCVD 416 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---------~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~ 416 (516)
.++|...+.||+|+||.||++... +++.||||++..... ...+.+.+|+.++.++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 357888899999999999999964 688999999975321 22456889999999995 9999999999999
Q ss_pred CCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccC
Q 010186 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496 (516)
Q Consensus 417 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 496 (516)
.+..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEeccc
Confidence 9999999999999999999843 356899999999999999999999998 9999999999999999999999999
Q ss_pred cccccccCC
Q 010186 497 MARIFAESE 505 (516)
Q Consensus 497 la~~~~~~~ 505 (516)
+++.+....
T Consensus 170 ~~~~~~~~~ 178 (298)
T 1phk_A 170 FSCQLDPGE 178 (298)
T ss_dssp TCEECCTTC
T ss_pred chhhcCCCc
Confidence 998876543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=6e-25 Score=219.95 Aligned_cols=152 Identities=34% Similarity=0.608 Sum_probs=125.7
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcE----EEEEEecc-CCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKE----VAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~----vavK~l~~-~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 421 (516)
.++|...++||+|+||.||++... +++. |++|.+.. ......+.+.+|+.+++.++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 456888899999999999999953 4543 57777754 33456678999999999999999999999998765 78
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+|+||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 93 ~v~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 99999999999999854 2346899999999999999999999998 999999999999999999999999999987
Q ss_pred ccCC
Q 010186 502 AESE 505 (516)
Q Consensus 502 ~~~~ 505 (516)
....
T Consensus 168 ~~~~ 171 (327)
T 3lzb_A 168 GAEE 171 (327)
T ss_dssp ----
T ss_pred cCcc
Confidence 6543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.92 E-value=7.3e-25 Score=217.43 Aligned_cols=151 Identities=23% Similarity=0.315 Sum_probs=129.8
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 423 (516)
-++|...+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++.+++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 367888999999999999999964 68899999997532 22346789999999999999999999999999999999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
|||+++++|.+++.. ...+++.++..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++....
T Consensus 113 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 999999999999843 346899999999999999999999998 99999999999999999999999999987654
Q ss_pred C
Q 010186 504 S 504 (516)
Q Consensus 504 ~ 504 (516)
.
T Consensus 187 ~ 187 (309)
T 2h34_A 187 E 187 (309)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-24 Score=214.80 Aligned_cols=150 Identities=26% Similarity=0.410 Sum_probs=128.7
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC----ccchHHHHHHHHHHhcCCCCCccceeeEEEe--CCeeE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS----EQGTAEFTNEVLLILKLQHKNLVKLLGFCVD--GDEKL 421 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~ 421 (516)
++|...+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 5788999999999999999996 468899999997532 2345679999999999999999999999853 45789
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+||||++++ |.+++.. .....+++..+..++.||+.||.|||+++ ++||||||+|||++.++.+||+|||+++.+
T Consensus 85 lv~e~~~~~-l~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDS-VPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEECCSEE-HHHHHHH-STTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEehhccCC-HHHHHHh-CcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccccc
Confidence 999999987 6665533 23456899999999999999999999998 999999999999999999999999999877
Q ss_pred cc
Q 010186 502 AE 503 (516)
Q Consensus 502 ~~ 503 (516)
..
T Consensus 160 ~~ 161 (305)
T 2wtk_C 160 HP 161 (305)
T ss_dssp CT
T ss_pred Cc
Confidence 54
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-25 Score=219.46 Aligned_cols=149 Identities=29% Similarity=0.472 Sum_probs=131.4
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
.++|...+.||+|+||.||++... +++.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 456788899999999999999975 5889999999876666778899999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+++++|.+++.. ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++..
T Consensus 98 ~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 98 CPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167 (302)
T ss_dssp CTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred CCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence 999999998743 2345899999999999999999999998 999999999999999999999999998643
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=230.65 Aligned_cols=152 Identities=32% Similarity=0.466 Sum_probs=131.4
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCc-------------cchHHHHHHHHHHhcCCCCCccceeeE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE-------------QGTAEFTNEVLLILKLQHKNLVKLLGF 413 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-------------~~~~~~~~Ei~~l~~l~H~niv~l~g~ 413 (516)
.++|...++||+|+||.||++... +++.||+|++.+... ...+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 457888899999999999999964 678999999875321 335678999999999999999999999
Q ss_pred EEeCCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC---cE
Q 010186 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM---NS 490 (516)
Q Consensus 414 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~---~~ 490 (516)
+.+....++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccE
Confidence 9999999999999999999888843 356899999999999999999999998 99999999999998775 69
Q ss_pred EEcccCcccccccCC
Q 010186 491 KISDFGMARIFAESE 505 (516)
Q Consensus 491 kl~DFGla~~~~~~~ 505 (516)
||+|||+++.+....
T Consensus 189 kl~Dfg~a~~~~~~~ 203 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDY 203 (504)
T ss_dssp EECCCTTCEECCTTS
T ss_pred EEEECCCCEEcCCCC
Confidence 999999999876543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.8e-25 Score=231.61 Aligned_cols=151 Identities=30% Similarity=0.453 Sum_probs=128.9
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
++|...+.||+|+||.||++... ++..||+|++.+.. ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 45778899999999999999964 68899999997532 3446779999999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCC---CcEEEcccCcccccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD---MNSKISDFGMARIFA 502 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~---~~~kl~DFGla~~~~ 502 (516)
|+++|+|.+.+. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.. +.+||+|||+++.+.
T Consensus 117 ~~~~g~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 117 CYKGGELFDEII---HRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp CCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred cCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 999999988874 2356899999999999999999999998 9999999999999764 459999999998876
Q ss_pred cCC
Q 010186 503 ESE 505 (516)
Q Consensus 503 ~~~ 505 (516)
...
T Consensus 191 ~~~ 193 (494)
T 3lij_A 191 NQK 193 (494)
T ss_dssp TTB
T ss_pred CCc
Confidence 543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.3e-25 Score=216.97 Aligned_cols=152 Identities=32% Similarity=0.488 Sum_probs=130.1
Q ss_pred hhCCCCCCc-eeeecCcEeEEEEEe---cCCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 010186 347 ATSNFSDSN-ILGQGGFGPVYKGVL---SDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK 420 (516)
Q Consensus 347 ~~~~f~~~~-~Lg~G~fg~Vy~~~~---~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 420 (516)
..++|...+ .||+|+||.||++.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++ ..+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 345566666 899999999999964 346789999997532 23356799999999999999999999999 56778
Q ss_pred EEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 93 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 999999999999999953 345899999999999999999999998 99999999999999999999999999988
Q ss_pred cccCC
Q 010186 501 FAESE 505 (516)
Q Consensus 501 ~~~~~ 505 (516)
+....
T Consensus 167 ~~~~~ 171 (291)
T 1xbb_A 167 LRADE 171 (291)
T ss_dssp CCTTC
T ss_pred eccCC
Confidence 76543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.5e-25 Score=220.74 Aligned_cols=152 Identities=25% Similarity=0.406 Sum_probs=134.4
Q ss_pred hCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCcc---ch--------------HHHHHHHHHHhcCCCCCccce
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQ---GT--------------AEFTNEVLLILKLQHKNLVKL 410 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~---~~--------------~~~~~Ei~~l~~l~H~niv~l 410 (516)
.++|...+.||+|+||.||++.. +++.||+|++...... .. +.+.+|+.++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 45788889999999999999999 8999999998752211 11 789999999999999999999
Q ss_pred eeEEEeCCeeEEEEEccCCCChhHH------hcCCCCCCCCCHHHHHHHHHHHHHHHHHhHc-CCCCCeeeCCCCCCCeE
Q 010186 411 LGFCVDGDEKLLVYEFMPNGSLDAI------LFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-DSRLRIVHRDLKASNVL 483 (516)
Q Consensus 411 ~g~~~~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~iiHrDlk~~NIL 483 (516)
++++.+.+..++||||+++++|.++ +.. .....+++..+..++.||+.||.|||+ .+ ++||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999998 522 225679999999999999999999998 77 999999999999
Q ss_pred ecCCCcEEEcccCcccccccC
Q 010186 484 LDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 484 ld~~~~~kl~DFGla~~~~~~ 504 (516)
++.++.+||+|||+++.+...
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~ 205 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK 205 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT
T ss_pred EcCCCcEEEeccccccccccc
Confidence 999999999999999876543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.3e-25 Score=214.04 Aligned_cols=148 Identities=29% Similarity=0.482 Sum_probs=130.3
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEe-----------
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD----------- 416 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----------- 416 (516)
++|...+.||+|+||.||++... +++.||+|++.... +.+.+|++++.+++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 45778899999999999999975 78999999997533 467899999999999999999998864
Q ss_pred -----CCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEE
Q 010186 417 -----GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSK 491 (516)
Q Consensus 417 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~k 491 (516)
....++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+|
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEE
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEE
Confidence 34579999999999999998532 2356899999999999999999999998 99999999999999999999
Q ss_pred EcccCcccccccC
Q 010186 492 ISDFGMARIFAES 504 (516)
Q Consensus 492 l~DFGla~~~~~~ 504 (516)
|+|||+++.+...
T Consensus 163 l~Dfg~~~~~~~~ 175 (284)
T 2a19_B 163 IGDFGLVTSLKND 175 (284)
T ss_dssp ECCCTTCEESSCC
T ss_pred ECcchhheecccc
Confidence 9999999887654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-24 Score=212.69 Aligned_cols=150 Identities=20% Similarity=0.330 Sum_probs=132.6
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 425 (516)
.++|...+.||+|+||.||++.. .+++.||+|++... ...+.+.+|+.++..+ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 45788889999999999999995 57899999998653 2345688999999999 89999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCc-----EEEcccCcccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN-----SKISDFGMARI 500 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~-----~kl~DFGla~~ 500 (516)
|+ +++|.+++... ...+++.++..++.||+.||.|||+.+ ++||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 99999998532 345899999999999999999999988 999999999999987776 99999999998
Q ss_pred cccCC
Q 010186 501 FAESE 505 (516)
Q Consensus 501 ~~~~~ 505 (516)
+....
T Consensus 161 ~~~~~ 165 (298)
T 1csn_A 161 YRDPV 165 (298)
T ss_dssp SBCTT
T ss_pred ccccc
Confidence 76553
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=4.5e-25 Score=224.85 Aligned_cols=149 Identities=32% Similarity=0.548 Sum_probs=121.9
Q ss_pred CCCCceeeecCcEeEEEEEec--CC--cEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEe-CCeeEEEE
Q 010186 351 FSDSNILGQGGFGPVYKGVLS--DG--KEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD-GDEKLLVY 424 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~~--~g--~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~ 424 (516)
|...+.||+|+||.||+|... ++ ..||+|.++.. .....+.|.+|+.++++++||||+++++++.+ .+..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 556788999999999999853 22 36899998753 33456789999999999999999999999765 45789999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||+++|+|.+++.. ....+++.+++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 171 e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 171 PYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp ECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred ECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999954 3345889999999999999999999998 999999999999999999999999999876543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=220.34 Aligned_cols=160 Identities=27% Similarity=0.291 Sum_probs=137.4
Q ss_pred cchHHHHHhhCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCC-----CCCccceee
Q 010186 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-----HKNLVKLLG 412 (516)
Q Consensus 339 ~~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----H~niv~l~g 412 (516)
+.+++..+..++|...++||+|+||.||++.. .+++.||||++.. .......+..|+.+++.++ ||||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 34445555678899999999999999999996 5688999999974 2344566788999999986 999999999
Q ss_pred EEEeCCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC------
Q 010186 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS------ 486 (516)
Q Consensus 413 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~------ 486 (516)
++...+..++||||+ +++|.+++... ....+++.++..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccccc
Confidence 999999999999999 99999998542 3345899999999999999999999998 999999999999976
Q ss_pred -------------------CCcEEEcccCcccccccC
Q 010186 487 -------------------DMNSKISDFGMARIFAES 504 (516)
Q Consensus 487 -------------------~~~~kl~DFGla~~~~~~ 504 (516)
++.+||+|||+++.....
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~ 215 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY 215 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCCC
Confidence 789999999999876543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-24 Score=216.57 Aligned_cols=156 Identities=26% Similarity=0.395 Sum_probs=133.1
Q ss_pred HHhhCCCCCC-ceeeecCcEeEEEEEec-CCcEEEEEEeccC--CccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCe
Q 010186 345 NLATSNFSDS-NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDE 419 (516)
Q Consensus 345 ~~~~~~f~~~-~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 419 (516)
+...+.|... +.||+|+||.||++... +++.||+|++... .......+.+|+.++..+ +||||+++++++...+.
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3344556655 78999999999999964 6899999998752 334567899999999999 56999999999999999
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC---CCcEEEcccC
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFG 496 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~---~~~~kl~DFG 496 (516)
.++||||+++|+|.+++.. .....+++.++..++.||+.||.|||+.+ ++||||||+|||++. ++.+||+|||
T Consensus 104 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp EEEEEECCTTEEGGGGGSS-CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred EEEEEEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 9999999999999998843 23456899999999999999999999998 999999999999988 7899999999
Q ss_pred cccccccC
Q 010186 497 MARIFAES 504 (516)
Q Consensus 497 la~~~~~~ 504 (516)
+++.+...
T Consensus 180 ~a~~~~~~ 187 (327)
T 3lm5_A 180 MSRKIGHA 187 (327)
T ss_dssp GCEEC---
T ss_pred cccccCCc
Confidence 99887644
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.9e-25 Score=221.42 Aligned_cols=150 Identities=29% Similarity=0.452 Sum_probs=126.1
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
.++|...+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 45688889999999999999985 478899999997532 223456789999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEec-----CCCcEEEcccCccc
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD-----SDMNSKISDFGMAR 499 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld-----~~~~~kl~DFGla~ 499 (516)
||+++ +|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++
T Consensus 113 e~~~~-~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 113 EYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp ECCSE-EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred ecCCC-CHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 99985 99888843 345899999999999999999999998 99999999999994 45569999999998
Q ss_pred ccccC
Q 010186 500 IFAES 504 (516)
Q Consensus 500 ~~~~~ 504 (516)
.+...
T Consensus 186 ~~~~~ 190 (329)
T 3gbz_A 186 AFGIP 190 (329)
T ss_dssp HHC--
T ss_pred ccCCc
Confidence 77543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-24 Score=213.50 Aligned_cols=149 Identities=27% Similarity=0.435 Sum_probs=132.4
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...+.||+|+||.||++... +++.||+|++... .....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46778899999999999999965 5788999998652 2233567899999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999998843 346899999999999999999999998 99999999999999999999999999976654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=216.78 Aligned_cols=151 Identities=32% Similarity=0.584 Sum_probs=129.9
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcE--EEEEEeccC-CccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKE--VAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~--vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 423 (516)
++|...+.||+|+||.||++... ++.. +++|.+... .....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 56778899999999999999954 5664 499988752 334566799999999999 999999999999999999999
Q ss_pred EEccCCCChhHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcE
Q 010186 424 YEFMPNGSLDAILFDPR-------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS 490 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~ 490 (516)
|||+++++|.+++.... ....+++.+++.++.||+.||.|||+.+ ++||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999986432 2346899999999999999999999998 9999999999999999999
Q ss_pred EEcccCcccccc
Q 010186 491 KISDFGMARIFA 502 (516)
Q Consensus 491 kl~DFGla~~~~ 502 (516)
||+|||+++...
T Consensus 182 kL~Dfg~~~~~~ 193 (327)
T 1fvr_A 182 KIADFGLSRGQE 193 (327)
T ss_dssp EECCTTCEESSC
T ss_pred EEcccCcCcccc
Confidence 999999997543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.8e-25 Score=220.31 Aligned_cols=150 Identities=28% Similarity=0.443 Sum_probs=127.2
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCc-cchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE-QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
++|...+.||+|+||.||++... +++.||+|++..... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46778899999999999999965 788999999975322 2233566899999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
++ |+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 82 LD-KDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP 153 (324)
T ss_dssp CS-EEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence 98 588887743 2346899999999999999999999998 999999999999999999999999999876543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.5e-25 Score=218.38 Aligned_cols=157 Identities=27% Similarity=0.447 Sum_probs=120.7
Q ss_pred HHHhhCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 010186 344 LNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 344 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 421 (516)
+.+..++|...+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++.+++||||+++++++...+..+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 344567888999999999999999994 478899999986532 344567889999999999999999999999999999
Q ss_pred EEEEccCCCChhHHhcC-----CCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccC
Q 010186 422 LVYEFMPNGSLDAILFD-----PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~-----~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 496 (516)
+||||+++++|.+++.. ......+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEecc
Confidence 99999999999998842 123456899999999999999999999998 9999999999999999999999999
Q ss_pred ccccccc
Q 010186 497 MARIFAE 503 (516)
Q Consensus 497 la~~~~~ 503 (516)
+++.+..
T Consensus 167 ~~~~~~~ 173 (303)
T 2vwi_A 167 VSAFLAT 173 (303)
T ss_dssp HHHHCC-
T ss_pred chheecc
Confidence 9987654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2e-24 Score=218.19 Aligned_cols=149 Identities=30% Similarity=0.528 Sum_probs=128.7
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeC--------
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-------- 417 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-------- 417 (516)
++|...+.||+|+||.||++.. .+|+.||+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 4678889999999999999996 578999999986532 23355788999999999999999999999874
Q ss_pred CeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCc
Q 010186 418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497 (516)
Q Consensus 418 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 497 (516)
+..++||||+++ +|...+.. ....+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 468999999986 66666543 3345899999999999999999999998 99999999999999999999999999
Q ss_pred cccccc
Q 010186 498 ARIFAE 503 (516)
Q Consensus 498 a~~~~~ 503 (516)
++.+..
T Consensus 171 a~~~~~ 176 (351)
T 3mi9_A 171 ARAFSL 176 (351)
T ss_dssp CEECCC
T ss_pred cccccc
Confidence 987753
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=6.8e-25 Score=218.99 Aligned_cols=160 Identities=29% Similarity=0.493 Sum_probs=135.0
Q ss_pred chHHHHHhhCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcC-CCCCccceeeEEEe-
Q 010186 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVD- 416 (516)
Q Consensus 340 ~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~- 416 (516)
++.++....++|...+.||+|+||.||++.. .+++.||+|++.... ...+.+.+|+.++.++ +||||+++++++..
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 3344445677889999999999999999996 478999999987533 3456899999999999 89999999999987
Q ss_pred -----CCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEE
Q 010186 417 -----GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSK 491 (516)
Q Consensus 417 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~k 491 (516)
.+..++||||+++++|.+++... ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+|
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEE
Confidence 45789999999999999998542 2356899999999999999999999998 99999999999999999999
Q ss_pred EcccCcccccccC
Q 010186 492 ISDFGMARIFAES 504 (516)
Q Consensus 492 l~DFGla~~~~~~ 504 (516)
|+|||+++.+...
T Consensus 170 l~Dfg~~~~~~~~ 182 (326)
T 2x7f_A 170 LVDFGVSAQLDRT 182 (326)
T ss_dssp ECCCTTTC-----
T ss_pred EeeCcCceecCcC
Confidence 9999999877543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.2e-24 Score=216.69 Aligned_cols=150 Identities=27% Similarity=0.398 Sum_probs=132.3
Q ss_pred HHhhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhc--CCCCCccceeeEEEeCC----
Q 010186 345 NLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILK--LQHKNLVKLLGFCVDGD---- 418 (516)
Q Consensus 345 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~~---- 418 (516)
....++|...+.||+|+||.||++.. +++.||||++.. .....+.+|++++.. ++||||+++++++...+
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 44556789999999999999999998 589999999964 334567888888887 79999999999998876
Q ss_pred eeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhH--------cCCCCCeeeCCCCCCCeEecCCCcE
Q 010186 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH--------EDSRLRIVHRDLKASNVLLDSDMNS 490 (516)
Q Consensus 419 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH--------~~~~~~iiHrDlk~~NILld~~~~~ 490 (516)
..++||||+++|+|.+++.. ..+++.+++.++.||+.||.||| +.+ ++||||||+||||+.++.+
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCE
T ss_pred eeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCE
Confidence 78999999999999999943 35899999999999999999999 666 9999999999999999999
Q ss_pred EEcccCcccccccCC
Q 010186 491 KISDFGMARIFAESE 505 (516)
Q Consensus 491 kl~DFGla~~~~~~~ 505 (516)
||+|||+++......
T Consensus 187 kL~Dfg~~~~~~~~~ 201 (342)
T 1b6c_B 187 CIADLGLAVRHDSAT 201 (342)
T ss_dssp EECCCTTCEEEETTT
T ss_pred EEEECCCceeccccc
Confidence 999999998876554
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-24 Score=223.51 Aligned_cols=145 Identities=26% Similarity=0.374 Sum_probs=121.9
Q ss_pred CCCC-ceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhc-CCCCCccceeeEEEe----CCeeEEE
Q 010186 351 FSDS-NILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILK-LQHKNLVKLLGFCVD----GDEKLLV 423 (516)
Q Consensus 351 f~~~-~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~----~~~~~lV 423 (516)
|... ++||+|+||.||++... +++.||||++.. ...+.+|++++.+ .+||||+++++++.. ....+||
T Consensus 63 y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv 137 (400)
T 1nxk_A 63 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 137 (400)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred ceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEE
Confidence 4443 68999999999999964 688999999863 2457788888744 589999999999875 5568999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC---CCcEEEcccCcccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARI 500 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~---~~~~kl~DFGla~~ 500 (516)
|||+++|+|.+++... ....+++.++..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 138 ~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 138 MECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 9999999999999642 3346899999999999999999999998 999999999999998 78999999999987
Q ss_pred cccC
Q 010186 501 FAES 504 (516)
Q Consensus 501 ~~~~ 504 (516)
....
T Consensus 214 ~~~~ 217 (400)
T 1nxk_A 214 TTSH 217 (400)
T ss_dssp CC--
T ss_pred cCCC
Confidence 6543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=3.3e-25 Score=224.62 Aligned_cols=150 Identities=27% Similarity=0.381 Sum_probs=134.0
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
.++|...+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++..++||||+++++++..++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 456888899999999999999965 6889999999764 33445679999999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC-CCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
|+++++|.+++.. ...+++..+..++.+|+.||.|||+. + |+||||||+|||++.++.+||+|||+++.+..
T Consensus 112 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999843 34689999999999999999999985 6 99999999999999999999999999986643
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=212.26 Aligned_cols=151 Identities=35% Similarity=0.587 Sum_probs=128.9
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccc-------hHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQG-------TAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 419 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~-------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 419 (516)
.++|...+.||+|+||.||++.. .+++.||+|++....... .+.+.+|+.++.+++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 45678889999999999999996 478999999986532221 267899999999999999999999986654
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCc-----EEEcc
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN-----SKISD 494 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~-----~kl~D 494 (516)
++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ ++++||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 799999999999888754 3456899999999999999999999975 35999999999999988776 99999
Q ss_pred cCccccccc
Q 010186 495 FGMARIFAE 503 (516)
Q Consensus 495 FGla~~~~~ 503 (516)
||+++....
T Consensus 173 fg~~~~~~~ 181 (287)
T 4f0f_A 173 FGLSQQSVH 181 (287)
T ss_dssp CTTCBCCSS
T ss_pred CCccccccc
Confidence 999986544
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=2.6e-24 Score=215.18 Aligned_cols=145 Identities=23% Similarity=0.417 Sum_probs=129.6
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCC-CCCccceeeEEEe--CCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVD--GDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~--~~~~~lV~ 424 (516)
++|...+.||+|+||.||++.. .+++.||+|+++. ...+.+.+|+.++..++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5688889999999999999985 5789999999975 34567899999999996 9999999999998 56789999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC-cEEEcccCccccccc
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-NSKISDFGMARIFAE 503 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~-~~kl~DFGla~~~~~ 503 (516)
||+++++|.+++. .+++.++..++.||+.||.|||+.+ ++||||||+|||++.++ .+||+|||+++.+..
T Consensus 113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999999883 3889999999999999999999998 99999999999999776 899999999987765
Q ss_pred CC
Q 010186 504 SE 505 (516)
Q Consensus 504 ~~ 505 (516)
..
T Consensus 184 ~~ 185 (330)
T 3nsz_A 184 GQ 185 (330)
T ss_dssp TC
T ss_pred CC
Confidence 43
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.91 E-value=9.2e-25 Score=216.00 Aligned_cols=149 Identities=27% Similarity=0.484 Sum_probs=130.2
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
++|...+.||+|+||.||++... +|+.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 46778899999999999999964 78999999998655445567899999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEe---cCCCcEEEcccCccccccc
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL---DSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILl---d~~~~~kl~DFGla~~~~~ 503 (516)
++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||||+|||+ +.++.+||+|||+++....
T Consensus 89 ~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 89 SGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 99999988842 346899999999999999999999998 9999999999999 7889999999999986543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5e-25 Score=220.30 Aligned_cols=155 Identities=35% Similarity=0.553 Sum_probs=130.3
Q ss_pred hhCCCCCCceeeecCcEeEEEEEe------cCCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 419 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~------~~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 419 (516)
..++|...+.||+|+||.||++.. .+++.||||++... .......+.+|+.++++++||||+++++++...+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 456788889999999999999984 24678999999653 34456679999999999999999999999999999
Q ss_pred eEEEEEccCCCChhHHhcCCCC----CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC---CCcEEE
Q 010186 420 KLLVYEFMPNGSLDAILFDPRK----RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKI 492 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~---~~~~kl 492 (516)
.++||||+++++|.+++..... ...+++.+++.++.||+.||.|||+.+ ++||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999864321 245899999999999999999999998 999999999999984 456999
Q ss_pred cccCcccccccC
Q 010186 493 SDFGMARIFAES 504 (516)
Q Consensus 493 ~DFGla~~~~~~ 504 (516)
+|||+++.+...
T Consensus 185 ~Dfg~~~~~~~~ 196 (327)
T 2yfx_A 185 GDFGMARDIYRA 196 (327)
T ss_dssp CCCHHHHHHHC-
T ss_pred Cccccccccccc
Confidence 999999866443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=215.61 Aligned_cols=153 Identities=24% Similarity=0.449 Sum_probs=126.3
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...+.||+|+||.||++.. .+++.||+|++... .......+.+|+.++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 4678889999999999999995 57899999999752 2344567899999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 425 EFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
||+++++|.+++... .....+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+..
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999999988431 12456899999999999999999999998 99999999999999999999999999987754
Q ss_pred C
Q 010186 504 S 504 (516)
Q Consensus 504 ~ 504 (516)
.
T Consensus 189 ~ 189 (310)
T 2wqm_A 189 K 189 (310)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.3e-25 Score=237.48 Aligned_cols=141 Identities=16% Similarity=0.190 Sum_probs=111.3
Q ss_pred eeecCcEeEEEEE-ecCCcEEEEEEeccCC----------ccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEE
Q 010186 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCS----------EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 357 Lg~G~fg~Vy~~~-~~~g~~vavK~l~~~~----------~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 424 (516)
.+.|++|.+..++ ...|+.+++|.+.+.. ....++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 5566666665544 3458899999986521 22345799999999999 7999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||++|++|.+++. ..+.++.. +|+.||+.||.|||+++ ||||||||+||||++++++||+|||+|+.+..+
T Consensus 322 Eyv~G~~L~d~i~---~~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLA---AGEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHH---TTCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHH---hCCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 9999999999994 34456654 48899999999999998 999999999999999999999999999988665
Q ss_pred CC
Q 010186 505 EG 506 (516)
Q Consensus 505 ~~ 506 (516)
.+
T Consensus 393 ~~ 394 (569)
T 4azs_A 393 CS 394 (569)
T ss_dssp -C
T ss_pred Cc
Confidence 43
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=8.3e-25 Score=237.64 Aligned_cols=144 Identities=34% Similarity=0.509 Sum_probs=126.0
Q ss_pred ceeeecCcEeEEEEEec---CCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCC
Q 010186 355 NILGQGGFGPVYKGVLS---DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~---~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 429 (516)
+.||+|+||.||+|.+. .++.||||+++... ....+++.+|++++.+++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 46789999997632 3346789999999999999999999999864 558899999999
Q ss_pred CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCC
Q 010186 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 505 (516)
|+|.+++. ....+++..+..|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+..+.
T Consensus 454 g~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 454 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523 (635)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred CCHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence 99999994 3456899999999999999999999998 9999999999999999999999999999876544
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=6.9e-25 Score=217.45 Aligned_cols=150 Identities=30% Similarity=0.452 Sum_probs=124.6
Q ss_pred CCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccC
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 428 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 428 (516)
++|...+.||+|+||.||++.. .++.||+|++... ...+.|.+|++++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 4567788999999999999998 4788999998642 34567999999999999999999999876 44899999999
Q ss_pred CCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCc-EEEcccCccccccc
Q 010186 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN-SKISDFGMARIFAE 503 (516)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~-~kl~DFGla~~~~~ 503 (516)
+|+|.+++........+++..++.++.||++||.|||+....+++||||||+|||++.++. +||+|||+++.+..
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 9999999965444445789999999999999999999943234999999999999998886 79999999987654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.7e-25 Score=231.19 Aligned_cols=151 Identities=32% Similarity=0.512 Sum_probs=132.8
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
++|...++||+|+||.||++... +++.||||++.+. .......+.+|++++++++||||+++++++.+....++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 45778899999999999999964 7899999998642 23456789999999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEec---CCCcEEEcccCcccccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD---SDMNSKISDFGMARIFA 502 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld---~~~~~kl~DFGla~~~~ 502 (516)
|+++|+|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.+.
T Consensus 102 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 102 LYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 9999999888743 346899999999999999999999998 99999999999995 45679999999998876
Q ss_pred cCC
Q 010186 503 ESE 505 (516)
Q Consensus 503 ~~~ 505 (516)
...
T Consensus 176 ~~~ 178 (486)
T 3mwu_A 176 QNT 178 (486)
T ss_dssp CC-
T ss_pred CCC
Confidence 543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-24 Score=214.41 Aligned_cols=147 Identities=31% Similarity=0.515 Sum_probs=124.3
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEE------------
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV------------ 415 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~------------ 415 (516)
++|...+.||+|+||.||++... +++.||+|++...+....+.+.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 56788899999999999999965 58999999998766666778999999999999999999999874
Q ss_pred --eCCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEec-CCCcEEE
Q 010186 416 --DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD-SDMNSKI 492 (516)
Q Consensus 416 --~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld-~~~~~kl 492 (516)
+....++||||++ |+|.+++. ...+++..+..++.||+.||.|||+.+ ++||||||+|||++ +++.+||
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEE
T ss_pred ccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEE
Confidence 3467899999998 69999983 246899999999999999999999998 99999999999997 5679999
Q ss_pred cccCccccccc
Q 010186 493 SDFGMARIFAE 503 (516)
Q Consensus 493 ~DFGla~~~~~ 503 (516)
+|||+++.+..
T Consensus 163 ~Dfg~~~~~~~ 173 (320)
T 2i6l_A 163 GDFGLARIMDP 173 (320)
T ss_dssp CCCTTCBCC--
T ss_pred ccCccccccCC
Confidence 99999998754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.91 E-value=9.3e-25 Score=221.84 Aligned_cols=152 Identities=22% Similarity=0.306 Sum_probs=126.0
Q ss_pred hhCCCCCCceeeecCcEeEEEEEecC------CcEEEEEEeccCCccc-----------hHHHHHHHHHHhcCCCCCccc
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLSD------GKEVAVKRLSSCSEQG-----------TAEFTNEVLLILKLQHKNLVK 409 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~------g~~vavK~l~~~~~~~-----------~~~~~~Ei~~l~~l~H~niv~ 409 (516)
..++|...+.||+|+||.||++.... ++.||||++....... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45678888999999999999998754 4789999987543211 112445666777889999999
Q ss_pred eeeEEEeC----CeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEec
Q 010186 410 LLGFCVDG----DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD 485 (516)
Q Consensus 410 l~g~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld 485 (516)
+++++... ...+|||||+ +++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99998875 4479999999 9999999853 3356999999999999999999999998 99999999999999
Q ss_pred --CCCcEEEcccCcccccccC
Q 010186 486 --SDMNSKISDFGMARIFAES 504 (516)
Q Consensus 486 --~~~~~kl~DFGla~~~~~~ 504 (516)
.++.+||+|||+++.+...
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~ 207 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPE 207 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGG
T ss_pred cCCCCeEEEEECCcceecccC
Confidence 8899999999999887654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=228.59 Aligned_cols=152 Identities=33% Similarity=0.514 Sum_probs=134.7
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 423 (516)
.++|...++||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 346778899999999999999965 78999999986532 34567899999999999999999999999999999999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEe---cCCCcEEEcccCcccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL---DSDMNSKISDFGMARI 500 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILl---d~~~~~kl~DFGla~~ 500 (516)
|||+++|+|.+.+.. ...+++.++..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999988843 356899999999999999999999998 9999999999999 4678999999999988
Q ss_pred cccCC
Q 010186 501 FAESE 505 (516)
Q Consensus 501 ~~~~~ 505 (516)
+....
T Consensus 179 ~~~~~ 183 (484)
T 3nyv_A 179 FEASK 183 (484)
T ss_dssp BCCCC
T ss_pred ccccc
Confidence 76543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-24 Score=215.89 Aligned_cols=149 Identities=31% Similarity=0.426 Sum_probs=126.7
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC--------ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--------EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 419 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 419 (516)
++|...+.||+|+||.||++... +++.||||++.... ......+.+|++++++++||||+++++++...+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 46788899999999999999964 68899999986522 122346889999999999999999999987655
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCc---EEEcccC
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN---SKISDFG 496 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~---~kl~DFG 496 (516)
.++||||+++++|.+++. ....+++.....++.||+.||.|||+.+ ++||||||+|||++.++. +||+|||
T Consensus 89 ~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 899999999999999884 3456899999999999999999999998 999999999999987654 9999999
Q ss_pred cccccccC
Q 010186 497 MARIFAES 504 (516)
Q Consensus 497 la~~~~~~ 504 (516)
+++.+...
T Consensus 163 ~~~~~~~~ 170 (322)
T 2ycf_A 163 HSKILGET 170 (322)
T ss_dssp TCEECCCC
T ss_pred cceecccc
Confidence 99877543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.5e-25 Score=221.73 Aligned_cols=158 Identities=30% Similarity=0.422 Sum_probs=134.9
Q ss_pred HHhhCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCC-CCCccceeeEEEe------
Q 010186 345 NLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVD------ 416 (516)
Q Consensus 345 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~------ 416 (516)
++...+|...++||+|+||.||++.. .+++.||+|++........+.+.+|+.++.++. ||||+++++++..
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 34456788889999999999999995 478999999997666666778999999999995 9999999999953
Q ss_pred --CCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcc
Q 010186 417 --GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD 494 (516)
Q Consensus 417 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~D 494 (516)
....++||||++ |+|.+++........+++.+++.++.||+.||.|||+.+ ++++||||||+|||++.++.+||+|
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEec
Confidence 334789999996 788888754334557999999999999999999999874 3599999999999999999999999
Q ss_pred cCcccccccC
Q 010186 495 FGMARIFAES 504 (516)
Q Consensus 495 FGla~~~~~~ 504 (516)
||+++.+...
T Consensus 182 fg~~~~~~~~ 191 (337)
T 3ll6_A 182 FGSATTISHY 191 (337)
T ss_dssp CTTCBCCSSC
T ss_pred Cccceecccc
Confidence 9999887654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.2e-24 Score=214.14 Aligned_cols=151 Identities=28% Similarity=0.479 Sum_probs=130.0
Q ss_pred hhCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
..++|...+.||+|+||.||++... +|+.||+|++... ...+.+.+|+.++..++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4567888899999999999999965 5899999999753 345679999999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
|+++++|.+++.. ....+++..+..++.+|+.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+...
T Consensus 105 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 105 YCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp CCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 9999999999842 2356899999999999999999999998 999999999999999999999999999877654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2e-24 Score=209.25 Aligned_cols=152 Identities=24% Similarity=0.381 Sum_probs=132.1
Q ss_pred hCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLLV 423 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV 423 (516)
.++|...+.||+|+||.||++... ++.||||++... +....+.|.+|+.++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 346777899999999999999984 889999999753 334456799999999999999999999999887 678999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
|||+++|+|.+++... ....+++.++..++.||+.||.|||+.+ ++++||||||+|||++.++.+||.|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 9999999999999642 3336899999999999999999999874 459999999999999999999999998876543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=221.51 Aligned_cols=149 Identities=30% Similarity=0.464 Sum_probs=124.5
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCC------
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD------ 418 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 418 (516)
.++|...+.||+|+||.||++.. .+|+.||||++... +....+.+.+|+++++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 35688889999999999999996 57899999999652 2334567899999999999999999999998763
Q ss_pred eeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcc
Q 010186 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (516)
Q Consensus 419 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 498 (516)
..++||||+ +++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 8899999843 45899999999999999999999998 999999999999999999999999999
Q ss_pred cccccC
Q 010186 499 RIFAES 504 (516)
Q Consensus 499 ~~~~~~ 504 (516)
+.....
T Consensus 176 ~~~~~~ 181 (367)
T 1cm8_A 176 RQADSE 181 (367)
T ss_dssp EECCSS
T ss_pred cccccc
Confidence 986543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=214.31 Aligned_cols=149 Identities=28% Similarity=0.497 Sum_probs=131.0
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEe-----------
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD----------- 416 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----------- 416 (516)
++|...+.||+|+||.||++.. .+++.||+|++.. .....+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 4677889999999999999996 4789999999965 23445678999999999999999999999865
Q ss_pred --CCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcc
Q 010186 417 --GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD 494 (516)
Q Consensus 417 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~D 494 (516)
.+..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred ccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEee
Confidence 3467999999999999999953 3345788999999999999999999998 99999999999999999999999
Q ss_pred cCccccccc
Q 010186 495 FGMARIFAE 503 (516)
Q Consensus 495 FGla~~~~~ 503 (516)
||+++.+..
T Consensus 160 fg~~~~~~~ 168 (303)
T 1zy4_A 160 FGLAKNVHR 168 (303)
T ss_dssp CCCCSCTTC
T ss_pred Ccchhhccc
Confidence 999987653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-25 Score=227.42 Aligned_cols=151 Identities=15% Similarity=0.186 Sum_probs=124.1
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC---CccchHHHHHHH---HHHhcCCCCCcccee-------eE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEV---LLILKLQHKNLVKLL-------GF 413 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei---~~l~~l~H~niv~l~-------g~ 413 (516)
.++|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+ +++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 45677889999999999999995 57999999999742 334457789999 555666899999998 66
Q ss_pred EEeCCe-----------------eEEEEEccCCCChhHHhcCCC----CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCe
Q 010186 414 CVDGDE-----------------KLLVYEFMPNGSLDAILFDPR----KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472 (516)
Q Consensus 414 ~~~~~~-----------------~~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i 472 (516)
+...+. .+|||||+ +|+|.+++.... ....+++..++.|+.||+.||.|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 665532 78999999 689999885311 1223456888899999999999999998 9
Q ss_pred eeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 473 VHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 473 iHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
+||||||+||||+.++.+||+|||+++...
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~ 257 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC
Confidence 999999999999999999999999998644
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=3.1e-24 Score=211.43 Aligned_cols=151 Identities=28% Similarity=0.477 Sum_probs=130.2
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
++|...+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (299)
T 2r3i_A 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence 46778899999999999999965 68999999986532 2345678999999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
|++ ++|.+++... ....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+...
T Consensus 83 ~~~-~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 156 (299)
T 2r3i_A 83 FLH-QDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 156 (299)
T ss_dssp CCS-EEHHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ccc-CCHHHHHHhh-hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHeEEcCCCCEEECcchhhhhccCC
Confidence 998 6998888542 2345889999999999999999999998 999999999999999999999999999876543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.8e-24 Score=210.99 Aligned_cols=151 Identities=28% Similarity=0.414 Sum_probs=129.6
Q ss_pred CCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEe----CCeeEE
Q 010186 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD----GDEKLL 422 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~l 422 (516)
.|...+.||+|+||.||+|.. .++..||+|.+... +....+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 356678899999999999996 46789999998652 34456679999999999999999999999875 345899
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEec-CCCcEEEcccCccccc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD-SDMNSKISDFGMARIF 501 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld-~~~~~kl~DFGla~~~ 501 (516)
||||+++++|.+++. ....+++..+..++.||+.||.|||+.+ .+++||||||+|||++ .++.+||+|||+++..
T Consensus 107 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 107 VTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEecCCCCHHHHHH---HccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 999999999999984 2356899999999999999999999874 3599999999999997 7899999999999765
Q ss_pred ccC
Q 010186 502 AES 504 (516)
Q Consensus 502 ~~~ 504 (516)
...
T Consensus 183 ~~~ 185 (290)
T 1t4h_A 183 RAS 185 (290)
T ss_dssp CTT
T ss_pred ccc
Confidence 543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-24 Score=217.03 Aligned_cols=147 Identities=34% Similarity=0.556 Sum_probs=122.5
Q ss_pred hhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHH--HhcCCCCCccceeeEEEe-----CCe
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLL--ILKLQHKNLVKLLGFCVD-----GDE 419 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~--l~~l~H~niv~l~g~~~~-----~~~ 419 (516)
..++|...+.||+|+||.||+|.. +++.||||++... ....+..|.++ +..++||||+++++.+.. ...
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 345788889999999999999987 6899999999753 23445555555 445899999999986543 225
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC---------CCCCeeeCCCCCCCeEecCCCcE
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED---------SRLRIVHRDLKASNVLLDSDMNS 490 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~---------~~~~iiHrDlk~~NILld~~~~~ 490 (516)
.++||||+++|+|.+++.. ...++..+..++.||++||.|||+. + |+||||||+||||+.++.+
T Consensus 87 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp EEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCE
T ss_pred EEEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcE
Confidence 6899999999999999943 2358999999999999999999998 6 9999999999999999999
Q ss_pred EEcccCcccccccC
Q 010186 491 KISDFGMARIFAES 504 (516)
Q Consensus 491 kl~DFGla~~~~~~ 504 (516)
||+|||+++.+...
T Consensus 160 kL~DFG~a~~~~~~ 173 (336)
T 3g2f_A 160 VISDFGLSMRLTGN 173 (336)
T ss_dssp EECCCTTCEECSSS
T ss_pred EEeeccceeecccc
Confidence 99999999887643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=218.78 Aligned_cols=150 Identities=25% Similarity=0.454 Sum_probs=130.6
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeC-----Cee
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-----DEK 420 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~ 420 (516)
.++|...+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 357888899999999999999954 68899999997533 33446789999999999999999999999765 358
Q ss_pred EEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
++||||++ |+|.+++.. ..+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999998 589888843 35899999999999999999999998 99999999999999999999999999988
Q ss_pred cccCC
Q 010186 501 FAESE 505 (516)
Q Consensus 501 ~~~~~ 505 (516)
.....
T Consensus 178 ~~~~~ 182 (364)
T 3qyz_A 178 ADPDH 182 (364)
T ss_dssp CCGGG
T ss_pred cCCCC
Confidence 76543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=218.69 Aligned_cols=150 Identities=19% Similarity=0.270 Sum_probs=123.6
Q ss_pred hCCCCCCceeeecCcEeEEEEEec----CCcEEEEEEeccCCcc-----------chHHHHHHHHHHhcCCCCCccceee
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS----DGKEVAVKRLSSCSEQ-----------GTAEFTNEVLLILKLQHKNLVKLLG 412 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~----~g~~vavK~l~~~~~~-----------~~~~~~~Ei~~l~~l~H~niv~l~g 412 (516)
.++|...+.||+|+||.||++... ++..+|+|++...... ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 457888899999999999999975 5778999998754321 2234678889999999999999999
Q ss_pred EEEe----CCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC
Q 010186 413 FCVD----GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM 488 (516)
Q Consensus 413 ~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~ 488 (516)
++.. ....++||||+ +++|.+++.. ...+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 67899999999 9999999843 337999999999999999999999998 99999999999999887
Q ss_pred --cEEEcccCcccccccC
Q 010186 489 --NSKISDFGMARIFAES 504 (516)
Q Consensus 489 --~~kl~DFGla~~~~~~ 504 (516)
.+||+|||+++.+...
T Consensus 189 ~~~~kL~Dfg~a~~~~~~ 206 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPN 206 (345)
T ss_dssp TTSEEECCCTTCEESSGG
T ss_pred CCcEEEEeCCCceecccc
Confidence 9999999999887543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.91 E-value=3e-24 Score=219.66 Aligned_cols=153 Identities=25% Similarity=0.389 Sum_probs=125.3
Q ss_pred HHhhCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeC------
Q 010186 345 NLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG------ 417 (516)
Q Consensus 345 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 417 (516)
+...++|...+.||+|+||.||++.. .+|+.||+|++.... ....+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567889999999999999999995 578999999986532 2234799999999999999999998543
Q ss_pred --------------------------------CeeEEEEEccCCCChhHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHh
Q 010186 418 --------------------------------DEKLLVYEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYL 464 (516)
Q Consensus 418 --------------------------------~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yL 464 (516)
...++||||++ |+|.+.+... .....+++..+..++.||++||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 23789999998 4776665321 2345699999999999999999999
Q ss_pred HcCCCCCeeeCCCCCCCeEec-CCCcEEEcccCcccccccCC
Q 010186 465 HEDSRLRIVHRDLKASNVLLD-SDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 465 H~~~~~~iiHrDlk~~NILld-~~~~~kl~DFGla~~~~~~~ 505 (516)
|+.+ |+||||||+|||++ .++.+||+|||+++.+....
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 196 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE 196 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC
Confidence 9988 99999999999998 68899999999999875544
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.91 E-value=6.2e-25 Score=215.34 Aligned_cols=156 Identities=24% Similarity=0.322 Sum_probs=121.2
Q ss_pred HhhCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC-ccc-hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 010186 346 LATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS-EQG-TAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 346 ~~~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~-~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 422 (516)
+..++|...+.||+|+||.||++.. .+++.||+|++.... ... .+.+.++...++.++||||+++++++.+++..++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 3456788889999999999999996 578999999997532 222 3334555566888899999999999999999999
Q ss_pred EEEccCCCChhHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcC-CCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 423 VYEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
||||+++ +|.+++... .....+++..+..++.||+.||.|||++ + ++||||||+|||++.++.+||+|||+++.
T Consensus 84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 9999985 877665321 2345699999999999999999999997 7 99999999999999999999999999987
Q ss_pred cccCC
Q 010186 501 FAESE 505 (516)
Q Consensus 501 ~~~~~ 505 (516)
+....
T Consensus 160 ~~~~~ 164 (290)
T 3fme_A 160 LVDDV 164 (290)
T ss_dssp -----
T ss_pred ccccc
Confidence 75543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-24 Score=222.26 Aligned_cols=150 Identities=26% Similarity=0.433 Sum_probs=125.2
Q ss_pred CCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCe------eEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE------KLL 422 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~------~~l 422 (516)
.+|...++||+|+||.||++....+..+|+|++..... ...+|+++++.++||||+++++++...+. .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 45778899999999999999987777799998865322 22479999999999999999999965443 789
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEec-CCCcEEEcccCccccc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD-SDMNSKISDFGMARIF 501 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld-~~~~~kl~DFGla~~~ 501 (516)
||||++++.+..+.........+++..+..++.||++||.|||+.+ |+||||||+||||+ .++.+||+|||+|+.+
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999998665544422233557899999999999999999999998 99999999999999 7899999999999987
Q ss_pred ccCC
Q 010186 502 AESE 505 (516)
Q Consensus 502 ~~~~ 505 (516)
....
T Consensus 193 ~~~~ 196 (394)
T 4e7w_A 193 IAGE 196 (394)
T ss_dssp CTTC
T ss_pred cCCC
Confidence 5544
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.91 E-value=5.3e-24 Score=208.97 Aligned_cols=144 Identities=12% Similarity=0.075 Sum_probs=126.7
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 423 (516)
.++|...+.||+|+||.||++... +++.||||++.... ....+.+.+|+..+.+++||||+++++++.+.+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 356888899999999999999965 58999999997632 23346799999999999999999999999999999999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 499 (516)
|||+++++|.+++.. + ....+...++.||+.||.|||+++ |+||||||+||||+.++.+||+++|...
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~~~ 177 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPATMP 177 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCCCT
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEeccccC
Confidence 999999999999832 1 355678899999999999999998 9999999999999999999999887653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.8e-24 Score=211.40 Aligned_cols=152 Identities=30% Similarity=0.480 Sum_probs=129.5
Q ss_pred hhCCCCCCceeeecCcEeEEEEEecC----CcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLSD----GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 421 (516)
..++|...+.||+|+||.||++...+ +..||+|.+... .....+.+.+|+.+++.++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34567788999999999999998543 236999998764 33456779999999999999999999999765 4579
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+||||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++..
T Consensus 89 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999853 2345899999999999999999999998 999999999999999999999999999877
Q ss_pred ccC
Q 010186 502 AES 504 (516)
Q Consensus 502 ~~~ 504 (516)
...
T Consensus 164 ~~~ 166 (281)
T 3cc6_A 164 EDE 166 (281)
T ss_dssp ---
T ss_pred ccc
Confidence 554
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.5e-24 Score=236.49 Aligned_cols=148 Identities=22% Similarity=0.345 Sum_probs=128.3
Q ss_pred hCCCCCCceeeecCcEeEEEEEec--CCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCe-----
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS--DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE----- 419 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~--~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 419 (516)
.++|...+.||+|+||.||++... +++.||||++... .......+.+|++++.+++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 467889999999999999999964 6899999998653 33445678999999999999999999999987655
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccc
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 499 (516)
.||||||+++++|.+++.. .+++.+++.++.||+.||.|||+++ |+||||||+||||+.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999887632 5899999999999999999999998 9999999999999886 99999999998
Q ss_pred ccccC
Q 010186 500 IFAES 504 (516)
Q Consensus 500 ~~~~~ 504 (516)
.+...
T Consensus 230 ~~~~~ 234 (681)
T 2pzi_A 230 RINSF 234 (681)
T ss_dssp ETTCC
T ss_pred hcccC
Confidence 87654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=2e-24 Score=219.65 Aligned_cols=148 Identities=30% Similarity=0.463 Sum_probs=115.4
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeC------C
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG------D 418 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~ 418 (516)
.++|...+.||+|+||.||++.. .+|+.||||++... +....+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 36788889999999999999984 57899999999652 233456788999999999999999999999754 4
Q ss_pred eeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcc
Q 010186 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (516)
Q Consensus 419 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 498 (516)
..++|+||+ +++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 579999999 6899888732 46899999999999999999999998 999999999999999999999999999
Q ss_pred ccccc
Q 010186 499 RIFAE 503 (516)
Q Consensus 499 ~~~~~ 503 (516)
+....
T Consensus 180 ~~~~~ 184 (367)
T 2fst_X 180 RHTAD 184 (367)
T ss_dssp -----
T ss_pred ccccc
Confidence 87654
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.91 E-value=2e-24 Score=178.23 Aligned_cols=103 Identities=24% Similarity=0.419 Sum_probs=92.9
Q ss_pred ccccccccCCCChHHHHHHHHHHHHHHHHHhccCCCCCccccccccCCCCCceEEEecccCCCChhhHHHHHHHHHHHHh
Q 010186 138 NIPKYNRLNISEPERYRSVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATADIL 217 (516)
Q Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~a~~~~~~~~~~~vyglaQC~~Dls~~~C~~Cl~~a~~~~~ 217 (516)
.+..|+..+++.++.|+.+++.+|++|...++. +..+|+++..+..+.++||||+||+||+++++|+.||+.++.+++
T Consensus 6 v~~~Cn~~~~t~~s~f~~nl~~ll~~L~~~a~~--s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~~ 83 (108)
T 3a2e_A 6 VSSACNTQKIPSGSPFNRNLRAMLADLRQNTAF--SGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRIF 83 (108)
T ss_dssp EEEEECSSBCCTTCTHHHHHHHHHHHHHHHGGG--TTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTHH
T ss_pred eeeecCCCccCCCChHHHHHHHHHHHHHhhCcc--ccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHHH
Confidence 456678889998999999999999999999876 445677777665667899999999999999999999999999999
Q ss_pred hhcCCCCCcEEecccccceeeeccc
Q 010186 218 SCCYFSRGARLLSRNCYLRYELYAF 242 (516)
Q Consensus 218 ~~c~~~~g~~v~~~~C~lr~~~~~f 242 (516)
++|++++||+||+++|+||||.++|
T Consensus 84 ~~C~~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 84 SICNNAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp HHTTSBSSEEEEETTEEEEEESSCC
T ss_pred HHCCCCceEEEECCCEEEEEeCCcC
Confidence 9999999999999999999999987
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4e-24 Score=215.87 Aligned_cols=149 Identities=26% Similarity=0.481 Sum_probs=129.5
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeC-----Cee
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-----DEK 420 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~ 420 (516)
.++|...+.||+|+||.||++... +|+.||||++.... ......+.+|+.+++.++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 357888899999999999999964 68899999997533 33456788999999999999999999988764 568
Q ss_pred EEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
++||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 589888843 35899999999999999999999998 99999999999999999999999999988
Q ss_pred cccC
Q 010186 501 FAES 504 (516)
Q Consensus 501 ~~~~ 504 (516)
+...
T Consensus 162 ~~~~ 165 (353)
T 2b9h_A 162 IDES 165 (353)
T ss_dssp CC--
T ss_pred cccc
Confidence 7543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.9e-24 Score=210.77 Aligned_cols=156 Identities=28% Similarity=0.423 Sum_probs=130.1
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEe--CCeeEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD--GDEKLLV 423 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV 423 (516)
++|...+.||+|+||.||++... +++.|++|++... +....+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 46778899999999999999964 6899999999753 33445679999999999999999999998864 5678999
Q ss_pred EEccCCCChhHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHhHcCC--CCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 424 YEFMPNGSLDAILFDPR-KRGILCWRKRTNIVNGIAKGMLYLHEDS--RLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ..+++||||||+|||++.++.+||+|||+++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~ 165 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence 99999999999985322 2345899999999999999999999875 23499999999999999999999999999987
Q ss_pred cccC
Q 010186 501 FAES 504 (516)
Q Consensus 501 ~~~~ 504 (516)
+...
T Consensus 166 ~~~~ 169 (279)
T 2w5a_A 166 LNHD 169 (279)
T ss_dssp C---
T ss_pred eccc
Confidence 6543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=7.9e-24 Score=207.52 Aligned_cols=152 Identities=32% Similarity=0.505 Sum_probs=133.7
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
.++|...+.||+|+||.||++... +++.||+|++... .....+.+.+|++++++++||||+++++++...+..++|+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 356888899999999999999965 6899999998653 3345678999999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCC---CcEEEcccCccccc
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD---MNSKISDFGMARIF 501 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~---~~~kl~DFGla~~~ 501 (516)
||+++++|.+++.. ...+++.++..++.||+.||.|||+.+ ++||||||+||+++.+ ..+||+|||+++.+
T Consensus 101 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 101 ELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 99999999888743 346899999999999999999999998 9999999999999764 46999999999877
Q ss_pred ccCC
Q 010186 502 AESE 505 (516)
Q Consensus 502 ~~~~ 505 (516)
....
T Consensus 175 ~~~~ 178 (287)
T 2wei_A 175 QQNT 178 (287)
T ss_dssp CCCS
T ss_pred cCCC
Confidence 6543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=2.9e-24 Score=222.50 Aligned_cols=148 Identities=30% Similarity=0.488 Sum_probs=120.9
Q ss_pred CCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeC----C--eeEE
Q 010186 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG----D--EKLL 422 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~----~--~~~l 422 (516)
+|...++||+|+||.||++... +|+.||||++.... ..+.+|+++++.++||||+++++++... + ..++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 4677789999999999999974 68999999986532 2235799999999999999999998642 2 2578
Q ss_pred EEEccCCCChhHHhcC-CCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCC-CcEEEcccCcccc
Q 010186 423 VYEFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGMARI 500 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~-~~~kl~DFGla~~ 500 (516)
||||+++ +|..++.. ......+++..+..++.||++||.|||+.+ |+||||||+||||+.+ +.+||+|||+++.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999986 45444321 123456899999999999999999999988 9999999999999965 5789999999998
Q ss_pred cccCC
Q 010186 501 FAESE 505 (516)
Q Consensus 501 ~~~~~ 505 (516)
+....
T Consensus 207 ~~~~~ 211 (420)
T 1j1b_A 207 LVRGE 211 (420)
T ss_dssp CCTTC
T ss_pred cccCC
Confidence 75543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.90 E-value=4.5e-24 Score=216.05 Aligned_cols=160 Identities=26% Similarity=0.291 Sum_probs=121.1
Q ss_pred HHHHHhhCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCe-
Q 010186 342 ETLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE- 419 (516)
Q Consensus 342 ~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~- 419 (516)
+......++|...+.||+|+||.||++.. .+++.||||++... ......+.+|++.+..++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 34455668899999999999999999996 46899999998653 2334567788888999999999999999976443
Q ss_pred ------eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhH--cCCCCCeeeCCCCCCCeEecC-CCcE
Q 010186 420 ------KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH--EDSRLRIVHRDLKASNVLLDS-DMNS 490 (516)
Q Consensus 420 ------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH--~~~~~~iiHrDlk~~NILld~-~~~~ 490 (516)
.++||||++++.+..+.........+++..+..++.||+.||.||| +.+ |+||||||+||||+. ++.+
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 7899999987543333221234556889999999999999999999 776 999999999999997 8999
Q ss_pred EEcccCcccccccCC
Q 010186 491 KISDFGMARIFAESE 505 (516)
Q Consensus 491 kl~DFGla~~~~~~~ 505 (516)
||+|||+++.+....
T Consensus 172 kl~Dfg~a~~~~~~~ 186 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSE 186 (360)
T ss_dssp EECCCTTCBCCCTTS
T ss_pred EEeeCCCceecCCCC
Confidence 999999999876554
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=6.8e-24 Score=216.09 Aligned_cols=147 Identities=29% Similarity=0.411 Sum_probs=123.6
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCC------e
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD------E 419 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~ 419 (516)
++|...+.||+|+||.||++.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 5788889999999999999985 46889999999752 3344567889999999999999999999998765 6
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccc
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 499 (516)
.++||||+++ +|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred eEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 8999999975 6777773 24889999999999999999999998 9999999999999999999999999998
Q ss_pred ccccC
Q 010186 500 IFAES 504 (516)
Q Consensus 500 ~~~~~ 504 (516)
.....
T Consensus 176 ~~~~~ 180 (371)
T 2xrw_A 176 TAGTS 180 (371)
T ss_dssp -----
T ss_pred ccccc
Confidence 77543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-24 Score=214.82 Aligned_cols=156 Identities=22% Similarity=0.321 Sum_probs=132.9
Q ss_pred HHHHHhhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccC--CccchHHHHHHHHHHhcCC--CCCccceeeEEEeC
Q 010186 342 ETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQ--HKNLVKLLGFCVDG 417 (516)
Q Consensus 342 ~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~ 417 (516)
+.+.+..++|...+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++ ||||+++++++...
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 3444566778889999999999999999888999999998653 3345678999999999996 59999999999999
Q ss_pred CeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCc
Q 010186 418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497 (516)
Q Consensus 418 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 497 (516)
+..++||| +.+++|.+++.. ...+++.++..++.||++||.|||+.+ ++||||||+|||+++ +.+||+|||+
T Consensus 101 ~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~ 172 (313)
T 3cek_A 101 QYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGI 172 (313)
T ss_dssp SEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred CEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccc
Confidence 99999999 678899999843 346899999999999999999999998 999999999999964 8999999999
Q ss_pred ccccccCC
Q 010186 498 ARIFAESE 505 (516)
Q Consensus 498 a~~~~~~~ 505 (516)
++.+....
T Consensus 173 ~~~~~~~~ 180 (313)
T 3cek_A 173 ANQMQPDT 180 (313)
T ss_dssp SCC-----
T ss_pred cccccCcc
Confidence 99876543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=9.7e-24 Score=208.26 Aligned_cols=145 Identities=26% Similarity=0.366 Sum_probs=125.3
Q ss_pred CCCCC-ceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHH-hcCCCCCccceeeEEEe----CCeeEE
Q 010186 350 NFSDS-NILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLI-LKLQHKNLVKLLGFCVD----GDEKLL 422 (516)
Q Consensus 350 ~f~~~-~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l-~~l~H~niv~l~g~~~~----~~~~~l 422 (516)
+|... +.||+|+||.||++.. .+++.||+|++.. ...+.+|+.++ +.++||||+++++++.. ....++
T Consensus 18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 92 (299)
T 3m2w_A 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 92 (299)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEE
Confidence 34444 7799999999999996 5789999999864 34677888888 55699999999999987 667899
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC---CCcEEEcccCccc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMAR 499 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~---~~~~kl~DFGla~ 499 (516)
||||+++|+|.+++... ....+++..+..++.||+.||.|||+.+ ++||||||+|||++. ++.+||+|||+++
T Consensus 93 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 93 VMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 99999999999998542 3346899999999999999999999998 999999999999998 7889999999998
Q ss_pred cccc
Q 010186 500 IFAE 503 (516)
Q Consensus 500 ~~~~ 503 (516)
....
T Consensus 169 ~~~~ 172 (299)
T 3m2w_A 169 ETTG 172 (299)
T ss_dssp ECTT
T ss_pred cccc
Confidence 7654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.90 E-value=9.8e-24 Score=210.48 Aligned_cols=153 Identities=29% Similarity=0.470 Sum_probs=129.0
Q ss_pred hhCCCCCCceeeecCcEeEEEEEe--cCCcEEEEEEeccCC--ccchHHHHHHHHHHhcC---CCCCccceeeEEE----
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVL--SDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKL---QHKNLVKLLGFCV---- 415 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~--~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~---- 415 (516)
..++|...+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 346788899999999999999997 468899999986522 22344677888877766 8999999999987
Q ss_pred -eCCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcc
Q 010186 416 -DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD 494 (516)
Q Consensus 416 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~D 494 (516)
.....++||||++ |+|.+++... ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4566899999998 6999888542 2345899999999999999999999998 99999999999999999999999
Q ss_pred cCcccccccC
Q 010186 495 FGMARIFAES 504 (516)
Q Consensus 495 FGla~~~~~~ 504 (516)
||+++.+...
T Consensus 164 fg~~~~~~~~ 173 (326)
T 1blx_A 164 FGLARIYSFQ 173 (326)
T ss_dssp CCSCCCCCGG
T ss_pred CcccccccCC
Confidence 9999877543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.6e-24 Score=209.90 Aligned_cols=151 Identities=32% Similarity=0.481 Sum_probs=125.0
Q ss_pred hhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeC-CeeEEEEE
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-DEKLLVYE 425 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~E 425 (516)
..++|...+.||+|+||.||++.. +|+.||+|+++.. ...+.+.+|+.++++++||||+++++++.+. +..++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 345678889999999999999987 4889999998753 3556799999999999999999999997655 46899999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
|+++++|.+++... ....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 96 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp CCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred cCCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 99999999998431 1223789999999999999999999998 999999999999999999999999999876543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.8e-24 Score=217.25 Aligned_cols=147 Identities=18% Similarity=0.295 Sum_probs=127.5
Q ss_pred hCCCCCCceeeecCcEeEEEEEecC---------CcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccc---------
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLSD---------GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVK--------- 409 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~--------- 409 (516)
.++|...+.||+|+||.||++.... ++.||+|++... +.+.+|++++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3578888999999999999999653 789999998753 46889999999999999987
Q ss_pred ------eeeEEEe-CCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCe
Q 010186 410 ------LLGFCVD-GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNV 482 (516)
Q Consensus 410 ------l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NI 482 (516)
+++++.. ....++||||+ +++|.+++... ....+++.+++.++.||+.||.|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6777776 67889999999 99999999532 2356999999999999999999999998 99999999999
Q ss_pred EecCCC--cEEEcccCcccccccC
Q 010186 483 LLDSDM--NSKISDFGMARIFAES 504 (516)
Q Consensus 483 Lld~~~--~~kl~DFGla~~~~~~ 504 (516)
|++.++ .+||+|||+++.+...
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~ 214 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPS 214 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGG
T ss_pred EEcCCCCceEEEecCcceeeccCC
Confidence 999998 9999999999887654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.1e-24 Score=210.45 Aligned_cols=152 Identities=33% Similarity=0.497 Sum_probs=124.0
Q ss_pred hCCCCCCceeeecCcEeEEEEEec--CCc--EEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS--DGK--EVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK 420 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~--~g~--~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 420 (516)
.++|...+.||+|+||.||++.+. +++ .||+|+++.. .....+.+.+|++++.+++||||+++++++...+ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 356778899999999999999853 333 6899988753 2344678999999999999999999999998765 8
Q ss_pred EEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
++|+||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHh--ccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 999999999999998853 2345899999999999999999999998 99999999999999999999999999988
Q ss_pred cccCC
Q 010186 501 FAESE 505 (516)
Q Consensus 501 ~~~~~ 505 (516)
+....
T Consensus 171 ~~~~~ 175 (291)
T 1u46_A 171 LPQND 175 (291)
T ss_dssp CCC-C
T ss_pred ccccc
Confidence 76543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.3e-24 Score=214.44 Aligned_cols=155 Identities=29% Similarity=0.497 Sum_probs=132.0
Q ss_pred chHHHHHhhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 010186 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG 417 (516)
Q Consensus 340 ~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 417 (516)
..+++++..++|...+.||+|+||.||++...+ .+++|+++.. .....+.+.+|+.++++++||||+++++++.+.
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 445556677889999999999999999998743 5999998653 233456788999999999999999999999999
Q ss_pred CeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCc
Q 010186 418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497 (516)
Q Consensus 418 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 497 (516)
+..++||||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ ++||||||+|||++ ++.+||+|||+
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSC
T ss_pred CceEEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCC
Confidence 999999999999999999953 2346899999999999999999999998 99999999999998 67999999999
Q ss_pred ccccc
Q 010186 498 ARIFA 502 (516)
Q Consensus 498 a~~~~ 502 (516)
++...
T Consensus 176 ~~~~~ 180 (319)
T 2y4i_B 176 FSISG 180 (319)
T ss_dssp CC---
T ss_pred ccccc
Confidence 87654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=6.5e-24 Score=231.49 Aligned_cols=157 Identities=26% Similarity=0.454 Sum_probs=134.4
Q ss_pred HHHHHhhCCCCCCceeeecCcEeEEEEEecC----CcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEe
Q 010186 342 ETLNLATSNFSDSNILGQGGFGPVYKGVLSD----GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416 (516)
Q Consensus 342 ~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 416 (516)
...++..++|...+.||+|+||.||+|.... +..||+|++... .....+.|.+|+.++++++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 3445556778889999999999999998642 457999998753 3334567999999999999999999999985
Q ss_pred CCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccC
Q 010186 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496 (516)
Q Consensus 417 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 496 (516)
.+..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred cCceEEEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecC
Confidence 4568999999999999999853 2345899999999999999999999998 9999999999999999999999999
Q ss_pred cccccccC
Q 010186 497 MARIFAES 504 (516)
Q Consensus 497 la~~~~~~ 504 (516)
+++.+...
T Consensus 537 ~a~~~~~~ 544 (656)
T 2j0j_A 537 LSRYMEDS 544 (656)
T ss_dssp CCCSCCC-
T ss_pred CCeecCCC
Confidence 99987544
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-23 Score=216.11 Aligned_cols=145 Identities=28% Similarity=0.455 Sum_probs=113.1
Q ss_pred CceeeecCcEeEEEEEec---CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEe--CCeeEEEEEccC
Q 010186 354 SNILGQGGFGPVYKGVLS---DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD--GDEKLLVYEFMP 428 (516)
Q Consensus 354 ~~~Lg~G~fg~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~~ 428 (516)
+++||+|+||.||++... +++.||+|++... .....+.+|+.+++.++||||+++++++.. ....+|||||++
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 468999999999999965 5789999999753 234578899999999999999999999965 667899999997
Q ss_pred CCChhHHhcC------CCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEe----cCCCcEEEcccCcc
Q 010186 429 NGSLDAILFD------PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL----DSDMNSKISDFGMA 498 (516)
Q Consensus 429 ~gsL~~~l~~------~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILl----d~~~~~kl~DFGla 498 (516)
+ +|.+++.. ......+++..+..++.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||++
T Consensus 104 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 104 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp E-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred C-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 5 77666531 112235899999999999999999999998 9999999999999 67789999999999
Q ss_pred cccccC
Q 010186 499 RIFAES 504 (516)
Q Consensus 499 ~~~~~~ 504 (516)
+.+...
T Consensus 180 ~~~~~~ 185 (405)
T 3rgf_A 180 RLFNSP 185 (405)
T ss_dssp C-----
T ss_pred eecCCC
Confidence 987643
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-23 Score=213.47 Aligned_cols=148 Identities=32% Similarity=0.484 Sum_probs=125.9
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCee----
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK---- 420 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~---- 420 (516)
.++|...+.||+|+||.||++.. .+|+.||||++... +....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 35788889999999999999995 46899999999753 233456789999999999999999999999887655
Q ss_pred --EEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcc
Q 010186 421 --LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (516)
Q Consensus 421 --~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 498 (516)
++||||++ ++|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999998 68888772 23899999999999999999999998 999999999999999999999999999
Q ss_pred cccccC
Q 010186 499 RIFAES 504 (516)
Q Consensus 499 ~~~~~~ 504 (516)
+.....
T Consensus 192 ~~~~~~ 197 (371)
T 4exu_A 192 RHADAE 197 (371)
T ss_dssp ------
T ss_pred cccccC
Confidence 876543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.1e-23 Score=204.86 Aligned_cols=150 Identities=22% Similarity=0.405 Sum_probs=126.2
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEE-EeCCeeEEEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC-VDGDEKLLVYE 425 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~-~~~~~~~lV~E 425 (516)
.++|...+.||+|+||.||++.. .+++.||||++.... ....+.+|+.++..++|++++..++.+ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 46788999999999999999995 578899999876532 234688999999999988877776665 56778899999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEe---cCCCcEEEcccCcccccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL---DSDMNSKISDFGMARIFA 502 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILl---d~~~~~kl~DFGla~~~~ 502 (516)
|+ +++|.+++.. ....+++.++..++.||+.||.|||+.+ ++||||||+|||+ +.++.+||+|||+++.+.
T Consensus 86 ~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 86 LL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred cc-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 99 9999999853 2345899999999999999999999998 9999999999999 788999999999999876
Q ss_pred cCC
Q 010186 503 ESE 505 (516)
Q Consensus 503 ~~~ 505 (516)
...
T Consensus 160 ~~~ 162 (296)
T 4hgt_A 160 DAR 162 (296)
T ss_dssp CTT
T ss_pred Ccc
Confidence 554
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.9e-24 Score=212.19 Aligned_cols=154 Identities=25% Similarity=0.432 Sum_probs=124.9
Q ss_pred HHhhCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCc------cchHHHHHHHHHHhcC----CCCCccceeeE
Q 010186 345 NLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSE------QGTAEFTNEVLLILKL----QHKNLVKLLGF 413 (516)
Q Consensus 345 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l----~H~niv~l~g~ 413 (516)
+...++|...+.||+|+||.||++.. .+++.||+|++..... .....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 33457789999999999999999985 5788999999965322 2234567899999888 89999999999
Q ss_pred EEeCCeeEEEEEc-cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEec-CCCcEE
Q 010186 414 CVDGDEKLLVYEF-MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD-SDMNSK 491 (516)
Q Consensus 414 ~~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld-~~~~~k 491 (516)
+...+..++|+|| +++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||||+||+++ .++.+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence 9999999999999 899999999843 346899999999999999999999998 99999999999999 889999
Q ss_pred EcccCcccccccC
Q 010186 492 ISDFGMARIFAES 504 (516)
Q Consensus 492 l~DFGla~~~~~~ 504 (516)
|+|||+++.+...
T Consensus 181 l~dfg~~~~~~~~ 193 (312)
T 2iwi_A 181 LIDFGSGALLHDE 193 (312)
T ss_dssp ECCCSSCEECCSS
T ss_pred EEEcchhhhcccC
Confidence 9999999887654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.90 E-value=4.1e-23 Score=202.98 Aligned_cols=150 Identities=22% Similarity=0.405 Sum_probs=128.8
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEE-EeCCeeEEEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC-VDGDEKLLVYE 425 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~-~~~~~~~lV~E 425 (516)
.++|...+.||+|+||.||++.. .+++.||+|++.... ..+.+.+|+.++..++|++++..++.+ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 45788889999999999999995 678999999986533 335689999999999988877666655 56677899999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEe---cCCCcEEEcccCcccccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL---DSDMNSKISDFGMARIFA 502 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILl---d~~~~~kl~DFGla~~~~ 502 (516)
|+ +++|.+++.. ....+++.++..++.||+.||.|||+++ ++||||||+|||+ +.++.+||+|||+++.+.
T Consensus 86 ~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 9999999853 2346899999999999999999999998 9999999999999 488899999999999876
Q ss_pred cCC
Q 010186 503 ESE 505 (516)
Q Consensus 503 ~~~ 505 (516)
...
T Consensus 160 ~~~ 162 (296)
T 3uzp_A 160 DAR 162 (296)
T ss_dssp CTT
T ss_pred ccc
Confidence 654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.9e-23 Score=217.09 Aligned_cols=150 Identities=24% Similarity=0.398 Sum_probs=128.8
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCC-CCccceeeEEEeCCeeEEEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH-KNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 425 (516)
.++|...++||+|+||.||++.. .+++.||||++.... ....+..|++++..++| ++|..+..+....+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 36788899999999999999995 578999999886532 23468899999999977 556666667778888999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEe---cCCCcEEEcccCcccccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL---DSDMNSKISDFGMARIFA 502 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILl---d~~~~~kl~DFGla~~~~ 502 (516)
|+ +++|.+++.. ....+++.+++.|+.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 9999999853 2346999999999999999999999998 9999999999999 688999999999999887
Q ss_pred cCC
Q 010186 503 ESE 505 (516)
Q Consensus 503 ~~~ 505 (516)
...
T Consensus 158 ~~~ 160 (483)
T 3sv0_A 158 DTS 160 (483)
T ss_dssp CTT
T ss_pred CCc
Confidence 654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.2e-23 Score=210.66 Aligned_cols=146 Identities=32% Similarity=0.486 Sum_probs=126.0
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCe------
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE------ 419 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~------ 419 (516)
++|...+.||+|+||.||++.. .+|+.||||++... +....+.+.+|+.+++.++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 5677889999999999999996 46899999999653 23335678999999999999999999999987654
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccc
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 499 (516)
.++||||++ ++|.+++. ..+++.++..++.||+.||.|||+++ ++||||||+|||++.++.+||+|||+++
T Consensus 104 ~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred EEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999998 58887762 24899999999999999999999998 9999999999999999999999999998
Q ss_pred cccc
Q 010186 500 IFAE 503 (516)
Q Consensus 500 ~~~~ 503 (516)
....
T Consensus 175 ~~~~ 178 (353)
T 3coi_A 175 HADA 178 (353)
T ss_dssp C---
T ss_pred CCCC
Confidence 7654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.4e-23 Score=208.06 Aligned_cols=154 Identities=26% Similarity=0.388 Sum_probs=126.6
Q ss_pred hhCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC-ccchHHHHHHHH-HHhcCCCCCccceeeEEEeCCeeEEE
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVL-LILKLQHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV 423 (516)
..++|...+.||+|+||.||++... +++.||||++.... ......+..|+. +++.++||||+++++++...+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 3467888899999999999999964 68999999997632 333445666666 67778999999999999999999999
Q ss_pred EEccCCCChhHHhcC--CCCCCCCCHHHHHHHHHHHHHHHHHhHcC-CCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 424 YEFMPNGSLDAILFD--PRKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
|||+++ +|.+++.. ......+++..+..++.|++.||.|||+. + ++||||||+|||++.++.+||+|||+++.
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999986 77766631 11245689999999999999999999998 7 99999999999999999999999999988
Q ss_pred cccC
Q 010186 501 FAES 504 (516)
Q Consensus 501 ~~~~ 504 (516)
+...
T Consensus 176 ~~~~ 179 (327)
T 3aln_A 176 LVDS 179 (327)
T ss_dssp ----
T ss_pred cccc
Confidence 7544
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.6e-23 Score=214.03 Aligned_cols=150 Identities=21% Similarity=0.290 Sum_probs=128.3
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcC------CCCCccceeeEEEeCCee
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKL------QHKNLVKLLGFCVDGDEK 420 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l------~H~niv~l~g~~~~~~~~ 420 (516)
..+|...++||+|+||.||++... +++.||||++... ......+.+|+.++..+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 356888899999999999999854 5889999999753 23445678888888776 577999999999999999
Q ss_pred EEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCc--EEEcccCcc
Q 010186 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN--SKISDFGMA 498 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~--~kl~DFGla 498 (516)
++||||++ ++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999996 5888887542 3345899999999999999999999998 999999999999999887 999999999
Q ss_pred ccccc
Q 010186 499 RIFAE 503 (516)
Q Consensus 499 ~~~~~ 503 (516)
+....
T Consensus 250 ~~~~~ 254 (429)
T 3kvw_A 250 CYEHQ 254 (429)
T ss_dssp EETTC
T ss_pred eecCC
Confidence 76544
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=9.9e-24 Score=210.38 Aligned_cols=154 Identities=26% Similarity=0.419 Sum_probs=132.9
Q ss_pred HHhhCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCc------cchHHHHHHHHHHhcCC--CCCccceeeEEE
Q 010186 345 NLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSE------QGTAEFTNEVLLILKLQ--HKNLVKLLGFCV 415 (516)
Q Consensus 345 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~ 415 (516)
....++|...+.||+|+||.||++.. .+++.||||++..... ...+.+.+|+.++++++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34456788899999999999999985 5788999999975322 12356788999999996 599999999999
Q ss_pred eCCeeEEEEEccCC-CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEec-CCCcEEEc
Q 010186 416 DGDEKLLVYEFMPN-GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD-SDMNSKIS 493 (516)
Q Consensus 416 ~~~~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld-~~~~~kl~ 493 (516)
..+..++|+||+.+ ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ +++.+||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence 99999999999986 899998843 356899999999999999999999998 99999999999999 78899999
Q ss_pred ccCcccccccC
Q 010186 494 DFGMARIFAES 504 (516)
Q Consensus 494 DFGla~~~~~~ 504 (516)
|||+++.+...
T Consensus 193 Dfg~~~~~~~~ 203 (320)
T 3a99_A 193 DFGSGALLKDT 203 (320)
T ss_dssp CCTTCEECCSS
T ss_pred eCccccccccc
Confidence 99999887644
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=8.6e-24 Score=219.56 Aligned_cols=150 Identities=25% Similarity=0.364 Sum_probs=122.4
Q ss_pred HhhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEE
Q 010186 346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 346 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 424 (516)
+...+|...++||+|+||.|+.....+++.||||++.+.. ...+.+|+.+++.+ +||||+++++++.+....+|||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 3445677889999999999765555689999999996532 23467899999999 8999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC-----CCcEEEcccCccc
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-----DMNSKISDFGMAR 499 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~-----~~~~kl~DFGla~ 499 (516)
||++ |+|.+++.... ..+.+.+...++.||+.||.|||+.+ |+||||||+||||+. ...+||+|||+++
T Consensus 98 E~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp ECCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred ECCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 9997 59999885432 23445566789999999999999998 999999999999943 3468899999999
Q ss_pred ccccC
Q 010186 500 IFAES 504 (516)
Q Consensus 500 ~~~~~ 504 (516)
.+...
T Consensus 172 ~~~~~ 176 (432)
T 3p23_A 172 KLAVG 176 (432)
T ss_dssp CC---
T ss_pred eccCC
Confidence 87654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-23 Score=214.14 Aligned_cols=149 Identities=11% Similarity=0.081 Sum_probs=110.9
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCc---cchHHHHHHH---HHHhcCCCCCcccee-------eEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE---QGTAEFTNEV---LLILKLQHKNLVKLL-------GFC 414 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei---~~l~~l~H~niv~l~-------g~~ 414 (516)
.+|...+.||+|+||.||++... +++.||||++..... ...+.+.+|+ ..+.. +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 34777899999999999999954 789999999986432 3455677885 45555 799977754 555
Q ss_pred EeC-----------------CeeEEEEEccCCCChhHHhcCCCCCCCCCHHHH------HHHHHHHHHHHHHhHcCCCCC
Q 010186 415 VDG-----------------DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKR------TNIVNGIAKGMLYLHEDSRLR 471 (516)
Q Consensus 415 ~~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~~l~yLH~~~~~~ 471 (516)
... ...+|||||++ |+|.+++... ...+.+..+ ..++.||+.||.|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 433 33799999999 8999998532 223344445 677899999999999998
Q ss_pred eeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 472 iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
|+||||||+||||+.++.+||+|||+|+.....
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~ 247 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR 247 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC
Confidence 999999999999999999999999999877543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.7e-23 Score=216.08 Aligned_cols=148 Identities=24% Similarity=0.301 Sum_probs=119.5
Q ss_pred CCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEEccCC
Q 010186 351 FSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 429 (516)
|...++||+|+||+||.....+|+.||||++... ..+.+.+|+.++.++ +||||+++++++.+.+..++||||++
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 4456789999999998766668999999998652 345678999999876 89999999999999999999999996
Q ss_pred CChhHHhcCCCCCC----CCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCC-------------CcEEE
Q 010186 430 GSLDAILFDPRKRG----ILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-------------MNSKI 492 (516)
Q Consensus 430 gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~-------------~~~kl 492 (516)
|+|.+++....... ..++..++.++.||+.||.|||+.+ |+||||||+||||+.+ +.+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 69999986432211 1133456789999999999999998 9999999999999754 48999
Q ss_pred cccCcccccccCC
Q 010186 493 SDFGMARIFAESE 505 (516)
Q Consensus 493 ~DFGla~~~~~~~ 505 (516)
+|||+++.+....
T Consensus 170 ~DFG~a~~~~~~~ 182 (434)
T 2rio_A 170 SDFGLCKKLDSGQ 182 (434)
T ss_dssp CCCTTCEECCC--
T ss_pred cccccceecCCCC
Confidence 9999999886554
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=8.5e-23 Score=204.35 Aligned_cols=151 Identities=23% Similarity=0.351 Sum_probs=129.5
Q ss_pred hCCCCCCceeeecCcEeEEEEEe--cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCC------CccceeeEEEeCCe
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL--SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHK------NLVKLLGFCVDGDE 419 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~--~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~------niv~l~g~~~~~~~ 419 (516)
.++|...+.||+|+||.||++.. .+++.||||+++.. ....+.+.+|+.++..++|+ +++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 45788889999999999999985 36889999999753 34456788999999888665 49999999999999
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC-------------
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS------------- 486 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~------------- 486 (516)
.++||||+ +++|.+++... ....+++..+..++.||+.||.|||+++ ++||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 88998888542 3346889999999999999999999998 999999999999987
Q ss_pred ------CCcEEEcccCcccccccC
Q 010186 487 ------DMNSKISDFGMARIFAES 504 (516)
Q Consensus 487 ------~~~~kl~DFGla~~~~~~ 504 (516)
++.+||+|||+++.....
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~ 190 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH 190 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC
T ss_pred ccccccCCCceEeeCcccccCccc
Confidence 668999999999876543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.3e-23 Score=211.39 Aligned_cols=135 Identities=25% Similarity=0.344 Sum_probs=112.6
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCC--------CCCccceeeEEE---
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ--------HKNLVKLLGFCV--- 415 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~--------H~niv~l~g~~~--- 415 (516)
.++|...++||+|+||.||++.. .+++.||||++... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 46788999999999999999985 56889999999753 344567889999999885 788999999988
Q ss_pred -eCCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC-CCCCeeeCCCCCCCeEecCCC
Q 010186 416 -DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDM 488 (516)
Q Consensus 416 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~iiHrDlk~~NILld~~~ 488 (516)
.....+|||||+.+ +|.+.+.. .....+++..+..++.||+.||.|||++ + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~ 184 (397)
T 1wak_A 115 VNGTHICMVFEVLGH-HLLKWIIK-SNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNE 184 (397)
T ss_dssp TTEEEEEEEECCCCC-BHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCH
T ss_pred CCCceEEEEEeccCc-cHHHHHHh-cccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccc
Confidence 45578999999954 55444432 2335689999999999999999999998 7 99999999999999775
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-23 Score=226.27 Aligned_cols=154 Identities=29% Similarity=0.427 Sum_probs=132.6
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEe------CCee
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD------GDEK 420 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~~~ 420 (516)
++|...+.||+|+||.||++.. .+|+.||||++... .....+.+.+|++++.+++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6788999999999999999996 46899999998753 34456679999999999999999999998765 6678
Q ss_pred EEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCc---EEEcccCc
Q 010186 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN---SKISDFGM 497 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~---~kl~DFGl 497 (516)
++||||+++|+|.+++........+++..+..++.+|+.||.|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 999999999999999976555556899999999999999999999998 999999999999997665 99999999
Q ss_pred ccccccCC
Q 010186 498 ARIFAESE 505 (516)
Q Consensus 498 a~~~~~~~ 505 (516)
++.+....
T Consensus 171 a~~~~~~~ 178 (676)
T 3qa8_A 171 AKELDQGE 178 (676)
T ss_dssp CCBTTSCC
T ss_pred cccccccc
Confidence 99876543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.5e-22 Score=203.35 Aligned_cols=148 Identities=24% Similarity=0.335 Sum_probs=119.3
Q ss_pred CCCCCC-ceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEe----CCeeEE
Q 010186 349 SNFSDS-NILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD----GDEKLL 422 (516)
Q Consensus 349 ~~f~~~-~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~l 422 (516)
++|... ++||+|+||.||++... +++.||||++... .....+....+..++||||+++++++.. ....++
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 103 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLI 103 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence 456663 56999999999999965 6899999998652 1222233344566799999999999876 345799
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC---CCcEEEcccCccc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMAR 499 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~---~~~~kl~DFGla~ 499 (516)
||||+++|+|.+++... ....+++.++..++.||+.||.|||+.+ ++||||||+|||++. ++.+||+|||+++
T Consensus 104 v~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 104 IMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 99999999999999643 3346999999999999999999999998 999999999999976 4559999999998
Q ss_pred ccccC
Q 010186 500 IFAES 504 (516)
Q Consensus 500 ~~~~~ 504 (516)
.....
T Consensus 180 ~~~~~ 184 (336)
T 3fhr_A 180 ETTQN 184 (336)
T ss_dssp EC---
T ss_pred ecccc
Confidence 76543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=3.5e-23 Score=205.61 Aligned_cols=152 Identities=22% Similarity=0.394 Sum_probs=116.2
Q ss_pred hhCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCc-cc-hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE-QG-TAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 423 (516)
..++|...+.||+|+||.||++... +|+.||||++..... .. .+.+.++..+++.++||||+++++++...+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3456777899999999999999964 689999999976432 22 23344555678888999999999999999999999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC-CCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
|||+ ++.+..+... ....+++..+..++.||+.||.|||+. + ++||||||+|||++.++.+||+|||+++.+.
T Consensus 103 ~e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 103 MELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp ECCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred Eecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 9999 4556555422 235689999999999999999999985 7 9999999999999999999999999998765
Q ss_pred cC
Q 010186 503 ES 504 (516)
Q Consensus 503 ~~ 504 (516)
..
T Consensus 177 ~~ 178 (318)
T 2dyl_A 177 DD 178 (318)
T ss_dssp --
T ss_pred CC
Confidence 44
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.3e-23 Score=219.90 Aligned_cols=136 Identities=20% Similarity=0.292 Sum_probs=109.9
Q ss_pred CCceeeecCcEeEEEEEecCCcEEEEEEeccCCcc--------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 353 DSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQ--------GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 353 ~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~--------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
..++||+|+||.||++.. .++.+++|+....... ..+.+.+|++++++++||||+++..++...+..+|||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 357899999999999954 5788899886542211 1345899999999999999997777777888889999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||+++++|.+++.. +..++.||++||.|||+++ |+||||||+|||++. .+||+|||+|+.+...
T Consensus 419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 99999999999843 4689999999999999998 999999999999998 9999999999988664
Q ss_pred C
Q 010186 505 E 505 (516)
Q Consensus 505 ~ 505 (516)
+
T Consensus 483 ~ 483 (540)
T 3en9_A 483 E 483 (540)
T ss_dssp H
T ss_pred c
Confidence 3
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.5e-22 Score=197.97 Aligned_cols=145 Identities=19% Similarity=0.159 Sum_probs=116.9
Q ss_pred HHHHHhhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCc------------------cchHHHHHHHHHHhcCC
Q 010186 342 ETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSE------------------QGTAEFTNEVLLILKLQ 403 (516)
Q Consensus 342 ~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~------------------~~~~~~~~Ei~~l~~l~ 403 (516)
..+......|...+.||+|+||.||++...+|+.||+|.++.... .....+.+|+.++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 344444556777899999999999999997799999999964221 12456899999999999
Q ss_pred CCCccceeeEEEeCCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeE
Q 010186 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVL 483 (516)
Q Consensus 404 H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIL 483 (516)
| +++.+++.. +..++||||+++++|.+ +.. .+...++.||+.||.|||+.+ |+||||||+|||
T Consensus 163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NIL 225 (282)
T 1zar_A 163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL 225 (282)
T ss_dssp --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEE
Confidence 4 666665543 56799999999999988 411 124469999999999999998 999999999999
Q ss_pred ecCCCcEEEcccCcccccccC
Q 010186 484 LDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 484 ld~~~~~kl~DFGla~~~~~~ 504 (516)
|+ ++.+||+|||+|+.....
T Consensus 226 l~-~~~vkl~DFG~a~~~~~~ 245 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVEVGEE 245 (282)
T ss_dssp EE-TTEEEECCCTTCEETTST
T ss_pred EE-CCcEEEEECCCCeECCCC
Confidence 99 999999999999876544
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.9e-22 Score=200.97 Aligned_cols=151 Identities=20% Similarity=0.309 Sum_probs=126.3
Q ss_pred hCCCCCCceeeecCcEeEEEEEec-CC-cEEEEEEeccCCccchHHHHHHHHHHhcCCCCC------ccceeeEEEeCCe
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLS-DG-KEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN------LVKLLGFCVDGDE 419 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~g-~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n------iv~l~g~~~~~~~ 419 (516)
.++|...+.||+|+||.||++... ++ +.||+|+++.. ....+.+.+|+.+++.++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 457888899999999999999964 34 68999999753 344567889999999987765 8999999999999
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEe---------------
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL--------------- 484 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILl--------------- 484 (516)
.++||||+ +++|.+++.. .....+++.++..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~-~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKE-NNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 5566555533 23346899999999999999999999997 9999999999999
Q ss_pred ----cCCCcEEEcccCcccccccC
Q 010186 485 ----DSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 485 ----d~~~~~kl~DFGla~~~~~~ 504 (516)
+.++.+||+|||+++.....
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~ 195 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH 195 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC
T ss_pred cccccCCCcEEEeecCcccccccc
Confidence 56789999999999875443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=5.8e-22 Score=202.54 Aligned_cols=154 Identities=23% Similarity=0.318 Sum_probs=127.8
Q ss_pred hhCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcCC-CC-----CccceeeEEEeCCe
Q 010186 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HK-----NLVKLLGFCVDGDE 419 (516)
Q Consensus 347 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~-----niv~l~g~~~~~~~ 419 (516)
..++|...+.||+|+||.||++... +++.||||+++.. ......+..|+.++..++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 3567888999999999999999954 6889999999752 334566788999888884 55 49999999999999
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEec--CCCcEEEcccCc
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD--SDMNSKISDFGM 497 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld--~~~~~kl~DFGl 497 (516)
.++||||++ ++|.+++... ....+++..+..++.||+.||.|||++ ..+|+||||||+||||+ .++.+||+|||+
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred eEEEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 999999996 5998888542 234589999999999999999999953 12499999999999994 477899999999
Q ss_pred ccccccC
Q 010186 498 ARIFAES 504 (516)
Q Consensus 498 a~~~~~~ 504 (516)
++.+...
T Consensus 208 a~~~~~~ 214 (382)
T 2vx3_A 208 SCQLGQR 214 (382)
T ss_dssp CEETTCC
T ss_pred ceecccc
Confidence 9887543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.87 E-value=2.1e-22 Score=204.74 Aligned_cols=151 Identities=23% Similarity=0.351 Sum_probs=128.1
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCC-----------CCCccceeeEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-----------HKNLVKLLGFCV 415 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~g~~~ 415 (516)
.++|...+.||+|+||.||++.. .+++.||||++.. +....+.+.+|+.++.+++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 35788889999999999999995 5789999999975 2334567889999998886 899999999998
Q ss_pred eCC----eeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC-CCCCeeeCCCCCCCeEec-----
Q 010186 416 DGD----EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLD----- 485 (516)
Q Consensus 416 ~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~iiHrDlk~~NILld----- 485 (516)
..+ ..++||||+ +++|.+++... ....+++..+..++.||+.||.|||++ + |+||||||+||||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 689999999 88999988542 234589999999999999999999998 7 99999999999994
Q ss_pred -CCCcEEEcccCcccccccC
Q 010186 486 -SDMNSKISDFGMARIFAES 504 (516)
Q Consensus 486 -~~~~~kl~DFGla~~~~~~ 504 (516)
..+.+||+|||+++.+...
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~ 191 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH 191 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC
T ss_pred cCcceEEEcccccccccCCC
Confidence 4458999999999877644
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.1e-20 Score=195.02 Aligned_cols=152 Identities=16% Similarity=0.173 Sum_probs=114.6
Q ss_pred CCCCCCceeeecCcEeEEEEE-ecCCcEEEEEEeccC---CccchHHHHHHHHHHhcCCC-CCccc---------eeeE-
Q 010186 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQH-KNLVK---------LLGF- 413 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~-~~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H-~niv~---------l~g~- 413 (516)
.+|...++||+|+||.||++. ..+|+.||||++... .....+.|.+|+.+++.++| +|... .+..
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 446677899999999999999 457999999998742 22346789999999999987 32211 1111
Q ss_pred -----------EEe-----CCeeEEEEEccCCCChhHHhcC----CCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCee
Q 010186 414 -----------CVD-----GDEKLLVYEFMPNGSLDAILFD----PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473 (516)
Q Consensus 414 -----------~~~-----~~~~~lV~Ey~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ii 473 (516)
... ....+++|++ .+++|.+++.. ......+++..++.++.||++||.|||+++ |+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 111 1234566665 46899888731 123456888899999999999999999998 99
Q ss_pred eCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 474 HRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 474 HrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||||||+||||+.++.+||+|||+++.....
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~ 264 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS 264 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc
Confidence 9999999999999999999999999876543
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=3.7e-20 Score=178.67 Aligned_cols=139 Identities=19% Similarity=0.189 Sum_probs=108.0
Q ss_pred CCCCceeeecCcEeEEEEEe-cCCcE--EEEEEeccCCcc------------------------chHHHHHHHHHHhcCC
Q 010186 351 FSDSNILGQGGFGPVYKGVL-SDGKE--VAVKRLSSCSEQ------------------------GTAEFTNEVLLILKLQ 403 (516)
Q Consensus 351 f~~~~~Lg~G~fg~Vy~~~~-~~g~~--vavK~l~~~~~~------------------------~~~~~~~Ei~~l~~l~ 403 (516)
|...+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+..+..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 45678899999999999997 68888 999987542111 0136889999999998
Q ss_pred CCCc--cceeeEEEeCCeeEEEEEccCC-C----ChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhH-cCCCCCeeeC
Q 010186 404 HKNL--VKLLGFCVDGDEKLLVYEFMPN-G----SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH-EDSRLRIVHR 475 (516)
Q Consensus 404 H~ni--v~l~g~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH-~~~~~~iiHr 475 (516)
|+++ +..++. +..+|||||+.+ | +|.++... .++.+...++.||+.+|.||| +.+ |+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 8764 344432 357899999942 4 66665421 234567789999999999999 887 9999
Q ss_pred CCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 476 DLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 476 Dlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||||+|||++. .++|+|||+|......
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~~~~ 222 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTLRHP 222 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEETTST
T ss_pred CCCHHHEEEcC--cEEEEECcccccCCCc
Confidence 99999999988 9999999999877543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=2.6e-17 Score=165.74 Aligned_cols=139 Identities=13% Similarity=0.153 Sum_probs=98.1
Q ss_pred CCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCc--------------cchHHH--------HHHHHHHhcCCCCC
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSE--------------QGTAEF--------TNEVLLILKLQHKN 406 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~--------------~~~~~~--------~~Ei~~l~~l~H~n 406 (516)
.-|.+.+.||+|+||.||+|...+|++||||+++.... ...... ..|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34788899999999999999988999999998764210 001111 23445555554333
Q ss_pred ccceeeEEEeCCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC
Q 010186 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS 486 (516)
Q Consensus 407 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~ 486 (516)
+.-..-+.. ...+|||||+++++|..+... .+...++.||+.+|.|||+.+ ||||||||.||||++
T Consensus 175 v~vp~p~~~--~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 175 FPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIRE 240 (397)
T ss_dssp CSCCCEEEE--ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEE
T ss_pred CCCCeeeec--cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeC
Confidence 221111111 234799999999988765411 123567899999999999988 999999999999987
Q ss_pred CC----------cEEEcccCccccc
Q 010186 487 DM----------NSKISDFGMARIF 501 (516)
Q Consensus 487 ~~----------~~kl~DFGla~~~ 501 (516)
++ .+.|+||+-+-..
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCcccccccccceEEEEeCCcccC
Confidence 76 3899999976543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=2e-12 Score=124.44 Aligned_cols=143 Identities=19% Similarity=0.111 Sum_probs=111.9
Q ss_pred CCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEEcc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
..|.....++.|+.+.||+... +++.+++|+...........+.+|..+++.+ .|..+.+++++....+..|+||||+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 92 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred ccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence 3466667788888899999885 3688999998653223345689999999988 4678889999999988999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC----------------------------------------
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED---------------------------------------- 467 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~---------------------------------------- 467 (516)
+|.+|.+.+.. ......++.+++++|..||+.
T Consensus 93 ~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T 3tm0_A 93 DGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp SSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred CCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence 99999876411 122346788999999999981
Q ss_pred ----------------CCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 468 ----------------SRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 468 ----------------~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
.+..++|+|++|.|||++++..+.|+||+.+..
T Consensus 165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 114499999999999998766677999998854
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.23 E-value=1.1e-11 Score=118.74 Aligned_cols=130 Identities=18% Similarity=0.144 Sum_probs=99.0
Q ss_pred eecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCC--ccceeeEEEeCCeeEEEEEccCCCChhHH
Q 010186 358 GQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN--LVKLLGFCVDGDEKLLVYEFMPNGSLDAI 435 (516)
Q Consensus 358 g~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~ 435 (516)
+.|..+.||+....+|..+++|..... ....+.+|+.+++.+.+.+ +.+++++...++..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 355569999998777888999987643 3356889999999885444 567888888877889999999998884
Q ss_pred hcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC-----------------------------------------------
Q 010186 436 LFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS----------------------------------------------- 468 (516)
Q Consensus 436 l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~----------------------------------------------- 468 (516)
... .. ...++.++++.|..||+..
T Consensus 104 ~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (264)
T 1nd4_A 104 SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 174 (264)
T ss_dssp TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence 211 11 2356777888888888643
Q ss_pred --------CCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 469 --------RLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 469 --------~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+..++|+|++|.|||++++..++|+|||.+..-
T Consensus 175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 123999999999999987766779999998654
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.07 E-value=4.2e-10 Score=113.35 Aligned_cols=141 Identities=16% Similarity=0.231 Sum_probs=106.3
Q ss_pred CceeeecCcEeEEEEEecCCcEEEEEEec--cCC-ccchHHHHHHHHHHhcCC--CCCccceeeEEEeC---CeeEEEEE
Q 010186 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLS--SCS-EQGTAEFTNEVLLILKLQ--HKNLVKLLGFCVDG---DEKLLVYE 425 (516)
Q Consensus 354 ~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~--~~~-~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~---~~~~lV~E 425 (516)
.+.|+.|.+..||+....+ ..+++|+.. ... ......+.+|..+++.+. +..+++++.++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 4668999999999988754 678888765 322 123457889999999886 45688899988776 34899999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC-------------------------------------
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS------------------------------------- 468 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~------------------------------------- 468 (516)
|+++..+.+.. ...++..++..++.++++.|..||+..
T Consensus 122 ~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 122 FVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred ecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99998874321 123678888899999999999999731
Q ss_pred ------------------CCCeeeCCCCCCCeEecCCCc--EEEcccCcccc
Q 010186 469 ------------------RLRIVHRDLKASNVLLDSDMN--SKISDFGMARI 500 (516)
Q Consensus 469 ------------------~~~iiHrDlk~~NILld~~~~--~kl~DFGla~~ 500 (516)
+..++|+|+++.|||++.++. +.|.||+++..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256999999999999987753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.61 E-value=8.1e-08 Score=94.16 Aligned_cols=137 Identities=18% Similarity=0.250 Sum_probs=98.9
Q ss_pred CceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcC-CCCC--ccceeeEEEeCC---eeEEEEEcc
Q 010186 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKN--LVKLLGFCVDGD---EKLLVYEFM 427 (516)
Q Consensus 354 ~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~n--iv~l~g~~~~~~---~~~lV~Ey~ 427 (516)
.+.++.|....||+.. ..+++|+.... .....+.+|..++..+ .+.. +.+.+......+ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3568999999999853 56888876432 3456789999999887 3333 445555443333 358999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC----------------------------------------
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED---------------------------------------- 467 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~---------------------------------------- 467 (516)
+|.+|..... ..++..++..++.++++.|..||+.
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9988865331 2366777778888888888888861
Q ss_pred ---------------CCCCeeeCCCCCCCeEecC--CCcEEEcccCccccc
Q 010186 468 ---------------SRLRIVHRDLKASNVLLDS--DMNSKISDFGMARIF 501 (516)
Q Consensus 468 ---------------~~~~iiHrDlk~~NILld~--~~~~kl~DFGla~~~ 501 (516)
.++.++|+|++|.||++++ +..+.|+||+.+..-
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 1245899999999999998 456789999998654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=7.7e-07 Score=87.35 Aligned_cols=137 Identities=20% Similarity=0.175 Sum_probs=94.8
Q ss_pred CceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCC---CccceeeEEE-eCCeeEEEEEccCC
Q 010186 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHK---NLVKLLGFCV-DGDEKLLVYEFMPN 429 (516)
Q Consensus 354 ~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~---niv~l~g~~~-~~~~~~lV~Ey~~~ 429 (516)
.+.++.|....||+. +..+++|+... ......+.+|..+|..+.+. .+.+.+.+.. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 355788888899987 56788887432 23456789999999998652 3567777764 34557899999999
Q ss_pred CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC------------------------------------------
Q 010186 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED------------------------------------------ 467 (516)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~------------------------------------------ 467 (516)
..+...... .++..+...++.++++.|..||+.
T Consensus 98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 888763211 134444455555555555555532
Q ss_pred ---------------CCCCeeeCCCCCCCeEecC---CCc-EEEcccCccccc
Q 010186 468 ---------------SRLRIVHRDLKASNVLLDS---DMN-SKISDFGMARIF 501 (516)
Q Consensus 468 ---------------~~~~iiHrDlk~~NILld~---~~~-~kl~DFGla~~~ 501 (516)
.++.++|+|++|.|||++. ++. +.|+||+.+..-
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2335799999999999987 455 489999988654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=5.9e-07 Score=86.23 Aligned_cols=135 Identities=20% Similarity=0.203 Sum_probs=93.7
Q ss_pred eeecCcE-eEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEEccCCCChh
Q 010186 357 LGQGGFG-PVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLD 433 (516)
Q Consensus 357 Lg~G~fg-~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 433 (516)
+..|..+ .||+.... ++..+.+|+-... ....+.+|...|+.+ .+--+.++++++.+.+..++|||++++.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 4555554 58987754 4667888876542 345688899998877 3445778999999999999999999998876
Q ss_pred HHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC----------------------------------------------
Q 010186 434 AILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED---------------------------------------------- 467 (516)
Q Consensus 434 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~---------------------------------------------- 467 (516)
+.... .......+..+++..|.-||+.
T Consensus 109 ~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 109 QVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred ccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 64411 0112223444455555555532
Q ss_pred ---------CCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 468 ---------SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 468 ---------~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
.++.++|+|+.+.|||++.++.+-|+||+.+..-
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 1123799999999999998777789999988653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=6.6e-07 Score=89.63 Aligned_cols=79 Identities=5% Similarity=-0.013 Sum_probs=55.7
Q ss_pred cee-eecCcEeEEEEEec-------CCcEEEEEEeccCC---ccchHHHHHHHHHHhcCC-C--CCccceeeEEEeC---
Q 010186 355 NIL-GQGGFGPVYKGVLS-------DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQ-H--KNLVKLLGFCVDG--- 417 (516)
Q Consensus 355 ~~L-g~G~fg~Vy~~~~~-------~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~-H--~niv~l~g~~~~~--- 417 (516)
+.| +.|....+|+.... ++..+++|+..... ......+.+|..+++.+. + ..+.+++.+..+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 78888999988764 26678888765422 112356788999888883 3 3577888887665
Q ss_pred CeeEEEEEccCCCChh
Q 010186 418 DEKLLVYEFMPNGSLD 433 (516)
Q Consensus 418 ~~~~lV~Ey~~~gsL~ 433 (516)
+..++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999987764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.06 E-value=1.5e-05 Score=80.94 Aligned_cols=75 Identities=11% Similarity=0.118 Sum_probs=50.0
Q ss_pred CceeeecCcEeEEEEEec-CCcEEEEEEeccCCc-------cchHHHHHHHHHHhcCCC--C-CccceeeEEEeCCeeEE
Q 010186 354 SNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE-------QGTAEFTNEVLLILKLQH--K-NLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 354 ~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-------~~~~~~~~Ei~~l~~l~H--~-niv~l~g~~~~~~~~~l 422 (516)
.+.||.|..+.||++... +++.++||...+... .....+..|.+++..+.+ + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 356899999999999754 467899998654211 123456788888887732 3 34455543 4556789
Q ss_pred EEEccCCC
Q 010186 423 VYEFMPNG 430 (516)
Q Consensus 423 V~Ey~~~g 430 (516)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.06 E-value=2.1e-05 Score=77.75 Aligned_cols=141 Identities=14% Similarity=0.213 Sum_probs=79.4
Q ss_pred ceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCC--CCCccceee------EEEeCCeeEEEEEc
Q 010186 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ--HKNLVKLLG------FCVDGDEKLLVYEF 426 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~--H~niv~l~g------~~~~~~~~~lV~Ey 426 (516)
+.|+.|....||+....+| .+++|+.... ...+..|..++..+. .-.+.+++. +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3465567889999887554 5888888652 233444555554442 112333332 22346678999999
Q ss_pred cCCCChh---------------HH---hcCCC-C-C-----CCCCHHHHH------------------------------
Q 010186 427 MPNGSLD---------------AI---LFDPR-K-R-----GILCWRKRT------------------------------ 451 (516)
Q Consensus 427 ~~~gsL~---------------~~---l~~~~-~-~-----~~l~~~~~~------------------------------ 451 (516)
++|..+. .+ ..... . . ..-.|....
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 00 00000 0 0 112332211
Q ss_pred -HHHHHHHHHHHHhHc----------CCCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 452 -NIVNGIAKGMLYLHE----------DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 452 -~i~~~ia~~l~yLH~----------~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
.+...+..++.+|++ ..+..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 011123445667763 1235699999999999998888999999998753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.01 E-value=2.6e-05 Score=75.50 Aligned_cols=79 Identities=20% Similarity=0.239 Sum_probs=58.6
Q ss_pred CCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCC-C--CCccceeeEEEeCCeeEEEEEc
Q 010186 350 NFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-H--KNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H--~niv~l~g~~~~~~~~~lV~Ey 426 (516)
.+...+.+|.|..+.||+.++.+|+.+.+|+...........|..|...|+.|. . -.+++.+++ +..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence 344557799999999999999999999999876544444556889999888873 2 234555554 235899999
Q ss_pred cCCCCh
Q 010186 427 MPNGSL 432 (516)
Q Consensus 427 ~~~gsL 432 (516)
++.+..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987664
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.86 E-value=8.3e-05 Score=72.81 Aligned_cols=138 Identities=17% Similarity=0.112 Sum_probs=92.7
Q ss_pred CceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCC---CCCccceeeEEEeCCeeEEEEEccCCC
Q 010186 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ---HKNLVKLLGFCVDGDEKLLVYEFMPNG 430 (516)
Q Consensus 354 ~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~Ey~~~g 430 (516)
.+.|+.|....+|+... ++..+++|+.... ....+..|...|+.|. ...+++.+.+....+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 45689999999999886 4678888876542 3567889988888873 367888999988888899999999988
Q ss_pred ChhH--------H---hcCCCC--C-----------------CCCCHHHHH---HHH----------------HHHHHH-
Q 010186 431 SLDA--------I---LFDPRK--R-----------------GILCWRKRT---NIV----------------NGIAKG- 460 (516)
Q Consensus 431 sL~~--------~---l~~~~~--~-----------------~~l~~~~~~---~i~----------------~~ia~~- 460 (516)
.+.. . ++.... . ..-+|.+.. ++. ..+..-
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 6521 1 111111 0 012465432 111 111111
Q ss_pred HHHhHc-CCCCCeeeCCCCCCCeEecCCCcEEEcccC
Q 010186 461 MLYLHE-DSRLRIVHRDLKASNVLLDSDMNSKISDFG 496 (516)
Q Consensus 461 l~yLH~-~~~~~iiHrDlk~~NILld~~~~~kl~DFG 496 (516)
...|.. ..++.++|+|+.+.|++++.++ +.|.||.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223421 2356799999999999999887 8999984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00016 Score=73.98 Aligned_cols=73 Identities=18% Similarity=0.242 Sum_probs=46.1
Q ss_pred CceeeecCcEeEEEEEecCCcEEEEEEeccC----Ccc-----chHHHHHHHHHHh-cCCCCCccceeeEEEeCCeeEEE
Q 010186 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSC----SEQ-----GTAEFTNEVLLIL-KLQHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 354 ~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~----~~~-----~~~~~~~Ei~~l~-~l~H~niv~l~g~~~~~~~~~lV 423 (516)
.+.||.|....||+... ++..++||...+. ... ....++.|+..+. ...+..+.+++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 45688999999999865 5678999954321 111 2234444544332 22334566777665 5667999
Q ss_pred EEcc-CC
Q 010186 424 YEFM-PN 429 (516)
Q Consensus 424 ~Ey~-~~ 429 (516)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00062 Score=66.12 Aligned_cols=138 Identities=13% Similarity=0.113 Sum_probs=75.8
Q ss_pred CceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCc-cceeeEEEeCCeeEEEEEcc-CCCC
Q 010186 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVYEFM-PNGS 431 (516)
Q Consensus 354 ~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~-~~gs 431 (516)
.+.|+.|....+|+. ..+++|+....... .....+|..++..+...++ .++++. +.+..++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 567888999999998 56888877653222 2234567777776632222 455543 344467999999 6554
Q ss_pred hhHH------------------hcCCCC--CCCCCH-HHHHHHHH--------------HHHHHHH----HhHc-CCCCC
Q 010186 432 LDAI------------------LFDPRK--RGILCW-RKRTNIVN--------------GIAKGML----YLHE-DSRLR 471 (516)
Q Consensus 432 L~~~------------------l~~~~~--~~~l~~-~~~~~i~~--------------~ia~~l~----yLH~-~~~~~ 471 (516)
+... ++.... ...... .....+.. .+...+. .|.. ..+..
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 4310 111110 000111 11111100 0111111 1111 23345
Q ss_pred eeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 472 IVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 472 iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 5667889999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00066 Score=66.46 Aligned_cols=143 Identities=16% Similarity=0.120 Sum_probs=78.8
Q ss_pred ceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCC--ccceee------EEEeCCeeEEEEEc
Q 010186 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN--LVKLLG------FCVDGDEKLLVYEF 426 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g------~~~~~~~~~lV~Ey 426 (516)
+.|+.|....+|+....+| .+++|+..+. ...+.+..|..++..+...+ +.+++. +....+..++++||
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 3466787888999887655 6788887652 12234566777776663211 333332 12234567899999
Q ss_pred cCCCChhH-----H---------hc----CCC-CC----CCCCHHHHHH------------HHHHHHHHHHHhHcC----
Q 010186 427 MPNGSLDA-----I---------LF----DPR-KR----GILCWRKRTN------------IVNGIAKGMLYLHED---- 467 (516)
Q Consensus 427 ~~~gsL~~-----~---------l~----~~~-~~----~~l~~~~~~~------------i~~~ia~~l~yLH~~---- 467 (516)
++|..+.. . ++ ... .. ....|..... +...+...+.++++.
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 99865421 0 11 000 00 0012322111 011234445555431
Q ss_pred CCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 468 ~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
.+..++|+|+.+.|||++.+..+.|+||+.+..
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 234599999999999998876668999997753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0018 Score=63.52 Aligned_cols=142 Identities=15% Similarity=0.137 Sum_probs=81.3
Q ss_pred ceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCC--CCccceeeE-----EEeCCeeEEEEEcc
Q 010186 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH--KNLVKLLGF-----CVDGDEKLLVYEFM 427 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~-----~~~~~~~~lV~Ey~ 427 (516)
..++ |....||+....+|+.+++|...+.. .....+..|..++..+.. -.+++++.. ....+..++|+||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3466 77788998877677789999886431 234566778887777632 224444442 22345668999999
Q ss_pred CCCChh-----HH---------hc----CCC--CCCCCCHHHH----------------------HHHHHHHHHHHHHhH
Q 010186 428 PNGSLD-----AI---------LF----DPR--KRGILCWRKR----------------------TNIVNGIAKGMLYLH 465 (516)
Q Consensus 428 ~~gsL~-----~~---------l~----~~~--~~~~l~~~~~----------------------~~i~~~ia~~l~yLH 465 (516)
+|..+. .. ++ ... ....+++... ...+..+...+.-+.
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 885542 00 00 000 1112222211 011111222222111
Q ss_pred c-CCCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 466 E-DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 466 ~-~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
. ..+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1 1234589999999999999 5 899999987754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0012 Score=64.96 Aligned_cols=140 Identities=15% Similarity=0.105 Sum_probs=71.7
Q ss_pred eeeecCcE-eEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCC--CCCccceeeEEEeCCeeEEEEEccCCCCh
Q 010186 356 ILGQGGFG-PVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ--HKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432 (516)
Q Consensus 356 ~Lg~G~fg-~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 432 (516)
.|+.|... .+|+....++..+++|...+... ..+..|+.++..+. .-.+.+++.+.... -+++||++++..+
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~l 99 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDALF 99 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCBH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcch
Confidence 35444433 36676654467777775543221 33455666666653 23456677663333 3789999977665
Q ss_pred hHHhc---------------------CCCC--CCCCCHHHHH-------H-------------HHHHHHHHHHHhH---c
Q 010186 433 DAILF---------------------DPRK--RGILCWRKRT-------N-------------IVNGIAKGMLYLH---E 466 (516)
Q Consensus 433 ~~~l~---------------------~~~~--~~~l~~~~~~-------~-------------i~~~ia~~l~yLH---~ 466 (516)
.+.+. .... ...+...... . ....+...+..+. .
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 43321 1000 0111111000 0 0001111222221 1
Q ss_pred CCCCCeeeCCCCCCCeEecCC----CcEEEcccCcccc
Q 010186 467 DSRLRIVHRDLKASNVLLDSD----MNSKISDFGMARI 500 (516)
Q Consensus 467 ~~~~~iiHrDlk~~NILld~~----~~~kl~DFGla~~ 500 (516)
..+..++|+|+.+.|||++.+ ..+.|+||+.+..
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 223469999999999999875 6899999998864
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0029 Score=65.25 Aligned_cols=73 Identities=18% Similarity=0.127 Sum_probs=47.3
Q ss_pred ceeeecCcEeEEEEEecC-CcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCc-cceeeEEEeCCeeEEEEEccCCCCh
Q 010186 355 NILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVYEFMPNGSL 432 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gsL 432 (516)
+.|+.|-...+|+....+ +..+++|+..+... ..-.-.+|..++..|...++ .++++.+. + .+|+||+++.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 457778889999998764 47788887754221 11123688888888855444 56777662 2 359999997554
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.21 E-value=0.00062 Score=69.79 Aligned_cols=72 Identities=18% Similarity=0.257 Sum_probs=48.6
Q ss_pred ceeeecCcEeEEEEEecC--------CcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCc-cceeeEEEeCCeeEEEEE
Q 010186 355 NILGQGGFGPVYKGVLSD--------GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E 425 (516)
+.|+.|....+|+....+ +..+.+|+.... .....+.+|..++..+...++ +++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 457778889999998653 468888887431 111456689888888743333 567765532 38999
Q ss_pred ccCCCCh
Q 010186 426 FMPNGSL 432 (516)
Q Consensus 426 y~~~gsL 432 (516)
|+++.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0013 Score=66.06 Aligned_cols=141 Identities=17% Similarity=0.204 Sum_probs=82.0
Q ss_pred ceeeecCcEeEEEEEec--------CCcEEEEEEeccCCccchHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEE
Q 010186 355 NILGQGGFGPVYKGVLS--------DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 425 (516)
+.|..|-...+|+.... +++.+.+|+..+. ......+.+|.++++.+. +.-..++++.+.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45666777889998864 2468888876332 234556778999888773 3223567766543 29999
Q ss_pred ccCCCChhHH-----------------hcCC--CCCCCCC--HHHHHHHHHHHH-------------------HHHHHhH
Q 010186 426 FMPNGSLDAI-----------------LFDP--RKRGILC--WRKRTNIVNGIA-------------------KGMLYLH 465 (516)
Q Consensus 426 y~~~gsL~~~-----------------l~~~--~~~~~l~--~~~~~~i~~~ia-------------------~~l~yLH 465 (516)
|++|..|..- ++.. ....... |.+..++..++- ..+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665311 1111 1111122 344444443321 1223332
Q ss_pred ----c-CCCCCeeeCCCCCCCeEecCC----CcEEEcccCcccc
Q 010186 466 ----E-DSRLRIVHRDLKASNVLLDSD----MNSKISDFGMARI 500 (516)
Q Consensus 466 ----~-~~~~~iiHrDlk~~NILld~~----~~~kl~DFGla~~ 500 (516)
. ..+..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 223459999999999999876 7899999998864
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0049 Score=60.91 Aligned_cols=32 Identities=25% Similarity=0.438 Sum_probs=28.0
Q ss_pred CCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 469 ~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
+..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 35699999999999999888899999987754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0013 Score=65.74 Aligned_cols=73 Identities=11% Similarity=0.062 Sum_probs=43.6
Q ss_pred ceeeecCcEeEEEEEecC---------CcEEEEEEeccCCccchHHHHHHHHHHhcCCCCC-ccceeeEEEeCCeeEEEE
Q 010186 355 NILGQGGFGPVYKGVLSD---------GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN-LVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~ 424 (516)
+.|+.|..-.+|+....+ +..+++|+..... ........|..++..+...+ +.++++.. . .++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 346777778899988653 2678888765422 12223467888887774333 44666543 2 37899
Q ss_pred EccCCCCh
Q 010186 425 EFMPNGSL 432 (516)
Q Consensus 425 Ey~~~gsL 432 (516)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99997544
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.30 E-value=0.077 Score=53.88 Aligned_cols=73 Identities=8% Similarity=0.004 Sum_probs=47.3
Q ss_pred ceeeecCcEeEEEEEecC--------CcEEEEEEeccCCccchHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEE
Q 010186 355 NILGQGGFGPVYKGVLSD--------GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 425 (516)
+.|..|-.-.+|+....+ +..+++|+..... ...-.-.+|..+++.+. +.-..++++.+ . .++|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence 456667778899988653 5788888865432 22223467888887773 22245566533 2 378999
Q ss_pred ccCCCCh
Q 010186 426 FMPNGSL 432 (516)
Q Consensus 426 y~~~gsL 432 (516)
|++|..|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.53 E-value=0.66 Score=46.57 Aligned_cols=29 Identities=24% Similarity=0.423 Sum_probs=25.0
Q ss_pred eeeCCCCCCCeEe------cCCCcEEEcccCcccc
Q 010186 472 IVHRDLKASNVLL------DSDMNSKISDFGMARI 500 (516)
Q Consensus 472 iiHrDlk~~NILl------d~~~~~kl~DFGla~~ 500 (516)
++|+|+.+.|||+ +++..++++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567799999998864
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=84.77 E-value=0.15 Score=52.47 Aligned_cols=60 Identities=15% Similarity=0.094 Sum_probs=18.0
Q ss_pred CceeeecCcEeEEEEEecC-CcEEEE------EEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEe
Q 010186 354 SNILGQGGFGPVYKGVLSD-GKEVAV------KRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416 (516)
Q Consensus 354 ~~~Lg~G~fg~Vy~~~~~~-g~~vav------K~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 416 (516)
.+.|| ||.||+|.+.. ..+||| |..+.. +.+....|.+|..++..++|||+++.+++...
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 45566 99999999754 468888 766542 23344578899999999999999999987654
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=83.44 E-value=4 Score=37.00 Aligned_cols=88 Identities=10% Similarity=0.022 Sum_probs=62.5
Q ss_pred CCCCccceeeEEEeCCeeEEEEEccCCCC-hhHHhcCCCCCCCCCHHHHHHHHHHHHHHHH-HhHcCCCCCeeeCCCCCC
Q 010186 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGS-LDAILFDPRKRGILCWRKRTNIVNGIAKGML-YLHEDSRLRIVHRDLKAS 480 (516)
Q Consensus 403 ~H~niv~l~g~~~~~~~~~lV~Ey~~~gs-L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~-yLH~~~~~~iiHrDlk~~ 480 (516)
.||.+ --.+-.+.+...+.++.-+++. +..+ ..++..++++++..|+.-.. ++++ -+|--|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 57777 2233355666666666553333 3333 23678899999999888777 6653 578899999
Q ss_pred CeEecCCCcEEEcccCcccccccC
Q 010186 481 NVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 481 NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||++|.++.++|.-.|+-..+.+.
T Consensus 114 NL~f~~~~~p~i~hRGi~~~lpP~ 137 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKESLPPD 137 (219)
T ss_dssp GEEECTTCCEEESCCEETTTBSSC
T ss_pred eEEEeCCCcEEEEEcCCcccCCCC
Confidence 999999999999999987666544
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=83.22 E-value=2.7 Score=37.92 Aligned_cols=89 Identities=9% Similarity=0.042 Sum_probs=64.3
Q ss_pred CCCCccceeeEEEeCCeeEEEEEccCC-CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCC
Q 010186 403 QHKNLVKLLGFCVDGDEKLLVYEFMPN-GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASN 481 (516)
Q Consensus 403 ~H~niv~l~g~~~~~~~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~N 481 (516)
.||+++.. .+-.+.+...+.++.-++ -++.. + ..++..++++++..|+.-..+++. -+|--|.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence 67888866 455555655555554432 22322 2 246788999999999988866654 4788999999
Q ss_pred eEecCCCcEEEcccCcccccccC
Q 010186 482 VLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 482 ILld~~~~~kl~DFGla~~~~~~ 504 (516)
|++|.++.++|.--|+-..+.+.
T Consensus 110 L~f~~~~~p~i~~RGik~~l~P~ 132 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVVDPL 132 (215)
T ss_dssp EEECTTSCEEESCCEETTTBSCC
T ss_pred EEEcCCCCEEEEEccCccCCCCC
Confidence 99999999999999986666544
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 516 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-48 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-45 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-45 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-45 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-43 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-43 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-43 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-42 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-42 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-42 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-41 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-41 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-41 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-41 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-41 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-40 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-40 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-39 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-39 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-38 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-38 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-38 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-38 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-37 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-37 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-37 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-37 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-36 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-36 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-36 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-36 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-35 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-35 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-35 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-34 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-34 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-33 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-32 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-32 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-32 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-31 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-31 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-31 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-31 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-29 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-29 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-29 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-28 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-26 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-26 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-26 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-26 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-26 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-24 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-23 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-23 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-22 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-22 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-18 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 2e-48
Identities = 48/168 (28%), Positives = 80/168 (47%), Gaps = 6/168 (3%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
+ +G G FG VYKG V + +++ + Q F NEV ++ K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
+G+ + +V ++ SL L + K +I A+GM YLH S
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS 124
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
I+HRDLK++N+ L D+ KI DFG+A + + G ++ G+
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 2e-45
Identities = 42/163 (25%), Positives = 74/163 (45%), Gaps = 7/163 (4%)
Query: 344 LNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGT-AEFTNEVLLILK 401
+ L +F + LG G G V+K G +A K + + + E+ ++ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 402 LQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
+V G E + E M GSLD +L +K G + + + + KG+
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504
YL + +I+HRD+K SN+L++S K+ DFG++ +S
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 3e-45
Identities = 49/192 (25%), Positives = 84/192 (43%), Gaps = 22/192 (11%)
Query: 322 YQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKR 380
Y+HV DL +DF+ + L G G FG VYK A K
Sbjct: 1 YEHVT---RDLNPEDFWEIIGEL-------------GDGAFGKVYKAQNKETSVLAAAKV 44
Query: 381 LSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR 440
+ + SE+ ++ E+ ++ H N+VKLL + ++ EF G++DA++
Sbjct: 45 IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML--E 102
Query: 441 KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500
L + + + YLH+ +I+HRDLKA N+L D + K++DFG++
Sbjct: 103 LERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAK 159
Query: 501 FAESEGEANTVR 512
+ ++
Sbjct: 160 NTRTIQRRDSFI 171
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 6e-45
Identities = 52/168 (30%), Positives = 81/168 (48%), Gaps = 7/168 (4%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
LG G FG V+ G + +VAVK L F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLV 71
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
+L + ++ E+M NGSL L P L K ++ IA+GM ++ E +
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN 129
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
+HRDL+A+N+L+ ++ KI+DFG+AR+ ++E A
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFP 173
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (392), Expect = 1e-43
Identities = 49/173 (28%), Positives = 78/173 (45%), Gaps = 16/173 (9%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGT---AEFTNEVLLILKLQ 403
FSD +G G FG VY + + + VA+K++S +Q + EV + KL+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
H N ++ G + LV E+ + D + + L + + +G +G+ Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAY 130
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
LH ++HRD+KA N+LL K+ DFG A I A + VGT
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------SFVGT 174
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 4e-43
Identities = 46/168 (27%), Positives = 75/168 (44%), Gaps = 7/168 (4%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
+ + LG G FG V G +VA+K + EF E +++ L H+ LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
+L G C ++ E+M NG L L + R R ++ + + + M YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK- 119
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
+ +HRDL A N L++ K+SDFG++R + E ++V
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFP 164
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 152 bits (386), Expect = 5e-43
Identities = 59/195 (30%), Positives = 93/195 (47%), Gaps = 22/195 (11%)
Query: 338 FID---LETLNLATSNFSDS---------NILGQGGFGPVYKGVLSDGKE----VAVKRL 381
FID E N A F+ ++G G FG V G L + VA+K L
Sbjct: 3 FIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL 62
Query: 382 -SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR 440
S +E+ +F +E ++ + H N++ L G +++ EFM NGSLD+ F +
Sbjct: 63 KSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS--FLRQ 120
Query: 441 KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500
G + ++ GIA GM YL + VHRDL A N+L++S++ K+SDFG++R
Sbjct: 121 NDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177
Query: 501 FAESEGEANTVRIVG 515
+ + +G
Sbjct: 178 LEDDTSDPTYTSALG 192
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 3e-42
Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 7/168 (4%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
S + +G G FG V+ G + +VA+K + +F E +++KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
+L G C++ LV+EFM +G L + +RG+ + + +GM YL E
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEE-- 119
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
++HRDL A N L+ + K+SDFGM R + + ++
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFP 165
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 149 bits (378), Expect = 4e-42
Identities = 48/163 (29%), Positives = 79/163 (48%), Gaps = 6/163 (3%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL 407
++ + + LG G +G VY+GV VAVK L + + EF E ++ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNL 75
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
V+LLG C ++ EFM G+L L + R + + I+ M YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLE-- 132
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
+ +HRDL A N L+ + K++DFG++R+ A+
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 174
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (376), Expect = 5e-42
Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 8/170 (4%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAEFTNEVLLILKLQHKN 406
++ +G G +G K SDGK + K L S +E +EV L+ +L+H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 407 LVKLLGFCVDGDEKLL--VYEFMPNGSLDAILFDPRK-RGILCWRKRTNIVNGIAKGMLY 463
+V+ +D L V E+ G L +++ K R L ++ + +
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 464 LHE--DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV 511
H D ++HRDLK +NV LD N K+ DFG+ARI A
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAF 174
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-41
Identities = 50/162 (30%), Positives = 79/162 (48%), Gaps = 6/162 (3%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
+ LGQG FG V+ G + VA+K L F E ++ KL+H+ LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
+L + +V E+M GSL L L + ++ IA GM Y+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVE--- 130
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
R+ VHRDL+A+N+L+ ++ K++DFG+AR+ ++E A
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (375), Expect = 2e-41
Identities = 54/205 (26%), Positives = 81/205 (39%), Gaps = 31/205 (15%)
Query: 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLS-SCSEQGTAEF 392
L +L +N +G+G FG V++ VAVK L S A+F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 393 TNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------- 444
E L+ + + N+VKLLG C G L++E+M G L+ L +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 445 -------------LCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSK 491
L ++ I +A GM YL E + VHRDL N L+ +M K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 492 ISDFGMARIFAESEGEANTVRIVGT 516
I+DFG++R ++
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIP 205
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 3e-41
Identities = 51/158 (32%), Positives = 76/158 (48%), Gaps = 8/158 (5%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
+G+G FG V G G +VAVK + + + F E ++ +L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLV 63
Query: 409 KLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
+LLG V+ L +V E+M GSL L R R +L + + M YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
VHRDL A NVL+ D +K+SDFG+ + + ++
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 157
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 5e-41
Identities = 52/179 (29%), Positives = 81/179 (45%), Gaps = 12/179 (6%)
Query: 344 LNLATSNFSDSNI-LGQGGFGPVYKGVL---SDGKEVAVKRLSSCSEQG-TAEFTNEVLL 398
L L N ++I LG G FG V +GV +VA+K L +E+ T E E +
Sbjct: 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62
Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIA 458
+ +L + +V+L+G C + +LV E G L L R+ + +++ ++
Sbjct: 63 MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVS 119
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN-TVRIVGT 516
GM YL VHRDL A NVLL + +KISDFG+++ +
Sbjct: 120 MGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 6e-41
Identities = 58/239 (24%), Positives = 91/239 (38%), Gaps = 41/239 (17%)
Query: 306 QIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPV 365
Q+Q+ ++ ++D ++ Y + + DLK + E N +LG G FG V
Sbjct: 4 QLQMVQVTGSSDNEYFYVDFREYEYDLK---WEFPRE-------NLEFGKVLGSGAFGKV 53
Query: 366 YKGVLSD------GKEVAVKRLSSCSEQGTAE-FTNEVLLILKL-QHKNLVKLLGFCVDG 417
+VAVK L ++ E +E+ ++ +L H+N+V LLG C
Sbjct: 54 MNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113
Query: 418 DEKLLVYEFMPNGSLDAILFDPRKR--------------------GILCWRKRTNIVNGI 457
L++E+ G L L R++ +L + +
Sbjct: 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 173
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
AKGM +L VHRDL A NVL+ KI DFG+AR
Sbjct: 174 AKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP 229
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-40
Identities = 47/169 (27%), Positives = 76/169 (44%), Gaps = 8/169 (4%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNL 407
++ LG+G +G V V + VAVK + + E+ + L H+N+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
VK G +G+ + L E+ G L + + + + G++YLH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHG- 121
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
+ I HRD+K N+LLD N KISDFG+A +F + E ++ GT
Sbjct: 122 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 6e-40
Identities = 45/171 (26%), Positives = 77/171 (45%), Gaps = 17/171 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
+G+G FG V++G G+EVAVK SS E+ + E+ + L+H+N++ +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSS-REERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 417 GDEKL----LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED----- 467
+ LV ++ +GSL L R + + A G+ +LH +
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV--RIVGT 516
+ I HRDLK+ N+L+ + I+D G+A + + VGT
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 1e-39
Identities = 51/191 (26%), Positives = 69/191 (36%), Gaps = 26/191 (13%)
Query: 349 SNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSCSEQGTAE-FTNEVLLILK 401
+ S LG G FG V + VAVK L + E +E+ ++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 402 L-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI---------------L 445
L H N+V LLG C G L++ E+ G L L R I L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 446 CWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
+ +AKGM +L +HRDL A N+LL +KI DFG+AR
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 506 GEANTVRIVGT 516
Sbjct: 200 NYVVKGNARLP 210
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 4e-39
Identities = 51/185 (27%), Positives = 80/185 (43%), Gaps = 19/185 (10%)
Query: 338 FIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSD---GKEVAVKRL--SSCSEQGTAEF 392
++D + L L + LG G FG V KG K VAVK L + E
Sbjct: 2 YLDRKLLTL------EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDEL 55
Query: 393 TNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN 452
E ++ +L + +V+++G C + + +LV E G L+ L + + +
Sbjct: 56 LAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIE 111
Query: 453 IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT-V 511
+V+ ++ GM YL VHRDL A NVLL + +KISDFG+++ E
Sbjct: 112 LVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168
Query: 512 RIVGT 516
Sbjct: 169 HGKWP 173
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-38
Identities = 42/170 (24%), Positives = 87/170 (51%), Gaps = 10/170 (5%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN 406
++ +GQG G VY + ++ G+EVA+++++ + NE+L++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
+V L + GDE +V E++ GSL ++ + + + + + +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD----EGQIAAVCRECLQALEFLHS 134
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
+++HRD+K+ N+LL D + K++DFG + + +T +VGT
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 179
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-38
Identities = 47/186 (25%), Positives = 84/186 (45%), Gaps = 16/186 (8%)
Query: 333 KAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGK----EVAVKRLSSCSEQG 388
Q I +L + +F+ ++G+G FG VY G L D AVK L+ ++ G
Sbjct: 16 AVQHVVIGPSSLIV---HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG 70
Query: 389 -TAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK-LLVYEFMPNGSLDAILFDPRKRGILC 446
++F E +++ H N++ LLG C+ + L+V +M +G L + + +
Sbjct: 71 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 130
Query: 447 WRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506
+ + + + VHRDL A N +LD K++DFG+AR + E
Sbjct: 131 DLIGFGLQVAKG-----MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185
Query: 507 EANTVR 512
++ +
Sbjct: 186 DSVHNK 191
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (350), Expect = 3e-38
Identities = 45/172 (26%), Positives = 73/172 (42%), Gaps = 14/172 (8%)
Query: 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQH 404
+F LG+G FG VY +A+K L + EV + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
N+++L G+ D L+ E+ P G++ L +K ++ + +A + Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYC 122
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
H R++HRD+K N+LL S KI+DFG + S + GT
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGT 167
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 4e-38
Identities = 46/170 (27%), Positives = 77/170 (45%), Gaps = 16/170 (9%)
Query: 355 NILGQGGFGPVYKGVLSD-GKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
+G+G F VYKG+ ++ EVA L ++ F E ++ LQH N+V+
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 412 GFCVDGDEK----LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
+ +LV E M +G+L L ++ ++ + + I KG+ +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTR 131
Query: 468 SRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGT 516
+ I+HRDLK N+ + S KI D G+A + S ++GT
Sbjct: 132 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGT 176
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-37
Identities = 54/174 (31%), Positives = 88/174 (50%), Gaps = 11/174 (6%)
Query: 343 TLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE-----VAVKRLS-SCSEQGTAEFTNEV 396
T + S + ++G G FG VYKG+L VA+K L +E+ +F E
Sbjct: 1 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60
Query: 397 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG 456
++ + H N+++L G +++ E+M NG+LD F K G + ++ G
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRG 118
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
IA GM YL + VHRDL A N+L++S++ K+SDFG++R+ + T
Sbjct: 119 IAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 169
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 2e-37
Identities = 53/174 (30%), Positives = 87/174 (50%), Gaps = 12/174 (6%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKE----VAVKRLS-SCSEQGTAEFTNEVLLILKL 402
+ F +LG G FG VYKG+ + +G++ VA+K L + S + E +E ++ +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
+ ++ +LLG C+ L+ + MP G L + + + + N IAKGM
Sbjct: 69 DNPHVCRLLGICLTSTV-QLITQLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
YL R+VHRDL A NVL+ + + KI+DFG+A++ E E +
Sbjct: 126 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 138 bits (349), Expect = 3e-37
Identities = 38/153 (24%), Positives = 67/153 (43%), Gaps = 8/153 (5%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
LG G FG V++ + G A K + + E E+ + L+H LV L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
D +E +++YEFM G L + + + + + + KG+ ++HE VH
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVH 147
Query: 475 RDLKASNVLLDSDMNS--KISDFGMARIFAESE 505
DLK N++ + ++ K+ DFG+ +
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 4e-37
Identities = 54/182 (29%), Positives = 80/182 (43%), Gaps = 17/182 (9%)
Query: 349 SNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLS-SCSEQGTAEFTNEVLLILK 401
+ S LGQG FG VY+GV VA+K ++ + S + EF NE ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 402 LQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRK-------RGILCWRKRTNIV 454
++V+LLG G L++ E M G L + L R K +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
IA GM YL+ + + VHRDL A N ++ D KI DFGM R E++ + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 515 GT 516
Sbjct: 197 LP 198
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 1e-36
Identities = 45/186 (24%), Positives = 80/186 (43%), Gaps = 24/186 (12%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDG---KEVAVKRLS-SCSEQGTAEFTNEVLLILKL-Q 403
++ +++G+G FG V K + + A+KR+ S+ +F E+ ++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL-------------FDPRKRGILCWRKR 450
H N++ LLG C L E+ P+G+L L L ++
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
+ +A+GM YL + + +HRDL A N+L+ + +KI+DFG++R
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KK 183
Query: 511 VRIVGT 516
Sbjct: 184 TMGRLP 189
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 137 bits (345), Expect = 1e-36
Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 17/170 (10%)
Query: 343 TLNLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLS---SCSEQGTAEFTNEVLL 398
T+N +FS I+G+GGFG VY +D GK A+K L +QG NE ++
Sbjct: 2 TMN----DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 57
Query: 399 ILKLQ---HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN 455
+ + +V + D+ + + M G L L + G+
Sbjct: 58 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAA 114
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
I G+ ++H +V+RDLK +N+LLD + +ISD G+A F++ +
Sbjct: 115 EIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 161
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 2e-36
Identities = 49/170 (28%), Positives = 72/170 (42%), Gaps = 10/170 (5%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQHK 405
+F ILG+G F V L+ +E A+K L E T E ++ +L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
VKL D ++ + NG L + K G I + YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLH 125
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515
I+HRDLK N+LL+ DM+ +I+DFG A++ + +A VG
Sbjct: 126 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 172
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 134 bits (339), Expect = 6e-36
Identities = 40/152 (26%), Positives = 70/152 (46%), Gaps = 8/152 (5%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
LG G FG V++ V + G+ K +++ NE+ ++ +L H L+ L
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96
Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
D E +L+ EF+ G L + + + + N + +G+ ++HE IVH
Sbjct: 97 DKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHL 151
Query: 476 DLKASNVLLDSDMNS--KISDFGMARIFAESE 505
D+K N++ ++ S KI DFG+A E
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATKLNPDE 183
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 1e-35
Identities = 49/174 (28%), Positives = 71/174 (40%), Gaps = 13/174 (7%)
Query: 350 NFSDSNILGQGGFGPVYKGVL----SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL 402
+ LG G FG V +G VAVK L + +F EV + L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
H+NL++L G + K+ V E P GSL + +G + +A+GM
Sbjct: 69 DHRNLIRLYGVVLTPPMKM-VTELAPLGSLL--DRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
YL R +HRDL A N+LL + KI DFG+ R +++
Sbjct: 126 YLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 2e-35
Identities = 37/165 (22%), Positives = 76/165 (46%), Gaps = 5/165 (3%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAE-FTNEVLLILKLQHK 405
+++ + +G+G +G V + VA+K++S Q + E+ ++L+ +H+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
N++ + + + ++ + A L+ K L + I +G+ Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
++HRDLK SN+LL++ + KI DFG+AR+
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 168
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 3e-35
Identities = 45/170 (26%), Positives = 76/170 (44%), Gaps = 15/170 (8%)
Query: 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
+++D+ ++G G FG VY+ L G+ VA+K++ E+ ++ KL H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIV 76
Query: 409 KLLGFCVDGDEK------LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
+L F EK LV +++P R + L + + + +
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGMARIFAESEGEANTV 511
Y+H I HRD+K N+LLD D K+ DFG A+ E + +
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 1e-34
Identities = 42/166 (25%), Positives = 73/166 (43%), Gaps = 12/166 (7%)
Query: 356 ILGQGGFGPVYKGVLSDGKE----VAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKL 410
+G+G FG V++G+ + VA+K +C+ E F E L + + H ++VKL
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
+G + + ++ E G L + F ++ L ++ + YL
Sbjct: 74 IGVITE-NPVWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYLES---K 127
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
R VHRD+ A NVL+ S+ K+ DFG++R E +
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLP 172
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 6e-34
Identities = 48/190 (25%), Positives = 68/190 (35%), Gaps = 25/190 (13%)
Query: 349 SNFSDSNILGQGGFGPVYKGV------LSDGKEVAVKRLSSCSEQGTAE--FTNEVLLIL 400
LG+G FG V + + + VAVK L + + +LI
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 401 KLQHKNLVKLLGFCV-DGDEKLLVYEFMPNGSLDAILFDPRK-------------RGILC 446
H N+V LLG C G +++ EF G+L L R + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 447 WRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506
+AKGM +L + +HRDL A N+LL KI DFG+AR +
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 507 EANTVRIVGT 516
Sbjct: 190 YVRKGDARLP 199
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-33
Identities = 50/191 (26%), Positives = 80/191 (41%), Gaps = 26/191 (13%)
Query: 349 SNFSDSNILGQGGFGPVYKGVL--------SDGKEVAVKRL-SSCSEQGTAEFTNEVLLI 399
LG+G FG V + +VAVK L S +E+ ++ +E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 400 LKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------------L 445
+ +HKN++ LLG C ++ E+ G+L L R G+ L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 446 CWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
+ + +A+GM YL + +HRDL A NVL+ D KI+DFG+AR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 506 GEANTVRIVGT 516
T
Sbjct: 190 YYKKTTNGRLP 200
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 125 bits (314), Expect = 4e-33
Identities = 47/167 (28%), Positives = 75/167 (44%), Gaps = 17/167 (10%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS---------SCSEQGTAEFTNEVLLI 399
N+ ILG+G V + + KE AVK + ++ EV ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 400 LKLQ-HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIA 458
K+ H N+++L LV++ M G L L ++ L ++ I+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALL 120
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
+ + LH+ L IVHRDLK N+LLD DMN K++DFG + E
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 164
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 2e-32
Identities = 33/152 (21%), Positives = 67/152 (44%), Gaps = 9/152 (5%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
LG+G FG V++ V S K K + E+ ++ +H+N++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
+E ++++EF+ + + L R+ + V+ + + + +LH I H
Sbjct: 72 SMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHS---HNIGHF 126
Query: 476 DLKASNVLLDSDMNS--KISDFGMARIFAESE 505
D++ N++ + +S KI +FG AR +
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 123 bits (308), Expect = 3e-32
Identities = 43/164 (26%), Positives = 75/164 (45%), Gaps = 8/164 (4%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNL 407
+ +G+G +G VYK + G+ A+K RL E + E+ ++ +L+H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
VKL +LV+E + + G L + + + G+ Y H+
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHD- 118
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV 511
R++HRDLK N+L++ + KI+DFG+AR F +
Sbjct: 119 --RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 122 bits (308), Expect = 5e-32
Identities = 37/160 (23%), Positives = 70/160 (43%), Gaps = 10/160 (6%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQH 404
+F LG G FG V+ +G+ A+K L + +E L++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
++++ G D + ++ +++ G L ++L ++ + V L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504
I++RDLK N+LLD + + KI+DFG A+ +
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 2e-31
Identities = 42/156 (26%), Positives = 70/156 (44%), Gaps = 12/156 (7%)
Query: 355 NILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAE-----FTNEVLLILKLQHKNLV 408
+ LG+G F VYK + + VA+K++ + E+ L+ +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
LL LV++FM +L + +G+ YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504
I+HRDLK +N+LLD + K++DFG+A+ F
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 121 bits (304), Expect = 2e-31
Identities = 36/164 (21%), Positives = 67/164 (40%), Gaps = 8/164 (4%)
Query: 355 NILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGT-AEFTNEVLLILKLQHKNLVKLLG 412
++LG G F V K VA+K ++ + +G NE+ ++ K++H N+V L
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
G L+ + + G L + ++G R + ++ + + YLH+ +
Sbjct: 75 IYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHR 131
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
+ LD D ISDFG++++ GT
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGT 172
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 5e-31
Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 8/165 (4%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKN 406
NF +G+G +G VYK G+ VA+K RL + +E + E+ L+ +L H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
+VKLL ++ LV+EF+ D + + + + +G+ + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV 511
R++HRDLK N+L++++ K++DFG+AR F
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE 162
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 6e-31
Identities = 45/172 (26%), Positives = 70/172 (40%), Gaps = 13/172 (7%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS---SCSEQGTAEFTNEV-LLILKLQH 404
+F +LG+G FG V+ + A+K L + E +L L +H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
L + + V E++ G L + + + T I G+ +L
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGLQFL 119
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
H IV+RDLK N+LLD D + KI+DFGM + + + NT GT
Sbjct: 120 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGT 166
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 114 bits (287), Expect = 2e-29
Identities = 40/170 (23%), Positives = 72/170 (42%), Gaps = 15/170 (8%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
ILG GG V+ L ++VAVK L + F E L H +V +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 412 GFCVDGDEKL----LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
+V E++ +L I+ G + ++ ++ + + + H+
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSHQ- 129
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE-ANTVRIVGT 516
I+HRD+K +N+++ + K+ DFG+AR A+S T ++GT
Sbjct: 130 --NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 8e-29
Identities = 45/181 (24%), Positives = 82/181 (45%), Gaps = 19/181 (10%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAEFTNEVLLILKLQHK 405
S + +GQG FG V+K G++VA+K++ + E E+ ++ L+H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 406 NLVKLLGFCVDGDEK--------LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGI 457
N+V L+ C LV++F + + ++ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG---LLSNVLVKFTLSEIKRVMQML 126
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR--IVG 515
G+ Y+H + +I+HRD+KA+NVL+ D K++DFG+AR F+ ++ V
Sbjct: 127 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 516 T 516
T
Sbjct: 184 T 184
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 9e-29
Identities = 40/159 (25%), Positives = 69/159 (43%), Gaps = 18/159 (11%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGF 413
+LG G G V + ++ A+K L C + EV L + Q ++V+++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 73
Query: 414 CVDGDEK----LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
+ L+V E + G L + + D R R+ + I+ I + + YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHS--- 129
Query: 470 LRIVHRDLKASNVLLDSDMNS---KISDFGMARIFAESE 505
+ I HRD+K N+L S + K++DFG A+
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 5e-28
Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 9/154 (5%)
Query: 355 NILGQGGFGPVYKGV-LSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
+G+G +G V+K + VA+K RL E + E+ L+ +L+HKN+V+L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
+ LV+EF + G L + + + KG+ + H
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKK---YFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRN 121
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
++HRDLK N+L++ + K+++FG+AR F
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 6e-28
Identities = 41/171 (23%), Positives = 71/171 (41%), Gaps = 19/171 (11%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAE------FTNEVLLILKLQ--HKN 406
+LG GGFG VY G+ +SD VA+K + E EV+L+ K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
+++LL + D +L+ E +RG L + + + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHN 128
Query: 467 DSRLRIVHRDLKASNVLLDSD-MNSKISDFGMARIFAESEGEANTVRIVGT 516
++HRD+K N+L+D + K+ DFG + ++ GT
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGT 172
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 1e-26
Identities = 42/171 (24%), Positives = 67/171 (39%), Gaps = 12/171 (7%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQHK 405
+F +LG+G FG V + G+ A+K L ++ A E ++ +H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
L L D V E+ G L L + + + I + YLH
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLH 122
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
+V+RD+K N++LD D + KI+DFG+ + A GT
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGT 168
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 2e-26
Identities = 43/160 (26%), Positives = 66/160 (41%), Gaps = 17/160 (10%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRL------SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
LG G F V K S G + A K + SS + EV ++ ++QH N++
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
L + + +L+ E + G L ++ L + T + I G+ YLH
Sbjct: 78 LHEVYENKTDVILILELVAGGELF---DFLAEKESLTEEEATEFLKQILNGVYYLHS--- 131
Query: 470 LRIVHRDLKASNVLLDSDMNS----KISDFGMARIFAESE 505
L+I H DLK N++L KI DFG+A
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 171
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 2e-26
Identities = 45/174 (25%), Positives = 79/174 (45%), Gaps = 20/174 (11%)
Query: 355 NILGQGGFGPVYKG--VLSDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKL---QHKNL 407
+G+G +G V+K + + G+ VA+KR+ + E EV ++ L +H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 408 VKLLGFCVDGDEK-----LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
V+L C LV+E + D + +++ + +G+
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVPEPGVPTETIKDMMFQLLRGLD 130
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
+LH R+VHRDLK N+L+ S K++DFG+ARI++ +V T
Sbjct: 131 FLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVT 178
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 3e-26
Identities = 45/165 (27%), Positives = 72/165 (43%), Gaps = 17/165 (10%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAEFTNEVLLILKLQHK 405
+ + D +G G +G V V G +VA+K+L SE E+ L+ ++H+
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 406 NLVKLLGFCVDGD------EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
N++ LL + + LV FM + K L + +V + K
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLK 132
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504
G+ Y+H I+HRDLK N+ ++ D KI DFG+AR
Sbjct: 133 GLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 105 bits (262), Expect = 7e-26
Identities = 32/159 (20%), Positives = 65/159 (40%), Gaps = 13/159 (8%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC- 414
+G G FG +Y G ++ G+EVA+K C + + E + +Q + + +C
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLE--CVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
+GD ++V E + D + + + + + Y+H +H
Sbjct: 73 AEGDYNVMVMELLGPSLED---LFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIH 126
Query: 475 RDLKASNVLLDSDMNSKI---SDFGMARIFAESEGEANT 510
RD+K N L+ + DFG+A+ + ++ +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 165
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 106 bits (264), Expect = 8e-26
Identities = 39/156 (25%), Positives = 59/156 (37%), Gaps = 10/156 (6%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQHK 405
F LG G FG V G A+K L + NE ++ +
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
LVKL D +V E++ G + + L + G I YLH
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
L +++RDLK N+L+D +++DFG A+
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 101 bits (252), Expect = 1e-24
Identities = 30/172 (17%), Positives = 64/172 (37%), Gaps = 20/172 (11%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH-KNLVKLLGFC 414
+G+G FG +++G L + ++VA+K + +E L + + F
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
+G +LV + + D + + + + +HE +V+
Sbjct: 71 QEGLHNVLVIDLLGPSLEDLLD---LCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVY 124
Query: 475 RDLKASNVLLDSDMNS-----KISDFGMARIFAESEGEANTVR-----IVGT 516
RD+K N L+ + + DFGM + + + + + + GT
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 102 bits (254), Expect = 2e-24
Identities = 39/190 (20%), Positives = 84/190 (44%), Gaps = 21/190 (11%)
Query: 324 HVQGRDNDLKAQDFFIDLETLNLATSNFSDSNI---LGQGGFGPVYKGV-LSDGKEVAVK 379
V N + ++++ D E+ + N D + LG+G + V++ + +++ ++V VK
Sbjct: 8 RVYTDVNTHRPREYW-DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVK 66
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKL--LVYEFMPNGSLDAIL 436
L ++ + E+ ++ L+ N++ L D + LV+E + N +
Sbjct: 67 ILKPVKKK---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY 123
Query: 437 FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDF 495
L + I K + Y H + I+HRD+K NV++D + ++ D+
Sbjct: 124 ------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDW 174
Query: 496 GMARIFAESE 505
G+A + +
Sbjct: 175 GLAEFYHPGQ 184
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 95.6 bits (237), Expect = 1e-23
Identities = 30/174 (17%), Positives = 54/174 (31%), Gaps = 28/174 (16%)
Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRL----------SSCSEQGTAEFTNEVLLILKLQH 404
++G+G V+ E VK + G F+ + + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 405 KNLVKLLGFCV----DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
+ L KL G V + ++ E + R + +++ I +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELID--------AKELYRVRVENPDE--VLDMILEE 115
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
+ + IVH DL NVL+ + I DF + E R V
Sbjct: 116 VAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDV 165
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.2 bits (241), Expect = 7e-23
Identities = 39/167 (23%), Positives = 70/167 (41%), Gaps = 15/167 (8%)
Query: 350 NFSDSNILGQGGFGPVYKGVL----SDGKEVAVKRLS----SCSEQGTAEFTNEVLLILK 401
NF +LG G +G V+ GK A+K L + T E ++
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 402 LQHK-NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
++ LV L + L+ +++ G L L + + + +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY------VGEI 138
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
+L L +L I++RD+K N+LLDS+ + ++DFG+++ F E E
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 185
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.6 bits (239), Expect = 2e-22
Identities = 42/159 (26%), Positives = 69/159 (43%), Gaps = 18/159 (11%)
Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
+G G G V + VA+K+LS ++ E++L+ + HKN++ LL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 413 FCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
+ + LV E M I + + + ++ + G+ +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLCGIKHLHS 137
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
I+HRDLK SN+++ SD KI DFG+AR S
Sbjct: 138 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.3 bits (236), Expect = 4e-22
Identities = 42/153 (27%), Positives = 66/153 (43%), Gaps = 15/153 (9%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
+G G +G V G VAVK+LS S E+ L+ ++H+N++ LL
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 414 CVDGD-----EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
+ + + L+ I K L ++ I +G+ Y+H
Sbjct: 86 FTPARSLEEFNDVYLVTHLMGADLNNI----VKCQKLTDDHVQFLIYQILRGLKYIHS-- 139
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
I+HRDLK SN+ ++ D KI DFG+AR
Sbjct: 140 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 82.8 bits (203), Expect = 9e-18
Identities = 40/176 (22%), Positives = 70/176 (39%), Gaps = 23/176 (13%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
LG G F V+ + + VA+K + + T +E+ L+ ++ + K
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 416 DGDEKLLVY--EFMPNGSLDAILFDPRKRGILCWRKRTN-----------IVNGIAKGML 462
+ KLL + PNG ++F+ +L K+ I + G+
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNS------KISDFGMARIFAESEGEANTVR 512
Y+H R I+H D+K NVL++ + KI+D G A + E + R
Sbjct: 140 YMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 516 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.98 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.98 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.98 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.97 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.97 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.97 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.97 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.97 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.97 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.97 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.97 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.97 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.97 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.97 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.97 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.97 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.97 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.97 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.97 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.97 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.97 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.96 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.96 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.96 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.96 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.96 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.96 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.96 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.96 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.96 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.96 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.96 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.96 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.96 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.96 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.96 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.96 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.96 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.95 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.95 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.95 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.95 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.95 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.95 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.94 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.94 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.94 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.94 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.94 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.93 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.93 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.93 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.84 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.64 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.17 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.64 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.12 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.47 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.54 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-34 Score=276.65 Aligned_cols=162 Identities=29% Similarity=0.414 Sum_probs=139.8
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
++|...+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..||||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 4577889999999999999996 468999999997532 33456799999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCCC
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 506 (516)
+++|+|.+++. ....+++.++..++.||+.||.|||+++ |+||||||+||||++++.+||+|||+|+.+..+..
T Consensus 85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999984 3457999999999999999999999998 99999999999999999999999999998876654
Q ss_pred ccCccceecC
Q 010186 507 EANTVRIVGT 516 (516)
Q Consensus 507 ~~~~~~~~GT 516 (516)
......++||
T Consensus 159 ~~~~~~~~GT 168 (271)
T d1nvra_ 159 ERLLNKMCGT 168 (271)
T ss_dssp ECCBCCCCSC
T ss_pred cccccceeeC
Confidence 4434456776
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.4e-34 Score=278.39 Aligned_cols=159 Identities=30% Similarity=0.477 Sum_probs=141.0
Q ss_pred HHHHhhCCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 010186 343 TLNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 343 ~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 421 (516)
++++..++|...+.||+|+||.||+|++. +++.||||+++.. ....++|.+|+.+|++++|||||+++|++.+++..+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 34455667888899999999999999965 5889999998753 345678999999999999999999999999999999
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+||||+++|+|.+++.. .....+++..++.++.||++||.|||+++ |+||||||+||||++++.+||+|||+|+.+
T Consensus 90 iv~E~~~~g~l~~~l~~-~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp EEEECCTTCBHHHHHHH-SCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred EEeecccCcchHHHhhh-ccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeec
Confidence 99999999999999854 23457899999999999999999999997 999999999999999999999999999988
Q ss_pred ccCCC
Q 010186 502 AESEG 506 (516)
Q Consensus 502 ~~~~~ 506 (516)
..+..
T Consensus 166 ~~~~~ 170 (287)
T d1opja_ 166 TGDTY 170 (287)
T ss_dssp CSSSS
T ss_pred CCCCc
Confidence 76543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-34 Score=274.61 Aligned_cols=164 Identities=32% Similarity=0.499 Sum_probs=133.5
Q ss_pred HHhhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 010186 345 NLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 345 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 422 (516)
++..++|...+.||+|+||.||+|+++ ..||||+++.. +....+.|.+|+.++.+++|||||+++|++.+ +..+|
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence 345678889999999999999999864 36999998653 34556789999999999999999999998754 56899
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
||||+++|+|.+++.. .+..+++.++..++.||++||.|||+++ ||||||||+||||+.++.+||+|||+|+...
T Consensus 81 v~Ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EEECCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EEecCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 9999999999999854 3346999999999999999999999987 9999999999999999999999999999886
Q ss_pred cCCCccCccceecC
Q 010186 503 ESEGEANTVRIVGT 516 (516)
Q Consensus 503 ~~~~~~~~~~~~GT 516 (516)
.........++.||
T Consensus 156 ~~~~~~~~~~~~gt 169 (276)
T d1uwha_ 156 RWSGSHQFEQLSGS 169 (276)
T ss_dssp ----------CCCC
T ss_pred ccCCcccccccccC
Confidence 55443333345555
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-33 Score=271.86 Aligned_cols=159 Identities=26% Similarity=0.492 Sum_probs=141.0
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
++|...+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.++++++||||+++++++.+++..||||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4688899999999999999995 579999999998655556778999999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCCCc
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~ 507 (516)
++|+|.+++.. ..+++.++..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.+..+...
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence 99999998742 35899999999999999999999998 999999999999999999999999999988655433
Q ss_pred cCccceecC
Q 010186 508 ANTVRIVGT 516 (516)
Q Consensus 508 ~~~~~~~GT 516 (516)
.. ..+||
T Consensus 173 ~~--~~~gt 179 (293)
T d1yhwa1 173 RS--TMVGT 179 (293)
T ss_dssp BC--CCCSC
T ss_pred cc--ccccC
Confidence 22 24565
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-33 Score=273.26 Aligned_cols=155 Identities=32% Similarity=0.534 Sum_probs=136.1
Q ss_pred HHhhCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 345 NLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 345 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++..++|...+.||+|+||.||+|.+++++.||||+++.. ....+.|.+|++++.+++|||||+++|++.+ +..++||
T Consensus 9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence 3445677788999999999999999988899999999763 3456789999999999999999999998754 5679999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||+++|+|.+++.. .....++|.+++.|+.||++||.|||+++ |+||||||+||||++++.+||+|||+|+.+.++
T Consensus 87 Ey~~~g~L~~~~~~-~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 87 EYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp ECCTTCBHHHHTTS-HHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHhh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCC
Confidence 99999999998743 22335899999999999999999999987 999999999999999999999999999988765
Q ss_pred C
Q 010186 505 E 505 (516)
Q Consensus 505 ~ 505 (516)
.
T Consensus 163 ~ 163 (272)
T d1qpca_ 163 E 163 (272)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=3.8e-33 Score=268.47 Aligned_cols=151 Identities=32% Similarity=0.575 Sum_probs=130.5
Q ss_pred CCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccC
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 428 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 428 (516)
++|...+.||+|+||.||+|.+.+++.||||+++.. ....++|.+|++++++++||||++++|++.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 567778899999999999999988899999999763 3455789999999999999999999999999999999999999
Q ss_pred CCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCC
Q 010186 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 505 (516)
+|+|.+++.. ....++|..++.++.||++||.|||+.+ |+||||||+|||||+++.+||+|||+|+.+....
T Consensus 84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC
Confidence 9999998854 3456899999999999999999999998 9999999999999999999999999999876554
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=3.3e-33 Score=272.07 Aligned_cols=151 Identities=28% Similarity=0.442 Sum_probs=137.2
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
+.|...+.||+|+||.||+|+. .+++.||||+++..+....+.|.+|++++++++|||||++++++.+.+..+|||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 3567788999999999999996 468899999998766777888999999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
++|+|.+++.. ....+++.++..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163 (288)
T ss_dssp TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence 99999998743 2356999999999999999999999998 999999999999999999999999999876543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=7e-33 Score=269.62 Aligned_cols=162 Identities=30% Similarity=0.421 Sum_probs=137.2
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...+.||+|+||+||+|.. .+|+.||||++.+. +....+.+.+|++++++++||||+++++++.+++..||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4578889999999999999996 47899999998652 2345677999999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||+++|+|.+++. ..+.+++.++..++.||+.||.|||+.+ |+||||||+||||++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999884 3456999999999999999999999998 999999999999999999999999999988765
Q ss_pred CCccCccceecC
Q 010186 505 EGEANTVRIVGT 516 (516)
Q Consensus 505 ~~~~~~~~~~GT 516 (516)
.........+||
T Consensus 162 ~~~~~~~~~~GT 173 (288)
T d1uu3a_ 162 SKQARANSFVGT 173 (288)
T ss_dssp --------CCCC
T ss_pred CcccccccccCC
Confidence 544444445676
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.3e-33 Score=278.04 Aligned_cols=153 Identities=28% Similarity=0.392 Sum_probs=136.7
Q ss_pred HhhCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 010186 346 LATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 346 ~~~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 423 (516)
+..++|...++||+|+||.||+|+. .+|+.||+|+++.. +....+.+.+|+.+|+.++|||||++++++.+.+..+||
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3456788899999999999999995 47899999999753 333456799999999999999999999999999999999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC-CCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
|||+++|+|.+++. ..+.+++..+..++.||+.||.|||+. + |+||||||+||||++++.+||+|||+|+.+.
T Consensus 83 mEy~~gg~L~~~l~---~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EECCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEcCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 99999999999984 335699999999999999999999974 6 9999999999999999999999999999876
Q ss_pred cC
Q 010186 503 ES 504 (516)
Q Consensus 503 ~~ 504 (516)
+.
T Consensus 157 ~~ 158 (322)
T d1s9ja_ 157 DS 158 (322)
T ss_dssp HH
T ss_pred CC
Confidence 54
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=9.3e-33 Score=270.52 Aligned_cols=153 Identities=35% Similarity=0.589 Sum_probs=125.7
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CC---cEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DG---KEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g---~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 423 (516)
++|...++||+|+||+||+|.+. ++ ..||||++... .....+.|.+|+++|++++|||||+++|++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45667789999999999999964 23 25889988653 444567899999999999999999999999999999999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
|||+++|+|.+++.. ..+.++|.+++.++.||++||.|||+++ |+||||||+||||++++.+||+|||+|+.+.+
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998853 3456999999999999999999999987 99999999999999999999999999998865
Q ss_pred CCC
Q 010186 504 SEG 506 (516)
Q Consensus 504 ~~~ 506 (516)
...
T Consensus 181 ~~~ 183 (299)
T d1jpaa_ 181 DTS 183 (299)
T ss_dssp ---
T ss_pred CCC
Confidence 543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.6e-32 Score=263.63 Aligned_cols=151 Identities=28% Similarity=0.422 Sum_probs=135.2
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...+.||+|+||.||+++.. +++.||+|++.+. +....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 35777899999999999999964 6889999998642 2344667899999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||+++|+|.+++. ....+++.++..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+....+
T Consensus 86 Ey~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999984 3456999999999999999999999998 999999999999999999999999999887654
Q ss_pred C
Q 010186 505 E 505 (516)
Q Consensus 505 ~ 505 (516)
.
T Consensus 160 ~ 160 (263)
T d2j4za1 160 R 160 (263)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=7.8e-32 Score=258.13 Aligned_cols=152 Identities=30% Similarity=0.492 Sum_probs=137.9
Q ss_pred hCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
.++|...++||+|+||+||+|+++++++||||++++.. ...++|.+|+.++.+++||||++++|++.+++..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 35788899999999999999999888899999998643 34578999999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCC
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 505 (516)
++|+|..++.. ....+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.+..
T Consensus 82 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 82 ANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp TTEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred CCCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 99999998743 3456889999999999999999999987 9999999999999999999999999999876554
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.7e-32 Score=269.57 Aligned_cols=169 Identities=30% Similarity=0.423 Sum_probs=139.0
Q ss_pred HHhhCCCCCCceeeecCcEeEEEEEecC-C-----cEEEEEEecc-CCccchHHHHHHHHHHhcC-CCCCccceeeEEEe
Q 010186 345 NLATSNFSDSNILGQGGFGPVYKGVLSD-G-----KEVAVKRLSS-CSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVD 416 (516)
Q Consensus 345 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~-g-----~~vavK~l~~-~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 416 (516)
++..++|...++||+|+||+||+|+... + ..||||++.. ........+.+|+.++.++ +|||||+++|++.+
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 4455778889999999999999999642 2 3689999865 3445567899999999998 89999999999999
Q ss_pred CCeeEEEEEccCCCChhHHhcCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCC
Q 010186 417 GDEKLLVYEFMPNGSLDAILFDPRK--------------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD 476 (516)
Q Consensus 417 ~~~~~lV~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrD 476 (516)
.+..+|||||+++|+|.+++...+. ...+++.+++.++.||++||.|||+++ |||||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRD 189 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD 189 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecc
Confidence 9999999999999999999965322 235899999999999999999999998 99999
Q ss_pred CCCCCeEecCCCcEEEcccCcccccccCCCccCccceecC
Q 010186 477 LKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516 (516)
Q Consensus 477 lk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~GT 516 (516)
|||+|||++.++.+||+|||+|+............+..||
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt 229 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP 229 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEEC
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCC
Confidence 9999999999999999999999988766544333334454
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2e-32 Score=266.03 Aligned_cols=153 Identities=31% Similarity=0.504 Sum_probs=130.8
Q ss_pred hCCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
.++|...+.||+|+||.||+|.++++++||||+++.. ....+.|.+|+.++++++|||||+++|++. .++.++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence 3467888999999999999999988889999999753 345678999999999999999999999985 46689999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCCC
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 506 (516)
++|+|..++... ....++|.+++.++.||+.||.|||+.+ |+||||||+|||||+++.+||+|||+|+.+.++..
T Consensus 94 ~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 94 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred CCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 999999888432 2346999999999999999999999998 99999999999999999999999999998865543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.8e-32 Score=262.78 Aligned_cols=152 Identities=33% Similarity=0.546 Sum_probs=131.0
Q ss_pred hCCCCCCc-eeeecCcEeEEEEEec---CCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 010186 348 TSNFSDSN-ILGQGGFGPVYKGVLS---DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 348 ~~~f~~~~-~Lg~G~fg~Vy~~~~~---~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 422 (516)
.++|...+ +||+|+||.||+|.++ ++..||||+++.. .....+.|.+|+++|.+++|||||+++|++.. +..+|
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 34455556 4999999999999864 3557999999764 33456789999999999999999999999865 56899
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
||||+++|+|.+++.. .+..+++.++..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 86 vmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999998843 3456999999999999999999999998 9999999999999999999999999999886
Q ss_pred cCC
Q 010186 503 ESE 505 (516)
Q Consensus 503 ~~~ 505 (516)
...
T Consensus 161 ~~~ 163 (285)
T d1u59a_ 161 ADD 163 (285)
T ss_dssp TCS
T ss_pred ccc
Confidence 544
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.7e-32 Score=264.35 Aligned_cols=157 Identities=28% Similarity=0.431 Sum_probs=125.6
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEe--CCeeEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD--GDEKLLV 423 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV 423 (516)
++|...+.||+|+||.||+++. .+|+.||||++... +....+.+.+|++++++++||||+++++++.+ .+..|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 4577889999999999999995 47899999999753 33445679999999999999999999999975 3457999
Q ss_pred EEccCCCChhHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCC--CCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 424 YEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDS--RLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
|||+++|+|.+++... .....+++..++.++.||+.||.|||+++ ..+|+||||||+||||++++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999988432 23456999999999999999999999864 23599999999999999999999999999998
Q ss_pred cccCC
Q 010186 501 FAESE 505 (516)
Q Consensus 501 ~~~~~ 505 (516)
+..+.
T Consensus 164 ~~~~~ 168 (269)
T d2java1 164 LNHDT 168 (269)
T ss_dssp C----
T ss_pred cccCC
Confidence 87554
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.2e-31 Score=266.49 Aligned_cols=160 Identities=26% Similarity=0.331 Sum_probs=140.6
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...+.||+|+||.||+++. .+|+.||||++++. .....+.+.+|+.+|++++||||+++++++.+.+..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 4688889999999999999995 57999999999752 3345677899999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||+++|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+...
T Consensus 85 ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 9999999999884 3456899999999999999999999998 999999999999999999999999999987654
Q ss_pred CCccCccceecC
Q 010186 505 EGEANTVRIVGT 516 (516)
Q Consensus 505 ~~~~~~~~~~GT 516 (516)
..... .++||
T Consensus 159 ~~~~~--~~~GT 168 (337)
T d1o6la_ 159 GATMK--TFCGT 168 (337)
T ss_dssp TCCBC--CCEEC
T ss_pred Ccccc--cceeC
Confidence 43322 35676
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.4e-32 Score=262.62 Aligned_cols=153 Identities=34% Similarity=0.616 Sum_probs=128.5
Q ss_pred hCCCCCCceeeecCcEeEEEEEecCC-----cEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVLSDG-----KEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~~~g-----~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 421 (516)
.+.|...++||+|+||.||+|.+++. ..||||++... ......+|.+|+.++.+++|||||+++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 45677789999999999999996532 37999999653 3344567999999999999999999999999999999
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+||||++++++.+++.. ....++|.+++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 86 ~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999999887743 3456999999999999999999999988 999999999999999999999999999988
Q ss_pred ccCC
Q 010186 502 AESE 505 (516)
Q Consensus 502 ~~~~ 505 (516)
..+.
T Consensus 161 ~~~~ 164 (283)
T d1mqba_ 161 EDDP 164 (283)
T ss_dssp ----
T ss_pred cCCC
Confidence 6554
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.5e-31 Score=257.89 Aligned_cols=149 Identities=29% Similarity=0.425 Sum_probs=128.0
Q ss_pred CCCceeeecCcEeEEEEEec-CCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEe----CCeeEEEE
Q 010186 352 SDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD----GDEKLLVY 424 (516)
Q Consensus 352 ~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 424 (516)
...++||+|+||.||+|+.. +++.||+|++... .....+.|.+|+++|++++|||||++++++.+ +...+|||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 34567999999999999964 6889999998653 34456679999999999999999999999875 34579999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEec-CCCcEEEcccCccccccc
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD-SDMNSKISDFGMARIFAE 503 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld-~~~~~kl~DFGla~~~~~ 503 (516)
||+++|+|.+++. ....+++.++..++.||++||.|||+++ ++|+||||||+||||+ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHh---ccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999984 3456899999999999999999999875 4599999999999996 578999999999987554
Q ss_pred C
Q 010186 504 S 504 (516)
Q Consensus 504 ~ 504 (516)
.
T Consensus 168 ~ 168 (270)
T d1t4ha_ 168 S 168 (270)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=1e-31 Score=263.98 Aligned_cols=150 Identities=30% Similarity=0.475 Sum_probs=133.6
Q ss_pred CCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
.|...+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+++|++++|||||++++++.+++..|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 477789999999999999995 578899999997533 2334578999999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCC
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 505 (516)
|+++|+|..++. .+..+++.++..++.||+.||.|||+++ |+||||||+||||++++.+||+|||+|+......
T Consensus 96 ~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (309)
T d1u5ra_ 96 YCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN 169 (309)
T ss_dssp CCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC
T ss_pred ecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCCC
Confidence 999999987763 3456999999999999999999999998 9999999999999999999999999998876543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.97 E-value=2.5e-31 Score=265.60 Aligned_cols=152 Identities=26% Similarity=0.430 Sum_probs=137.0
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
++|.+.+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.++++++|||||++++++.+.+..||||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4688889999999999999996 478999999998766666778999999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC--CCcEEEcccCcccccccCC
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS--DMNSKISDFGMARIFAESE 505 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~--~~~~kl~DFGla~~~~~~~ 505 (516)
++|+|.+++.. ..+.+++.++..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+|+.+....
T Consensus 106 ~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999998843 3456999999999999999999999998 999999999999964 5789999999999886554
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=6.6e-32 Score=264.95 Aligned_cols=173 Identities=31% Similarity=0.447 Sum_probs=143.6
Q ss_pred hHHHHHhhCCCCCCceeeecCcEeEEEEEec------CCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeE
Q 010186 341 LETLNLATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGF 413 (516)
Q Consensus 341 ~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~ 413 (516)
+.+++.+.++|...+.||+|+||.||+|+.. +++.||||+++... ....++|.+|++++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3456667788999999999999999999863 35789999997633 3346679999999999999999999999
Q ss_pred EEeCCeeEEEEEccCCCChhHHhcCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCe
Q 010186 414 CVDGDEKLLVYEFMPNGSLDAILFDPR---------------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472 (516)
Q Consensus 414 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i 472 (516)
+.+.+..++||||+++|+|.+++.... ....+++.+++.|+.||+.||.|||+++ +
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---e
Confidence 999999999999999999999885321 1235899999999999999999999998 9
Q ss_pred eeCCCCCCCeEecCCCcEEEcccCcccccccCCCccCccceecC
Q 010186 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516 (516)
Q Consensus 473 iHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~GT 516 (516)
|||||||+|||||.++.+||+|||+|+.+.+......+....||
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~ 205 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIP 205 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcC
Confidence 99999999999999999999999999987655443333333443
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.97 E-value=3.5e-31 Score=264.78 Aligned_cols=152 Identities=26% Similarity=0.380 Sum_probs=136.5
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
++|...+.||+|+||.||+|.. .+|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..||||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4578889999999999999995 579999999998755555678899999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEec--CCCcEEEcccCcccccccCC
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD--SDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld--~~~~~kl~DFGla~~~~~~~ 505 (516)
++|+|.+++.. ....+++.++..++.||+.||.|||+.+ |+||||||+||||+ .++.+||+|||+|+.+..+.
T Consensus 109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999887732 3446999999999999999999999998 99999999999998 57899999999999887654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.6e-31 Score=257.30 Aligned_cols=145 Identities=34% Similarity=0.505 Sum_probs=125.9
Q ss_pred ceeeecCcEeEEEEEecC---CcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEccCC
Q 010186 355 NILGQGGFGPVYKGVLSD---GKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~---g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 429 (516)
++||+|+||.||+|.+++ ++.||||+++.. +....+.|.+|+++|++++|||||+++|++.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 569999999999998643 468999999653 23345679999999999999999999999865 467899999999
Q ss_pred CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCCC
Q 010186 430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (516)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 506 (516)
|+|.+++. ....+++.+++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 92 g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 92 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 99999984 3456999999999999999999999988 99999999999999999999999999998765543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.97 E-value=4.5e-31 Score=255.42 Aligned_cols=151 Identities=30% Similarity=0.420 Sum_probs=134.8
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCcc---------chHHHHHHHHHHhcCC-CCCccceeeEEEeC
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQ---------GTAEFTNEVLLILKLQ-HKNLVKLLGFCVDG 417 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~---------~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~ 417 (516)
++|...+.||+|+||+||+++. .+|+.||||++++.... ..+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5688889999999999999995 57899999999753211 1235889999999996 99999999999999
Q ss_pred CeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCc
Q 010186 418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497 (516)
Q Consensus 418 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 497 (516)
+..||||||+++|+|.+++. .++.+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 99999999999999999994 3457999999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCC
Q 010186 498 ARIFAESE 505 (516)
Q Consensus 498 a~~~~~~~ 505 (516)
++.+.+..
T Consensus 157 a~~~~~~~ 164 (277)
T d1phka_ 157 SCQLDPGE 164 (277)
T ss_dssp CEECCTTC
T ss_pred eeEccCCC
Confidence 99887643
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=2.6e-31 Score=260.98 Aligned_cols=151 Identities=27% Similarity=0.441 Sum_probs=122.3
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
+.|...+.||+|+||+||++... +++.||||++.+.. ....+.+.+|+.++++++||||+++++++.+++..||||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 45788899999999999999964 68999999997532 23345688999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEec---CCCcEEEcccCccccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD---SDMNSKISDFGMARIFAE 503 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld---~~~~~kl~DFGla~~~~~ 503 (516)
+++|+|.+++. ..+.+++.++..++.||+.||.|||+++ |+||||||+|||+. +++.+||+|||+|+....
T Consensus 89 ~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 89 VSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred cCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 99999999984 3457999999999999999999999998 99999999999994 578999999999998765
Q ss_pred CC
Q 010186 504 SE 505 (516)
Q Consensus 504 ~~ 505 (516)
..
T Consensus 163 ~~ 164 (307)
T d1a06a_ 163 GS 164 (307)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=4.8e-31 Score=260.10 Aligned_cols=150 Identities=25% Similarity=0.396 Sum_probs=134.8
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...+.||+|+||.||+++. .+|+.||||++++. .....+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 3577889999999999999996 56899999999642 3345678999999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||+++|+|..++. ....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.+.+.
T Consensus 84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999998884 4456888999999999999999999998 999999999999999999999999999987654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.4e-30 Score=254.51 Aligned_cols=151 Identities=27% Similarity=0.391 Sum_probs=134.3
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC------ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS------EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 421 (516)
++|...+.||+|+||+||+|+. .+|+.||||++++.. ....+.|.+|+.+|++++|||||++++++.+.+..|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5688889999999999999996 578999999996522 123567999999999999999999999999999999
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC----cEEEcccCc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM----NSKISDFGM 497 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~----~~kl~DFGl 497 (516)
|||||+++|+|.+++. ..+.+++.++..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 90 iv~E~~~gg~L~~~i~---~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 90 LILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCccccchhc---cccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhh
Confidence 9999999999999984 3356999999999999999999999998 99999999999998776 499999999
Q ss_pred ccccccCC
Q 010186 498 ARIFAESE 505 (516)
Q Consensus 498 a~~~~~~~ 505 (516)
|+.+....
T Consensus 164 a~~~~~~~ 171 (293)
T d1jksa_ 164 AHKIDFGN 171 (293)
T ss_dssp CEECTTSC
T ss_pred hhhcCCCc
Confidence 99876543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.1e-31 Score=260.02 Aligned_cols=175 Identities=27% Similarity=0.387 Sum_probs=136.2
Q ss_pred cchHHHHHhhCCCCCCceeeecCcEeEEEEEec------CCcEEEEEEeccC-CccchHHHHHHHHHHhcC-CCCCccce
Q 010186 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKL 410 (516)
Q Consensus 339 ~~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l 410 (516)
++..++++..++|...++||+|+||.||+|... +++.||||+++.. .....+.+.+|...+.++ +|+||+.+
T Consensus 3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 355666777788999999999999999999853 3468999999753 334456788888888877 78999999
Q ss_pred eeEEEeCC-eeEEEEEccCCCChhHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCC
Q 010186 411 LGFCVDGD-EKLLVYEFMPNGSLDAILFDPR-------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD 476 (516)
Q Consensus 411 ~g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrD 476 (516)
++++...+ ..++||||+++|+|.+++.... ....+++.++..++.||++||.|||+++ |+|||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrD 159 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 159 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCc
Confidence 99987654 6899999999999999985322 1345899999999999999999999998 99999
Q ss_pred CCCCCeEecCCCcEEEcccCcccccccCCCccCccceecC
Q 010186 477 LKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516 (516)
Q Consensus 477 lk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~GT 516 (516)
|||+||||++++.+||+|||+|+..........+..+.||
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt 199 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 199 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCG
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeC
Confidence 9999999999999999999999988766555444445565
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5e-31 Score=259.40 Aligned_cols=170 Identities=32% Similarity=0.473 Sum_probs=141.7
Q ss_pred HHHhhCCCCCCceeeecCcEeEEEEEec------CCcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEe
Q 010186 344 LNLATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416 (516)
Q Consensus 344 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 416 (516)
+++..++|...+.||+|+||.||+|.+. +++.||||++++. .......|.+|+.++++++||||++++|++..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 4445567788899999999999999863 3578999999753 33445679999999999999999999999999
Q ss_pred CCeeEEEEEccCCCChhHHhcCC-------CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCc
Q 010186 417 GDEKLLVYEFMPNGSLDAILFDP-------RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN 489 (516)
Q Consensus 417 ~~~~~lV~Ey~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~ 489 (516)
.+..++||||+++|+|.+++... .....+++..+..++.|+++||.|||+++ |+||||||+|||||++++
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCC
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCce
Confidence 99999999999999999887421 12235789999999999999999999987 999999999999999999
Q ss_pred EEEcccCcccccccCCCccCccceecC
Q 010186 490 SKISDFGMARIFAESEGEANTVRIVGT 516 (516)
Q Consensus 490 ~kl~DFGla~~~~~~~~~~~~~~~~GT 516 (516)
+||+|||+|+.+..........+..||
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t 198 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLP 198 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEEC
T ss_pred EEEeecccceeccCCcceeeccceecc
Confidence 999999999988765543333333343
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.9e-30 Score=253.49 Aligned_cols=151 Identities=21% Similarity=0.314 Sum_probs=133.5
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
++|...+.||+|+||+||+|... +++.||||.++... .....+.+|+++|+.++||||+++++++.+++..||||||+
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 46788899999999999999964 68899999997643 33456889999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCC--CcEEEcccCcccccccCC
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD--MNSKISDFGMARIFAESE 505 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~--~~~kl~DFGla~~~~~~~ 505 (516)
++|+|.+++.. ....+++.++..++.||+.||.|||+++ |+||||||+|||++.+ ..+||+|||+++......
T Consensus 84 ~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 84 SGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 99999999843 2346899999999999999999999998 9999999999999854 489999999999876543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.8e-30 Score=256.41 Aligned_cols=162 Identities=32% Similarity=0.546 Sum_probs=131.0
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCc----EEEEEEecc-CCccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGK----EVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~----~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 422 (516)
++|...++||+|+||+||+|.+. +|+ +||+|+++. .+.+..+.|.+|++++++++|||||+++|++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 35788899999999999999864 444 689998865 3445677899999999999999999999999865 5678
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
++||+.+|+|.+++.. ....+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999887753 3456999999999999999999999987 9999999999999999999999999999887
Q ss_pred cCCCccCccceecC
Q 010186 503 ESEGEANTVRIVGT 516 (516)
Q Consensus 503 ~~~~~~~~~~~~GT 516 (516)
.......+....||
T Consensus 163 ~~~~~~~~~~~~gt 176 (317)
T d1xkka_ 163 AEEKEYHAEGGKVP 176 (317)
T ss_dssp TTCC--------CC
T ss_pred cccccccccccccC
Confidence 66554443334454
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.96 E-value=3e-30 Score=257.87 Aligned_cols=150 Identities=25% Similarity=0.320 Sum_probs=135.1
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 424 (516)
++|...+.||+|+||.||+++. .+|+.||||++.+. +....+.+.+|+++|+.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 4678889999999999999996 47999999998642 2345667899999999999999999999999999999999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
||+++|+|..++. ..+.+++.++..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999999884 3346999999999999999999999998 999999999999999999999999999987643
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1e-30 Score=252.74 Aligned_cols=154 Identities=27% Similarity=0.461 Sum_probs=124.5
Q ss_pred HhhCCCCCCceeeecCcEeEEEEEecC----CcEEEEEEeccC-CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 010186 346 LATSNFSDSNILGQGGFGPVYKGVLSD----GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK 420 (516)
Q Consensus 346 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 420 (516)
+..++|...+.||+|+||.||+|++.. +..||||.++.. .....+.|.+|+.++++++||||++++|++. .+..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 345678888999999999999998642 346899998653 3344567999999999999999999999985 4678
Q ss_pred EEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
++||||+++|+|.+++.. ....+++..++.++.||++||.|||+++ ++||||||+|||+++++.+||+|||+|+.
T Consensus 83 ~iv~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhee
Confidence 999999999999988743 3456899999999999999999999998 99999999999999999999999999998
Q ss_pred cccCC
Q 010186 501 FAESE 505 (516)
Q Consensus 501 ~~~~~ 505 (516)
+....
T Consensus 158 ~~~~~ 162 (273)
T d1mp8a_ 158 MEDST 162 (273)
T ss_dssp -----
T ss_pred ccCCc
Confidence 76543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.96 E-value=3.3e-30 Score=258.98 Aligned_cols=151 Identities=29% Similarity=0.383 Sum_probs=130.6
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC---CccchHHHHH---HHHHHhcCCCCCccceeeEEEeCCeeE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTN---EVLLILKLQHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~---Ei~~l~~l~H~niv~l~g~~~~~~~~~ 421 (516)
++|...++||+|+||.||+|+. .+|+.||||++.+. .......+.+ |+.+++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5688889999999999999996 46899999998642 1122233444 467778889999999999999999999
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+||||+++|+|.+++. ....+++.++..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHH---hcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 9999999999999984 3456889999999999999999999998 999999999999999999999999999987
Q ss_pred ccCC
Q 010186 502 AESE 505 (516)
Q Consensus 502 ~~~~ 505 (516)
....
T Consensus 158 ~~~~ 161 (364)
T d1omwa3 158 SKKK 161 (364)
T ss_dssp SSSC
T ss_pred CCCc
Confidence 6553
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.6e-30 Score=254.60 Aligned_cols=169 Identities=29% Similarity=0.394 Sum_probs=141.8
Q ss_pred HHhhCCCCCCceeeecCcEeEEEEEe------cCCcEEEEEEeccCC-ccchHHHHHHHHHHhcC-CCCCccceeeEEEe
Q 010186 345 NLATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVD 416 (516)
Q Consensus 345 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 416 (516)
++..++|...++||+|+||.||+|++ .+++.||||++++.. ......|.+|+.+++++ +|||||+++|++.+
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 34456777889999999999999985 245689999997633 34456799999999999 79999999999999
Q ss_pred CCeeEEEEEccCCCChhHHhcCCC---------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCC
Q 010186 417 GDEKLLVYEFMPNGSLDAILFDPR---------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASN 481 (516)
Q Consensus 417 ~~~~~lV~Ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~N 481 (516)
.+..+|||||+++|+|.+++.... ....+++..+..++.||++||.|||+++ ++||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccc
Confidence 999999999999999999985432 2236899999999999999999999998 9999999999
Q ss_pred eEecCCCcEEEcccCcccccccCCCccCccceecC
Q 010186 482 VLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516 (516)
Q Consensus 482 ILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~GT 516 (516)
||++.++.+||+|||+++...............||
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt 210 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 210 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEEC
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccC
Confidence 99999999999999999988765544433334454
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.5e-30 Score=250.82 Aligned_cols=152 Identities=28% Similarity=0.438 Sum_probs=131.2
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
++|...+.||+|+||+||+|.. .+|+.||||+++... ....+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 4788889999999999999995 578999999996532 2346789999999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCC
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 505 (516)
|+.++.+..... .....+++.++..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+....+.
T Consensus 82 ~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 998765554432 23456999999999999999999999998 9999999999999999999999999998876544
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=6.2e-30 Score=252.50 Aligned_cols=151 Identities=26% Similarity=0.364 Sum_probs=132.8
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC---CccchHHHHHHHHHHh-cCCCCCccceeeEEEeCCeeEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLIL-KLQHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~-~l~H~niv~l~g~~~~~~~~~lV 423 (516)
++|...+.||+|+||+||+|+. .+++.||||++++. .....+.+..|+.++. .++||||+++++++.+++..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 4678889999999999999996 46899999999752 2345566777777765 68999999999999999999999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccccc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 503 (516)
|||+++|+|.+++. ....+++.++..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 82 mEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999984 3456899999999999999999999998 99999999999999999999999999997765
Q ss_pred CC
Q 010186 504 SE 505 (516)
Q Consensus 504 ~~ 505 (516)
..
T Consensus 156 ~~ 157 (320)
T d1xjda_ 156 GD 157 (320)
T ss_dssp TT
T ss_pred cc
Confidence 44
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=6.7e-30 Score=251.44 Aligned_cols=154 Identities=31% Similarity=0.554 Sum_probs=131.9
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCc--EEEEEEeccC-CccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGK--EVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~--~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 423 (516)
++|...++||+|+||.||+|++. +|. .||||+++.. .....+.|.+|+++|.++ +|||||+++|++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 56777889999999999999965 444 5788888653 344567899999999999 799999999999999999999
Q ss_pred EEccCCCChhHHhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcE
Q 010186 424 YEFMPNGSLDAILFDP-------------RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS 490 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~ 490 (516)
|||+++|+|.++++.. .....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998643 23457999999999999999999999997 9999999999999999999
Q ss_pred EEcccCcccccccCC
Q 010186 491 KISDFGMARIFAESE 505 (516)
Q Consensus 491 kl~DFGla~~~~~~~ 505 (516)
||+|||+|+......
T Consensus 167 kl~DfG~a~~~~~~~ 181 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV 181 (309)
T ss_dssp EECCTTCEESSCEEC
T ss_pred EEccccccccccccc
Confidence 999999998765443
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=6.8e-30 Score=250.35 Aligned_cols=147 Identities=29% Similarity=0.414 Sum_probs=126.9
Q ss_pred CceeeecCcEeEEEEEe-cCCcEEEEEEeccCCc-----cchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEcc
Q 010186 354 SNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSE-----QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427 (516)
Q Consensus 354 ~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~-----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 427 (516)
.++||+|+||+||+|.. .+|+.||||+++.... ...+.+.+|+.++++++|||||++++++.+++..+|||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 46899999999999995 4689999999865322 12356899999999999999999999999999999999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCCC
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 506 (516)
+++++..+. .....+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 83 ~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp SEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred cchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 998887766 34556889999999999999999999998 99999999999999999999999999988766543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.96 E-value=1.1e-29 Score=247.19 Aligned_cols=150 Identities=27% Similarity=0.438 Sum_probs=135.1
Q ss_pred CCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEEc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 426 (516)
++|...++||+|+||.||+|+.++|+.||||+++.. +....+.+.+|+.+|++++||||+++++++...+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 467888999999999999999989999999999653 233467899999999999999999999999999999999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccC
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 504 (516)
+.++.+..+. ...+.+++.++..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|......
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 9988887776 34567999999999999999999999987 999999999999999999999999999887544
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.1e-29 Score=245.72 Aligned_cols=147 Identities=32% Similarity=0.562 Sum_probs=128.4
Q ss_pred CceeeecCcEeEEEEEecCC----cEEEEEEecc-CCccchHHHHHHHHHHhcCCCCCccceeeEEEe-CCeeEEEEEcc
Q 010186 354 SNILGQGGFGPVYKGVLSDG----KEVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD-GDEKLLVYEFM 427 (516)
Q Consensus 354 ~~~Lg~G~fg~Vy~~~~~~g----~~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~Ey~ 427 (516)
.++||+|+||+||+|++.++ ..||||+++. .+....++|.+|++++++++||||++++|++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 47899999999999996432 2689999975 344566789999999999999999999999876 45889999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCC
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 505 (516)
++|+|.+++.. ....+++..++.++.|+++||.|||+.+ |+||||||+|||||+++.+||+|||+++.+....
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999998854 3445788999999999999999999997 9999999999999999999999999999876553
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.5e-30 Score=248.72 Aligned_cols=152 Identities=32% Similarity=0.489 Sum_probs=123.9
Q ss_pred CCCCCCceeeecCcEeEEEEEec--CC--cEEEEEEeccC---CccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS--DG--KEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~--~g--~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 421 (516)
++|...+.||+|+||.||+|++. ++ .+||||++++. +....++|.+|+.++++++||||++++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 45777889999999999999853 22 37899998753 33445689999999999999999999999976 4678
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccccc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 501 (516)
+||||+++|++.+.+.. ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+
T Consensus 87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 99999999999887743 3346999999999999999999999988 999999999999999999999999999988
Q ss_pred ccCCC
Q 010186 502 AESEG 506 (516)
Q Consensus 502 ~~~~~ 506 (516)
..+..
T Consensus 162 ~~~~~ 166 (273)
T d1u46a_ 162 PQNDD 166 (273)
T ss_dssp CC-CC
T ss_pred ccCCC
Confidence 66544
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=8.5e-30 Score=249.50 Aligned_cols=167 Identities=30% Similarity=0.422 Sum_probs=135.4
Q ss_pred HhhCCCCCCceeeecCcEeEEEEEecC--------CcEEEEEEeccC-CccchHHHHHHHHHHhcC-CCCCccceeeEEE
Q 010186 346 LATSNFSDSNILGQGGFGPVYKGVLSD--------GKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCV 415 (516)
Q Consensus 346 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~--------g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~ 415 (516)
+..++|...+.||+|+||.||+|+... +..||||++++. ......++.+|...+.++ +|||||++++++.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 445677778999999999999998532 347999999763 334567889999999888 8999999999999
Q ss_pred eCCeeEEEEEccCCCChhHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCe
Q 010186 416 DGDEKLLVYEFMPNGSLDAILFDPRK-------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNV 482 (516)
Q Consensus 416 ~~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NI 482 (516)
+++..++||||+++|+|.+++..... ...+++.+++.++.||+.||.|||+.+ ||||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccce
Confidence 99999999999999999999964332 246899999999999999999999998 99999999999
Q ss_pred EecCCCcEEEcccCcccccccCCCccCccceec
Q 010186 483 LLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515 (516)
Q Consensus 483 Lld~~~~~kl~DFGla~~~~~~~~~~~~~~~~G 515 (516)
|++.++.+||+|||+++..........+....|
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 199 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 199 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCC
T ss_pred eecCCCCeEeccchhhccccccccccccccCCC
Confidence 999999999999999998876654443333334
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.8e-30 Score=247.67 Aligned_cols=150 Identities=33% Similarity=0.490 Sum_probs=124.7
Q ss_pred CCCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeC-CeeEEEEEcc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-DEKLLVYEFM 427 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey~ 427 (516)
++|...+.||+|+||.||+|.+ .|++||||+++.. ...+.|.+|++++++++||||++++|++.+. +..+|||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 4566778999999999999998 5789999999753 3457899999999999999999999999764 5689999999
Q ss_pred CCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCC
Q 010186 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 505 (516)
++|+|.+++... ....++|..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~ 157 (262)
T d1byga_ 84 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 157 (262)
T ss_dssp TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCC
Confidence 999999998532 2235899999999999999999999987 9999999999999999999999999999876543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.96 E-value=1.5e-29 Score=245.11 Aligned_cols=150 Identities=24% Similarity=0.372 Sum_probs=131.3
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC---ccchHHHHHHHHHHhcCCCCCccceeeEEEeCC----ee
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD----EK 420 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~ 420 (516)
++|...+.||+|+||.||+|+. .+|+.||||++++.. ....+.|.+|+++++.++||||+++++++...+ ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 5688889999999999999995 579999999997532 233557999999999999999999999998654 37
Q ss_pred EEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 421 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
||||||+++++|.+++. ..+.+++.++..++.||+.||.|||+++ |+||||||+||||+.++..+|+|||+++.
T Consensus 87 ~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhh
Confidence 89999999999998884 3456999999999999999999999998 99999999999999999999999999987
Q ss_pred cccC
Q 010186 501 FAES 504 (516)
Q Consensus 501 ~~~~ 504 (516)
....
T Consensus 161 ~~~~ 164 (277)
T d1o6ya_ 161 IADS 164 (277)
T ss_dssp CC--
T ss_pred hccc
Confidence 6544
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.8e-29 Score=247.55 Aligned_cols=148 Identities=27% Similarity=0.398 Sum_probs=124.4
Q ss_pred CCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHH--HHHHHHhcCCCCCccceeeEEEeCC----eeEEE
Q 010186 350 NFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFT--NEVLLILKLQHKNLVKLLGFCVDGD----EKLLV 423 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~--~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lV 423 (516)
+|...+.||+|+||.||+|++ +|+.||||+++.. ....+. .|+..+..++||||++++|++.+.+ ..++|
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 355678899999999999997 6899999998653 233344 4555556789999999999998754 57999
Q ss_pred EEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC-----CCCeeeCCCCCCCeEecCCCcEEEcccCcc
Q 010186 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS-----RLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (516)
Q Consensus 424 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-----~~~iiHrDlk~~NILld~~~~~kl~DFGla 498 (516)
|||+++|+|.+++.. ..++|.+++.++.|++.||.|||+.. .++|+||||||+||||+.++.+||+|||++
T Consensus 80 ~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 999999999999953 35899999999999999999999741 245999999999999999999999999999
Q ss_pred cccccCC
Q 010186 499 RIFAESE 505 (516)
Q Consensus 499 ~~~~~~~ 505 (516)
+.+....
T Consensus 156 ~~~~~~~ 162 (303)
T d1vjya_ 156 VRHDSAT 162 (303)
T ss_dssp EEEETTT
T ss_pred ccccCCC
Confidence 9886654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=4e-29 Score=241.42 Aligned_cols=150 Identities=27% Similarity=0.432 Sum_probs=128.8
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCc------cchHHHHHHHHHHhcCC--CCCccceeeEEEeCCe
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSE------QGTAEFTNEVLLILKLQ--HKNLVKLLGFCVDGDE 419 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~ 419 (516)
++|...++||+|+||.||+|+. .+|+.||||++.+... .....+.+|+.++++++ ||||+++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5688889999999999999995 5789999999875221 12345779999999986 8999999999999999
Q ss_pred eEEEEEccCC-CChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCC-CcEEEcccCc
Q 010186 420 KLLVYEFMPN-GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGM 497 (516)
Q Consensus 420 ~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~-~~~kl~DFGl 497 (516)
.++||||+.+ +++.+++. ....+++.++..++.||++||.|||+.+ |+||||||+|||++.+ +.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 57777773 3456999999999999999999999998 9999999999999854 7999999999
Q ss_pred ccccccC
Q 010186 498 ARIFAES 504 (516)
Q Consensus 498 a~~~~~~ 504 (516)
|+.....
T Consensus 158 a~~~~~~ 164 (273)
T d1xwsa_ 158 GALLKDT 164 (273)
T ss_dssp CEECCSS
T ss_pred ceecccc
Confidence 9876543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.8e-28 Score=243.49 Aligned_cols=148 Identities=26% Similarity=0.389 Sum_probs=126.0
Q ss_pred CCCCCC-ceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcC-CCCCccceeeEEEe----CCeeE
Q 010186 349 SNFSDS-NILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVD----GDEKL 421 (516)
Q Consensus 349 ~~f~~~-~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~----~~~~~ 421 (516)
++|.+. ++||+|+||.||+|.. .+++.||||+++. ...+.+|+.++.++ +|||||++++++.+ ....|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 356654 5699999999999995 5789999999864 34678899887654 89999999999875 35689
Q ss_pred EEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC---CCcEEEcccCcc
Q 010186 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMA 498 (516)
Q Consensus 422 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~---~~~~kl~DFGla 498 (516)
|||||+++|+|.+++.. +....+++.++..++.||+.||.|||+.+ |+||||||+|||+++ ++.+||+|||+|
T Consensus 86 ivmEy~~gg~L~~~i~~-~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEECCCSEEHHHHHHS-CSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEECCCCCcHHHHHHh-cCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 99999999999999954 23356999999999999999999999998 999999999999986 457999999999
Q ss_pred cccccCC
Q 010186 499 RIFAESE 505 (516)
Q Consensus 499 ~~~~~~~ 505 (516)
+.+....
T Consensus 162 ~~~~~~~ 168 (335)
T d2ozaa1 162 KETTSHN 168 (335)
T ss_dssp EECCCCC
T ss_pred eeccCCC
Confidence 9876554
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.9e-28 Score=245.25 Aligned_cols=149 Identities=29% Similarity=0.462 Sum_probs=124.2
Q ss_pred CCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccceeeEEEeCC------eeEE
Q 010186 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD------EKLL 422 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~~~l 422 (516)
+|...++||+|+||+||+|+. .+|+.||||++..... .+.+|+++|++++||||+++++++.... ..+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 356678899999999999996 4689999999976332 2347999999999999999999986532 3689
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC-cEEEcccCccccc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-NSKISDFGMARIF 501 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~-~~kl~DFGla~~~ 501 (516)
||||++++.+..+.........+++.++..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999988765554432234567999999999999999999999988 99999999999999775 8999999999987
Q ss_pred ccCC
Q 010186 502 AESE 505 (516)
Q Consensus 502 ~~~~ 505 (516)
...+
T Consensus 174 ~~~~ 177 (350)
T d1q5ka_ 174 VRGE 177 (350)
T ss_dssp CTTS
T ss_pred cCCc
Confidence 6554
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=5.8e-28 Score=235.48 Aligned_cols=151 Identities=26% Similarity=0.400 Sum_probs=135.2
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC--ccchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 425 (516)
++|...++||+|+||+||+|+. .+++.||||+++... ......+.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4688889999999999999995 578899999996532 3346789999999999999999999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccccCC
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 505 (516)
++.+++|..++. ..+.+++..+..++.|++.||+|||+++ |+||||||+||||+.++.+||+|||+|+......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999988874 4456889999999999999999999998 9999999999999999999999999999876543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.95 E-value=7.1e-28 Score=238.98 Aligned_cols=145 Identities=23% Similarity=0.419 Sum_probs=127.6
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCC-CCCccceeeEEEeC--CeeEEEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDG--DEKLLVY 424 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~lV~ 424 (516)
++|...++||+|+||+||+|+. .+|+.||||++++. ..+.+.+|+.+|..++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 4688899999999999999995 57899999999753 3567899999999995 99999999999854 4589999
Q ss_pred EccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCC-cEEEcccCccccccc
Q 010186 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-NSKISDFGMARIFAE 503 (516)
Q Consensus 425 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~-~~kl~DFGla~~~~~ 503 (516)
||+++++|..+. +.+++.++..++.||+.||.|||+++ |+||||||+||||+.++ .+||+|||+|+.+.+
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999997764 35899999999999999999999998 99999999999998765 699999999998765
Q ss_pred CC
Q 010186 504 SE 505 (516)
Q Consensus 504 ~~ 505 (516)
..
T Consensus 183 ~~ 184 (328)
T d3bqca1 183 GQ 184 (328)
T ss_dssp TC
T ss_pred CC
Confidence 54
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3.2e-28 Score=243.16 Aligned_cols=150 Identities=23% Similarity=0.435 Sum_probs=126.9
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCC-ccchHHHHHHHHHHhcCCCCCccceeeEEEeCC----eeEE
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD----EKLL 422 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~l 422 (516)
++|...+.||+|+||+||+|+. .+|+.||||++.+.. ....+.+++|+.+|+.++||||+++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 4688889999999999999985 579999999997643 344567899999999999999999999997653 2455
Q ss_pred EEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcccccc
Q 010186 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502 (516)
Q Consensus 423 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 502 (516)
++||+.+|+|.+++.. ..+++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+...
T Consensus 88 l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 6677889999999842 35899999999999999999999998 9999999999999999999999999998775
Q ss_pred cCC
Q 010186 503 ESE 505 (516)
Q Consensus 503 ~~~ 505 (516)
...
T Consensus 161 ~~~ 163 (345)
T d1pmea_ 161 PDH 163 (345)
T ss_dssp GGG
T ss_pred CCC
Confidence 543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=2.5e-27 Score=234.02 Aligned_cols=150 Identities=29% Similarity=0.494 Sum_probs=127.9
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeC--------
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-------- 417 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-------- 417 (516)
++|...+.||+|+||+||+|+. .+|+.||||++... .......+.+|+++|++++||||+++++.+...
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 5788889999999999999995 57999999998642 334566789999999999999999999998653
Q ss_pred CeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCc
Q 010186 418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497 (516)
Q Consensus 418 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 497 (516)
+..++||||++++.+..+. .....+++.....++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 3578999999988877665 34456889999999999999999999998 99999999999999999999999999
Q ss_pred ccccccC
Q 010186 498 ARIFAES 504 (516)
Q Consensus 498 a~~~~~~ 504 (516)
++.+...
T Consensus 164 ~~~~~~~ 170 (318)
T d3blha1 164 ARAFSLA 170 (318)
T ss_dssp CEECCC-
T ss_pred eeecccc
Confidence 9877644
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.9e-27 Score=237.74 Aligned_cols=150 Identities=30% Similarity=0.457 Sum_probs=124.4
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeCC------
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD------ 418 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 418 (516)
.++|...+.||+|+||+||+|.. .+|+.||||+++.. +....+.+.+|+++|+.++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 35788889999999999999995 56999999999753 3344567899999999999999999999998765
Q ss_pred eeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCcc
Q 010186 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498 (516)
Q Consensus 419 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 498 (516)
..+|||||+ +.+|..+.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 469999999 567777763 345999999999999999999999998 999999999999999999999999999
Q ss_pred cccccCC
Q 010186 499 RIFAESE 505 (516)
Q Consensus 499 ~~~~~~~ 505 (516)
+......
T Consensus 169 ~~~~~~~ 175 (346)
T d1cm8a_ 169 RQADSEM 175 (346)
T ss_dssp EECCSSC
T ss_pred eccCCcc
Confidence 8876543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=7.4e-28 Score=237.81 Aligned_cols=151 Identities=26% Similarity=0.360 Sum_probs=132.5
Q ss_pred CCCCCCceeeecCcEeEEEEEe----cCCcEEEEEEeccC----CccchHHHHHHHHHHhcCCC-CCccceeeEEEeCCe
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL----SDGKEVAVKRLSSC----SEQGTAEFTNEVLLILKLQH-KNLVKLLGFCVDGDE 419 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~----~~g~~vavK~l~~~----~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~ 419 (516)
++|...+.||+|+||.||+|.. .+|+.||||++++. +....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 4588889999999999999984 24789999998652 22345678999999999966 899999999999999
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccc
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 499 (516)
.+++|||+++|+|.+++. ....+++.....++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+
T Consensus 104 ~~~v~e~~~~~~L~~~i~---~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHH---hcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999984 3445788899999999999999999998 9999999999999999999999999998
Q ss_pred ccccCC
Q 010186 500 IFAESE 505 (516)
Q Consensus 500 ~~~~~~ 505 (516)
.+....
T Consensus 178 ~~~~~~ 183 (322)
T d1vzoa_ 178 EFVADE 183 (322)
T ss_dssp ECCGGG
T ss_pred hhcccc
Confidence 875543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=5.6e-27 Score=230.04 Aligned_cols=153 Identities=27% Similarity=0.427 Sum_probs=126.3
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cC-CcEEEEEEeccC--CccchHHHHHHHHHHhcC---CCCCccceeeEEEe----
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SD-GKEVAVKRLSSC--SEQGTAEFTNEVLLILKL---QHKNLVKLLGFCVD---- 416 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~---- 416 (516)
.++|...+.||+|+||.||+|+. .+ ++.||||+++.. .......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46788899999999999999996 34 567999998652 223344577888777665 89999999999863
Q ss_pred -CCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEccc
Q 010186 417 -GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDF 495 (516)
Q Consensus 417 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 495 (516)
....+++|||++++.+..... .....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 235789999999988765553 24456899999999999999999999998 999999999999999999999999
Q ss_pred CcccccccCC
Q 010186 496 GMARIFAESE 505 (516)
Q Consensus 496 Gla~~~~~~~ 505 (516)
|+++......
T Consensus 161 g~~~~~~~~~ 170 (305)
T d1blxa_ 161 GLARIYSFQM 170 (305)
T ss_dssp CSCCCCCGGG
T ss_pred hhhhhhcccc
Confidence 9998765443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.94 E-value=1.2e-26 Score=226.25 Aligned_cols=150 Identities=21% Similarity=0.330 Sum_probs=129.7
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCC-CCccceeeEEEeCCeeEEEEE
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH-KNLVKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 425 (516)
.++|.+.+.||+|+||.||+|+. .+|+.||||++.... ....+.+|++.++.++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 46788899999999999999995 468999999886532 33467889999999965 899999999999999999999
Q ss_pred ccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC-----CCcEEEcccCcccc
Q 010186 426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-----DMNSKISDFGMARI 500 (516)
Q Consensus 426 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~-----~~~~kl~DFGla~~ 500 (516)
|+ +++|.+++.. ....+++.+...++.|++.||+|||+.+ |+||||||+||||+. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 98 6899888743 3346899999999999999999999998 999999999999974 56899999999998
Q ss_pred cccCC
Q 010186 501 FAESE 505 (516)
Q Consensus 501 ~~~~~ 505 (516)
+.+..
T Consensus 156 ~~~~~ 160 (293)
T d1csna_ 156 YRDPV 160 (293)
T ss_dssp SBCTT
T ss_pred cccCc
Confidence 86543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.1e-26 Score=232.35 Aligned_cols=150 Identities=27% Similarity=0.416 Sum_probs=126.3
Q ss_pred hCCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeC-----Ce
Q 010186 348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-----DE 419 (516)
Q Consensus 348 ~~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 419 (516)
.++|...++||+|+||+||+|+. .+|+.||||++.+. +....+.+.+|+++|+.++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 45788889999999999999995 57999999999753 233456789999999999999999999998743 33
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccc
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 499 (516)
.++++||+.+|+|.+++.. +.+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 4677888899999999832 35999999999999999999999998 9999999999999999999999999997
Q ss_pred ccccC
Q 010186 500 IFAES 504 (516)
Q Consensus 500 ~~~~~ 504 (516)
.....
T Consensus 170 ~~~~~ 174 (348)
T d2gfsa1 170 HTDDE 174 (348)
T ss_dssp CCTGG
T ss_pred ccCcc
Confidence 76543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.93 E-value=3.7e-26 Score=223.44 Aligned_cols=149 Identities=21% Similarity=0.344 Sum_probs=122.4
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCccce-eeEEEeCCeeEEEEEc
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL-LGFCVDGDEKLLVYEF 426 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l-~g~~~~~~~~~lV~Ey 426 (516)
++|...+.||+|+||.||+|+. .+|+.||||++.... ..+++..|+++++.++|+|++.. .++..+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 4688899999999999999995 568999999887532 33468899999999987765554 5556777889999999
Q ss_pred cCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecC---CCcEEEcccCccccccc
Q 010186 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAE 503 (516)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~---~~~~kl~DFGla~~~~~ 503 (516)
+++ +|...+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++. +..+||+|||+|+.+..
T Consensus 85 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LGP-SLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CCC-BHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cCC-chhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 954 55554432 3456899999999999999999999998 999999999999854 55799999999998876
Q ss_pred CC
Q 010186 504 SE 505 (516)
Q Consensus 504 ~~ 505 (516)
..
T Consensus 159 ~~ 160 (299)
T d1ckia_ 159 AR 160 (299)
T ss_dssp TT
T ss_pred cc
Confidence 54
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=4.7e-26 Score=228.13 Aligned_cols=148 Identities=29% Similarity=0.404 Sum_probs=120.7
Q ss_pred CCCCCCceeeecCcEeEEEEEec-CCcEEEEEEeccC--CccchHHHHHHHHHHhcCCCCCccceeeEEEeC------Ce
Q 010186 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG------DE 419 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~ 419 (516)
++|...++||+|+||+||+|... +|+.||||++... +......+.+|+.++++++||||+++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 56888899999999999999964 6999999999753 233455789999999999999999999999643 57
Q ss_pred eEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEcccCccc
Q 010186 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (516)
Q Consensus 420 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 499 (516)
.|+||||+.++.+..+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 89999999876665442 34889999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCC
Q 010186 500 IFAESE 505 (516)
Q Consensus 500 ~~~~~~ 505 (516)
......
T Consensus 168 ~~~~~~ 173 (355)
T d2b1pa1 168 TAGTSF 173 (355)
T ss_dssp ------
T ss_pred cccccc
Confidence 776543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=1.7e-22 Score=183.76 Aligned_cols=135 Identities=20% Similarity=0.211 Sum_probs=106.8
Q ss_pred CCCceeeecCcEeEEEEEecCCcEEEEEEeccCCc------------------cchHHHHHHHHHHhcCCCCCccceeeE
Q 010186 352 SDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSE------------------QGTAEFTNEVLLILKLQHKNLVKLLGF 413 (516)
Q Consensus 352 ~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~------------------~~~~~~~~Ei~~l~~l~H~niv~l~g~ 413 (516)
..+++||+|+||.||+|...+|++||||+++.... ........|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 34688999999999999988899999998753110 001234568888999999999988765
Q ss_pred EEeCCeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCCeeeCCCCCCCeEecCCCcEEEc
Q 010186 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKIS 493 (516)
Q Consensus 414 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~ 493 (516)
. ..+++|||+++..+..+ ++.....++.|++++|.|||+++ |+||||||+|||++++ .++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~l----------~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYRV----------RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGGC----------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred c----CCEEEEEeeccccccch----------hhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence 3 24799999998765432 23445678999999999999998 9999999999999865 58999
Q ss_pred ccCcccccccC
Q 010186 494 DFGMARIFAES 504 (516)
Q Consensus 494 DFGla~~~~~~ 504 (516)
|||+|+....+
T Consensus 145 DFG~a~~~~~~ 155 (191)
T d1zara2 145 DFPQSVEVGEE 155 (191)
T ss_dssp CCTTCEETTST
T ss_pred ECCCcccCCCC
Confidence 99999877544
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.84 E-value=1.6e-21 Score=195.28 Aligned_cols=152 Identities=23% Similarity=0.275 Sum_probs=120.7
Q ss_pred CCCCCCceeeecCcEeEEEEEe-cCCcEEEEEEeccCCccchHHHHHHHHHHhcCC-----------CCCccceeeEEEe
Q 010186 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-----------HKNLVKLLGFCVD 416 (516)
Q Consensus 349 ~~f~~~~~Lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~g~~~~ 416 (516)
++|...++||+|+||+||+|+. .+|+.||||++++.. ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4588899999999999999995 579999999997532 23457788999888775 5789999998865
Q ss_pred C--CeeEEEEEccCCCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHc-CCCCCeeeCCCCCCCeEecCCC-----
Q 010186 417 G--DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-DSRLRIVHRDLKASNVLLDSDM----- 488 (516)
Q Consensus 417 ~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~iiHrDlk~~NILld~~~----- 488 (516)
. ...+++++++..+..............+++..+..++.||+.||.|||+ .+ |+||||||+||||+.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 3 4566777777665543333233455678899999999999999999997 65 99999999999998665
Q ss_pred -cEEEcccCcccccccC
Q 010186 489 -NSKISDFGMARIFAES 504 (516)
Q Consensus 489 -~~kl~DFGla~~~~~~ 504 (516)
.+||+|||.|+.....
T Consensus 169 ~~~kl~dfg~s~~~~~~ 185 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH 185 (362)
T ss_dssp EEEEECCCTTCEETTBC
T ss_pred ceeeEeecccccccccc
Confidence 3999999999876544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.64 E-value=1.1e-07 Score=88.68 Aligned_cols=142 Identities=19% Similarity=0.113 Sum_probs=95.2
Q ss_pred CCCCCceeeecCcEeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEEccC
Q 010186 350 NFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMP 428 (516)
Q Consensus 350 ~f~~~~~Lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~ 428 (516)
.|...+..+-++...||+... +++.+.+|+...........+.+|...+..+ .+--+.+++.+...++..++|||+++
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~ 93 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD 93 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred ceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecc
Confidence 344434333344568998765 5666788887665444555678898888776 34446788888888899999999999
Q ss_pred CCChhHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC----------------------------------------
Q 010186 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS---------------------------------------- 468 (516)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~---------------------------------------- 468 (516)
+.++....... . ....++.++++.+..||+..
T Consensus 94 G~~~~~~~~~~-----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T d1j7la_ 94 GVLCSEEYEDE-----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp SEEHHHHTTTC-----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCS
T ss_pred ccccccccccc-----c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccch
Confidence 98886544211 0 11223344444444444321
Q ss_pred ----------------CCCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 469 ----------------RLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 469 ----------------~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12279999999999999877778999998864
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.17 E-value=2.1e-06 Score=79.12 Aligned_cols=141 Identities=16% Similarity=0.098 Sum_probs=85.4
Q ss_pred eeecCc-EeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCC--CCCccceeeEEEeCCeeEEEEEccCCCChh
Q 010186 357 LGQGGF-GPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ--HKNLVKLLGFCVDGDEKLLVYEFMPNGSLD 433 (516)
Q Consensus 357 Lg~G~f-g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 433 (516)
+..|.. ..||+...+++..+.+|.-.... ...+..|...++.+. .-.+.+++.+..+++..++||||+++.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 344443 67899988788888889765432 335677887777663 344677888888888899999999987663
Q ss_pred HHh-----------------cCCC-CCCCC--CHHHHHHHH--------------------HHHHHHHHHhHcC----CC
Q 010186 434 AIL-----------------FDPR-KRGIL--CWRKRTNIV--------------------NGIAKGMLYLHED----SR 469 (516)
Q Consensus 434 ~~l-----------------~~~~-~~~~l--~~~~~~~i~--------------------~~ia~~l~yLH~~----~~ 469 (516)
+.. +... ....+ .+.....-. ......+..+.+. .+
T Consensus 95 ~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 174 (255)
T d1nd4a_ 95 SSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGED 174 (255)
T ss_dssp TSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCC
T ss_pred cccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCC
Confidence 211 0000 00000 000000000 0011122222221 12
Q ss_pred CCeeeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 470 ~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
+.++|+|+.|.|||++++..+-|+||+.+..
T Consensus 175 ~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 175 LVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp EEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 3389999999999999877778999998864
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.64 E-value=0.00011 Score=72.17 Aligned_cols=75 Identities=12% Similarity=0.160 Sum_probs=48.1
Q ss_pred ceeeecCcEeEEEEEecC-CcEEEEEEeccC----C---ccchHHHHHHHHHHhcC-CC--CCccceeeEEEeCCeeEEE
Q 010186 355 NILGQGGFGPVYKGVLSD-GKEVAVKRLSSC----S---EQGTAEFTNEVLLILKL-QH--KNLVKLLGFCVDGDEKLLV 423 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~-g~~vavK~l~~~----~---~~~~~~~~~Ei~~l~~l-~H--~niv~l~g~~~~~~~~~lV 423 (516)
+.||.|..-.||+....+ ++.++||.-.+. . .........|.+.|..+ .+ ..+++++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 458999999999998654 678999975431 1 11233455677777665 23 345566544 55667899
Q ss_pred EEccCCCC
Q 010186 424 YEFMPNGS 431 (516)
Q Consensus 424 ~Ey~~~gs 431 (516)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.12 E-value=0.0013 Score=62.20 Aligned_cols=135 Identities=17% Similarity=0.144 Sum_probs=77.7
Q ss_pred EeEEEEEecCCcEEEEEEeccCCccchHHHHHHHHHHhcCCCCCc-----ccee--eEEEeCCeeEEEEEccCCCChhH-
Q 010186 363 GPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL-----VKLL--GFCVDGDEKLLVYEFMPNGSLDA- 434 (516)
Q Consensus 363 g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-----v~l~--g~~~~~~~~~lV~Ey~~~gsL~~- 434 (516)
=.||+...++|+.+++|+..+. ....+++..|...+..|...++ +..- ......+..+.++++++|..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 3699999999999999988763 2345667888888877632221 1111 12344566789999998754421
Q ss_pred ----H------h-------cC--CCCCCCCCHH----------------------HHHHHHHHHHHHHHHh-HcCCCCCe
Q 010186 435 ----I------L-------FD--PRKRGILCWR----------------------KRTNIVNGIAKGMLYL-HEDSRLRI 472 (516)
Q Consensus 435 ----~------l-------~~--~~~~~~l~~~----------------------~~~~i~~~ia~~l~yL-H~~~~~~i 472 (516)
+ + .. ......+++. .....+..+...+.-+ .+..+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0 0 00 0111111111 1112222232222221 22234568
Q ss_pred eeCCCCCCCeEecCCCcEEEcccCcccc
Q 010186 473 VHRDLKASNVLLDSDMNSKISDFGMARI 500 (516)
Q Consensus 473 iHrDlk~~NILld~~~~~kl~DFGla~~ 500 (516)
||+|+.+.|||++++ ..+.||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999753 45899998763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.47 E-value=0.0034 Score=61.05 Aligned_cols=72 Identities=18% Similarity=0.265 Sum_probs=47.1
Q ss_pred ceeeecCcEeEEEEEecCC--------cEEEEEEeccCCccchHHHHHHHHHHhcCCCCCc-cceeeEEEeCCeeEEEEE
Q 010186 355 NILGQGGFGPVYKGVLSDG--------KEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVYE 425 (516)
Q Consensus 355 ~~Lg~G~fg~Vy~~~~~~g--------~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E 425 (516)
+.|+.|-.=.+|+....++ +.|.+++... . .......+|..+++.+.-.++ .++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 4577777788999886543 4566665542 2 233456688888888743344 477777642 68999
Q ss_pred ccCCCCh
Q 010186 426 FMPNGSL 432 (516)
Q Consensus 426 y~~~gsL 432 (516)
|+++..|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.54 E-value=0.62 Score=42.42 Aligned_cols=31 Identities=32% Similarity=0.357 Sum_probs=27.3
Q ss_pred CCCeeeCCCCCCCeEecCCCcEEEcccCccc
Q 010186 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499 (516)
Q Consensus 469 ~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 499 (516)
+.++||+|+.+.||+++.+...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 3459999999999999988877899999875
|